Mitch Report
Antony Kaspi & Mark Ziemann
date generated: 2024-08-16
Background
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Input profiles
Here is the first few lines of the input profile.
| x | |
|---|---|
| IFI6 | 7.165952 |
| PARP14 | 6.817516 |
| EPSTI1 | 6.723178 |
| IFI44L | 5.887858 |
| LY6E | 5.536140 |
| OAS1 | 5.457649 |
Here are some metrics about the input data profile:
| Profile metrics | |
|---|---|
| num_genesets | 10461 |
| num_genes_in_profile | 15135 |
| duplicated_genes_present | 0 |
| num_profile_genes_in_sets | 11528 |
| num_profile_genes_not_in_sets | 3607 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Input genesets
Here are some metrics about the gene sets used:
GMT file of genesets:| Gene sets metrics | |
|---|---|
| num_genesets | 10461 |
| num_genesets_excluded | 4513 |
| num_genesets_included | 5948 |
Differential pathway expression
Interactive enrichment scatterplot
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
Results table
Top N= 50 gene sets| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| GOMF TAP BINDING | 7 | 8.90e-06 | 0.969 | 1.09e-03 |
| GOBP POSITIVE REGULATION OF PYROPTOSIS | 5 | 1.57e-03 | 0.816 | 6.13e-02 |
| GOCC MHC CLASS I PROTEIN COMPLEX | 9 | 2.49e-05 | 0.811 | 2.49e-03 |
| GOBP CYTOLYSIS | 5 | 1.95e-03 | 0.800 | 7.24e-02 |
| GOMF STRUCTURAL CONSTITUENT OF EYE LENS | 5 | 2.01e-03 | -0.798 | 7.44e-02 |
| GOMF PYRUVATE DEHYDROGENASE ACETYL TRANSFERRING KINASE ACTIVITY | 5 | 2.18e-03 | -0.791 | 7.85e-02 |
| GOCC STEREOCILIUM BASE | 5 | 2.34e-03 | -0.786 | 8.20e-02 |
| GOBP MODULATION OF MICROTUBULE CYTOSKELETON INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION | 5 | 2.41e-03 | 0.784 | 8.33e-02 |
| GOBP RESPONSE TO MOLECULE OF FUNGAL ORIGIN | 5 | 3.25e-03 | 0.760 | 1.04e-01 |
| GOCC EKC KEOPS COMPLEX | 5 | 3.26e-03 | -0.760 | 1.04e-01 |
| GOMF CCR1 CHEMOKINE RECEPTOR BINDING | 5 | 3.74e-03 | -0.749 | 1.14e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL CHEMOTAXIS | 5 | 3.86e-03 | -0.746 | 1.15e-01 |
| GOBP REGULATION OF ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE | 8 | 3.51e-04 | 0.730 | 1.97e-02 |
| GOMF NEUROPEPTIDE RECEPTOR ACTIVITY | 5 | 5.34e-03 | -0.719 | 1.37e-01 |
| GOBP INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY | 7 | 1.12e-03 | 0.711 | 4.74e-02 |
| GOBP ISG15 PROTEIN CONJUGATION | 6 | 2.68e-03 | 0.708 | 8.95e-02 |
| GOMF OXALATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 6.44e-03 | -0.704 | 1.53e-01 |
| GOMF CXCR CHEMOKINE RECEPTOR BINDING | 6 | 3.35e-03 | -0.692 | 1.06e-01 |
| GOBP UREA CYCLE | 5 | 8.00e-03 | -0.685 | 1.76e-01 |
| GOBP UREA METABOLIC PROCESS | 5 | 8.00e-03 | -0.685 | 1.76e-01 |
| GOCC RIPOPTOSOME | 6 | 3.78e-03 | 0.683 | 1.14e-01 |
| GOMF NADPLUS PROTEIN CYSTEINE ADP RIBOSYLTRANSFERASE ACTIVITY | 6 | 3.83e-03 | 0.682 | 1.15e-01 |
| GOBP REGULATION OF CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION | 5 | 8.67e-03 | 0.678 | 1.84e-01 |
| GOBP PROTECTION FROM NATURAL KILLER CELL MEDIATED CYTOTOXICITY | 5 | 9.10e-03 | 0.674 | 1.88e-01 |
| GOBP POSITIVE REGULATION OF URINE VOLUME | 5 | 9.32e-03 | -0.671 | 1.90e-01 |
| GOBP REGULATION OF 3 UTR MEDIATED MRNA STABILIZATION | 5 | 9.84e-03 | 0.667 | 1.96e-01 |
| GOBP REGULATION OF FLAGELLATED SPERM MOTILITY | 5 | 1.02e-02 | -0.663 | 2.02e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE SATELLITE CELL PROLIFERATION | 6 | 5.00e-03 | 0.662 | 1.32e-01 |
| GOBP GOLGI DISASSEMBLY | 6 | 5.21e-03 | 0.659 | 1.35e-01 |
| GOCC CYTOSOLIC SMALL RIBOSOMAL SUBUNIT | 38 | 2.44e-12 | -0.657 | 2.12e-09 |
| GOBP REGULATION OF ACYL COA BIOSYNTHETIC PROCESS | 5 | 1.11e-02 | -0.656 | 2.12e-01 |
| GOBP ZINC ION IMPORT ACROSS PLASMA MEMBRANE | 8 | 1.38e-03 | -0.653 | 5.47e-02 |
| GOBP CYTIDINE TO URIDINE EDITING | 7 | 2.84e-03 | 0.651 | 9.37e-02 |
| GOCC CD95 DEATH INDUCING SIGNALING COMPLEX | 6 | 6.07e-03 | 0.647 | 1.47e-01 |
| GOBP 5 PHOSPHORIBOSE 1 DIPHOSPHATE METABOLIC PROCESS | 5 | 1.27e-02 | -0.644 | 2.33e-01 |
| GOCC CYTOSOLIC LARGE RIBOSOMAL SUBUNIT | 55 | 2.57e-16 | -0.638 | 3.18e-13 |
| GOBP REGULATION OF NATURAL KILLER CELL DIFFERENTIATION | 9 | 1.04e-03 | 0.631 | 4.53e-02 |
| GOBP POSITIVE REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 11 | 2.94e-04 | 0.630 | 1.75e-02 |
| GOCC MHC PROTEIN COMPLEX | 21 | 5.91e-07 | 0.629 | 1.12e-04 |
| GOBP DNA CYTOSINE DEAMINATION | 7 | 4.05e-03 | 0.627 | 1.18e-01 |
| GOMF DEOXYCYTIDINE DEAMINASE ACTIVITY | 7 | 4.29e-03 | 0.623 | 1.22e-01 |
| GOBP CYTIDINE METABOLIC PROCESS | 8 | 2.33e-03 | 0.622 | 8.19e-02 |
| GOMF CYTIDINE DEAMINASE ACTIVITY | 8 | 2.33e-03 | 0.622 | 8.19e-02 |
| GOCC KNL1 SPC105 COMPLEX | 5 | 1.63e-02 | 0.620 | 2.72e-01 |
| GOMF BETA N ACETYLHEXOSAMINIDASE ACTIVITY | 5 | 1.68e-02 | 0.617 | 2.72e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN | 19 | 3.26e-06 | 0.617 | 5.06e-04 |
| GOBP INNER DYNEIN ARM ASSEMBLY | 6 | 9.22e-03 | -0.614 | 1.89e-01 |
| GOCC MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX III | 13 | 1.48e-04 | -0.608 | 1.04e-02 |
| GOMF ARMADILLO REPEAT DOMAIN BINDING | 7 | 5.58e-03 | 0.605 | 1.39e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C | 13 | 1.78e-04 | -0.600 | 1.20e-02 |
Results (complete table)
Click HERE to show results for all gene sets
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| GOMF TAP BINDING | 7 | 8.90e-06 | 9.69e-01 | 1.09e-03 |
| GOBP POSITIVE REGULATION OF PYROPTOSIS | 5 | 1.57e-03 | 8.16e-01 | 6.13e-02 |
| GOCC MHC CLASS I PROTEIN COMPLEX | 9 | 2.49e-05 | 8.11e-01 | 2.49e-03 |
| GOBP CYTOLYSIS | 5 | 1.95e-03 | 8.00e-01 | 7.24e-02 |
| GOMF STRUCTURAL CONSTITUENT OF EYE LENS | 5 | 2.01e-03 | -7.98e-01 | 7.44e-02 |
| GOMF PYRUVATE DEHYDROGENASE ACETYL TRANSFERRING KINASE ACTIVITY | 5 | 2.18e-03 | -7.91e-01 | 7.85e-02 |
| GOCC STEREOCILIUM BASE | 5 | 2.34e-03 | -7.86e-01 | 8.20e-02 |
| GOBP MODULATION OF MICROTUBULE CYTOSKELETON INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION | 5 | 2.41e-03 | 7.84e-01 | 8.33e-02 |
| GOBP RESPONSE TO MOLECULE OF FUNGAL ORIGIN | 5 | 3.25e-03 | 7.60e-01 | 1.04e-01 |
| GOCC EKC KEOPS COMPLEX | 5 | 3.26e-03 | -7.60e-01 | 1.04e-01 |
| GOMF CCR1 CHEMOKINE RECEPTOR BINDING | 5 | 3.74e-03 | -7.49e-01 | 1.14e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL CHEMOTAXIS | 5 | 3.86e-03 | -7.46e-01 | 1.15e-01 |
| GOBP REGULATION OF ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE | 8 | 3.51e-04 | 7.30e-01 | 1.97e-02 |
| GOMF NEUROPEPTIDE RECEPTOR ACTIVITY | 5 | 5.34e-03 | -7.19e-01 | 1.37e-01 |
| GOBP INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY | 7 | 1.12e-03 | 7.11e-01 | 4.74e-02 |
| GOBP ISG15 PROTEIN CONJUGATION | 6 | 2.68e-03 | 7.08e-01 | 8.95e-02 |
| GOMF OXALATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 6.44e-03 | -7.04e-01 | 1.53e-01 |
| GOMF CXCR CHEMOKINE RECEPTOR BINDING | 6 | 3.35e-03 | -6.92e-01 | 1.06e-01 |
| GOBP UREA CYCLE | 5 | 8.00e-03 | -6.85e-01 | 1.76e-01 |
| GOBP UREA METABOLIC PROCESS | 5 | 8.00e-03 | -6.85e-01 | 1.76e-01 |
| GOCC RIPOPTOSOME | 6 | 3.78e-03 | 6.83e-01 | 1.14e-01 |
| GOMF NADPLUS PROTEIN CYSTEINE ADP RIBOSYLTRANSFERASE ACTIVITY | 6 | 3.83e-03 | 6.82e-01 | 1.15e-01 |
| GOBP REGULATION OF CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION | 5 | 8.67e-03 | 6.78e-01 | 1.84e-01 |
| GOBP PROTECTION FROM NATURAL KILLER CELL MEDIATED CYTOTOXICITY | 5 | 9.10e-03 | 6.74e-01 | 1.88e-01 |
| GOBP POSITIVE REGULATION OF URINE VOLUME | 5 | 9.32e-03 | -6.71e-01 | 1.90e-01 |
| GOBP REGULATION OF 3 UTR MEDIATED MRNA STABILIZATION | 5 | 9.84e-03 | 6.67e-01 | 1.96e-01 |
| GOBP REGULATION OF FLAGELLATED SPERM MOTILITY | 5 | 1.02e-02 | -6.63e-01 | 2.02e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE SATELLITE CELL PROLIFERATION | 6 | 5.00e-03 | 6.62e-01 | 1.32e-01 |
| GOBP GOLGI DISASSEMBLY | 6 | 5.21e-03 | 6.59e-01 | 1.35e-01 |
| GOCC CYTOSOLIC SMALL RIBOSOMAL SUBUNIT | 38 | 2.44e-12 | -6.57e-01 | 2.12e-09 |
| GOBP REGULATION OF ACYL COA BIOSYNTHETIC PROCESS | 5 | 1.11e-02 | -6.56e-01 | 2.12e-01 |
| GOBP ZINC ION IMPORT ACROSS PLASMA MEMBRANE | 8 | 1.38e-03 | -6.53e-01 | 5.47e-02 |
| GOBP CYTIDINE TO URIDINE EDITING | 7 | 2.84e-03 | 6.51e-01 | 9.37e-02 |
| GOCC CD95 DEATH INDUCING SIGNALING COMPLEX | 6 | 6.07e-03 | 6.47e-01 | 1.47e-01 |
| GOBP 5 PHOSPHORIBOSE 1 DIPHOSPHATE METABOLIC PROCESS | 5 | 1.27e-02 | -6.44e-01 | 2.33e-01 |
| GOCC CYTOSOLIC LARGE RIBOSOMAL SUBUNIT | 55 | 2.57e-16 | -6.38e-01 | 3.18e-13 |
| GOBP REGULATION OF NATURAL KILLER CELL DIFFERENTIATION | 9 | 1.04e-03 | 6.31e-01 | 4.53e-02 |
| GOBP POSITIVE REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 11 | 2.94e-04 | 6.30e-01 | 1.75e-02 |
| GOCC MHC PROTEIN COMPLEX | 21 | 5.91e-07 | 6.29e-01 | 1.12e-04 |
| GOBP DNA CYTOSINE DEAMINATION | 7 | 4.05e-03 | 6.27e-01 | 1.18e-01 |
| GOMF DEOXYCYTIDINE DEAMINASE ACTIVITY | 7 | 4.29e-03 | 6.23e-01 | 1.22e-01 |
| GOBP CYTIDINE METABOLIC PROCESS | 8 | 2.33e-03 | 6.22e-01 | 8.19e-02 |
| GOMF CYTIDINE DEAMINASE ACTIVITY | 8 | 2.33e-03 | 6.22e-01 | 8.19e-02 |
| GOCC KNL1 SPC105 COMPLEX | 5 | 1.63e-02 | 6.20e-01 | 2.72e-01 |
| GOMF BETA N ACETYLHEXOSAMINIDASE ACTIVITY | 5 | 1.68e-02 | 6.17e-01 | 2.72e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN | 19 | 3.26e-06 | 6.17e-01 | 5.06e-04 |
| GOBP INNER DYNEIN ARM ASSEMBLY | 6 | 9.22e-03 | -6.14e-01 | 1.89e-01 |
| GOCC MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX III | 13 | 1.48e-04 | -6.08e-01 | 1.04e-02 |
| GOMF ARMADILLO REPEAT DOMAIN BINDING | 7 | 5.58e-03 | 6.05e-01 | 1.39e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C | 13 | 1.78e-04 | -6.00e-01 | 1.20e-02 |
| GOBP RESPONSE TO SELENIUM ION | 5 | 2.03e-02 | -5.99e-01 | 2.96e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS IB | 12 | 3.29e-04 | 5.99e-01 | 1.87e-02 |
| GOMF 5 3 DNA HELICASE ACTIVITY | 8 | 3.63e-03 | 5.94e-01 | 1.12e-01 |
| GOBP REGULATION OF WNT PROTEIN SECRETION | 5 | 2.15e-02 | -5.94e-01 | 3.06e-01 |
| GOBP CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION | 6 | 1.18e-02 | 5.93e-01 | 2.21e-01 |
| GOBP PROTEIN POLY ADP RIBOSYLATION | 10 | 1.16e-03 | 5.93e-01 | 4.87e-02 |
| GOMF DIPHOSPHOTRANSFERASE ACTIVITY | 5 | 2.18e-02 | -5.92e-01 | 3.07e-01 |
| GOMF UBIQUINOL CYTOCHROME C REDUCTASE ACTIVITY | 6 | 1.20e-02 | -5.92e-01 | 2.23e-01 |
| GOBP IRON IMPORT INTO CELL | 5 | 2.19e-02 | -5.92e-01 | 3.07e-01 |
| GOMF UDP GALACTOSE BETA N ACETYLGLUCOSAMINE BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY | 5 | 2.19e-02 | 5.92e-01 | 3.07e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL DIFFERENTIATION | 8 | 3.75e-03 | 5.92e-01 | 1.14e-01 |
| GOMF IMMUNOGLOBULIN RECEPTOR BINDING | 5 | 2.21e-02 | -5.91e-01 | 3.07e-01 |
| GOBP POSITIVE REGULATION OF RIG I SIGNALING PATHWAY | 8 | 4.09e-03 | 5.86e-01 | 1.18e-01 |
| GOBP CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION | 8 | 4.09e-03 | -5.86e-01 | 1.18e-01 |
| GOBP POSITIVE REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY | 5 | 2.37e-02 | 5.84e-01 | 3.18e-01 |
| GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS | 5 | 2.39e-02 | -5.83e-01 | 3.19e-01 |
| GOMF HISTONE H3K27 METHYLTRANSFERASE ACTIVITY | 6 | 1.34e-02 | 5.83e-01 | 2.41e-01 |
| GOBP EOSINOPHIL MIGRATION | 17 | 3.15e-05 | -5.83e-01 | 2.94e-03 |
| GOMF GLYCINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 2.45e-02 | -5.81e-01 | 3.23e-01 |
| GOCC SIGNAL PEPTIDASE COMPLEX | 5 | 2.46e-02 | -5.81e-01 | 3.23e-01 |
| GOBP BASE CONVERSION OR SUBSTITUTION EDITING | 11 | 9.41e-04 | 5.76e-01 | 4.14e-02 |
| GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR | 6 | 1.50e-02 | -5.73e-01 | 2.59e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR | 5 | 2.71e-02 | -5.71e-01 | 3.35e-01 |
| GOBP EMBRYONIC CLEAVAGE | 7 | 8.99e-03 | 5.70e-01 | 1.87e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE ADAPTATION | 5 | 2.74e-02 | 5.70e-01 | 3.37e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE ADAPTATION | 5 | 2.74e-02 | 5.70e-01 | 3.37e-01 |
| GOBP REGULATION OF MITOCHONDRIAL TRANSCRIPTION | 5 | 2.75e-02 | -5.69e-01 | 3.37e-01 |
| GOCC DEATH INDUCING SIGNALING COMPLEX | 9 | 3.12e-03 | 5.69e-01 | 1.01e-01 |
| GOMF CHEMOKINE ACTIVITY | 22 | 4.08e-06 | -5.67e-01 | 5.91e-04 |
| GOBP OXALATE TRANSPORT | 6 | 1.61e-02 | -5.67e-01 | 2.70e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS | 11 | 1.15e-03 | 5.66e-01 | 4.83e-02 |
| GOBP BRADYKININ CATABOLIC PROCESS | 6 | 1.63e-02 | 5.66e-01 | 2.72e-01 |
| GOBP POSITIVE REGULATION OF STEROID HORMONE SECRETION | 5 | 2.86e-02 | -5.65e-01 | 3.46e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITE DEVELOPMENT | 5 | 2.89e-02 | 5.64e-01 | 3.47e-01 |
| GOBP ACTIN CROSSLINK FORMATION | 11 | 1.21e-03 | -5.63e-01 | 4.99e-02 |
| GOBP REGULATION OF METAPHASE PLATE CONGRESSION | 13 | 4.47e-04 | 5.62e-01 | 2.40e-02 |
| GOBP DETECTION OF VIRUS | 5 | 3.02e-02 | 5.60e-01 | 3.52e-01 |
| GOBP CLEARANCE OF FOREIGN INTRACELLULAR NUCLEIC ACIDS | 5 | 3.02e-02 | 5.60e-01 | 3.52e-01 |
| GOMF BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY | 7 | 1.05e-02 | 5.59e-01 | 2.05e-01 |
| GOMF DOLICHYL DIPHOSPHOOLIGOSACCHARIDE PROTEIN GLYCOTRANSFERASE ACTIVITY | 5 | 3.05e-02 | -5.59e-01 | 3.53e-01 |
| GOBP GLOMERULUS MORPHOGENESIS | 5 | 3.06e-02 | -5.59e-01 | 3.53e-01 |
| GOBP UTP BIOSYNTHETIC PROCESS | 8 | 6.36e-03 | -5.57e-01 | 1.52e-01 |
| GOCC CYTOSOLIC RIBOSOME | 110 | 9.09e-24 | -5.54e-01 | 7.90e-20 |
| GOBP DISACCHARIDE METABOLIC PROCESS | 6 | 1.88e-02 | 5.54e-01 | 2.87e-01 |
| GOMF DOUBLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY | 6 | 1.92e-02 | -5.52e-01 | 2.89e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE BINDING | 12 | 9.37e-04 | -5.52e-01 | 4.14e-02 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A HEME GROUP OF DONORS | 14 | 3.65e-04 | -5.50e-01 | 2.02e-02 |
| GOMF UBIQUITIN LIGASE INHIBITOR ACTIVITY | 8 | 7.25e-03 | -5.48e-01 | 1.66e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 12 | 1.01e-03 | -5.48e-01 | 4.42e-02 |
| GOCC CYTOCHROME COMPLEX | 32 | 8.66e-08 | -5.47e-01 | 1.93e-05 |
| GOBP REGULATION OF URINE VOLUME | 8 | 7.49e-03 | -5.46e-01 | 1.70e-01 |
| GOBP GLYCEROL 3 PHOSPHATE METABOLIC PROCESS | 8 | 7.60e-03 | 5.45e-01 | 1.71e-01 |
| GOBP LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL | 5 | 3.50e-02 | -5.44e-01 | 3.81e-01 |
| GOBP ALDITOL PHOSPHATE METABOLIC PROCESS | 11 | 1.78e-03 | 5.44e-01 | 6.71e-02 |
| GOBP PHARYNGEAL ARCH ARTERY MORPHOGENESIS | 5 | 3.54e-02 | 5.43e-01 | 3.82e-01 |
| GOBP CARDIAC VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION | 5 | 3.54e-02 | -5.43e-01 | 3.82e-01 |
| GOBP MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 5 | 3.55e-02 | 5.43e-01 | 3.82e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN | 24 | 4.25e-06 | 5.42e-01 | 6.05e-04 |
| GOMF PROTEIN KINASE C ACTIVITY | 12 | 1.17e-03 | 5.41e-01 | 4.88e-02 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 6 | 2.18e-02 | 5.41e-01 | 3.07e-01 |
| GOBP METANEPHRIC MESENCHYME DEVELOPMENT | 6 | 2.20e-02 | 5.40e-01 | 3.07e-01 |
| GOBP PEPTIDYL LYSINE HYDROXYLATION | 5 | 3.66e-02 | 5.40e-01 | 3.90e-01 |
| GOMF HISTONE H3K9 DEMETHYLASE ACTIVITY | 11 | 1.94e-03 | 5.40e-01 | 7.24e-02 |
| GOBP CELL MIGRATION INVOLVED IN GASTRULATION | 5 | 3.69e-02 | -5.39e-01 | 3.91e-01 |
| GOBP NATURAL KILLER CELL CHEMOTAXIS | 7 | 1.36e-02 | -5.39e-01 | 2.44e-01 |
| GOBP BASEMENT MEMBRANE ASSEMBLY | 5 | 3.79e-02 | 5.36e-01 | 3.97e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 11 | 2.11e-03 | 5.35e-01 | 7.70e-02 |
| GOBP REGULATION OF DNA DIRECTED DNA POLYMERASE ACTIVITY | 9 | 5.50e-03 | -5.34e-01 | 1.38e-01 |
| GOBP BONE MARROW DEVELOPMENT | 8 | 8.89e-03 | -5.34e-01 | 1.87e-01 |
| GOBP NEUTROPHIL APOPTOTIC PROCESS | 5 | 3.94e-02 | 5.32e-01 | 4.07e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 5 | 3.95e-02 | 5.32e-01 | 4.07e-01 |
| GOCC MHC CLASS II PROTEIN COMPLEX | 13 | 9.43e-04 | 5.30e-01 | 4.14e-02 |
| GOBP REGULATION OF GROWTH HORMONE RECEPTOR SIGNALING PATHWAY | 6 | 2.47e-02 | 5.29e-01 | 3.23e-01 |
| GOBP NADH OXIDATION | 5 | 4.05e-02 | 5.29e-01 | 4.11e-01 |
| GOBP REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS | 7 | 1.54e-02 | -5.29e-01 | 2.61e-01 |
| GOMF NADPLUS PROTEIN ADP RIBOSYLTRANSFERASE ACTIVITY | 24 | 7.59e-06 | 5.28e-01 | 9.84e-04 |
| GOBP UTP METABOLIC PROCESS | 10 | 3.87e-03 | -5.27e-01 | 1.15e-01 |
| GOBP CELL MOTILITY INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION | 7 | 1.57e-02 | 5.27e-01 | 2.65e-01 |
| GOBP TOXIN TRANSPORT | 6 | 2.54e-02 | -5.27e-01 | 3.29e-01 |
| GOBP WNT PROTEIN SECRETION | 6 | 2.56e-02 | -5.26e-01 | 3.30e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS OXYGEN AS ACCEPTOR | 10 | 3.97e-03 | -5.26e-01 | 1.17e-01 |
| GOBP DORSAL VENTRAL AXIS SPECIFICATION | 6 | 2.59e-02 | 5.25e-01 | 3.31e-01 |
| GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC CLASS II PROTEIN COMPLEX | 12 | 1.66e-03 | 5.24e-01 | 6.41e-02 |
| GOBP LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS | 5 | 4.27e-02 | -5.23e-01 | 4.23e-01 |
| GOBP RESPONSE TO INTERLEUKIN 15 | 10 | 4.17e-03 | 5.23e-01 | 1.19e-01 |
| GOMF D1 DOPAMINE RECEPTOR BINDING | 5 | 4.28e-02 | -5.23e-01 | 4.23e-01 |
| GOMF CASPASE BINDING | 8 | 1.06e-02 | 5.22e-01 | 2.07e-01 |
| GOBP NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY | 6 | 2.71e-02 | 5.21e-01 | 3.35e-01 |
| GOCC UBIQUINONE BIOSYNTHESIS COMPLEX | 6 | 2.72e-02 | -5.21e-01 | 3.36e-01 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING COMPRESSION RESISTANCE | 7 | 1.72e-02 | -5.20e-01 | 2.74e-01 |
| GOBP REGULATION OF RELAXATION OF MUSCLE | 5 | 4.45e-02 | 5.19e-01 | 4.29e-01 |
| GOBP DNA REPLICATION SYNTHESIS OF RNA PRIMER | 7 | 1.78e-02 | 5.17e-01 | 2.81e-01 |
| GOBP DETECTION OF BACTERIUM | 10 | 4.63e-03 | 5.17e-01 | 1.28e-01 |
| GOBP URETER DEVELOPMENT | 5 | 4.59e-02 | -5.16e-01 | 4.34e-01 |
| GOBP POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION | 18 | 1.54e-04 | 5.15e-01 | 1.05e-02 |
| GOBP MDA 5 SIGNALING PATHWAY | 10 | 4.81e-03 | 5.15e-01 | 1.29e-01 |
| GOBP MONOCYTE EXTRAVASATION | 6 | 2.90e-02 | 5.15e-01 | 3.48e-01 |
| GOMF OLIGOSACCHARYL TRANSFERASE ACTIVITY | 6 | 2.93e-02 | -5.14e-01 | 3.49e-01 |
| GOBP REGULATION OF HYDROGEN PEROXIDE MEDIATED PROGRAMMED CELL DEATH | 7 | 1.87e-02 | -5.13e-01 | 2.87e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON DIPHENOLS AND RELATED SUBSTANCES AS DONORS | 8 | 1.20e-02 | -5.13e-01 | 2.23e-01 |
| GOCC TRAMP COMPLEX | 5 | 4.70e-02 | 5.13e-01 | 4.41e-01 |
| GOCC BOX C D RNP COMPLEX | 5 | 4.81e-02 | -5.10e-01 | 4.45e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 6 | 3.08e-02 | -5.09e-01 | 3.54e-01 |
| GOBP MITOCHONDRIAL TRANSLATIONAL ELONGATION | 5 | 4.87e-02 | -5.09e-01 | 4.46e-01 |
| GOBP RESPONSE TO INTERFERON BETA | 25 | 1.10e-05 | 5.08e-01 | 1.29e-03 |
| GOBP NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 5 | 4.92e-02 | 5.08e-01 | 4.46e-01 |
| GOBP NEGATIVE REGULATION OF TRANSLATIONAL ELONGATION | 5 | 4.92e-02 | 5.08e-01 | 4.46e-01 |
| GOMF LARGE RIBOSOMAL SUBUNIT RRNA BINDING | 5 | 4.93e-02 | -5.08e-01 | 4.46e-01 |
| GOMF MINOR GROOVE OF ADENINE THYMINE RICH DNA BINDING | 5 | 4.93e-02 | -5.08e-01 | 4.46e-01 |
| GOMF BICARBONATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 18 | 1.93e-04 | -5.08e-01 | 1.27e-02 |
| GOBP REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION | 8 | 1.30e-02 | 5.07e-01 | 2.38e-01 |
| GOBP POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE | 7 | 2.03e-02 | 5.07e-01 | 2.96e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 9 | 8.51e-03 | 5.06e-01 | 1.82e-01 |
| GOCC LUMENAL SIDE OF ENDOPLASMIC RETICULUM MEMBRANE | 23 | 3.01e-05 | 5.03e-01 | 2.85e-03 |
| GOMF HISTONE H3K9ME2 METHYLTRANSFERASE ACTIVITY | 6 | 3.31e-02 | 5.02e-01 | 3.72e-01 |
| GOBP SYNAPSE PRUNING | 8 | 1.39e-02 | -5.02e-01 | 2.48e-01 |
| GOBP POSITIVE REGULATION OF TAU PROTEIN KINASE ACTIVITY | 5 | 5.20e-02 | -5.02e-01 | 4.58e-01 |
| GOCC RESPIRATORY CHAIN COMPLEX IV | 20 | 1.04e-04 | -5.01e-01 | 7.80e-03 |
| GOBP MITOCHONDRIAL RESPIRASOME ASSEMBLY | 8 | 1.43e-02 | -5.00e-01 | 2.52e-01 |
| GOMF BETA 2 MICROGLOBULIN BINDING | 8 | 1.43e-02 | 5.00e-01 | 2.52e-01 |
| GOMF G PROTEIN BETA SUBUNIT BINDING | 9 | 9.64e-03 | -4.98e-01 | 1.94e-01 |
| GOBP MITOCHONDRIAL PROTEIN CATABOLIC PROCESS | 6 | 3.47e-02 | 4.98e-01 | 3.80e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB | 17 | 3.80e-04 | 4.98e-01 | 2.08e-02 |
| GOBP POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY | 25 | 1.70e-05 | 4.97e-01 | 1.80e-03 |
| GOMF GAMMA CATENIN BINDING | 5 | 5.44e-02 | 4.97e-01 | 4.62e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION | 5 | 5.47e-02 | 4.96e-01 | 4.63e-01 |
| GOCC COMMITMENT COMPLEX | 5 | 5.50e-02 | 4.96e-01 | 4.63e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL DIFFERENTIATION | 6 | 3.56e-02 | -4.95e-01 | 3.83e-01 |
| GOBP REGULATION OF CILIUM DEPENDENT CELL MOTILITY | 11 | 4.47e-03 | -4.95e-01 | 1.25e-01 |
| GOCC NUCLEAR PORE CENTRAL TRANSPORT CHANNEL | 6 | 3.60e-02 | -4.94e-01 | 3.86e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT ASSEMBLY | 15 | 9.38e-04 | -4.93e-01 | 4.14e-02 |
| GOCC CTF18 RFC LIKE COMPLEX | 7 | 2.39e-02 | -4.93e-01 | 3.19e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGOSOME MATURATION | 6 | 3.67e-02 | 4.92e-01 | 3.90e-01 |
| GOBP NEGATIVE REGULATION OF PLASMINOGEN ACTIVATION | 5 | 5.67e-02 | -4.92e-01 | 4.70e-01 |
| GOMF ATP GATED ION CHANNEL ACTIVITY | 6 | 3.69e-02 | 4.92e-01 | 3.91e-01 |
| GOCC RAGULATOR COMPLEX | 5 | 5.73e-02 | -4.91e-01 | 4.70e-01 |
| GOMF THIOL OXIDASE ACTIVITY | 6 | 3.74e-02 | -4.91e-01 | 3.94e-01 |
| GOBP DNA LIGATION INVOLVED IN DNA REPAIR | 5 | 5.75e-02 | 4.91e-01 | 4.70e-01 |
| GOMF CCR CHEMOKINE RECEPTOR BINDING | 18 | 3.15e-04 | -4.90e-01 | 1.84e-02 |
| GOBP TRANSFORMING GROWTH FACTOR BETA2 PRODUCTION | 6 | 3.75e-02 | 4.90e-01 | 3.95e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION | 8 | 1.65e-02 | 4.90e-01 | 2.72e-01 |
| GOBP NEGATIVE REGULATION OF COLLATERAL SPROUTING | 6 | 3.79e-02 | -4.89e-01 | 3.97e-01 |
| GOMF DOUBLE STRANDED TELOMERIC DNA BINDING | 9 | 1.12e-02 | -4.88e-01 | 2.13e-01 |
| GOMF SECONDARY ACTIVE SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 1.69e-02 | -4.88e-01 | 2.72e-01 |
| GOMF RDNA BINDING | 9 | 1.15e-02 | -4.86e-01 | 2.17e-01 |
| GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION | 11 | 5.22e-03 | 4.86e-01 | 1.35e-01 |
| GOBP PRIMARY ALCOHOL CATABOLIC PROCESS | 7 | 2.59e-02 | 4.86e-01 | 3.31e-01 |
| GOBP MAINTENANCE OF LENS TRANSPARENCY | 6 | 3.92e-02 | 4.86e-01 | 4.05e-01 |
| GOBP CADMIUM ION TRANSMEMBRANE TRANSPORT | 5 | 6.00e-02 | -4.86e-01 | 4.79e-01 |
| GOBP SECRETION OF LYSOSOMAL ENZYMES | 7 | 2.64e-02 | -4.85e-01 | 3.31e-01 |
| GOBP PROTEIN AUTO ADP RIBOSYLATION | 11 | 5.43e-03 | 4.84e-01 | 1.37e-01 |
| GOBP ALDITOL CATABOLIC PROCESS | 6 | 4.00e-02 | 4.84e-01 | 4.09e-01 |
| GOBP SMOOTH MUSCLE CELL CHEMOTAXIS | 5 | 6.11e-02 | -4.84e-01 | 4.84e-01 |
| GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 10 | 8.22e-03 | -4.83e-01 | 1.78e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL GENOME REPLICATION | 45 | 2.16e-08 | 4.82e-01 | 6.06e-06 |
| GOBP OUTER MITOCHONDRIAL MEMBRANE ORGANIZATION | 15 | 1.22e-03 | -4.82e-01 | 5.00e-02 |
| GOBP NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS | 8 | 1.82e-02 | 4.82e-01 | 2.84e-01 |
| GOBP REGULATION OF STORE OPERATED CALCIUM CHANNEL ACTIVITY | 5 | 6.20e-02 | 4.82e-01 | 4.87e-01 |
| GOBP TRNA THREONYLCARBAMOYLADENOSINE MODIFICATION | 5 | 6.25e-02 | -4.81e-01 | 4.87e-01 |
| GOMF ADENYLATE CYCLASE BINDING | 6 | 4.14e-02 | -4.81e-01 | 4.15e-01 |
| GOMF TRANSCRIPTION REGULATOR ACTIVATOR ACTIVITY | 5 | 6.27e-02 | 4.81e-01 | 4.88e-01 |
| GOBP DENDRITIC CELL APOPTOTIC PROCESS | 8 | 1.88e-02 | 4.80e-01 | 2.87e-01 |
| GOBP PROTEIN HISTIDYL MODIFICATION TO DIPHTHAMIDE | 6 | 4.20e-02 | -4.79e-01 | 4.19e-01 |
| GOCC MHC CLASS I PEPTIDE LOADING COMPLEX | 8 | 1.90e-02 | 4.79e-01 | 2.88e-01 |
| GOBP DETECTION OF OTHER ORGANISM | 12 | 4.07e-03 | 4.79e-01 | 1.18e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE ADAPTATION | 6 | 4.23e-02 | 4.79e-01 | 4.21e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION | 12 | 4.13e-03 | 4.78e-01 | 1.19e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS | 19 | 3.12e-04 | 4.78e-01 | 1.84e-02 |
| GOBP RIBONUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS | 6 | 4.29e-02 | 4.77e-01 | 4.23e-01 |
| GOCC OLIGOSACCHARYLTRANSFERASE COMPLEX | 12 | 4.33e-03 | -4.76e-01 | 1.23e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR KINASE ACTIVITY | 6 | 4.41e-02 | 4.75e-01 | 4.28e-01 |
| GOMF MHC CLASS II RECEPTOR ACTIVITY | 7 | 2.98e-02 | 4.74e-01 | 3.50e-01 |
| GOCC POLYSOMAL RIBOSOME | 30 | 7.11e-06 | -4.74e-01 | 9.55e-04 |
| GOBP POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 7 | 3.00e-02 | -4.74e-01 | 3.52e-01 |
| GOBP CYTOPLASMIC TRANSLATION | 145 | 8.81e-23 | -4.73e-01 | 3.83e-19 |
| GOMF HISTONE H3K36 METHYLTRANSFERASE ACTIVITY | 11 | 6.68e-03 | 4.72e-01 | 1.57e-01 |
| GOMF NADPLUS NUCLEOSIDASE ACTIVITY | 10 | 1.01e-02 | 4.70e-01 | 2.00e-01 |
| GOCC CHROMOSOME PASSENGER COMPLEX | 6 | 4.67e-02 | 4.69e-01 | 4.39e-01 |
| GOBP ETHANOL CATABOLIC PROCESS | 6 | 4.68e-02 | 4.69e-01 | 4.40e-01 |
| GOBP ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE | 10 | 1.04e-02 | -4.68e-01 | 2.05e-01 |
| GOBP REGULATION OF MYOFIBROBLAST DIFFERENTIATION | 6 | 4.77e-02 | -4.67e-01 | 4.43e-01 |
| GOBP LACTATE TRANSMEMBRANE TRANSPORT | 5 | 7.07e-02 | -4.67e-01 | 5.17e-01 |
| GOBP SULFATE TRANSPORT | 11 | 7.52e-03 | -4.65e-01 | 1.70e-01 |
| GOBP DNA METHYLATION ON CYTOSINE | 5 | 7.16e-02 | -4.65e-01 | 5.17e-01 |
| GOBP BICARBONATE TRANSPORT | 20 | 3.16e-04 | -4.65e-01 | 1.84e-02 |
| GOBP ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE | 21 | 2.32e-04 | 4.64e-01 | 1.47e-02 |
| GOBP THERMOCEPTION | 6 | 4.90e-02 | 4.64e-01 | 4.46e-01 |
| GOBP GENITALIA MORPHOGENESIS | 5 | 7.26e-02 | 4.64e-01 | 5.21e-01 |
| GOBP T CELL CYTOKINE PRODUCTION | 24 | 8.67e-05 | 4.63e-01 | 6.89e-03 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION | 7 | 3.41e-02 | -4.63e-01 | 3.77e-01 |
| GOMF ATP DEPENDENT PROTEIN DISAGGREGASE ACTIVITY | 6 | 5.04e-02 | 4.61e-01 | 4.51e-01 |
| GOMF EXTRACELLULARLY ATP GATED MONOATOMIC CATION CHANNEL ACTIVITY | 5 | 7.43e-02 | 4.61e-01 | 5.24e-01 |
| GOMF GLUTATHIONE BINDING | 8 | 2.41e-02 | -4.61e-01 | 3.20e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT CYTOCHROME C TO OXYGEN | 19 | 5.28e-04 | -4.59e-01 | 2.68e-02 |
| GOCC INHIBITORY SYNAPSE | 5 | 7.57e-02 | 4.59e-01 | 5.29e-01 |
| GOMF PEPTIDE ANTIGEN BINDING | 30 | 1.45e-05 | 4.57e-01 | 1.60e-03 |
| GOBP RESPONSE TO INTERLEUKIN 2 | 6 | 5.36e-02 | 4.55e-01 | 4.61e-01 |
| GOBP REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 20 | 4.33e-04 | 4.55e-01 | 2.35e-02 |
| GOBP REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 6 | 5.38e-02 | 4.55e-01 | 4.61e-01 |
| GOBP PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE | 8 | 2.61e-02 | -4.54e-01 | 3.31e-01 |
| GOBP MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX ASSEMBLY | 8 | 2.63e-02 | -4.54e-01 | 3.31e-01 |
| GOCC AXON HILLOCK | 6 | 5.48e-02 | 4.53e-01 | 4.63e-01 |
| GOBP GLYOXYLATE METABOLIC PROCESS | 5 | 7.97e-02 | -4.53e-01 | 5.39e-01 |
| GOBP NEGATIVE REGULATION OF GLUCONEOGENESIS | 12 | 6.67e-03 | -4.52e-01 | 1.57e-01 |
| GOBP PROTEIN FOLDING IN ENDOPLASMIC RETICULUM | 11 | 9.48e-03 | -4.52e-01 | 1.92e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDINES | 25 | 9.70e-05 | 4.50e-01 | 7.46e-03 |
| GOBP GLYCINE TRANSPORT | 6 | 5.67e-02 | -4.49e-01 | 4.70e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 8 | 2.78e-02 | 4.49e-01 | 3.41e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 9 | 1.98e-02 | -4.49e-01 | 2.92e-01 |
| GOMF PYRIMIDINE NUCLEOTIDE BINDING | 6 | 5.76e-02 | -4.48e-01 | 4.70e-01 |
| GOMF POLY A SPECIFIC RIBONUCLEASE ACTIVITY | 12 | 7.31e-03 | 4.47e-01 | 1.67e-01 |
| GOBP MAST CELL CYTOKINE PRODUCTION | 5 | 8.34e-02 | 4.47e-01 | 5.45e-01 |
| GOBP REGULATION OF KILLING OF CELLS OF ANOTHER ORGANISM | 5 | 8.36e-02 | 4.47e-01 | 5.45e-01 |
| GOMF CALCIUM INDUCED CALCIUM RELEASE ACTIVITY | 5 | 8.39e-02 | 4.46e-01 | 5.46e-01 |
| GOBP GTP BIOSYNTHETIC PROCESS | 9 | 2.05e-02 | -4.46e-01 | 2.98e-01 |
| GOBP REGULATION OF TAU PROTEIN KINASE ACTIVITY | 8 | 2.91e-02 | -4.46e-01 | 3.48e-01 |
| GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 1 SIGNALING PATHWAY | 8 | 2.91e-02 | 4.45e-01 | 3.48e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS | 8 | 2.92e-02 | -4.45e-01 | 3.49e-01 |
| GOMF PROCOLLAGEN PROLINE DIOXYGENASE ACTIVITY | 6 | 5.91e-02 | -4.45e-01 | 4.76e-01 |
| GOCC MITOTIC COHESIN COMPLEX | 6 | 5.99e-02 | 4.44e-01 | 4.79e-01 |
| GOBP 4FE 4S CLUSTER ASSEMBLY | 5 | 8.60e-02 | -4.43e-01 | 5.53e-01 |
| GOMF STRUCTURAL CONSTITUENT OF RIBOSOME | 156 | 1.22e-21 | -4.43e-01 | 3.53e-18 |
| GOBP GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 10 | 1.53e-02 | -4.43e-01 | 2.60e-01 |
| GOBP MITOCHONDRIAL RNA CATABOLIC PROCESS | 6 | 6.03e-02 | 4.43e-01 | 4.80e-01 |
| GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA | 9 | 2.15e-02 | -4.43e-01 | 3.06e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION | 8 | 3.04e-02 | 4.42e-01 | 3.53e-01 |
| GOBP PLANAR CELL POLARITY PATHWAY INVOLVED IN NEURAL TUBE CLOSURE | 5 | 8.72e-02 | -4.42e-01 | 5.57e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION | 16 | 2.26e-03 | 4.41e-01 | 8.06e-02 |
| GOBP FATTY ACYL COA CATABOLIC PROCESS | 6 | 6.21e-02 | -4.40e-01 | 4.87e-01 |
| GOMF ISOCITRATE DEHYDROGENASE NAD P PLUS ACTIVITY | 5 | 8.87e-02 | -4.40e-01 | 5.58e-01 |
| GOCC UNIPLEX COMPLEX | 5 | 8.96e-02 | 4.38e-01 | 5.59e-01 |
| GOMF ANAPHASE PROMOTING COMPLEX BINDING | 7 | 4.49e-02 | 4.38e-01 | 4.31e-01 |
| GOBP POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE | 10 | 1.65e-02 | 4.38e-01 | 2.72e-01 |
| GOBP REGULATION OF BASEMENT MEMBRANE ORGANIZATION | 9 | 2.30e-02 | 4.38e-01 | 3.12e-01 |
| GOMF SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 1.65e-02 | -4.38e-01 | 2.72e-01 |
| GOMF ATP DEPENDENT PEPTIDASE ACTIVITY | 7 | 4.53e-02 | 4.37e-01 | 4.31e-01 |
| GOBP REGULATION OF BILE ACID BIOSYNTHETIC PROCESS | 5 | 9.09e-02 | 4.37e-01 | 5.62e-01 |
| GOBP SIGNAL COMPLEX ASSEMBLY | 6 | 6.43e-02 | 4.36e-01 | 4.94e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITIC CELL APOPTOTIC PROCESS | 5 | 9.12e-02 | 4.36e-01 | 5.63e-01 |
| GOMF PYRIMIDINE NUCLEOBASE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 9.14e-02 | 4.36e-01 | 5.63e-01 |
| GOBP RESPONSE TO PROTOZOAN | 20 | 7.41e-04 | 4.36e-01 | 3.46e-02 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX CATALYTIC CORE F 1 | 6 | 6.50e-02 | -4.35e-01 | 4.98e-01 |
| GOBP L LYSINE TRANSPORT | 5 | 9.24e-02 | -4.35e-01 | 5.65e-01 |
| GOMF L LYSINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 9.24e-02 | -4.35e-01 | 5.65e-01 |
| GOBP COLLAGEN ACTIVATED SIGNALING PATHWAY | 10 | 1.73e-02 | 4.35e-01 | 2.75e-01 |
| GOBP ETHANOL METABOLIC PROCESS | 9 | 2.43e-02 | 4.33e-01 | 3.21e-01 |
| GOCC CONE PHOTORECEPTOR OUTER SEGMENT | 5 | 9.54e-02 | -4.31e-01 | 5.73e-01 |
| GOBP ESCRT COMPLEX DISASSEMBLY | 10 | 1.84e-02 | 4.31e-01 | 2.86e-01 |
| GOBP MITOCHONDRIAL ATP TRANSMEMBRANE TRANSPORT | 6 | 6.82e-02 | -4.30e-01 | 5.09e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 5 | 9.60e-02 | 4.30e-01 | 5.75e-01 |
| GOBP INTERLEUKIN 4 MEDIATED SIGNALING PATHWAY | 8 | 3.53e-02 | 4.30e-01 | 3.82e-01 |
| GOCC MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O | 11 | 1.37e-02 | -4.29e-01 | 2.44e-01 |
| GOBP REGULATION OF T CELL MEDIATED CYTOTOXICITY | 33 | 1.97e-05 | 4.29e-01 | 2.00e-03 |
| GOBP NEGATIVE REGULATION OF LOW DENSITY LIPOPROTEIN RECEPTOR ACTIVITY | 5 | 9.65e-02 | -4.29e-01 | 5.76e-01 |
| GOCC HISTONE PRE MRNA 3 END PROCESSING COMPLEX | 6 | 6.95e-02 | -4.28e-01 | 5.14e-01 |
| GOCC SMALL RIBOSOMAL SUBUNIT | 72 | 3.47e-10 | -4.28e-01 | 1.44e-07 |
| GOBP PENTOSE PHOSPHATE SHUNT NON OXIDATIVE BRANCH | 5 | 9.83e-02 | 4.27e-01 | 5.81e-01 |
| GOCC MEIOTIC SPINDLE | 10 | 1.95e-02 | 4.27e-01 | 2.91e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY | 6 | 7.05e-02 | 4.26e-01 | 5.17e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX | 14 | 5.75e-03 | -4.26e-01 | 1.42e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX EIF3M | 7 | 5.08e-02 | -4.26e-01 | 4.53e-01 |
| GOBP LATE ENDOSOME TO GOLGI TRANSPORT | 5 | 9.92e-02 | -4.26e-01 | 5.82e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY | 7 | 5.11e-02 | 4.26e-01 | 4.54e-01 |
| GOBP OVULATION | 7 | 5.12e-02 | -4.26e-01 | 4.54e-01 |
| GOBP COMMON MYELOID PROGENITOR CELL PROLIFERATION | 6 | 7.11e-02 | -4.25e-01 | 5.17e-01 |
| GOBP RENAL SODIUM ION ABSORPTION | 6 | 7.12e-02 | 4.25e-01 | 5.17e-01 |
| GOBP RENAL SODIUM ION TRANSPORT | 6 | 7.12e-02 | 4.25e-01 | 5.17e-01 |
| GOBP SUCCINYL COA CATABOLIC PROCESS | 6 | 7.13e-02 | -4.25e-01 | 5.17e-01 |
| GOCC MITOCHONDRIAL PERMEABILITY TRANSITION PORE COMPLEX | 6 | 7.14e-02 | -4.25e-01 | 5.17e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 8 | 3.75e-02 | 4.25e-01 | 3.95e-01 |
| GOBP PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES | 11 | 1.48e-02 | -4.24e-01 | 2.57e-01 |
| GOBP NEGATIVE REGULATION OF GLYCOGEN METABOLIC PROCESS | 5 | 1.00e-01 | -4.24e-01 | 5.84e-01 |
| GOBP INTRACELLULAR ZINC ION HOMEOSTASIS | 24 | 3.28e-04 | -4.24e-01 | 1.87e-02 |
| GOCC LUMENAL SIDE OF MEMBRANE | 31 | 4.53e-05 | 4.23e-01 | 4.05e-03 |
| GOBP POSITIVE REGULATION OF MEMORY T CELL DIFFERENTIATION | 5 | 1.02e-01 | 4.23e-01 | 5.87e-01 |
| GOBP PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX | 19 | 1.46e-03 | -4.22e-01 | 5.73e-02 |
| GOBP PROTEIN LOCALIZATION TO CELL CORTEX | 8 | 3.91e-02 | 4.21e-01 | 4.05e-01 |
| GOBP SKELETAL MUSCLE SATELLITE CELL PROLIFERATION | 10 | 2.11e-02 | 4.21e-01 | 3.04e-01 |
| GOCC DNA REPLICATION FACTOR C COMPLEX | 5 | 1.03e-01 | -4.21e-01 | 5.92e-01 |
| GOBP RESPONSE TO INTERFERON ALPHA | 15 | 4.75e-03 | 4.21e-01 | 1.29e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT ASSEMBLY | 24 | 3.59e-04 | -4.21e-01 | 2.00e-02 |
| GOBP NEGATIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS | 6 | 7.43e-02 | -4.21e-01 | 5.24e-01 |
| GOBP MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 15 | 4.78e-03 | 4.21e-01 | 1.29e-01 |
| GOBP PYROPTOSIS | 27 | 1.58e-04 | 4.20e-01 | 1.07e-02 |
| GOBP FC EPSILON RECEPTOR SIGNALING PATHWAY | 22 | 6.71e-04 | 4.19e-01 | 3.23e-02 |
| GOBP MICROGLIAL CELL PROLIFERATION | 5 | 1.05e-01 | -4.18e-01 | 5.96e-01 |
| GOBP NK T CELL PROLIFERATION | 7 | 5.54e-02 | 4.18e-01 | 4.65e-01 |
| GOCC HAUS COMPLEX | 8 | 4.10e-02 | 4.17e-01 | 4.13e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL DEPOLARIZATION | 6 | 7.68e-02 | -4.17e-01 | 5.30e-01 |
| GOBP VIRAL TRANSLATIONAL TERMINATION REINITIATION | 5 | 1.07e-01 | -4.16e-01 | 5.96e-01 |
| GOBP CONNECTIVE TISSUE REPLACEMENT INVOLVED IN INFLAMMATORY RESPONSE WOUND HEALING | 5 | 1.07e-01 | 4.16e-01 | 5.96e-01 |
| GOBP OSMOSENSORY SIGNALING PATHWAY | 5 | 1.07e-01 | 4.16e-01 | 5.96e-01 |
| GOBP REGULATION OF BILE ACID METABOLIC PROCESS | 6 | 7.82e-02 | 4.15e-01 | 5.35e-01 |
| GOBP POSITIVE REGULATION OF SULFUR METABOLIC PROCESS | 5 | 1.08e-01 | 4.15e-01 | 5.99e-01 |
| GOMF EXCITATORY EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 10 | 2.32e-02 | 4.15e-01 | 3.14e-01 |
| GOBP ACROSOMAL VESICLE EXOCYTOSIS | 5 | 1.08e-01 | -4.15e-01 | 5.99e-01 |
| GOBP POSITIVE REGULATION OF VESICLE FUSION | 6 | 7.91e-02 | 4.14e-01 | 5.37e-01 |
| GOCC IRON SULFUR CLUSTER ASSEMBLY COMPLEX | 12 | 1.31e-02 | -4.14e-01 | 2.38e-01 |
| GOMF PORIN ACTIVITY | 6 | 8.00e-02 | -4.13e-01 | 5.40e-01 |
| GOMF HISTONE H3K27ME2 H3K27ME3 DEMETHYLASE ACTIVITY | 5 | 1.10e-01 | 4.12e-01 | 6.02e-01 |
| GOCC DYSTROPHIN ASSOCIATED GLYCOPROTEIN COMPLEX | 11 | 1.79e-02 | 4.12e-01 | 2.81e-01 |
| GOBP APOLIPOPROTEIN A I MEDIATED SIGNALING PATHWAY | 5 | 1.11e-01 | -4.12e-01 | 6.04e-01 |
| GOBP POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY | 45 | 1.84e-06 | 4.11e-01 | 3.02e-04 |
| GOBP DNA DEAMINATION | 11 | 1.85e-02 | 4.10e-01 | 2.87e-01 |
| GOBP ENDOTHELIN RECEPTOR SIGNALING PATHWAY | 6 | 8.20e-02 | 4.10e-01 | 5.43e-01 |
| GOBP POSITIVE REGULATION OF PLASMINOGEN ACTIVATION | 6 | 8.23e-02 | -4.10e-01 | 5.43e-01 |
| GOMF HISTONE H3K36 DEMETHYLASE ACTIVITY | 10 | 2.49e-02 | 4.10e-01 | 3.24e-01 |
| GOBP UTERINE SMOOTH MUSCLE CONTRACTION | 5 | 1.13e-01 | -4.09e-01 | 6.08e-01 |
| GOCC ENDOPLASMIC RETICULUM CHAPERONE COMPLEX | 9 | 3.36e-02 | -4.09e-01 | 3.75e-01 |
| GOBP REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION | 9 | 3.38e-02 | 4.09e-01 | 3.76e-01 |
| GOBP ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE | 6 | 8.30e-02 | -4.09e-01 | 5.44e-01 |
| GOBP PYRUVATE TRANSPORT | 5 | 1.14e-01 | -4.08e-01 | 6.11e-01 |
| GOMF TORC2 COMPLEX BINDING | 5 | 1.15e-01 | -4.07e-01 | 6.12e-01 |
| GOBP NEGATIVE REGULATION OF P38MAPK CASCADE | 7 | 6.25e-02 | 4.07e-01 | 4.87e-01 |
| GOCC MCM COMPLEX | 8 | 4.66e-02 | -4.06e-01 | 4.38e-01 |
| GOBP POST FERTILIZATION EPIGENETIC REGULATION OF GENE EXPRESSION | 12 | 1.49e-02 | -4.06e-01 | 2.58e-01 |
| GOMF UBIQUINONE BINDING | 6 | 8.53e-02 | -4.06e-01 | 5.50e-01 |
| GOBP REGULATION OF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 5 | 1.16e-01 | 4.06e-01 | 6.15e-01 |
| GOBP RESPONSE TO TYPE I INTERFERON | 64 | 2.07e-08 | 4.05e-01 | 5.98e-06 |
| GOBP NK T CELL DIFFERENTIATION | 8 | 4.72e-02 | 4.05e-01 | 4.41e-01 |
| GOBP METANEPHROS MORPHOGENESIS | 13 | 1.15e-02 | 4.05e-01 | 2.16e-01 |
| GOCC RIBOSOMAL SUBUNIT | 180 | 8.16e-21 | -4.05e-01 | 1.42e-17 |
| GOBP MITOTIC NUCLEAR MEMBRANE DISASSEMBLY | 7 | 6.39e-02 | 4.04e-01 | 4.91e-01 |
| GOBP HISTAMINE SECRETION | 11 | 2.02e-02 | 4.04e-01 | 2.96e-01 |
| GOBP HISTAMINE TRANSPORT | 11 | 2.02e-02 | 4.04e-01 | 2.96e-01 |
| GOMF ICOSANOID TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 8.66e-02 | -4.04e-01 | 5.55e-01 |
| GOMF 2 ACYLGLYCEROL 3 PHOSPHATE O ACYLTRANSFERASE ACTIVITY | 9 | 3.59e-02 | -4.04e-01 | 3.85e-01 |
| GOBP PEPTIDE CROSS LINKING | 8 | 4.82e-02 | -4.03e-01 | 4.45e-01 |
| GOCC TRANSLATION PREINITIATION COMPLEX | 18 | 3.14e-03 | -4.02e-01 | 1.02e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 6 | 8.87e-02 | -4.01e-01 | 5.58e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS OXYGEN AS ACCEPTOR | 7 | 6.62e-02 | -4.01e-01 | 5.02e-01 |
| GOBP EPITHELIAL CILIUM MOVEMENT INVOLVED IN DETERMINATION OF LEFT RIGHT ASYMMETRY | 6 | 8.90e-02 | -4.01e-01 | 5.59e-01 |
| GOBP REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY | 9 | 3.73e-02 | 4.01e-01 | 3.94e-01 |
| GOMF CHEMOKINE RECEPTOR BINDING | 28 | 2.47e-04 | -4.00e-01 | 1.54e-02 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS POLYSACCHARIDE CHAIN BIOSYNTHETIC PROCESS | 6 | 8.97e-02 | -4.00e-01 | 5.59e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE CAPPING | 14 | 9.64e-03 | 4.00e-01 | 1.94e-01 |
| GOCC PHOSPHORYLASE KINASE COMPLEX | 5 | 1.22e-01 | -4.00e-01 | 6.24e-01 |
| GOBP AXO DENDRITIC PROTEIN TRANSPORT | 5 | 1.22e-01 | -3.99e-01 | 6.25e-01 |
| GOBP ANTEROGRADE NEURONAL DENSE CORE VESICLE TRANSPORT | 5 | 1.22e-01 | -3.99e-01 | 6.25e-01 |
| GOBP METANEPHRIC NEPHRON MORPHOGENESIS | 12 | 1.68e-02 | 3.99e-01 | 2.72e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX CATALYTIC DOMAIN | 16 | 5.82e-03 | -3.98e-01 | 1.43e-01 |
| GOBP MONOCYTE ACTIVATION | 11 | 2.22e-02 | -3.98e-01 | 3.08e-01 |
| GOBP REGULATION OF SOMATIC STEM CELL POPULATION MAINTENANCE | 7 | 6.84e-02 | 3.98e-01 | 5.10e-01 |
| GOBP MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON | 6 | 9.16e-02 | -3.98e-01 | 5.63e-01 |
| GOBP POLYOL CATABOLIC PROCESS | 7 | 6.86e-02 | 3.98e-01 | 5.11e-01 |
| GOBP VENTRICULAR COMPACT MYOCARDIUM MORPHOGENESIS | 5 | 1.24e-01 | 3.97e-01 | 6.28e-01 |
| GOMF DENEDDYLASE ACTIVITY | 6 | 9.26e-02 | -3.97e-01 | 5.66e-01 |
| GOMF DOLICHYL PHOSPHATE MANNOSE PROTEIN MANNOSYLTRANSFERASE ACTIVITY | 8 | 5.23e-02 | -3.96e-01 | 4.58e-01 |
| GOBP NERVE GROWTH FACTOR SIGNALING PATHWAY | 8 | 5.24e-02 | 3.96e-01 | 4.58e-01 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE V1 DOMAIN | 9 | 4.02e-02 | -3.95e-01 | 4.10e-01 |
| GOMF PROTEIN ANTIGEN BINDING | 5 | 1.26e-01 | -3.95e-01 | 6.32e-01 |
| GOBP NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 19 | 2.91e-03 | 3.95e-01 | 9.53e-02 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MICROTUBULE | 5 | 1.27e-01 | -3.94e-01 | 6.35e-01 |
| GOBP EMBRYONIC BRAIN DEVELOPMENT | 12 | 1.82e-02 | -3.94e-01 | 2.84e-01 |
| GOMF CD4 RECEPTOR BINDING | 6 | 9.50e-02 | 3.94e-01 | 5.72e-01 |
| GOBP CELLULAR RESPONSE TO INTERFERON BETA | 19 | 2.99e-03 | 3.93e-01 | 9.75e-02 |
| GOMF CARBOHYDRATE MONOATOMIC CATION SYMPORTER ACTIVITY | 7 | 7.17e-02 | 3.93e-01 | 5.17e-01 |
| GOBP THYROID HORMONE MEDIATED SIGNALING PATHWAY | 6 | 9.55e-02 | 3.93e-01 | 5.74e-01 |
| GOBP PROTEIN RNA COMPLEX DISASSEMBLY | 8 | 5.44e-02 | -3.93e-01 | 4.62e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 5 | 1.29e-01 | -3.92e-01 | 6.40e-01 |
| GOBP PODOCYTE CELL MIGRATION | 6 | 9.67e-02 | 3.92e-01 | 5.77e-01 |
| GOBP TRIF DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 11 | 2.48e-02 | 3.91e-01 | 3.23e-01 |
| GOBP ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER | 12 | 1.91e-02 | 3.91e-01 | 2.88e-01 |
| GOBP NEGATIVE T CELL SELECTION | 5 | 1.30e-01 | 3.91e-01 | 6.40e-01 |
| GOBP PROTEIN DNA COVALENT CROSS LINKING REPAIR | 7 | 7.36e-02 | -3.90e-01 | 5.23e-01 |
| GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC PROTEIN COMPLEX | 16 | 6.87e-03 | 3.90e-01 | 1.60e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOBLAST PROLIFERATION | 6 | 9.78e-02 | 3.90e-01 | 5.79e-01 |
| GOCC ENDOLYSOSOME LUMEN | 5 | 1.31e-01 | -3.90e-01 | 6.41e-01 |
| GOMF ATP TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 2.51e-02 | -3.90e-01 | 3.25e-01 |
| GOMF ADP TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 4.28e-02 | -3.90e-01 | 4.23e-01 |
| GOBP INTRACELLULAR TRANSPORT OF VIRUS | 9 | 4.30e-02 | 3.90e-01 | 4.23e-01 |
| GOBP REGULATION OF DEVELOPMENT HETEROCHRONIC | 5 | 1.31e-01 | 3.90e-01 | 6.42e-01 |
| GOMF CO SMAD BINDING | 8 | 5.64e-02 | 3.90e-01 | 4.70e-01 |
| GOCC INTRACILIARY TRANSPORT PARTICLE A | 8 | 5.65e-02 | 3.89e-01 | 4.70e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE CATABOLIC PROCESS | 12 | 1.95e-02 | -3.89e-01 | 2.91e-01 |
| GOMF U1 SNRNA BINDING | 8 | 5.69e-02 | 3.89e-01 | 4.70e-01 |
| GOMF T CELL RECEPTOR BINDING | 8 | 5.69e-02 | 3.89e-01 | 4.70e-01 |
| GOBP POSITIVE REGULATION OF CELL KILLING | 42 | 1.34e-05 | 3.88e-01 | 1.49e-03 |
| GOBP THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY | 7 | 7.54e-02 | 3.88e-01 | 5.29e-01 |
| GOBP PEPTIDYL PROLINE HYDROXYLATION TO 4 HYDROXY L PROLINE | 8 | 5.74e-02 | -3.88e-01 | 4.70e-01 |
| GOMF PEPTIDYL PROLINE 4 DIOXYGENASE ACTIVITY | 8 | 5.74e-02 | -3.88e-01 | 4.70e-01 |
| GOMF C3HC4 TYPE RING FINGER DOMAIN BINDING | 5 | 1.34e-01 | 3.87e-01 | 6.48e-01 |
| GOMF 3 5 CYCLIC GMP PHOSPHODIESTERASE ACTIVITY | 10 | 3.40e-02 | 3.87e-01 | 3.77e-01 |
| GOBP MODULATION OF PROCESS OF ANOTHER ORGANISM | 9 | 4.43e-02 | 3.87e-01 | 4.28e-01 |
| GOBP TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE CLEARANCE | 5 | 1.35e-01 | -3.86e-01 | 6.52e-01 |
| GOCC SHELTERIN COMPLEX | 6 | 1.02e-01 | -3.86e-01 | 5.87e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION | 8 | 5.95e-02 | -3.85e-01 | 4.77e-01 |
| GOCC TIM23 MITOCHONDRIAL IMPORT INNER MEMBRANE TRANSLOCASE COMPLEX | 16 | 7.91e-03 | -3.84e-01 | 1.75e-01 |
| GOMF MONOATOMIC CATION BICARBONATE SYMPORTER ACTIVITY | 9 | 4.64e-02 | -3.83e-01 | 4.37e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL | 16 | 8.05e-03 | 3.83e-01 | 1.76e-01 |
| GOBP REGULATION OF MESENCHYMAL STEM CELL DIFFERENTIATION | 6 | 1.05e-01 | -3.83e-01 | 5.94e-01 |
| GOCC SPERM ANNULUS | 5 | 1.39e-01 | -3.82e-01 | 6.59e-01 |
| GOBP MAINTENANCE OF ORGANELLE LOCATION | 11 | 2.82e-02 | 3.82e-01 | 3.44e-01 |
| GOCC ALPHA DNA POLYMERASE PRIMASE COMPLEX | 5 | 1.39e-01 | 3.82e-01 | 6.61e-01 |
| GOBP CARDIOBLAST DIFFERENTIATION | 10 | 3.67e-02 | -3.81e-01 | 3.90e-01 |
| GOBP NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 11 | 2.87e-02 | -3.81e-01 | 3.47e-01 |
| GOBP NEGATIVE REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY | 6 | 1.06e-01 | -3.81e-01 | 5.96e-01 |
| GOBP NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY | 6 | 1.06e-01 | -3.81e-01 | 5.96e-01 |
| GOBP REGULATION OF RIG I SIGNALING PATHWAY | 18 | 5.23e-03 | 3.80e-01 | 1.35e-01 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX | 19 | 4.17e-03 | -3.80e-01 | 1.19e-01 |
| GOBP MUCUS SECRETION | 10 | 3.77e-02 | 3.80e-01 | 3.96e-01 |
| GOBP PEXOPHAGY | 6 | 1.08e-01 | -3.79e-01 | 5.98e-01 |
| GOMF PROTON TRANSPORTING ATP SYNTHASE ACTIVITY ROTATIONAL MECHANISM | 17 | 6.86e-03 | -3.79e-01 | 1.60e-01 |
| GOBP REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT | 20 | 3.38e-03 | 3.79e-01 | 1.06e-01 |
| GOBP HIPPOCAMPAL NEURON APOPTOTIC PROCESS | 5 | 1.43e-01 | -3.79e-01 | 6.65e-01 |
| GOBP REGULATION OF T CIRCLE FORMATION | 5 | 1.43e-01 | -3.78e-01 | 6.65e-01 |
| GOBP HISTIDINE CATABOLIC PROCESS | 5 | 1.43e-01 | -3.78e-01 | 6.65e-01 |
| GOBP NATURAL KILLER CELL DIFFERENTIATION | 19 | 4.35e-03 | 3.78e-01 | 1.23e-01 |
| GOCC COMPLEX OF COLLAGEN TRIMERS | 7 | 8.34e-02 | 3.78e-01 | 5.45e-01 |
| GOMF GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE NADPLUS NON PHOSPHORYLATING ACTIVITY | 6 | 1.09e-01 | 3.77e-01 | 6.00e-01 |
| GOMF DICARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 18 | 5.66e-03 | -3.77e-01 | 1.41e-01 |
| GOBP CARDIAC RIGHT VENTRICLE MORPHOGENESIS | 9 | 5.08e-02 | 3.76e-01 | 4.52e-01 |
| GOBP MITOTIC SISTER CHROMATID COHESION CENTROMERIC | 5 | 1.46e-01 | -3.76e-01 | 6.68e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL PROCESS | 73 | 2.90e-08 | 3.76e-01 | 7.70e-06 |
| GOBP PLUS END DIRECTED ORGANELLE TRANSPORT ALONG MICROTUBULE | 6 | 1.11e-01 | 3.76e-01 | 6.04e-01 |
| GOBP INTERFERON MEDIATED SIGNALING PATHWAY | 73 | 2.92e-08 | 3.76e-01 | 7.70e-06 |
| GOCC CATSPER COMPLEX | 5 | 1.46e-01 | 3.75e-01 | 6.69e-01 |
| GOBP VITAMIN B6 METABOLIC PROCESS | 5 | 1.47e-01 | -3.75e-01 | 6.69e-01 |
| GOBP VENOUS BLOOD VESSEL MORPHOGENESIS | 5 | 1.47e-01 | -3.75e-01 | 6.69e-01 |
| GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL ACTIVATION | 7 | 8.60e-02 | 3.75e-01 | 5.53e-01 |
| GOCC CHROMOSOME TELOMERIC REPEAT REGION | 12 | 2.48e-02 | -3.74e-01 | 3.23e-01 |
| GOCC RNA POLYMERASE II TRANSCRIPTION REPRESSOR COMPLEX | 13 | 1.96e-02 | 3.74e-01 | 2.91e-01 |
| GOBP NEGATIVE REGULATION OF CYCLASE ACTIVITY | 5 | 1.48e-01 | -3.74e-01 | 6.70e-01 |
| GOMF TELOMERASE INHIBITOR ACTIVITY | 5 | 1.48e-01 | -3.74e-01 | 6.70e-01 |
| GOBP CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND | 10 | 4.12e-02 | 3.73e-01 | 4.14e-01 |
| GOCC LARGE RIBOSOMAL SUBUNIT | 112 | 9.78e-12 | -3.73e-01 | 7.72e-09 |
| GOCC SPERM PLASMA MEMBRANE | 5 | 1.49e-01 | -3.72e-01 | 6.72e-01 |
| GOBP RIBONUCLEOSIDE CATABOLIC PROCESS | 15 | 1.27e-02 | 3.72e-01 | 2.33e-01 |
| GOBP FLUID TRANSPORT | 16 | 1.01e-02 | -3.72e-01 | 2.00e-01 |
| GOBP C TERMINAL PROTEIN AMINO ACID MODIFICATION | 8 | 6.97e-02 | 3.70e-01 | 5.14e-01 |
| GOBP DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 9 | 5.44e-02 | 3.70e-01 | 4.62e-01 |
| GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O | 14 | 1.65e-02 | -3.70e-01 | 2.72e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 9 | 5.46e-02 | 3.70e-01 | 4.63e-01 |
| GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE | 5 | 1.52e-01 | 3.70e-01 | 6.74e-01 |
| GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN | 9 | 5.46e-02 | -3.70e-01 | 4.63e-01 |
| GOBP PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX ASSEMBLY | 14 | 1.66e-02 | -3.70e-01 | 2.72e-01 |
| GOCC EUKARYOTIC 48S PREINITIATION COMPLEX | 16 | 1.05e-02 | -3.70e-01 | 2.05e-01 |
| GOBP REGULATION OF MICROVILLUS LENGTH | 5 | 1.53e-01 | -3.69e-01 | 6.74e-01 |
| GOBP PROLINE METABOLIC PROCESS | 6 | 1.18e-01 | -3.69e-01 | 6.17e-01 |
| GOMF BICARBONATE MONOATOMIC ANION ANTIPORTER ACTIVITY | 6 | 1.18e-01 | -3.69e-01 | 6.17e-01 |
| GOBP INTERLEUKIN 2 MEDIATED SIGNALING PATHWAY | 5 | 1.53e-01 | 3.69e-01 | 6.75e-01 |
| GOMF 1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE ACTIVITY | 6 | 1.18e-01 | -3.68e-01 | 6.19e-01 |
| GOBP PROSTATE GLANDULAR ACINUS DEVELOPMENT | 5 | 1.54e-01 | 3.68e-01 | 6.75e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS | 5 | 1.54e-01 | -3.68e-01 | 6.76e-01 |
| GOCC CATENIN COMPLEX | 8 | 7.18e-02 | 3.68e-01 | 5.18e-01 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE INHIBITOR ACTIVITY | 11 | 3.48e-02 | -3.68e-01 | 3.81e-01 |
| GOMF HISTONE H4 DEMETHYLASE ACTIVITY | 5 | 1.55e-01 | 3.67e-01 | 6.77e-01 |
| GOCC COHESIN COMPLEX | 8 | 7.21e-02 | 3.67e-01 | 5.19e-01 |
| GOBP REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION | 50 | 7.12e-06 | 3.67e-01 | 9.55e-04 |
| GOMF PHOSPHATIDYLSERINE FLIPPASE ACTIVITY | 5 | 1.55e-01 | 3.67e-01 | 6.78e-01 |
| GOMF ANKYRIN REPEAT BINDING | 6 | 1.20e-01 | -3.66e-01 | 6.21e-01 |
| GOBP IMMUNOLOGICAL MEMORY PROCESS | 12 | 2.81e-02 | 3.66e-01 | 3.43e-01 |
| GOMF RNA POLYMERASE I ACTIVITY | 9 | 5.72e-02 | -3.66e-01 | 4.70e-01 |
| GOCC CUL4B RING E3 UBIQUITIN LIGASE COMPLEX | 6 | 1.21e-01 | -3.66e-01 | 6.22e-01 |
| GOBP REGULATION OF STRIATED MUSCLE TISSUE DEVELOPMENT | 8 | 7.30e-02 | 3.66e-01 | 5.22e-01 |
| GOMF POLY G BINDING | 8 | 7.31e-02 | 3.66e-01 | 5.22e-01 |
| GOCC TRANSCRIPTION FACTOR AP 1 COMPLEX | 5 | 1.57e-01 | -3.66e-01 | 6.80e-01 |
| GOBP TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY | 9 | 5.75e-02 | 3.66e-01 | 4.70e-01 |
| GOBP REGULATION OF COLLATERAL SPROUTING | 9 | 5.76e-02 | -3.66e-01 | 4.70e-01 |
| GOBP PROTOPORPHYRINOGEN IX BIOSYNTHETIC PROCESS | 8 | 7.36e-02 | -3.65e-01 | 5.23e-01 |
| GOBP RESPONSE TO HEPATOCYTE GROWTH FACTOR | 15 | 1.43e-02 | -3.65e-01 | 2.52e-01 |
| GOBP REGULATION OF MITOCHONDRIAL RNA CATABOLIC PROCESS | 5 | 1.57e-01 | 3.65e-01 | 6.80e-01 |
| GOBP POSITIVE REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS | 5 | 1.57e-01 | -3.65e-01 | 6.80e-01 |
| GOBP NEGATIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 10 | 4.56e-02 | 3.65e-01 | 4.33e-01 |
| GOBP POSITIVE REGULATION OF INTERFERON BETA PRODUCTION | 36 | 1.53e-04 | 3.65e-01 | 1.05e-02 |
| GOMF EUKARYOTIC INITIATION FACTOR 4E BINDING | 9 | 5.85e-02 | -3.64e-01 | 4.73e-01 |
| GOBP MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION | 6 | 1.22e-01 | 3.64e-01 | 6.25e-01 |
| GOCC RNA POLYMERASE I TRANSCRIPTION REGULATOR COMPLEX | 5 | 1.59e-01 | 3.64e-01 | 6.83e-01 |
| GOCC RNA POLYMERASE TRANSCRIPTION FACTOR SL1 COMPLEX | 5 | 1.59e-01 | 3.64e-01 | 6.83e-01 |
| GOBP DNA REPLICATION DEPENDENT CHROMATIN ASSEMBLY | 6 | 1.23e-01 | -3.64e-01 | 6.25e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR EXTRAVASATION | 11 | 3.67e-02 | 3.64e-01 | 3.90e-01 |
| GOBP FOREBRAIN MORPHOGENESIS | 6 | 1.23e-01 | 3.64e-01 | 6.25e-01 |
| GOBP POSITIVE REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION | 6 | 1.23e-01 | -3.63e-01 | 6.26e-01 |
| GOCC RESPIRASOME | 90 | 2.69e-09 | -3.63e-01 | 8.34e-07 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION | 12 | 2.95e-02 | -3.63e-01 | 3.49e-01 |
| GOBP REGULATION OF CILIUM MOVEMENT | 16 | 1.20e-02 | -3.63e-01 | 2.23e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL LIFE CYCLE | 20 | 5.13e-03 | 3.62e-01 | 1.35e-01 |
| GOMF RNA DIRECTED DNA POLYMERASE ACTIVITY | 5 | 1.62e-01 | -3.61e-01 | 6.87e-01 |
| GOMF TELOMERASE ACTIVITY | 5 | 1.62e-01 | -3.61e-01 | 6.87e-01 |
| GOMF CARNITINE O ACYLTRANSFERASE ACTIVITY | 5 | 1.62e-01 | -3.61e-01 | 6.87e-01 |
| GOBP ATRIOVENTRICULAR VALVE DEVELOPMENT | 16 | 1.24e-02 | 3.61e-01 | 2.29e-01 |
| GOBP PROTEIN LOCALIZATION TO PRESYNAPSE | 6 | 1.26e-01 | -3.61e-01 | 6.31e-01 |
| GOBP ENDOCARDIAL CUSHION MORPHOGENESIS | 18 | 8.10e-03 | 3.61e-01 | 1.77e-01 |
| GOCC OUTER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX | 22 | 3.45e-03 | -3.60e-01 | 1.08e-01 |
| GOBP RESPONSE TO GROWTH HORMONE | 24 | 2.30e-03 | 3.60e-01 | 8.16e-02 |
| GOMF ALPHA CATENIN BINDING | 5 | 1.64e-01 | 3.59e-01 | 6.90e-01 |
| GOBP REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 8 | 7.84e-02 | -3.59e-01 | 5.36e-01 |
| GOBP REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY | 7 | 9.99e-02 | 3.59e-01 | 5.84e-01 |
| GOBP ONE CARBON COMPOUND TRANSPORT | 27 | 1.24e-03 | -3.59e-01 | 5.07e-02 |
| GOBP REGULATION OF HISTAMINE SECRETION BY MAST CELL | 6 | 1.28e-01 | 3.59e-01 | 6.36e-01 |
| GOBP MITOTIC DNA REPLICATION CHECKPOINT SIGNALING | 8 | 7.96e-02 | -3.58e-01 | 5.39e-01 |
| GOBP NEGATIVE REGULATION OF B CELL PROLIFERATION | 13 | 2.55e-02 | 3.58e-01 | 3.30e-01 |
| GOBP METANEPHRIC EPITHELIUM DEVELOPMENT | 11 | 4.00e-02 | 3.58e-01 | 4.09e-01 |
| GOBP METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT | 11 | 4.00e-02 | 3.58e-01 | 4.09e-01 |
| GOBP POSITIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 7 | 1.01e-01 | 3.58e-01 | 5.87e-01 |
| GOBP FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX | 15 | 1.66e-02 | -3.57e-01 | 2.72e-01 |
| GOBP REGULATION OF CILIUM BEAT FREQUENCY | 10 | 5.05e-02 | -3.57e-01 | 4.51e-01 |
| GOCC JUXTAPARANODE REGION OF AXON | 9 | 6.38e-02 | -3.57e-01 | 4.91e-01 |
| GOBP DETECTION OF EXTERNAL BIOTIC STIMULUS | 15 | 1.68e-02 | 3.57e-01 | 2.72e-01 |
| GOMF UBIQUITIN MODIFICATION DEPENDENT HISTONE BINDING | 6 | 1.31e-01 | 3.56e-01 | 6.41e-01 |
| GOBP NECROPTOTIC SIGNALING PATHWAY | 7 | 1.02e-01 | 3.56e-01 | 5.90e-01 |
| GOCC HOST CELLULAR COMPONENT | 8 | 8.09e-02 | 3.56e-01 | 5.41e-01 |
| GOCC MYELIN SHEATH ABAXONAL REGION | 5 | 1.68e-01 | 3.56e-01 | 6.96e-01 |
| GOCC DENDRITIC FILOPODIUM | 5 | 1.69e-01 | 3.55e-01 | 6.96e-01 |
| GOBP NEURONAL SIGNAL TRANSDUCTION | 5 | 1.69e-01 | -3.55e-01 | 6.98e-01 |
| GOBP RIBOSOME ASSEMBLY | 57 | 3.61e-06 | -3.55e-01 | 5.41e-04 |
| GOMF NUCLEOSIDE TRIPHOSPHATE DIPHOSPHATASE ACTIVITY | 8 | 8.23e-02 | -3.55e-01 | 5.43e-01 |
| GOMF MITOCHONDRIAL RIBOSOME BINDING | 8 | 8.24e-02 | -3.55e-01 | 5.43e-01 |
| GOBP DISTAL TUBULE DEVELOPMENT | 6 | 1.33e-01 | 3.55e-01 | 6.46e-01 |
| GOBP REGULATION OF CILIUM BEAT FREQUENCY INVOLVED IN CILIARY MOTILITY | 6 | 1.33e-01 | -3.55e-01 | 6.46e-01 |
| GOMF GLUCURONOSYLTRANSFERASE ACTIVITY | 12 | 3.35e-02 | -3.54e-01 | 3.74e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 3 KINASE ACTIVITY | 7 | 1.04e-01 | 3.54e-01 | 5.94e-01 |
| GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 5 | 1.70e-01 | 3.54e-01 | 6.98e-01 |
| GOCC CYCLIN CDK POSITIVE TRANSCRIPTION ELONGATION FACTOR COMPLEX | 6 | 1.33e-01 | 3.54e-01 | 6.47e-01 |
| GOBP CELLULAR RESPONSE TO EPINEPHRINE STIMULUS | 8 | 8.32e-02 | 3.54e-01 | 5.44e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY | 10 | 5.29e-02 | -3.54e-01 | 4.60e-01 |
| GOBP POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 11 | 4.23e-02 | -3.54e-01 | 4.21e-01 |
| GOBP MEMBRANE DISASSEMBLY | 10 | 5.30e-02 | 3.53e-01 | 4.60e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY | 5 | 1.71e-01 | 3.53e-01 | 6.99e-01 |
| GOCC DENDRITIC SPINE MEMBRANE | 8 | 8.36e-02 | -3.53e-01 | 5.45e-01 |
| GOBP NUCLEAR MRNA SURVEILLANCE | 10 | 5.30e-02 | 3.53e-01 | 4.60e-01 |
| GOMF ADENYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 15 | 1.79e-02 | -3.53e-01 | 2.81e-01 |
| GOBP CONNECTIVE TISSUE REPLACEMENT | 9 | 6.66e-02 | 3.53e-01 | 5.03e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 15 | 1.79e-02 | 3.53e-01 | 2.81e-01 |
| GOBP LUTEINIZATION | 7 | 1.06e-01 | -3.53e-01 | 5.96e-01 |
| GOBP REGULATION OF MACROPHAGE FUSION | 5 | 1.72e-01 | -3.53e-01 | 7.02e-01 |
| GOBP NEGATIVE REGULATION OF RIG I SIGNALING PATHWAY | 8 | 8.41e-02 | 3.53e-01 | 5.46e-01 |
| GOBP PURINE NUCLEOBASE TRANSMEMBRANE TRANSPORT | 6 | 1.35e-01 | 3.53e-01 | 6.52e-01 |
| GOBP DAMP METABOLIC PROCESS | 5 | 1.72e-01 | -3.52e-01 | 7.02e-01 |
| GOMF GDP PHOSPHATASE ACTIVITY | 7 | 1.06e-01 | 3.52e-01 | 5.96e-01 |
| GOBP XENOPHAGY | 12 | 3.46e-02 | 3.52e-01 | 3.80e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE CATABOLIC PROCESS | 7 | 1.07e-01 | 3.52e-01 | 5.96e-01 |
| GOBP PRIMITIVE HEMOPOIESIS | 6 | 1.35e-01 | 3.52e-01 | 6.52e-01 |
| GOCC POSTSYNAPTIC RECYCLING ENDOSOME | 8 | 8.47e-02 | -3.52e-01 | 5.48e-01 |
| GOBP ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM | 8 | 8.48e-02 | -3.52e-01 | 5.48e-01 |
| GOBP MITRAL VALVE DEVELOPMENT | 9 | 6.77e-02 | 3.52e-01 | 5.08e-01 |
| GOBP REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY | 14 | 2.28e-02 | 3.51e-01 | 3.12e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST PROLIFERATION | 5 | 1.74e-01 | 3.51e-01 | 7.05e-01 |
| GOCC NODE OF RANVIER | 7 | 1.08e-01 | 3.50e-01 | 5.99e-01 |
| GOBP REGULATION PROTEIN CATABOLIC PROCESS AT SYNAPSE | 6 | 1.38e-01 | -3.49e-01 | 6.59e-01 |
| GOBP POSITIVE REGULATION OF NEUTROPHIL ACTIVATION | 5 | 1.76e-01 | -3.49e-01 | 7.07e-01 |
| GOCC PARANODAL JUNCTION | 5 | 1.76e-01 | -3.49e-01 | 7.07e-01 |
| GOMF PROTON CHANNEL ACTIVITY | 20 | 6.89e-03 | -3.49e-01 | 1.60e-01 |
| GOMF MRNA 5 PHOSPHATASE ACTIVITY | 11 | 4.51e-02 | -3.49e-01 | 4.31e-01 |
| GOBP ATRIAL SEPTUM DEVELOPMENT | 13 | 2.96e-02 | 3.49e-01 | 3.49e-01 |
| GOBP INTERLEUKIN 33 MEDIATED SIGNALING PATHWAY | 6 | 1.40e-01 | 3.48e-01 | 6.61e-01 |
| GOBP MOTOR NEURON MIGRATION | 5 | 1.77e-01 | -3.48e-01 | 7.08e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS | 9 | 7.05e-02 | -3.48e-01 | 5.17e-01 |
| GOBP MESENCHYMAL STEM CELL DIFFERENTIATION | 8 | 8.81e-02 | -3.48e-01 | 5.58e-01 |
| GOMF STRUCTURAL CONSTITUENT OF MYELIN SHEATH | 5 | 1.78e-01 | 3.48e-01 | 7.09e-01 |
| GOMF PROTEIN PHOSPHATASE ACTIVATOR ACTIVITY | 14 | 2.43e-02 | 3.48e-01 | 3.21e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION | 12 | 3.70e-02 | 3.48e-01 | 3.91e-01 |
| GOBP BONE TRABECULA FORMATION | 6 | 1.40e-01 | -3.48e-01 | 6.62e-01 |
| GOBP SYNAPTIC ASSEMBLY AT NEUROMUSCULAR JUNCTION | 5 | 1.78e-01 | 3.48e-01 | 7.10e-01 |
| GOBP ISOCITRATE METABOLIC PROCESS | 6 | 1.40e-01 | -3.48e-01 | 6.62e-01 |
| GOBP PROTEIN MATURATION BY 4FE 4S CLUSTER TRANSFER | 7 | 1.11e-01 | -3.48e-01 | 6.04e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS OXYGEN AS ACCEPTOR | 8 | 8.87e-02 | -3.48e-01 | 5.58e-01 |
| GOBP MESODERMAL CELL FATE COMMITMENT | 5 | 1.79e-01 | -3.47e-01 | 7.10e-01 |
| GOBP WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION | 5 | 1.79e-01 | 3.47e-01 | 7.10e-01 |
| GOBP TONIC SMOOTH MUSCLE CONTRACTION | 5 | 1.79e-01 | -3.47e-01 | 7.10e-01 |
| GOBP REGULATION OF COMPLEMENT DEPENDENT CYTOTOXICITY | 6 | 1.41e-01 | 3.47e-01 | 6.64e-01 |
| GOBP POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS | 6 | 1.42e-01 | -3.47e-01 | 6.64e-01 |
| GOBP NEGATIVE REGULATION OF CHROMOSOME SEGREGATION | 45 | 5.97e-05 | 3.46e-01 | 5.03e-03 |
| GOBP BONE MINERALIZATION INVOLVED IN BONE MATURATION | 8 | 9.04e-02 | 3.46e-01 | 5.61e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH OXIDATION OF A PAIR OF DONORS RESULTING IN THE REDUCTION OF MOLECULAR OXYGEN TO TWO MOLECULES OF WATER | 7 | 1.13e-01 | -3.46e-01 | 6.10e-01 |
| GOBP DICARBOXYLIC ACID BIOSYNTHETIC PROCESS | 9 | 7.27e-02 | -3.45e-01 | 5.21e-01 |
| GOMF CHLORIDE CHANNEL REGULATOR ACTIVITY | 7 | 1.14e-01 | 3.45e-01 | 6.10e-01 |
| GOCC MIB COMPLEX | 13 | 3.11e-02 | -3.45e-01 | 3.55e-01 |
| GOBP RESPONSE TO SALT STRESS | 18 | 1.12e-02 | -3.45e-01 | 2.13e-01 |
| GOBP ISOTYPE SWITCHING TO IGA ISOTYPES | 7 | 1.14e-01 | 3.45e-01 | 6.10e-01 |
| GOMF ACTIVIN RECEPTOR ACTIVITY | 8 | 9.08e-02 | 3.45e-01 | 5.62e-01 |
| GOMF DNA METHYLTRANSFERASE ACTIVITY | 6 | 1.43e-01 | -3.45e-01 | 6.65e-01 |
| GOBP ODONTOBLAST DIFFERENTIATION | 9 | 7.31e-02 | 3.45e-01 | 5.22e-01 |
| GOBP BRANCHED CHAIN AMINO ACID BIOSYNTHETIC PROCESS | 5 | 1.82e-01 | 3.45e-01 | 7.13e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET AGGREGATION | 5 | 1.82e-01 | -3.45e-01 | 7.13e-01 |
| GOBP DEFENSE RESPONSE TO SYMBIONT | 255 | 2.85e-21 | 3.45e-01 | 6.18e-18 |
| GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 6 | 1.44e-01 | -3.45e-01 | 6.65e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION | 6 | 1.45e-01 | 3.44e-01 | 6.66e-01 |
| GOBP RESPONSE TO LIPOTEICHOIC ACID | 9 | 7.39e-02 | -3.44e-01 | 5.24e-01 |
| GOBP KIDNEY MESENCHYME DEVELOPMENT | 7 | 1.15e-01 | 3.44e-01 | 6.12e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS | 11 | 4.84e-02 | 3.44e-01 | 4.45e-01 |
| GOBP REGULATION OF CELLULAR PH REDUCTION | 5 | 1.83e-01 | 3.44e-01 | 7.14e-01 |
| GOBP ACETYL COA BIOSYNTHETIC PROCESS | 17 | 1.43e-02 | -3.43e-01 | 2.52e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME SEGREGATION | 26 | 2.47e-03 | 3.43e-01 | 8.39e-02 |
| GOBP MEIOTIC SPINDLE ASSEMBLY | 11 | 4.89e-02 | 3.43e-01 | 4.46e-01 |
| GOBP ALDITOL METABOLIC PROCESS | 16 | 1.76e-02 | 3.43e-01 | 2.79e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEPARATION | 15 | 2.16e-02 | 3.43e-01 | 3.06e-01 |
| GOBP REGULATION OF MUCUS SECRETION | 5 | 1.85e-01 | 3.42e-01 | 7.16e-01 |
| GOBP HEMIDESMOSOME ASSEMBLY | 5 | 1.86e-01 | -3.42e-01 | 7.16e-01 |
| GOBP REGULATION OF APOPTOTIC DNA FRAGMENTATION | 7 | 1.18e-01 | -3.42e-01 | 6.17e-01 |
| GOBP EYELID DEVELOPMENT IN CAMERA TYPE EYE | 6 | 1.47e-01 | -3.42e-01 | 6.70e-01 |
| GOMF PROCOLLAGEN PROLINE 4 DIOXYGENASE ACTIVITY | 5 | 1.86e-01 | -3.41e-01 | 7.17e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 5 | 1.86e-01 | 3.41e-01 | 7.17e-01 |
| GOBP PROTEIN DEMETHYLATION | 12 | 4.08e-02 | 3.41e-01 | 4.12e-01 |
| GOMF BIOTIN BINDING | 5 | 1.87e-01 | 3.41e-01 | 7.17e-01 |
| GOMF DEAMINASE ACTIVITY | 23 | 4.68e-03 | 3.41e-01 | 1.28e-01 |
| GOBP REGULATION OF CONNECTIVE TISSUE REPLACEMENT | 5 | 1.87e-01 | 3.41e-01 | 7.17e-01 |
| GOMF PEPTIDE ALPHA N ACETYLTRANSFERASE ACTIVITY | 7 | 1.19e-01 | -3.40e-01 | 6.20e-01 |
| GOMF OUTWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY | 6 | 1.49e-01 | 3.40e-01 | 6.72e-01 |
| GOBP MAINTENANCE OF GASTROINTESTINAL EPITHELIUM | 7 | 1.20e-01 | 3.40e-01 | 6.20e-01 |
| GOMF CYCLOHYDROLASE ACTIVITY | 5 | 1.88e-01 | 3.40e-01 | 7.18e-01 |
| GOBP NEURONAL STEM CELL POPULATION MAINTENANCE | 16 | 1.87e-02 | 3.39e-01 | 2.87e-01 |
| GOBP RIG I SIGNALING PATHWAY | 24 | 4.03e-03 | 3.39e-01 | 1.18e-01 |
| GOCC RIBOSOME | 224 | 2.40e-18 | -3.39e-01 | 3.48e-15 |
| GOBP CRISTAE FORMATION | 17 | 1.56e-02 | -3.39e-01 | 2.63e-01 |
| GOBP PHOTOTRANSDUCTION VISIBLE LIGHT | 12 | 4.21e-02 | 3.39e-01 | 4.20e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE MEMBRANE | 16 | 1.90e-02 | 3.39e-01 | 2.88e-01 |
| GOBP IMMUNOLOGICAL MEMORY FORMATION PROCESS | 9 | 7.89e-02 | 3.38e-01 | 5.37e-01 |
| GOBP CELL PROLIFERATION IN FOREBRAIN | 11 | 5.24e-02 | 3.38e-01 | 4.58e-01 |
| GOBP NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 6 | 1.52e-01 | 3.38e-01 | 6.74e-01 |
| GOBP NEGATIVE REGULATION OF SODIUM ION TRANSPORT | 6 | 1.52e-01 | 3.38e-01 | 6.74e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA | 5 | 1.91e-01 | -3.38e-01 | 7.21e-01 |
| GOBP COPII COATED VESICLE CARGO LOADING | 15 | 2.37e-02 | 3.37e-01 | 3.18e-01 |
| GOBP NEGATIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 5 | 1.92e-01 | -3.37e-01 | 7.21e-01 |
| GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY INVOLVED IN CARDIAC MUSCLE CELL ACTION POTENTIAL REPOLARIZATION | 6 | 1.53e-01 | 3.37e-01 | 6.74e-01 |
| GOMF DNA CLAMP LOADER ACTIVITY | 9 | 8.01e-02 | -3.37e-01 | 5.40e-01 |
| GOCC ARP2 3 PROTEIN COMPLEX | 9 | 8.02e-02 | -3.37e-01 | 5.40e-01 |
| GOBP REGULATION OF RIBONUCLEASE ACTIVITY | 8 | 9.91e-02 | 3.37e-01 | 5.82e-01 |
| GOBP RETROGRADE TRANSPORT VESICLE RECYCLING WITHIN GOLGI | 9 | 8.04e-02 | 3.37e-01 | 5.41e-01 |
| GOCC POLYSOME | 62 | 4.62e-06 | -3.37e-01 | 6.47e-04 |
| GOBP REGULATION OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY | 7 | 1.23e-01 | -3.37e-01 | 6.26e-01 |
| GOBP EPIGENETIC PROGRAMMING IN THE ZYGOTIC PRONUCLEI | 8 | 9.94e-02 | -3.36e-01 | 5.82e-01 |
| GOMF CYCLIC NUCLEOTIDE DEPENDENT PROTEIN KINASE ACTIVITY | 6 | 1.54e-01 | -3.36e-01 | 6.75e-01 |
| GOBP COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY | 6 | 1.54e-01 | 3.36e-01 | 6.75e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST | 34 | 7.01e-04 | 3.36e-01 | 3.33e-02 |
| GOBP T CELL MEDIATED CYTOTOXICITY | 41 | 1.99e-04 | 3.36e-01 | 1.29e-02 |
| GOMF PROTEIN LIPID COMPLEX BINDING | 19 | 1.13e-02 | -3.36e-01 | 2.14e-01 |
| GOBP MEMBRANE FUSION INVOLVED IN VIRAL ENTRY INTO HOST CELL | 5 | 1.94e-01 | -3.36e-01 | 7.23e-01 |
| GOMF CALCIUM MONOATOMIC CATION ANTIPORTER ACTIVITY | 7 | 1.25e-01 | -3.35e-01 | 6.29e-01 |
| GOMF NADPLUS PROTEIN LYSINE ADP RIBOSYLTRANSFERASE ACTIVITY | 5 | 1.96e-01 | 3.34e-01 | 7.27e-01 |
| GOBP ACETYL COA METABOLIC PROCESS | 28 | 2.21e-03 | -3.34e-01 | 7.90e-02 |
| GOMF PROTEIN CYSTEINE S STEAROYLTRANSFERASE ACTIVITY | 6 | 1.56e-01 | 3.34e-01 | 6.79e-01 |
| GOBP POSITIVE REGULATION OF ATP METABOLIC PROCESS | 8 | 1.02e-01 | -3.34e-01 | 5.89e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET | 6 | 1.57e-01 | -3.34e-01 | 6.80e-01 |
| GOBP CELLULAR RESPONSE TO NICOTINE | 5 | 1.97e-01 | -3.33e-01 | 7.28e-01 |
| GOBP PANCREATIC JUICE SECRETION | 5 | 1.97e-01 | -3.33e-01 | 7.28e-01 |
| GOMF OXIDOREDUCTION DRIVEN ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 65 | 3.52e-06 | -3.33e-01 | 5.37e-04 |
| GOBP CELL CELL ADHESION MEDIATED BY INTEGRIN | 14 | 3.12e-02 | -3.33e-01 | 3.56e-01 |
| GOBP REGULATION OF ICOSANOID SECRETION | 9 | 8.44e-02 | 3.32e-01 | 5.46e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 6 | 1.59e-01 | 3.32e-01 | 6.83e-01 |
| GOBP AMINO ACID SALVAGE | 5 | 1.99e-01 | -3.32e-01 | 7.31e-01 |
| GOBP L METHIONINE SALVAGE FROM METHYLTHIOADENOSINE | 5 | 1.99e-01 | -3.32e-01 | 7.31e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 30 | 1.67e-03 | 3.32e-01 | 6.41e-02 |
| GOBP ADP TRANSPORT | 10 | 6.95e-02 | -3.32e-01 | 5.14e-01 |
| GOBP RESPONSE TO TYPE III INTERFERON | 7 | 1.29e-01 | 3.31e-01 | 6.39e-01 |
| GOBP NEGATIVE REGULATION OF GRANULOCYTE DIFFERENTIATION | 6 | 1.60e-01 | -3.31e-01 | 6.85e-01 |
| GOBP RENAL WATER TRANSPORT | 5 | 2.00e-01 | -3.31e-01 | 7.31e-01 |
| GOCC POSTSYNAPTIC ENDOSOME | 11 | 5.74e-02 | -3.31e-01 | 4.70e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE DEPOLARIZATION | 5 | 2.01e-01 | 3.31e-01 | 7.32e-01 |
| GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION | 6 | 1.61e-01 | 3.31e-01 | 6.87e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY | 13 | 3.91e-02 | 3.30e-01 | 4.05e-01 |
| GOBP INHIBITORY SYNAPSE ASSEMBLY | 6 | 1.61e-01 | 3.30e-01 | 6.87e-01 |
| GOBP OUTER DYNEIN ARM ASSEMBLY | 7 | 1.30e-01 | -3.30e-01 | 6.40e-01 |
| GOCC GRANULAR COMPONENT | 6 | 1.61e-01 | -3.30e-01 | 6.87e-01 |
| GOBP ATRIAL SEPTUM MORPHOGENESIS | 8 | 1.06e-01 | 3.30e-01 | 5.96e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 18 | 1.53e-02 | 3.30e-01 | 2.61e-01 |
| GOBP LYMPHOCYTE CHEMOTAXIS | 37 | 5.15e-04 | -3.30e-01 | 2.64e-02 |
| GOBP POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION | 6 | 1.62e-01 | -3.30e-01 | 6.87e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR ACTIVITY | 10 | 7.11e-02 | 3.30e-01 | 5.17e-01 |
| GOBP REGULATION OF NEUTROPHIL EXTRAVASATION | 6 | 1.62e-01 | 3.30e-01 | 6.87e-01 |
| GOBP NATURAL KILLER CELL PROLIFERATION | 11 | 5.85e-02 | 3.29e-01 | 4.73e-01 |
| GOBP STRESS GRANULE DISASSEMBLY | 5 | 2.02e-01 | -3.29e-01 | 7.32e-01 |
| GOMF CROSSOVER JUNCTION DNA ENDONUCLEASE ACTIVITY | 6 | 1.63e-01 | -3.29e-01 | 6.88e-01 |
| GOBP EMBRYONIC NEUROCRANIUM MORPHOGENESIS | 6 | 1.63e-01 | -3.29e-01 | 6.88e-01 |
| GOCC SODIUM POTASSIUM EXCHANGING ATPASE COMPLEX | 5 | 2.03e-01 | -3.29e-01 | 7.32e-01 |
| GOBP REGULATION OF MITOPHAGY | 14 | 3.32e-02 | -3.29e-01 | 3.72e-01 |
| GOBP REGULATION OF VIRAL GENOME REPLICATION | 72 | 1.43e-06 | 3.29e-01 | 2.40e-04 |
| GOBP INTERFERON BETA PRODUCTION | 52 | 4.21e-05 | 3.28e-01 | 3.85e-03 |
| GOBP REGULATION OF DNA TOPOISOMERASE ATP HYDROLYZING ACTIVITY | 5 | 2.03e-01 | 3.28e-01 | 7.32e-01 |
| GOBP SUPPRESSION OF VIRAL RELEASE BY HOST | 14 | 3.34e-02 | 3.28e-01 | 3.74e-01 |
| GOBP DETOXIFICATION OF COPPER ION | 9 | 8.84e-02 | -3.28e-01 | 5.58e-01 |
| GOMF MUTSALPHA COMPLEX BINDING | 6 | 1.65e-01 | 3.28e-01 | 6.90e-01 |
| GOBP VENTRAL SPINAL CORD DEVELOPMENT | 16 | 2.33e-02 | -3.28e-01 | 3.15e-01 |
| GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY | 5 | 2.05e-01 | 3.27e-01 | 7.33e-01 |
| GOBP REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 9 | 8.91e-02 | 3.27e-01 | 5.59e-01 |
| GOBP POSITIVE REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 6 | 1.65e-01 | 3.27e-01 | 6.93e-01 |
| GOMF THREONINE TYPE ENDOPEPTIDASE ACTIVITY | 7 | 1.34e-01 | 3.27e-01 | 6.51e-01 |
| GOBP CELLULAR RESPONSE TO CAFFEINE | 8 | 1.10e-01 | 3.27e-01 | 6.01e-01 |
| GOBP S ADENOSYLMETHIONINE CYCLE | 7 | 1.36e-01 | -3.26e-01 | 6.52e-01 |
| GOMF FIBRONECTIN BINDING | 18 | 1.68e-02 | -3.26e-01 | 2.72e-01 |
| GOBP INHIBITORY POSTSYNAPTIC POTENTIAL | 6 | 1.67e-01 | 3.26e-01 | 6.95e-01 |
| GOCC PHOSPHOLIPID TRANSLOCATING ATPASE COMPLEX | 11 | 6.16e-02 | 3.26e-01 | 4.85e-01 |
| GOMF LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY | 12 | 5.10e-02 | -3.25e-01 | 4.53e-01 |
| GOBP UBIQUITIN RECYCLING | 13 | 4.24e-02 | 3.25e-01 | 4.21e-01 |
| GOBP MESENCHYME MORPHOGENESIS | 23 | 6.98e-03 | 3.25e-01 | 1.61e-01 |
| GOBP CONVERGENT EXTENSION | 8 | 1.12e-01 | -3.25e-01 | 6.05e-01 |
| GOBP POSITIVE REGULATION OF MAST CELL ACTIVATION | 13 | 4.31e-02 | 3.24e-01 | 4.24e-01 |
| GOBP RRNA CATABOLIC PROCESS | 18 | 1.73e-02 | 3.24e-01 | 2.75e-01 |
| GOBP POSITIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE | 5 | 2.10e-01 | -3.24e-01 | 7.43e-01 |
| GOCC NUCLEOTIDE EXCISION REPAIR COMPLEX | 11 | 6.32e-02 | -3.23e-01 | 4.89e-01 |
| GOMF ATPASE COUPLED LIPID TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 2.11e-01 | -3.23e-01 | 7.44e-01 |
| GOBP REGULATION OF RAB PROTEIN SIGNAL TRANSDUCTION | 7 | 1.39e-01 | 3.23e-01 | 6.59e-01 |
| GOBP PSEUDOPODIUM ORGANIZATION | 10 | 7.68e-02 | 3.23e-01 | 5.30e-01 |
| GOMF SUMO POLYMER BINDING | 6 | 1.70e-01 | -3.23e-01 | 6.99e-01 |
| GOBP POSITIVE REGULATION OF SPINDLE ASSEMBLY | 7 | 1.39e-01 | 3.23e-01 | 6.59e-01 |
| GOBP PROTEIN RETENTION IN ER LUMEN | 7 | 1.39e-01 | -3.23e-01 | 6.59e-01 |
| GOCC EXORIBONUCLEASE COMPLEX | 19 | 1.50e-02 | 3.22e-01 | 2.58e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL PROLIFERATION | 8 | 1.14e-01 | 3.22e-01 | 6.11e-01 |
| GOBP LIPID DROPLET DISASSEMBLY | 5 | 2.12e-01 | -3.22e-01 | 7.45e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEUBIQUITINATION | 5 | 2.12e-01 | -3.22e-01 | 7.45e-01 |
| GOMF CALCIUM INDEPENDENT PHOSPHOLIPASE A2 ACTIVITY | 8 | 1.15e-01 | -3.22e-01 | 6.11e-01 |
| GOBP ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE | 19 | 1.51e-02 | -3.22e-01 | 2.59e-01 |
| GOMF RIBOSOMAL SMALL SUBUNIT BINDING | 17 | 2.17e-02 | -3.22e-01 | 3.06e-01 |
| GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT INTO CELL | 6 | 1.73e-01 | 3.22e-01 | 7.02e-01 |
| GOBP REGULATION OF T CELL MEDIATED IMMUNITY | 65 | 7.56e-06 | 3.21e-01 | 9.84e-04 |
| GOBP ASYMMETRIC NEUROBLAST DIVISION | 5 | 2.14e-01 | -3.21e-01 | 7.46e-01 |
| GOBP PROTEIN O LINKED MANNOSYLATION | 16 | 2.63e-02 | -3.21e-01 | 3.31e-01 |
| GOBP REGULATORY T CELL DIFFERENTIATION | 30 | 2.37e-03 | 3.21e-01 | 8.26e-02 |
| GOCC LAMIN FILAMENT | 5 | 2.15e-01 | -3.20e-01 | 7.46e-01 |
| GOBP MICROGLIA DIFFERENTIATION | 10 | 7.96e-02 | 3.20e-01 | 5.39e-01 |
| GOBP MITOTIC SISTER CHROMATID SEPARATION | 57 | 2.93e-05 | 3.20e-01 | 2.83e-03 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS | 9 | 9.64e-02 | -3.20e-01 | 5.76e-01 |
| GOBP GLYCOSIDE CATABOLIC PROCESS | 7 | 1.43e-01 | -3.20e-01 | 6.65e-01 |
| GOBP REGULATION OF MDA 5 SIGNALING PATHWAY | 6 | 1.75e-01 | 3.20e-01 | 7.05e-01 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA SIGNALING PATHWAY | 6 | 1.75e-01 | -3.20e-01 | 7.05e-01 |
| GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 26 | 4.78e-03 | -3.20e-01 | 1.29e-01 |
| GOBP ER OVERLOAD RESPONSE | 11 | 6.65e-02 | -3.20e-01 | 5.03e-01 |
| GOMF NADPLUS PROTEIN ASPARTATE ADP RIBOSYLTRANSFERASE ACTIVITY | 5 | 2.16e-01 | 3.20e-01 | 7.47e-01 |
| GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 8 | 1.18e-01 | 3.19e-01 | 6.17e-01 |
| GOBP BIOLOGICAL PHASE | 5 | 2.16e-01 | 3.19e-01 | 7.47e-01 |
| GOMF PEPTIDYL PROLINE DIOXYGENASE ACTIVITY | 10 | 8.05e-02 | -3.19e-01 | 5.41e-01 |
| GOBP PULMONARY VALVE MORPHOGENESIS | 10 | 8.07e-02 | 3.19e-01 | 5.41e-01 |
| GOMF HISTONE H3K9 MONOMETHYLTRANSFERASE ACTIVITY | 5 | 2.17e-01 | 3.19e-01 | 7.49e-01 |
| GOBP REGULATION OF XENOPHAGY | 7 | 1.44e-01 | 3.19e-01 | 6.65e-01 |
| GOBP RESPONSE TO FOLIC ACID | 6 | 1.77e-01 | -3.18e-01 | 7.08e-01 |
| GOCC EPSILON DNA POLYMERASE COMPLEX | 5 | 2.18e-01 | -3.18e-01 | 7.49e-01 |
| GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE | 12 | 5.67e-02 | -3.18e-01 | 4.70e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 13 | 4.74e-02 | -3.18e-01 | 4.42e-01 |
| GOCC INNER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX | 144 | 4.91e-11 | -3.18e-01 | 2.80e-08 |
| GOMF LONG CHAIN FATTY ACID TRANSPORTER ACTIVITY | 13 | 4.82e-02 | -3.16e-01 | 4.45e-01 |
| GOBP NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 9 | 1.00e-01 | -3.16e-01 | 5.84e-01 |
| GOMF THIOESTERASE BINDING | 9 | 1.00e-01 | 3.16e-01 | 5.84e-01 |
| GOBP L SERINE BIOSYNTHETIC PROCESS | 5 | 2.20e-01 | -3.16e-01 | 7.49e-01 |
| GOBP REPLACEMENT OSSIFICATION | 16 | 2.85e-02 | -3.16e-01 | 3.46e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN KINASE A SIGNALING | 5 | 2.21e-01 | -3.16e-01 | 7.49e-01 |
| GOBP POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION | 20 | 1.45e-02 | 3.16e-01 | 2.54e-01 |
| GOMF GALACTOSYLTRANSFERASE ACTIVITY | 19 | 1.72e-02 | 3.16e-01 | 2.74e-01 |
| GOBP REGULATION OF DNA DEMETHYLATION | 8 | 1.22e-01 | -3.15e-01 | 6.25e-01 |
| GOBP CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES | 13 | 4.92e-02 | 3.15e-01 | 4.46e-01 |
| GOBP CALMODULIN DEPENDENT KINASE SIGNALING PATHWAY | 7 | 1.49e-01 | -3.15e-01 | 6.72e-01 |
| GOBP CAMKK AMPK SIGNALING CASCADE | 6 | 1.82e-01 | -3.15e-01 | 7.13e-01 |
| GOBP INTERLEUKIN 17 MEDIATED SIGNALING PATHWAY | 8 | 1.23e-01 | 3.15e-01 | 6.26e-01 |
| GOBP NEURONAL ACTION POTENTIAL PROPAGATION | 5 | 2.23e-01 | -3.15e-01 | 7.51e-01 |
| GOMF SEQUENCE SPECIFIC MRNA BINDING | 8 | 1.23e-01 | 3.15e-01 | 6.26e-01 |
| GOBP POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION | 20 | 1.49e-02 | 3.15e-01 | 2.58e-01 |
| GOMF CALCIUM RELEASE CHANNEL ACTIVITY | 16 | 2.94e-02 | 3.14e-01 | 3.49e-01 |
| GOMF NEUROPEPTIDE RECEPTOR BINDING | 10 | 8.52e-02 | -3.14e-01 | 5.50e-01 |
| GOBP REGULATION OF MICROTUBULE NUCLEATION | 19 | 1.77e-02 | 3.14e-01 | 2.80e-01 |
| GOMF 1 ACYLGLYCEROPHOSPHOCHOLINE O ACYLTRANSFERASE ACTIVITY | 7 | 1.50e-01 | -3.14e-01 | 6.73e-01 |
| GOBP TROPHOBLAST GIANT CELL DIFFERENTIATION | 5 | 2.24e-01 | 3.14e-01 | 7.52e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPIRATION | 8 | 1.24e-01 | -3.14e-01 | 6.28e-01 |
| GOBP NEGATIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 5 | 2.24e-01 | -3.14e-01 | 7.53e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 9 | 1.03e-01 | 3.14e-01 | 5.93e-01 |
| GOCC F ACTIN CAPPING PROTEIN COMPLEX | 6 | 1.84e-01 | -3.13e-01 | 7.15e-01 |
| GOBP TRANSLATIONAL READTHROUGH | 8 | 1.25e-01 | 3.13e-01 | 6.29e-01 |
| GOBP POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION | 6 | 1.84e-01 | 3.13e-01 | 7.16e-01 |
| GOBP REGULATION OF GLUCOCORTICOID RECEPTOR SIGNALING PATHWAY | 5 | 2.26e-01 | 3.13e-01 | 7.56e-01 |
| GOCC RNA POLYMERASE I COMPLEX | 10 | 8.70e-02 | -3.13e-01 | 5.56e-01 |
| GOBP NK T CELL ACTIVATION | 9 | 1.05e-01 | 3.13e-01 | 5.94e-01 |
| GOBP MALONYL COA METABOLIC PROCESS | 6 | 1.85e-01 | -3.12e-01 | 7.16e-01 |
| GOMF L ASPARTATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 1.52e-01 | -3.12e-01 | 6.74e-01 |
| GOBP ATP SYNTHESIS COUPLED ELECTRON TRANSPORT | 92 | 2.41e-07 | -3.12e-01 | 4.86e-05 |
| GOBP NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION | 7 | 1.53e-01 | -3.12e-01 | 6.75e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX | 6 | 1.86e-01 | 3.12e-01 | 7.17e-01 |
| GOCC EXTRINSIC COMPONENT OF MITOCHONDRIAL INNER MEMBRANE | 7 | 1.54e-01 | -3.11e-01 | 6.75e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET ACTIVATION | 10 | 8.83e-02 | -3.11e-01 | 5.58e-01 |
| GOBP DIPEPTIDE TRANSMEMBRANE TRANSPORT | 7 | 1.54e-01 | -3.11e-01 | 6.75e-01 |
| GOBP MUSCLE HYPERTROPHY IN RESPONSE TO STRESS | 13 | 5.22e-02 | 3.11e-01 | 4.58e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 13 | 5.24e-02 | 3.11e-01 | 4.58e-01 |
| GOBP REGULATION OF CELL KILLING | 68 | 9.52e-06 | 3.11e-01 | 1.13e-03 |
| GOBP REGULATION OF DNA CATABOLIC PROCESS | 8 | 1.28e-01 | -3.11e-01 | 6.37e-01 |
| GOCC CENTRIOLAR SUBDISTAL APPENDAGE | 9 | 1.07e-01 | 3.11e-01 | 5.96e-01 |
| GOBP ZYMOGEN INHIBITION | 7 | 1.55e-01 | 3.10e-01 | 6.77e-01 |
| GOBP REGULATION OF TRANSFORMING GROWTH FACTOR BETA ACTIVATION | 5 | 2.29e-01 | -3.10e-01 | 7.58e-01 |
| GOCC AP 1 ADAPTOR COMPLEX | 11 | 7.47e-02 | -3.10e-01 | 5.26e-01 |
| GOBP CELLULAR RESPONSE TO INDOLE 3 METHANOL | 5 | 2.29e-01 | 3.10e-01 | 7.58e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 7 | 1.55e-01 | -3.10e-01 | 6.77e-01 |
| GOBP AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION | 5 | 2.30e-01 | -3.10e-01 | 7.58e-01 |
| GOBP AV NODE CELL TO BUNDLE OF HIS CELL SIGNALING | 5 | 2.30e-01 | -3.10e-01 | 7.58e-01 |
| GOBP POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 16 | 3.19e-02 | 3.10e-01 | 3.62e-01 |
| GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION | 5 | 2.30e-01 | 3.10e-01 | 7.58e-01 |
| GOMF EXTRACELLULAR MATRIX CONSTITUENT CONFERRING ELASTICITY | 5 | 2.31e-01 | -3.10e-01 | 7.58e-01 |
| GOBP REGULATION OF PROTEIN OLIGOMERIZATION | 5 | 2.31e-01 | 3.09e-01 | 7.58e-01 |
| GOBP REGULATION OF I KAPPAB PHOSPHORYLATION | 5 | 2.31e-01 | -3.09e-01 | 7.58e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 6 | 1.90e-01 | -3.09e-01 | 7.19e-01 |
| GOCC GLYCOPROTEIN COMPLEX | 12 | 6.37e-02 | 3.09e-01 | 4.91e-01 |
| GOBP TRABECULA FORMATION | 15 | 3.84e-02 | -3.09e-01 | 4.00e-01 |
| GOBP INTERLEUKIN 3 MEDIATED SIGNALING PATHWAY | 6 | 1.91e-01 | 3.09e-01 | 7.21e-01 |
| GOMF ARYLSULFATASE ACTIVITY | 8 | 1.31e-01 | 3.08e-01 | 6.41e-01 |
| GOBP PITUITARY GLAND DEVELOPMENT | 11 | 7.68e-02 | 3.08e-01 | 5.30e-01 |
| GOBP CHOLESTEROL CATABOLIC PROCESS | 5 | 2.33e-01 | -3.08e-01 | 7.62e-01 |
| GOMF PHOSPHATASE ACTIVATOR ACTIVITY | 16 | 3.32e-02 | 3.08e-01 | 3.72e-01 |
| GOMF PENTOSYLTRANSFERASE ACTIVITY | 47 | 2.67e-04 | 3.07e-01 | 1.62e-02 |
| GOBP MITOTIC SPINDLE ELONGATION | 11 | 7.75e-02 | 3.07e-01 | 5.33e-01 |
| GOMF TRNA CYTOSINE METHYLTRANSFERASE ACTIVITY | 9 | 1.10e-01 | 3.07e-01 | 6.02e-01 |
| GOCC NEURONAL DENSE CORE VESICLE | 8 | 1.32e-01 | -3.07e-01 | 6.46e-01 |
| GOCC SERINE TYPE PEPTIDASE COMPLEX | 6 | 1.93e-01 | -3.07e-01 | 7.22e-01 |
| GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK FORMATION | 5 | 2.35e-01 | -3.07e-01 | 7.63e-01 |
| GOBP VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY | 7 | 1.61e-01 | 3.06e-01 | 6.87e-01 |
| GOCC NUCLEAR LAMINA | 12 | 6.66e-02 | -3.06e-01 | 5.03e-01 |
| GOBP REGULATION OF PLASMINOGEN ACTIVATION | 13 | 5.66e-02 | -3.05e-01 | 4.70e-01 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 4F COMPLEX | 11 | 7.96e-02 | -3.05e-01 | 5.39e-01 |
| GOBP GROOMING BEHAVIOR | 6 | 1.96e-01 | -3.05e-01 | 7.27e-01 |
| GOBP N TERMINAL PROTEIN LIPIDATION | 5 | 2.38e-01 | 3.05e-01 | 7.67e-01 |
| GOBP REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 9 | 1.13e-01 | 3.05e-01 | 6.10e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC PLASTICITY | 7 | 1.63e-01 | 3.05e-01 | 6.88e-01 |
| GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE MEMBRANE | 17 | 2.98e-02 | -3.04e-01 | 3.50e-01 |
| GOBP MAINTENANCE OF DNA REPEAT ELEMENTS | 6 | 1.97e-01 | 3.04e-01 | 7.28e-01 |
| GOMF ASPARTIC ENDOPEPTIDASE ACTIVITY INTRAMEMBRANE CLEAVING | 7 | 1.64e-01 | 3.04e-01 | 6.90e-01 |
| GOBP POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 17 | 3.03e-02 | 3.03e-01 | 3.53e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL PROLIFERATION | 9 | 1.15e-01 | 3.03e-01 | 6.12e-01 |
| GOMF ELECTRON TRANSFER ACTIVITY | 102 | 1.24e-07 | -3.03e-01 | 2.59e-05 |
| GOMF INTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 18 | 2.61e-02 | 3.03e-01 | 3.31e-01 |
| GOMF NUCLEAR VITAMIN D RECEPTOR BINDING | 15 | 4.24e-02 | 3.03e-01 | 4.21e-01 |
| GOBP ESTABLISHMENT OF MITOTIC SISTER CHROMATID COHESION | 7 | 1.66e-01 | 3.03e-01 | 6.93e-01 |
| GOBP VESICLE TETHERING INVOLVED IN EXOCYTOSIS | 9 | 1.16e-01 | 3.03e-01 | 6.15e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 6 | 2.00e-01 | -3.02e-01 | 7.31e-01 |
| GOBP GLYCINE METABOLIC PROCESS | 10 | 9.84e-02 | -3.02e-01 | 5.81e-01 |
| GOBP PHAGOCYTOSIS RECOGNITION | 11 | 8.30e-02 | -3.02e-01 | 5.44e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID TRANSPORT | 11 | 8.31e-02 | 3.02e-01 | 5.44e-01 |
| GOBP POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 16 | 3.67e-02 | 3.02e-01 | 3.90e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC CELL CLEARANCE | 6 | 2.01e-01 | -3.02e-01 | 7.32e-01 |
| GOMF PROTON TRANSMEMBRANE TRANSPORTER ACTIVITY | 107 | 7.20e-08 | -3.02e-01 | 1.69e-05 |
| GOMF POLY A RNA POLYMERASE ACTIVITY | 8 | 1.40e-01 | 3.01e-01 | 6.61e-01 |
| GOCC PRERIBOSOME LARGE SUBUNIT PRECURSOR | 19 | 2.30e-02 | -3.01e-01 | 3.12e-01 |
| GOBP GASTRIC ACID SECRETION | 6 | 2.01e-01 | 3.01e-01 | 7.32e-01 |
| GOCC MITOCHONDRIAL PYRUVATE DEHYDROGENASE COMPLEX | 7 | 1.69e-01 | -3.00e-01 | 6.96e-01 |
| GOBP NEGATIVE REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS | 6 | 2.03e-01 | -3.00e-01 | 7.32e-01 |
| GOMF EUKARYOTIC TRANSLATION INITIATION FACTOR 2ALPHA KINASE ACTIVITY | 6 | 2.03e-01 | 3.00e-01 | 7.32e-01 |
| GOBP SPINDLE ELONGATION | 13 | 6.14e-02 | 3.00e-01 | 4.85e-01 |
| GOBP PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING | 13 | 6.14e-02 | -3.00e-01 | 4.85e-01 |
| GOBP EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS | 14 | 5.23e-02 | -3.00e-01 | 4.58e-01 |
| GOBP REGULATION OF WOUND HEALING SPREADING OF EPIDERMAL CELLS | 7 | 1.70e-01 | 3.00e-01 | 6.98e-01 |
| GOBP REGULATION OF RESPIRATORY SYSTEM PROCESS | 8 | 1.42e-01 | -2.99e-01 | 6.65e-01 |
| GOMF CLATHRIN HEAVY CHAIN BINDING | 9 | 1.20e-01 | 2.99e-01 | 6.21e-01 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST | 23 | 1.32e-02 | 2.99e-01 | 2.40e-01 |
| GOBP SLEEP | 10 | 1.02e-01 | -2.99e-01 | 5.88e-01 |
| GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 8 | 1.44e-01 | 2.99e-01 | 6.65e-01 |
| GOBP GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT | 9 | 1.21e-01 | 2.99e-01 | 6.23e-01 |
| GOBP OOCYTE MATURATION | 16 | 3.88e-02 | 2.98e-01 | 4.03e-01 |
| GOBP POSITIVE REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS | 8 | 1.44e-01 | -2.98e-01 | 6.65e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN SUMOYLATION | 11 | 8.68e-02 | 2.98e-01 | 5.56e-01 |
| GOBP NEGATIVE REGULATION OF LIPASE ACTIVITY | 7 | 1.72e-01 | 2.98e-01 | 7.02e-01 |
| GOBP PROTEIN LINEAR POLYUBIQUITINATION | 5 | 2.49e-01 | 2.98e-01 | 7.76e-01 |
| GOBP SEGMENT SPECIFICATION | 6 | 2.06e-01 | -2.98e-01 | 7.35e-01 |
| GOBP REGULATION OF AMYLOID BETA CLEARANCE | 13 | 6.32e-02 | -2.98e-01 | 4.89e-01 |
| GOMF NAD DEPENDENT PROTEIN DEACETYLASE ACTIVITY | 7 | 1.73e-01 | 2.97e-01 | 7.03e-01 |
| GOBP POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 10 | 1.03e-01 | 2.97e-01 | 5.93e-01 |
| GOBP RETINAL BIPOLAR NEURON DIFFERENTIATION | 5 | 2.51e-01 | 2.97e-01 | 7.77e-01 |
| GOBP B CELL HOMEOSTASIS | 29 | 5.69e-03 | 2.97e-01 | 1.41e-01 |
| GOBP SYNAPTIC TRANSMISSION CHOLINERGIC | 10 | 1.04e-01 | -2.97e-01 | 5.94e-01 |
| GOMF DESUMOYLASE ACTIVITY | 7 | 1.74e-01 | 2.97e-01 | 7.05e-01 |
| GOBP REGULATION OF LONG TERM SYNAPTIC DEPRESSION | 7 | 1.75e-01 | 2.96e-01 | 7.05e-01 |
| GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 26 | 8.94e-03 | 2.96e-01 | 1.87e-01 |
| GOBP REGULATION OF PHOSPHOLIPID TRANSPORT | 12 | 7.62e-02 | -2.96e-01 | 5.30e-01 |
| GOBP BONE GROWTH | 16 | 4.06e-02 | -2.96e-01 | 4.12e-01 |
| GOBP ASTROCYTE CELL MIGRATION | 6 | 2.10e-01 | -2.96e-01 | 7.44e-01 |
| GOBP ENDOCARDIAL CUSHION DEVELOPMENT | 22 | 1.64e-02 | 2.96e-01 | 2.72e-01 |
| GOBP GLUCOSE CATABOLIC PROCESS | 21 | 1.91e-02 | -2.96e-01 | 2.88e-01 |
| GOBP REGULATION OF FATTY ACID TRANSPORT | 17 | 3.51e-02 | 2.95e-01 | 3.81e-01 |
| GOMF CHEMOKINE BINDING | 16 | 4.10e-02 | -2.95e-01 | 4.13e-01 |
| GOMF CERAMIDE 1 PHOSPHATE BINDING | 6 | 2.11e-01 | 2.95e-01 | 7.44e-01 |
| GOBP NOSE DEVELOPMENT | 6 | 2.11e-01 | 2.95e-01 | 7.44e-01 |
| GOBP MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 18 | 3.06e-02 | 2.94e-01 | 3.53e-01 |
| GOBP DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION | 12 | 7.76e-02 | -2.94e-01 | 5.33e-01 |
| GOMF NUCLEAR THYROID HORMONE RECEPTOR BINDING | 28 | 7.07e-03 | 2.94e-01 | 1.63e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY | 13 | 6.66e-02 | 2.94e-01 | 5.03e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION | 22 | 1.71e-02 | 2.94e-01 | 2.74e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT | 12 | 7.82e-02 | 2.94e-01 | 5.35e-01 |
| GOBP REGULATION OF MICROTUBULE BINDING | 7 | 1.79e-01 | -2.94e-01 | 7.10e-01 |
| GOBP THALAMUS DEVELOPMENT | 6 | 2.13e-01 | -2.94e-01 | 7.46e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS | 6 | 2.13e-01 | -2.93e-01 | 7.46e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 7 | 1.79e-01 | 2.93e-01 | 7.10e-01 |
| GOMF VOLTAGE GATED CHLORIDE CHANNEL ACTIVITY | 7 | 1.79e-01 | 2.93e-01 | 7.10e-01 |
| GOMF 5S RRNA BINDING | 9 | 1.28e-01 | -2.93e-01 | 6.36e-01 |
| GOMF STRUCTURAL MOLECULE ACTIVITY CONFERRING ELASTICITY | 7 | 1.79e-01 | -2.93e-01 | 7.10e-01 |
| GOCC PERICHROMATIN FIBRILS | 5 | 2.57e-01 | -2.93e-01 | 7.84e-01 |
| GOBP OSTEOCLAST PROLIFERATION | 7 | 1.80e-01 | -2.93e-01 | 7.10e-01 |
| GOCC LAMELLIPODIUM MEMBRANE | 18 | 3.26e-02 | -2.91e-01 | 3.68e-01 |
| GOBP MESODERMAL CELL DIFFERENTIATION | 12 | 8.09e-02 | -2.91e-01 | 5.41e-01 |
| GOBP SECRETORY GRANULE LOCALIZATION | 9 | 1.31e-01 | -2.91e-01 | 6.41e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS | 5 | 2.61e-01 | -2.91e-01 | 7.87e-01 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE PHOSPHORYLATION | 6 | 2.18e-01 | -2.90e-01 | 7.49e-01 |
| GOCC PRESYNAPTIC CYTOSOL | 12 | 8.18e-02 | -2.90e-01 | 5.43e-01 |
| GOBP MAINTENANCE OF APICAL BASAL CELL POLARITY | 6 | 2.18e-01 | 2.90e-01 | 7.49e-01 |
| GOMF INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY | 6 | 2.19e-01 | -2.90e-01 | 7.49e-01 |
| GOBP PROTON TRANSMEMBRANE TRANSPORT | 122 | 3.33e-08 | -2.90e-01 | 8.50e-06 |
| GOBP AXIS ELONGATION | 9 | 1.33e-01 | -2.89e-01 | 6.46e-01 |
| GOMF INOSITOL TETRAKISPHOSPHATE PHOSPHATASE ACTIVITY | 7 | 1.85e-01 | 2.89e-01 | 7.16e-01 |
| GOBP GROWTH HORMONE SECRETION | 8 | 1.57e-01 | -2.89e-01 | 6.80e-01 |
| GOMF FERROUS IRON TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 2.20e-01 | -2.89e-01 | 7.49e-01 |
| GOCC CMG COMPLEX | 11 | 9.70e-02 | -2.89e-01 | 5.77e-01 |
| GOCC LSM1 7 PAT1 COMPLEX | 5 | 2.63e-01 | -2.89e-01 | 7.88e-01 |
| GOMF SERINE TYPE CARBOXYPEPTIDASE ACTIVITY | 5 | 2.64e-01 | 2.89e-01 | 7.88e-01 |
| GOMF PROTEIN DEMETHYLASE ACTIVITY | 28 | 8.35e-03 | 2.88e-01 | 1.80e-01 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGA ISOTYPES | 6 | 2.22e-01 | 2.88e-01 | 7.51e-01 |
| GOMF ADENOSINE DEAMINASE ACTIVITY | 8 | 1.59e-01 | 2.88e-01 | 6.83e-01 |
| GOBP ANTIVIRAL INNATE IMMUNE RESPONSE | 38 | 2.16e-03 | 2.88e-01 | 7.84e-02 |
| GOBP NEUTROPHIL HOMEOSTASIS | 15 | 5.40e-02 | 2.87e-01 | 4.61e-01 |
| GOBP RESPONSE TO INTERLEUKIN 9 | 6 | 2.23e-01 | 2.87e-01 | 7.51e-01 |
| GOBP MESENCHYMAL CELL APOPTOTIC PROCESS | 6 | 2.23e-01 | 2.87e-01 | 7.51e-01 |
| GOBP TRANSPOSITION | 20 | 2.62e-02 | 2.87e-01 | 3.31e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT BIOGENESIS | 74 | 1.98e-05 | -2.87e-01 | 2.00e-03 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION | 28 | 8.58e-03 | 2.87e-01 | 1.82e-01 |
| GOBP REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY | 57 | 1.79e-04 | 2.87e-01 | 1.20e-02 |
| GOBP CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 8 | 1.60e-01 | -2.87e-01 | 6.85e-01 |
| GOBP CERAMIDE 1 PHOSPHATE TRANSPORT | 5 | 2.67e-01 | 2.87e-01 | 7.91e-01 |
| GOMF CERAMIDE 1 PHOSPHATE TRANSFER ACTIVITY | 5 | 2.67e-01 | 2.87e-01 | 7.91e-01 |
| GOBP REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 37 | 2.54e-03 | 2.87e-01 | 8.52e-02 |
| GOBP RESPIRATORY CHAIN COMPLEX III ASSEMBLY | 9 | 1.36e-01 | 2.87e-01 | 6.53e-01 |
| GOMF RNA POLYMERASE III ACTIVITY | 10 | 1.16e-01 | -2.87e-01 | 6.15e-01 |
| GOMF TRANSLATION ELONGATION FACTOR ACTIVITY | 19 | 3.05e-02 | -2.87e-01 | 3.53e-01 |
| GOCC ENDOCYTIC VESICLE LUMEN | 11 | 1.01e-01 | -2.86e-01 | 5.84e-01 |
| GOMF APOLIPOPROTEIN BINDING | 10 | 1.18e-01 | -2.86e-01 | 6.17e-01 |
| GOBP REGULATION OF T HELPER 1 CELL DIFFERENTIATION | 8 | 1.62e-01 | 2.86e-01 | 6.87e-01 |
| GOBP SEMINIFEROUS TUBULE DEVELOPMENT | 13 | 7.48e-02 | 2.85e-01 | 5.26e-01 |
| GOBP REGULATION OF MEMBRANE TUBULATION | 5 | 2.69e-01 | 2.85e-01 | 7.93e-01 |
| GOBP VESICLE MEDIATED CHOLESTEROL TRANSPORT | 8 | 1.62e-01 | 2.85e-01 | 6.87e-01 |
| GOBP TYROSINE METABOLIC PROCESS | 7 | 1.92e-01 | 2.85e-01 | 7.22e-01 |
| GOCC NUCLEAR ENVELOPE LUMEN | 7 | 1.93e-01 | -2.84e-01 | 7.22e-01 |
| GOMF TFIID CLASS TRANSCRIPTION FACTOR COMPLEX BINDING | 10 | 1.19e-01 | -2.84e-01 | 6.20e-01 |
| GOBP LATERAL VENTRICLE DEVELOPMENT | 8 | 1.64e-01 | -2.84e-01 | 6.90e-01 |
| GOBP REGULATION OF GAMMA DELTA T CELL ACTIVATION | 8 | 1.64e-01 | 2.84e-01 | 6.90e-01 |
| GOMF HISTONE H2A UBIQUITIN LIGASE ACTIVITY | 5 | 2.72e-01 | 2.84e-01 | 7.94e-01 |
| GOMF PROTEIN CONTAINING COMPLEX DESTABILIZING ACTIVITY | 11 | 1.04e-01 | 2.83e-01 | 5.94e-01 |
| GOBP PROTON MOTIVE FORCE DRIVEN ATP SYNTHESIS | 73 | 2.97e-05 | -2.83e-01 | 2.84e-03 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I | 31 | 6.46e-03 | 2.83e-01 | 1.53e-01 |
| GOBP TOXIN METABOLIC PROCESS | 6 | 2.30e-01 | -2.83e-01 | 7.58e-01 |
| GOBP GROWTH PLATE CARTILAGE CHONDROCYTE DIFFERENTIATION | 6 | 2.31e-01 | -2.83e-01 | 7.58e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION | 6 | 2.31e-01 | 2.82e-01 | 7.58e-01 |
| GOMF ARRESTIN FAMILY PROTEIN BINDING | 5 | 2.74e-01 | -2.82e-01 | 7.96e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX | 43 | 1.36e-03 | -2.82e-01 | 5.43e-02 |
| GOBP CYCLIC NUCLEOTIDE CATABOLIC PROCESS | 11 | 1.05e-01 | 2.82e-01 | 5.96e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 7 | 1.97e-01 | 2.82e-01 | 7.28e-01 |
| GOBP FATTY ACID ALPHA OXIDATION | 5 | 2.75e-01 | 2.82e-01 | 7.96e-01 |
| GOCC CYTOPLASMIC EXOSOME RNASE COMPLEX | 15 | 5.88e-02 | 2.82e-01 | 4.75e-01 |
| GOMF MUTLALPHA COMPLEX BINDING | 6 | 2.32e-01 | 2.82e-01 | 7.59e-01 |
| GOBP ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 47 | 8.38e-04 | 2.82e-01 | 3.85e-02 |
| GOMF SUPEROXIDE GENERATING NAD P H OXIDASE ACTIVITY | 5 | 2.75e-01 | 2.82e-01 | 7.96e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION | 49 | 6.55e-04 | 2.81e-01 | 3.20e-02 |
| GOCC CD40 RECEPTOR COMPLEX | 11 | 1.06e-01 | 2.81e-01 | 5.96e-01 |
| GOBP SPINAL CORD MOTOR NEURON DIFFERENTIATION | 12 | 9.16e-02 | -2.81e-01 | 5.63e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 5 | 2.76e-01 | 2.81e-01 | 7.98e-01 |
| GOBP PHOSPHATIDYLSERINE ACYL CHAIN REMODELING | 8 | 1.69e-01 | -2.81e-01 | 6.96e-01 |
| GOBP REGULATION OF MITOCHONDRIAL DNA METABOLIC PROCESS | 6 | 2.33e-01 | -2.81e-01 | 7.62e-01 |
| GOBP DCMP CATABOLIC PROCESS | 5 | 2.77e-01 | 2.81e-01 | 7.98e-01 |
| GOBP CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS | 19 | 3.43e-02 | 2.81e-01 | 3.78e-01 |
| GOBP TOLL SIGNALING PATHWAY | 9 | 1.45e-01 | 2.80e-01 | 6.68e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN NEDDYLATION | 5 | 2.78e-01 | -2.80e-01 | 7.99e-01 |
| GOBP POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION | 65 | 9.34e-05 | 2.80e-01 | 7.25e-03 |
| GOMF NUCLEOSIDE DIPHOSPHATE KINASE ACTIVITY | 15 | 6.02e-02 | -2.80e-01 | 4.80e-01 |
| GOMF PHOSPHATE ION BINDING | 5 | 2.78e-01 | -2.80e-01 | 7.99e-01 |
| GOBP REGULATION OF MYOBLAST PROLIFERATION | 7 | 1.99e-01 | 2.80e-01 | 7.31e-01 |
| GOMF HIGH DENSITY LIPOPROTEIN PARTICLE BINDING | 9 | 1.46e-01 | -2.80e-01 | 6.68e-01 |
| GOBP CELLULAR RESPONSE TO SALT STRESS | 11 | 1.08e-01 | -2.80e-01 | 5.99e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 9 | 1.46e-01 | 2.80e-01 | 6.69e-01 |
| GOCC OUTER KINETOCHORE | 18 | 4.04e-02 | 2.79e-01 | 4.11e-01 |
| GOBP VOCALIZATION BEHAVIOR | 9 | 1.47e-01 | -2.79e-01 | 6.70e-01 |
| GOBP NEGATIVE REGULATION OF CENTROSOME DUPLICATION | 11 | 1.09e-01 | 2.79e-01 | 6.00e-01 |
| GOBP GLUTATHIONE METABOLIC PROCESS | 36 | 3.79e-03 | -2.79e-01 | 1.14e-01 |
| GOMF ALDEHYDE DEHYDROGENASE NAD P PLUS ACTIVITY | 12 | 9.45e-02 | 2.79e-01 | 5.70e-01 |
| GOBP RESPONSE TO ACTINOMYCIN D | 5 | 2.80e-01 | -2.79e-01 | 7.99e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 15 | 6.16e-02 | -2.79e-01 | 4.85e-01 |
| GOBP L PROLINE BIOSYNTHETIC PROCESS | 5 | 2.80e-01 | -2.79e-01 | 7.99e-01 |
| GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 12 | 9.46e-02 | 2.79e-01 | 5.71e-01 |
| GOBP REGULATION OF MUSCLE ORGAN DEVELOPMENT | 9 | 1.48e-01 | 2.79e-01 | 6.70e-01 |
| GOBP PHENOTYPIC SWITCHING | 5 | 2.81e-01 | -2.78e-01 | 7.99e-01 |
| GOMF TRANSLATION INITIATION FACTOR ACTIVITY | 48 | 8.54e-04 | -2.78e-01 | 3.88e-02 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN | 6 | 2.38e-01 | -2.78e-01 | 7.67e-01 |
| GOMF AZOLE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 2.38e-01 | 2.78e-01 | 7.67e-01 |
| GOBP PHARYNGEAL SYSTEM DEVELOPMENT | 11 | 1.10e-01 | 2.78e-01 | 6.02e-01 |
| GOBP SYNAPTIC VESICLE LUMEN ACIDIFICATION | 13 | 8.25e-02 | -2.78e-01 | 5.43e-01 |
| GOBP DENSE CORE GRANULE LOCALIZATION | 6 | 2.38e-01 | -2.78e-01 | 7.67e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION VIA CPG ISLAND METHYLATION | 7 | 2.03e-01 | -2.78e-01 | 7.32e-01 |
| GOBP REGULATION OF STRESS GRANULE ASSEMBLY | 7 | 2.03e-01 | -2.78e-01 | 7.32e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS | 5 | 2.82e-01 | 2.78e-01 | 8.00e-01 |
| GOCC CHAPERONIN CONTAINING T COMPLEX | 9 | 1.49e-01 | -2.78e-01 | 6.72e-01 |
| GOBP CONSTITUTIVE SECRETORY PATHWAY | 7 | 2.03e-01 | -2.78e-01 | 7.32e-01 |
| GOBP PYRIMIDINE NUCLEOBASE METABOLIC PROCESS | 17 | 4.76e-02 | 2.78e-01 | 4.43e-01 |
| GOCC MICROTUBULE MINUS END | 7 | 2.04e-01 | 2.78e-01 | 7.32e-01 |
| GOBP REGULATION OF LYMPHOCYTE CHEMOTAXIS | 17 | 4.78e-02 | -2.77e-01 | 4.43e-01 |
| GOBP FOREBRAIN REGIONALIZATION | 5 | 2.83e-01 | -2.77e-01 | 8.02e-01 |
| GOBP DOPAMINERGIC NEURON DIFFERENTIATION | 15 | 6.30e-02 | 2.77e-01 | 4.89e-01 |
| GOBP REGULATION OF PENTOSE PHOSPHATE SHUNT | 6 | 2.40e-01 | -2.77e-01 | 7.68e-01 |
| GOMF MRNA 5 UTR BINDING | 23 | 2.15e-02 | -2.77e-01 | 3.06e-01 |
| GOBP LYMPHOCYTE MIGRATION INTO LYMPHOID ORGANS | 6 | 2.40e-01 | -2.77e-01 | 7.68e-01 |
| GOBP T HELPER 1 CELL DIFFERENTIATION | 16 | 5.53e-02 | 2.77e-01 | 4.64e-01 |
| GOBP ISOLEUCINE METABOLIC PROCESS | 7 | 2.05e-01 | 2.77e-01 | 7.33e-01 |
| GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 3 PHOSPHOMONOESTERS | 14 | 7.33e-02 | -2.77e-01 | 5.22e-01 |
| GOBP POSITIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING | 12 | 9.73e-02 | 2.76e-01 | 5.77e-01 |
| GOBP REGULATION OF RESPONSE TO OSMOTIC STRESS | 11 | 1.12e-01 | -2.76e-01 | 6.08e-01 |
| GOBP SUCCINYL COA METABOLIC PROCESS | 10 | 1.30e-01 | -2.76e-01 | 6.40e-01 |
| GOBP RESPONSE TO NERVE GROWTH FACTOR | 33 | 6.09e-03 | 2.76e-01 | 1.47e-01 |
| GOBP MACROPHAGE COLONY STIMULATING FACTOR SIGNALING PATHWAY | 6 | 2.42e-01 | -2.76e-01 | 7.71e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE CAPPING | 8 | 1.77e-01 | -2.76e-01 | 7.08e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION | 8 | 1.77e-01 | 2.76e-01 | 7.08e-01 |
| GOBP FOLIC ACID TRANSPORT | 9 | 1.52e-01 | -2.75e-01 | 6.74e-01 |
| GOBP OXIDATIVE PHOSPHORYLATION | 134 | 3.80e-08 | -2.75e-01 | 9.17e-06 |
| GOBP POSITIVE REGULATION OF GLYCOLYTIC PROCESS | 17 | 4.93e-02 | 2.75e-01 | 4.46e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE BINDING | 7 | 2.08e-01 | 2.75e-01 | 7.38e-01 |
| GOBP T HELPER 1 TYPE IMMUNE RESPONSE | 31 | 8.07e-03 | 2.75e-01 | 1.77e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS DISULFIDE AS ACCEPTOR | 5 | 2.87e-01 | 2.75e-01 | 8.05e-01 |
| GOCC SERINE TYPE ENDOPEPTIDASE COMPLEX | 5 | 2.88e-01 | -2.74e-01 | 8.05e-01 |
| GOBP TELOMERE MAINTENANCE VIA RECOMBINATION | 14 | 7.56e-02 | -2.74e-01 | 5.29e-01 |
| GOBP T CELL MEDIATED IMMUNITY | 85 | 1.25e-05 | 2.74e-01 | 1.43e-03 |
| GOBP PEPTIDYL LYSINE DEACETYLATION | 7 | 2.09e-01 | 2.74e-01 | 7.41e-01 |
| GOBP PROTEIN N LINKED GLYCOSYLATION VIA ASPARAGINE | 22 | 2.60e-02 | -2.74e-01 | 3.31e-01 |
| GOBP REGULATION OF GENE EXPRESSION BY GENOMIC IMPRINTING | 8 | 1.80e-01 | 2.74e-01 | 7.10e-01 |
| GOBP MYOSIN FILAMENT ORGANIZATION | 5 | 2.89e-01 | -2.74e-01 | 8.06e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO EARLY ENDOSOME | 8 | 1.80e-01 | 2.74e-01 | 7.10e-01 |
| GOBP L PHENYLALANINE METABOLIC PROCESS | 5 | 2.89e-01 | 2.74e-01 | 8.06e-01 |
| GOBP INTRACELLULAR SPHINGOLIPID HOMEOSTASIS | 5 | 2.90e-01 | -2.73e-01 | 8.06e-01 |
| GOBP REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION | 6 | 2.47e-01 | 2.73e-01 | 7.76e-01 |
| GOBP POSITIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 5 | 2.91e-01 | -2.73e-01 | 8.06e-01 |
| GOBP NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT | 8 | 1.82e-01 | 2.73e-01 | 7.13e-01 |
| GOBP PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING | 13 | 8.86e-02 | 2.73e-01 | 5.58e-01 |
| GOBP REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY | 6 | 2.47e-01 | 2.73e-01 | 7.76e-01 |
| GOBP NEGATIVE REGULATION OF STEROID METABOLIC PROCESS | 16 | 5.90e-02 | -2.73e-01 | 4.76e-01 |
| GOBP AMPA GLUTAMATE RECEPTOR CLUSTERING | 6 | 2.47e-01 | -2.73e-01 | 7.76e-01 |
| GOBP RESPONSE TO UV C | 12 | 1.02e-01 | 2.73e-01 | 5.89e-01 |
| GOBP DTMP METABOLIC PROCESS | 6 | 2.48e-01 | 2.72e-01 | 7.76e-01 |
| GOBP B CELL APOPTOTIC PROCESS | 23 | 2.38e-02 | 2.72e-01 | 3.19e-01 |
| GOBP PROTEIN LOCALIZATION TO AXON | 5 | 2.92e-01 | -2.72e-01 | 8.08e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION | 13 | 8.95e-02 | -2.72e-01 | 5.59e-01 |
| GOBP AUTOPHAGY OF PEROXISOME | 10 | 1.37e-01 | -2.72e-01 | 6.54e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS | 22 | 2.74e-02 | 2.72e-01 | 3.37e-01 |
| GOBP CHITIN METABOLIC PROCESS | 5 | 2.93e-01 | -2.72e-01 | 8.08e-01 |
| GOMF CHITINASE ACTIVITY | 5 | 2.93e-01 | -2.72e-01 | 8.08e-01 |
| GOBP POSITIVE REGULATION OF PLATELET AGGREGATION | 7 | 2.14e-01 | 2.71e-01 | 7.46e-01 |
| GOBP COLLAGEN CATABOLIC PROCESS | 24 | 2.14e-02 | -2.71e-01 | 3.06e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT | 12 | 1.04e-01 | 2.71e-01 | 5.94e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT | 11 | 1.20e-01 | 2.71e-01 | 6.20e-01 |
| GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR BINDING | 11 | 1.20e-01 | -2.71e-01 | 6.22e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEASE ACTIVITY | 6 | 2.51e-01 | -2.70e-01 | 7.78e-01 |
| GOCC CELL POLE | 5 | 2.95e-01 | -2.70e-01 | 8.10e-01 |
| GOBP DETECTION OF BIOTIC STIMULUS | 23 | 2.49e-02 | 2.70e-01 | 3.24e-01 |
| GOCC DNA RECOMBINASE MEDIATOR COMPLEX | 7 | 2.16e-01 | -2.70e-01 | 7.47e-01 |
| GOBP 2FE 2S CLUSTER ASSEMBLY | 11 | 1.21e-01 | -2.70e-01 | 6.23e-01 |
| GOBP REGULATION OF VIRAL PROCESS | 133 | 8.07e-08 | 2.70e-01 | 1.84e-05 |
| GOBP G QUADRUPLEX DNA UNWINDING | 7 | 2.17e-01 | 2.70e-01 | 7.48e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION | 46 | 1.58e-03 | 2.69e-01 | 6.13e-02 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CILIUM | 6 | 2.53e-01 | -2.69e-01 | 7.79e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS | 24 | 2.24e-02 | 2.69e-01 | 3.09e-01 |
| GOBP OOCYTE DIFFERENTIATION | 35 | 5.86e-03 | 2.69e-01 | 1.44e-01 |
| GOBP REGULATION OF PROSTAGLANDIN SECRETION | 8 | 1.88e-01 | 2.69e-01 | 7.17e-01 |
| GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 14 | 8.15e-02 | 2.69e-01 | 5.42e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION | 18 | 4.83e-02 | 2.69e-01 | 4.45e-01 |
| GOBP G PROTEIN COUPLED SEROTONIN RECEPTOR SIGNALING PATHWAY | 6 | 2.55e-01 | 2.68e-01 | 7.81e-01 |
| GOBP SEROTONIN RECEPTOR SIGNALING PATHWAY | 6 | 2.55e-01 | 2.68e-01 | 7.81e-01 |
| GOMF G PROTEIN COUPLED SEROTONIN RECEPTOR ACTIVITY | 6 | 2.55e-01 | 2.68e-01 | 7.81e-01 |
| GOMF SEROTONIN RECEPTOR ACTIVITY | 6 | 2.55e-01 | 2.68e-01 | 7.81e-01 |
| GOCC GTPASE ACTIVATOR COMPLEX | 11 | 1.24e-01 | -2.68e-01 | 6.26e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN | 10 | 1.42e-01 | -2.68e-01 | 6.65e-01 |
| GOMF ZINC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 19 | 4.33e-02 | -2.68e-01 | 4.24e-01 |
| GOMF MHC CLASS II PROTEIN COMPLEX BINDING | 22 | 2.97e-02 | 2.68e-01 | 3.50e-01 |
| GOBP STRESS INDUCED PREMATURE SENESCENCE | 5 | 3.00e-01 | -2.68e-01 | 8.14e-01 |
| GOBP CAP DEPENDENT TRANSLATIONAL INITIATION | 7 | 2.20e-01 | -2.68e-01 | 7.49e-01 |
| GOBP PLATELET MORPHOGENESIS | 19 | 4.36e-02 | -2.67e-01 | 4.25e-01 |
| GOBP RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES | 12 | 1.09e-01 | -2.67e-01 | 5.99e-01 |
| GOMF NUCLEOTIDASE ACTIVITY | 10 | 1.43e-01 | 2.67e-01 | 6.65e-01 |
| GOBP FATTY ACID DERIVATIVE CATABOLIC PROCESS | 12 | 1.09e-01 | -2.67e-01 | 6.00e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME SEPARATION | 25 | 2.09e-02 | 2.67e-01 | 3.02e-01 |
| GOBP RESPONSE TO EPINEPHRINE | 10 | 1.44e-01 | 2.67e-01 | 6.65e-01 |
| GOMF I SMAD BINDING | 14 | 8.43e-02 | 2.67e-01 | 5.46e-01 |
| GOBP SIALYLATION | 5 | 3.02e-01 | 2.66e-01 | 8.14e-01 |
| GOBP NEGATIVE REGULATION OF RESPIRATORY BURST | 5 | 3.03e-01 | 2.66e-01 | 8.14e-01 |
| GOBP AMINOPHOSPHOLIPID TRANSPORT | 8 | 1.92e-01 | 2.66e-01 | 7.22e-01 |
| GOBP CELLULAR RESPONSE TO ALKALOID | 27 | 1.67e-02 | 2.66e-01 | 2.72e-01 |
| GOMF NEUROTRANSMITTER BINDING | 5 | 3.03e-01 | 2.66e-01 | 8.14e-01 |
| GOBP REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 17 | 5.77e-02 | 2.66e-01 | 4.70e-01 |
| GOBP REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 29 | 1.33e-02 | 2.66e-01 | 2.41e-01 |
| GOBP PROTEIN LOCALIZATION TO MEMBRANE RAFT | 5 | 3.04e-01 | -2.66e-01 | 8.14e-01 |
| GOBP UV PROTECTION | 9 | 1.68e-01 | -2.66e-01 | 6.96e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS | 6 | 2.60e-01 | 2.66e-01 | 7.86e-01 |
| GOCC KERATIN FILAMENT | 8 | 1.94e-01 | -2.65e-01 | 7.24e-01 |
| GOMF MIRNA INHIBITOR ACTIVITY VIA BASE PAIRING | 5 | 3.05e-01 | -2.65e-01 | 8.15e-01 |
| GOBP MYOTUBE CELL DEVELOPMENT | 25 | 2.19e-02 | 2.65e-01 | 3.07e-01 |
| GOMF THIAMINE PYROPHOSPHATE BINDING | 5 | 3.05e-01 | 2.65e-01 | 8.15e-01 |
| GOBP RIBOSOMAL LARGE SUBUNIT EXPORT FROM NUCLEUS | 7 | 2.25e-01 | -2.65e-01 | 7.55e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL WATER HOMEOSTASIS | 13 | 9.89e-02 | -2.64e-01 | 5.82e-01 |
| GOBP REGULATION OF RHODOPSIN MEDIATED SIGNALING PATHWAY | 7 | 2.26e-01 | 2.64e-01 | 7.56e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT | 10 | 1.48e-01 | 2.64e-01 | 6.71e-01 |
| GOBP MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE | 14 | 8.73e-02 | 2.64e-01 | 5.57e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS | 77 | 6.30e-05 | 2.64e-01 | 5.21e-03 |
| GOBP RESPIRATORY ELECTRON TRANSPORT CHAIN | 112 | 1.44e-06 | -2.64e-01 | 2.40e-04 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION ARBORIZATION | 6 | 2.63e-01 | -2.64e-01 | 7.88e-01 |
| GOCC MICROVILLUS MEMBRANE | 18 | 5.31e-02 | -2.63e-01 | 4.60e-01 |
| GOBP REGULATION OF NADP METABOLIC PROCESS | 8 | 1.97e-01 | -2.63e-01 | 7.28e-01 |
| GOBP REGULATION OF DNA LIGATION | 6 | 2.64e-01 | -2.63e-01 | 7.88e-01 |
| GOMF SCAVENGER RECEPTOR ACTIVITY | 13 | 1.01e-01 | -2.63e-01 | 5.84e-01 |
| GOBP ESTABLISHMENT OF TISSUE POLARITY | 43 | 2.85e-03 | -2.63e-01 | 9.37e-02 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 58 | 5.33e-04 | 2.63e-01 | 2.68e-02 |
| GOCC DYNEIN AXONEMAL PARTICLE | 10 | 1.50e-01 | -2.63e-01 | 6.73e-01 |
| GOBP POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS | 14 | 8.86e-02 | -2.63e-01 | 5.58e-01 |
| GOBP ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION | 20 | 4.19e-02 | -2.63e-01 | 4.19e-01 |
| GOMF COPPER CHAPERONE ACTIVITY | 7 | 2.29e-01 | 2.63e-01 | 7.58e-01 |
| GOBP MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 16 | 6.89e-02 | 2.63e-01 | 5.12e-01 |
| GOBP RNA POLYMERASE I PREINITIATION COMPLEX ASSEMBLY | 8 | 1.98e-01 | 2.63e-01 | 7.31e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE POTENTIAL | 8 | 1.99e-01 | 2.62e-01 | 7.31e-01 |
| GOBP MORPHOGENESIS OF AN ENDOTHELIUM | 13 | 1.02e-01 | -2.62e-01 | 5.87e-01 |
| GOBP ORNITHINE METABOLIC PROCESS | 5 | 3.10e-01 | -2.62e-01 | 8.21e-01 |
| GOMF APOLIPOPROTEIN A I BINDING | 5 | 3.10e-01 | -2.62e-01 | 8.21e-01 |
| GOBP TYPE I INTERFERON PRODUCTION | 108 | 2.58e-06 | 2.62e-01 | 4.07e-04 |
| GOBP REGULATION OF HEART RATE BY CHEMICAL SIGNAL | 5 | 3.10e-01 | 2.62e-01 | 8.21e-01 |
| GOBP RESPONSE TO CORTISOL | 5 | 3.11e-01 | -2.62e-01 | 8.21e-01 |
| GOBP AMINOPHOSPHOLIPID TRANSLOCATION | 6 | 2.67e-01 | 2.62e-01 | 7.91e-01 |
| GOMF AMINOPHOSPHOLIPID FLIPPASE ACTIVITY | 6 | 2.67e-01 | 2.62e-01 | 7.91e-01 |
| GOMF ARYL HYDROCARBON RECEPTOR BINDING | 6 | 2.67e-01 | 2.62e-01 | 7.91e-01 |
| GOBP SPONTANEOUS SYNAPTIC TRANSMISSION | 7 | 2.31e-01 | 2.62e-01 | 7.58e-01 |
| GOBP RESPONSE TO L PHENYLALANINE DERIVATIVE | 5 | 3.12e-01 | -2.61e-01 | 8.21e-01 |
| GOMF SODIUM CHANNEL INHIBITOR ACTIVITY | 5 | 3.12e-01 | 2.61e-01 | 8.21e-01 |
| GOMF OXYGEN BINDING | 10 | 1.53e-01 | -2.61e-01 | 6.74e-01 |
| GOBP OPTIC NERVE DEVELOPMENT | 11 | 1.34e-01 | -2.61e-01 | 6.49e-01 |
| GOMF SELENIUM BINDING | 6 | 2.68e-01 | -2.61e-01 | 7.92e-01 |
| GOBP NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY | 10 | 1.53e-01 | -2.61e-01 | 6.74e-01 |
| GOBP AMYLOID BETA CLEARANCE BY TRANSCYTOSIS | 7 | 2.32e-01 | -2.61e-01 | 7.59e-01 |
| GOBP NUCLEOBASE CATABOLIC PROCESS | 6 | 2.69e-01 | 2.61e-01 | 7.93e-01 |
| GOBP OXIDATIVE RNA DEMETHYLATION | 5 | 3.13e-01 | 2.61e-01 | 8.22e-01 |
| GOMF OXIDATIVE RNA DEMETHYLASE ACTIVITY | 5 | 3.13e-01 | 2.61e-01 | 8.22e-01 |
| GOBP POSITIVE REGULATION OF ACTIN NUCLEATION | 12 | 1.18e-01 | -2.60e-01 | 6.19e-01 |
| GOBP RESPIRATORY SYSTEM PROCESS | 23 | 3.08e-02 | -2.60e-01 | 3.54e-01 |
| GOCC CALCINEURIN COMPLEX | 5 | 3.14e-01 | -2.60e-01 | 8.22e-01 |
| GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 BINDING | 8 | 2.03e-01 | -2.60e-01 | 7.32e-01 |
| GOBP HISTIDINE METABOLIC PROCESS | 7 | 2.34e-01 | -2.60e-01 | 7.62e-01 |
| GOBP REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY | 19 | 5.00e-02 | 2.60e-01 | 4.48e-01 |
| GOBP AMIDE CATABOLIC PROCESS | 11 | 1.36e-01 | -2.60e-01 | 6.52e-01 |
| GOBP GLUCOSYLCERAMIDE METABOLIC PROCESS | 5 | 3.15e-01 | -2.60e-01 | 8.22e-01 |
| GOBP REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS | 19 | 5.03e-02 | -2.59e-01 | 4.50e-01 |
| GOMF PROTEIN PHOSPHATASE 2A BINDING | 26 | 2.21e-02 | 2.59e-01 | 3.07e-01 |
| GOCC CILIARY TRANSITION FIBER | 7 | 2.35e-01 | 2.59e-01 | 7.63e-01 |
| GOBP NEGATIVE REGULATION OF MONONUCLEAR CELL MIGRATION | 15 | 8.24e-02 | 2.59e-01 | 5.43e-01 |
| GOBP LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS | 14 | 9.35e-02 | 2.59e-01 | 5.67e-01 |
| GOBP RESPONSE TO SORBITOL | 6 | 2.72e-01 | 2.59e-01 | 7.94e-01 |
| GOBP TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 15 | 8.27e-02 | 2.59e-01 | 5.44e-01 |
| GOBP REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 11 | 1.38e-01 | 2.59e-01 | 6.57e-01 |
| GOBP HYPOTHALAMUS CELL MIGRATION | 5 | 3.17e-01 | -2.59e-01 | 8.23e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE MIGRATION | 9 | 1.79e-01 | 2.59e-01 | 7.10e-01 |
| GOBP NEURON FATE SPECIFICATION | 5 | 3.17e-01 | -2.58e-01 | 8.23e-01 |
| GOMF PHOSPHOLIPID SCRAMBLASE ACTIVITY | 9 | 1.80e-01 | 2.58e-01 | 7.10e-01 |
| GOBP IRON ION TRANSMEMBRANE TRANSPORT | 19 | 5.15e-02 | -2.58e-01 | 4.55e-01 |
| GOBP PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY | 6 | 2.74e-01 | -2.58e-01 | 7.95e-01 |
| GOBP SENSORY PERCEPTION OF TEMPERATURE STIMULUS | 16 | 7.39e-02 | 2.58e-01 | 5.24e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION | 17 | 6.56e-02 | -2.58e-01 | 5.00e-01 |
| GOMF UBIQUITIN LIKE PROTEIN SPECIFIC ENDOPEPTIDASE ACTIVITY | 5 | 3.18e-01 | 2.58e-01 | 8.23e-01 |
| GOBP ATP BIOSYNTHETIC PROCESS | 93 | 1.75e-05 | -2.58e-01 | 1.84e-03 |
| GOBP ALPHA BETA T CELL PROLIFERATION | 32 | 1.16e-02 | 2.58e-01 | 2.18e-01 |
| GOBP 3 UTR MEDIATED MRNA STABILIZATION | 18 | 5.85e-02 | 2.58e-01 | 4.73e-01 |
| GOBP METANEPHRIC NEPHRON DEVELOPMENT | 17 | 6.60e-02 | 2.58e-01 | 5.02e-01 |
| GOBP EMBRYONIC PROCESS INVOLVED IN FEMALE PREGNANCY | 6 | 2.75e-01 | 2.57e-01 | 7.96e-01 |
| GOBP VESICLE CARGO LOADING | 27 | 2.08e-02 | 2.57e-01 | 3.02e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS | 7 | 2.39e-01 | -2.57e-01 | 7.68e-01 |
| GOMF RNA POLYMERASE I TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 8 | 2.08e-01 | 2.57e-01 | 7.39e-01 |
| GOMF PHOSPHORYLATION DEPENDENT PROTEIN BINDING | 6 | 2.76e-01 | 2.57e-01 | 7.97e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 18 | 5.92e-02 | -2.57e-01 | 4.76e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 83 | 5.29e-05 | 2.57e-01 | 4.60e-03 |
| GOBP PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE | 36 | 7.69e-03 | -2.57e-01 | 1.72e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED DNA REPLICATION | 12 | 1.24e-01 | -2.57e-01 | 6.26e-01 |
| GOCC MULTIVESICULAR BODY INTERNAL VESICLE | 5 | 3.21e-01 | -2.56e-01 | 8.27e-01 |
| GOBP SKELETAL MUSCLE CELL PROLIFERATION | 15 | 8.56e-02 | 2.56e-01 | 5.52e-01 |
| GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS | 5 | 3.21e-01 | -2.56e-01 | 8.27e-01 |
| GOBP TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS | 17 | 6.75e-02 | -2.56e-01 | 5.08e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 16 | 7.63e-02 | -2.56e-01 | 5.30e-01 |
| GOBP CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS | 11 | 1.42e-01 | 2.56e-01 | 6.64e-01 |
| GOCC SMALL SUBUNIT PROCESSOME | 70 | 2.17e-04 | -2.56e-01 | 1.39e-02 |
| GOBP RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR | 16 | 7.66e-02 | -2.56e-01 | 5.30e-01 |
| GOBP POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST | 12 | 1.25e-01 | 2.56e-01 | 6.30e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF T CELL POLARITY | 6 | 2.79e-01 | 2.55e-01 | 7.99e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 8 | 2.11e-01 | 2.55e-01 | 7.44e-01 |
| GOBP NEGATIVE REGULATION OF CYTOPLASMIC TRANSLATION | 7 | 2.42e-01 | 2.55e-01 | 7.71e-01 |
| GOBP POSITIVE REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 8 | 2.12e-01 | 2.55e-01 | 7.44e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF LIPID ANTIGEN VIA MHC CLASS IB | 5 | 3.23e-01 | 2.55e-01 | 8.29e-01 |
| GOBP EXONUCLEOLYTIC CATABOLISM OF DEADENYLATED MRNA | 13 | 1.12e-01 | 2.55e-01 | 6.06e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL BINDING | 13 | 1.12e-01 | 2.55e-01 | 6.07e-01 |
| GOCC ATG12 ATG5 ATG16 COMPLEX | 5 | 3.25e-01 | 2.54e-01 | 8.29e-01 |
| GOBP REGULATION OF MITOCHONDRIAL ATP SYNTHESIS COUPLED ELECTRON TRANSPORT | 6 | 2.81e-01 | 2.54e-01 | 7.99e-01 |
| GOBP SPINDLE MIDZONE ASSEMBLY | 13 | 1.13e-01 | 2.54e-01 | 6.08e-01 |
| GOMF PHOSPHATIDATE PHOSPHATASE ACTIVITY | 8 | 2.14e-01 | 2.54e-01 | 7.46e-01 |
| GOBP RESPONSE TO VIRUS | 329 | 2.84e-15 | 2.54e-01 | 3.08e-12 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 5 | 3.26e-01 | -2.54e-01 | 8.29e-01 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS I | 9 | 1.87e-01 | 2.54e-01 | 7.17e-01 |
| GOMF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY | 18 | 6.23e-02 | 2.54e-01 | 4.87e-01 |
| GOBP EPITHELIAL CELL FATE COMMITMENT | 6 | 2.82e-01 | -2.54e-01 | 8.00e-01 |
| GOMF GLUTATHIONE TRANSFERASE ACTIVITY | 18 | 6.24e-02 | -2.54e-01 | 4.87e-01 |
| GOBP VESICLE UNCOATING | 6 | 2.82e-01 | 2.54e-01 | 8.00e-01 |
| GOCC PROTEASOME CORE COMPLEX ALPHA SUBUNIT COMPLEX | 7 | 2.45e-01 | 2.54e-01 | 7.73e-01 |
| GOBP SIRNA PROCESSING | 8 | 2.14e-01 | -2.54e-01 | 7.46e-01 |
| GOBP REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE | 5 | 3.27e-01 | 2.53e-01 | 8.29e-01 |
| GOBP TOLERANCE INDUCTION | 17 | 7.07e-02 | 2.53e-01 | 5.17e-01 |
| GOCC AMPA GLUTAMATE RECEPTOR COMPLEX | 7 | 2.46e-01 | -2.53e-01 | 7.75e-01 |
| GOMF ALDEHYDE LYASE ACTIVITY | 5 | 3.27e-01 | 2.53e-01 | 8.29e-01 |
| GOBP SERINE PHOSPHORYLATION OF STAT PROTEIN | 6 | 2.83e-01 | -2.53e-01 | 8.02e-01 |
| GOBP DEFENSE RESPONSE TO FUNGUS | 19 | 5.65e-02 | -2.53e-01 | 4.70e-01 |
| GOBP NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 5 | 3.28e-01 | 2.53e-01 | 8.29e-01 |
| GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS | 6 | 2.84e-01 | 2.53e-01 | 8.02e-01 |
| GOMF PEPTIDOGLYCAN BINDING | 7 | 2.47e-01 | -2.53e-01 | 7.76e-01 |
| GOMF C4 DICARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 1.47e-01 | -2.53e-01 | 6.69e-01 |
| GOBP NEGATIVE REGULATION OF SCHWANN CELL PROLIFERATION | 7 | 2.47e-01 | 2.53e-01 | 7.76e-01 |
| GOBP SCHWANN CELL PROLIFERATION | 7 | 2.47e-01 | 2.53e-01 | 7.76e-01 |
| GOCC GROWTH CONE MEMBRANE | 5 | 3.28e-01 | 2.52e-01 | 8.30e-01 |
| GOBP MANNOSYLATION | 20 | 5.10e-02 | -2.52e-01 | 4.53e-01 |
| GOBP REGULATION OF CELL PROJECTION SIZE | 7 | 2.48e-01 | -2.52e-01 | 7.76e-01 |
| GOBP NEGATIVE REGULATION OF GLUCOSE IMPORT | 9 | 1.91e-01 | -2.52e-01 | 7.21e-01 |
| GOMF DYNACTIN BINDING | 10 | 1.68e-01 | -2.52e-01 | 6.96e-01 |
| GOBP RESPONSE TO LECTIN | 15 | 9.12e-02 | 2.52e-01 | 5.63e-01 |
| GOBP GLUTAMINE METABOLIC PROCESS | 20 | 5.13e-02 | -2.52e-01 | 4.54e-01 |
| GOBP PRIMARY MIRNA PROCESSING | 17 | 7.24e-02 | 2.52e-01 | 5.21e-01 |
| GOCC PTW PP1 PHOSPHATASE COMPLEX | 7 | 2.49e-01 | -2.52e-01 | 7.76e-01 |
| GOMF ADP RIBOSE DIPHOSPHATASE ACTIVITY | 6 | 2.86e-01 | 2.52e-01 | 8.04e-01 |
| GOMF 2 IRON 2 SULFUR CLUSTER BINDING | 21 | 4.60e-02 | -2.52e-01 | 4.34e-01 |
| GOBP REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 8 | 2.18e-01 | 2.51e-01 | 7.49e-01 |
| GOBP RESPONSE TO FORSKOLIN | 5 | 3.30e-01 | 2.51e-01 | 8.30e-01 |
| GOMF PHOSPHATIDYLSERINE FLOPPASE ACTIVITY | 8 | 2.18e-01 | 2.51e-01 | 7.49e-01 |
| GOBP ENDODERMAL CELL DIFFERENTIATION | 29 | 1.92e-02 | -2.51e-01 | 2.90e-01 |
| GOBP RIBOSOME ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 7 | 2.50e-01 | 2.51e-01 | 7.77e-01 |
| GOBP REGULATION OF CATECHOLAMINE METABOLIC PROCESS | 12 | 1.33e-01 | -2.51e-01 | 6.46e-01 |
| GOBP NEGATIVE REGULATION OF NEUROBLAST PROLIFERATION | 5 | 3.32e-01 | -2.51e-01 | 8.31e-01 |
| GOCC SMAD PROTEIN COMPLEX | 8 | 2.20e-01 | 2.51e-01 | 7.49e-01 |
| GOBP UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS | 8 | 2.20e-01 | -2.51e-01 | 7.49e-01 |
| GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX PROTON TRANSPORTING DOMAIN | 25 | 3.02e-02 | -2.50e-01 | 3.52e-01 |
| GOCC MITOTIC SPINDLE POLE | 35 | 1.04e-02 | 2.50e-01 | 2.05e-01 |
| GOBP REGULATION OF CELL MATURATION | 11 | 1.51e-01 | 2.50e-01 | 6.73e-01 |
| GOBP EPIDERMIS MORPHOGENESIS | 15 | 9.34e-02 | 2.50e-01 | 5.67e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 10 | 1.71e-01 | 2.50e-01 | 6.99e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION | 6 | 2.89e-01 | 2.50e-01 | 8.06e-01 |
| GOCC ER TO GOLGI TRANSPORT VESICLE MEMBRANE | 54 | 1.48e-03 | 2.50e-01 | 5.80e-02 |
| GOBP CYSTEINE METABOLIC PROCESS | 7 | 2.52e-01 | -2.50e-01 | 7.78e-01 |
| GOMF BUBBLE DNA BINDING | 8 | 2.21e-01 | 2.50e-01 | 7.49e-01 |
| GOBP REGULATION BY VIRUS OF VIRAL PROTEIN LEVELS IN HOST CELL | 7 | 2.52e-01 | 2.50e-01 | 7.78e-01 |
| GOBP RESPONSE TO VITAMIN A | 6 | 2.89e-01 | -2.50e-01 | 8.06e-01 |
| GOMF CALCIUM CHANNEL INHIBITOR ACTIVITY | 8 | 2.21e-01 | -2.50e-01 | 7.49e-01 |
| GOMF ARACHIDONATE COA LIGASE ACTIVITY | 8 | 2.21e-01 | 2.50e-01 | 7.49e-01 |
| GOBP REGULATION OF TETRAPYRROLE METABOLIC PROCESS | 7 | 2.53e-01 | -2.50e-01 | 7.78e-01 |
| GOBP REGULATION OF SREBP SIGNALING PATHWAY | 6 | 2.90e-01 | 2.50e-01 | 8.06e-01 |
| GOBP MRNA 3 END PROCESSING BY STEM LOOP BINDING AND CLEAVAGE | 6 | 2.90e-01 | -2.50e-01 | 8.06e-01 |
| GOBP POSITIVE REGULATION OF SPROUTING ANGIOGENESIS | 13 | 1.19e-01 | -2.49e-01 | 6.20e-01 |
| GOBP RESPONSE TO INTERLEUKIN 7 | 14 | 1.06e-01 | -2.49e-01 | 5.96e-01 |
| GOBP REGULATION OF PODOSOME ASSEMBLY | 12 | 1.35e-01 | -2.49e-01 | 6.52e-01 |
| GOMF CULLIN FAMILY PROTEIN BINDING | 24 | 3.47e-02 | -2.49e-01 | 3.80e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS ANTIGEN | 42 | 5.26e-03 | 2.49e-01 | 1.36e-01 |
| GOBP GLUCOSAMINE CONTAINING COMPOUND CATABOLIC PROCESS | 8 | 2.23e-01 | -2.49e-01 | 7.52e-01 |
| GOCC GOLGI TRANSPORT COMPLEX | 9 | 1.97e-01 | 2.49e-01 | 7.28e-01 |
| GOBP N ACETYLGLUCOSAMINE METABOLIC PROCESS | 13 | 1.21e-01 | 2.49e-01 | 6.22e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 6 | 2.93e-01 | -2.48e-01 | 8.08e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PLANAR POLARITY | 30 | 1.87e-02 | -2.48e-01 | 2.87e-01 |
| GOBP THYMIC T CELL SELECTION | 11 | 1.55e-01 | 2.48e-01 | 6.77e-01 |
| GOBP TETRAPYRROLE BIOSYNTHETIC PROCESS | 30 | 1.88e-02 | -2.48e-01 | 2.87e-01 |
| GOBP GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION | 5 | 3.37e-01 | 2.48e-01 | 8.36e-01 |
| GOBP POSITIVE REGULATION OF VIRAL LIFE CYCLE | 21 | 4.94e-02 | 2.48e-01 | 4.46e-01 |
| GOBP NEGATIVE REGULATION OF FIBRINOLYSIS | 6 | 2.93e-01 | -2.48e-01 | 8.08e-01 |
| GOBP BONE MORPHOGENESIS | 48 | 3.01e-03 | -2.48e-01 | 9.78e-02 |
| GOBP DOPAMINE BIOSYNTHETIC PROCESS | 7 | 2.57e-01 | 2.47e-01 | 7.85e-01 |
| GOBP INOSITOL METABOLIC PROCESS | 7 | 2.58e-01 | -2.47e-01 | 7.85e-01 |
| GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION | 27 | 2.63e-02 | 2.47e-01 | 3.31e-01 |
| GOMF ACETYLCHOLINE RECEPTOR BINDING | 9 | 1.99e-01 | -2.47e-01 | 7.31e-01 |
| GOMF NOTCH BINDING | 13 | 1.23e-01 | 2.47e-01 | 6.26e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE | 49 | 2.79e-03 | -2.47e-01 | 9.29e-02 |
| GOBP ENDOCHONDRAL BONE MORPHOGENESIS | 30 | 1.94e-02 | -2.47e-01 | 2.91e-01 |
| GOMF METALLOCARBOXYPEPTIDASE ACTIVITY | 11 | 1.57e-01 | -2.46e-01 | 6.80e-01 |
| GOMF TRANSFERRIN RECEPTOR BINDING | 8 | 2.28e-01 | 2.46e-01 | 7.58e-01 |
| GOBP HEART FIELD SPECIFICATION | 7 | 2.59e-01 | -2.46e-01 | 7.85e-01 |
| GOBP REGULATION OF BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION | 39 | 7.83e-03 | 2.46e-01 | 1.74e-01 |
| GOBP CLUSTERING OF VOLTAGE GATED SODIUM CHANNELS | 5 | 3.41e-01 | 2.46e-01 | 8.39e-01 |
| GOMF PHOSPHATIDYLINOSITOL 5 PHOSPHATE BINDING | 17 | 7.90e-02 | 2.46e-01 | 5.37e-01 |
| GOCC MITOCHONDRIAL PROTEIN CONTAINING COMPLEX | 283 | 1.18e-12 | -2.46e-01 | 1.14e-09 |
| GOBP STRIATUM DEVELOPMENT | 16 | 8.85e-02 | -2.46e-01 | 5.58e-01 |
| GOBP SUBPALLIUM DEVELOPMENT | 16 | 8.85e-02 | -2.46e-01 | 5.58e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS | 9 | 2.01e-01 | 2.46e-01 | 7.32e-01 |
| GOBP EMBRYONIC HEMOPOIESIS | 15 | 9.93e-02 | 2.46e-01 | 5.82e-01 |
| GOMF ABC TYPE XENOBIOTIC TRANSPORTER ACTIVITY | 9 | 2.02e-01 | -2.46e-01 | 7.32e-01 |
| GOBP CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION | 16 | 8.87e-02 | 2.46e-01 | 5.58e-01 |
| GOMF ANDROGEN BINDING | 5 | 3.41e-01 | 2.46e-01 | 8.39e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION | 11 | 1.59e-01 | 2.45e-01 | 6.83e-01 |
| GOBP MEDIUM CHAIN FATTY ACID METABOLIC PROCESS | 9 | 2.03e-01 | 2.45e-01 | 7.32e-01 |
| GOCC NADH DEHYDROGENASE COMPLEX | 47 | 3.63e-03 | -2.45e-01 | 1.12e-01 |
| GOBP L ASPARTATE TRANSMEMBRANE TRANSPORT | 9 | 2.03e-01 | -2.45e-01 | 7.32e-01 |
| GOMF RNA POLYMERASE II ACTIVITY | 11 | 1.59e-01 | -2.45e-01 | 6.83e-01 |
| GOBP HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION | 5 | 3.42e-01 | -2.45e-01 | 8.41e-01 |
| GOBP CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 6 | 2.99e-01 | 2.45e-01 | 8.13e-01 |
| GOBP LNCRNA MEDIATED POST TRANSCRIPTIONAL GENE SILENCING | 6 | 2.99e-01 | -2.45e-01 | 8.13e-01 |
| GOBP PIGMENT BIOSYNTHETIC PROCESS | 42 | 6.03e-03 | -2.45e-01 | 1.47e-01 |
| GOBP POSITIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE | 5 | 3.43e-01 | -2.45e-01 | 8.41e-01 |
| GOBP CELLULAR RESPONSE TO HYDROPEROXIDE | 6 | 2.99e-01 | -2.45e-01 | 8.13e-01 |
| GOBP RESPONSE TO INTERLEUKIN 17 | 14 | 1.13e-01 | 2.45e-01 | 6.08e-01 |
| GOMF MUSCLE ALPHA ACTININ BINDING | 9 | 2.03e-01 | -2.45e-01 | 7.32e-01 |
| GOCC EXTRINSIC COMPONENT OF SYNAPTIC VESICLE MEMBRANE | 7 | 2.62e-01 | -2.45e-01 | 7.87e-01 |
| GOMF CYTOSKELETON NUCLEAR MEMBRANE ANCHOR ACTIVITY | 5 | 3.44e-01 | 2.44e-01 | 8.41e-01 |
| GOBP RHODOPSIN MEDIATED SIGNALING PATHWAY | 9 | 2.04e-01 | 2.44e-01 | 7.33e-01 |
| GOBP CALCIUM ION TRANSPORT INTO CYTOSOL | 11 | 1.61e-01 | 2.44e-01 | 6.87e-01 |
| GOBP IRON SULFUR CLUSTER ASSEMBLY | 29 | 2.30e-02 | -2.44e-01 | 3.12e-01 |
| GOMF DYSTROGLYCAN BINDING | 9 | 2.05e-01 | 2.44e-01 | 7.33e-01 |
| GOBP REGULATION OF NK T CELL PROLIFERATION | 5 | 3.46e-01 | 2.44e-01 | 8.42e-01 |
| GOBP LIPOPHAGY | 7 | 2.65e-01 | -2.44e-01 | 7.89e-01 |
| GOBP PROTEIN O LINKED GLYCOSYLATION VIA THREONINE | 8 | 2.33e-01 | 2.43e-01 | 7.62e-01 |
| GOMF TELOMERASE RNA BINDING | 21 | 5.36e-02 | 2.43e-01 | 4.61e-01 |
| GOMF LIGAND GATED CALCIUM CHANNEL ACTIVITY | 22 | 4.83e-02 | 2.43e-01 | 4.45e-01 |
| GOBP CHROMOSOME SEPARATION | 73 | 3.31e-04 | 2.43e-01 | 1.87e-02 |
| GOBP TYPE II INTERFERON MEDIATED SIGNALING PATHWAY | 21 | 5.39e-02 | 2.43e-01 | 4.61e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 12 | 1.45e-01 | -2.43e-01 | 6.68e-01 |
| GOCC PROTEASE INHIBITOR COMPLEX | 5 | 3.47e-01 | 2.43e-01 | 8.43e-01 |
| GOBP RESPONSE TO FRUCTOSE | 6 | 3.03e-01 | -2.43e-01 | 8.14e-01 |
| GOBP TRANSFERRIN TRANSPORT | 8 | 2.34e-01 | -2.43e-01 | 7.63e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC | 17 | 8.32e-02 | 2.43e-01 | 5.44e-01 |
| GOBP CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS | 12 | 1.45e-01 | -2.43e-01 | 6.68e-01 |
| GOBP MELANIN METABOLIC PROCESS | 16 | 9.29e-02 | -2.43e-01 | 5.67e-01 |
| GOBP INTERFERON ALPHA PRODUCTION | 24 | 3.97e-02 | 2.43e-01 | 4.07e-01 |
| GOCC GAMMA TUBULIN RING COMPLEX | 7 | 2.66e-01 | -2.43e-01 | 7.91e-01 |
| GOMF MDM2 MDM4 FAMILY PROTEIN BINDING | 9 | 2.08e-01 | -2.42e-01 | 7.40e-01 |
| GOBP NEGATIVE REGULATION OF LYASE ACTIVITY | 7 | 2.67e-01 | -2.42e-01 | 7.91e-01 |
| GOBP REGULATION OF RECEPTOR CATABOLIC PROCESS | 10 | 1.86e-01 | -2.42e-01 | 7.16e-01 |
| GOBP REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 22 | 5.00e-02 | -2.41e-01 | 4.48e-01 |
| GOCC CANONICAL INFLAMMASOME COMPLEX | 12 | 1.48e-01 | 2.41e-01 | 6.70e-01 |
| GOMF SPECTRIN BINDING | 18 | 7.64e-02 | 2.41e-01 | 5.30e-01 |
| GOBP ARGININE METABOLIC PROCESS | 11 | 1.66e-01 | -2.41e-01 | 6.93e-01 |
| GOMF NUCLEOTIDE RECEPTOR ACTIVITY | 11 | 1.67e-01 | 2.41e-01 | 6.94e-01 |
| GOMF SPHINGOLIPID TRANSFER ACTIVITY | 7 | 2.70e-01 | 2.41e-01 | 7.93e-01 |
| GOCC LAMININ COMPLEX | 5 | 3.51e-01 | -2.41e-01 | 8.46e-01 |
| GOBP NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 116 | 7.73e-06 | -2.41e-01 | 9.88e-04 |
| GOBP PYRAMIDAL NEURON DEVELOPMENT | 8 | 2.39e-01 | -2.41e-01 | 7.68e-01 |
| GOBP LEUCINE TRANSPORT | 8 | 2.39e-01 | -2.40e-01 | 7.68e-01 |
| GOBP NEGATIVE REGULATION OF AMINO ACID TRANSPORT | 8 | 2.39e-01 | -2.40e-01 | 7.68e-01 |
| GOMF UBIQUITIN UBIQUITIN LIGASE ACTIVITY | 14 | 1.20e-01 | -2.40e-01 | 6.20e-01 |
| GOBP MITOTIC METAPHASE CHROMOSOME ALIGNMENT | 57 | 1.73e-03 | 2.40e-01 | 6.57e-02 |
| GOBP OLIGOPEPTIDE TRANSMEMBRANE TRANSPORT | 8 | 2.40e-01 | -2.40e-01 | 7.68e-01 |
| GOMF NEUROTRANSMITTER TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 2.71e-01 | 2.40e-01 | 7.94e-01 |
| GOBP MRNA PSEUDOURIDINE SYNTHESIS | 9 | 2.12e-01 | 2.40e-01 | 7.45e-01 |
| GOBP RRNA 5 END PROCESSING | 5 | 3.53e-01 | -2.40e-01 | 8.46e-01 |
| GOMF HISTONE H3 KINASE ACTIVITY | 10 | 1.89e-01 | 2.40e-01 | 7.18e-01 |
| GOMF NAD P H DEHYDROGENASE QUINONE ACTIVITY | 45 | 5.37e-03 | -2.40e-01 | 1.37e-01 |
| GOBP WOUND HEALING INVOLVED IN INFLAMMATORY RESPONSE | 7 | 2.72e-01 | 2.40e-01 | 7.94e-01 |
| GOBP ALCOHOL CATABOLIC PROCESS | 20 | 6.37e-02 | 2.40e-01 | 4.91e-01 |
| GOBP ANGIOTENSIN ACTIVATED SIGNALING PATHWAY | 9 | 2.14e-01 | 2.39e-01 | 7.46e-01 |
| GOBP INTERLEUKIN 10 PRODUCTION | 38 | 1.07e-02 | 2.39e-01 | 2.08e-01 |
| GOMF NITRIC OXIDE SYNTHASE BINDING | 8 | 2.41e-01 | 2.39e-01 | 7.70e-01 |
| GOBP REGULATION OF STEROID HORMONE SECRETION | 11 | 1.70e-01 | -2.39e-01 | 6.98e-01 |
| GOBP POSITIVE REGULATION OF DEOXYRIBONUCLEASE ACTIVITY | 5 | 3.54e-01 | -2.39e-01 | 8.46e-01 |
| GOBP REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 22 | 5.23e-02 | 2.39e-01 | 4.58e-01 |
| GOBP RESPONSE TO NITRIC OXIDE | 14 | 1.22e-01 | 2.39e-01 | 6.23e-01 |
| GOBP HEPATIC STELLATE CELL ACTIVATION | 6 | 3.11e-01 | -2.39e-01 | 8.21e-01 |
| GOCC BETA CATENIN TCF COMPLEX | 12 | 1.52e-01 | 2.39e-01 | 6.74e-01 |
| GOBP VOLUNTARY MUSCULOSKELETAL MOVEMENT | 7 | 2.74e-01 | -2.39e-01 | 7.96e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 9 | 2.16e-01 | 2.38e-01 | 7.47e-01 |
| GOBP PLASMINOGEN ACTIVATION | 16 | 9.89e-02 | -2.38e-01 | 5.82e-01 |
| GOMF THREONINE TYPE PEPTIDASE ACTIVITY | 12 | 1.53e-01 | 2.38e-01 | 6.75e-01 |
| GOBP REGULATION OF SISTER CHROMATID SEGREGATION | 94 | 6.85e-05 | 2.38e-01 | 5.62e-03 |
| GOMF HISTONE ACETYLTRANSFERASE BINDING | 20 | 6.57e-02 | 2.38e-01 | 5.00e-01 |
| GOBP RESPIRATORY CHAIN COMPLEX IV ASSEMBLY | 28 | 2.95e-02 | -2.38e-01 | 3.49e-01 |
| GOBP SPINDLE ASSEMBLY INVOLVED IN FEMALE MEIOSIS | 8 | 2.44e-01 | 2.38e-01 | 7.73e-01 |
| GOMF TBP CLASS PROTEIN BINDING | 23 | 4.86e-02 | 2.38e-01 | 4.45e-01 |
| GOBP REGULATION OF CELLULAR EXTRAVASATION | 23 | 4.86e-02 | 2.38e-01 | 4.45e-01 |
| GOBP VESICLE FUSION WITH GOLGI APPARATUS | 9 | 2.17e-01 | 2.38e-01 | 7.49e-01 |
| GOCC AXOLEMMA | 8 | 2.45e-01 | -2.37e-01 | 7.73e-01 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY | 10 | 1.94e-01 | 2.37e-01 | 7.23e-01 |
| GOBP REGULATION OF MICROTUBULE POLYMERIZATION | 53 | 2.80e-03 | 2.37e-01 | 9.29e-02 |
| GOMF PROTEIN TYROSINE THREONINE PHOSPHATASE ACTIVITY | 8 | 2.45e-01 | 2.37e-01 | 7.73e-01 |
| GOMF ATPASE COUPLED ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 20 | 6.62e-02 | -2.37e-01 | 5.02e-01 |
| GOBP CELLULAR DETOXIFICATION OF ALDEHYDE | 7 | 2.77e-01 | 2.37e-01 | 7.98e-01 |
| GOBP RESPONSE TO CHEMOKINE | 48 | 4.50e-03 | -2.37e-01 | 1.25e-01 |
| GOBP LENS MORPHOGENESIS IN CAMERA TYPE EYE | 11 | 1.73e-01 | 2.37e-01 | 7.05e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS | 34 | 1.68e-02 | 2.37e-01 | 2.72e-01 |
| GOBP GDP METABOLIC PROCESS | 11 | 1.74e-01 | 2.37e-01 | 7.05e-01 |
| GOBP POSITIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 9 | 2.19e-01 | 2.37e-01 | 7.49e-01 |
| GOCC CYTOPLASMIC SIDE OF LYSOSOMAL MEMBRANE | 11 | 1.74e-01 | -2.37e-01 | 7.05e-01 |
| GOBP FOREGUT MORPHOGENESIS | 6 | 3.15e-01 | 2.37e-01 | 8.23e-01 |
| GOBP MITOCHONDRIAL ELECTRON TRANSPORT SUCCINATE TO UBIQUINONE | 5 | 3.60e-01 | -2.36e-01 | 8.46e-01 |
| GOBP NEGATIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 8 | 2.47e-01 | 2.36e-01 | 7.76e-01 |
| GOBP FARNESYL DIPHOSPHATE METABOLIC PROCESS | 5 | 3.60e-01 | -2.36e-01 | 8.46e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS NAD P AS ACCEPTOR | 11 | 1.75e-01 | -2.36e-01 | 7.05e-01 |
| GOMF TRAIL BINDING | 5 | 3.60e-01 | 2.36e-01 | 8.46e-01 |
| GOCC KINETOCHORE MICROTUBULE | 19 | 7.47e-02 | 2.36e-01 | 5.26e-01 |
| GOBP DESMOSOME ORGANIZATION | 6 | 3.16e-01 | 2.36e-01 | 8.23e-01 |
| GOCC RNA POLYMERASE II CORE COMPLEX | 15 | 1.14e-01 | -2.36e-01 | 6.10e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 6 | 3.17e-01 | 2.36e-01 | 8.23e-01 |
| GOMF CARBON NITROGEN LIGASE ACTIVITY WITH GLUTAMINE AS AMIDO N DONOR | 8 | 2.48e-01 | -2.36e-01 | 7.76e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY | 20 | 6.81e-02 | -2.36e-01 | 5.09e-01 |
| GOCC PRERIBOSOME | 103 | 3.63e-05 | -2.36e-01 | 3.35e-03 |
| GOBP ACTIN FILAMENT NETWORK FORMATION | 8 | 2.48e-01 | -2.36e-01 | 7.76e-01 |
| GOBP ELECTRON TRANSPORT CHAIN | 150 | 6.54e-07 | -2.36e-01 | 1.21e-04 |
| GOBP EMBRYONIC DIGESTIVE TRACT DEVELOPMENT | 13 | 1.42e-01 | -2.36e-01 | 6.64e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS | 7 | 2.81e-01 | 2.36e-01 | 7.99e-01 |
| GOBP REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 34 | 1.76e-02 | -2.35e-01 | 2.79e-01 |
| GOCC PHOTORECEPTOR OUTER SEGMENT MEMBRANE | 12 | 1.58e-01 | 2.35e-01 | 6.82e-01 |
| GOMF DEATH RECEPTOR BINDING | 16 | 1.03e-01 | 2.35e-01 | 5.93e-01 |
| GOMF MISMATCH REPAIR COMPLEX BINDING | 10 | 1.98e-01 | 2.35e-01 | 7.30e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS II | 26 | 3.80e-02 | 2.35e-01 | 3.97e-01 |
| GOBP MRNA 5 SPLICE SITE RECOGNITION | 6 | 3.19e-01 | 2.35e-01 | 8.25e-01 |
| GOBP EXTRACELLULAR MATRIX DISASSEMBLY | 36 | 1.47e-02 | -2.35e-01 | 2.56e-01 |
| GOBP VACUOLE FUSION | 12 | 1.59e-01 | 2.35e-01 | 6.83e-01 |
| GOMF MINUS END DIRECTED MICROTUBULE MOTOR ACTIVITY | 12 | 1.59e-01 | 2.35e-01 | 6.83e-01 |
| GOBP PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER | 17 | 9.37e-02 | -2.35e-01 | 5.67e-01 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT KINASE ACTIVITY | 10 | 1.99e-01 | 2.35e-01 | 7.31e-01 |
| GOBP REGULATION OF TRANSLATIONAL ELONGATION | 11 | 1.78e-01 | 2.34e-01 | 7.10e-01 |
| GOBP METHYLGLYOXAL METABOLIC PROCESS | 6 | 3.21e-01 | -2.34e-01 | 8.27e-01 |
| GOBP ENDOCARDIAL CUSHION FORMATION | 13 | 1.44e-01 | 2.34e-01 | 6.65e-01 |
| GOMF PROTEIN KINASE B BINDING | 9 | 2.24e-01 | 2.34e-01 | 7.53e-01 |
| GOBP POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY | 20 | 7.07e-02 | 2.33e-01 | 5.17e-01 |
| GOBP MEMBRANE RAFT LOCALIZATION | 6 | 3.22e-01 | -2.33e-01 | 8.29e-01 |
| GOMF FILAMIN BINDING | 8 | 2.53e-01 | 2.33e-01 | 7.79e-01 |
| GOBP FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS | 8 | 2.54e-01 | -2.33e-01 | 7.79e-01 |
| GOBP GAMMA DELTA T CELL DIFFERENTIATION | 7 | 2.86e-01 | 2.33e-01 | 8.04e-01 |
| GOBP REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION | 7 | 2.86e-01 | 2.33e-01 | 8.04e-01 |
| GOBP REGULATION OF DENDRITIC CELL CHEMOTAXIS | 6 | 3.23e-01 | 2.33e-01 | 8.29e-01 |
| GOBP POSITIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION | 10 | 2.03e-01 | 2.33e-01 | 7.32e-01 |
| GOBP REGULATION OF RETROGRADE TRANSPORT ENDOSOME TO GOLGI | 7 | 2.87e-01 | 2.32e-01 | 8.05e-01 |
| GOBP SPHINGOMYELIN CATABOLIC PROCESS | 5 | 3.68e-01 | -2.32e-01 | 8.55e-01 |
| GOBP REGULATION OF LIPOPROTEIN LIPASE ACTIVITY | 6 | 3.25e-01 | -2.32e-01 | 8.29e-01 |
| GOBP POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE | 94 | 1.01e-04 | 2.32e-01 | 7.65e-03 |
| GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 2B COMPLEX | 5 | 3.69e-01 | -2.32e-01 | 8.55e-01 |
| GOMF POLYOL TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 3.25e-01 | 2.32e-01 | 8.29e-01 |
| GOBP NEGATIVE REGULATION OF MICROGLIAL CELL ACTIVATION | 7 | 2.88e-01 | 2.32e-01 | 8.05e-01 |
| GOMF HISTONE UBIQUITIN LIGASE ACTIVITY | 11 | 1.83e-01 | 2.32e-01 | 7.14e-01 |
| GOCC SPERM PRINCIPAL PIECE | 16 | 1.09e-01 | 2.32e-01 | 5.99e-01 |
| GOBP BONE TRABECULA MORPHOGENESIS | 8 | 2.57e-01 | -2.32e-01 | 7.84e-01 |
| GOBP POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 39 | 1.24e-02 | 2.32e-01 | 2.29e-01 |
| GOBP TRANSEPITHELIAL TRANSPORT | 17 | 9.85e-02 | -2.31e-01 | 5.81e-01 |
| GOMF N6 METHYLADENOSINE CONTAINING RNA BINDING | 10 | 2.05e-01 | 2.31e-01 | 7.33e-01 |
| GOMF ACYL COA OXIDASE ACTIVITY | 5 | 3.71e-01 | -2.31e-01 | 8.57e-01 |
| GOBP NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS | 12 | 1.66e-01 | -2.31e-01 | 6.93e-01 |
| GOBP REGULATION OF GLYCOGEN CATABOLIC PROCESS | 6 | 3.27e-01 | -2.31e-01 | 8.29e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION | 52 | 3.99e-03 | 2.31e-01 | 1.17e-01 |
| GOBP HYPEROSMOTIC SALINITY RESPONSE | 8 | 2.58e-01 | -2.31e-01 | 7.85e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 6 | 3.27e-01 | -2.31e-01 | 8.29e-01 |
| GOBP PROTEIN LOCALIZATION TO EARLY ENDOSOME | 11 | 1.85e-01 | 2.31e-01 | 7.16e-01 |
| GOBP NEURAL FOLD FORMATION | 5 | 3.72e-01 | 2.31e-01 | 8.57e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN | 58 | 2.39e-03 | 2.31e-01 | 8.29e-02 |
| GOBP FEVER GENERATION | 6 | 3.28e-01 | 2.31e-01 | 8.29e-01 |
| GOCC SCAR COMPLEX | 11 | 1.85e-01 | -2.31e-01 | 7.16e-01 |
| GOCC CORE MEDIATOR COMPLEX | 26 | 4.19e-02 | 2.31e-01 | 4.19e-01 |
| GOBP REGULATION OF APOPTOTIC CELL CLEARANCE | 8 | 2.59e-01 | -2.30e-01 | 7.85e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 28 | 3.49e-02 | -2.30e-01 | 3.81e-01 |
| GOMF FOUR WAY JUNCTION HELICASE ACTIVITY | 6 | 3.29e-01 | 2.30e-01 | 8.30e-01 |
| GOBP G1 TO G0 TRANSITION | 14 | 1.36e-01 | -2.30e-01 | 6.52e-01 |
| GOBP REGULATION OF AXON GUIDANCE | 6 | 3.29e-01 | 2.30e-01 | 8.30e-01 |
| GOCC CARBOXY TERMINAL DOMAIN PROTEIN KINASE COMPLEX | 18 | 9.12e-02 | 2.30e-01 | 5.63e-01 |
| GOBP TRICARBOXYLIC ACID CYCLE | 29 | 3.22e-02 | -2.30e-01 | 3.64e-01 |
| GOBP NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 5 | 3.73e-01 | -2.30e-01 | 8.59e-01 |
| GOBP SPINDLE LOCALIZATION | 47 | 6.45e-03 | 2.30e-01 | 1.53e-01 |
| GOBP RIBONUCLEOSIDE METABOLIC PROCESS | 23 | 5.66e-02 | 2.30e-01 | 4.70e-01 |
| GOBP CELLULAR RESPONSE TO X RAY | 7 | 2.93e-01 | -2.30e-01 | 8.08e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID OXIDATION | 8 | 2.61e-01 | 2.29e-01 | 7.87e-01 |
| GOBP NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT | 6 | 3.30e-01 | 2.29e-01 | 8.30e-01 |
| GOBP REGULATION OF HEPATOCYTE APOPTOTIC PROCESS | 7 | 2.93e-01 | 2.29e-01 | 8.08e-01 |
| GOBP MODULATION BY SYMBIONT OF ENTRY INTO HOST | 38 | 1.46e-02 | 2.29e-01 | 2.55e-01 |
| GOBP NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY | 25 | 4.77e-02 | 2.29e-01 | 4.43e-01 |
| GOBP NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 11 | 1.89e-01 | 2.29e-01 | 7.18e-01 |
| GOCC ROUGH ENDOPLASMIC RETICULUM MEMBRANE | 23 | 5.77e-02 | -2.29e-01 | 4.70e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE | 7 | 2.95e-01 | -2.28e-01 | 8.10e-01 |
| GOBP REGULATION OF PRESYNAPSE ORGANIZATION | 15 | 1.26e-01 | -2.28e-01 | 6.31e-01 |
| GOBP MICROTUBULE NUCLEATION | 43 | 9.64e-03 | 2.28e-01 | 1.94e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY | 23 | 5.82e-02 | -2.28e-01 | 4.72e-01 |
| GOMF CAMP RESPONSE ELEMENT BINDING | 10 | 2.12e-01 | -2.28e-01 | 7.44e-01 |
| GOMF COMPLEMENT RECEPTOR ACTIVITY | 7 | 2.96e-01 | 2.28e-01 | 8.11e-01 |
| GOBP CORNIFIED ENVELOPE ASSEMBLY | 5 | 3.77e-01 | -2.28e-01 | 8.61e-01 |
| GOMF SNORNA BINDING | 32 | 2.58e-02 | -2.28e-01 | 3.31e-01 |
| GOBP POSITIVE REGULATION OF MEIOTIC CELL CYCLE | 14 | 1.41e-01 | 2.27e-01 | 6.63e-01 |
| GOMF ACID AMINO ACID LIGASE ACTIVITY | 16 | 1.16e-01 | -2.27e-01 | 6.13e-01 |
| GOMF SNAP RECEPTOR ACTIVITY | 34 | 2.19e-02 | 2.27e-01 | 3.07e-01 |
| GOBP TRANSEPITHELIAL CHLORIDE TRANSPORT | 5 | 3.79e-01 | -2.27e-01 | 8.62e-01 |
| GOMF COBALAMIN BINDING | 8 | 2.66e-01 | 2.27e-01 | 7.91e-01 |
| GOBP REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 9 | 2.38e-01 | 2.27e-01 | 7.67e-01 |
| GOBP NEUTROPHIL EXTRAVASATION | 11 | 1.93e-01 | 2.27e-01 | 7.22e-01 |
| GOMF MRF BINDING | 5 | 3.80e-01 | 2.27e-01 | 8.62e-01 |
| GOBP NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE | 10 | 2.15e-01 | 2.27e-01 | 7.46e-01 |
| GOBP RETROGRADE AXONAL TRANSPORT | 14 | 1.42e-01 | -2.27e-01 | 6.65e-01 |
| GOBP DEFENSE RESPONSE TO TUMOR CELL | 11 | 1.93e-01 | -2.27e-01 | 7.23e-01 |
| GOCC FLEMMING BODY | 31 | 2.91e-02 | 2.26e-01 | 3.48e-01 |
| GOBP HYDROGEN PEROXIDE CATABOLIC PROCESS | 12 | 1.74e-01 | -2.26e-01 | 7.05e-01 |
| GOBP POSITIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS | 11 | 1.94e-01 | 2.26e-01 | 7.23e-01 |
| GOBP CELLULAR RESPONSE TO COPPER ION | 17 | 1.06e-01 | -2.26e-01 | 5.96e-01 |
| GOBP NATURAL KILLER CELL ACTIVATION | 55 | 3.74e-03 | 2.26e-01 | 1.14e-01 |
| GOBP RIBOSOMAL SUBUNIT EXPORT FROM NUCLEUS | 14 | 1.43e-01 | -2.26e-01 | 6.65e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 11 | 1.95e-01 | 2.26e-01 | 7.25e-01 |
| GOBP FACIAL NERVE MORPHOGENESIS | 5 | 3.82e-01 | -2.26e-01 | 8.64e-01 |
| GOBP NEUROEPITHELIAL CELL DIFFERENTIATION | 19 | 8.87e-02 | 2.26e-01 | 5.58e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME | 12 | 1.77e-01 | -2.25e-01 | 7.07e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST MIGRATION | 7 | 3.02e-01 | -2.25e-01 | 8.14e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I | 8 | 2.70e-01 | -2.25e-01 | 7.93e-01 |
| GOBP CYCLOOXYGENASE PATHWAY | 8 | 2.70e-01 | 2.25e-01 | 7.93e-01 |
| GOBP SYNAPTIC VESICLE MATURATION | 21 | 7.42e-02 | -2.25e-01 | 5.24e-01 |
| GOMF TRANSLATION FACTOR ACTIVITY RNA BINDING | 80 | 5.06e-04 | -2.25e-01 | 2.62e-02 |
| GOBP REGULATION OF MICROVILLUS ORGANIZATION | 11 | 1.96e-01 | -2.25e-01 | 7.28e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN KINASE C SIGNALING | 5 | 3.84e-01 | -2.25e-01 | 8.64e-01 |
| GOBP REGULATION OF CHROMOSOME SEGREGATION | 117 | 2.73e-05 | 2.25e-01 | 2.66e-03 |
| GOBP SYNAPTIC VESICLE CLUSTERING | 7 | 3.03e-01 | -2.25e-01 | 8.14e-01 |
| GOBP DERMATAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 6 | 3.41e-01 | -2.25e-01 | 8.39e-01 |
| GOCC LSM2 8 COMPLEX | 7 | 3.03e-01 | -2.25e-01 | 8.14e-01 |
| GOMF N ACETYLLACTOSAMINE SYNTHASE ACTIVITY | 5 | 3.85e-01 | 2.25e-01 | 8.64e-01 |
| GOMF STEROID DEHYDROGENASE ACTIVITY ACTING ON THE CH OH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 17 | 1.09e-01 | 2.24e-01 | 6.00e-01 |
| GOBP REGULATION OF PROTEIN MONOUBIQUITINATION | 6 | 3.41e-01 | 2.24e-01 | 8.39e-01 |
| GOBP PEROXISOME FISSION | 9 | 2.44e-01 | 2.24e-01 | 7.73e-01 |
| GOBP PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING | 5 | 3.85e-01 | -2.24e-01 | 8.64e-01 |
| GOBP GERMINAL CENTER FORMATION | 12 | 1.79e-01 | 2.24e-01 | 7.10e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME | 12 | 1.79e-01 | -2.24e-01 | 7.10e-01 |
| GOMF NEDD8 TRANSFERASE ACTIVITY | 7 | 3.05e-01 | 2.24e-01 | 8.15e-01 |
| GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 40 | 1.43e-02 | 2.24e-01 | 2.52e-01 |
| GOBP LATE NUCLEOPHAGY | 8 | 2.73e-01 | -2.24e-01 | 7.94e-01 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE REGULATOR ACTIVITY | 23 | 6.32e-02 | -2.24e-01 | 4.89e-01 |
| GOBP LIPOPROTEIN CATABOLIC PROCESS | 13 | 1.62e-01 | -2.24e-01 | 6.87e-01 |
| GOBP PEPTIDYL L CYSTEINE S PALMITOYLATION | 18 | 1.00e-01 | 2.24e-01 | 5.84e-01 |
| GOCC RIBBON SYNAPSE | 9 | 2.45e-01 | -2.24e-01 | 7.73e-01 |
| GOCC BETA CATENIN DESTRUCTION COMPLEX | 9 | 2.45e-01 | 2.24e-01 | 7.73e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 20 | 8.36e-02 | 2.23e-01 | 5.45e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 99 | 1.24e-04 | 2.23e-01 | 9.05e-03 |
| GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE C END DEGRON RULE PATHWAY | 12 | 1.81e-01 | -2.23e-01 | 7.12e-01 |
| GOMF BILE ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 3.44e-01 | -2.23e-01 | 8.41e-01 |
| GOBP POSITIVE REGULATION OF ER ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 6 | 3.44e-01 | -2.23e-01 | 8.41e-01 |
| GOMF PYRIMIDINE NUCLEOSIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 3.88e-01 | 2.23e-01 | 8.65e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDINES | 5 | 3.88e-01 | -2.23e-01 | 8.65e-01 |
| GOBP POSITIVE REGULATION OF DNA DEMETHYLATION | 7 | 3.07e-01 | -2.23e-01 | 8.19e-01 |
| GOMF PROTEIN SERINE THREONINE PHOSPHATASE INHIBITOR ACTIVITY | 8 | 2.76e-01 | -2.23e-01 | 7.96e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEAR BODY | 12 | 1.82e-01 | -2.23e-01 | 7.13e-01 |
| GOBP TRANSLATIONAL INITIATION | 111 | 5.21e-05 | -2.22e-01 | 4.57e-03 |
| GOBP LYMPHOCYTE ANERGY | 5 | 3.89e-01 | 2.22e-01 | 8.65e-01 |
| GOBP MYELIN MAINTENANCE | 14 | 1.50e-01 | -2.22e-01 | 6.72e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN | 35 | 2.28e-02 | 2.22e-01 | 3.12e-01 |
| GOMF PHOSPHATIDIC ACID TRANSFER ACTIVITY | 7 | 3.08e-01 | -2.22e-01 | 8.19e-01 |
| GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 82 | 5.05e-04 | 2.22e-01 | 2.62e-02 |
| GOBP TRICARBOXYLIC ACID METABOLIC PROCESS | 12 | 1.82e-01 | -2.22e-01 | 7.13e-01 |
| GOBP TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR | 10 | 2.24e-01 | 2.22e-01 | 7.52e-01 |
| GOBP STEROID HORMONE SECRETION | 14 | 1.50e-01 | -2.22e-01 | 6.73e-01 |
| GOMF ANTIGEN BINDING | 49 | 7.18e-03 | 2.22e-01 | 1.65e-01 |
| GOBP POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS | 9 | 2.49e-01 | -2.22e-01 | 7.76e-01 |
| GOBP COBALAMIN TRANSPORT | 5 | 3.90e-01 | 2.22e-01 | 8.66e-01 |
| GOBP NEGATIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 6 | 3.47e-01 | -2.22e-01 | 8.43e-01 |
| GOMF DNA DNA ANNEALING ACTIVITY | 7 | 3.09e-01 | -2.22e-01 | 8.20e-01 |
| GOBP REGULATION OF LIPOPROTEIN METABOLIC PROCESS | 13 | 1.66e-01 | -2.22e-01 | 6.93e-01 |
| GOBP TELOMERIC D LOOP DISASSEMBLY | 7 | 3.09e-01 | -2.22e-01 | 8.20e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN NAD P H AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 15 | 1.37e-01 | -2.22e-01 | 6.57e-01 |
| GOMF HISTONE H3K4ME H3K4ME2 H3K4ME3 DEMETHYLASE ACTIVITY | 5 | 3.91e-01 | -2.22e-01 | 8.68e-01 |
| GOBP FC RECEPTOR SIGNALING PATHWAY | 46 | 9.40e-03 | 2.21e-01 | 1.91e-01 |
| GOBP DIACYLGLYCEROL BIOSYNTHETIC PROCESS | 8 | 2.78e-01 | 2.21e-01 | 7.99e-01 |
| GOBP SODIUM ION EXPORT ACROSS PLASMA MEMBRANE | 6 | 3.48e-01 | -2.21e-01 | 8.43e-01 |
| GOCC CATION TRANSPORTING ATPASE COMPLEX | 6 | 3.48e-01 | -2.21e-01 | 8.43e-01 |
| GOBP URATE METABOLIC PROCESS | 5 | 3.92e-01 | -2.21e-01 | 8.68e-01 |
| GOCC TRANSCRIPTION FACTOR TFTC COMPLEX | 18 | 1.05e-01 | -2.21e-01 | 5.95e-01 |
| GOMF ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 2.05e-01 | -2.21e-01 | 7.33e-01 |
| GOBP NEGATIVE REGULATION OF ERAD PATHWAY | 6 | 3.49e-01 | 2.21e-01 | 8.45e-01 |
| GOMF GLYCEROPHOSPHOLIPID FLIPPASE ACTIVITY | 11 | 2.05e-01 | 2.21e-01 | 7.34e-01 |
| GOMF MAP KINASE KINASE KINASE ACTIVITY | 22 | 7.35e-02 | 2.20e-01 | 5.23e-01 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY | 6 | 3.50e-01 | -2.20e-01 | 8.46e-01 |
| GOBP L ALANINE TRANSPORT | 7 | 3.13e-01 | -2.20e-01 | 8.22e-01 |
| GOMF L ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 3.13e-01 | -2.20e-01 | 8.22e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEOPLASM | 14 | 1.54e-01 | -2.20e-01 | 6.75e-01 |
| GOBP AEROBIC RESPIRATION | 179 | 3.94e-07 | -2.20e-01 | 7.77e-05 |
| GOBP HEXOSE CATABOLIC PROCESS | 31 | 3.40e-02 | -2.20e-01 | 3.77e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE | 10 | 2.28e-01 | -2.20e-01 | 7.58e-01 |
| GOBP REGULATION OF GTP BINDING | 8 | 2.81e-01 | 2.20e-01 | 7.99e-01 |
| GOMF MHC CLASS I RECEPTOR ACTIVITY | 10 | 2.28e-01 | 2.20e-01 | 7.58e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEAR DIVISION | 55 | 4.80e-03 | 2.20e-01 | 1.29e-01 |
| GOBP PROSTAGLANDIN SECRETION | 10 | 2.29e-01 | 2.20e-01 | 7.58e-01 |
| GOBP GLANDULAR EPITHELIAL CELL MATURATION | 5 | 3.95e-01 | 2.20e-01 | 8.70e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION | 90 | 3.19e-04 | 2.20e-01 | 1.85e-02 |
| GOBP CHROMOSOME CONDENSATION | 29 | 4.07e-02 | 2.20e-01 | 4.12e-01 |
| GOBP RESPONSE TO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR | 6 | 3.52e-01 | 2.20e-01 | 8.46e-01 |
| GOCC COPII VESICLE COAT | 15 | 1.41e-01 | 2.20e-01 | 6.63e-01 |
| GOBP CELLULAR RESPONSE TO ALDEHYDE | 11 | 2.07e-01 | 2.20e-01 | 7.37e-01 |
| GOBP ORGANELLE INHERITANCE | 15 | 1.41e-01 | 2.20e-01 | 6.63e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE CHECKPOINT | 17 | 1.17e-01 | 2.19e-01 | 6.17e-01 |
| GOBP POSITIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 6 | 3.52e-01 | -2.19e-01 | 8.46e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID BETA CLEARANCE | 6 | 3.53e-01 | -2.19e-01 | 8.46e-01 |
| GOBP POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION | 26 | 5.32e-02 | 2.19e-01 | 4.60e-01 |
| GOBP CATECHOLAMINE UPTAKE | 6 | 3.53e-01 | -2.19e-01 | 8.46e-01 |
| GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 52 | 6.32e-03 | 2.19e-01 | 1.52e-01 |
| GOMF SPHINGOSINE N ACYLTRANSFERASE ACTIVITY | 5 | 3.97e-01 | 2.19e-01 | 8.71e-01 |
| GOBP PIGMENT GRANULE LOCALIZATION | 22 | 7.61e-02 | -2.19e-01 | 5.30e-01 |
| GOBP REGULATION OF PROTEIN K48 LINKED UBIQUITINATION | 6 | 3.54e-01 | 2.18e-01 | 8.46e-01 |
| GOBP PROTEIN PALMITOYLATION | 26 | 5.42e-02 | 2.18e-01 | 4.62e-01 |
| GOMF ALDITOL NADPPLUS 1 OXIDOREDUCTASE ACTIVITY | 5 | 3.99e-01 | -2.18e-01 | 8.71e-01 |
| GOBP ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY | 13 | 1.74e-01 | -2.18e-01 | 7.05e-01 |
| GOBP REGULATION OF EXIT FROM MITOSIS | 16 | 1.31e-01 | 2.18e-01 | 6.41e-01 |
| GOBP RETINAL ROD CELL DIFFERENTIATION | 6 | 3.55e-01 | 2.18e-01 | 8.46e-01 |
| GOBP CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS | 30 | 3.89e-02 | 2.18e-01 | 4.03e-01 |
| GOMF PROLINE RICH REGION BINDING | 15 | 1.44e-01 | -2.18e-01 | 6.65e-01 |
| GOBP WATER TRANSPORT | 11 | 2.11e-01 | -2.18e-01 | 7.44e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 10 | 2.33e-01 | 2.18e-01 | 7.62e-01 |
| GOBP REGULATION OF PHOSPHOLIPID TRANSLOCATION | 5 | 4.00e-01 | -2.18e-01 | 8.71e-01 |
| GOBP RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM | 24 | 6.52e-02 | 2.17e-01 | 4.98e-01 |
| GOBP EXTRACELLULAR TRANSPORT | 27 | 5.06e-02 | -2.17e-01 | 4.51e-01 |
| GOBP MATURATION OF LSU RRNA | 28 | 4.65e-02 | -2.17e-01 | 4.38e-01 |
| GOCC EQUATORIAL MICROTUBULE ORGANIZING CENTER | 5 | 4.00e-01 | -2.17e-01 | 8.71e-01 |
| GOBP SERINE FAMILY AMINO ACID CATABOLIC PROCESS | 9 | 2.59e-01 | 2.17e-01 | 7.85e-01 |
| GOBP PEPTIDYL PROLINE HYDROXYLATION | 10 | 2.35e-01 | -2.17e-01 | 7.63e-01 |
| GOBP SOMITOGENESIS | 29 | 4.32e-02 | -2.17e-01 | 4.24e-01 |
| GOBP ESTABLISHMENT OF LYMPHOCYTE POLARITY | 12 | 1.93e-01 | 2.17e-01 | 7.23e-01 |
| GOBP RELAXATION OF SMOOTH MUSCLE | 7 | 3.21e-01 | 2.17e-01 | 8.27e-01 |
| GOBP SUCKLING BEHAVIOR | 6 | 3.58e-01 | -2.17e-01 | 8.46e-01 |
| GOBP REGULATION OF ER ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 8 | 2.89e-01 | -2.17e-01 | 8.06e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING | 17 | 1.22e-01 | -2.17e-01 | 6.25e-01 |
| GOBP NUCLEOSIDE TRANSMEMBRANE TRANSPORT | 5 | 4.02e-01 | 2.16e-01 | 8.72e-01 |
| GOBP NUCLEOSIDE TRANSPORT | 5 | 4.02e-01 | 2.16e-01 | 8.72e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 12 | 1.94e-01 | -2.16e-01 | 7.24e-01 |
| GOBP POSITIVE REGULATION OF RUFFLE ASSEMBLY | 11 | 2.14e-01 | -2.16e-01 | 7.46e-01 |
| GOBP FEMALE MEIOSIS CHROMOSOME SEGREGATION | 6 | 3.59e-01 | 2.16e-01 | 8.46e-01 |
| GOCC ENZYME ACTIVATOR COMPLEX | 16 | 1.34e-01 | -2.16e-01 | 6.50e-01 |
| GOCC ELONGATOR HOLOENZYME COMPLEX | 6 | 3.59e-01 | -2.16e-01 | 8.46e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE METABOLIC PROCESS | 5 | 4.03e-01 | 2.16e-01 | 8.72e-01 |
| GOBP DOPAMINE RECEPTOR SIGNALING PATHWAY | 20 | 9.45e-02 | -2.16e-01 | 5.70e-01 |
| GOBP PROTOPORPHYRINOGEN IX METABOLIC PROCESS | 10 | 2.37e-01 | -2.16e-01 | 7.66e-01 |
| GOBP CELLULAR RESPONSE TO PARATHYROID HORMONE STIMULUS | 6 | 3.60e-01 | 2.16e-01 | 8.46e-01 |
| GOBP RESPONSE TO PARATHYROID HORMONE | 6 | 3.60e-01 | 2.16e-01 | 8.46e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION | 8 | 2.90e-01 | -2.16e-01 | 8.06e-01 |
| GOBP NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE | 74 | 1.34e-03 | 2.16e-01 | 5.36e-02 |
| GOCC SNARE COMPLEX | 39 | 1.98e-02 | 2.16e-01 | 2.92e-01 |
| GOMF CONNEXIN BINDING | 5 | 4.04e-01 | 2.16e-01 | 8.72e-01 |
| GOBP CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 82 | 7.41e-04 | 2.16e-01 | 3.46e-02 |
| GOMF INSULIN LIKE GROWTH FACTOR I BINDING | 8 | 2.91e-01 | -2.16e-01 | 8.07e-01 |
| GOBP MAST CELL ACTIVATION | 49 | 9.06e-03 | 2.16e-01 | 1.88e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT BIOGENESIS | 99 | 2.13e-04 | -2.16e-01 | 1.37e-02 |
| GOMF INTERLEUKIN 1 RECEPTOR BINDING | 10 | 2.38e-01 | 2.15e-01 | 7.67e-01 |
| GOBP CELL KILLING | 118 | 5.51e-05 | 2.15e-01 | 4.69e-03 |
| GOBP REGULATION OF COLLAGEN METABOLIC PROCESS | 20 | 9.59e-02 | -2.15e-01 | 5.75e-01 |
| GOBP SKELETAL MUSCLE ADAPTATION | 10 | 2.39e-01 | -2.15e-01 | 7.68e-01 |
| GOMF PRE MRNA INTRONIC BINDING | 10 | 2.40e-01 | 2.15e-01 | 7.68e-01 |
| GOBP REGULATION OF T HELPER CELL DIFFERENTIATION | 28 | 4.97e-02 | 2.14e-01 | 4.48e-01 |
| GOBP PROTEIN LOCALIZATION TO PHOTORECEPTOR OUTER SEGMENT | 5 | 4.07e-01 | -2.14e-01 | 8.75e-01 |
| GOCC PROTEASOME CORE COMPLEX | 18 | 1.16e-01 | 2.14e-01 | 6.14e-01 |
| GOMF MHC PROTEIN COMPLEX BINDING | 27 | 5.42e-02 | 2.14e-01 | 4.62e-01 |
| GOCC SPERM MIDPIECE | 32 | 3.63e-02 | -2.14e-01 | 3.88e-01 |
| GOBP IRIS MORPHOGENESIS | 5 | 4.08e-01 | -2.14e-01 | 8.75e-01 |
| GOBP REGULATION OF PROTEIN COMPLEX STABILITY | 10 | 2.42e-01 | 2.14e-01 | 7.71e-01 |
| GOMF RNA 7 METHYLGUANOSINE CAP BINDING | 12 | 2.00e-01 | 2.14e-01 | 7.31e-01 |
| GOBP FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA | 13 | 1.83e-01 | -2.14e-01 | 7.13e-01 |
| GOBP DE NOVO CENTRIOLE ASSEMBLY | 5 | 4.08e-01 | -2.13e-01 | 8.76e-01 |
| GOBP DE NOVO CENTRIOLE ASSEMBLY INVOLVED IN MULTI CILIATED EPITHELIAL CELL DIFFERENTIATION | 5 | 4.08e-01 | -2.13e-01 | 8.76e-01 |
| GOCC CHROMOCENTER | 11 | 2.20e-01 | 2.13e-01 | 7.49e-01 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY BINDING | 39 | 2.11e-02 | 2.13e-01 | 3.04e-01 |
| GOBP B CELL LINEAGE COMMITMENT | 5 | 4.09e-01 | -2.13e-01 | 8.76e-01 |
| GOBP REGULATION OF SNARE COMPLEX ASSEMBLY | 12 | 2.01e-01 | -2.13e-01 | 7.32e-01 |
| GOMF FRIZZLED BINDING | 12 | 2.01e-01 | -2.13e-01 | 7.32e-01 |
| GOBP THYROID HORMONE TRANSPORT | 6 | 3.66e-01 | -2.13e-01 | 8.53e-01 |
| GOBP CARDIAC NEURAL CREST CELL DEVELOPMENT INVOLVED IN OUTFLOW TRACT MORPHOGENESIS | 7 | 3.30e-01 | 2.13e-01 | 8.30e-01 |
| GOBP PHOTORECEPTOR CELL MAINTENANCE | 24 | 7.14e-02 | -2.13e-01 | 5.17e-01 |
| GOBP REGULATION OF MEIOTIC NUCLEAR DIVISION | 14 | 1.69e-01 | 2.13e-01 | 6.96e-01 |
| GOMF INOSITOL PHOSPHATE PHOSPHATASE ACTIVITY | 17 | 1.29e-01 | 2.13e-01 | 6.40e-01 |
| GOBP POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION | 12 | 2.03e-01 | 2.12e-01 | 7.32e-01 |
| GOBP SPECIFICATION OF SYMMETRY | 78 | 1.20e-03 | -2.12e-01 | 4.99e-02 |
| GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 27 | 5.65e-02 | 2.12e-01 | 4.70e-01 |
| GOBP CELL DIFFERENTIATION IN SPINAL CORD | 17 | 1.30e-01 | -2.12e-01 | 6.40e-01 |
| GOBP ACTIN POLYMERIZATION DEPENDENT CELL MOTILITY | 7 | 3.31e-01 | -2.12e-01 | 8.31e-01 |
| GOBP REGULATION OF AMPA RECEPTOR ACTIVITY | 8 | 2.99e-01 | -2.12e-01 | 8.14e-01 |
| GOMF RIBOSOMAL LARGE SUBUNIT BINDING | 14 | 1.70e-01 | -2.12e-01 | 6.98e-01 |
| GOBP EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS | 6 | 3.69e-01 | -2.12e-01 | 8.55e-01 |
| GOBP PHOSPHOLIPID TRANSLOCATION | 36 | 2.79e-02 | 2.12e-01 | 3.42e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 17 | 1.31e-01 | -2.12e-01 | 6.41e-01 |
| GOMF PURINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 23 | 7.90e-02 | -2.12e-01 | 5.37e-01 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR BINDING | 26 | 6.19e-02 | 2.12e-01 | 4.86e-01 |
| GOBP NEGATIVE REGULATION OF GLYCOLYTIC PROCESS | 15 | 1.56e-01 | 2.12e-01 | 6.79e-01 |
| GOMF 3 HYDROXYACYL COA DEHYDROGENASE ACTIVITY | 7 | 3.32e-01 | -2.12e-01 | 8.32e-01 |
| GOBP NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION | 38 | 2.41e-02 | 2.11e-01 | 3.20e-01 |
| GOMF PROTEIN GLUTAMIC ACID LIGASE ACTIVITY | 5 | 4.13e-01 | -2.11e-01 | 8.77e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CYTOKINESIS | 8 | 3.01e-01 | 2.11e-01 | 8.14e-01 |
| GOBP REGULATION OF MITOTIC CYTOKINESIS | 8 | 3.01e-01 | 2.11e-01 | 8.14e-01 |
| GOBP SEROTONIN TRANSPORT | 10 | 2.47e-01 | 2.11e-01 | 7.76e-01 |
| GOCC TUBULAR ENDOSOME | 5 | 4.13e-01 | -2.11e-01 | 8.77e-01 |
| GOBP REGULATION OF NMDA RECEPTOR ACTIVITY | 9 | 2.73e-01 | -2.11e-01 | 7.94e-01 |
| GOMF FAD BINDING | 32 | 3.89e-02 | -2.11e-01 | 4.03e-01 |
| GOBP CEREBRAL CORTEX NEURON DIFFERENTIATION | 12 | 2.06e-01 | 2.11e-01 | 7.35e-01 |
| GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME | 6 | 3.71e-01 | 2.11e-01 | 8.57e-01 |
| GOMF ADENOSINE RECEPTOR BINDING | 5 | 4.14e-01 | 2.11e-01 | 8.77e-01 |
| GOCC DNA REPLICATION PREINITIATION COMPLEX | 12 | 2.06e-01 | -2.11e-01 | 7.35e-01 |
| GOBP RENAL WATER HOMEOSTASIS | 10 | 2.49e-01 | -2.11e-01 | 7.76e-01 |
| GOBP PROTEIN HETEROTETRAMERIZATION | 12 | 2.07e-01 | 2.11e-01 | 7.36e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 6 | 3.72e-01 | 2.11e-01 | 8.57e-01 |
| GOBP NEGATIVE REGULATION OF MONOCYTE DIFFERENTIATION | 5 | 4.15e-01 | -2.10e-01 | 8.78e-01 |
| GOBP ENDOPLASMIC RETICULUM PLASMA MEMBRANE TETHERING | 6 | 3.72e-01 | 2.10e-01 | 8.57e-01 |
| GOCC MISMATCH REPAIR COMPLEX | 7 | 3.36e-01 | 2.10e-01 | 8.36e-01 |
| GOMF G RICH STRAND TELOMERIC DNA BINDING | 10 | 2.50e-01 | -2.10e-01 | 7.77e-01 |
| GOBP CRANIOFACIAL SUTURE MORPHOGENESIS | 7 | 3.36e-01 | -2.10e-01 | 8.36e-01 |
| GOCC ACTIVIN RECEPTOR COMPLEX | 5 | 4.16e-01 | 2.10e-01 | 8.79e-01 |
| GOBP TELOMERIC LOOP DISASSEMBLY | 9 | 2.75e-01 | -2.10e-01 | 7.96e-01 |
| GOBP INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY | 16 | 1.46e-01 | 2.10e-01 | 6.69e-01 |
| GOBP REGULATION OF DENDRITE EXTENSION | 13 | 1.91e-01 | 2.10e-01 | 7.21e-01 |
| GOBP MONOCYTE CHEMOTAXIS | 37 | 2.74e-02 | -2.10e-01 | 3.37e-01 |
| GOMF TROPOMYOSIN BINDING | 8 | 3.05e-01 | -2.10e-01 | 8.15e-01 |
| GOBP ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION | 31 | 4.39e-02 | 2.09e-01 | 4.27e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS | 6 | 3.75e-01 | -2.09e-01 | 8.60e-01 |
| GOBP CYTOPLASM ORGANIZATION | 12 | 2.10e-01 | 2.09e-01 | 7.44e-01 |
| GOBP FEEDING BEHAVIOR | 39 | 2.40e-02 | -2.09e-01 | 3.20e-01 |
| GOBP BILE ACID SECRETION | 6 | 3.76e-01 | -2.09e-01 | 8.60e-01 |
| GOBP RESPONSE TO BACTERIAL LIPOPROTEIN | 6 | 3.76e-01 | -2.09e-01 | 8.60e-01 |
| GOBP PYRAMIDAL NEURON DIFFERENTIATION | 9 | 2.78e-01 | -2.09e-01 | 7.99e-01 |
| GOBP PIGMENT METABOLIC PROCESS | 52 | 9.24e-03 | -2.09e-01 | 1.89e-01 |
| GOMF P TYPE TRANSMEMBRANE TRANSPORTER ACTIVITY | 14 | 1.77e-01 | 2.09e-01 | 7.07e-01 |
| GOBP MAMMARY GLAND ALVEOLUS DEVELOPMENT | 11 | 2.31e-01 | -2.09e-01 | 7.58e-01 |
| GOBP MORPHOGENESIS OF A POLARIZED EPITHELIUM | 60 | 5.23e-03 | -2.09e-01 | 1.35e-01 |
| GOBP UV DAMAGE EXCISION REPAIR | 12 | 2.11e-01 | -2.08e-01 | 7.44e-01 |
| GOBP CELLULAR RESPONSE TO ANTIBIOTIC | 11 | 2.31e-01 | -2.08e-01 | 7.59e-01 |
| GOCC NURD COMPLEX | 15 | 1.63e-01 | -2.08e-01 | 6.88e-01 |
| GOBP CHONDROCYTE HYPERTROPHY | 5 | 4.20e-01 | -2.08e-01 | 8.80e-01 |
| GOBP DIET INDUCED THERMOGENESIS | 6 | 3.77e-01 | -2.08e-01 | 8.61e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 22 | 9.10e-02 | -2.08e-01 | 5.62e-01 |
| GOBP POSITIVE REGULATION OF BONE MINERALIZATION | 25 | 7.17e-02 | 2.08e-01 | 5.17e-01 |
| GOBP PROTEIN K29 LINKED UBIQUITINATION | 6 | 3.78e-01 | 2.08e-01 | 8.61e-01 |
| GOMF PROTEIN PHOSPHATASE 2B BINDING | 5 | 4.21e-01 | 2.08e-01 | 8.81e-01 |
| GOBP MICROTUBULE ANCHORING | 21 | 9.94e-02 | 2.08e-01 | 5.82e-01 |
| GOBP THYROID GLAND DEVELOPMENT | 17 | 1.38e-01 | 2.08e-01 | 6.59e-01 |
| GOBP NADH METABOLIC PROCESS | 10 | 2.56e-01 | 2.08e-01 | 7.82e-01 |
| GOBP STRAND INVASION | 5 | 4.21e-01 | -2.08e-01 | 8.81e-01 |
| GOBP POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 96 | 4.48e-04 | 2.07e-01 | 2.40e-02 |
| GOBP CELLULAR HYPEROSMOTIC RESPONSE | 15 | 1.64e-01 | -2.07e-01 | 6.90e-01 |
| GOBP PROTEIN LOCALIZATION TO CONDENSED CHROMOSOME | 15 | 1.64e-01 | 2.07e-01 | 6.90e-01 |
| GOBP OUTFLOW TRACT SEPTUM MORPHOGENESIS | 16 | 1.51e-01 | 2.07e-01 | 6.73e-01 |
| GOMF MEMBRANE INSERTASE ACTIVITY | 17 | 1.39e-01 | -2.07e-01 | 6.61e-01 |
| GOBP COPPER ION TRANSPORT | 13 | 1.96e-01 | 2.07e-01 | 7.27e-01 |
| GOBP NODAL SIGNALING PATHWAY | 7 | 3.43e-01 | 2.07e-01 | 8.41e-01 |
| GOBP VIRAL GENOME REPLICATION | 113 | 1.48e-04 | 2.07e-01 | 1.04e-02 |
| GOCC MYOSIN FILAMENT | 11 | 2.35e-01 | 2.07e-01 | 7.63e-01 |
| GOBP POSITIVE REGULATION OF MITOPHAGY | 6 | 3.81e-01 | -2.07e-01 | 8.63e-01 |
| GOBP SENSORY PERCEPTION OF TASTE | 13 | 1.97e-01 | -2.06e-01 | 7.29e-01 |
| GOBP EATING BEHAVIOR | 18 | 1.30e-01 | -2.06e-01 | 6.40e-01 |
| GOBP COPPER ION TRANSMEMBRANE TRANSPORT | 6 | 3.82e-01 | 2.06e-01 | 8.63e-01 |
| GOMF COPPER ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 3.82e-01 | 2.06e-01 | 8.63e-01 |
| GOMF INTERLEUKIN 1 RECEPTOR ACTIVITY | 5 | 4.24e-01 | 2.06e-01 | 8.81e-01 |
| GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS | 42 | 2.08e-02 | 2.06e-01 | 3.02e-01 |
| GOBP EYE PHOTORECEPTOR CELL DEVELOPMENT | 15 | 1.67e-01 | 2.06e-01 | 6.95e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE CHEMOTAXIS | 6 | 3.82e-01 | 2.06e-01 | 8.64e-01 |
| GOCC SPINDLE MICROTUBULE | 75 | 2.05e-03 | 2.06e-01 | 7.53e-02 |
| GOBP NEGATIVE REGULATION OF VASCULAR PERMEABILITY | 7 | 3.45e-01 | -2.06e-01 | 8.42e-01 |
| GOBP NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY | 8 | 3.13e-01 | -2.06e-01 | 8.22e-01 |
| GOBP LONG CHAIN FATTY ACYL COA METABOLIC PROCESS | 19 | 1.21e-01 | 2.06e-01 | 6.22e-01 |
| GOMF HEPARIN BINDING | 68 | 3.39e-03 | -2.06e-01 | 1.06e-01 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION | 8 | 3.14e-01 | 2.06e-01 | 8.22e-01 |
| GOBP MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION | 9 | 2.86e-01 | 2.05e-01 | 8.04e-01 |
| GOMF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 5 | 4.26e-01 | -2.05e-01 | 8.82e-01 |
| GOBP SUBSTRATE DEPENDENT CELL MIGRATION CELL EXTENSION | 7 | 3.47e-01 | 2.05e-01 | 8.43e-01 |
| GOBP POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT | 13 | 2.00e-01 | -2.05e-01 | 7.31e-01 |
| GOMF ACTIVIN RECEPTOR BINDING | 6 | 3.84e-01 | 2.05e-01 | 8.64e-01 |
| GOBP ADENINE TRANSPORT | 6 | 3.84e-01 | -2.05e-01 | 8.64e-01 |
| GOMF PROTEIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 25 | 7.60e-02 | -2.05e-01 | 5.30e-01 |
| GOCC ZYMOGEN GRANULE | 7 | 3.48e-01 | 2.05e-01 | 8.43e-01 |
| GOMF EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 20 | 1.13e-01 | 2.05e-01 | 6.08e-01 |
| GOBP MEIOTIC CHROMOSOME SEPARATION | 5 | 4.28e-01 | -2.05e-01 | 8.82e-01 |
| GOMF MOLECULAR TAG ACTIVITY | 12 | 2.20e-01 | -2.05e-01 | 7.49e-01 |
| GOBP SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR | 6 | 3.85e-01 | -2.05e-01 | 8.64e-01 |
| GOMF PHOSPHATIDYLSERINE 1 ACYLHYDROLASE ACTIVITY | 7 | 3.49e-01 | 2.05e-01 | 8.43e-01 |
| GOCC EARLY PHAGOSOME | 9 | 2.88e-01 | 2.05e-01 | 8.05e-01 |
| GOBP REGULATION OF SPROUTING ANGIOGENESIS | 23 | 8.96e-02 | -2.05e-01 | 5.59e-01 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE COMPLEX | 23 | 8.96e-02 | -2.05e-01 | 5.59e-01 |
| GOBP AMYLOID BETA CLEARANCE | 30 | 5.26e-02 | -2.05e-01 | 4.59e-01 |
| GOBP ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 14 | 1.85e-01 | -2.04e-01 | 7.16e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 5 | 4.29e-01 | 2.04e-01 | 8.82e-01 |
| GOBP NUCLEUS LOCALIZATION | 27 | 6.63e-02 | 2.04e-01 | 5.03e-01 |
| GOMF LEUCINE BINDING | 6 | 3.86e-01 | -2.04e-01 | 8.65e-01 |
| GOBP POSITIVE REGULATION OF PLATELET ACTIVATION | 5 | 4.29e-01 | 2.04e-01 | 8.82e-01 |
| GOMF LIPID PHOSPHATASE ACTIVITY | 11 | 2.41e-01 | 2.04e-01 | 7.70e-01 |
| GOBP POSITIVE REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY | 5 | 4.30e-01 | 2.04e-01 | 8.82e-01 |
| GOBP PROTEIN LOCALIZATION TO CYTOPLASMIC STRESS GRANULE | 8 | 3.18e-01 | 2.04e-01 | 8.24e-01 |
| GOBP FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE | 11 | 2.42e-01 | -2.04e-01 | 7.71e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 14 | 1.87e-01 | 2.04e-01 | 7.17e-01 |
| GOBP CLEAVAGE FURROW FORMATION | 7 | 3.51e-01 | 2.04e-01 | 8.46e-01 |
| GOBP T CELL SELECTION | 31 | 4.99e-02 | 2.04e-01 | 4.48e-01 |
| GOBP PURINE RIBONUCLEOSIDE SALVAGE | 6 | 3.88e-01 | -2.03e-01 | 8.65e-01 |
| GOBP ATP METABOLIC PROCESS | 119 | 1.29e-04 | -2.03e-01 | 9.34e-03 |
| GOBP REGULATION OF RECEPTOR RECYCLING | 18 | 1.35e-01 | 2.03e-01 | 6.52e-01 |
| GOBP ESTABLISHMENT OF SPINDLE ORIENTATION | 32 | 4.70e-02 | 2.03e-01 | 4.41e-01 |
| GOCC PORE COMPLEX | 21 | 1.08e-01 | -2.03e-01 | 5.98e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5 | 9 | 2.92e-01 | 2.03e-01 | 8.08e-01 |
| GOBP REGULATION OF PLASMA MEMBRANE REPAIR | 7 | 3.53e-01 | -2.03e-01 | 8.46e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR EXTRAVASATION | 5 | 4.33e-01 | 2.03e-01 | 8.82e-01 |
| GOBP SKELETAL MYOFIBRIL ASSEMBLY | 5 | 4.33e-01 | 2.02e-01 | 8.82e-01 |
| GOBP POSITIVE REGULATION OF CHROMATIN BINDING | 9 | 2.93e-01 | 2.02e-01 | 8.08e-01 |
| GOBP ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY | 15 | 1.75e-01 | 2.02e-01 | 7.06e-01 |
| GOBP LIPID TRANSPORT ACROSS BLOOD BRAIN BARRIER | 6 | 3.91e-01 | -2.02e-01 | 8.68e-01 |
| GOBP NADH DEHYDROGENASE COMPLEX ASSEMBLY | 59 | 7.31e-03 | -2.02e-01 | 1.67e-01 |
| GOMF PROTEIN ARGININE OMEGA N MONOMETHYLTRANSFERASE ACTIVITY | 5 | 4.34e-01 | 2.02e-01 | 8.83e-01 |
| GOCC PROTEIN FOLDING CHAPERONE COMPLEX | 39 | 2.93e-02 | -2.02e-01 | 3.49e-01 |
| GOMF RRNA BINDING | 64 | 5.29e-03 | -2.02e-01 | 1.36e-01 |
| GOBP REGULATION OF TRANSLATION AT SYNAPSE | 6 | 3.92e-01 | -2.02e-01 | 8.68e-01 |
| GOBP PEPTIDYL CYSTEINE MODIFICATION | 36 | 3.64e-02 | 2.02e-01 | 3.89e-01 |
| GOBP NUCLEOSIDE METABOLIC PROCESS | 41 | 2.56e-02 | 2.02e-01 | 3.30e-01 |
| GOMF NEUROPEPTIDE ACTIVITY | 10 | 2.70e-01 | -2.01e-01 | 7.93e-01 |
| GOMF MANNOSYL OLIGOSACCHARIDE MANNOSIDASE ACTIVITY | 9 | 2.96e-01 | 2.01e-01 | 8.10e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT | 8 | 3.25e-01 | -2.01e-01 | 8.29e-01 |
| GOBP NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS | 6 | 3.94e-01 | 2.01e-01 | 8.69e-01 |
| GOCC GROWTH FACTOR COMPLEX | 5 | 4.37e-01 | -2.01e-01 | 8.84e-01 |
| GOBP NEGATIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 8 | 3.25e-01 | 2.01e-01 | 8.29e-01 |
| GOBP REGULATION OF ALPHA BETA T CELL ACTIVATION | 78 | 2.20e-03 | 2.01e-01 | 7.90e-02 |
| GOMF GLYCOLIPID MANNOSYLTRANSFERASE ACTIVITY | 5 | 4.37e-01 | 2.01e-01 | 8.85e-01 |
| GOBP INOSITOL TRISPHOSPHATE METABOLIC PROCESS | 10 | 2.72e-01 | 2.01e-01 | 7.94e-01 |
| GOBP NEUROTROPHIN SIGNALING PATHWAY | 26 | 7.68e-02 | 2.01e-01 | 5.30e-01 |
| GOBP LEUKOCYTE MEDIATED CYTOTOXICITY | 85 | 1.41e-03 | 2.00e-01 | 5.56e-02 |
| GOBP REGULATION OF PRO B CELL DIFFERENTIATION | 7 | 3.59e-01 | 2.00e-01 | 8.46e-01 |
| GOBP REGULATION OF MITOCHONDRIAL GENE EXPRESSION | 30 | 5.76e-02 | -2.00e-01 | 4.70e-01 |
| GOBP CHRONIC INFLAMMATORY RESPONSE | 12 | 2.30e-01 | -2.00e-01 | 7.58e-01 |
| GOBP REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS | 11 | 2.50e-01 | -2.00e-01 | 7.77e-01 |
| GOCC STEREOCILIUM TIP | 11 | 2.50e-01 | 2.00e-01 | 7.77e-01 |
| GOMF MRNA METHYLTRANSFERASE ACTIVITY | 13 | 2.12e-01 | 2.00e-01 | 7.44e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 11 | 2.51e-01 | 2.00e-01 | 7.78e-01 |
| GOBP COLLATERAL SPROUTING | 15 | 1.80e-01 | -2.00e-01 | 7.11e-01 |
| GOMF 3 HYDROXYACYL COA DEHYDRATASE ACTIVITY | 7 | 3.60e-01 | 2.00e-01 | 8.46e-01 |
| GOBP POLYADENYLATION DEPENDENT RNA CATABOLIC PROCESS | 8 | 3.28e-01 | 2.00e-01 | 8.29e-01 |
| GOBP ELASTIN METABOLIC PROCESS | 7 | 3.60e-01 | -2.00e-01 | 8.46e-01 |
| GOBP MYOFIBROBLAST DIFFERENTIATION | 9 | 2.99e-01 | -2.00e-01 | 8.14e-01 |
| GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION | 41 | 2.70e-02 | -2.00e-01 | 3.35e-01 |
| GOBP RESPONSE TO DEXAMETHASONE | 24 | 9.07e-02 | 2.00e-01 | 5.62e-01 |
| GOBP REGULATION OF GLOMERULAR FILTRATION | 5 | 4.40e-01 | 2.00e-01 | 8.85e-01 |
| GOBP CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE | 8 | 3.28e-01 | -2.00e-01 | 8.30e-01 |
| GOBP SEQUESTERING OF IRON ION | 5 | 4.40e-01 | 2.00e-01 | 8.85e-01 |
| GOBP SECONDARY METABOLIC PROCESS | 28 | 6.78e-02 | -1.99e-01 | 5.08e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 6 | 3.98e-01 | -1.99e-01 | 8.71e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 3.98e-01 | 1.99e-01 | 8.71e-01 |
| GOCC PHOTORECEPTOR DISC MEMBRANE | 10 | 2.75e-01 | 1.99e-01 | 7.96e-01 |
| GOBP DETOXIFICATION OF INORGANIC COMPOUND | 15 | 1.82e-01 | -1.99e-01 | 7.13e-01 |
| GOBP INTERLEUKIN 18 PRODUCTION | 8 | 3.29e-01 | -1.99e-01 | 8.30e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 14 | 1.97e-01 | 1.99e-01 | 7.28e-01 |
| GOBP REGULATION OF MAST CELL ACTIVATION | 30 | 5.92e-02 | 1.99e-01 | 4.76e-01 |
| GOBP NEUTROPHIL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 18 | 1.44e-01 | 1.99e-01 | 6.65e-01 |
| GOBP REGULATION OF GLIAL CELL APOPTOTIC PROCESS | 9 | 3.01e-01 | 1.99e-01 | 8.14e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION | 103 | 4.93e-04 | 1.99e-01 | 2.58e-02 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION | 10 | 2.77e-01 | 1.99e-01 | 7.98e-01 |
| GOCC OXIDOREDUCTASE COMPLEX | 112 | 2.84e-04 | -1.99e-01 | 1.70e-02 |
| GOBP GLYCOSIDE METABOLIC PROCESS | 12 | 2.34e-01 | -1.99e-01 | 7.62e-01 |
| GOBP RESPONSE TO INDOLE 3 METHANOL | 6 | 3.99e-01 | 1.99e-01 | 8.71e-01 |
| GOBP SPERM EGG RECOGNITION | 22 | 1.07e-01 | -1.98e-01 | 5.97e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION | 17 | 1.57e-01 | 1.98e-01 | 6.80e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 17 | 1.57e-01 | -1.98e-01 | 6.80e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE HYPERTROPHY | 18 | 1.45e-01 | 1.98e-01 | 6.68e-01 |
| GOBP AORTIC VALVE MORPHOGENESIS | 16 | 1.70e-01 | 1.98e-01 | 6.98e-01 |
| GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY | 25 | 8.63e-02 | -1.98e-01 | 5.54e-01 |
| GOBP REGULATION OF RESPONSE TO TUMOR CELL | 15 | 1.84e-01 | 1.98e-01 | 7.15e-01 |
| GOBP HEART VALVE MORPHOGENESIS | 33 | 4.89e-02 | 1.98e-01 | 4.46e-01 |
| GOBP PROGESTERONE METABOLIC PROCESS | 8 | 3.32e-01 | 1.98e-01 | 8.31e-01 |
| GOBP REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 123 | 1.51e-04 | 1.98e-01 | 1.05e-02 |
| GOMF TRANSLATION REGULATOR ACTIVITY NUCLEIC ACID BINDING | 96 | 8.07e-04 | -1.98e-01 | 3.75e-02 |
| GOBP DIAPEDESIS | 6 | 4.01e-01 | 1.98e-01 | 8.72e-01 |
| GOMF TPR DOMAIN BINDING | 7 | 3.65e-01 | -1.98e-01 | 8.50e-01 |
| GOMF TRANSLATION REGULATOR ACTIVITY | 120 | 1.84e-04 | -1.98e-01 | 1.22e-02 |
| GOCC AMPHISOME MEMBRANE | 11 | 2.56e-01 | 1.98e-01 | 7.84e-01 |
| GOBP INNER MITOCHONDRIAL MEMBRANE ORGANIZATION | 38 | 3.50e-02 | -1.98e-01 | 3.81e-01 |
| GOBP SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT | 27 | 7.55e-02 | 1.98e-01 | 5.29e-01 |
| GOBP WOUND HEALING SPREADING OF EPIDERMAL CELLS | 15 | 1.85e-01 | 1.98e-01 | 7.16e-01 |
| GOBP HEPARIN BIOSYNTHETIC PROCESS | 8 | 3.33e-01 | -1.97e-01 | 8.34e-01 |
| GOBP IMMATURE B CELL DIFFERENTIATION | 10 | 2.80e-01 | 1.97e-01 | 7.99e-01 |
| GOBP DERMATAN SULFATE METABOLIC PROCESS | 7 | 3.66e-01 | -1.97e-01 | 8.52e-01 |
| GOBP REGULATION OF ANOIKIS | 17 | 1.59e-01 | 1.97e-01 | 6.83e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL ACTIVATION | 31 | 5.75e-02 | 1.97e-01 | 4.70e-01 |
| GOBP ZINC ION TRANSPORT | 21 | 1.18e-01 | -1.97e-01 | 6.18e-01 |
| GOMF TESTOSTERONE DEHYDROGENASE NADPLUS ACTIVITY | 5 | 4.46e-01 | 1.97e-01 | 8.87e-01 |
| GOMF TESTOSTERONE DEHYDROGENASE NAD P ACTIVITY | 5 | 4.46e-01 | 1.97e-01 | 8.87e-01 |
| GOBP MACROPHAGE FUSION | 6 | 4.03e-01 | -1.97e-01 | 8.72e-01 |
| GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 6 | 4.03e-01 | 1.97e-01 | 8.72e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION | 73 | 3.64e-03 | 1.97e-01 | 1.12e-01 |
| GOBP LUNG SACCULE DEVELOPMENT | 5 | 4.46e-01 | 1.97e-01 | 8.88e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMATIN | 5 | 4.46e-01 | 1.97e-01 | 8.88e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION | 8 | 3.36e-01 | 1.97e-01 | 8.36e-01 |
| GOBP NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 13 | 2.20e-01 | -1.97e-01 | 7.49e-01 |
| GOCC COPI COATED VESICLE MEMBRANE | 18 | 1.49e-01 | -1.96e-01 | 6.72e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND SALVAGE | 7 | 3.68e-01 | 1.96e-01 | 8.55e-01 |
| GOBP PULMONARY VALVE DEVELOPMENT | 14 | 2.03e-01 | 1.96e-01 | 7.32e-01 |
| GOCC PHOTORECEPTOR RIBBON SYNAPSE | 7 | 3.69e-01 | -1.96e-01 | 8.55e-01 |
| GOMF AMIDINE LYASE ACTIVITY | 6 | 4.05e-01 | -1.96e-01 | 8.74e-01 |
| GOBP POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION | 16 | 1.74e-01 | 1.96e-01 | 7.05e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEOLUS | 17 | 1.62e-01 | -1.96e-01 | 6.87e-01 |
| GOMF IRON ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 3.37e-01 | -1.96e-01 | 8.36e-01 |
| GOBP NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE | 13 | 2.21e-01 | 1.96e-01 | 7.49e-01 |
| GOBP MUCOSA ASSOCIATED LYMPHOID TISSUE DEVELOPMENT | 5 | 4.48e-01 | 1.96e-01 | 8.88e-01 |
| GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 20 | 1.29e-01 | 1.96e-01 | 6.40e-01 |
| GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 10 | 2.83e-01 | -1.96e-01 | 8.02e-01 |
| GOBP RESPONSE TO INTERLEUKIN 4 | 29 | 6.79e-02 | 1.96e-01 | 5.09e-01 |
| GOBP DENDRITE SELF AVOIDANCE | 6 | 4.06e-01 | -1.96e-01 | 8.74e-01 |
| GOBP SPERM DNA CONDENSATION | 8 | 3.37e-01 | 1.96e-01 | 8.36e-01 |
| GOBP REGULATION OF INCLUSION BODY ASSEMBLY | 15 | 1.89e-01 | -1.96e-01 | 7.18e-01 |
| GOBP CARDIAC MUSCLE CELL CONTRACTION | 41 | 3.01e-02 | 1.96e-01 | 3.52e-01 |
| GOMF STRUCTURAL MOLECULE ACTIVITY | 408 | 1.37e-11 | -1.96e-01 | 9.91e-09 |
| GOMF CYTOKINE ACTIVITY | 80 | 2.52e-03 | -1.95e-01 | 8.51e-02 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY | 13 | 2.23e-01 | 1.95e-01 | 7.51e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 13 | 2.23e-01 | 1.95e-01 | 7.51e-01 |
| GOMF SIGNALING RECEPTOR INHIBITOR ACTIVITY | 10 | 2.85e-01 | -1.95e-01 | 8.04e-01 |
| GOBP GLOMERULAR MESANGIAL CELL PROLIFERATION | 7 | 3.71e-01 | -1.95e-01 | 8.57e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATIONAL INITIATION | 24 | 9.84e-02 | -1.95e-01 | 5.81e-01 |
| GOBP MAINTENANCE OF BLOOD BRAIN BARRIER | 23 | 1.06e-01 | 1.95e-01 | 5.96e-01 |
| GOMF U4 SNRNA BINDING | 6 | 4.08e-01 | 1.95e-01 | 8.76e-01 |
| GOBP REGULATION OF MEMBRANE INVAGINATION | 11 | 2.63e-01 | -1.95e-01 | 7.88e-01 |
| GOCC PROTEIN PHOSPHATASE TYPE 2A COMPLEX | 15 | 1.92e-01 | 1.95e-01 | 7.22e-01 |
| GOMF UBIQUITIN LIKE MODIFIER ACTIVATING ENZYME ACTIVITY | 10 | 2.87e-01 | 1.94e-01 | 8.05e-01 |
| GOBP MITOTIC CHROMOSOME CONDENSATION | 19 | 1.43e-01 | 1.94e-01 | 6.65e-01 |
| GOBP REGULATION OF RESPONSE TO BIOTIC STIMULUS | 382 | 8.14e-11 | 1.94e-01 | 3.96e-08 |
| GOBP POSITIVE REGULATION OF FIBROBLAST PROLIFERATION | 36 | 4.38e-02 | -1.94e-01 | 4.26e-01 |
| GOBP HEART TRABECULA FORMATION | 8 | 3.42e-01 | -1.94e-01 | 8.40e-01 |
| GOMF GUANYLYLTRANSFERASE ACTIVITY | 7 | 3.74e-01 | 1.94e-01 | 8.60e-01 |
| GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH | 8 | 3.42e-01 | -1.94e-01 | 8.40e-01 |
| GOCC ATG1 ULK1 KINASE COMPLEX | 6 | 4.10e-01 | -1.94e-01 | 8.77e-01 |
| GOBP REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION | 10 | 2.88e-01 | -1.94e-01 | 8.05e-01 |
| GOMF NUCLEAR STEROID RECEPTOR ACTIVITY | 16 | 1.79e-01 | 1.94e-01 | 7.10e-01 |
| GOBP CELLULAR RESPONSE TO THYROID HORMONE STIMULUS | 13 | 2.26e-01 | -1.94e-01 | 7.56e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN EXECUTION PHASE OF APOPTOSIS | 5 | 4.53e-01 | 1.94e-01 | 8.91e-01 |
| GOBP ENDODERM FORMATION | 33 | 5.40e-02 | -1.94e-01 | 4.61e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTRASPECIES INTERACTION BETWEEN ORGANISMS | 27 | 8.15e-02 | -1.94e-01 | 5.42e-01 |
| GOBP SPERMINE METABOLIC PROCESS | 5 | 4.53e-01 | -1.94e-01 | 8.92e-01 |
| GOBP NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION | 12 | 2.46e-01 | 1.94e-01 | 7.74e-01 |
| GOBP RESPONSE TO ELECTRICAL STIMULUS | 26 | 8.78e-02 | -1.93e-01 | 5.58e-01 |
| GOBP REGULATION OF ADAPTIVE IMMUNE RESPONSE | 150 | 4.41e-05 | 1.93e-01 | 3.99e-03 |
| GOBP ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS | 26 | 8.78e-02 | 1.93e-01 | 5.58e-01 |
| GOBP REGULATION OF FOCAL ADHESION DISASSEMBLY | 6 | 4.12e-01 | 1.93e-01 | 8.77e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN GLUCOSE DEPRIVATION | 8 | 3.44e-01 | 1.93e-01 | 8.41e-01 |
| GOBP CARDIAC ATRIUM DEVELOPMENT | 19 | 1.45e-01 | 1.93e-01 | 6.66e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE ADAPTATION | 6 | 4.12e-01 | -1.93e-01 | 8.77e-01 |
| GOBP MEMBRANE RAFT ORGANIZATION | 22 | 1.17e-01 | -1.93e-01 | 6.17e-01 |
| GOBP HIPPO SIGNALING | 31 | 6.29e-02 | 1.93e-01 | 4.89e-01 |
| GOMF CARDIOLIPIN BINDING | 8 | 3.45e-01 | 1.93e-01 | 8.42e-01 |
| GOMF CHLORIDE ION BINDING | 5 | 4.55e-01 | -1.93e-01 | 8.93e-01 |
| GOBP POSITIVE REGULATION OF CHEMOKINE PRODUCTION | 49 | 1.96e-02 | 1.93e-01 | 2.91e-01 |
| GOBP REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 26 | 8.93e-02 | -1.93e-01 | 5.59e-01 |
| GOBP LATERAL MESODERM DEVELOPMENT | 6 | 4.14e-01 | -1.93e-01 | 8.77e-01 |
| GOBP NEGATIVE REGULATION OF METALLOPEPTIDASE ACTIVITY | 7 | 3.78e-01 | -1.93e-01 | 8.61e-01 |
| GOBP REGULATION OF THE FORCE OF HEART CONTRACTION | 10 | 2.92e-01 | 1.92e-01 | 8.08e-01 |
| GOBP TRANSPORT OF VIRUS | 19 | 1.47e-01 | 1.92e-01 | 6.69e-01 |
| GOBP MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS | 13 | 2.30e-01 | 1.92e-01 | 7.58e-01 |
| GOBP REGULATION OF CELL FATE SPECIFICATION | 16 | 1.83e-01 | -1.92e-01 | 7.14e-01 |
| GOMF MICROFILAMENT MOTOR ACTIVITY | 20 | 1.37e-01 | 1.92e-01 | 6.54e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOSOME | 26 | 9.00e-02 | 1.92e-01 | 5.60e-01 |
| GOBP CARDIAC LEFT VENTRICLE MORPHOGENESIS | 7 | 3.79e-01 | 1.92e-01 | 8.62e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION | 22 | 1.19e-01 | 1.92e-01 | 6.20e-01 |
| GOMF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING | 8 | 3.47e-01 | -1.92e-01 | 8.43e-01 |
| GOBP PEPTIDYL HISTIDINE MODIFICATION | 8 | 3.47e-01 | -1.92e-01 | 8.43e-01 |
| GOBP ATP TRANSPORT | 16 | 1.84e-01 | -1.92e-01 | 7.15e-01 |
| GOBP BRANCHED CHAIN AMINO ACID TRANSPORT | 10 | 2.94e-01 | -1.92e-01 | 8.08e-01 |
| GOBP REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY | 9 | 3.20e-01 | -1.92e-01 | 8.26e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE | 37 | 4.39e-02 | -1.92e-01 | 4.27e-01 |
| GOBP GLUTAMATE METABOLIC PROCESS | 19 | 1.49e-01 | -1.91e-01 | 6.72e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY | 12 | 2.51e-01 | 1.91e-01 | 7.78e-01 |
| GOBP T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL | 10 | 2.95e-01 | 1.91e-01 | 8.10e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS | 15 | 2.00e-01 | -1.91e-01 | 7.32e-01 |
| GOBP NEUROTRANSMITTER METABOLIC PROCESS | 12 | 2.52e-01 | -1.91e-01 | 7.78e-01 |
| GOMF KINETOCHORE BINDING | 6 | 4.18e-01 | 1.91e-01 | 8.79e-01 |
| GOBP COLLAGEN BIOSYNTHETIC PROCESS | 23 | 1.14e-01 | -1.91e-01 | 6.10e-01 |
| GOBP NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION | 8 | 3.51e-01 | -1.91e-01 | 8.46e-01 |
| GOMF RACEMASE AND EPIMERASE ACTIVITY | 15 | 2.01e-01 | -1.91e-01 | 7.32e-01 |
| GOBP AORTA DEVELOPMENT | 37 | 4.50e-02 | 1.90e-01 | 4.31e-01 |
| GOBP VENTRICULAR SEPTUM DEVELOPMENT | 44 | 2.89e-02 | 1.90e-01 | 3.47e-01 |
| GOBP POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION | 13 | 2.34e-01 | 1.90e-01 | 7.63e-01 |
| GOBP PROTEIN DESUMOYLATION | 8 | 3.51e-01 | 1.90e-01 | 8.46e-01 |
| GOBP ACYLGLYCEROL HOMEOSTASIS | 21 | 1.31e-01 | -1.90e-01 | 6.41e-01 |
| GOBP SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION | 9 | 3.23e-01 | 1.90e-01 | 8.29e-01 |
| GOBP RESPONSE TO FOLLICLE STIMULATING HORMONE | 7 | 3.84e-01 | -1.90e-01 | 8.64e-01 |
| GOBP RESPONSE TO ZINC ION | 32 | 6.31e-02 | -1.90e-01 | 4.89e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID FIBRIL FORMATION | 10 | 2.99e-01 | -1.90e-01 | 8.13e-01 |
| GOMF PLUS END DIRECTED MICROTUBULE MOTOR ACTIVITY | 12 | 2.55e-01 | 1.90e-01 | 7.81e-01 |
| GOMF UDP XYLOSYLTRANSFERASE ACTIVITY | 9 | 3.24e-01 | 1.90e-01 | 8.29e-01 |
| GOBP FEMALE MEIOTIC NUCLEAR DIVISION | 29 | 7.71e-02 | 1.90e-01 | 5.31e-01 |
| GOBP FATTY ACID HOMEOSTASIS | 11 | 2.76e-01 | -1.90e-01 | 7.97e-01 |
| GOBP MITOPHAGY | 35 | 5.24e-02 | -1.90e-01 | 4.58e-01 |
| GOBP SOMITE DEVELOPMENT | 38 | 4.33e-02 | -1.90e-01 | 4.24e-01 |
| GOBP NUCLEOLUS ORGANIZATION | 17 | 1.76e-01 | 1.90e-01 | 7.07e-01 |
| GOBP REGULATION OF MICROTUBULE BASED MOVEMENT | 27 | 8.85e-02 | -1.89e-01 | 5.58e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN KINASE ACTIVITY | 18 | 1.64e-01 | 1.89e-01 | 6.90e-01 |
| GOBP REGULATION OF MYOBLAST FUSION | 14 | 2.20e-01 | 1.89e-01 | 7.49e-01 |
| GOBP POSITIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION | 11 | 2.77e-01 | 1.89e-01 | 7.98e-01 |
| GOBP INTRACELLULAR TRIGLYCERIDE HOMEOSTASIS | 6 | 4.22e-01 | -1.89e-01 | 8.81e-01 |
| GOBP EARLY ENDOSOME TO RECYCLING ENDOSOME TRANSPORT | 6 | 4.23e-01 | -1.89e-01 | 8.81e-01 |
| GOMF WW DOMAIN BINDING | 16 | 1.91e-01 | 1.89e-01 | 7.21e-01 |
| GOMF ANKYRIN BINDING | 10 | 3.02e-01 | 1.89e-01 | 8.14e-01 |
| GOBP CYTOPLASMIC TRANSLATIONAL INITIATION | 37 | 4.71e-02 | -1.89e-01 | 4.41e-01 |
| GOCC COSTAMERE | 13 | 2.39e-01 | 1.89e-01 | 7.68e-01 |
| GOBP FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 29 | 7.89e-02 | 1.89e-01 | 5.37e-01 |
| GOBP EMBRYONIC BODY MORPHOGENESIS | 7 | 3.88e-01 | 1.88e-01 | 8.65e-01 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 10 | 3.02e-01 | -1.88e-01 | 8.14e-01 |
| GOBP CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS | 16 | 1.92e-01 | 1.88e-01 | 7.22e-01 |
| GOBP NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY | 9 | 3.28e-01 | 1.88e-01 | 8.29e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE | 12 | 2.59e-01 | -1.88e-01 | 7.85e-01 |
| GOCC EARLY ENDOSOME MEMBRANE | 148 | 7.85e-05 | 1.88e-01 | 6.38e-03 |
| GOMF NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 27 | 9.05e-02 | -1.88e-01 | 5.61e-01 |
| GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS | 24 | 1.10e-01 | 1.88e-01 | 6.02e-01 |
| GOBP INTRACELLULAR MONOATOMIC ANION HOMEOSTASIS | 7 | 3.88e-01 | 1.88e-01 | 8.65e-01 |
| GOBP CARTILAGE CONDENSATION | 5 | 4.66e-01 | 1.88e-01 | 9.00e-01 |
| GOBP RELAXATION OF MUSCLE | 22 | 1.27e-01 | 1.88e-01 | 6.33e-01 |
| GOBP REFLEX | 7 | 3.89e-01 | -1.88e-01 | 8.65e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION | 12 | 2.59e-01 | -1.88e-01 | 7.85e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY | 21 | 1.36e-01 | -1.88e-01 | 6.52e-01 |
| GOBP SMAD PROTEIN SIGNAL TRANSDUCTION | 53 | 1.80e-02 | 1.88e-01 | 2.81e-01 |
| GOMF G PROTEIN COUPLED CHEMOATTRACTANT RECEPTOR ACTIVITY | 8 | 3.57e-01 | -1.88e-01 | 8.46e-01 |
| GOCC MSL COMPLEX | 5 | 4.67e-01 | 1.88e-01 | 9.00e-01 |
| GOBP POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 28 | 8.53e-02 | 1.88e-01 | 5.50e-01 |
| GOBP DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT | 6 | 4.25e-01 | 1.88e-01 | 8.81e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY | 10 | 3.04e-01 | -1.88e-01 | 8.14e-01 |
| GOBP TRYPTOPHAN TRANSPORT | 5 | 4.67e-01 | -1.88e-01 | 9.00e-01 |
| GOCC MON1 CCZ1 COMPLEX | 5 | 4.67e-01 | 1.88e-01 | 9.00e-01 |
| GOBP NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS | 13 | 2.41e-01 | 1.88e-01 | 7.70e-01 |
| GOBP SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING | 26 | 9.76e-02 | -1.88e-01 | 5.78e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS | 5 | 4.67e-01 | 1.88e-01 | 9.00e-01 |
| GOBP HAIR FOLLICLE MATURATION | 10 | 3.04e-01 | 1.88e-01 | 8.15e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION | 16 | 1.94e-01 | 1.87e-01 | 7.24e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 18 | 1.69e-01 | 1.87e-01 | 6.96e-01 |
| GOBP POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION | 8 | 3.59e-01 | 1.87e-01 | 8.46e-01 |
| GOBP METANEPHRIC RENAL VESICLE MORPHOGENESIS | 8 | 3.59e-01 | 1.87e-01 | 8.46e-01 |
| GOBP RENAL VESICLE DEVELOPMENT | 8 | 3.59e-01 | 1.87e-01 | 8.46e-01 |
| GOBP REGULATION OF DENDRITIC CELL DIFFERENTIATION | 14 | 2.25e-01 | 1.87e-01 | 7.55e-01 |
| GOBP CO TRANSCRIPTIONAL RNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY | 6 | 4.27e-01 | -1.87e-01 | 8.82e-01 |
| GOBP POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 29 | 8.10e-02 | 1.87e-01 | 5.41e-01 |
| GOBP BLOOD COAGULATION FIBRIN CLOT FORMATION | 6 | 4.27e-01 | -1.87e-01 | 8.82e-01 |
| GOBP GLOMERULAR EPITHELIAL CELL DEVELOPMENT | 8 | 3.59e-01 | 1.87e-01 | 8.46e-01 |
| GOBP RNA SURVEILLANCE | 17 | 1.82e-01 | 1.87e-01 | 7.13e-01 |
| GOMF ACTIVE MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 148 | 8.68e-05 | -1.87e-01 | 6.89e-03 |
| GOMF SULFURIC ESTER HYDROLASE ACTIVITY | 11 | 2.83e-01 | 1.87e-01 | 8.01e-01 |
| GOBP N GLYCAN PROCESSING | 12 | 2.62e-01 | 1.87e-01 | 7.87e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL TRANSCRIPTION | 14 | 2.26e-01 | 1.87e-01 | 7.56e-01 |
| GOCC EXTERNAL SIDE OF APICAL PLASMA MEMBRANE | 5 | 4.69e-01 | -1.87e-01 | 9.00e-01 |
| GOCC XY BODY | 12 | 2.62e-01 | -1.87e-01 | 7.87e-01 |
| GOMF MICROTUBULE MOTOR ACTIVITY | 50 | 2.24e-02 | 1.87e-01 | 3.09e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS | 13 | 2.44e-01 | -1.87e-01 | 7.73e-01 |
| GOBP REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 77 | 4.64e-03 | 1.87e-01 | 1.28e-01 |
| GOMF INORGANIC PHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 3.61e-01 | -1.87e-01 | 8.47e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION | 30 | 7.70e-02 | 1.87e-01 | 5.31e-01 |
| GOBP REGULATION OF T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL | 6 | 4.29e-01 | 1.87e-01 | 8.82e-01 |
| GOMF MALATE DEHYDROGENASE ACTIVITY | 6 | 4.29e-01 | -1.86e-01 | 8.82e-01 |
| GOBP SMOOTH MUSCLE TISSUE DEVELOPMENT | 10 | 3.07e-01 | 1.86e-01 | 8.19e-01 |
| GOBP LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR | 7 | 3.93e-01 | 1.86e-01 | 8.68e-01 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 17 | 1.83e-01 | 1.86e-01 | 7.14e-01 |
| GOBP PHOSPHATIDYLCHOLINE CATABOLIC PROCESS | 12 | 2.64e-01 | -1.86e-01 | 7.88e-01 |
| GOBP G PROTEIN COUPLED OPIOID RECEPTOR SIGNALING PATHWAY | 7 | 3.93e-01 | -1.86e-01 | 8.68e-01 |
| GOBP REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 21 | 1.40e-01 | 1.86e-01 | 6.61e-01 |
| GOBP RESPONSE TO GLUCAGON | 11 | 2.85e-01 | 1.86e-01 | 8.04e-01 |
| GOCC SORTING ENDOSOME | 5 | 4.71e-01 | -1.86e-01 | 9.02e-01 |
| GOBP REGULATION OF ENTRY OF BACTERIUM INTO HOST CELL | 5 | 4.71e-01 | -1.86e-01 | 9.02e-01 |
| GOBP REGULATION OF HEART RATE BY CARDIAC CONDUCTION | 19 | 1.61e-01 | 1.86e-01 | 6.87e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 5 | 4.71e-01 | 1.86e-01 | 9.02e-01 |
| GOBP POSITIVE REGULATION OF MAST CELL CHEMOTAXIS | 5 | 4.72e-01 | -1.86e-01 | 9.02e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION | 10 | 3.09e-01 | 1.86e-01 | 8.20e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 20 | 1.50e-01 | 1.86e-01 | 6.73e-01 |
| GOBP REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 52 | 2.05e-02 | 1.86e-01 | 2.99e-01 |
| GOBP GLUTATHIONE TRANSMEMBRANE TRANSPORT | 6 | 4.31e-01 | -1.86e-01 | 8.82e-01 |
| GOMF DEMETHYLASE ACTIVITY | 36 | 5.40e-02 | 1.86e-01 | 4.61e-01 |
| GOBP PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS | 39 | 4.50e-02 | -1.86e-01 | 4.31e-01 |
| GOBP REGULATION OF LYSOSOME SIZE | 8 | 3.64e-01 | -1.86e-01 | 8.50e-01 |
| GOCC BORC COMPLEX | 8 | 3.64e-01 | -1.86e-01 | 8.50e-01 |
| GOBP INTERLEUKIN 17A MEDIATED SIGNALING PATHWAY | 5 | 4.73e-01 | 1.85e-01 | 9.02e-01 |
| GOBP HYPOTHALAMUS CELL DIFFERENTIATION | 6 | 4.32e-01 | -1.85e-01 | 8.82e-01 |
| GOBP HYPOTHALAMUS GONADOTROPHIN RELEASING HORMONE NEURON DIFFERENTIATION | 6 | 4.32e-01 | -1.85e-01 | 8.82e-01 |
| GOBP NEUTROPHIL CHEMOTAXIS | 67 | 8.74e-03 | -1.85e-01 | 1.85e-01 |
| GOMF POLY PURINE TRACT BINDING | 26 | 1.02e-01 | 1.85e-01 | 5.88e-01 |
| GOBP NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 5 | 4.73e-01 | 1.85e-01 | 9.02e-01 |
| GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 5 | 4.73e-01 | 1.85e-01 | 9.02e-01 |
| GOBP INFLAMMATORY CELL APOPTOTIC PROCESS | 16 | 2.00e-01 | 1.85e-01 | 7.31e-01 |
| GOBP REGULATION OF REMOVAL OF SUPEROXIDE RADICALS | 5 | 4.73e-01 | -1.85e-01 | 9.02e-01 |
| GOBP REGULATION OF ANIMAL ORGAN MORPHOGENESIS | 60 | 1.32e-02 | -1.85e-01 | 2.40e-01 |
| GOBP NEUTROPHIL CLEARANCE | 5 | 4.74e-01 | 1.85e-01 | 9.02e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION | 12 | 2.67e-01 | 1.85e-01 | 7.91e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 27 | 9.64e-02 | 1.85e-01 | 5.76e-01 |
| GOBP PREPULSE INHIBITION | 6 | 4.33e-01 | -1.85e-01 | 8.82e-01 |
| GOBP MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY | 23 | 1.25e-01 | -1.85e-01 | 6.29e-01 |
| GOBP NEGATIVE REGULATION OF LIPID TRANSPORT | 17 | 1.87e-01 | -1.85e-01 | 7.17e-01 |
| GOBP RESPONSE TO OXYGEN GLUCOSE DEPRIVATION | 12 | 2.68e-01 | 1.85e-01 | 7.91e-01 |
| GOBP CELL CYCLE DNA REPLICATION INITIATION | 5 | 4.74e-01 | -1.85e-01 | 9.03e-01 |
| GOBP PROTEIN TO MEMBRANE DOCKING | 5 | 4.74e-01 | -1.85e-01 | 9.03e-01 |
| GOBP GLOMERULAR MESANGIUM DEVELOPMENT | 9 | 3.37e-01 | -1.85e-01 | 8.36e-01 |
| GOBP MEIOTIC CELL CYCLE PHASE TRANSITION | 9 | 3.37e-01 | 1.85e-01 | 8.36e-01 |
| GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL | 44 | 3.41e-02 | 1.85e-01 | 3.77e-01 |
| GOBP ENDOTHELIAL CELL ACTIVATION | 7 | 3.98e-01 | -1.85e-01 | 8.71e-01 |
| GOBP RADIAL GLIAL CELL DIFFERENTIATION | 7 | 3.98e-01 | 1.84e-01 | 8.71e-01 |
| GOMF ENDOPEPTIDASE ACTIVATOR ACTIVITY | 13 | 2.50e-01 | 1.84e-01 | 7.77e-01 |
| GOBP CYTOSOLIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 121 | 4.67e-04 | 1.84e-01 | 2.46e-02 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION | 13 | 2.50e-01 | -1.84e-01 | 7.77e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 10 | 3.13e-01 | -1.84e-01 | 8.22e-01 |
| GOCC NUCLEAR REPLICATION FORK | 31 | 7.62e-02 | -1.84e-01 | 5.30e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 9 | 3.39e-01 | 1.84e-01 | 8.38e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL | 17 | 1.90e-01 | -1.84e-01 | 7.19e-01 |
| GOBP LOCOMOTORY EXPLORATION BEHAVIOR | 6 | 4.37e-01 | -1.83e-01 | 8.84e-01 |
| GOBP MONOACYLGLYCEROL METABOLIC PROCESS | 7 | 4.01e-01 | 1.83e-01 | 8.72e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 19 | 1.67e-01 | -1.83e-01 | 6.95e-01 |
| GOBP REGULATION OF GRANULOCYTE DIFFERENTIATION | 11 | 2.93e-01 | -1.83e-01 | 8.08e-01 |
| GOBP REGULATION OF HEPATOCYTE PROLIFERATION | 10 | 3.16e-01 | 1.83e-01 | 8.23e-01 |
| GOBP NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY | 18 | 1.79e-01 | 1.83e-01 | 7.10e-01 |
| GOBP INTERLEUKIN 13 PRODUCTION | 11 | 2.93e-01 | 1.83e-01 | 8.08e-01 |
| GOBP REGULATION OF RRNA PROCESSING | 16 | 2.05e-01 | 1.83e-01 | 7.33e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY | 13 | 2.54e-01 | 1.83e-01 | 7.79e-01 |
| GOCC HIPPOCAMPAL MOSSY FIBER TO CA3 SYNAPSE | 26 | 1.07e-01 | 1.83e-01 | 5.96e-01 |
| GOMF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 9 | 3.42e-01 | -1.83e-01 | 8.41e-01 |
| GOMF GTP DEPENDENT PROTEIN BINDING | 19 | 1.68e-01 | 1.83e-01 | 6.96e-01 |
| GOBP PLATELET ACTIVATING FACTOR METABOLIC PROCESS | 7 | 4.03e-01 | -1.83e-01 | 8.72e-01 |
| GOBP EXCRETION | 10 | 3.17e-01 | -1.83e-01 | 8.23e-01 |
| GOBP MAINTENANCE OF CENTROSOME LOCATION | 6 | 4.39e-01 | 1.83e-01 | 8.85e-01 |
| GOCC MEDIATOR COMPLEX | 36 | 5.81e-02 | 1.83e-01 | 4.71e-01 |
| GOMF HISTONE H3K9 METHYLTRANSFERASE ACTIVITY | 10 | 3.18e-01 | 1.83e-01 | 8.23e-01 |
| GOBP REGULATION OF PINOCYTOSIS | 10 | 3.18e-01 | -1.82e-01 | 8.23e-01 |
| GOBP PHOSPHOLIPID DEPHOSPHORYLATION | 32 | 7.42e-02 | 1.82e-01 | 5.24e-01 |
| GOCC ENDOPLASMIC RETICULUM EXIT SITE | 26 | 1.08e-01 | 1.82e-01 | 5.98e-01 |
| GOBP T CELL EXTRAVASATION | 11 | 2.95e-01 | 1.82e-01 | 8.10e-01 |
| GOCC PLATELET DENSE TUBULAR NETWORK | 6 | 4.40e-01 | 1.82e-01 | 8.85e-01 |
| GOCC PLATELET DENSE TUBULAR NETWORK MEMBRANE | 6 | 4.40e-01 | 1.82e-01 | 8.85e-01 |
| GOBP GLUTATHIONE TRANSPORT | 7 | 4.04e-01 | -1.82e-01 | 8.72e-01 |
| GOMF GLYCOSPHINGOLIPID BINDING | 6 | 4.40e-01 | 1.82e-01 | 8.85e-01 |
| GOBP POSITIVE REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 6 | 4.40e-01 | -1.82e-01 | 8.85e-01 |
| GOBP SELF PROTEOLYSIS | 8 | 3.73e-01 | -1.82e-01 | 8.58e-01 |
| GOBP REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 32 | 7.48e-02 | 1.82e-01 | 5.26e-01 |
| GOBP CIRCADIAN SLEEP WAKE CYCLE SLEEP | 7 | 4.04e-01 | -1.82e-01 | 8.72e-01 |
| GOBP UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS | 12 | 2.75e-01 | -1.82e-01 | 7.96e-01 |
| GOBP PROSTATE GLAND GROWTH | 6 | 4.40e-01 | -1.82e-01 | 8.85e-01 |
| GOBP REGULATION OF ENDOSOME SIZE | 13 | 2.56e-01 | -1.82e-01 | 7.84e-01 |
| GOBP REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 129 | 3.69e-04 | 1.82e-01 | 2.03e-02 |
| GOBP CELLULAR RESPONSE TO NITROSATIVE STRESS | 5 | 4.82e-01 | 1.82e-01 | 9.08e-01 |
| GOBP LUNG MORPHOGENESIS | 29 | 9.07e-02 | -1.82e-01 | 5.62e-01 |
| GOCC MEIOTIC COHESIN COMPLEX | 5 | 4.82e-01 | 1.81e-01 | 9.08e-01 |
| GOBP RECEPTOR CATABOLIC PROCESS | 24 | 1.24e-01 | -1.81e-01 | 6.28e-01 |
| GOBP RESPONSE TO GRAVITY | 5 | 4.83e-01 | 1.81e-01 | 9.08e-01 |
| GOBP RETROGRADE TRANS SYNAPTIC SIGNALING | 7 | 4.06e-01 | -1.81e-01 | 8.74e-01 |
| GOBP EMBRYONIC FORELIMB MORPHOGENESIS | 13 | 2.58e-01 | -1.81e-01 | 7.85e-01 |
| GOBP MICROTUBULE POLYMERIZATION | 83 | 4.37e-03 | 1.81e-01 | 1.23e-01 |
| GOBP CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS | 18 | 1.84e-01 | 1.81e-01 | 7.15e-01 |
| GOMF PROTEIN DISULFIDE REDUCTASE ACTIVITY | 25 | 1.18e-01 | -1.81e-01 | 6.17e-01 |
| GOMF CALCIUM ACTIVATED POTASSIUM CHANNEL ACTIVITY | 8 | 3.76e-01 | -1.81e-01 | 8.60e-01 |
| GOCC FICOLIN 1 RICH GRANULE LUMEN | 119 | 6.69e-04 | -1.81e-01 | 3.23e-02 |
| GOMF 3 5 DNA EXONUCLEASE ACTIVITY | 12 | 2.79e-01 | -1.81e-01 | 7.99e-01 |
| GOBP DEOXYRIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 5 | 4.84e-01 | 1.81e-01 | 9.10e-01 |
| GOMF K63 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 26 | 1.11e-01 | 1.81e-01 | 6.04e-01 |
| GOBP INTRACELLULAR PROTEIN TRANSMEMBRANE TRANSPORT | 51 | 2.59e-02 | -1.80e-01 | 3.31e-01 |
| GOCC SPERM HEAD | 6 | 4.44e-01 | -1.80e-01 | 8.87e-01 |
| GOMF EXTRACELLULAR MATRIX BINDING | 21 | 1.53e-01 | -1.80e-01 | 6.74e-01 |
| GOBP REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY | 8 | 3.77e-01 | 1.80e-01 | 8.61e-01 |
| GOMF LIGAND GATED MONOATOMIC CATION CHANNEL ACTIVITY | 42 | 4.33e-02 | 1.80e-01 | 4.24e-01 |
| GOBP COMMISSURAL NEURON AXON GUIDANCE | 9 | 3.49e-01 | 1.80e-01 | 8.45e-01 |
| GOCC MICOS COMPLEX | 8 | 3.78e-01 | -1.80e-01 | 8.61e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS | 5 | 4.86e-01 | -1.80e-01 | 9.11e-01 |
| GOBP T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 8 | 3.78e-01 | 1.80e-01 | 8.61e-01 |
| GOBP REGULATION OF LAMELLIPODIUM ASSEMBLY | 29 | 9.36e-02 | -1.80e-01 | 5.67e-01 |
| GOBP VITAMIN BIOSYNTHETIC PROCESS | 17 | 1.99e-01 | -1.80e-01 | 7.31e-01 |
| GOCC MANCHETTE | 14 | 2.44e-01 | -1.80e-01 | 7.73e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME | 12 | 2.81e-01 | 1.80e-01 | 7.99e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 67 | 1.10e-02 | 1.80e-01 | 2.12e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE | 17 | 2.00e-01 | -1.80e-01 | 7.31e-01 |
| GOBP INTERLEUKIN 5 PRODUCTION | 7 | 4.11e-01 | 1.80e-01 | 8.77e-01 |
| GOBP CELLULAR RESPONSE TO VIRUS | 47 | 3.33e-02 | 1.79e-01 | 3.74e-01 |
| GOCC EXOCYST | 11 | 3.03e-01 | 1.79e-01 | 8.14e-01 |
| GOBP POSITIVE REGULATION OF TISSUE REMODELING | 7 | 4.11e-01 | 1.79e-01 | 8.77e-01 |
| GOBP NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS | 5 | 4.88e-01 | 1.79e-01 | 9.11e-01 |
| GOBP REGULATION OF NEUTROPHIL DEGRANULATION | 7 | 4.12e-01 | 1.79e-01 | 8.77e-01 |
| GOCC MRNA CAP BINDING COMPLEX | 11 | 3.04e-01 | 1.79e-01 | 8.14e-01 |
| GOBP PARTURITION | 5 | 4.88e-01 | -1.79e-01 | 9.11e-01 |
| GOBP NOTCH RECEPTOR PROCESSING | 8 | 3.80e-01 | 1.79e-01 | 8.63e-01 |
| GOBP REGULATION OF BROWN FAT CELL DIFFERENTIATION | 18 | 1.88e-01 | 1.79e-01 | 7.18e-01 |
| GOBP CARDIAC VENTRICLE DEVELOPMENT | 67 | 1.13e-02 | 1.79e-01 | 2.14e-01 |
| GOBP CYCLIC GMP AMP TRANSMEMBRANE IMPORT ACROSS PLASMA MEMBRANE | 5 | 4.88e-01 | 1.79e-01 | 9.12e-01 |
| GOBP POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 54 | 2.29e-02 | 1.79e-01 | 3.12e-01 |
| GOBP T HELPER 2 CELL DIFFERENTIATION | 15 | 2.30e-01 | 1.79e-01 | 7.58e-01 |
| GOCC NUCLEAR CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 15 | 2.30e-01 | 1.79e-01 | 7.58e-01 |
| GOBP HEART VALVE DEVELOPMENT | 42 | 4.50e-02 | 1.79e-01 | 4.31e-01 |
| GOCC CYTOLYTIC GRANULE | 8 | 3.81e-01 | -1.79e-01 | 8.63e-01 |
| GOBP REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT | 10 | 3.28e-01 | -1.79e-01 | 8.29e-01 |
| GOBP TRACHEA DEVELOPMENT | 12 | 2.84e-01 | -1.79e-01 | 8.02e-01 |
| GOBP RESPONSE TO DISACCHARIDE | 5 | 4.89e-01 | 1.79e-01 | 9.12e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 16 | 2.16e-01 | -1.79e-01 | 7.47e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX | 5 | 4.90e-01 | 1.78e-01 | 9.12e-01 |
| GOBP CYTOSOLIC RIBOSOME ASSEMBLY | 5 | 4.90e-01 | -1.78e-01 | 9.12e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST FUSION | 10 | 3.29e-01 | 1.78e-01 | 8.30e-01 |
| GOBP NEGATIVE REGULATION OF MOTOR NEURON APOPTOTIC PROCESS | 8 | 3.82e-01 | 1.78e-01 | 8.64e-01 |
| GOMF PHOSPHATIDYLETHANOLAMINE BINDING | 12 | 2.85e-01 | -1.78e-01 | 8.04e-01 |
| GOBP CAMP CATABOLIC PROCESS | 7 | 4.14e-01 | 1.78e-01 | 8.77e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION | 13 | 2.66e-01 | 1.78e-01 | 7.91e-01 |
| GOBP RESPONSE TO INTERLEUKIN 3 | 7 | 4.14e-01 | 1.78e-01 | 8.77e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS | 30 | 9.16e-02 | 1.78e-01 | 5.63e-01 |
| GOBP SPERMATID NUCLEUS DIFFERENTIATION | 17 | 2.04e-01 | 1.78e-01 | 7.32e-01 |
| GOMF TOLL LIKE RECEPTOR BINDING | 13 | 2.67e-01 | 1.78e-01 | 7.91e-01 |
| GOBP REGULATION OF SPONTANEOUS SYNAPTIC TRANSMISSION | 6 | 4.50e-01 | 1.78e-01 | 8.89e-01 |
| GOBP INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION | 25 | 1.24e-01 | -1.78e-01 | 6.26e-01 |
| GOBP ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS | 213 | 7.95e-06 | 1.78e-01 | 1.00e-03 |
| GOMF NUCLEAR IMPORT SIGNAL RECEPTOR ACTIVITY | 19 | 1.80e-01 | -1.78e-01 | 7.10e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION | 75 | 7.80e-03 | -1.78e-01 | 1.73e-01 |
| GOBP REGULATION OF SECONDARY METABOLIC PROCESS | 12 | 2.86e-01 | -1.78e-01 | 8.05e-01 |
| GOMF LAMIN BINDING | 14 | 2.50e-01 | 1.78e-01 | 7.77e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND CATABOLIC PROCESS | 8 | 3.85e-01 | 1.78e-01 | 8.64e-01 |
| GOBP POSITIVE REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 11 | 3.08e-01 | -1.77e-01 | 8.19e-01 |
| GOBP CLATHRIN COATED VESICLE CARGO LOADING | 7 | 4.16e-01 | 1.77e-01 | 8.79e-01 |
| GOMF TRNA METHYLTRANSFERASE ACTIVITY | 33 | 7.78e-02 | 1.77e-01 | 5.34e-01 |
| GOCC CUL5 RING UBIQUITIN LIGASE COMPLEX | 8 | 3.85e-01 | 1.77e-01 | 8.64e-01 |
| GOBP POSITIVE REGULATION OF T CELL PROLIFERATION | 69 | 1.09e-02 | 1.77e-01 | 2.10e-01 |
| GOCC CONTRACTILE RING | 10 | 3.32e-01 | 1.77e-01 | 8.31e-01 |
| GOBP NEGATIVE REGULATION OF CELL KILLING | 22 | 1.50e-01 | 1.77e-01 | 6.73e-01 |
| GOBP REGULATION OF ISOMERASE ACTIVITY | 7 | 4.17e-01 | 1.77e-01 | 8.79e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 5 | 4.93e-01 | 1.77e-01 | 9.13e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 22 | 1.51e-01 | 1.77e-01 | 6.73e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL STORAGE | 6 | 4.53e-01 | 1.77e-01 | 8.91e-01 |
| GOBP CELL REDOX HOMEOSTASIS | 35 | 7.00e-02 | -1.77e-01 | 5.15e-01 |
| GOBP NEUROPEPTIDE SIGNALING PATHWAY | 25 | 1.26e-01 | -1.77e-01 | 6.30e-01 |
| GOBP RESPONSE TO BILE ACID | 5 | 4.93e-01 | 1.77e-01 | 9.13e-01 |
| GOBP RELAXATION OF CARDIAC MUSCLE | 13 | 2.69e-01 | 1.77e-01 | 7.93e-01 |
| GOBP POSITIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE | 11 | 3.10e-01 | 1.77e-01 | 8.21e-01 |
| GOBP DNA UNWINDING INVOLVED IN DNA REPLICATION | 21 | 1.61e-01 | -1.77e-01 | 6.87e-01 |
| GOMF MAP KINASE KINASE ACTIVITY | 14 | 2.52e-01 | 1.77e-01 | 7.78e-01 |
| GOCC TELOMERASE HOLOENZYME COMPLEX | 20 | 1.71e-01 | 1.77e-01 | 7.00e-01 |
| GOBP STEROID CATABOLIC PROCESS | 14 | 2.53e-01 | -1.77e-01 | 7.78e-01 |
| GOMF POLY PYRIMIDINE TRACT BINDING | 22 | 1.52e-01 | 1.77e-01 | 6.74e-01 |
| GOBP POSITIVE REGULATION OF TYPE II INTERFERON PRODUCTION | 50 | 3.09e-02 | 1.77e-01 | 3.54e-01 |
| GOBP RESPONSE TO INTERLEUKIN 12 | 9 | 3.59e-01 | 1.77e-01 | 8.46e-01 |
| GOCC CILIARY ROOTLET | 11 | 3.11e-01 | -1.76e-01 | 8.21e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 5 PHOSPHATASE ACTIVITY | 12 | 2.90e-01 | 1.76e-01 | 8.06e-01 |
| GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 13 | 2.71e-01 | 1.76e-01 | 7.94e-01 |
| GOBP REGULATION OF NEUTROPHIL MIGRATION | 33 | 7.98e-02 | 1.76e-01 | 5.39e-01 |
| GOBP REGULATION OF MUSCLE HYPERTROPHY | 39 | 5.70e-02 | 1.76e-01 | 4.70e-01 |
| GOBP ASPARTATE TRANSMEMBRANE TRANSPORT | 13 | 2.72e-01 | -1.76e-01 | 7.94e-01 |
| GOMF SECONDARY ACTIVE MONOCARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 3.60e-01 | -1.76e-01 | 8.46e-01 |
| GOBP POSITIVE REGULATION OF RNA BINDING | 6 | 4.56e-01 | -1.76e-01 | 8.94e-01 |
| GOBP EXTRACELLULAR MATRIX CONSTITUENT SECRETION | 11 | 3.13e-01 | -1.76e-01 | 8.22e-01 |
| GOMF PRIMARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 131 | 5.31e-04 | -1.76e-01 | 2.68e-02 |
| GOBP REGULATION OF PROTEIN NEDDYLATION | 19 | 1.85e-01 | -1.75e-01 | 7.16e-01 |
| GOBP UREA TRANSPORT | 5 | 4.97e-01 | 1.75e-01 | 9.13e-01 |
| GOBP NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 10 | 3.37e-01 | 1.75e-01 | 8.36e-01 |
| GOBP PRESYNAPTIC ACTIVE ZONE ORGANIZATION | 5 | 4.97e-01 | -1.75e-01 | 9.13e-01 |
| GOBP CELLULAR RESPIRATION | 216 | 9.38e-06 | -1.75e-01 | 1.13e-03 |
| GOBP REGULATION OF B CELL APOPTOTIC PROCESS | 17 | 2.11e-01 | 1.75e-01 | 7.44e-01 |
| GOBP NCRNA EXPORT FROM NUCLEUS | 9 | 3.63e-01 | 1.75e-01 | 8.49e-01 |
| GOMF G QUADRUPLEX RNA BINDING | 5 | 4.97e-01 | 1.75e-01 | 9.13e-01 |
| GOBP OOCYTE CONSTRUCTION | 5 | 4.98e-01 | 1.75e-01 | 9.13e-01 |
| GOBP REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS | 13 | 2.74e-01 | -1.75e-01 | 7.96e-01 |
| GOBP MODIFICATION OF POSTSYNAPTIC STRUCTURE | 13 | 2.74e-01 | -1.75e-01 | 7.96e-01 |
| GOMF OPSONIN BINDING | 8 | 3.91e-01 | -1.75e-01 | 8.68e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN KINASE ACTIVITY BY REGULATION OF PROTEIN PHOSPHORYLATION | 6 | 4.58e-01 | 1.75e-01 | 8.96e-01 |
| GOBP IMMUNE RESPONSE INHIBITING SIGNAL TRANSDUCTION | 8 | 3.92e-01 | -1.75e-01 | 8.68e-01 |
| GOMF INSULIN RECEPTOR SUBSTRATE BINDING | 11 | 3.15e-01 | 1.75e-01 | 8.23e-01 |
| GOBP CRANIAL NERVE STRUCTURAL ORGANIZATION | 5 | 4.98e-01 | -1.75e-01 | 9.13e-01 |
| GOBP REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 169 | 9.07e-05 | 1.75e-01 | 7.10e-03 |
| GOBP LIPOPROTEIN LOCALIZATION | 14 | 2.58e-01 | 1.75e-01 | 7.85e-01 |
| GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 28 | 1.10e-01 | 1.75e-01 | 6.01e-01 |
| GOMF STEROID DEHYDROGENASE ACTIVITY | 22 | 1.56e-01 | 1.75e-01 | 6.79e-01 |
| GOMF CARGO RECEPTOR ACTIVITY | 40 | 5.62e-02 | -1.75e-01 | 4.70e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR CATABOLIC PROCESS | 6 | 4.59e-01 | -1.74e-01 | 8.96e-01 |
| GOMF ADENINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 5.00e-01 | -1.74e-01 | 9.14e-01 |
| GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 16 | 2.27e-01 | 1.74e-01 | 7.58e-01 |
| GOBP ANTEROGRADE DENDRITIC TRANSPORT | 7 | 4.24e-01 | -1.74e-01 | 8.81e-01 |
| GOBP GALACTOSE CATABOLIC PROCESS | 5 | 5.00e-01 | -1.74e-01 | 9.14e-01 |
| GOBP NEUROMUSCULAR PROCESS CONTROLLING POSTURE | 11 | 3.17e-01 | -1.74e-01 | 8.23e-01 |
| GOMF COLLAGEN BINDING | 43 | 4.85e-02 | -1.74e-01 | 4.45e-01 |
| GOBP REGULATION OF DNA DUPLEX UNWINDING | 5 | 5.01e-01 | 1.74e-01 | 9.15e-01 |
| GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 5 | 5.01e-01 | -1.74e-01 | 9.15e-01 |
| GOBP HYALURONAN BIOSYNTHETIC PROCESS | 9 | 3.67e-01 | 1.74e-01 | 8.54e-01 |
| GOBP REGULATION OF INNATE IMMUNE RESPONSE | 322 | 9.40e-08 | 1.74e-01 | 2.04e-05 |
| GOBP NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 162 | 1.42e-04 | -1.73e-01 | 1.02e-02 |
| GOBP ICOSANOID SECRETION | 17 | 2.16e-01 | 1.73e-01 | 7.47e-01 |
| GOBP RESPONSE TO CADMIUM ION | 45 | 4.42e-02 | -1.73e-01 | 4.28e-01 |
| GOMF RETINOL BINDING | 5 | 5.02e-01 | 1.73e-01 | 9.15e-01 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE IN 5 ETS OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 8 | 3.96e-01 | -1.73e-01 | 8.71e-01 |
| GOBP GROWTH PLATE CARTILAGE DEVELOPMENT | 10 | 3.43e-01 | -1.73e-01 | 8.41e-01 |
| GOBP GLYCOSYLCERAMIDE METABOLIC PROCESS | 9 | 3.69e-01 | -1.73e-01 | 8.55e-01 |
| GOBP DEFINITIVE HEMOPOIESIS | 12 | 2.99e-01 | 1.73e-01 | 8.14e-01 |
| GOBP CELL JUNCTION DISASSEMBLY | 17 | 2.17e-01 | -1.73e-01 | 7.48e-01 |
| GOCC PLATELET DENSE GRANULE LUMEN | 8 | 3.97e-01 | 1.73e-01 | 8.71e-01 |
| GOMF PHOSPHATIDIC ACID BINDING | 16 | 2.31e-01 | 1.73e-01 | 7.58e-01 |
| GOBP AUTOPHAGOSOME MEMBRANE DOCKING | 7 | 4.28e-01 | 1.73e-01 | 8.82e-01 |
| GOBP ENDOTHELIAL CELL CHEMOTAXIS | 11 | 3.20e-01 | -1.73e-01 | 8.27e-01 |
| GOMF SINGLE STRANDED DNA HELICASE ACTIVITY | 23 | 1.51e-01 | -1.73e-01 | 6.73e-01 |
| GOMF INTERLEUKIN 6 RECEPTOR BINDING | 5 | 5.03e-01 | 1.73e-01 | 9.15e-01 |
| GOBP ENDOLYSOSOMAL TOLL LIKE RECEPTOR SIGNALING PATHWAY | 37 | 6.88e-02 | 1.73e-01 | 5.12e-01 |
| GOBP RETINA HOMEOSTASIS | 38 | 6.53e-02 | -1.73e-01 | 4.98e-01 |
| GOBP REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 18 | 2.04e-01 | 1.73e-01 | 7.33e-01 |
| GOBP PODOSOME ASSEMBLY | 18 | 2.04e-01 | -1.73e-01 | 7.33e-01 |
| GOCC COLLAGEN TRIMER | 37 | 6.91e-02 | -1.73e-01 | 5.12e-01 |
| GOMF CHEMOATTRACTANT ACTIVITY | 16 | 2.32e-01 | -1.73e-01 | 7.59e-01 |
| GOCC POLAR MICROTUBULE | 5 | 5.04e-01 | -1.73e-01 | 9.15e-01 |
| GOBP LYMPHOCYTE HOMEOSTASIS | 61 | 1.98e-02 | 1.73e-01 | 2.92e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE MIGRATION | 34 | 8.17e-02 | 1.73e-01 | 5.43e-01 |
| GOBP LAYER FORMATION IN CEREBRAL CORTEX | 8 | 3.98e-01 | -1.73e-01 | 8.71e-01 |
| GOBP SEGMENTATION | 47 | 4.09e-02 | -1.72e-01 | 4.13e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 12 | 3.01e-01 | -1.72e-01 | 8.14e-01 |
| GOMF GLUTATHIONE DISULFIDE OXIDOREDUCTASE ACTIVITY | 5 | 5.04e-01 | 1.72e-01 | 9.15e-01 |
| GOBP ANTIMICROBIAL HUMORAL RESPONSE | 34 | 8.19e-02 | -1.72e-01 | 5.43e-01 |
| GOBP REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES | 8 | 3.98e-01 | -1.72e-01 | 8.71e-01 |
| GOBP NEGATIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 7 | 4.30e-01 | -1.72e-01 | 8.82e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 10 | 3.46e-01 | 1.72e-01 | 8.42e-01 |
| GOBP POSITIVE REGULATION OF MICROTUBULE NUCLEATION | 8 | 3.99e-01 | 1.72e-01 | 8.71e-01 |
| GOBP NOREPINEPHRINE TRANSPORT | 7 | 4.30e-01 | -1.72e-01 | 8.82e-01 |
| GOBP CIRCADIAN REGULATION OF GENE EXPRESSION | 57 | 2.47e-02 | 1.72e-01 | 3.23e-01 |
| GOBP POSTSYNAPSE TO NUCLEUS SIGNALING PATHWAY | 5 | 5.05e-01 | -1.72e-01 | 9.16e-01 |
| GOBP PROTEIN DEGLYCOSYLATION | 15 | 2.49e-01 | 1.72e-01 | 7.76e-01 |
| GOBP PLASMA MEMBRANE RAFT ORGANIZATION | 9 | 3.72e-01 | -1.72e-01 | 8.57e-01 |
| GOBP OOGENESIS | 58 | 2.37e-02 | 1.72e-01 | 3.18e-01 |
| GOBP GAP JUNCTION ASSEMBLY | 8 | 4.00e-01 | 1.72e-01 | 8.71e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS | 8 | 4.00e-01 | 1.72e-01 | 8.71e-01 |
| GOMF METALLOCHAPERONE ACTIVITY | 12 | 3.03e-01 | 1.72e-01 | 8.14e-01 |
| GOBP POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 18 | 2.07e-01 | -1.72e-01 | 7.37e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR | 14 | 2.66e-01 | -1.72e-01 | 7.91e-01 |
| GOBP REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 8 | 4.01e-01 | -1.72e-01 | 8.72e-01 |
| GOMF QUINONE BINDING | 14 | 2.67e-01 | -1.71e-01 | 7.91e-01 |
| GOBP FRUCTOSE TRANSMEMBRANE TRANSPORT | 7 | 4.32e-01 | -1.71e-01 | 8.82e-01 |
| GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 12 | 3.04e-01 | 1.71e-01 | 8.14e-01 |
| GOMF MYOSIN V BINDING | 10 | 3.48e-01 | -1.71e-01 | 8.43e-01 |
| GOMF ATP DEPENDENT PROTEIN FOLDING CHAPERONE | 30 | 1.04e-01 | -1.71e-01 | 5.94e-01 |
| GOMF RNA EXONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 38 | 6.77e-02 | 1.71e-01 | 5.08e-01 |
| GOBP REGULATION OF HAIR FOLLICLE DEVELOPMENT | 10 | 3.48e-01 | 1.71e-01 | 8.43e-01 |
| GOBP CYTOPLASMIC SEQUESTERING OF NF KAPPAB | 8 | 4.02e-01 | -1.71e-01 | 8.72e-01 |
| GOBP FREE UBIQUITIN CHAIN POLYMERIZATION | 9 | 3.74e-01 | 1.71e-01 | 8.60e-01 |
| GOMF STAT FAMILY PROTEIN BINDING | 8 | 4.02e-01 | 1.71e-01 | 8.72e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION | 9 | 3.74e-01 | -1.71e-01 | 8.60e-01 |
| GOBP INTRA GOLGI VESICLE MEDIATED TRANSPORT | 30 | 1.05e-01 | 1.71e-01 | 5.95e-01 |
| GOBP SPINAL CORD DEVELOPMENT | 45 | 4.73e-02 | -1.71e-01 | 4.42e-01 |
| GOBP MITOCHONDRIAL TRANSMEMBRANE TRANSPORT | 56 | 2.70e-02 | -1.71e-01 | 3.35e-01 |
| GOMF PHOSPHOLIPASE A1 ACTIVITY | 10 | 3.49e-01 | 1.71e-01 | 8.45e-01 |
| GOBP 7 METHYLGUANOSINE RNA CAPPING | 8 | 4.03e-01 | 1.71e-01 | 8.72e-01 |
| GOBP PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS | 21 | 1.75e-01 | 1.71e-01 | 7.06e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING | 33 | 8.97e-02 | 1.71e-01 | 5.59e-01 |
| GOBP ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS | 278 | 1.03e-06 | -1.71e-01 | 1.80e-04 |
| GOBP CELLULAR RESPONSE TO ETHER | 6 | 4.69e-01 | 1.71e-01 | 9.01e-01 |
| GOBP INTRACILIARY RETROGRADE TRANSPORT | 10 | 3.50e-01 | 1.71e-01 | 8.46e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 5 | 5.09e-01 | 1.70e-01 | 9.18e-01 |
| GOBP NEGATIVE REGULATION OF CENTRIOLE REPLICATION | 7 | 4.35e-01 | 1.70e-01 | 8.83e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY | 38 | 6.92e-02 | 1.70e-01 | 5.13e-01 |
| GOBP NEGATIVE REGULATION OF RUFFLE ASSEMBLY | 6 | 4.70e-01 | 1.70e-01 | 9.01e-01 |
| GOBP T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE | 57 | 2.62e-02 | 1.70e-01 | 3.31e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR BINDING | 6 | 4.70e-01 | 1.70e-01 | 9.01e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 20 | 1.88e-01 | 1.70e-01 | 7.17e-01 |
| GOBP FAT CELL PROLIFERATION | 9 | 3.77e-01 | -1.70e-01 | 8.61e-01 |
| GOBP SKIN MORPHOGENESIS | 9 | 3.77e-01 | 1.70e-01 | 8.61e-01 |
| GOBP RUFFLE ORGANIZATION | 45 | 4.86e-02 | -1.70e-01 | 4.45e-01 |
| GOMF 7S RNA BINDING | 7 | 4.36e-01 | -1.70e-01 | 8.84e-01 |
| GOMF METAL DEPENDENT DEUBIQUITINASE ACTIVITY | 11 | 3.29e-01 | -1.70e-01 | 8.30e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS BY CYTOCHROME C | 6 | 4.71e-01 | -1.70e-01 | 9.02e-01 |
| GOBP NEGATIVE REGULATION OF MEIOTIC CELL CYCLE | 11 | 3.30e-01 | 1.70e-01 | 8.30e-01 |
| GOCC PRE SNORNP COMPLEX | 7 | 4.37e-01 | -1.70e-01 | 8.85e-01 |
| GOBP LYMPHOCYTE MEDIATED IMMUNITY | 194 | 4.81e-05 | 1.70e-01 | 4.27e-03 |
| GOBP POSITIVE REGULATION OF RECEPTOR RECYCLING | 11 | 3.30e-01 | 1.69e-01 | 8.30e-01 |
| GOMF SINGLE STRANDED RNA BINDING | 68 | 1.58e-02 | 1.69e-01 | 2.65e-01 |
| GOBP POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 23 | 1.60e-01 | -1.69e-01 | 6.85e-01 |
| GOMF HISTONE H3 METHYLTRANSFERASE ACTIVITY | 38 | 7.09e-02 | 1.69e-01 | 5.17e-01 |
| GOBP FIBROBLAST APOPTOTIC PROCESS | 23 | 1.60e-01 | 1.69e-01 | 6.85e-01 |
| GOMF FLIPPASE ACTIVITY | 13 | 2.90e-01 | 1.69e-01 | 8.06e-01 |
| GOBP RESPONSE TO L GLUTAMATE | 12 | 3.10e-01 | -1.69e-01 | 8.21e-01 |
| GOBP REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE | 28 | 1.21e-01 | -1.69e-01 | 6.23e-01 |
| GOBP REGULATION OF RESPONSE TO TYPE II INTERFERON | 10 | 3.54e-01 | 1.69e-01 | 8.46e-01 |
| GOBP NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS | 33 | 9.27e-02 | 1.69e-01 | 5.66e-01 |
| GOBP ACTIN FILAMENT BUNDLE ORGANIZATION | 123 | 1.21e-03 | -1.69e-01 | 4.99e-02 |
| GOMF AROMATIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 4.39e-01 | 1.69e-01 | 8.85e-01 |
| GOBP NEGATIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 22 | 1.70e-01 | 1.69e-01 | 6.98e-01 |
| GOBP INTRACELLULAR AMINO ACID HOMEOSTASIS | 5 | 5.13e-01 | -1.69e-01 | 9.18e-01 |
| GOMF RETINAL DEHYDROGENASE ACTIVITY | 5 | 5.13e-01 | -1.69e-01 | 9.18e-01 |
| GOBP POSTSYNAPSE ASSEMBLY | 18 | 2.15e-01 | 1.69e-01 | 7.46e-01 |
| GOBP REGULATION OF MORPHOGENESIS OF AN EPITHELIUM | 30 | 1.09e-01 | -1.69e-01 | 6.00e-01 |
| GOMF MONOATOMIC ANION SODIUM SYMPORTER ACTIVITY | 6 | 4.74e-01 | 1.69e-01 | 9.02e-01 |
| GOBP PROTEIN LOCALIZATION TO PERINUCLEAR REGION OF CYTOPLASM | 5 | 5.13e-01 | -1.69e-01 | 9.18e-01 |
| GOBP LACTATE METABOLIC PROCESS | 15 | 2.58e-01 | -1.69e-01 | 7.85e-01 |
| GOBP DNA REPLICATION CHECKPOINT SIGNALING | 16 | 2.43e-01 | -1.69e-01 | 7.72e-01 |
| GOBP REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 22 | 1.71e-01 | 1.69e-01 | 6.99e-01 |
| GOBP ACTIVATION OF JANUS KINASE ACTIVITY | 7 | 4.40e-01 | 1.69e-01 | 8.85e-01 |
| GOBP TAURINE TRANSPORT | 6 | 4.74e-01 | 1.69e-01 | 9.03e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS | 271 | 1.88e-06 | 1.69e-01 | 3.03e-04 |
| GOCC POSTSYNAPTIC DENSITY MEMBRANE | 41 | 6.19e-02 | -1.69e-01 | 4.86e-01 |
| GOCC MESSENGER RIBONUCLEOPROTEIN COMPLEX | 10 | 3.56e-01 | -1.69e-01 | 8.46e-01 |
| GOCC MICROVILLUS | 58 | 2.66e-02 | -1.68e-01 | 3.32e-01 |
| GOBP PIGMENT ACCUMULATION | 10 | 3.57e-01 | -1.68e-01 | 8.46e-01 |
| GOBP PIGMENT GRANULE MATURATION | 10 | 3.57e-01 | -1.68e-01 | 8.46e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS | 49 | 4.15e-02 | -1.68e-01 | 4.16e-01 |
| GOBP POSITIVE REGULATION OF OSSIFICATION | 31 | 1.05e-01 | 1.68e-01 | 5.94e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE PHOSPHATASE ACTIVITY | 15 | 2.60e-01 | 1.68e-01 | 7.85e-01 |
| GOBP STARTLE RESPONSE | 14 | 2.76e-01 | -1.68e-01 | 7.97e-01 |
| GOBP REGULATION OF DEOXYRIBONUCLEASE ACTIVITY | 9 | 3.83e-01 | -1.68e-01 | 8.64e-01 |
| GOCC COPII COATED ER TO GOLGI TRANSPORT VESICLE | 80 | 9.42e-03 | 1.68e-01 | 1.91e-01 |
| GOBP GLUCURONATE CATABOLIC PROCESS TO XYLULOSE 5 PHOSPHATE | 5 | 5.15e-01 | -1.68e-01 | 9.19e-01 |
| GOBP PARAXIAL MESODERM DEVELOPMENT | 8 | 4.11e-01 | 1.68e-01 | 8.77e-01 |
| GOBP METAPHASE CHROMOSOME ALIGNMENT | 92 | 5.43e-03 | 1.68e-01 | 1.37e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 5 | 5.16e-01 | -1.68e-01 | 9.19e-01 |
| GOBP POSITIVE REGULATION OF RNA EXPORT FROM NUCLEUS | 5 | 5.16e-01 | -1.68e-01 | 9.19e-01 |
| GOBP CARDIOLIPIN METABOLIC PROCESS | 13 | 2.95e-01 | -1.68e-01 | 8.10e-01 |
| GOCC TRANSCRIPTION FACTOR TFIIH HOLO COMPLEX | 12 | 3.14e-01 | 1.68e-01 | 8.22e-01 |
| GOBP HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS | 10 | 3.58e-01 | 1.68e-01 | 8.46e-01 |
| GOBP LEUKOTRIENE BIOSYNTHETIC PROCESS | 9 | 3.84e-01 | 1.68e-01 | 8.64e-01 |
| GOBP POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION | 40 | 6.68e-02 | 1.68e-01 | 5.03e-01 |
| GOBP MITOCHONDRIAL DNA REPAIR | 5 | 5.17e-01 | -1.67e-01 | 9.19e-01 |
| GOBP LEUKOCYTE HOMEOSTASIS | 83 | 8.42e-03 | 1.67e-01 | 1.81e-01 |
| GOMF RNA POLYMERASE III TYPE 3 PROMOTER SEQUENCE SPECIFIC DNA BINDING | 7 | 4.43e-01 | 1.67e-01 | 8.87e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 19 | 2.07e-01 | 1.67e-01 | 7.36e-01 |
| GOBP EMBRYONIC HEART TUBE MORPHOGENESIS | 40 | 6.71e-02 | -1.67e-01 | 5.06e-01 |
| GOBP RESPONSE TO CELL CYCLE CHECKPOINT SIGNALING | 7 | 4.44e-01 | -1.67e-01 | 8.87e-01 |
| GOBP INTERLEUKIN 11 MEDIATED SIGNALING PATHWAY | 5 | 5.18e-01 | 1.67e-01 | 9.19e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY | 42 | 6.12e-02 | -1.67e-01 | 4.84e-01 |
| GOMF CADHERIN BINDING INVOLVED IN CELL CELL ADHESION | 12 | 3.17e-01 | -1.67e-01 | 8.23e-01 |
| GOMF NUCLEOSIDE DIPHOSPHATE PHOSPHATASE ACTIVITY | 14 | 2.80e-01 | 1.67e-01 | 7.99e-01 |
| GOCC ORGANELLE INNER MEMBRANE | 479 | 4.73e-10 | -1.67e-01 | 1.87e-07 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 14 | 2.80e-01 | -1.67e-01 | 7.99e-01 |
| GOMF LACTATE DEHYDROGENASE ACTIVITY | 5 | 5.18e-01 | -1.67e-01 | 9.19e-01 |
| GOBP IMMUNOLOGICAL SYNAPSE FORMATION | 12 | 3.17e-01 | 1.67e-01 | 8.23e-01 |
| GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION | 24 | 1.58e-01 | 1.67e-01 | 6.81e-01 |
| GOCC SNO S RNA CONTAINING RIBONUCLEOPROTEIN COMPLEX | 23 | 1.67e-01 | -1.67e-01 | 6.95e-01 |
| GOBP INTRACILIARY ANTEROGRADE TRANSPORT | 16 | 2.49e-01 | -1.67e-01 | 7.76e-01 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL PROLIFERATION | 8 | 4.15e-01 | 1.67e-01 | 8.77e-01 |
| GOMF MANNOSIDASE ACTIVITY | 15 | 2.64e-01 | 1.67e-01 | 7.88e-01 |
| GOMF INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY | 31 | 1.09e-01 | 1.67e-01 | 5.99e-01 |
| GOBP REGULATION OF PROTON TRANSPORT | 13 | 2.99e-01 | -1.66e-01 | 8.13e-01 |
| GOCC PERICILIARY MEMBRANE COMPARTMENT | 5 | 5.19e-01 | 1.66e-01 | 9.19e-01 |
| GOBP PRESYNAPSE ORGANIZATION | 23 | 1.67e-01 | -1.66e-01 | 6.95e-01 |
| GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING | 9 | 3.87e-01 | 1.66e-01 | 8.65e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA SINGLE STRAND ANNEALING | 6 | 4.80e-01 | -1.66e-01 | 9.08e-01 |
| GOBP DICARBOXYLIC ACID TRANSPORT | 60 | 2.60e-02 | -1.66e-01 | 3.31e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN | 6 | 4.81e-01 | -1.66e-01 | 9.08e-01 |
| GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 21 | 1.88e-01 | 1.66e-01 | 7.17e-01 |
| GOCC EXTRINSIC COMPONENT OF POSTSYNAPTIC MEMBRANE | 6 | 4.81e-01 | 1.66e-01 | 9.08e-01 |
| GOBP INTERLEUKIN 1 PRODUCTION | 79 | 1.08e-02 | 1.66e-01 | 2.09e-01 |
| GOBP REGULATION OF LAMELLIPODIUM ORGANIZATION | 41 | 6.62e-02 | -1.66e-01 | 5.03e-01 |
| GOMF STRUCTURAL CONSTITUENT OF NUCLEAR PORE | 21 | 1.88e-01 | 1.66e-01 | 7.18e-01 |
| GOMF POLY A BINDING | 20 | 1.99e-01 | 1.66e-01 | 7.31e-01 |
| GOBP PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION | 26 | 1.44e-01 | 1.66e-01 | 6.65e-01 |
| GOCC BRAHMA COMPLEX | 13 | 3.01e-01 | 1.66e-01 | 8.14e-01 |
| GOBP REGULATION OF PROTEIN DEUBIQUITINATION | 10 | 3.65e-01 | -1.66e-01 | 8.50e-01 |
| GOBP MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER | 13 | 3.01e-01 | 1.66e-01 | 8.14e-01 |
| GOBP REGULATION OF CARDIAC CONDUCTION | 15 | 2.67e-01 | 1.66e-01 | 7.91e-01 |
| GOMF MACROMOLECULE TRANSMEMBRANE TRANSPORTER ACTIVITY | 30 | 1.17e-01 | -1.66e-01 | 6.16e-01 |
| GOCC SPINDLE POLE CENTROSOME | 13 | 3.02e-01 | -1.65e-01 | 8.14e-01 |
| GOBP REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY | 6 | 4.83e-01 | -1.65e-01 | 9.08e-01 |
| GOCC PREFOLDIN COMPLEX | 7 | 4.49e-01 | -1.65e-01 | 8.89e-01 |
| GOCC MUSCLE MYOSIN COMPLEX | 5 | 5.22e-01 | 1.65e-01 | 9.20e-01 |
| GOBP REGULATION OF PROTEIN LIPIDATION | 9 | 3.90e-01 | -1.65e-01 | 8.67e-01 |
| GOBP REGULATION OF P38MAPK CASCADE | 36 | 8.61e-02 | 1.65e-01 | 5.53e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 55 | 3.41e-02 | 1.65e-01 | 3.77e-01 |
| GOBP MULTINUCLEAR OSTEOCLAST DIFFERENTIATION | 8 | 4.19e-01 | -1.65e-01 | 8.79e-01 |
| GOCC NLRP3 INFLAMMASOME COMPLEX | 8 | 4.19e-01 | 1.65e-01 | 8.79e-01 |
| GOBP NEGATIVE REGULATION OF CELL VOLUME | 5 | 5.23e-01 | 1.65e-01 | 9.20e-01 |
| GOBP MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY | 97 | 5.01e-03 | -1.65e-01 | 1.32e-01 |
| GOBP REGULATION OF KERATINOCYTE DIFFERENTIATION | 25 | 1.53e-01 | 1.65e-01 | 6.75e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 7 | 4.50e-01 | 1.65e-01 | 8.89e-01 |
| GOBP CATECHOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 8 | 4.19e-01 | 1.65e-01 | 8.80e-01 |
| GOBP NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 31 | 1.12e-01 | 1.65e-01 | 6.07e-01 |
| GOBP OLIGOPEPTIDE IMPORT ACROSS PLASMA MEMBRANE | 5 | 5.23e-01 | -1.65e-01 | 9.20e-01 |
| GOBP NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY | 24 | 1.62e-01 | -1.65e-01 | 6.87e-01 |
| GOBP NEGATIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 18 | 2.26e-01 | 1.65e-01 | 7.56e-01 |
| GOBP POSITIVE REGULATION OF NUCLEAR DIVISION | 32 | 1.07e-01 | 1.65e-01 | 5.96e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX RECEPTOR RECYCLING | 7 | 4.51e-01 | -1.65e-01 | 8.89e-01 |
| GOBP NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 8 | 4.21e-01 | 1.64e-01 | 8.81e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS | 6 | 4.85e-01 | 1.64e-01 | 9.10e-01 |
| GOBP GLOMERULAR EPITHELIUM DEVELOPMENT | 12 | 3.24e-01 | 1.64e-01 | 8.29e-01 |
| GOBP REGULATION OF HEPATIC STELLATE CELL ACTIVATION | 5 | 5.24e-01 | -1.64e-01 | 9.20e-01 |
| GOBP DE NOVO PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS | 5 | 5.25e-01 | 1.64e-01 | 9.20e-01 |
| GOBP NEGATIVE REGULATION OF COAGULATION | 26 | 1.47e-01 | -1.64e-01 | 6.70e-01 |
| GOBP NEGATIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 14 | 2.87e-01 | 1.64e-01 | 8.05e-01 |
| GOMF NF KAPPAB BINDING | 28 | 1.33e-01 | -1.64e-01 | 6.46e-01 |
| GOMF PRIMARY MIRNA BINDING | 10 | 3.69e-01 | 1.64e-01 | 8.55e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 31 | 1.14e-01 | -1.64e-01 | 6.10e-01 |
| GOMF FATTY ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 4.87e-01 | -1.64e-01 | 9.11e-01 |
| GOBP CELL DIFFERENTIATION IN HINDBRAIN | 11 | 3.46e-01 | -1.64e-01 | 8.43e-01 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS III | 6 | 4.87e-01 | 1.64e-01 | 9.11e-01 |
| GOCC VCP NPL4 UFD1 AAA ATPASE COMPLEX | 8 | 4.22e-01 | -1.64e-01 | 8.81e-01 |
| GOBP NEURON PROJECTION MAINTENANCE | 9 | 3.95e-01 | -1.64e-01 | 8.70e-01 |
| GOBP POSITIVE REGULATION OF VASOCONSTRICTION | 14 | 2.89e-01 | 1.64e-01 | 8.06e-01 |
| GOBP MATING BEHAVIOR | 15 | 2.72e-01 | 1.64e-01 | 7.94e-01 |
| GOBP PHOSPHATIDYLCHOLINE METABOLIC PROCESS | 52 | 4.11e-02 | -1.64e-01 | 4.14e-01 |
| GOBP PHOSPHATIDYLGLYCEROL METABOLIC PROCESS | 23 | 1.74e-01 | -1.64e-01 | 7.05e-01 |
| GOBP MITOCHONDRIAL TRANSCRIPTION | 19 | 2.17e-01 | -1.64e-01 | 7.48e-01 |
| GOBP PROTEIN MATURATION BY PROTEIN FOLDING | 8 | 4.23e-01 | -1.64e-01 | 8.81e-01 |
| GOBP EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION | 8 | 4.23e-01 | 1.64e-01 | 8.81e-01 |
| GOBP NEGATIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS | 5 | 5.27e-01 | -1.64e-01 | 9.22e-01 |
| GOCC PHAGOCYTIC VESICLE MEMBRANE | 74 | 1.51e-02 | 1.63e-01 | 2.59e-01 |
| GOBP TRIGLYCERIDE CATABOLIC PROCESS | 16 | 2.58e-01 | -1.63e-01 | 7.85e-01 |
| GOMF HYALURONIC ACID BINDING | 11 | 3.48e-01 | -1.63e-01 | 8.43e-01 |
| GOBP PROLINE TRANSMEMBRANE TRANSPORT | 7 | 4.54e-01 | -1.63e-01 | 8.93e-01 |
| GOBP RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS | 204 | 6.03e-05 | -1.63e-01 | 5.03e-03 |
| GOMF HEXOSAMINIDASE ACTIVITY | 13 | 3.08e-01 | 1.63e-01 | 8.19e-01 |
| GOBP SULFUR COMPOUND TRANSPORT | 39 | 7.79e-02 | -1.63e-01 | 5.34e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 23 | 1.76e-01 | 1.63e-01 | 7.06e-01 |
| GOBP RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 23 | 1.76e-01 | 1.63e-01 | 7.07e-01 |
| GOBP NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT | 12 | 3.28e-01 | -1.63e-01 | 8.29e-01 |
| GOBP SYNAPTONEMAL COMPLEX ORGANIZATION | 16 | 2.59e-01 | 1.63e-01 | 7.85e-01 |
| GOBP MONOSACCHARIDE CATABOLIC PROCESS | 39 | 7.84e-02 | -1.63e-01 | 5.36e-01 |
| GOBP POSITIVE REGULATION OF CILIUM ASSEMBLY | 24 | 1.67e-01 | -1.63e-01 | 6.96e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS | 119 | 2.17e-03 | 1.63e-01 | 7.85e-02 |
| GOBP NEGATIVE REGULATION OF FAT CELL PROLIFERATION | 5 | 5.28e-01 | -1.63e-01 | 9.22e-01 |
| GOBP DNA LIGATION | 16 | 2.60e-01 | 1.63e-01 | 7.85e-01 |
| GOMF MHC CLASS IB PROTEIN BINDING | 5 | 5.29e-01 | 1.63e-01 | 9.23e-01 |
| GOBP PROTEIN TRANSMEMBRANE TRANSPORT | 59 | 3.07e-02 | -1.63e-01 | 3.54e-01 |
| GOMF GLYCOSAMINOGLYCAN BINDING | 100 | 5.00e-03 | -1.63e-01 | 1.32e-01 |
| GOBP POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 9 | 3.98e-01 | 1.63e-01 | 8.71e-01 |
| GOBP NUCLEOBASE METABOLIC PROCESS | 32 | 1.12e-01 | 1.63e-01 | 6.05e-01 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 5 | 5.29e-01 | 1.63e-01 | 9.23e-01 |
| GOMF RNA POLYMERASE CORE ENZYME BINDING | 40 | 7.56e-02 | 1.62e-01 | 5.29e-01 |
| GOBP ENDONUCLEOLYTIC CLEAVAGE OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 17 | 2.46e-01 | -1.62e-01 | 7.76e-01 |
| GOBP CILIUM DISASSEMBLY | 5 | 5.30e-01 | 1.62e-01 | 9.23e-01 |
| GOBP CAVEOLIN MEDIATED ENDOCYTOSIS | 8 | 4.26e-01 | 1.62e-01 | 8.82e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 33 | 1.07e-01 | 1.62e-01 | 5.96e-01 |
| GOCC RNAI EFFECTOR COMPLEX | 22 | 1.88e-01 | -1.62e-01 | 7.17e-01 |
| GOMF HEXOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 13 | 3.11e-01 | -1.62e-01 | 8.21e-01 |
| GOMF MANNOSYLTRANSFERASE ACTIVITY | 22 | 1.88e-01 | -1.62e-01 | 7.17e-01 |
| GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION INITIATION | 13 | 3.12e-01 | -1.62e-01 | 8.21e-01 |
| GOBP POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY | 31 | 1.19e-01 | 1.62e-01 | 6.20e-01 |
| GOBP RESPONSE TO LAMINAR FLUID SHEAR STRESS | 11 | 3.53e-01 | 1.62e-01 | 8.46e-01 |
| GOBP MHC CLASS II BIOSYNTHETIC PROCESS | 16 | 2.62e-01 | 1.62e-01 | 7.87e-01 |
| GOBP POSITIVE REGULATION OF PODOSOME ASSEMBLY | 9 | 4.01e-01 | -1.62e-01 | 8.72e-01 |
| GOMF INOSITOL 1 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 4.93e-01 | 1.62e-01 | 9.13e-01 |
| GOMF RETINOIC ACID BINDING | 6 | 4.93e-01 | -1.62e-01 | 9.13e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEAR ENVELOPE | 13 | 3.13e-01 | -1.62e-01 | 8.22e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 33 | 1.08e-01 | 1.62e-01 | 5.99e-01 |
| GOMF RECEPTOR SERINE THREONINE KINASE BINDING | 11 | 3.54e-01 | 1.62e-01 | 8.46e-01 |
| GOBP MUSCLE HYPERTROPHY | 55 | 3.85e-02 | 1.61e-01 | 4.00e-01 |
| GOMF ORGANOPHOSPHATE ESTER TRANSMEMBRANE TRANSPORTER ACTIVITY | 32 | 1.14e-01 | -1.61e-01 | 6.11e-01 |
| GOBP ALANINE TRANSPORT | 11 | 3.55e-01 | -1.61e-01 | 8.46e-01 |
| GOBP REGULATION OF LYMPHOCYTE DIFFERENTIATION | 150 | 6.73e-04 | 1.61e-01 | 3.23e-02 |
| GOMF SEMAPHORIN RECEPTOR BINDING | 11 | 3.55e-01 | -1.61e-01 | 8.46e-01 |
| GOCC LATERAL ELEMENT | 9 | 4.03e-01 | 1.61e-01 | 8.72e-01 |
| GOBP NEGATIVE REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS | 5 | 5.33e-01 | -1.61e-01 | 9.23e-01 |
| GOBP DETECTION OF CALCIUM ION | 9 | 4.04e-01 | 1.61e-01 | 8.72e-01 |
| GOMF PHOSPHATASE INHIBITOR ACTIVITY | 31 | 1.22e-01 | -1.61e-01 | 6.23e-01 |
| GOBP BLASTOCYST GROWTH | 19 | 2.25e-01 | 1.61e-01 | 7.55e-01 |
| GOBP REGULATION OF PROTEIN AUTOUBIQUITINATION | 5 | 5.34e-01 | 1.61e-01 | 9.23e-01 |
| GOBP REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 18 | 2.38e-01 | -1.61e-01 | 7.67e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION | 31 | 1.22e-01 | -1.60e-01 | 6.25e-01 |
| GOBP INTERLEUKIN 4 PRODUCTION | 21 | 2.03e-01 | 1.60e-01 | 7.32e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ADAPTOR ACTIVITY | 14 | 2.99e-01 | 1.60e-01 | 8.13e-01 |
| GOBP ENDOSOMAL VESICLE FUSION | 12 | 3.36e-01 | 1.60e-01 | 8.36e-01 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE I PROMOTER | 10 | 3.80e-01 | 1.60e-01 | 8.62e-01 |
| GOCC NONHOMOLOGOUS END JOINING COMPLEX | 9 | 4.05e-01 | 1.60e-01 | 8.73e-01 |
| GOBP RAC PROTEIN SIGNAL TRANSDUCTION | 40 | 7.94e-02 | -1.60e-01 | 5.39e-01 |
| GOBP PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS | 7 | 4.63e-01 | 1.60e-01 | 8.99e-01 |
| GOMF SYNTAXIN 1 BINDING | 11 | 3.57e-01 | 1.60e-01 | 8.46e-01 |
| GOBP EXCITATORY SYNAPSE ASSEMBLY | 18 | 2.39e-01 | 1.60e-01 | 7.68e-01 |
| GOBP REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 9 | 4.05e-01 | -1.60e-01 | 8.74e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 6 | 4.97e-01 | -1.60e-01 | 9.13e-01 |
| GOBP INTERLEUKIN 12 PRODUCTION | 45 | 6.33e-02 | 1.60e-01 | 4.89e-01 |
| GOBP PROTEIN K11 LINKED DEUBIQUITINATION | 9 | 4.06e-01 | -1.60e-01 | 8.74e-01 |
| GOBP MACROPHAGE PROLIFERATION | 8 | 4.34e-01 | -1.60e-01 | 8.82e-01 |
| GOBP N TERMINAL PROTEIN AMINO ACID ACETYLATION | 15 | 2.84e-01 | -1.60e-01 | 8.02e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN GLYCOSYLATION | 7 | 4.64e-01 | 1.60e-01 | 9.00e-01 |
| GOBP POSITIVE THYMIC T CELL SELECTION | 8 | 4.34e-01 | 1.60e-01 | 8.83e-01 |
| GOBP SECONDARY PALATE DEVELOPMENT | 12 | 3.38e-01 | 1.60e-01 | 8.37e-01 |
| GOBP POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 24 | 1.76e-01 | -1.60e-01 | 7.07e-01 |
| GOBP REGULATION OF AUTOPHAGOSOME MATURATION | 16 | 2.70e-01 | 1.59e-01 | 7.93e-01 |
| GOBP CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 20 | 2.18e-01 | 1.59e-01 | 7.49e-01 |
| GOBP BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS | 9 | 4.08e-01 | -1.59e-01 | 8.76e-01 |
| GOBP REGULATION OF PLATELET AGGREGATION | 16 | 2.71e-01 | 1.59e-01 | 7.94e-01 |
| GOBP AXONAL TRANSPORT OF MITOCHONDRION | 12 | 3.40e-01 | 1.59e-01 | 8.39e-01 |
| GOMF SOLUTE PROTON SYMPORTER ACTIVITY | 19 | 2.30e-01 | -1.59e-01 | 7.58e-01 |
| GOCC CCR4 NOT COMPLEX | 14 | 3.03e-01 | 1.59e-01 | 8.14e-01 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 25 | 1.69e-01 | 1.59e-01 | 6.96e-01 |
| GOBP BILE ACID METABOLIC PROCESS | 28 | 1.45e-01 | 1.59e-01 | 6.68e-01 |
| GOBP ADHESION OF SYMBIONT TO HOST | 8 | 4.36e-01 | -1.59e-01 | 8.84e-01 |
| GOBP PROTEIN KINASE C SIGNALING | 18 | 2.43e-01 | 1.59e-01 | 7.73e-01 |
| GOMF NUCLEAR RECEPTOR ACTIVITY | 32 | 1.20e-01 | 1.59e-01 | 6.21e-01 |
| GOBP REGULATION OF LYMPHOID PROGENITOR CELL DIFFERENTIATION | 10 | 3.84e-01 | 1.59e-01 | 8.64e-01 |
| GOBP SEMI LUNAR VALVE DEVELOPMENT | 23 | 1.88e-01 | 1.59e-01 | 7.17e-01 |
| GOBP PROTEIN LIPID COMPLEX ASSEMBLY | 20 | 2.19e-01 | 1.59e-01 | 7.49e-01 |
| GOCC KINOCILIUM | 6 | 5.01e-01 | -1.59e-01 | 9.15e-01 |
| GOBP LEUCINE IMPORT ACROSS PLASMA MEMBRANE | 5 | 5.39e-01 | -1.59e-01 | 9.23e-01 |
| GOCC NEURON PROJECTION MEMBRANE | 28 | 1.47e-01 | -1.59e-01 | 6.69e-01 |
| GOBP POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY | 29 | 1.40e-01 | 1.59e-01 | 6.61e-01 |
| GOMF 3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY | 11 | 3.63e-01 | 1.58e-01 | 8.49e-01 |
| GOBP PARALLEL ACTIN FILAMENT BUNDLE ASSEMBLY | 5 | 5.40e-01 | -1.58e-01 | 9.23e-01 |
| GOBP REGULATION OF GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS | 5 | 5.40e-01 | 1.58e-01 | 9.23e-01 |
| GOBP IMMATURE T CELL PROLIFERATION | 7 | 4.68e-01 | 1.58e-01 | 9.00e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 20 | 2.21e-01 | 1.58e-01 | 7.49e-01 |
| GOBP POSITIVE REGULATION OF BEHAVIOR | 10 | 3.86e-01 | -1.58e-01 | 8.65e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 15 | 2.89e-01 | -1.58e-01 | 8.06e-01 |
| GOBP PRENYLATION | 10 | 3.86e-01 | -1.58e-01 | 8.65e-01 |
| GOCC RPAP3 R2TP PREFOLDIN LIKE COMPLEX | 10 | 3.86e-01 | -1.58e-01 | 8.65e-01 |
| GOMF GLUTATHIONE PEROXIDASE ACTIVITY | 13 | 3.24e-01 | -1.58e-01 | 8.29e-01 |
| GOBP FEMALE GENITALIA DEVELOPMENT | 11 | 3.64e-01 | 1.58e-01 | 8.50e-01 |
| GOMF SULFUR AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 4.13e-01 | -1.58e-01 | 8.77e-01 |
| GOMF HISTONE METHYLTRANSFERASE BINDING | 14 | 3.07e-01 | 1.58e-01 | 8.18e-01 |
| GOBP PRE MIRNA PROCESSING | 14 | 3.07e-01 | 1.58e-01 | 8.18e-01 |
| GOBP REGULATION OF NK T CELL ACTIVATION | 7 | 4.70e-01 | 1.58e-01 | 9.01e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 10 | 3.88e-01 | -1.58e-01 | 8.65e-01 |
| GOMF RNA EXONUCLEASE ACTIVITY | 43 | 7.40e-02 | 1.58e-01 | 5.24e-01 |
| GOBP DETECTION OF TEMPERATURE STIMULUS | 13 | 3.26e-01 | 1.57e-01 | 8.29e-01 |
| GOMF ALPHA ACTININ BINDING | 15 | 2.91e-01 | -1.57e-01 | 8.07e-01 |
| GOBP REGULATION OF MITOTIC RECOMBINATION | 5 | 5.43e-01 | 1.57e-01 | 9.23e-01 |
| GOBP MAINTENANCE OF SISTER CHROMATID COHESION | 12 | 3.46e-01 | -1.57e-01 | 8.42e-01 |
| GOBP REGULATION OF GLUTAMATE SECRETION | 9 | 4.14e-01 | -1.57e-01 | 8.77e-01 |
| GOBP DNA PROTECTION | 5 | 5.43e-01 | -1.57e-01 | 9.23e-01 |
| GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II | 29 | 1.43e-01 | 1.57e-01 | 6.65e-01 |
| GOBP EXTRACELLULAR MATRIX ASSEMBLY | 20 | 2.24e-01 | 1.57e-01 | 7.53e-01 |
| GOMF CYTOSKELETAL MOTOR ACTIVITY | 75 | 1.88e-02 | 1.57e-01 | 2.87e-01 |
| GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 7 | 4.72e-01 | 1.57e-01 | 9.02e-01 |
| GOBP CELLULAR RESPONSE TO ZINC ION | 15 | 2.92e-01 | -1.57e-01 | 8.08e-01 |
| GOBP TROPHECTODERMAL CELL DIFFERENTIATION | 12 | 3.46e-01 | -1.57e-01 | 8.43e-01 |
| GOMF SPHINGOSINE 1 PHOSPHATE PHOSPHATASE ACTIVITY | 5 | 5.43e-01 | 1.57e-01 | 9.23e-01 |
| GOBP TOLL LIKE RECEPTOR SIGNALING PATHWAY | 60 | 3.57e-02 | 1.57e-01 | 3.83e-01 |
| GOBP REGULATION OF MACROPHAGE PROLIFERATION | 5 | 5.44e-01 | 1.57e-01 | 9.23e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE RESPONSE | 510 | 1.59e-09 | 1.57e-01 | 5.12e-07 |
| GOBP DNA TOPOLOGICAL CHANGE | 9 | 4.15e-01 | 1.57e-01 | 8.79e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE HYPERTROPHY | 21 | 2.14e-01 | 1.57e-01 | 7.46e-01 |
| GOMF DNA NUCLEASE ACTIVITY | 55 | 4.45e-02 | -1.57e-01 | 4.29e-01 |
| GOBP SCHWANN CELL MIGRATION | 5 | 5.44e-01 | 1.57e-01 | 9.23e-01 |
| GOBP PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 157 | 7.20e-04 | 1.57e-01 | 3.40e-02 |
| GOBP MITOTIC RECOMBINATION | 22 | 2.04e-01 | -1.57e-01 | 7.32e-01 |
| GOBP PROTEIN PROCESSING INVOLVED IN PROTEIN TARGETING TO MITOCHONDRION | 7 | 4.73e-01 | 1.57e-01 | 9.02e-01 |
| GOBP CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 15 | 2.94e-01 | -1.56e-01 | 8.09e-01 |
| GOMF SULFOTRANSFERASE ACTIVITY | 20 | 2.26e-01 | -1.56e-01 | 7.56e-01 |
| GOBP RESPONSE TO COPPER ION | 24 | 1.85e-01 | -1.56e-01 | 7.16e-01 |
| GOBP CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER | 12 | 3.48e-01 | -1.56e-01 | 8.43e-01 |
| GOBP NAD METABOLIC PROCESS | 30 | 1.39e-01 | 1.56e-01 | 6.59e-01 |
| GOBP PROTEIN TARGETING TO VACUOLE INVOLVED IN AUTOPHAGY | 5 | 5.45e-01 | -1.56e-01 | 9.24e-01 |
| GOBP LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS | 11 | 3.70e-01 | -1.56e-01 | 8.55e-01 |
| GOBP RESPONSE TO CORTICOSTERONE | 6 | 5.08e-01 | -1.56e-01 | 9.18e-01 |
| GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 63 | 3.22e-02 | 1.56e-01 | 3.65e-01 |
| GOMF ANGIOTENSIN RECEPTOR BINDING | 5 | 5.46e-01 | -1.56e-01 | 9.25e-01 |
| GOBP REGULATION OF VITAMIN METABOLIC PROCESS | 9 | 4.18e-01 | -1.56e-01 | 8.79e-01 |
| GOCC BBAF COMPLEX | 9 | 4.18e-01 | 1.56e-01 | 8.79e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 17 | 2.66e-01 | 1.56e-01 | 7.91e-01 |
| GOCC DERLIN 1 RETROTRANSLOCATION COMPLEX | 8 | 4.45e-01 | -1.56e-01 | 8.87e-01 |
| GOMF DIACYLGLYCEROL BINDING | 10 | 3.94e-01 | -1.56e-01 | 8.68e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 12 | 3.50e-01 | -1.56e-01 | 8.46e-01 |
| GOBP NUCLEOTIDE TRANSMEMBRANE TRANSPORT | 24 | 1.87e-01 | -1.56e-01 | 7.17e-01 |
| GOBP RESPONSE TO ATP | 20 | 2.28e-01 | 1.56e-01 | 7.58e-01 |
| GOBP RESPONSE TO VITAMIN D | 23 | 1.96e-01 | 1.56e-01 | 7.28e-01 |
| GOBP BLOOD VESSEL REMODELING | 24 | 1.87e-01 | 1.56e-01 | 7.17e-01 |
| GOBP REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY | 6 | 5.09e-01 | -1.56e-01 | 9.18e-01 |
| GOBP NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION | 85 | 1.33e-02 | 1.55e-01 | 2.41e-01 |
| GOCC INTEGRIN COMPLEX | 22 | 2.07e-01 | -1.55e-01 | 7.37e-01 |
| GOMF ESTRADIOL 17 BETA DEHYDROGENASE NAD P ACTIVITY | 10 | 3.95e-01 | 1.55e-01 | 8.70e-01 |
| GOBP CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS | 10 | 3.95e-01 | -1.55e-01 | 8.70e-01 |
| GOBP CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 82 | 1.52e-02 | 1.55e-01 | 2.59e-01 |
| GOMF DNA EXONUCLEASE ACTIVITY | 22 | 2.08e-01 | -1.55e-01 | 7.39e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE BINDING | 32 | 1.29e-01 | 1.55e-01 | 6.40e-01 |
| GOBP REGULATION OF HEART RATE | 48 | 6.31e-02 | 1.55e-01 | 4.89e-01 |
| GOBP GLUCAN BIOSYNTHETIC PROCESS | 33 | 1.23e-01 | -1.55e-01 | 6.26e-01 |
| GOBP CGMP BIOSYNTHETIC PROCESS | 7 | 4.78e-01 | -1.55e-01 | 9.05e-01 |
| GOMF GUANYLATE CYCLASE ACTIVITY | 7 | 4.78e-01 | -1.55e-01 | 9.05e-01 |
| GOBP RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM | 44 | 7.54e-02 | -1.55e-01 | 5.29e-01 |
| GOBP REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 13 | 3.34e-01 | -1.55e-01 | 8.35e-01 |
| GOCC ENDOPLASMIC RETICULUM PLASMA MEMBRANE CONTACT SITE | 9 | 4.22e-01 | 1.55e-01 | 8.81e-01 |
| GOCC FILOPODIUM MEMBRANE | 13 | 3.34e-01 | 1.55e-01 | 8.35e-01 |
| GOBP MITOCHONDRIAL MEMBRANE ORGANIZATION | 108 | 5.53e-03 | -1.55e-01 | 1.38e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 15 | 3.00e-01 | -1.55e-01 | 8.14e-01 |
| GOBP HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS | 29 | 1.50e-01 | 1.55e-01 | 6.72e-01 |
| GOBP RESPONSE TO ACTIVITY | 46 | 6.98e-02 | -1.55e-01 | 5.14e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID SECRETION | 6 | 5.13e-01 | -1.54e-01 | 9.18e-01 |
| GOBP NEGATIVE REGULATION OF HEPATOCYTE APOPTOTIC PROCESS | 6 | 5.13e-01 | 1.54e-01 | 9.18e-01 |
| GOMF HISTONE READER ACTIVITY | 11 | 3.76e-01 | -1.54e-01 | 8.60e-01 |
| GOBP BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS | 11 | 3.76e-01 | -1.54e-01 | 8.60e-01 |
| GOCC CKM COMPLEX | 5 | 5.50e-01 | 1.54e-01 | 9.26e-01 |
| GOBP POLYSACCHARIDE CATABOLIC PROCESS | 16 | 2.86e-01 | -1.54e-01 | 8.04e-01 |
| GOBP REGULATION OF CHROMATIN BINDING | 11 | 3.76e-01 | 1.54e-01 | 8.60e-01 |
| GOMF ADENYLYLTRANSFERASE ACTIVITY | 24 | 1.91e-01 | 1.54e-01 | 7.21e-01 |
| GOBP REGULATION OF MONOCYTE CHEMOTAXIS | 17 | 2.72e-01 | 1.54e-01 | 7.94e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 19 | 2.45e-01 | 1.54e-01 | 7.73e-01 |
| GOMF GLYCOGEN BINDING | 6 | 5.14e-01 | -1.54e-01 | 9.18e-01 |
| GOBP T HELPER CELL LINEAGE COMMITMENT | 13 | 3.37e-01 | 1.54e-01 | 8.36e-01 |
| GOBP HINDLIMB MORPHOGENESIS | 12 | 3.56e-01 | 1.54e-01 | 8.46e-01 |
| GOBP CELL MIGRATION INVOLVED IN HEART DEVELOPMENT | 7 | 4.81e-01 | -1.54e-01 | 9.08e-01 |
| GOBP XENOBIOTIC EXPORT FROM CELL | 8 | 4.51e-01 | -1.54e-01 | 8.90e-01 |
| GOCC RNA N6 METHYLADENOSINE METHYLTRANSFERASE COMPLEX | 9 | 4.24e-01 | -1.54e-01 | 8.81e-01 |
| GOBP BRANCH ELONGATION OF AN EPITHELIUM | 5 | 5.51e-01 | -1.54e-01 | 9.26e-01 |
| GOCC U6 SNRNP | 8 | 4.51e-01 | -1.54e-01 | 8.90e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 15 | 3.03e-01 | 1.54e-01 | 8.14e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H QUINONE OR SIMILAR COMPOUND AS ACCEPTOR | 53 | 5.31e-02 | -1.54e-01 | 4.60e-01 |
| GOBP REGULATION OF ATP METABOLIC PROCESS | 18 | 2.59e-01 | -1.54e-01 | 7.85e-01 |
| GOBP POLYSACCHARIDE BIOSYNTHETIC PROCESS | 45 | 7.48e-02 | -1.54e-01 | 5.26e-01 |
| GOBP NEURON FATE COMMITMENT | 15 | 3.03e-01 | -1.54e-01 | 8.14e-01 |
| GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 15 | 3.03e-01 | 1.53e-01 | 8.14e-01 |
| GOBP LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 18 | 2.60e-01 | -1.53e-01 | 7.85e-01 |
| GOBP NUCLEAR RNA SURVEILLANCE | 14 | 3.20e-01 | 1.53e-01 | 8.27e-01 |
| GOBP POSITIVE REGULATION OF CHROMATIN ORGANIZATION | 13 | 3.38e-01 | -1.53e-01 | 8.37e-01 |
| GOBP CALCIUM IMPORT INTO THE MITOCHONDRION | 11 | 3.78e-01 | 1.53e-01 | 8.61e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY TRANSPOSING C C BONDS | 11 | 3.78e-01 | -1.53e-01 | 8.61e-01 |
| GOMF GLUCOSE BINDING | 9 | 4.26e-01 | -1.53e-01 | 8.82e-01 |
| GOCC PROTEIN COMPLEX INVOLVED IN CELL MATRIX ADHESION | 10 | 4.02e-01 | 1.53e-01 | 8.72e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE | 548 | 1.06e-09 | 1.53e-01 | 3.68e-07 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION | 195 | 2.33e-04 | 1.53e-01 | 1.47e-02 |
| GOBP MIDBODY ABSCISSION | 16 | 2.89e-01 | 1.53e-01 | 8.06e-01 |
| GOBP POSITIVE REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION | 5 | 5.54e-01 | -1.53e-01 | 9.26e-01 |
| GOBP GOLGI TO PLASMA MEMBRANE TRANSPORT | 52 | 5.66e-02 | 1.53e-01 | 4.70e-01 |
| GOMF PROTEASOME ACTIVATING ACTIVITY | 6 | 5.17e-01 | 1.53e-01 | 9.19e-01 |
| GOMF FRUCTOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 5.17e-01 | -1.53e-01 | 9.19e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 178 | 4.50e-04 | 1.53e-01 | 2.40e-02 |
| GOBP POSITIVE REGULATION OF SISTER CHROMATID COHESION | 8 | 4.55e-01 | 1.53e-01 | 8.93e-01 |
| GOBP INTRACELLULAR SODIUM ION HOMEOSTASIS | 9 | 4.28e-01 | 1.53e-01 | 8.82e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS | 18 | 2.63e-01 | -1.53e-01 | 7.87e-01 |
| GOMF PHOSPHATE ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 4.28e-01 | -1.53e-01 | 8.82e-01 |
| GOBP REGULATION OF RNA BINDING | 8 | 4.55e-01 | -1.52e-01 | 8.93e-01 |
| GOMF CALCIUM DEPENDENT CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 9 | 4.28e-01 | -1.52e-01 | 8.82e-01 |
| GOBP REGULATION OF GENE SILENCING BY REGULATORY NCRNA | 22 | 2.16e-01 | 1.52e-01 | 7.47e-01 |
| GOBP PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY | 16 | 2.91e-01 | 1.52e-01 | 8.07e-01 |
| GOMF QUATERNARY AMMONIUM GROUP BINDING | 27 | 1.70e-01 | 1.52e-01 | 6.99e-01 |
| GOBP NUCLEAR MIGRATION | 20 | 2.38e-01 | 1.52e-01 | 7.67e-01 |
| GOBP POSITIVE REGULATION OF AXON EXTENSION | 27 | 1.71e-01 | -1.52e-01 | 6.99e-01 |
| GOBP INTRACELLULAR POTASSIUM ION HOMEOSTASIS | 8 | 4.56e-01 | -1.52e-01 | 8.94e-01 |
| GOBP DORSAL AORTA DEVELOPMENT | 5 | 5.56e-01 | -1.52e-01 | 9.26e-01 |
| GOBP DORSAL AORTA MORPHOGENESIS | 5 | 5.56e-01 | -1.52e-01 | 9.26e-01 |
| GOBP PEPTIDE BIOSYNTHETIC PROCESS | 633 | 8.20e-11 | -1.52e-01 | 3.96e-08 |
| GOBP PROTEIN O LINKED GLYCOSYLATION VIA SERINE | 6 | 5.19e-01 | 1.52e-01 | 9.19e-01 |
| GOBP GRANULOCYTE CHEMOTAXIS | 80 | 1.87e-02 | -1.52e-01 | 2.87e-01 |
| GOBP RESPONSE TO UV A | 9 | 4.29e-01 | -1.52e-01 | 8.82e-01 |
| GOMF ADP PHOSPHATASE ACTIVITY | 5 | 5.56e-01 | -1.52e-01 | 9.26e-01 |
| GOBP POSITIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 9 | 4.30e-01 | 1.52e-01 | 8.82e-01 |
| GOBP FIBROBLAST ACTIVATION | 11 | 3.83e-01 | -1.52e-01 | 8.64e-01 |
| GOBP ABSCISSION | 6 | 5.19e-01 | 1.52e-01 | 9.19e-01 |
| GOBP REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS | 7 | 4.87e-01 | -1.52e-01 | 9.11e-01 |
| GOMF FERROUS IRON BINDING | 20 | 2.40e-01 | -1.52e-01 | 7.68e-01 |
| GOBP CARBOHYDRATE PHOSPHORYLATION | 20 | 2.40e-01 | 1.52e-01 | 7.68e-01 |
| GOBP NEGATIVE REGULATION OF MIRNA METABOLIC PROCESS | 19 | 2.53e-01 | 1.52e-01 | 7.78e-01 |
| GOBP ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL COMMUNICATION | 9 | 4.31e-01 | 1.52e-01 | 8.82e-01 |
| GOBP SYNAPTIC TRANSMISSION GABAERGIC | 22 | 2.19e-01 | -1.51e-01 | 7.49e-01 |
| GOBP MITOTIC SISTER CHROMATID SEGREGATION | 175 | 5.58e-04 | 1.51e-01 | 2.77e-02 |
| GOBP COPPER ION HOMEOSTASIS | 17 | 2.80e-01 | 1.51e-01 | 7.99e-01 |
| GOBP REGULATION OF PIGMENT CELL DIFFERENTIATION | 6 | 5.21e-01 | 1.51e-01 | 9.20e-01 |
| GOBP NEGATIVE REGULATION OF ANOIKIS | 13 | 3.45e-01 | 1.51e-01 | 8.42e-01 |
| GOCC PHAGOCYTIC CUP | 23 | 2.10e-01 | -1.51e-01 | 7.43e-01 |
| GOBP SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE | 17 | 2.81e-01 | 1.51e-01 | 7.99e-01 |
| GOCC EXTRINSIC COMPONENT OF ORGANELLE MEMBRANE | 24 | 2.00e-01 | -1.51e-01 | 7.32e-01 |
| GOBP NEGATIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE | 8 | 4.60e-01 | 1.51e-01 | 8.96e-01 |
| GOCC ENDOLYSOSOME MEMBRANE | 16 | 2.96e-01 | 1.51e-01 | 8.10e-01 |
| GOBP RESPONSE TO FATTY ACID | 32 | 1.40e-01 | 1.51e-01 | 6.61e-01 |
| GOBP REGULATION OF OXIDOREDUCTASE ACTIVITY | 48 | 7.09e-02 | 1.51e-01 | 5.17e-01 |
| GOCC PIGMENT GRANULE | 101 | 8.92e-03 | -1.51e-01 | 1.87e-01 |
| GOBP CELLULAR RESPONSE TO VITAMIN | 19 | 2.56e-01 | 1.51e-01 | 7.82e-01 |
| GOBP EXTRACELLULAR EXOSOME ASSEMBLY | 6 | 5.23e-01 | 1.51e-01 | 9.20e-01 |
| GOMF CALCIUM ACTIVATED CATION CHANNEL ACTIVITY | 17 | 2.83e-01 | -1.50e-01 | 8.02e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS | 25 | 1.93e-01 | 1.50e-01 | 7.22e-01 |
| GOMF NUCLEAR GLUCOCORTICOID RECEPTOR BINDING | 10 | 4.10e-01 | 1.50e-01 | 8.77e-01 |
| GOBP GANGLION DEVELOPMENT | 9 | 4.35e-01 | -1.50e-01 | 8.83e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 38 | 1.09e-01 | 1.50e-01 | 5.99e-01 |
| GOBP CHROMOSOME LOCALIZATION | 106 | 7.52e-03 | 1.50e-01 | 1.70e-01 |
| GOBP DENTATE GYRUS DEVELOPMENT | 12 | 3.67e-01 | -1.50e-01 | 8.54e-01 |
| GOBP POSITIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 7 | 4.91e-01 | -1.50e-01 | 9.13e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 39 | 1.04e-01 | 1.50e-01 | 5.94e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 43 | 8.82e-02 | 1.50e-01 | 5.58e-01 |
| GOBP REGULATION OF IMMUNE RESPONSE | 632 | 1.45e-10 | 1.50e-01 | 6.30e-08 |
| GOBP T HELPER 17 CELL LINEAGE COMMITMENT | 9 | 4.35e-01 | 1.50e-01 | 8.83e-01 |
| GOBP CORONARY VASCULATURE MORPHOGENESIS | 11 | 3.88e-01 | 1.50e-01 | 8.65e-01 |
| GOBP INCLUSION BODY ASSEMBLY | 20 | 2.45e-01 | -1.50e-01 | 7.73e-01 |
| GOBP CELLULAR RESPONSE TO COCAINE | 5 | 5.61e-01 | 1.50e-01 | 9.29e-01 |
| GOBP NEUROMUSCULAR JUNCTION DEVELOPMENT | 33 | 1.36e-01 | 1.50e-01 | 6.52e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 9 | 4.36e-01 | 1.50e-01 | 8.84e-01 |
| GOCC MICROTUBULE ORGANIZING CENTER ATTACHMENT SITE | 6 | 5.25e-01 | 1.50e-01 | 9.20e-01 |
| GOMF TUMOR NECROSIS FACTOR RECEPTOR ACTIVITY | 7 | 4.92e-01 | -1.50e-01 | 9.13e-01 |
| GOBP VITAMIN D BIOSYNTHETIC PROCESS | 6 | 5.25e-01 | -1.50e-01 | 9.20e-01 |
| GOMF SPHINGOLIPID TRANSPORTER ACTIVITY | 14 | 3.32e-01 | 1.50e-01 | 8.31e-01 |
| GOBP BARBED END ACTIN FILAMENT CAPPING | 21 | 2.35e-01 | -1.50e-01 | 7.63e-01 |
| GOBP RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 28 | 1.71e-01 | 1.50e-01 | 6.99e-01 |
| GOBP TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 23 | 2.14e-01 | 1.50e-01 | 7.46e-01 |
| GOCC ZONULA ADHERENS | 8 | 4.64e-01 | 1.50e-01 | 8.99e-01 |
| GOBP THYMUS DEVELOPMENT | 34 | 1.31e-01 | 1.50e-01 | 6.41e-01 |
| GOBP ADAPTIVE IMMUNE RESPONSE | 302 | 8.24e-06 | 1.50e-01 | 1.02e-03 |
| GOBP AZOLE TRANSMEMBRANE TRANSPORT | 7 | 4.93e-01 | 1.50e-01 | 9.13e-01 |
| GOBP PYRIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS | 19 | 2.59e-01 | 1.50e-01 | 7.85e-01 |
| GOBP ENDOPLASMIC RETICULUM LOCALIZATION | 9 | 4.38e-01 | 1.49e-01 | 8.85e-01 |
| GOBP BONE MINERALIZATION | 71 | 2.96e-02 | 1.49e-01 | 3.49e-01 |
| GOBP REGULATION OF TORC2 SIGNALING | 8 | 4.64e-01 | -1.49e-01 | 9.00e-01 |
| GOBP CELLULAR RESPONSE TO ESTROGEN STIMULUS | 15 | 3.17e-01 | 1.49e-01 | 8.23e-01 |
| GOBP REGULATION OF TYPE 2 IMMUNE RESPONSE | 20 | 2.48e-01 | 1.49e-01 | 7.76e-01 |
| GOBP MAGNESIUM ION TRANSPORT | 14 | 3.34e-01 | -1.49e-01 | 8.35e-01 |
| GOBP CHONDROCYTE PROLIFERATION | 9 | 4.39e-01 | -1.49e-01 | 8.85e-01 |
| GOBP POSITIVE T CELL SELECTION | 24 | 2.06e-01 | 1.49e-01 | 7.35e-01 |
| GOCC SYNAPTIC CLEFT | 7 | 4.95e-01 | 1.49e-01 | 9.13e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION | 12 | 3.72e-01 | -1.49e-01 | 8.57e-01 |
| GOCC GATOR2 COMPLEX | 5 | 5.64e-01 | 1.49e-01 | 9.29e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN POLYUBIQUITINATION | 6 | 5.28e-01 | 1.49e-01 | 9.22e-01 |
| GOBP REGULATION OF CHOLESTEROL EFFLUX | 26 | 1.89e-01 | -1.49e-01 | 7.18e-01 |
| GOBP TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY | 65 | 3.80e-02 | 1.49e-01 | 3.97e-01 |
| GOMF SEQUENCE SPECIFIC SINGLE STRANDED DNA BINDING | 14 | 3.35e-01 | -1.49e-01 | 8.36e-01 |
| GOBP P38MAPK CASCADE | 45 | 8.44e-02 | 1.49e-01 | 5.46e-01 |
| GOBP COLLAGEN METABOLIC PROCESS | 56 | 5.43e-02 | -1.49e-01 | 4.62e-01 |
| GOBP REGULATION OF IMMUNOGLOBULIN PRODUCTION | 57 | 5.22e-02 | 1.49e-01 | 4.58e-01 |
| GOBP REGULATION OF SMOOTH MUSCLE CONTRACTION | 29 | 1.66e-01 | -1.49e-01 | 6.93e-01 |
| GOBP POSITIVE REGULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 10 | 4.16e-01 | -1.49e-01 | 8.79e-01 |
| GOBP CARDIAC ATRIUM MORPHOGENESIS | 13 | 3.54e-01 | 1.49e-01 | 8.46e-01 |
| GOBP REGULATION OF HIPPO SIGNALING | 21 | 2.39e-01 | 1.48e-01 | 7.68e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE | 43 | 9.26e-02 | 1.48e-01 | 5.66e-01 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED DNA REPLICATION | 9 | 4.42e-01 | 1.48e-01 | 8.86e-01 |
| GOBP REGULATION OF MONOOXYGENASE ACTIVITY | 28 | 1.75e-01 | 1.48e-01 | 7.05e-01 |
| GOMF IMMUNOGLOBULIN BINDING | 13 | 3.55e-01 | 1.48e-01 | 8.46e-01 |
| GOCC GAMMA TUBULIN COMPLEX | 16 | 3.05e-01 | -1.48e-01 | 8.15e-01 |
| GOBP POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 18 | 2.77e-01 | -1.48e-01 | 7.98e-01 |
| GOBP CELLULAR RESPONSE TO POTASSIUM ION | 7 | 4.98e-01 | -1.48e-01 | 9.13e-01 |
| GOBP DNA INTEGRATION | 6 | 5.31e-01 | 1.48e-01 | 9.23e-01 |
| GOMF PHOSPHATIDYLGLYCEROL BINDING | 11 | 3.96e-01 | 1.48e-01 | 8.71e-01 |
| GOBP NON CANONICAL WNT SIGNALING PATHWAY | 40 | 1.06e-01 | -1.48e-01 | 5.96e-01 |
| GOBP HEAT GENERATION | 10 | 4.19e-01 | 1.48e-01 | 8.79e-01 |
| GOMF TAU PROTEIN BINDING | 40 | 1.07e-01 | -1.48e-01 | 5.96e-01 |
| GOBP AORTA MORPHOGENESIS | 18 | 2.79e-01 | 1.48e-01 | 7.99e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 3 PHOSPHATASE ACTIVITY | 11 | 3.97e-01 | 1.47e-01 | 8.71e-01 |
| GOBP CEREBELLAR CORTEX FORMATION | 15 | 3.23e-01 | -1.47e-01 | 8.29e-01 |
| GOBP REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 18 | 2.79e-01 | -1.47e-01 | 7.99e-01 |
| GOBP COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 22 | 2.32e-01 | -1.47e-01 | 7.59e-01 |
| GOBP UBIQUITIN DEPENDENT ENDOCYTOSIS | 5 | 5.69e-01 | 1.47e-01 | 9.31e-01 |
| GOBP MEIOTIC SPINDLE ORGANIZATION | 16 | 3.08e-01 | 1.47e-01 | 8.19e-01 |
| GOCC MICROTUBULE END | 29 | 1.70e-01 | 1.47e-01 | 6.98e-01 |
| GOBP TETRAPYRROLE METABOLIC PROCESS | 47 | 8.09e-02 | -1.47e-01 | 5.41e-01 |
| GOMF OLIGOPEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 5.69e-01 | -1.47e-01 | 9.31e-01 |
| GOBP REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 31 | 1.56e-01 | 1.47e-01 | 6.79e-01 |
| GOBP 5S CLASS RRNA TRANSCRIPTION BY RNA POLYMERASE III | 6 | 5.32e-01 | -1.47e-01 | 9.23e-01 |
| GOCC TRANSCRIPTION FACTOR TFIIIC COMPLEX | 6 | 5.32e-01 | -1.47e-01 | 9.23e-01 |
| GOMF TITIN BINDING | 8 | 4.71e-01 | -1.47e-01 | 9.02e-01 |
| GOCC RIBONUCLEOPROTEIN COMPLEX | 675 | 9.62e-11 | -1.47e-01 | 4.40e-08 |
| GOBP RESPONSE TO POTASSIUM ION | 11 | 3.98e-01 | -1.47e-01 | 8.71e-01 |
| GOBP NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 5 | 5.69e-01 | 1.47e-01 | 9.31e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL CELL JUNCTION | 18 | 2.80e-01 | 1.47e-01 | 7.99e-01 |
| GOMF ANTIPORTER ACTIVITY | 92 | 1.49e-02 | -1.47e-01 | 2.58e-01 |
| GOBP NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY | 21 | 2.44e-01 | -1.47e-01 | 7.73e-01 |
| GOBP PROTEIN DENEDDYLATION | 11 | 3.99e-01 | -1.47e-01 | 8.71e-01 |
| GOBP VERY LONG CHAIN FATTY ACID METABOLIC PROCESS | 25 | 2.04e-01 | 1.47e-01 | 7.32e-01 |
| GOBP POSITIVE REGULATION OF VIRAL PROCESS | 58 | 5.33e-02 | 1.47e-01 | 4.60e-01 |
| GOCC GOLGI ASSOCIATED VESICLE MEMBRANE | 48 | 7.86e-02 | -1.47e-01 | 5.37e-01 |
| GOCC AMPHISOME | 13 | 3.60e-01 | 1.47e-01 | 8.46e-01 |
| GOBP PROTEIN RETENTION IN GOLGI APPARATUS | 5 | 5.70e-01 | 1.47e-01 | 9.31e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 27 | 1.87e-01 | 1.47e-01 | 7.17e-01 |
| GOBP NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY | 19 | 2.68e-01 | 1.47e-01 | 7.93e-01 |
| GOBP METHIONINE BIOSYNTHETIC PROCESS | 10 | 4.22e-01 | -1.47e-01 | 8.81e-01 |
| GOBP DENDRITIC CELL DIFFERENTIATION | 35 | 1.33e-01 | 1.47e-01 | 6.48e-01 |
| GOCC N TERMINAL PROTEIN ACETYLTRANSFERASE COMPLEX | 9 | 4.46e-01 | -1.47e-01 | 8.88e-01 |
| GOMF METAL CATION PROTON ANTIPORTER ACTIVITY | 16 | 3.10e-01 | -1.47e-01 | 8.21e-01 |
| GOCC FANCONI ANAEMIA NUCLEAR COMPLEX | 13 | 3.60e-01 | 1.47e-01 | 8.46e-01 |
| GOBP REGULATION OF DEFENSE RESPONSE TO BACTERIUM | 9 | 4.47e-01 | -1.47e-01 | 8.88e-01 |
| GOBP FERROPTOSIS | 5 | 5.70e-01 | 1.47e-01 | 9.31e-01 |
| GOBP SPLICEOSOMAL CONFORMATIONAL CHANGES TO GENERATE CATALYTIC CONFORMATION | 5 | 5.71e-01 | 1.46e-01 | 9.31e-01 |
| GOBP CHONDROITIN SULFATE BIOSYNTHETIC PROCESS | 17 | 2.96e-01 | -1.46e-01 | 8.10e-01 |
| GOBP PEPTIDE METABOLIC PROCESS | 727 | 2.44e-11 | -1.46e-01 | 1.63e-08 |
| GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY | 54 | 6.28e-02 | -1.46e-01 | 4.89e-01 |
| GOBP CARDIAC VENTRICLE MORPHOGENESIS | 32 | 1.52e-01 | 1.46e-01 | 6.74e-01 |
| GOBP RESPONSE TO X RAY | 24 | 2.15e-01 | -1.46e-01 | 7.46e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL DIFFERENTIATION | 10 | 4.23e-01 | -1.46e-01 | 8.81e-01 |
| GOMF BMP BINDING | 6 | 5.35e-01 | -1.46e-01 | 9.23e-01 |
| GOMF JUN KINASE KINASE KINASE ACTIVITY | 10 | 4.23e-01 | 1.46e-01 | 8.81e-01 |
| GOBP ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT | 14 | 3.43e-01 | -1.46e-01 | 8.41e-01 |
| GOBP REPRODUCTIVE BEHAVIOR | 19 | 2.70e-01 | 1.46e-01 | 7.93e-01 |
| GOBP REGULATION OF MITOTIC NUCLEAR DIVISION | 94 | 1.44e-02 | 1.46e-01 | 2.52e-01 |
| GOBP INFLAMMASOME MEDIATED SIGNALING PATHWAY | 34 | 1.40e-01 | 1.46e-01 | 6.62e-01 |
| GOBP CELLULAR RESPONSE TO EXOGENOUS DSRNA | 13 | 3.62e-01 | 1.46e-01 | 8.48e-01 |
| GOMF ACTININ BINDING | 20 | 2.58e-01 | -1.46e-01 | 7.85e-01 |
| GOMF FIBROBLAST GROWTH FACTOR BINDING | 13 | 3.62e-01 | -1.46e-01 | 8.48e-01 |
| GOBP TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE | 30 | 1.66e-01 | -1.46e-01 | 6.94e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 BISPHOSPHATE BINDING | 21 | 2.47e-01 | 1.46e-01 | 7.76e-01 |
| GOBP SULFUR AMINO ACID BIOSYNTHETIC PROCESS | 11 | 4.02e-01 | -1.46e-01 | 8.72e-01 |
| GOCC REPLICATION FORK | 63 | 4.52e-02 | -1.46e-01 | 4.31e-01 |
| GOBP MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS | 6 | 5.36e-01 | 1.46e-01 | 9.23e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL EFFLUX | 19 | 2.71e-01 | -1.46e-01 | 7.94e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 18 | 2.84e-01 | -1.46e-01 | 8.03e-01 |
| GOBP MODULATION BY HOST OF VIRAL GENOME REPLICATION | 24 | 2.16e-01 | 1.46e-01 | 7.47e-01 |
| GOCC VACUOLAR PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN | 9 | 4.49e-01 | -1.46e-01 | 8.89e-01 |
| GOBP PROTEIN TARGETING TO MITOCHONDRION | 102 | 1.11e-02 | -1.46e-01 | 2.12e-01 |
| GOCC MITOCHONDRIAL SMALL RIBOSOMAL SUBUNIT | 32 | 1.54e-01 | -1.46e-01 | 6.75e-01 |
| GOBP RESPONSE TO INTERLEUKIN 6 | 23 | 2.26e-01 | 1.46e-01 | 7.56e-01 |
| GOMF MHC PROTEIN BINDING | 21 | 2.48e-01 | 1.46e-01 | 7.76e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO TUMOR CELL | 9 | 4.49e-01 | 1.46e-01 | 8.89e-01 |
| GOBP NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 26 | 1.99e-01 | 1.46e-01 | 7.31e-01 |
| GOBP L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE | 10 | 4.26e-01 | -1.46e-01 | 8.81e-01 |
| GOCC EXTERNAL ENCAPSULATING STRUCTURE | 221 | 1.99e-04 | -1.46e-01 | 1.29e-02 |
| GOBP POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 16 | 3.14e-01 | -1.45e-01 | 8.22e-01 |
| GOMF SERINE TYPE EXOPEPTIDASE ACTIVITY | 9 | 4.50e-01 | 1.45e-01 | 8.89e-01 |
| GOBP CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT | 17 | 3.00e-01 | 1.45e-01 | 8.14e-01 |
| GOMF CALMODULIN DEPENDENT PROTEIN PHOSPHATASE ACTIVITY | 5 | 5.74e-01 | 1.45e-01 | 9.32e-01 |
| GOMF L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 43 | 9.95e-02 | -1.45e-01 | 5.82e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS | 15 | 3.30e-01 | 1.45e-01 | 8.30e-01 |
| GOBP LENS FIBER CELL DIFFERENTIATION | 22 | 2.38e-01 | 1.45e-01 | 7.67e-01 |
| GOBP ACTIVATION OF INNATE IMMUNE RESPONSE | 215 | 2.50e-04 | 1.45e-01 | 1.54e-02 |
| GOBP ENTRAINMENT OF CIRCADIAN CLOCK | 24 | 2.18e-01 | 1.45e-01 | 7.49e-01 |
| GOMF UBIQUITIN SPECIFIC PROTEASE BINDING | 19 | 2.73e-01 | -1.45e-01 | 7.94e-01 |
| GOBP PURINE NUCLEOBASE BIOSYNTHETIC PROCESS | 10 | 4.27e-01 | -1.45e-01 | 8.82e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY | 49 | 7.91e-02 | 1.45e-01 | 5.37e-01 |
| GOCC NUCLEOID | 43 | 1.00e-01 | -1.45e-01 | 5.84e-01 |
| GOBP POSITIVE REGULATION OF HEPATOCYTE PROLIFERATION | 6 | 5.39e-01 | 1.45e-01 | 9.23e-01 |
| GOMF FATTY ACID BINDING | 30 | 1.70e-01 | -1.45e-01 | 6.98e-01 |
| GOBP ENDOCRINE PROCESS | 38 | 1.23e-01 | -1.45e-01 | 6.25e-01 |
| GOCC CRD MEDIATED MRNA STABILITY COMPLEX | 5 | 5.76e-01 | -1.45e-01 | 9.33e-01 |
| GOBP CGMP MEDIATED SIGNALING | 14 | 3.50e-01 | -1.44e-01 | 8.45e-01 |
| GOBP POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 6 | 5.40e-01 | 1.44e-01 | 9.23e-01 |
| GOBP REGULATION OF NUCLEAR DIVISION | 106 | 1.04e-02 | 1.44e-01 | 2.05e-01 |
| GOBP T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 77 | 2.89e-02 | 1.44e-01 | 3.47e-01 |
| GOBP NEGATIVE REGULATION OF BONE MINERALIZATION | 12 | 3.88e-01 | 1.44e-01 | 8.65e-01 |
| GOBP RNA STABILIZATION | 55 | 6.48e-02 | 1.44e-01 | 4.97e-01 |
| GOBP NEURAL RETINA DEVELOPMENT | 40 | 1.15e-01 | 1.44e-01 | 6.12e-01 |
| GOBP ADAPTATION OF SIGNALING PATHWAY | 11 | 4.09e-01 | 1.44e-01 | 8.76e-01 |
| GOBP TRNA 5 LEADER REMOVAL | 13 | 3.69e-01 | 1.44e-01 | 8.55e-01 |
| GOBP RESPONSE TO MAGNESIUM ION | 9 | 4.55e-01 | 1.44e-01 | 8.93e-01 |
| GOBP PROTEIN K63 LINKED UBIQUITINATION | 52 | 7.29e-02 | 1.44e-01 | 5.22e-01 |
| GOBP ACTIVATION INDUCED CELL DEATH OF T CELLS | 8 | 4.81e-01 | 1.44e-01 | 9.08e-01 |
| GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 34 | 1.47e-01 | 1.44e-01 | 6.70e-01 |
| GOMF PHOSPHATIDYLINOSITOL MONOPHOSPHATE PHOSPHATASE ACTIVITY | 14 | 3.52e-01 | 1.44e-01 | 8.46e-01 |
| GOBP REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 8 | 4.82e-01 | 1.44e-01 | 9.08e-01 |
| GOBP AMIDE BIOSYNTHETIC PROCESS | 731 | 5.16e-11 | -1.44e-01 | 2.80e-08 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 10 | 4.32e-01 | 1.44e-01 | 8.82e-01 |
| GOBP INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE | 58 | 5.88e-02 | -1.44e-01 | 4.75e-01 |
| GOBP MIRNA PROCESSING | 40 | 1.16e-01 | 1.44e-01 | 6.15e-01 |
| GOBP DITERPENOID BIOSYNTHETIC PROCESS | 7 | 5.11e-01 | -1.44e-01 | 9.18e-01 |
| GOMF SODIUM PROTON ANTIPORTER ACTIVITY | 9 | 4.56e-01 | 1.44e-01 | 8.94e-01 |
| GOBP REGULATION OF THYMOCYTE APOPTOTIC PROCESS | 9 | 4.56e-01 | -1.44e-01 | 8.94e-01 |
| GOMF CALMODULIN DEPENDENT PROTEIN KINASE ACTIVITY | 20 | 2.67e-01 | -1.44e-01 | 7.91e-01 |
| GOBP PLASMA MEMBRANE TUBULATION | 15 | 3.36e-01 | 1.43e-01 | 8.36e-01 |
| GOBP SYMPATHETIC GANGLION DEVELOPMENT | 6 | 5.43e-01 | -1.43e-01 | 9.23e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 60 | 5.49e-02 | 1.43e-01 | 4.63e-01 |
| GOBP SIGNAL PEPTIDE PROCESSING | 13 | 3.71e-01 | -1.43e-01 | 8.57e-01 |
| GOBP POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION | 14 | 3.54e-01 | 1.43e-01 | 8.46e-01 |
| GOBP ERBB2 SIGNALING PATHWAY | 9 | 4.57e-01 | 1.43e-01 | 8.95e-01 |
| GOBP REGULATION OF DNA DAMAGE CHECKPOINT | 24 | 2.25e-01 | -1.43e-01 | 7.55e-01 |
| GOBP REGULATION OF SODIUM ION TRANSPORT | 45 | 9.72e-02 | 1.43e-01 | 5.77e-01 |
| GOBP ICOSANOID BIOSYNTHETIC PROCESS | 33 | 1.56e-01 | 1.43e-01 | 6.78e-01 |
| GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE | 10 | 4.34e-01 | -1.43e-01 | 8.83e-01 |
| GOBP GLYCOSYL COMPOUND CATABOLIC PROCESS | 27 | 1.99e-01 | 1.43e-01 | 7.31e-01 |
| GOBP INTERLEUKIN 2 PRODUCTION | 45 | 9.75e-02 | 1.43e-01 | 5.78e-01 |
| GOCC PINOSOME | 6 | 5.45e-01 | -1.43e-01 | 9.23e-01 |
| GOBP REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 114 | 8.56e-03 | 1.43e-01 | 1.82e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN CELL CYCLE ARREST | 14 | 3.55e-01 | 1.43e-01 | 8.46e-01 |
| GOBP ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE | 18 | 2.95e-01 | -1.43e-01 | 8.10e-01 |
| GOMF CGMP BINDING | 7 | 5.13e-01 | 1.43e-01 | 9.18e-01 |
| GOBP FC GAMMA RECEPTOR SIGNALING PATHWAY | 29 | 1.84e-01 | 1.43e-01 | 7.15e-01 |
| GOBP C4 DICARBOXYLATE TRANSPORT | 19 | 2.82e-01 | -1.43e-01 | 8.00e-01 |
| GOMF MAP KINASE ACTIVITY | 12 | 3.92e-01 | 1.43e-01 | 8.68e-01 |
| GOBP PLASMA MEMBRANE FUSION | 9 | 4.59e-01 | -1.42e-01 | 8.96e-01 |
| GOMF ALKALI METAL ION BINDING | 10 | 4.36e-01 | -1.42e-01 | 8.84e-01 |
| GOBP REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS | 9 | 4.60e-01 | 1.42e-01 | 8.96e-01 |
| GOBP T FOLLICULAR HELPER CELL DIFFERENTIATION | 5 | 5.82e-01 | -1.42e-01 | 9.35e-01 |
| GOBP PROTEASOME ASSEMBLY | 12 | 3.94e-01 | 1.42e-01 | 8.69e-01 |
| GOBP GLIAL CELL APOPTOTIC PROCESS | 14 | 3.57e-01 | 1.42e-01 | 8.46e-01 |
| GOBP MYOTUBE DIFFERENTIATION INVOLVED IN SKELETAL MUSCLE REGENERATION | 6 | 5.46e-01 | -1.42e-01 | 9.25e-01 |
| GOBP INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 64 | 4.94e-02 | 1.42e-01 | 4.46e-01 |
| GOBP L ASCORBIC ACID METABOLIC PROCESS | 8 | 4.86e-01 | -1.42e-01 | 9.11e-01 |
| GOBP O GLYCAN PROCESSING | 32 | 1.64e-01 | 1.42e-01 | 6.90e-01 |
| GOBP PHOSPHATE ION TRANSMEMBRANE TRANSPORT | 14 | 3.58e-01 | -1.42e-01 | 8.46e-01 |
| GOCC CLATHRIN VESICLE COAT | 28 | 1.94e-01 | -1.42e-01 | 7.23e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS | 49 | 8.57e-02 | -1.42e-01 | 5.52e-01 |
| GOBP FILOPODIUM ASSEMBLY | 51 | 8.00e-02 | 1.42e-01 | 5.40e-01 |
| GOBP SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 14 | 3.59e-01 | -1.42e-01 | 8.46e-01 |
| GOBP ADRENERGIC RECEPTOR SIGNALING PATHWAY | 16 | 3.27e-01 | 1.42e-01 | 8.29e-01 |
| GOBP INNATE IMMUNE RESPONSE | 634 | 1.43e-09 | 1.42e-01 | 4.78e-07 |
| GOBP NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 39 | 1.26e-01 | 1.42e-01 | 6.31e-01 |
| GOBP DNA REPAIR DEPENDENT CHROMATIN REMODELING | 20 | 2.73e-01 | 1.42e-01 | 7.94e-01 |
| GOMF LIPOPEPTIDE BINDING | 6 | 5.48e-01 | 1.42e-01 | 9.25e-01 |
| GOBP PURINE NUCLEOTIDE TRANSPORT | 31 | 1.73e-01 | -1.41e-01 | 7.03e-01 |
| GOBP POSITIVE REGULATION OF LAMELLIPODIUM MORPHOGENESIS | 7 | 5.17e-01 | 1.41e-01 | 9.19e-01 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION | 46 | 9.74e-02 | -1.41e-01 | 5.77e-01 |
| GOBP VITAMIN TRANSMEMBRANE TRANSPORT | 12 | 3.97e-01 | -1.41e-01 | 8.71e-01 |
| GOBP ACTIVATION OF PROTEIN KINASE ACTIVITY | 65 | 4.92e-02 | 1.41e-01 | 4.46e-01 |
| GOBP COENZYME A METABOLIC PROCESS | 19 | 2.87e-01 | -1.41e-01 | 8.05e-01 |
| GOBP POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 15 | 3.44e-01 | -1.41e-01 | 8.41e-01 |
| GOBP POSITIVE REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 6 | 5.50e-01 | -1.41e-01 | 9.26e-01 |
| GOBP FAT SOLUBLE VITAMIN METABOLIC PROCESS | 19 | 2.87e-01 | -1.41e-01 | 8.05e-01 |
| GOBP BASE EXCISION REPAIR AP SITE FORMATION | 12 | 3.98e-01 | 1.41e-01 | 8.71e-01 |
| GOBP MOTOR NEURON APOPTOTIC PROCESS | 16 | 3.29e-01 | 1.41e-01 | 8.30e-01 |
| GOMF MANGANESE ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 5.19e-01 | 1.41e-01 | 9.19e-01 |
| GOBP ALPHA BETA T CELL ACTIVATION | 121 | 7.50e-03 | 1.41e-01 | 1.70e-01 |
| GOBP MALE MEIOSIS I | 16 | 3.29e-01 | 1.41e-01 | 8.30e-01 |
| GOMF ANNEALING ACTIVITY | 10 | 4.41e-01 | -1.41e-01 | 8.85e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 22 | 2.53e-01 | -1.41e-01 | 7.78e-01 |
| GOMF S ACYLTRANSFERASE ACTIVITY | 25 | 2.23e-01 | 1.41e-01 | 7.51e-01 |
| GOBP REGULATION OF HYPERSENSITIVITY | 8 | 4.90e-01 | 1.41e-01 | 9.12e-01 |
| GOCC DENDRITE TERMINUS | 11 | 4.19e-01 | -1.41e-01 | 8.79e-01 |
| GOBP MYELOID CELL APOPTOTIC PROCESS | 28 | 1.98e-01 | 1.41e-01 | 7.29e-01 |
| GOMF SINGLE STRANDED DNA 5 3 DNA EXONUCLEASE ACTIVITY | 5 | 5.86e-01 | -1.41e-01 | 9.36e-01 |
| GOBP TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION | 9 | 4.65e-01 | -1.41e-01 | 9.00e-01 |
| GOBP NEGATIVE REGULATION OF RNA CATABOLIC PROCESS | 65 | 5.00e-02 | 1.41e-01 | 4.48e-01 |
| GOBP SNORNA LOCALIZATION | 6 | 5.51e-01 | -1.41e-01 | 9.26e-01 |
| GOBP LEUKOCYTE MEDIATED IMMUNITY | 264 | 8.73e-05 | 1.41e-01 | 6.89e-03 |
| GOMF CARGO ADAPTOR ACTIVITY | 17 | 3.16e-01 | -1.41e-01 | 8.23e-01 |
| GOBP SEBACEOUS GLAND DEVELOPMENT | 6 | 5.52e-01 | -1.40e-01 | 9.26e-01 |
| GOCC PLATELET ALPHA GRANULE MEMBRANE | 13 | 3.81e-01 | -1.40e-01 | 8.63e-01 |
| GOBP EPHRIN RECEPTOR SIGNALING PATHWAY | 30 | 1.83e-01 | 1.40e-01 | 7.14e-01 |
| GOBP RESPONSE TO ALDOSTERONE | 13 | 3.81e-01 | -1.40e-01 | 8.63e-01 |
| GOBP NEUROENDOCRINE CELL DIFFERENTIATION | 5 | 5.87e-01 | 1.40e-01 | 9.36e-01 |
| GOMF NAD DEPENDENT HISTONE DEACETYLASE ACTIVITY | 5 | 5.87e-01 | 1.40e-01 | 9.36e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM | 10 | 4.42e-01 | -1.40e-01 | 8.86e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON NITROGEN BONDS | 36 | 1.45e-01 | -1.40e-01 | 6.68e-01 |
| GOBP PIRNA PROCESSING | 9 | 4.67e-01 | 1.40e-01 | 9.00e-01 |
| GOCC ROUGH ENDOPLASMIC RETICULUM | 48 | 9.34e-02 | -1.40e-01 | 5.67e-01 |
| GOMF PEROXIREDOXIN ACTIVITY | 8 | 4.93e-01 | -1.40e-01 | 9.13e-01 |
| GOBP LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE | 37 | 1.41e-01 | 1.40e-01 | 6.63e-01 |
| GOBP CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY | 20 | 2.79e-01 | -1.40e-01 | 7.99e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND | 8 | 4.93e-01 | 1.40e-01 | 9.13e-01 |
| GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM | 19 | 2.91e-01 | 1.40e-01 | 8.07e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON ETHER BONDS | 6 | 5.53e-01 | -1.40e-01 | 9.26e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 8 | 4.93e-01 | 1.40e-01 | 9.13e-01 |
| GOBP SYNAPTIC VESICLE RECYCLING VIA ENDOSOME | 5 | 5.88e-01 | 1.40e-01 | 9.36e-01 |
| GOBP REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 11 | 4.22e-01 | -1.40e-01 | 8.81e-01 |
| GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE II | 14 | 3.66e-01 | -1.40e-01 | 8.52e-01 |
| GOBP REGULATION OF BRANCHING MORPHOGENESIS OF A NERVE | 5 | 5.89e-01 | -1.40e-01 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST MIGRATION | 10 | 4.44e-01 | 1.40e-01 | 8.87e-01 |
| GOBP TYPE B PANCREATIC CELL APOPTOTIC PROCESS | 6 | 5.54e-01 | 1.40e-01 | 9.26e-01 |
| GOBP REGULATION OF T CELL ACTIVATION | 259 | 1.15e-04 | 1.40e-01 | 8.50e-03 |
| GOBP DISRUPTION OF ANATOMICAL STRUCTURE IN ANOTHER ORGANISM | 33 | 1.66e-01 | 1.40e-01 | 6.93e-01 |
| GOBP POSITIVE REGULATION OF NEUTROPHIL MIGRATION | 25 | 2.28e-01 | 1.39e-01 | 7.58e-01 |
| GOBP POSITIVE REGULATION OF GLUCONEOGENESIS | 16 | 3.34e-01 | 1.39e-01 | 8.35e-01 |
| GOMF GLYCEROL 3 PHOSPHATE O ACYLTRANSFERASE ACTIVITY | 5 | 5.90e-01 | 1.39e-01 | 9.36e-01 |
| GOBP SNRNA CATABOLIC PROCESS | 5 | 5.90e-01 | 1.39e-01 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 12 | 4.04e-01 | 1.39e-01 | 8.72e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE POTENTIAL | 5 | 5.90e-01 | -1.39e-01 | 9.36e-01 |
| GOBP PROTEIN DEPALMITOYLATION | 8 | 4.96e-01 | -1.39e-01 | 9.13e-01 |
| GOBP PEPTIDYL TYROSINE DEPHOSPHORYLATION | 21 | 2.70e-01 | 1.39e-01 | 7.93e-01 |
| GOBP NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY | 21 | 2.70e-01 | 1.39e-01 | 7.93e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 9 | 4.70e-01 | -1.39e-01 | 9.01e-01 |
| GOBP DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN | 10 | 4.47e-01 | 1.39e-01 | 8.88e-01 |
| GOBP PROSTATE GLAND MORPHOGENESIS | 11 | 4.25e-01 | -1.39e-01 | 8.81e-01 |
| GOCC TETRASPANIN ENRICHED MICRODOMAIN | 10 | 4.47e-01 | 1.39e-01 | 8.88e-01 |
| GOMF ACTIVIN BINDING | 10 | 4.47e-01 | 1.39e-01 | 8.88e-01 |
| GOMF RNA POLYMERASE BINDING | 55 | 7.50e-02 | 1.39e-01 | 5.26e-01 |
| GOBP MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 11 | 4.25e-01 | 1.39e-01 | 8.81e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL | 9 | 4.71e-01 | 1.39e-01 | 9.02e-01 |
| GOBP ALPHA BETA T CELL DIFFERENTIATION | 87 | 2.54e-02 | 1.39e-01 | 3.29e-01 |
| GOBP REGULATION OF PHOSPHOLIPID CATABOLIC PROCESS | 6 | 5.56e-01 | -1.39e-01 | 9.26e-01 |
| GOCC CILIARY MEMBRANE | 50 | 8.98e-02 | 1.39e-01 | 5.59e-01 |
| GOBP POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION | 18 | 3.09e-01 | -1.39e-01 | 8.20e-01 |
| GOCC COLLAGEN CONTAINING EXTRACELLULAR MATRIX | 182 | 1.29e-03 | -1.39e-01 | 5.19e-02 |
| GOMF SULFUR COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 41 | 1.25e-01 | -1.39e-01 | 6.29e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION | 342 | 1.15e-05 | 1.39e-01 | 1.33e-03 |
| GOMF PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY | 40 | 1.30e-01 | 1.39e-01 | 6.40e-01 |
| GOBP MEGAKARYOCYTE DEVELOPMENT | 14 | 3.70e-01 | -1.39e-01 | 8.55e-01 |
| GOMF MANNOSE BINDING | 12 | 4.06e-01 | -1.38e-01 | 8.74e-01 |
| GOBP CELLULAR RESPONSE TO FATTY ACID | 17 | 3.23e-01 | 1.38e-01 | 8.29e-01 |
| GOCC INSULIN RESPONSIVE COMPARTMENT | 6 | 5.57e-01 | -1.38e-01 | 9.27e-01 |
| GOBP PYRIMIDINE NUCLEOBASE CATABOLIC PROCESS | 5 | 5.92e-01 | 1.38e-01 | 9.36e-01 |
| GOBP REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 16 | 3.38e-01 | 1.38e-01 | 8.37e-01 |
| GOBP REGULATION OF MITOCHONDRIAL FISSION | 25 | 2.31e-01 | 1.38e-01 | 7.59e-01 |
| GOBP REGULATION OF DENDRITE DEVELOPMENT | 65 | 5.40e-02 | 1.38e-01 | 4.61e-01 |
| GOBP POLYSACCHARIDE METABOLIC PROCESS | 71 | 4.42e-02 | -1.38e-01 | 4.28e-01 |
| GOBP CLATHRIN COAT ASSEMBLY | 12 | 4.07e-01 | -1.38e-01 | 8.75e-01 |
| GOBP POSITIVE REGULATION OF DNA LIGATION | 5 | 5.93e-01 | -1.38e-01 | 9.36e-01 |
| GOBP RESPONSE TO MINERALOCORTICOID | 21 | 2.73e-01 | -1.38e-01 | 7.94e-01 |
| GOBP REGULATION OF JNK CASCADE | 102 | 1.60e-02 | 1.38e-01 | 2.68e-01 |
| GOBP MYELOID CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 71 | 4.43e-02 | 1.38e-01 | 4.28e-01 |
| GOBP SISTER CHROMATID SEGREGATION | 211 | 5.59e-04 | 1.38e-01 | 2.77e-02 |
| GOBP ACROSOME ASSEMBLY | 13 | 3.89e-01 | 1.38e-01 | 8.66e-01 |
| GOBP ENDODERM DEVELOPMENT | 48 | 9.86e-02 | -1.38e-01 | 5.81e-01 |
| GOBP TONGUE DEVELOPMENT | 7 | 5.28e-01 | -1.38e-01 | 9.22e-01 |
| GOBP TRNA TRANSCRIPTION | 11 | 4.29e-01 | -1.38e-01 | 8.82e-01 |
| GOBP UBIQUINONE METABOLIC PROCESS | 19 | 2.98e-01 | -1.38e-01 | 8.13e-01 |
| GOCC ORGANELLAR RIBOSOME | 89 | 2.48e-02 | -1.38e-01 | 3.24e-01 |
| GOMF DOUBLE STRANDED RNA BINDING | 64 | 5.70e-02 | 1.38e-01 | 4.70e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION | 16 | 3.41e-01 | -1.38e-01 | 8.39e-01 |
| GOMF SNARE BINDING | 75 | 3.96e-02 | 1.38e-01 | 4.07e-01 |
| GOBP REGULATION OF CHOLESTEROL STORAGE | 16 | 3.41e-01 | 1.37e-01 | 8.39e-01 |
| GOBP ESTABLISHMENT OF BLOOD BRAIN BARRIER | 8 | 5.01e-01 | 1.37e-01 | 9.15e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX CONSTITUENT SECRETION | 8 | 5.01e-01 | -1.37e-01 | 9.15e-01 |
| GOMF MAP KINASE TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY | 10 | 4.52e-01 | 1.37e-01 | 8.90e-01 |
| GOBP SNRNA TRANSCRIPTION | 17 | 3.27e-01 | -1.37e-01 | 8.29e-01 |
| GOMF LONG CHAIN FATTY ACID BINDING | 12 | 4.10e-01 | -1.37e-01 | 8.77e-01 |
| GOMF IONOTROPIC GLUTAMATE RECEPTOR BINDING | 15 | 3.57e-01 | -1.37e-01 | 8.46e-01 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE | 337 | 1.58e-05 | 1.37e-01 | 1.71e-03 |
| GOBP CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS | 20 | 2.88e-01 | 1.37e-01 | 8.05e-01 |
| GOBP POSITIVE REGULATION OF NK T CELL ACTIVATION | 5 | 5.95e-01 | 1.37e-01 | 9.36e-01 |
| GOBP NEGATIVE ADAPTATION OF SIGNALING PATHWAY | 9 | 4.76e-01 | 1.37e-01 | 9.04e-01 |
| GOBP POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 12 | 4.11e-01 | -1.37e-01 | 8.77e-01 |
| GOBP EYE PHOTORECEPTOR CELL DIFFERENTIATION | 21 | 2.77e-01 | 1.37e-01 | 7.98e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION | 15 | 3.58e-01 | 1.37e-01 | 8.46e-01 |
| GOBP MULTI CILIATED EPITHELIAL CELL DIFFERENTIATION | 7 | 5.30e-01 | -1.37e-01 | 9.23e-01 |
| GOBP PML BODY ORGANIZATION | 6 | 5.62e-01 | -1.37e-01 | 9.29e-01 |
| GOBP DIGESTIVE TRACT MORPHOGENESIS | 17 | 3.29e-01 | 1.37e-01 | 8.30e-01 |
| GOBP POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 54 | 8.25e-02 | 1.37e-01 | 5.43e-01 |
| GOBP EXIT FROM MITOSIS | 29 | 2.03e-01 | 1.37e-01 | 7.32e-01 |
| GOBP REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 10 | 4.55e-01 | -1.37e-01 | 8.93e-01 |
| GOMF ORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 145 | 4.58e-03 | -1.37e-01 | 1.27e-01 |
| GOBP POSITIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 6 | 5.63e-01 | 1.37e-01 | 9.29e-01 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 8 | 5.04e-01 | 1.36e-01 | 9.15e-01 |
| GOMF MICROTUBULE MINUS END BINDING | 14 | 3.77e-01 | 1.36e-01 | 8.61e-01 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION | 246 | 2.37e-04 | 1.36e-01 | 1.48e-02 |
| GOMF 3 5 RNA HELICASE ACTIVITY | 5 | 5.97e-01 | 1.36e-01 | 9.36e-01 |
| GOMF PURINE RIBONUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 19 | 3.04e-01 | -1.36e-01 | 8.14e-01 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE SIGNAL SEQUENCE RECOGNITION | 5 | 5.98e-01 | 1.36e-01 | 9.36e-01 |
| GOBP REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 20 | 2.92e-01 | 1.36e-01 | 8.07e-01 |
| GOBP RNA DESTABILIZATION | 96 | 2.12e-02 | 1.36e-01 | 3.04e-01 |
| GOBP PEPTIDYL THREONINE DEPHOSPHORYLATION | 18 | 3.17e-01 | 1.36e-01 | 8.23e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION MEMBRANE | 46 | 1.10e-01 | -1.36e-01 | 6.02e-01 |
| GOMF VOLTAGE GATED MONOATOMIC ANION CHANNEL ACTIVITY | 12 | 4.14e-01 | 1.36e-01 | 8.77e-01 |
| GOBP ADP BIOSYNTHETIC PROCESS | 5 | 5.98e-01 | -1.36e-01 | 9.36e-01 |
| GOMF RNA STEM LOOP BINDING | 14 | 3.78e-01 | 1.36e-01 | 8.61e-01 |
| GOBP NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 39 | 1.42e-01 | -1.36e-01 | 6.64e-01 |
| GOBP EXOCYTIC PROCESS | 59 | 7.08e-02 | 1.36e-01 | 5.17e-01 |
| GOBP EMBRYONIC HEART TUBE DEVELOPMENT | 45 | 1.14e-01 | -1.36e-01 | 6.11e-01 |
| GOBP REGULATION OF L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE | 6 | 5.64e-01 | -1.36e-01 | 9.29e-01 |
| GOBP CELLULAR RESPONSE TO COLD | 10 | 4.57e-01 | 1.36e-01 | 8.94e-01 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING | 25 | 2.40e-01 | 1.36e-01 | 7.68e-01 |
| GOBP MECHANOSENSORY BEHAVIOR | 6 | 5.64e-01 | 1.36e-01 | 9.29e-01 |
| GOBP NEGATIVE REGULATION OF BONE REMODELING | 9 | 4.80e-01 | -1.36e-01 | 9.08e-01 |
| GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY | 15 | 3.63e-01 | 1.36e-01 | 8.49e-01 |
| GOBP LYSOSOMAL MEMBRANE ORGANIZATION | 14 | 3.79e-01 | 1.36e-01 | 8.62e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 57 | 7.65e-02 | 1.36e-01 | 5.30e-01 |
| GOBP T HELPER 17 TYPE IMMUNE RESPONSE | 31 | 1.91e-01 | 1.36e-01 | 7.21e-01 |
| GOBP PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 5 | 5.99e-01 | -1.36e-01 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF CELL CELL ADHESION | 222 | 5.16e-04 | 1.36e-01 | 2.64e-02 |
| GOBP CARDIAC CONDUCTION | 48 | 1.04e-01 | 1.36e-01 | 5.94e-01 |
| GOCC FILOPODIUM TIP | 15 | 3.64e-01 | 1.36e-01 | 8.50e-01 |
| GOBP ZINC ION IMPORT INTO ORGANELLE | 6 | 5.65e-01 | -1.36e-01 | 9.29e-01 |
| GOBP PROTEIN INSERTION INTO MEMBRANE | 68 | 5.35e-02 | -1.35e-01 | 4.61e-01 |
| GOBP POSTSYNAPTIC SPECIALIZATION ASSEMBLY | 15 | 3.64e-01 | 1.35e-01 | 8.50e-01 |
| GOBP NON LYTIC VIRAL RELEASE | 14 | 3.80e-01 | 1.35e-01 | 8.63e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME | 7 | 5.35e-01 | -1.35e-01 | 9.23e-01 |
| GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE | 31 | 1.92e-01 | -1.35e-01 | 7.22e-01 |
| GOBP NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 9 | 4.82e-01 | 1.35e-01 | 9.08e-01 |
| GOBP NATURAL KILLER CELL DEGRANULATION | 9 | 4.82e-01 | 1.35e-01 | 9.08e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 7 | 5.35e-01 | -1.35e-01 | 9.23e-01 |
| GOBP TRANSCRIPTION DEPENDENT TETHERING OF RNA POLYMERASE II GENE DNA AT NUCLEAR PERIPHERY | 7 | 5.36e-01 | -1.35e-01 | 9.23e-01 |
| GOBP PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE | 8 | 5.08e-01 | 1.35e-01 | 9.18e-01 |
| GOBP BONE DEVELOPMENT | 126 | 8.93e-03 | -1.35e-01 | 1.87e-01 |
| GOBP CELL CELL ADHESION INVOLVED IN GASTRULATION | 10 | 4.60e-01 | -1.35e-01 | 8.96e-01 |
| GOBP MRNA EXPORT FROM NUCLEUS | 64 | 6.23e-02 | 1.35e-01 | 4.87e-01 |
| GOBP G2 MI TRANSITION OF MEIOTIC CELL CYCLE | 6 | 5.67e-01 | 1.35e-01 | 9.30e-01 |
| GOBP NEUROTRANSMITTER REUPTAKE | 14 | 3.83e-01 | -1.35e-01 | 8.64e-01 |
| GOBP RESPONSE TO PAIN | 18 | 3.23e-01 | 1.35e-01 | 8.29e-01 |
| GOBP ANTERIOR POSTERIOR AXIS SPECIFICATION | 25 | 2.44e-01 | -1.35e-01 | 7.73e-01 |
| GOBP IMMUNE RESPONSE TO TUMOR CELL | 17 | 3.37e-01 | 1.35e-01 | 8.36e-01 |
| GOBP CYCLIC NUCLEOTIDE MEDIATED SIGNALING | 40 | 1.41e-01 | -1.35e-01 | 6.63e-01 |
| GOBP POSITIVE REGULATION OF SYNAPSE MATURATION | 6 | 5.68e-01 | 1.35e-01 | 9.31e-01 |
| GOCC FEMALE GERM CELL NUCLEUS | 9 | 4.85e-01 | 1.35e-01 | 9.10e-01 |
| GOBP POSTSYNAPTIC DENSITY ASSEMBLY | 11 | 4.40e-01 | 1.35e-01 | 8.85e-01 |
| GOBP MOTOR NEURON AXON GUIDANCE | 14 | 3.84e-01 | -1.34e-01 | 8.64e-01 |
| GOMF NAD RETINOL DEHYDROGENASE ACTIVITY | 8 | 5.10e-01 | 1.34e-01 | 9.18e-01 |
| GOBP NEGATIVE REGULATION OF CELL SIZE | 9 | 4.85e-01 | -1.34e-01 | 9.10e-01 |
| GOBP LEUCINE CATABOLIC PROCESS | 5 | 6.03e-01 | 1.34e-01 | 9.36e-01 |
| GOBP MULTICELLULAR ORGANISM GROWTH | 106 | 1.71e-02 | -1.34e-01 | 2.74e-01 |
| GOBP INTERLEUKIN 1 ALPHA PRODUCTION | 5 | 6.04e-01 | -1.34e-01 | 9.36e-01 |
| GOBP MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 16 | 3.54e-01 | -1.34e-01 | 8.46e-01 |
| GOBP CRANIAL NERVE FORMATION | 5 | 6.04e-01 | -1.34e-01 | 9.36e-01 |
| GOMF PROTEIN ARGININE N METHYLTRANSFERASE ACTIVITY | 11 | 4.42e-01 | 1.34e-01 | 8.86e-01 |
| GOCC LAMELLAR BODY | 5 | 6.04e-01 | -1.34e-01 | 9.36e-01 |
| GOMF VOLUME SENSITIVE ANION CHANNEL ACTIVITY | 7 | 5.40e-01 | -1.34e-01 | 9.23e-01 |
| GOMF SOLUTE MONOATOMIC CATION SYMPORTER ACTIVITY | 61 | 7.08e-02 | -1.34e-01 | 5.17e-01 |
| GOMF L ARGININE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 5.12e-01 | -1.34e-01 | 9.18e-01 |
| GOBP AMINE CATABOLIC PROCESS | 12 | 4.23e-01 | 1.34e-01 | 8.81e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL MATURATION | 8 | 5.13e-01 | 1.34e-01 | 9.18e-01 |
| GOCC MITOTIC SPINDLE MIDZONE | 11 | 4.43e-01 | 1.34e-01 | 8.87e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 56 | 8.38e-02 | 1.34e-01 | 5.45e-01 |
| GOMF PHOSPHOLIPASE INHIBITOR ACTIVITY | 8 | 5.13e-01 | 1.34e-01 | 9.18e-01 |
| GOCC TRAPPIII PROTEIN COMPLEX | 12 | 4.23e-01 | -1.34e-01 | 8.81e-01 |
| GOBP REGULATION OF RECEPTOR CLUSTERING | 9 | 4.88e-01 | 1.34e-01 | 9.11e-01 |
| GOCC G PROTEIN COUPLED RECEPTOR COMPLEX | 5 | 6.05e-01 | 1.33e-01 | 9.36e-01 |
| GOBP RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY | 53 | 9.31e-02 | 1.33e-01 | 5.67e-01 |
| GOBP NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS | 38 | 1.55e-01 | -1.33e-01 | 6.77e-01 |
| GOCC RISC LOADING COMPLEX | 8 | 5.14e-01 | -1.33e-01 | 9.18e-01 |
| GOBP FEMALE MEIOSIS I | 10 | 4.65e-01 | 1.33e-01 | 9.00e-01 |
| GOCC MITOCHONDRIAL TRICARBOXYLIC ACID CYCLE ENZYME COMPLEX | 11 | 4.44e-01 | -1.33e-01 | 8.87e-01 |
| GOBP ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE | 9 | 4.89e-01 | 1.33e-01 | 9.12e-01 |
| GOBP DUMP CATABOLIC PROCESS | 5 | 6.06e-01 | 1.33e-01 | 9.36e-01 |
| GOBP TYPE II INTERFERON PRODUCTION | 71 | 5.25e-02 | 1.33e-01 | 4.59e-01 |
| GOBP IMMUNE RESPONSE REGULATING SIGNALING PATHWAY | 353 | 1.85e-05 | 1.33e-01 | 1.92e-03 |
| GOBP TETRAHYDROFOLATE BIOSYNTHETIC PROCESS | 5 | 6.06e-01 | 1.33e-01 | 9.36e-01 |
| GOMF C METHYLTRANSFERASE ACTIVITY | 7 | 5.42e-01 | 1.33e-01 | 9.23e-01 |
| GOMF CARD DOMAIN BINDING | 12 | 4.25e-01 | 1.33e-01 | 8.81e-01 |
| GOMF C ACYLTRANSFERASE ACTIVITY | 14 | 3.89e-01 | -1.33e-01 | 8.65e-01 |
| GOBP REGULATION OF IMMUNE EFFECTOR PROCESS | 253 | 2.84e-04 | 1.33e-01 | 1.70e-02 |
| GOBP MAINTENANCE OF SYNAPSE STRUCTURE | 17 | 3.43e-01 | -1.33e-01 | 8.41e-01 |
| GOMF LIPASE INHIBITOR ACTIVITY | 10 | 4.67e-01 | 1.33e-01 | 9.00e-01 |
| GOMF PRE MIRNA BINDING | 8 | 5.15e-01 | 1.33e-01 | 9.19e-01 |
| GOBP CENTRAL NERVOUS SYSTEM MYELIN FORMATION | 5 | 6.07e-01 | -1.33e-01 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF NEUROBLAST PROLIFERATION | 15 | 3.74e-01 | 1.33e-01 | 8.60e-01 |
| GOBP DEFENSE RESPONSE TO OTHER ORGANISM | 772 | 4.99e-10 | 1.33e-01 | 1.89e-07 |
| GOBP REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 41 | 1.42e-01 | -1.33e-01 | 6.65e-01 |
| GOBP MEMBRANE RAFT ASSEMBLY | 9 | 4.91e-01 | -1.32e-01 | 9.13e-01 |
| GOBP REGULATION OF ENDOCRINE PROCESS | 15 | 3.75e-01 | -1.32e-01 | 8.60e-01 |
| GOBP SUBSTRATE DEPENDENT CELL MIGRATION | 18 | 3.31e-01 | 1.32e-01 | 8.31e-01 |
| GOBP ASTROCYTE ACTIVATION | 16 | 3.59e-01 | 1.32e-01 | 8.46e-01 |
| GOMF DNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS | 8 | 5.17e-01 | -1.32e-01 | 9.19e-01 |
| GOBP METHIONINE METABOLIC PROCESS | 12 | 4.27e-01 | -1.32e-01 | 8.82e-01 |
| GOCC CORVET COMPLEX | 7 | 5.44e-01 | -1.32e-01 | 9.23e-01 |
| GOBP REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 33 | 1.89e-01 | 1.32e-01 | 7.18e-01 |
| GOCC PROTEASOME CORE COMPLEX BETA SUBUNIT COMPLEX | 10 | 4.69e-01 | 1.32e-01 | 9.00e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL MIGRATION | 5 | 6.09e-01 | 1.32e-01 | 9.36e-01 |
| GOBP NCRNA CATABOLIC PROCESS | 49 | 1.09e-01 | 1.32e-01 | 6.00e-01 |
| GOBP POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 17 | 3.45e-01 | -1.32e-01 | 8.42e-01 |
| GOMF GLUCOSIDASE ACTIVITY | 6 | 5.75e-01 | 1.32e-01 | 9.33e-01 |
| GOBP WATER SOLUBLE VITAMIN BIOSYNTHETIC PROCESS | 9 | 4.92e-01 | -1.32e-01 | 9.13e-01 |
| GOCC SPECTRIN | 6 | 5.75e-01 | 1.32e-01 | 9.33e-01 |
| GOBP ORGANELLE FUSION | 131 | 9.14e-03 | 1.32e-01 | 1.88e-01 |
| GOBP CELLULAR EXTRAVASATION | 45 | 1.26e-01 | 1.32e-01 | 6.31e-01 |
| GOBP RESPONSE TO GLYCOPROTEIN | 8 | 5.19e-01 | 1.32e-01 | 9.19e-01 |
| GOBP NEGATIVE REGULATION OF VASOCONSTRICTION | 6 | 5.77e-01 | -1.32e-01 | 9.33e-01 |
| GOBP NAIL DEVELOPMENT | 5 | 6.10e-01 | 1.32e-01 | 9.36e-01 |
| GOBP TROPHOBLAST CELL MIGRATION | 11 | 4.50e-01 | -1.32e-01 | 8.89e-01 |
| GOMF HISTONE H3K4 MONOMETHYLTRANSFERASE ACTIVITY | 8 | 5.19e-01 | -1.32e-01 | 9.19e-01 |
| GOBP G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY | 5 | 6.11e-01 | -1.32e-01 | 9.36e-01 |
| GOBP REGULATION OF OXIDATIVE PHOSPHORYLATION | 20 | 3.09e-01 | -1.31e-01 | 8.20e-01 |
| GOBP MEDIUM CHAIN FATTY ACYL COA METABOLIC PROCESS | 5 | 6.11e-01 | -1.31e-01 | 9.36e-01 |
| GOBP PROTEIN NITROSYLATION | 12 | 4.31e-01 | 1.31e-01 | 8.82e-01 |
| GOBP OLIGOSACCHARIDE BIOSYNTHETIC PROCESS | 13 | 4.12e-01 | 1.31e-01 | 8.77e-01 |
| GOCC TRICARBOXYLIC ACID CYCLE ENZYME COMPLEX | 15 | 3.79e-01 | -1.31e-01 | 8.61e-01 |
| GOBP LINOLEIC ACID METABOLIC PROCESS | 10 | 4.72e-01 | -1.31e-01 | 9.02e-01 |
| GOMF SMALL MOLECULE SENSOR ACTIVITY | 31 | 2.06e-01 | -1.31e-01 | 7.35e-01 |
| GOBP AMINO SUGAR CATABOLIC PROCESS | 13 | 4.14e-01 | -1.31e-01 | 8.77e-01 |
| GOBP PROTEIN NEDDYLATION | 27 | 2.39e-01 | -1.31e-01 | 7.68e-01 |
| GOBP XMP METABOLIC PROCESS | 7 | 5.49e-01 | 1.31e-01 | 9.25e-01 |
| GOBP T CELL DIFFERENTIATION | 219 | 8.67e-04 | 1.31e-01 | 3.92e-02 |
| GOBP FATTY ACYL COA BIOSYNTHETIC PROCESS | 20 | 3.11e-01 | 1.31e-01 | 8.21e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION | 47 | 1.21e-01 | -1.31e-01 | 6.22e-01 |
| GOBP SKIN DEVELOPMENT | 144 | 6.80e-03 | 1.31e-01 | 1.59e-01 |
| GOBP PROTEIN N LINKED GLYCOSYLATION | 59 | 8.23e-02 | -1.31e-01 | 5.43e-01 |
| GOBP POSITIVE REGULATION OF CIRCADIAN RHYTHM | 8 | 5.22e-01 | -1.31e-01 | 9.20e-01 |
| GOBP REGULATION OF EXCITATORY SYNAPSE ASSEMBLY | 7 | 5.49e-01 | 1.31e-01 | 9.26e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE TISSUE MORPHOGENESIS | 22 | 2.89e-01 | 1.31e-01 | 8.06e-01 |
| GOBP MITOCHONDRIAL TRANSLATION | 128 | 1.08e-02 | -1.31e-01 | 2.09e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL CHEMOTAXIS | 5 | 6.13e-01 | 1.31e-01 | 9.36e-01 |
| GOBP UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 5 | 6.13e-01 | -1.31e-01 | 9.36e-01 |
| GOBP REGULATION OF GERMINAL CENTER FORMATION | 7 | 5.50e-01 | 1.31e-01 | 9.26e-01 |
| GOBP RESPONSE TO ISCHEMIA | 45 | 1.30e-01 | -1.31e-01 | 6.40e-01 |
| GOMF PHOSPHATIDYLINOSITOL KINASE ACTIVITY | 23 | 2.79e-01 | 1.31e-01 | 7.99e-01 |
| GOBP BILE ACID BIOSYNTHETIC PROCESS | 22 | 2.90e-01 | 1.30e-01 | 8.06e-01 |
| GOBP CARTILAGE DEVELOPMENT | 102 | 2.30e-02 | -1.30e-01 | 3.12e-01 |
| GOBP NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS | 8 | 5.23e-01 | -1.30e-01 | 9.20e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION | 26 | 2.50e-01 | 1.30e-01 | 7.77e-01 |
| GOBP NECROPTOTIC PROCESS | 35 | 1.82e-01 | 1.30e-01 | 7.13e-01 |
| GOBP POLYOL METABOLIC PROCESS | 74 | 5.27e-02 | 1.30e-01 | 4.59e-01 |
| GOBP MEIOTIC CHROMOSOME SEGREGATION | 60 | 8.12e-02 | 1.30e-01 | 5.41e-01 |
| GOBP CELL SURFACE PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 52 | 1.04e-01 | 1.30e-01 | 5.94e-01 |
| GOBP PROTEIN LOCALIZATION TO ADHERENS JUNCTION | 6 | 5.81e-01 | 1.30e-01 | 9.35e-01 |
| GOMF HISTONE DEUBIQUITINASE ACTIVITY | 6 | 5.81e-01 | 1.30e-01 | 9.35e-01 |
| GOBP REGULATION OF T HELPER 17 CELL DIFFERENTIATION | 13 | 4.17e-01 | 1.30e-01 | 8.79e-01 |
| GOCC DENSE CORE GRANULE | 12 | 4.36e-01 | -1.30e-01 | 8.84e-01 |
| GOMF MONOCARBOXYLATE SODIUM SYMPORTER ACTIVITY | 6 | 5.82e-01 | -1.30e-01 | 9.36e-01 |
| GOBP RIBOSOME DISASSEMBLY | 13 | 4.18e-01 | 1.30e-01 | 8.79e-01 |
| GOBP NEGATIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 8 | 5.26e-01 | 1.30e-01 | 9.21e-01 |
| GOBP MALATE METABOLIC PROCESS | 7 | 5.53e-01 | -1.29e-01 | 9.26e-01 |
| GOBP GLUTAMATERGIC NEURON DIFFERENTIATION | 7 | 5.53e-01 | 1.29e-01 | 9.26e-01 |
| GOBP REGULATION OF GLUCOSE IMPORT | 38 | 1.68e-01 | -1.29e-01 | 6.96e-01 |
| GOBP POSITIVE REGULATION OF PSEUDOPODIUM ASSEMBLY | 7 | 5.53e-01 | 1.29e-01 | 9.26e-01 |
| GOMF SODIUM CHANNEL REGULATOR ACTIVITY | 25 | 2.63e-01 | 1.29e-01 | 7.88e-01 |
| GOBP MITOTIC CYTOKINESIS | 81 | 4.44e-02 | 1.29e-01 | 4.28e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 3 KINASE ACTIVITY | 6 | 5.84e-01 | 1.29e-01 | 9.36e-01 |
| GOBP REGULATION OF ACTIN FILAMENT LENGTH | 110 | 1.94e-02 | -1.29e-01 | 2.91e-01 |
| GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 15 | 3.86e-01 | 1.29e-01 | 8.65e-01 |
| GOBP IRON ION TRANSPORT | 39 | 1.63e-01 | -1.29e-01 | 6.88e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 23 | 2.84e-01 | -1.29e-01 | 8.02e-01 |
| GOBP WHITE FAT CELL DIFFERENTIATION | 13 | 4.20e-01 | -1.29e-01 | 8.81e-01 |
| GOBP REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY | 15 | 3.87e-01 | 1.29e-01 | 8.65e-01 |
| GOBP LIPID HOMEOSTASIS | 107 | 2.12e-02 | -1.29e-01 | 3.04e-01 |
| GOBP NEGATIVE REGULATION OF MAST CELL ACTIVATION | 8 | 5.27e-01 | 1.29e-01 | 9.22e-01 |
| GOBP RIBOSOMAL SMALL SUBUNIT EXPORT FROM NUCLEUS | 8 | 5.27e-01 | 1.29e-01 | 9.22e-01 |
| GOBP HEAT ACCLIMATION | 6 | 5.84e-01 | 1.29e-01 | 9.36e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR RECEPTOR BINDING | 11 | 4.59e-01 | -1.29e-01 | 8.96e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 27 | 2.47e-01 | -1.29e-01 | 7.76e-01 |
| GOBP PERICARDIUM DEVELOPMENT | 9 | 5.03e-01 | 1.29e-01 | 9.15e-01 |
| GOBP MYELOID PROGENITOR CELL DIFFERENTIATION | 5 | 6.18e-01 | 1.29e-01 | 9.37e-01 |
| GOMF ATPASE COUPLED INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY | 22 | 2.96e-01 | 1.29e-01 | 8.10e-01 |
| GOBP LONG TERM SYNAPTIC DEPRESSION | 15 | 3.88e-01 | 1.29e-01 | 8.65e-01 |
| GOCC CELL SUBSTRATE JUNCTION | 364 | 2.60e-05 | -1.29e-01 | 2.56e-03 |
| GOBP REGULATION OF MONOATOMIC ANION TRANSPORT | 9 | 5.04e-01 | -1.29e-01 | 9.15e-01 |
| GOCC CYTOSOLIC REGION | 18 | 3.44e-01 | -1.29e-01 | 8.41e-01 |
| GOBP REGULATION OF NEURON MATURATION | 6 | 5.85e-01 | 1.29e-01 | 9.36e-01 |
| GOBP EMBRYONIC VISCEROCRANIUM MORPHOGENESIS | 7 | 5.56e-01 | -1.29e-01 | 9.26e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE ACTIVATION | 12 | 4.40e-01 | 1.29e-01 | 8.85e-01 |
| GOBP RECEPTOR GUANYLYL CYCLASE SIGNALING PATHWAY | 6 | 5.85e-01 | 1.29e-01 | 9.36e-01 |
| GOBP GLUCAN METABOLIC PROCESS | 57 | 9.33e-02 | -1.29e-01 | 5.67e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS | 5 | 6.19e-01 | -1.29e-01 | 9.37e-01 |
| GOBP MONOATOMIC ANION HOMEOSTASIS | 12 | 4.41e-01 | 1.29e-01 | 8.85e-01 |
| GOMF ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 306 | 1.16e-04 | -1.28e-01 | 8.55e-03 |
| GOBP FATTY ACID TRANSMEMBRANE TRANSPORT | 17 | 3.59e-01 | -1.28e-01 | 8.46e-01 |
| GOMF DNA DAMAGE SENSOR ACTIVITY | 18 | 3.46e-01 | -1.28e-01 | 8.42e-01 |
| GOBP AMIDE METABOLIC PROCESS | 940 | 3.90e-11 | -1.28e-01 | 2.42e-08 |
| GOBP MEGAKARYOCYTE DIFFERENTIATION | 36 | 1.83e-01 | -1.28e-01 | 7.13e-01 |
| GOBP CHEMOKINE C X C MOTIF LIGAND 12 SIGNALING PATHWAY | 5 | 6.19e-01 | 1.28e-01 | 9.37e-01 |
| GOBP CONVERGENT EXTENSION INVOLVED IN GASTRULATION | 6 | 5.87e-01 | -1.28e-01 | 9.36e-01 |
| GOBP MYOTUBE DIFFERENTIATION | 75 | 5.52e-02 | 1.28e-01 | 4.64e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 9 | 5.06e-01 | -1.28e-01 | 9.16e-01 |
| GOBP KERATINOCYTE DEVELOPMENT | 5 | 6.20e-01 | -1.28e-01 | 9.37e-01 |
| GOMF METAL CATION MONOATOMIC CATION ANTIPORTER ACTIVITY | 23 | 2.88e-01 | -1.28e-01 | 8.05e-01 |
| GOMF ASPARTIC TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 5 | 6.20e-01 | -1.28e-01 | 9.37e-01 |
| GOBP REGULATION OF INTRACELLULAR LIPID TRANSPORT | 6 | 5.87e-01 | -1.28e-01 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS | 26 | 2.59e-01 | 1.28e-01 | 7.85e-01 |
| GOCC TRIGLYCERIDE RICH PLASMA LIPOPROTEIN PARTICLE | 13 | 4.25e-01 | 1.28e-01 | 8.81e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 36 | 1.85e-01 | -1.28e-01 | 7.16e-01 |
| GOBP VIRAL RNA GENOME REPLICATION | 26 | 2.60e-01 | 1.28e-01 | 7.85e-01 |
| GOBP CORTICOSTEROID RECEPTOR SIGNALING PATHWAY | 12 | 4.44e-01 | 1.28e-01 | 8.87e-01 |
| GOBP INTRACELLULAR STEROL TRANSPORT | 27 | 2.51e-01 | 1.28e-01 | 7.78e-01 |
| GOMF P TYPE CALCIUM TRANSPORTER ACTIVITY | 8 | 5.32e-01 | 1.28e-01 | 9.23e-01 |
| GOCC HEMIDESMOSOME | 6 | 5.88e-01 | 1.28e-01 | 9.36e-01 |
| GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY | 11 | 4.64e-01 | 1.28e-01 | 9.00e-01 |
| GOBP ACROSOME REACTION | 14 | 4.09e-01 | -1.27e-01 | 8.76e-01 |
| GOBP NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY | 19 | 3.36e-01 | -1.27e-01 | 8.36e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 31 | 2.20e-01 | 1.27e-01 | 7.49e-01 |
| GOMF CELL CELL ADHESION MEDIATOR ACTIVITY | 26 | 2.61e-01 | -1.27e-01 | 7.87e-01 |
| GOBP CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE | 18 | 3.50e-01 | -1.27e-01 | 8.46e-01 |
| GOMF INTRACELLULAR CHLORIDE CHANNEL ACTIVITY | 9 | 5.09e-01 | -1.27e-01 | 9.18e-01 |
| GOCC INNER KINETOCHORE | 17 | 3.64e-01 | -1.27e-01 | 8.50e-01 |
| GOBP NEGATIVE REGULATION OF LIPID STORAGE | 18 | 3.51e-01 | -1.27e-01 | 8.46e-01 |
| GOBP REGULATION OF GLUCOCORTICOID SECRETION | 7 | 5.60e-01 | -1.27e-01 | 9.28e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 20 | 3.25e-01 | 1.27e-01 | 8.29e-01 |
| GOBP CELL VOLUME HOMEOSTASIS | 26 | 2.62e-01 | 1.27e-01 | 7.87e-01 |
| GOCC A BAND | 21 | 3.14e-01 | 1.27e-01 | 8.22e-01 |
| GOBP CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT | 8 | 5.35e-01 | -1.27e-01 | 9.23e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H | 75 | 5.78e-02 | -1.27e-01 | 4.70e-01 |
| GOBP PEPTIDYL PROLINE MODIFICATION | 30 | 2.30e-01 | -1.27e-01 | 7.58e-01 |
| GOCC ESC E Z COMPLEX | 10 | 4.88e-01 | -1.27e-01 | 9.11e-01 |
| GOCC CAMP DEPENDENT PROTEIN KINASE COMPLEX | 6 | 5.91e-01 | -1.27e-01 | 9.36e-01 |
| GOBP MYOBLAST FATE COMMITMENT | 5 | 6.24e-01 | 1.27e-01 | 9.40e-01 |
| GOCC SUMO LIGASE COMPLEX | 13 | 4.29e-01 | 1.27e-01 | 8.82e-01 |
| GOCC PERICENTRIOLAR MATERIAL | 20 | 3.27e-01 | 1.27e-01 | 8.29e-01 |
| GOBP REGULATION OF FATTY ACID OXIDATION | 23 | 2.93e-01 | 1.27e-01 | 8.08e-01 |
| GOBP REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 32 | 2.15e-01 | 1.27e-01 | 7.46e-01 |
| GOBP ORGANIC ACID TRANSMEMBRANE TRANSPORT | 100 | 2.89e-02 | -1.27e-01 | 3.47e-01 |
| GOBP GENERATION OF PRECURSOR METABOLITES AND ENERGY | 407 | 1.28e-05 | -1.27e-01 | 1.44e-03 |
| GOBP POSITIVE REGULATION OF LYMPHOCYTE MIGRATION | 32 | 2.15e-01 | -1.27e-01 | 7.47e-01 |
| GOMF E BOX BINDING | 26 | 2.64e-01 | 1.27e-01 | 7.88e-01 |
| GOBP POLYOL TRANSMEMBRANE TRANSPORT | 6 | 5.91e-01 | 1.27e-01 | 9.36e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 52 | 1.15e-01 | -1.27e-01 | 6.12e-01 |
| GOBP ORGANELLE MEMBRANE FUSION | 98 | 3.06e-02 | 1.27e-01 | 3.53e-01 |
| GOBP REGULATION OF CHRONIC INFLAMMATORY RESPONSE | 6 | 5.92e-01 | -1.26e-01 | 9.36e-01 |
| GOBP HAIR CELL DIFFERENTIATION | 30 | 2.31e-01 | 1.26e-01 | 7.58e-01 |
| GOMF PEPTIDASE ACTIVATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 20 | 3.28e-01 | -1.26e-01 | 8.29e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING NITROGENOUS GROUPS | 18 | 3.53e-01 | -1.26e-01 | 8.46e-01 |
| GOMF NUCLEAR RETINOID X RECEPTOR BINDING | 14 | 4.13e-01 | 1.26e-01 | 8.77e-01 |
| GOBP REGULATION OF MITOCHONDRIAL TRANSLATION | 25 | 2.74e-01 | -1.26e-01 | 7.96e-01 |
| GOMF SOLUTE INORGANIC ANION ANTIPORTER ACTIVITY | 17 | 3.67e-01 | -1.26e-01 | 8.54e-01 |
| GOBP AMINOACYL TRNA METABOLISM INVOLVED IN TRANSLATIONAL FIDELITY | 8 | 5.36e-01 | 1.26e-01 | 9.23e-01 |
| GOMF AMINOACYL TRNA EDITING ACTIVITY | 8 | 5.36e-01 | 1.26e-01 | 9.23e-01 |
| GOBP CHONDROITIN SULFATE METABOLIC PROCESS | 21 | 3.18e-01 | -1.26e-01 | 8.23e-01 |
| GOMF DEAD H BOX RNA HELICASE BINDING | 7 | 5.64e-01 | 1.26e-01 | 9.29e-01 |
| GOMF ORGANIC ACID SODIUM SYMPORTER ACTIVITY | 15 | 3.98e-01 | -1.26e-01 | 8.71e-01 |
| GOBP MICROTUBULE SEVERING | 7 | 5.64e-01 | -1.26e-01 | 9.29e-01 |
| GOBP NEURON CELLULAR HOMEOSTASIS | 41 | 1.63e-01 | -1.26e-01 | 6.88e-01 |
| GOBP STEM CELL DIVISION | 20 | 3.30e-01 | -1.26e-01 | 8.30e-01 |
| GOBP PEPTIDYL SERINE MODIFICATION | 221 | 1.30e-03 | 1.26e-01 | 5.22e-02 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY | 18 | 3.56e-01 | -1.26e-01 | 8.46e-01 |
| GOBP ACTIVIN RECEPTOR SIGNALING PATHWAY | 26 | 2.67e-01 | 1.26e-01 | 7.91e-01 |
| GOBP LIVER MORPHOGENESIS | 16 | 3.84e-01 | 1.26e-01 | 8.64e-01 |
| GOBP CAMP MEDIATED SIGNALING | 27 | 2.58e-01 | -1.26e-01 | 7.85e-01 |
| GOBP INOSITOL PHOSPHATE METABOLIC PROCESS | 28 | 2.50e-01 | 1.26e-01 | 7.77e-01 |
| GOBP SMOOTHENED SIGNALING PATHWAY | 98 | 3.17e-02 | -1.26e-01 | 3.61e-01 |
| GOBP REGULATION OF FIBROBLAST PROLIFERATION | 64 | 8.23e-02 | -1.26e-01 | 5.43e-01 |
| GOMF LIGASE ACTIVITY FORMING PHOSPHORIC ESTER BONDS | 6 | 5.94e-01 | -1.26e-01 | 9.36e-01 |
| GOBP SPINDLE ASSEMBLY | 122 | 1.67e-02 | 1.26e-01 | 2.72e-01 |
| GOBP REGULATION OF MONOCYTE DIFFERENTIATION | 17 | 3.70e-01 | -1.26e-01 | 8.55e-01 |
| GOCC CHROMATOID BODY | 6 | 5.94e-01 | 1.26e-01 | 9.36e-01 |
| GOMF ADENOSINE 3 5 BISPHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 6.27e-01 | -1.26e-01 | 9.40e-01 |
| GOBP REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 85 | 4.57e-02 | 1.25e-01 | 4.33e-01 |
| GOBP STRIATED MUSCLE CELL PROLIFERATION | 39 | 1.75e-01 | 1.25e-01 | 7.06e-01 |
| GOMF INOSITOL BISPHOSPHATE PHOSPHATASE ACTIVITY | 5 | 6.27e-01 | 1.25e-01 | 9.40e-01 |
| GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGG ISOTYPES | 7 | 5.66e-01 | 1.25e-01 | 9.29e-01 |
| GOBP MODIFICATION OF SYNAPTIC STRUCTURE | 18 | 3.57e-01 | -1.25e-01 | 8.46e-01 |
| GOMF HISTONE KINASE ACTIVITY | 18 | 3.57e-01 | 1.25e-01 | 8.46e-01 |
| GOBP TYPE 2 IMMUNE RESPONSE | 26 | 2.69e-01 | 1.25e-01 | 7.93e-01 |
| GOBP REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 82 | 5.01e-02 | 1.25e-01 | 4.48e-01 |
| GOBP ASSOCIATIVE LEARNING | 49 | 1.30e-01 | -1.25e-01 | 6.40e-01 |
| GOBP POSITIVE REGULATION OF NEURON DIFFERENTIATION | 40 | 1.71e-01 | -1.25e-01 | 6.99e-01 |
| GOBP NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION | 7 | 5.66e-01 | -1.25e-01 | 9.29e-01 |
| GOBP IMMUNOGLOBULIN PRODUCTION | 84 | 4.76e-02 | 1.25e-01 | 4.43e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 6 | 5.96e-01 | 1.25e-01 | 9.36e-01 |
| GOBP HOMOLOGOUS CHROMOSOME SEGREGATION | 37 | 1.89e-01 | 1.25e-01 | 7.18e-01 |
| GOBP GLUCOCORTICOID BIOSYNTHETIC PROCESS | 5 | 6.29e-01 | 1.25e-01 | 9.40e-01 |
| GOBP REGULATION OF GLUCOCORTICOID BIOSYNTHETIC PROCESS | 5 | 6.29e-01 | 1.25e-01 | 9.40e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME CONDENSATION | 8 | 5.41e-01 | 1.25e-01 | 9.23e-01 |
| GOCC CONDENSIN COMPLEX | 8 | 5.41e-01 | 1.25e-01 | 9.23e-01 |
| GOCC DNA REPAIR COMPLEX | 22 | 3.11e-01 | 1.25e-01 | 8.21e-01 |
| GOMF STEROID HYDROXYLASE ACTIVITY | 7 | 5.68e-01 | -1.25e-01 | 9.30e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE RESPONSE | 144 | 9.85e-03 | 1.25e-01 | 1.96e-01 |
| GOCC CYTOPLASMIC DYNEIN COMPLEX | 16 | 3.88e-01 | 1.25e-01 | 8.65e-01 |
| GOBP RESPONSE TO OXYGEN RADICAL | 18 | 3.60e-01 | -1.25e-01 | 8.46e-01 |
| GOBP ACTIVATED T CELL PROLIFERATION | 30 | 2.38e-01 | 1.25e-01 | 7.67e-01 |
| GOMF TUMOR NECROSIS FACTOR BINDING | 7 | 5.68e-01 | -1.25e-01 | 9.31e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS | 22 | 3.12e-01 | 1.25e-01 | 8.21e-01 |
| GOMF RNA POLYMERASE II C TERMINAL DOMAIN BINDING | 10 | 4.95e-01 | 1.25e-01 | 9.13e-01 |
| GOBP AMINO SUGAR BIOSYNTHETIC PROCESS | 10 | 4.95e-01 | -1.25e-01 | 9.13e-01 |
| GOBP NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 10 | 4.95e-01 | -1.25e-01 | 9.13e-01 |
| GOMF MECHANOSENSITIVE MONOATOMIC ION CHANNEL ACTIVITY | 8 | 5.42e-01 | -1.25e-01 | 9.23e-01 |
| GOBP NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE | 9 | 5.18e-01 | -1.25e-01 | 9.19e-01 |
| GOBP COCHLEA MORPHOGENESIS | 5 | 6.30e-01 | -1.24e-01 | 9.40e-01 |
| GOBP NUCLEAR PORE LOCALIZATION | 5 | 6.30e-01 | -1.24e-01 | 9.40e-01 |
| GOBP P BODY ASSEMBLY | 21 | 3.24e-01 | 1.24e-01 | 8.29e-01 |
| GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 8 | 5.43e-01 | 1.24e-01 | 9.23e-01 |
| GOBP REGULATION OF LYSOSOME ORGANIZATION | 10 | 4.96e-01 | 1.24e-01 | 9.13e-01 |
| GOCC ACROSOMAL MEMBRANE | 12 | 4.56e-01 | 1.24e-01 | 8.94e-01 |
| GOCC FICOLIN 1 RICH GRANULE | 168 | 5.53e-03 | -1.24e-01 | 1.38e-01 |
| GOMF LONG CHAIN FATTY ACID COA LIGASE ACTIVITY | 10 | 4.96e-01 | 1.24e-01 | 9.13e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN MITOCHONDRION | 5 | 6.30e-01 | 1.24e-01 | 9.40e-01 |
| GOBP DEMETHYLATION | 39 | 1.80e-01 | 1.24e-01 | 7.10e-01 |
| GOBP GTP METABOLIC PROCESS | 22 | 3.13e-01 | -1.24e-01 | 8.22e-01 |
| GOBP CENTROMERIC SISTER CHROMATID COHESION | 10 | 4.97e-01 | -1.24e-01 | 9.13e-01 |
| GOBP STEROL BIOSYNTHETIC PROCESS | 51 | 1.26e-01 | -1.24e-01 | 6.30e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL | 21 | 3.25e-01 | 1.24e-01 | 8.29e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 8 | 5.44e-01 | 1.24e-01 | 9.23e-01 |
| GOCC VESICLE TETHERING COMPLEX | 52 | 1.22e-01 | 1.24e-01 | 6.25e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION | 32 | 2.25e-01 | -1.24e-01 | 7.55e-01 |
| GOBP REGULATION OF MUSCLE ADAPTATION | 51 | 1.26e-01 | 1.24e-01 | 6.31e-01 |
| GOBP CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION | 13 | 4.39e-01 | 1.24e-01 | 8.85e-01 |
| GOBP MIRNA METABOLIC PROCESS | 77 | 6.04e-02 | 1.24e-01 | 4.81e-01 |
| GOBP NATURAL KILLER CELL MEDIATED IMMUNITY | 46 | 1.46e-01 | 1.24e-01 | 6.69e-01 |
| GOCC AXONEMAL MICROTUBULE | 19 | 3.50e-01 | -1.24e-01 | 8.46e-01 |
| GOBP REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 57 | 1.06e-01 | 1.24e-01 | 5.96e-01 |
| GOBP NLS BEARING PROTEIN IMPORT INTO NUCLEUS | 14 | 4.23e-01 | 1.24e-01 | 8.81e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 7 | 5.71e-01 | 1.24e-01 | 9.31e-01 |
| GOCC GBAF COMPLEX | 13 | 4.40e-01 | -1.24e-01 | 8.85e-01 |
| GOBP G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY | 5 | 6.33e-01 | -1.23e-01 | 9.41e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 47 | 1.43e-01 | -1.23e-01 | 6.65e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN BINDING | 49 | 1.35e-01 | -1.23e-01 | 6.52e-01 |
| GOBP ENERGY RESERVE METABOLIC PROCESS | 58 | 1.04e-01 | -1.23e-01 | 5.94e-01 |
| GOBP REGULATION OF CAVEOLIN MEDIATED ENDOCYTOSIS | 5 | 6.33e-01 | 1.23e-01 | 9.41e-01 |
| GOCC LEWY BODY | 7 | 5.72e-01 | -1.23e-01 | 9.31e-01 |
| GOCC LATERAL PART OF CELL | 5 | 6.33e-01 | 1.23e-01 | 9.41e-01 |
| GOCC BBSOME | 8 | 5.46e-01 | -1.23e-01 | 9.25e-01 |
| GOBP TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 130 | 1.54e-02 | 1.23e-01 | 2.61e-01 |
| GOBP FEMALE GAMETE GENERATION | 93 | 4.02e-02 | 1.23e-01 | 4.10e-01 |
| GOCC MITOCHONDRIAL ENVELOPE | 698 | 3.65e-08 | -1.23e-01 | 9.06e-06 |
| GOBP REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 135 | 1.36e-02 | 1.23e-01 | 2.44e-01 |
| GOMF UBIQUITIN CONJUGATING ENZYME BINDING | 25 | 2.87e-01 | 1.23e-01 | 8.05e-01 |
| GOCC NBAF COMPLEX | 14 | 4.26e-01 | 1.23e-01 | 8.81e-01 |
| GOCC PRESYNAPTIC ENDOCYTIC ZONE | 7 | 5.73e-01 | -1.23e-01 | 9.32e-01 |
| GOBP SULFUR AMINO ACID METABOLIC PROCESS | 21 | 3.29e-01 | -1.23e-01 | 8.30e-01 |
| GOBP RENAL ABSORPTION | 14 | 4.26e-01 | 1.23e-01 | 8.81e-01 |
| GOBP PHOSPHATIDIC ACID METABOLIC PROCESS | 29 | 2.52e-01 | 1.23e-01 | 7.78e-01 |
| GOBP SUBSTANTIA NIGRA DEVELOPMENT | 34 | 2.15e-01 | -1.23e-01 | 7.46e-01 |
| GOCC GTPASE COMPLEX | 26 | 2.78e-01 | -1.23e-01 | 7.99e-01 |
| GOBP MRNA SPLICE SITE RECOGNITION | 28 | 2.61e-01 | 1.23e-01 | 7.87e-01 |
| GOBP LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 29 | 2.53e-01 | -1.23e-01 | 7.78e-01 |
| GOMF CAMP DEPENDENT PROTEIN KINASE REGULATOR ACTIVITY | 11 | 4.81e-01 | -1.23e-01 | 9.08e-01 |
| GOBP POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS | 59 | 1.03e-01 | -1.23e-01 | 5.93e-01 |
| GOBP REGULATION OF CELL FATE COMMITMENT | 19 | 3.55e-01 | -1.23e-01 | 8.46e-01 |
| GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 9 | 5.24e-01 | 1.23e-01 | 9.20e-01 |
| GOBP SARCOMERE ORGANIZATION | 21 | 3.31e-01 | -1.23e-01 | 8.31e-01 |
| GOCC TRANSCRIPTION REPRESSOR COMPLEX | 62 | 9.54e-02 | 1.23e-01 | 5.73e-01 |
| GOBP POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 13 | 4.44e-01 | -1.23e-01 | 8.87e-01 |
| GOBP NEGATIVE REGULATION OF OSSIFICATION | 22 | 3.20e-01 | 1.23e-01 | 8.26e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE | 38 | 1.91e-01 | 1.23e-01 | 7.21e-01 |
| GOBP INTEGRIN ACTIVATION | 17 | 3.82e-01 | -1.22e-01 | 8.64e-01 |
| GOCC HOPS COMPLEX | 9 | 5.25e-01 | 1.22e-01 | 9.20e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING | 8 | 5.49e-01 | -1.22e-01 | 9.25e-01 |
| GOBP CELL ADHESION MEDIATED BY INTEGRIN | 60 | 1.01e-01 | -1.22e-01 | 5.87e-01 |
| GOBP INTERLEUKIN 17 PRODUCTION | 27 | 2.71e-01 | 1.22e-01 | 7.94e-01 |
| GOMF HISTONE H4K12 ACETYLTRANSFERASE ACTIVITY | 12 | 4.63e-01 | -1.22e-01 | 8.99e-01 |
| GOMF FLAVIN ADENINE DINUCLEOTIDE BINDING | 68 | 8.15e-02 | -1.22e-01 | 5.42e-01 |
| GOBP DE NOVO NAD BIOSYNTHETIC PROCESS | 5 | 6.36e-01 | -1.22e-01 | 9.41e-01 |
| GOBP REGULATION OF MONOATOMIC ANION TRANSMEMBRANE TRANSPORT | 5 | 6.36e-01 | -1.22e-01 | 9.41e-01 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 25 | 2.91e-01 | 1.22e-01 | 8.06e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR INTERNALIZATION | 18 | 3.70e-01 | 1.22e-01 | 8.55e-01 |
| GOBP REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 145 | 1.12e-02 | 1.22e-01 | 2.14e-01 |
| GOBP UDP GLUCOSE METABOLIC PROCESS | 6 | 6.05e-01 | 1.22e-01 | 9.36e-01 |
| GOBP RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION | 14 | 4.29e-01 | -1.22e-01 | 8.82e-01 |
| GOCC FLOTILLIN COMPLEX | 8 | 5.50e-01 | 1.22e-01 | 9.26e-01 |
| GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY INTERCONVERTING ALDOSES AND KETOSES | 6 | 6.05e-01 | -1.22e-01 | 9.36e-01 |
| GOBP MOTILE CILIUM ASSEMBLY | 37 | 1.99e-01 | -1.22e-01 | 7.31e-01 |
| GOBP NEUTROPHIL DEGRANULATION | 12 | 4.65e-01 | 1.22e-01 | 9.00e-01 |
| GOBP AXONEMAL DYNEIN COMPLEX ASSEMBLY | 13 | 4.47e-01 | -1.22e-01 | 8.88e-01 |
| GOBP TRABECULA MORPHOGENESIS | 30 | 2.48e-01 | -1.22e-01 | 7.76e-01 |
| GOBP XENOBIOTIC CATABOLIC PROCESS | 11 | 4.84e-01 | 1.22e-01 | 9.09e-01 |
| GOCC DNA POLYMERASE COMPLEX | 19 | 3.58e-01 | -1.22e-01 | 8.46e-01 |
| GOBP VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS | 46 | 1.53e-01 | -1.22e-01 | 6.74e-01 |
| GOBP REGULATION OF ATP BIOSYNTHETIC PROCESS | 13 | 4.47e-01 | -1.22e-01 | 8.88e-01 |
| GOMF GLUCOSYLTRANSFERASE ACTIVITY | 15 | 4.15e-01 | 1.22e-01 | 8.77e-01 |
| GOBP REGULATION OF TELOMERE CAPPING | 23 | 3.13e-01 | 1.22e-01 | 8.22e-01 |
| GOBP CIRCADIAN SLEEP WAKE CYCLE | 8 | 5.51e-01 | -1.22e-01 | 9.26e-01 |
| GOBP CENP A CONTAINING CHROMATIN ASSEMBLY | 9 | 5.28e-01 | 1.22e-01 | 9.22e-01 |
| GOBP T CELL RECEPTOR SIGNALING PATHWAY | 102 | 3.40e-02 | 1.22e-01 | 3.77e-01 |
| GOCC OUTER DYNEIN ARM | 5 | 6.38e-01 | -1.22e-01 | 9.41e-01 |
| GOBP S ADENOSYLMETHIONINE METABOLIC PROCESS | 11 | 4.85e-01 | -1.22e-01 | 9.10e-01 |
| GOBP MUSCLE CELL CELLULAR HOMEOSTASIS | 16 | 4.00e-01 | 1.21e-01 | 8.71e-01 |
| GOBP MAST CELL MEDIATED IMMUNITY | 44 | 1.64e-01 | 1.21e-01 | 6.89e-01 |
| GOCC PRP19 COMPLEX | 12 | 4.67e-01 | 1.21e-01 | 9.00e-01 |
| GOCC SPECIFIC GRANULE MEMBRANE | 75 | 6.97e-02 | 1.21e-01 | 5.14e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS | 20 | 3.48e-01 | 1.21e-01 | 8.43e-01 |
| GOBP ACTIVATION OF IMMUNE RESPONSE | 379 | 5.42e-05 | 1.21e-01 | 4.66e-03 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DEVELOPMENT | 6 | 6.07e-01 | 1.21e-01 | 9.36e-01 |
| GOBP RESOLUTION OF RECOMBINATION INTERMEDIATES | 6 | 6.07e-01 | -1.21e-01 | 9.36e-01 |
| GOBP RETINA DEVELOPMENT IN CAMERA TYPE EYE | 90 | 4.71e-02 | 1.21e-01 | 4.41e-01 |
| GOBP HISTONE H4 K16 ACETYLATION | 7 | 5.79e-01 | 1.21e-01 | 9.34e-01 |
| GOBP VASODILATION | 23 | 3.15e-01 | -1.21e-01 | 8.22e-01 |
| GOBP AMINOGLYCAN CATABOLIC PROCESS | 23 | 3.15e-01 | -1.21e-01 | 8.22e-01 |
| GOBP SPECIFICATION OF ANIMAL ORGAN IDENTITY | 13 | 4.50e-01 | -1.21e-01 | 8.89e-01 |
| GOCC BLOC COMPLEX | 14 | 4.33e-01 | 1.21e-01 | 8.82e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 64 | 9.43e-02 | 1.21e-01 | 5.70e-01 |
| GOCC PARALLEL FIBER TO PURKINJE CELL SYNAPSE | 9 | 5.30e-01 | 1.21e-01 | 9.23e-01 |
| GOBP LATE ENDOSOME TO LYSOSOME TRANSPORT | 21 | 3.38e-01 | 1.21e-01 | 8.36e-01 |
| GOBP MITOCHONDRIAL GENE EXPRESSION | 161 | 8.22e-03 | -1.21e-01 | 1.78e-01 |
| GOBP REGULATION OF EPIDERMIS DEVELOPMENT | 37 | 2.03e-01 | 1.21e-01 | 7.32e-01 |
| GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION | 8 | 5.54e-01 | -1.21e-01 | 9.26e-01 |
| GOBP EOSINOPHIL ACTIVATION | 6 | 6.08e-01 | -1.21e-01 | 9.36e-01 |
| GOBP MITOCHONDRIAL FUSION | 32 | 2.37e-01 | 1.21e-01 | 7.67e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MATURATION | 17 | 3.89e-01 | -1.21e-01 | 8.65e-01 |
| GOBP REGULATION OF MEMBRANE LIPID DISTRIBUTION | 45 | 1.62e-01 | 1.21e-01 | 6.87e-01 |
| GOCC PROTEIN PHOSPHATASE 4 COMPLEX | 5 | 6.41e-01 | -1.21e-01 | 9.42e-01 |
| GOBP ORGANIC CATION TRANSPORT | 32 | 2.38e-01 | -1.21e-01 | 7.67e-01 |
| GOBP EMBRYONIC PLACENTA MORPHOGENESIS | 17 | 3.90e-01 | -1.21e-01 | 8.66e-01 |
| GOBP POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY | 115 | 2.57e-02 | 1.21e-01 | 3.31e-01 |
| GOBP IMMUNOGLOBULIN V D J RECOMBINATION | 8 | 5.55e-01 | -1.21e-01 | 9.26e-01 |
| GOBP TETRAHYDROBIOPTERIN METABOLIC PROCESS | 7 | 5.81e-01 | 1.20e-01 | 9.35e-01 |
| GOBP POSITIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 161 | 8.49e-03 | 1.20e-01 | 1.82e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 93 | 4.51e-02 | 1.20e-01 | 4.31e-01 |
| GOBP ADP METABOLIC PROCESS | 7 | 5.82e-01 | -1.20e-01 | 9.35e-01 |
| GOBP MYOBLAST MIGRATION | 9 | 5.32e-01 | 1.20e-01 | 9.23e-01 |
| GOBP ORGANELLE TRANSPORT ALONG MICROTUBULE | 75 | 7.23e-02 | 1.20e-01 | 5.20e-01 |
| GOBP ALLANTOIN METABOLIC PROCESS | 5 | 6.42e-01 | 1.20e-01 | 9.42e-01 |
| GOBP LIGAND GATED ION CHANNEL SIGNALING PATHWAY | 18 | 3.78e-01 | 1.20e-01 | 8.61e-01 |
| GOBP INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY | 7 | 5.82e-01 | -1.20e-01 | 9.36e-01 |
| GOBP TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 15 | 4.21e-01 | 1.20e-01 | 8.81e-01 |
| GOCC CHITOSOME | 14 | 4.37e-01 | -1.20e-01 | 8.85e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID METABOLIC PROCESS | 6 | 6.11e-01 | -1.20e-01 | 9.36e-01 |
| GOMF PHOSPHATIDYL PHOSPHOLIPASE B ACTIVITY | 9 | 5.33e-01 | -1.20e-01 | 9.23e-01 |
| GOMF PRE MRNA 3 SPLICE SITE BINDING | 5 | 6.43e-01 | -1.20e-01 | 9.42e-01 |
| GOBP REGULATION OF VASCULAR WOUND HEALING | 7 | 5.83e-01 | 1.20e-01 | 9.36e-01 |
| GOBP REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 17 | 3.92e-01 | 1.20e-01 | 8.68e-01 |
| GOBP MEMBRANE FISSION | 41 | 1.85e-01 | 1.20e-01 | 7.16e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL FOLD | 10 | 5.12e-01 | 1.20e-01 | 9.18e-01 |
| GOBP TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 44 | 1.70e-01 | 1.20e-01 | 6.98e-01 |
| GOBP POST GOLGI VESICLE MEDIATED TRANSPORT | 96 | 4.29e-02 | 1.20e-01 | 4.23e-01 |
| GOBP OTOLITH DEVELOPMENT | 5 | 6.43e-01 | 1.20e-01 | 9.42e-01 |
| GOBP FOLIC ACID CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 7 | 5.84e-01 | 1.20e-01 | 9.36e-01 |
| GOBP POST EMBRYONIC ANIMAL ORGAN MORPHOGENESIS | 7 | 5.84e-01 | -1.20e-01 | 9.36e-01 |
| GOBP OLFACTORY BEHAVIOR | 5 | 6.43e-01 | -1.20e-01 | 9.42e-01 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 21 | 3.43e-01 | -1.20e-01 | 8.41e-01 |
| GOBP PROTEIN K27 LINKED UBIQUITINATION | 7 | 5.84e-01 | -1.20e-01 | 9.36e-01 |
| GOBP NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS | 9 | 5.35e-01 | -1.20e-01 | 9.23e-01 |
| GOBP REGULATION OF NUCLEASE ACTIVITY | 20 | 3.55e-01 | 1.19e-01 | 8.46e-01 |
| GOBP ADIPONECTIN ACTIVATED SIGNALING PATHWAY | 7 | 5.84e-01 | -1.19e-01 | 9.36e-01 |
| GOCC NPBAF COMPLEX | 14 | 4.39e-01 | 1.19e-01 | 8.85e-01 |
| GOBP L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT | 45 | 1.66e-01 | -1.19e-01 | 6.93e-01 |
| GOBP REGULATION OF AMINE METABOLIC PROCESS | 19 | 3.68e-01 | -1.19e-01 | 8.54e-01 |
| GOBP AROMATIC AMINO ACID METABOLIC PROCESS | 16 | 4.09e-01 | 1.19e-01 | 8.76e-01 |
| GOCC ASYMMETRIC GLUTAMATERGIC EXCITATORY SYNAPSE | 8 | 5.59e-01 | 1.19e-01 | 9.27e-01 |
| GOBP HEPATOCYTE APOPTOTIC PROCESS | 16 | 4.09e-01 | 1.19e-01 | 8.76e-01 |
| GOBP PHAGOSOME ACIDIFICATION | 7 | 5.85e-01 | -1.19e-01 | 9.36e-01 |
| GOBP FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS | 30 | 2.59e-01 | 1.19e-01 | 7.85e-01 |
| GOMF ENDODEOXYRIBONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 11 | 4.94e-01 | -1.19e-01 | 9.13e-01 |
| GOBP REGULATION OF HEART CONTRACTION | 100 | 3.97e-02 | 1.19e-01 | 4.07e-01 |
| GOBP REGULATION OF PROTEIN DEPOLYMERIZATION | 66 | 9.44e-02 | -1.19e-01 | 5.70e-01 |
| GOBP AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS | 10 | 5.14e-01 | -1.19e-01 | 9.19e-01 |
| GOMF RNA POLYMERASE III TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 9 | 5.36e-01 | 1.19e-01 | 9.23e-01 |
| GOBP REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 9 | 5.36e-01 | 1.19e-01 | 9.23e-01 |
| GOCC PLATELET DENSE GRANULE | 13 | 4.58e-01 | -1.19e-01 | 8.95e-01 |
| GOMF RNA POLYMERASE II INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 7 | 5.86e-01 | 1.19e-01 | 9.36e-01 |
| GOBP REGULATION OF BONE MINERALIZATION | 47 | 1.59e-01 | 1.19e-01 | 6.83e-01 |
| GOBP POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 11 | 4.95e-01 | 1.19e-01 | 9.13e-01 |
| GOCC ASTROCYTE PROJECTION | 7 | 5.86e-01 | -1.19e-01 | 9.36e-01 |
| GOBP BLEB ASSEMBLY | 10 | 5.16e-01 | 1.19e-01 | 9.19e-01 |
| GOBP LEUKOCYTE APOPTOTIC PROCESS | 89 | 5.32e-02 | 1.19e-01 | 4.60e-01 |
| GOBP DE NOVO AMP BIOSYNTHETIC PROCESS | 6 | 6.15e-01 | 1.19e-01 | 9.36e-01 |
| GOBP PHOSPHOLIPID EFFLUX | 9 | 5.38e-01 | -1.19e-01 | 9.23e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION | 64 | 1.01e-01 | 1.19e-01 | 5.86e-01 |
| GOMF CHEMOREPELLENT ACTIVITY | 14 | 4.42e-01 | -1.19e-01 | 8.86e-01 |
| GOBP MEIOTIC TELOMERE CLUSTERING | 6 | 6.15e-01 | -1.19e-01 | 9.36e-01 |
| GOBP REGULATION OF TRANSLATIONAL TERMINATION | 9 | 5.38e-01 | -1.19e-01 | 9.23e-01 |
| GOBP GANGLIOSIDE CATABOLIC PROCESS | 5 | 6.46e-01 | 1.19e-01 | 9.43e-01 |
| GOBP ESTABLISHMENT OF ENDOTHELIAL BARRIER | 40 | 1.95e-01 | 1.18e-01 | 7.25e-01 |
| GOBP ADHERENS JUNCTION MAINTENANCE | 6 | 6.15e-01 | -1.18e-01 | 9.36e-01 |
| GOMF LIGAND GATED CHANNEL ACTIVITY | 50 | 1.48e-01 | 1.18e-01 | 6.70e-01 |
| GOBP PIGMENT CATABOLIC PROCESS | 6 | 6.15e-01 | 1.18e-01 | 9.36e-01 |
| GOBP CELLULAR RESPONSE TO ETHANOL | 10 | 5.17e-01 | 1.18e-01 | 9.19e-01 |
| GOBP MICROTUBULE ORGANIZING CENTER LOCALIZATION | 29 | 2.70e-01 | 1.18e-01 | 7.93e-01 |
| GOBP REGULATION OF ASTROCYTE DIFFERENTIATION | 16 | 4.13e-01 | 1.18e-01 | 8.77e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 13 | 4.61e-01 | -1.18e-01 | 8.97e-01 |
| GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 17 | 3.99e-01 | 1.18e-01 | 8.71e-01 |
| GOCC PARANODE REGION OF AXON | 5 | 6.47e-01 | -1.18e-01 | 9.43e-01 |
| GOCC ENDOPLASMIC RETICULUM PALMITOYLTRANSFERASE COMPLEX | 7 | 5.89e-01 | 1.18e-01 | 9.36e-01 |
| GOCC CALCIUM CHANNEL COMPLEX | 39 | 2.02e-01 | 1.18e-01 | 7.32e-01 |
| GOMF FOLIC ACID BINDING | 10 | 5.18e-01 | -1.18e-01 | 9.19e-01 |
| GOBP NUCLEAR PORE COMPLEX ASSEMBLY | 11 | 4.98e-01 | 1.18e-01 | 9.13e-01 |
| GOBP MITOTIC G1 S TRANSITION CHECKPOINT SIGNALING | 24 | 3.17e-01 | 1.18e-01 | 8.23e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS ENZYMATIC MODIFICATION | 6 | 6.17e-01 | -1.18e-01 | 9.36e-01 |
| GOMF HEPARAN SULFATE SULFOTRANSFERASE ACTIVITY | 6 | 6.17e-01 | -1.18e-01 | 9.36e-01 |
| GOBP DENDRITIC TRANSPORT | 10 | 5.19e-01 | -1.18e-01 | 9.19e-01 |
| GOBP NEGATIVE REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 29 | 2.72e-01 | 1.18e-01 | 7.94e-01 |
| GOBP PHOSPHATIDYLINOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 56 | 1.27e-01 | 1.18e-01 | 6.35e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 9 | 5.41e-01 | 1.18e-01 | 9.23e-01 |
| GOBP PROTEIN RNA COMPLEX ORGANIZATION | 196 | 4.57e-03 | -1.18e-01 | 1.27e-01 |
| GOBP GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 34 | 2.35e-01 | 1.18e-01 | 7.63e-01 |
| GOBP POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 31 | 2.57e-01 | 1.18e-01 | 7.85e-01 |
| GOBP METANEPHROS DEVELOPMENT | 40 | 1.99e-01 | 1.18e-01 | 7.31e-01 |
| GOBP EXCITATORY CHEMICAL SYNAPTIC TRANSMISSION | 7 | 5.90e-01 | 1.18e-01 | 9.36e-01 |
| GOCC SEH1 ASSOCIATED COMPLEX | 8 | 5.65e-01 | 1.17e-01 | 9.29e-01 |
| GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 12 | 4.81e-01 | 1.17e-01 | 9.08e-01 |
| GOBP DETECTION OF STIMULUS | 115 | 2.99e-02 | 1.17e-01 | 3.51e-01 |
| GOBP NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 6 | 6.19e-01 | -1.17e-01 | 9.37e-01 |
| GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR BINDING | 18 | 3.89e-01 | -1.17e-01 | 8.66e-01 |
| GOBP ESTABLISHMENT OF SISTER CHROMATID COHESION | 10 | 5.21e-01 | 1.17e-01 | 9.20e-01 |
| GOBP PROTEIN TRANSPORT TO VACUOLE INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 14 | 4.48e-01 | -1.17e-01 | 8.88e-01 |
| GOBP CARDIAC MUSCLE CELL CARDIAC MUSCLE CELL ADHESION | 5 | 6.50e-01 | 1.17e-01 | 9.44e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO TYPE II INTERFERON | 5 | 6.50e-01 | 1.17e-01 | 9.44e-01 |
| GOBP REGULATION OF MAST CELL CHEMOTAXIS | 7 | 5.92e-01 | -1.17e-01 | 9.36e-01 |
| GOBP CHEMOSENSORY BEHAVIOR | 8 | 5.66e-01 | 1.17e-01 | 9.29e-01 |
| GOBP NEGATIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 5 | 6.50e-01 | -1.17e-01 | 9.44e-01 |
| GOMF INSULIN LIKE GROWTH FACTOR BINDING | 11 | 5.02e-01 | -1.17e-01 | 9.15e-01 |
| GOMF PHOSPHATIDYLCHOLINE BINDING | 21 | 3.55e-01 | 1.17e-01 | 8.46e-01 |
| GOBP REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 90 | 5.60e-02 | -1.17e-01 | 4.69e-01 |
| GOBP VITAMIN TRANSPORT | 31 | 2.61e-01 | -1.17e-01 | 7.87e-01 |
| GOBP TERPENOID METABOLIC PROCESS | 48 | 1.62e-01 | -1.17e-01 | 6.87e-01 |
| GOBP RESPONSE TO INTERLEUKIN 18 | 7 | 5.94e-01 | 1.17e-01 | 9.36e-01 |
| GOCC CUL2 RING UBIQUITIN LIGASE COMPLEX | 20 | 3.67e-01 | -1.16e-01 | 8.54e-01 |
| GOBP DENDRITE EXTENSION | 21 | 3.56e-01 | 1.16e-01 | 8.46e-01 |
| GOBP NEURAL TUBE FORMATION | 80 | 7.20e-02 | -1.16e-01 | 5.19e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE MIGRATION | 17 | 4.06e-01 | -1.16e-01 | 8.74e-01 |
| GOBP PROGRAMMED NECROTIC CELL DEATH | 45 | 1.77e-01 | 1.16e-01 | 7.08e-01 |
| GOBP CYTOCHROME COMPLEX ASSEMBLY | 37 | 2.21e-01 | -1.16e-01 | 7.49e-01 |
| GOCC KATANIN COMPLEX | 5 | 6.52e-01 | -1.16e-01 | 9.46e-01 |
| GOBP T HELPER 17 CELL DIFFERENTIATION | 21 | 3.57e-01 | 1.16e-01 | 8.46e-01 |
| GOMF CAMP BINDING | 16 | 4.21e-01 | -1.16e-01 | 8.81e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 44 | 1.83e-01 | 1.16e-01 | 7.13e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 24 | 3.25e-01 | 1.16e-01 | 8.29e-01 |
| GOBP POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT | 16 | 4.21e-01 | 1.16e-01 | 8.81e-01 |
| GOBP AUTOPHAGOSOME MATURATION | 60 | 1.20e-01 | 1.16e-01 | 6.21e-01 |
| GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 229 | 2.53e-03 | 1.16e-01 | 8.51e-02 |
| GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS VIA LACTOSYLCERAMIDE | 5 | 6.53e-01 | 1.16e-01 | 9.46e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION | 10 | 5.25e-01 | -1.16e-01 | 9.21e-01 |
| GOCC DENDRITE MEMBRANE | 15 | 4.37e-01 | -1.16e-01 | 8.84e-01 |
| GOBP NEGATIVE CHEMOTAXIS | 24 | 3.25e-01 | -1.16e-01 | 8.29e-01 |
| GOMF IGG BINDING | 6 | 6.23e-01 | 1.16e-01 | 9.39e-01 |
| GOBP RIBOSOME BIOGENESIS | 310 | 4.65e-04 | -1.16e-01 | 2.46e-02 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT MODIFYING ACTIVITY | 17 | 4.08e-01 | 1.16e-01 | 8.76e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA ACTIVATION | 7 | 5.95e-01 | -1.16e-01 | 9.36e-01 |
| GOBP FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE | 11 | 5.06e-01 | 1.16e-01 | 9.16e-01 |
| GOMF PHOSPHOSERINE RESIDUE BINDING | 10 | 5.26e-01 | -1.16e-01 | 9.21e-01 |
| GOBP HEART PROCESS | 130 | 2.28e-02 | 1.16e-01 | 3.12e-01 |
| GOMF PHOSPHOLIPASE A2 ACTIVITY | 15 | 4.38e-01 | -1.16e-01 | 8.85e-01 |
| GOBP VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE | 129 | 2.34e-02 | 1.16e-01 | 3.15e-01 |
| GOBP DENDRITIC CELL CYTOKINE PRODUCTION | 13 | 4.70e-01 | 1.16e-01 | 9.01e-01 |
| GOCC P BODY | 88 | 6.08e-02 | 1.16e-01 | 4.83e-01 |
| GOBP RESPONSE TO AMINO ACID STARVATION | 50 | 1.57e-01 | 1.16e-01 | 6.80e-01 |
| GOBP GOLGI TO ENDOSOME TRANSPORT | 17 | 4.09e-01 | 1.16e-01 | 8.76e-01 |
| GOMF AP 1 ADAPTOR COMPLEX BINDING | 5 | 6.54e-01 | 1.16e-01 | 9.46e-01 |
| GOBP PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 16 | 4.23e-01 | 1.16e-01 | 8.81e-01 |
| GOBP CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 211 | 3.87e-03 | 1.16e-01 | 1.15e-01 |
| GOBP AXONEME ASSEMBLY | 40 | 2.06e-01 | -1.16e-01 | 7.35e-01 |
| GOCC H3 HISTONE ACETYLTRANSFERASE COMPLEX | 8 | 5.72e-01 | 1.16e-01 | 9.31e-01 |
| GOBP DNA DOUBLE STRAND BREAK PROCESSING | 17 | 4.10e-01 | 1.16e-01 | 8.77e-01 |
| GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 14 | 4.54e-01 | -1.15e-01 | 8.93e-01 |
| GOBP ESTROUS CYCLE | 11 | 5.07e-01 | -1.15e-01 | 9.18e-01 |
| GOBP LYMPH VESSEL DEVELOPMENT | 14 | 4.55e-01 | 1.15e-01 | 8.93e-01 |
| GOCC RNA POLYMERASE III COMPLEX | 18 | 3.97e-01 | -1.15e-01 | 8.71e-01 |
| GOBP NUCLEAR ENVELOPE ORGANIZATION | 53 | 1.46e-01 | 1.15e-01 | 6.69e-01 |
| GOBP POLYADENYLATION DEPENDENT SNORNA 3 END PROCESSING | 8 | 5.72e-01 | 1.15e-01 | 9.31e-01 |
| GOBP TRANSCRIPTION ELONGATION COUPLED CHROMATIN REMODELING | 7 | 5.97e-01 | 1.15e-01 | 9.36e-01 |
| GOBP RESPONSE TO DIETARY EXCESS | 16 | 4.25e-01 | -1.15e-01 | 8.81e-01 |
| GOBP GOLGI ORGANIZATION | 132 | 2.24e-02 | 1.15e-01 | 3.09e-01 |
| GOBP REELIN MEDIATED SIGNALING PATHWAY | 5 | 6.56e-01 | -1.15e-01 | 9.47e-01 |
| GOBP THIAMINE TRANSPORT | 5 | 6.56e-01 | -1.15e-01 | 9.47e-01 |
| GOBP MITOCHONDRION LOCALIZATION | 38 | 2.20e-01 | 1.15e-01 | 7.49e-01 |
| GOMF PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING | 12 | 4.90e-01 | -1.15e-01 | 9.12e-01 |
| GOCC MITOTIC SPINDLE MICROTUBULE | 14 | 4.56e-01 | 1.15e-01 | 8.94e-01 |
| GOMF DNA ENDONUCLEASE ACTIVITY | 36 | 2.33e-01 | -1.15e-01 | 7.61e-01 |
| GOBP REGULATION OF BLOOD CIRCULATION | 126 | 2.60e-02 | 1.15e-01 | 3.31e-01 |
| GOCC GAP JUNCTION | 9 | 5.50e-01 | 1.15e-01 | 9.26e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN REGULATION OF CONTRACTION | 6 | 6.26e-01 | -1.15e-01 | 9.40e-01 |
| GOMF HYDROLASE ACTIVITY HYDROLYZING N GLYCOSYL COMPOUNDS | 32 | 2.61e-01 | 1.15e-01 | 7.87e-01 |
| GOBP STRESS FIBER ASSEMBLY | 84 | 6.89e-02 | -1.15e-01 | 5.12e-01 |
| GOBP BINDING OF SPERM TO ZONA PELLUCIDA | 17 | 4.12e-01 | -1.15e-01 | 8.77e-01 |
| GOBP NEUTRAL LIPID BIOSYNTHETIC PROCESS | 38 | 2.21e-01 | 1.15e-01 | 7.49e-01 |
| GOMF GROWTH FACTOR ACTIVITY | 59 | 1.27e-01 | -1.15e-01 | 6.35e-01 |
| GOBP CHOLESTEROL STORAGE | 21 | 3.63e-01 | 1.15e-01 | 8.49e-01 |
| GOBP EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION | 8 | 5.74e-01 | -1.15e-01 | 9.32e-01 |
| GOCC PRESYNAPTIC MEMBRANE | 80 | 7.64e-02 | 1.15e-01 | 5.30e-01 |
| GOBP BIOMINERAL TISSUE DEVELOPMENT | 96 | 5.24e-02 | 1.15e-01 | 4.58e-01 |
| GOBP NUCLEOPHAGY | 19 | 3.87e-01 | -1.15e-01 | 8.65e-01 |
| GOBP NUCLEAR CHROMOSOME SEGREGATION | 268 | 1.28e-03 | 1.15e-01 | 5.19e-02 |
| GOBP POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS | 69 | 1.00e-01 | -1.15e-01 | 5.84e-01 |
| GOMF FUCOSYLTRANSFERASE ACTIVITY | 6 | 6.27e-01 | 1.15e-01 | 9.40e-01 |
| GOBP REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 7 | 6.00e-01 | -1.14e-01 | 9.36e-01 |
| GOBP MONOUBIQUITINATED PROTEIN DEUBIQUITINATION | 8 | 5.75e-01 | -1.14e-01 | 9.33e-01 |
| GOBP HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 20 | 3.76e-01 | -1.14e-01 | 8.60e-01 |
| GOBP HISTONE METHYLATION | 34 | 2.48e-01 | 1.14e-01 | 7.76e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CILIUM | 10 | 5.31e-01 | -1.14e-01 | 9.23e-01 |
| GOBP ARTERY DEVELOPMENT | 59 | 1.29e-01 | 1.14e-01 | 6.39e-01 |
| GOBP MODIFIED AMINO ACID TRANSPORT | 36 | 2.35e-01 | -1.14e-01 | 7.63e-01 |
| GOBP ROSTROCAUDAL NEURAL TUBE PATTERNING | 5 | 6.58e-01 | 1.14e-01 | 9.48e-01 |
| GOMF CDP ALCOHOL PHOSPHATIDYLTRANSFERASE ACTIVITY | 8 | 5.76e-01 | -1.14e-01 | 9.33e-01 |
| GOCC EARLY ENDOSOME | 338 | 3.26e-04 | 1.14e-01 | 1.87e-02 |
| GOMF PALMITOYLTRANSFERASE ACTIVITY | 29 | 2.88e-01 | 1.14e-01 | 8.05e-01 |
| GOBP TOOTH MINERALIZATION | 16 | 4.30e-01 | -1.14e-01 | 8.82e-01 |
| GOBP MITOTIC CELL CYCLE CHECKPOINT SIGNALING | 128 | 2.61e-02 | 1.14e-01 | 3.31e-01 |
| GOBP MITOCHONDRIAL TRANSPORT | 173 | 9.83e-03 | -1.14e-01 | 1.96e-01 |
| GOMF GUANYLATE KINASE ACTIVITY | 9 | 5.54e-01 | 1.14e-01 | 9.26e-01 |
| GOBP NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY | 25 | 3.24e-01 | -1.14e-01 | 8.29e-01 |
| GOBP RESPONSE TO NICOTINE | 24 | 3.34e-01 | -1.14e-01 | 8.35e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION | 91 | 6.07e-02 | 1.14e-01 | 4.83e-01 |
| GOBP NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS | 12 | 4.95e-01 | 1.14e-01 | 9.13e-01 |
| GOBP REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY | 44 | 1.92e-01 | -1.14e-01 | 7.22e-01 |
| GOMF DYNEIN INTERMEDIATE CHAIN BINDING | 24 | 3.35e-01 | 1.14e-01 | 8.35e-01 |
| GOBP OXALOACETATE METABOLIC PROCESS | 7 | 6.02e-01 | -1.14e-01 | 9.36e-01 |
| GOBP RESPONSE TO PROSTAGLANDIN E | 15 | 4.46e-01 | -1.14e-01 | 8.88e-01 |
| GOCC MITOCHONDRIAL INTERMEMBRANE SPACE PROTEIN TRANSPORTER COMPLEX | 6 | 6.30e-01 | -1.14e-01 | 9.40e-01 |
| GOBP GLUTAMATE RECEPTOR SIGNALING PATHWAY | 26 | 3.16e-01 | 1.14e-01 | 8.23e-01 |
| GOMF SYNTAXIN BINDING | 44 | 1.92e-01 | 1.14e-01 | 7.22e-01 |
| GOBP NEGATIVE REGULATION OF CHOLESTEROL STORAGE | 10 | 5.34e-01 | 1.14e-01 | 9.23e-01 |
| GOMF SUMO BINDING | 17 | 4.17e-01 | -1.14e-01 | 8.79e-01 |
| GOBP POSITIVE REGULATION OF VIRAL GENOME REPLICATION | 28 | 2.98e-01 | 1.14e-01 | 8.13e-01 |
| GOBP ENDOCRINE SYSTEM DEVELOPMENT | 63 | 1.19e-01 | 1.14e-01 | 6.20e-01 |
| GOBP POSITIVE REGULATION OF CELL ACTIVATION | 282 | 1.07e-03 | 1.14e-01 | 4.59e-02 |
| GOBP RESPONSE TO FUNGICIDE | 6 | 6.30e-01 | 1.13e-01 | 9.40e-01 |
| GOMF ACIDIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 14 | 4.63e-01 | -1.13e-01 | 8.99e-01 |
| GOBP THYROID HORMONE METABOLIC PROCESS | 12 | 4.96e-01 | 1.13e-01 | 9.13e-01 |
| GOMF PLATELET DERIVED GROWTH FACTOR BINDING | 6 | 6.30e-01 | -1.13e-01 | 9.40e-01 |
| GOMF PROTEIN SERINE KINASE ACTIVITY | 294 | 8.51e-04 | 1.13e-01 | 3.88e-02 |
| GOMF WNT PROTEIN BINDING | 14 | 4.63e-01 | -1.13e-01 | 8.99e-01 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL PIGMENTATION | 7 | 6.03e-01 | -1.13e-01 | 9.36e-01 |
| GOBP NEUROINFLAMMATORY RESPONSE | 56 | 1.42e-01 | 1.13e-01 | 6.65e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS | 15 | 4.47e-01 | 1.13e-01 | 8.88e-01 |
| GOBP ACTIN FILAMENT SEVERING | 16 | 4.33e-01 | 1.13e-01 | 8.82e-01 |
| GOMF PROTEIN ARGININE OMEGA N ASYMMETRIC METHYLTRANSFERASE ACTIVITY | 6 | 6.31e-01 | -1.13e-01 | 9.40e-01 |
| GOBP PEPTIDYL SERINE AUTOPHOSPHORYLATION | 8 | 5.79e-01 | 1.13e-01 | 9.34e-01 |
| GOBP CELLULAR RESPONSE TO KETONE | 65 | 1.15e-01 | 1.13e-01 | 6.11e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 25 | 3.27e-01 | 1.13e-01 | 8.29e-01 |
| GOBP REGULATION OF BONE REMODELING | 32 | 2.68e-01 | -1.13e-01 | 7.91e-01 |
| GOBP NEGATIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 6 | 6.31e-01 | -1.13e-01 | 9.40e-01 |
| GOBP SEX DETERMINATION | 6 | 6.31e-01 | 1.13e-01 | 9.40e-01 |
| GOBP CYTOKINE PRODUCTION | 544 | 7.15e-06 | 1.13e-01 | 9.55e-04 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING SULPHUR CONTAINING GROUPS | 37 | 2.34e-01 | -1.13e-01 | 7.63e-01 |
| GOBP NEUTRAL LIPID CATABOLIC PROCESS | 22 | 3.59e-01 | -1.13e-01 | 8.46e-01 |
| GOMF GENERAL TRANSCRIPTION INITIATION FACTOR BINDING | 51 | 1.63e-01 | 1.13e-01 | 6.88e-01 |
| GOBP NEGATIVE REGULATION OF B CELL ACTIVATION | 24 | 3.39e-01 | 1.13e-01 | 8.37e-01 |
| GOBP JNK CASCADE | 127 | 2.83e-02 | 1.13e-01 | 3.45e-01 |
| GOBP REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION | 7 | 6.05e-01 | -1.13e-01 | 9.36e-01 |
| GOBP CELL CYCLE DNA REPLICATION | 40 | 2.18e-01 | -1.13e-01 | 7.49e-01 |
| GOCC TRNA METHYLTRANSFERASE COMPLEX | 7 | 6.06e-01 | -1.13e-01 | 9.36e-01 |
| GOBP NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS | 19 | 3.96e-01 | 1.13e-01 | 8.70e-01 |
| GOBP POSITIVE REGULATION OF CELL MATURATION | 6 | 6.33e-01 | 1.13e-01 | 9.41e-01 |
| GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 68 | 1.09e-01 | 1.13e-01 | 6.00e-01 |
| GOMF BRANCHED CHAIN AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 6.06e-01 | -1.12e-01 | 9.36e-01 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE III PROMOTER | 8 | 5.82e-01 | -1.12e-01 | 9.35e-01 |
| GOBP ATRIOVENTRICULAR CANAL DEVELOPMENT | 5 | 6.63e-01 | -1.12e-01 | 9.49e-01 |
| GOMF CARBON NITROGEN LYASE ACTIVITY | 11 | 5.18e-01 | -1.12e-01 | 9.19e-01 |
| GOBP CELL JUNCTION MAINTENANCE | 28 | 3.03e-01 | -1.12e-01 | 8.14e-01 |
| GOBP CARNITINE TRANSPORT | 6 | 6.34e-01 | -1.12e-01 | 9.41e-01 |
| GOBP FAT PAD DEVELOPMENT | 7 | 6.07e-01 | 1.12e-01 | 9.36e-01 |
| GOBP BASE EXCISION REPAIR GAP FILLING | 13 | 4.83e-01 | 1.12e-01 | 9.09e-01 |
| GOMF DISULFIDE OXIDOREDUCTASE ACTIVITY | 32 | 2.72e-01 | -1.12e-01 | 7.94e-01 |
| GOMF SUPERCOILED DNA BINDING | 6 | 6.34e-01 | 1.12e-01 | 9.41e-01 |
| GOBP IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY | 14 | 4.67e-01 | 1.12e-01 | 9.00e-01 |
| GOBP CARDIAC SEPTUM DEVELOPMENT | 69 | 1.07e-01 | 1.12e-01 | 5.97e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION | 26 | 3.22e-01 | 1.12e-01 | 8.29e-01 |
| GOBP SYNAPTIC TRANSMISSION DOPAMINERGIC | 10 | 5.39e-01 | -1.12e-01 | 9.23e-01 |
| GOBP ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS | 21 | 3.74e-01 | 1.12e-01 | 8.60e-01 |
| GOBP APICAL PROTEIN LOCALIZATION | 9 | 5.60e-01 | -1.12e-01 | 9.28e-01 |
| GOBP APOPTOTIC CHROMOSOME CONDENSATION | 5 | 6.64e-01 | 1.12e-01 | 9.49e-01 |
| GOBP HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY | 10 | 5.40e-01 | 1.12e-01 | 9.23e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE BINDING | 145 | 2.01e-02 | 1.12e-01 | 2.95e-01 |
| GOBP PLASMA CELL DIFFERENTIATION | 6 | 6.35e-01 | -1.12e-01 | 9.41e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 13 | 4.85e-01 | -1.12e-01 | 9.10e-01 |
| GOBP CELLULAR RESPONSE TO UV A | 7 | 6.08e-01 | -1.12e-01 | 9.36e-01 |
| GOBP PATTERN SPECIFICATION PROCESS | 215 | 4.82e-03 | -1.12e-01 | 1.29e-01 |
| GOMF INTERLEUKIN 17 RECEPTOR ACTIVITY | 5 | 6.65e-01 | -1.12e-01 | 9.49e-01 |
| GOBP REGULATION OF COAGULATION | 40 | 2.22e-01 | -1.12e-01 | 7.51e-01 |
| GOBP REGULATION OF LEUKOCYTE DIFFERENTIATION | 233 | 3.40e-03 | 1.12e-01 | 1.06e-01 |
| GOBP REGULATION OF APPETITE | 8 | 5.85e-01 | -1.12e-01 | 9.36e-01 |
| GOBP AMYLOID BETA CLEARANCE BY CELLULAR CATABOLIC PROCESS | 7 | 6.09e-01 | -1.12e-01 | 9.36e-01 |
| GOBP LEUKOCYTE DEGRANULATION | 59 | 1.39e-01 | 1.12e-01 | 6.59e-01 |
| GOMF HORMONE RECEPTOR BINDING | 10 | 5.42e-01 | -1.11e-01 | 9.23e-01 |
| GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE | 204 | 6.16e-03 | 1.11e-01 | 1.48e-01 |
| GOBP POSITIVE REGULATION OF TOLERANCE INDUCTION | 8 | 5.85e-01 | 1.11e-01 | 9.36e-01 |
| GOBP DICARBOXYLIC ACID CATABOLIC PROCESS | 14 | 4.70e-01 | 1.11e-01 | 9.01e-01 |
| GOBP NEGATIVE REGULATION OF CELL MATRIX ADHESION | 26 | 3.26e-01 | 1.11e-01 | 8.29e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE RECYCLING | 6 | 6.37e-01 | -1.11e-01 | 9.41e-01 |
| GOBP HUMORAL IMMUNE RESPONSE | 94 | 6.25e-02 | -1.11e-01 | 4.87e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION INTRACELLULAR COMPONENT | 16 | 4.41e-01 | 1.11e-01 | 8.85e-01 |
| GOBP POSITIVE REGULATION OF JNK CASCADE | 66 | 1.18e-01 | 1.11e-01 | 6.19e-01 |
| GOBP REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL | 9 | 5.64e-01 | -1.11e-01 | 9.29e-01 |
| GOMF THIOREDOXIN DEPENDENT PEROXIREDOXIN ACTIVITY | 6 | 6.38e-01 | -1.11e-01 | 9.41e-01 |
| GOBP LATE ENDOSOME TO VACUOLE TRANSPORT | 34 | 2.62e-01 | 1.11e-01 | 7.87e-01 |
| GOBP REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS | 15 | 4.56e-01 | -1.11e-01 | 8.94e-01 |
| GOBP ATTACHMENT OF GPI ANCHOR TO PROTEIN | 6 | 6.38e-01 | -1.11e-01 | 9.41e-01 |
| GOBP RESPONSE TO SODIUM PHOSPHATE | 6 | 6.38e-01 | 1.11e-01 | 9.41e-01 |
| GOBP POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY | 5 | 6.67e-01 | 1.11e-01 | 9.49e-01 |
| GOBP TELENCEPHALON GLIAL CELL MIGRATION | 19 | 4.02e-01 | 1.11e-01 | 8.72e-01 |
| GOCC PHAGOPHORE ASSEMBLY SITE MEMBRANE | 21 | 3.79e-01 | -1.11e-01 | 8.62e-01 |
| GOBP METHYLGUANOSINE CAP DECAPPING | 16 | 4.43e-01 | 1.11e-01 | 8.86e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC | 5 | 6.68e-01 | -1.11e-01 | 9.49e-01 |
| GOMF LYSOPHOSPHOLIPID ACYLTRANSFERASE ACTIVITY | 21 | 3.79e-01 | -1.11e-01 | 8.62e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE PHOSPHATASE ACTIVITY | 11 | 5.25e-01 | 1.11e-01 | 9.20e-01 |
| GOBP GLUTAMINE TRANSPORT | 7 | 6.12e-01 | -1.11e-01 | 9.36e-01 |
| GOMF L GLUTAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 6.12e-01 | -1.11e-01 | 9.36e-01 |
| GOMF SULFURTRANSFERASE ACTIVITY | 11 | 5.25e-01 | -1.11e-01 | 9.20e-01 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE DIFFERENTIATION | 6 | 6.39e-01 | -1.11e-01 | 9.41e-01 |
| GOBP REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 13 | 4.90e-01 | -1.11e-01 | 9.12e-01 |
| GOBP URONIC ACID METABOLIC PROCESS | 7 | 6.12e-01 | 1.11e-01 | 9.36e-01 |
| GOBP CITRULLINE METABOLIC PROCESS | 5 | 6.68e-01 | 1.11e-01 | 9.49e-01 |
| GOCC CORNIFIED ENVELOPE | 15 | 4.59e-01 | -1.11e-01 | 8.96e-01 |
| GOBP CELLULAR COMPONENT MAINTENANCE | 49 | 1.81e-01 | -1.11e-01 | 7.12e-01 |
| GOBP NEGATIVE REGULATION OF MRNA PROCESSING | 21 | 3.81e-01 | -1.11e-01 | 8.63e-01 |
| GOMF LIPOPROTEIN PARTICLE RECEPTOR BINDING | 20 | 3.92e-01 | -1.11e-01 | 8.68e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 8 | 5.89e-01 | -1.10e-01 | 9.36e-01 |
| GOBP SODIUM ION HOMEOSTASIS | 13 | 4.91e-01 | -1.10e-01 | 9.13e-01 |
| GOBP EAR MORPHOGENESIS | 48 | 1.86e-01 | 1.10e-01 | 7.17e-01 |
| GOBP VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT | 25 | 3.40e-01 | 1.10e-01 | 8.39e-01 |
| GOBP LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE | 146 | 2.16e-02 | 1.10e-01 | 3.06e-01 |
| GOCC PRESPLICEOSOME | 16 | 4.45e-01 | 1.10e-01 | 8.87e-01 |
| GOMF CTPASE ACTIVITY | 5 | 6.69e-01 | -1.10e-01 | 9.49e-01 |
| GOBP FORMATION OF PRIMARY GERM LAYER | 67 | 1.19e-01 | -1.10e-01 | 6.20e-01 |
| GOBP GLIAL CELL ACTIVATION | 40 | 2.28e-01 | 1.10e-01 | 7.58e-01 |
| GOBP CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 7 | 6.14e-01 | 1.10e-01 | 9.36e-01 |
| GOBP GLUTAMATE SECRETION NEUROTRANSMISSION | 6 | 6.41e-01 | 1.10e-01 | 9.42e-01 |
| GOBP IMP BIOSYNTHETIC PROCESS | 10 | 5.47e-01 | 1.10e-01 | 9.25e-01 |
| GOBP CELLULAR RESPONSE TO LEPTIN STIMULUS | 10 | 5.47e-01 | 1.10e-01 | 9.25e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION TERMINATION | 23 | 3.62e-01 | -1.10e-01 | 8.48e-01 |
| GOBP REGULATION OF PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION | 6 | 6.41e-01 | 1.10e-01 | 9.42e-01 |
| GOBP NEURONAL ACTION POTENTIAL | 15 | 4.61e-01 | 1.10e-01 | 8.97e-01 |
| GOBP C21 STEROID HORMONE BIOSYNTHETIC PROCESS | 9 | 5.68e-01 | -1.10e-01 | 9.31e-01 |
| GOBP NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 10 | 5.48e-01 | -1.10e-01 | 9.25e-01 |
| GOBP TETRAHYDROFOLATE METABOLIC PROCESS | 15 | 4.62e-01 | 1.10e-01 | 8.98e-01 |
| GOBP T CELL TOLERANCE INDUCTION | 8 | 5.91e-01 | 1.10e-01 | 9.36e-01 |
| GOBP NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS | 245 | 3.16e-03 | -1.10e-01 | 1.02e-01 |
| GOMF INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 8 | 5.91e-01 | 1.10e-01 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE | 10 | 5.48e-01 | 1.10e-01 | 9.25e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION | 29 | 3.07e-01 | -1.10e-01 | 8.18e-01 |
| GOCC ZONA PELLUCIDA RECEPTOR COMPLEX | 6 | 6.42e-01 | -1.10e-01 | 9.42e-01 |
| GOCC STEREOCILIUM BUNDLE | 38 | 2.42e-01 | -1.10e-01 | 7.71e-01 |
| GOBP ESTABLISHMENT OF CELL POLARITY | 120 | 3.82e-02 | 1.10e-01 | 3.99e-01 |
| GOBP DIENCEPHALON DEVELOPMENT | 28 | 3.15e-01 | 1.10e-01 | 8.23e-01 |
| GOCC CATALYTIC STEP 1 SPLICEOSOME | 12 | 5.11e-01 | 1.10e-01 | 9.18e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION | 5 | 6.72e-01 | 1.09e-01 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO FOOD | 6 | 6.43e-01 | -1.09e-01 | 9.42e-01 |
| GOBP RESPONSE TO AMINE | 23 | 3.64e-01 | 1.09e-01 | 8.50e-01 |
| GOBP VIRAL LIFE CYCLE | 260 | 2.46e-03 | 1.09e-01 | 8.39e-02 |
| GOBP POSITIVE REGULATION OF HEMOPOIESIS | 148 | 2.19e-02 | 1.09e-01 | 3.07e-01 |
| GOCC CHROMAFFIN GRANULE | 8 | 5.93e-01 | -1.09e-01 | 9.36e-01 |
| GOBP IMMUNE EFFECTOR PROCESS | 412 | 1.52e-04 | 1.09e-01 | 1.05e-02 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 23 | 3.65e-01 | 1.09e-01 | 8.50e-01 |
| GOBP LEUKOCYTE CELL CELL ADHESION | 278 | 1.78e-03 | 1.09e-01 | 6.71e-02 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 30 | 3.01e-01 | 1.09e-01 | 8.14e-01 |
| GOBP POSITIVE REGULATION OF GLOMERULAR MESANGIAL CELL PROLIFERATION | 5 | 6.73e-01 | -1.09e-01 | 9.49e-01 |
| GOBP RESPONSE TO ZINC ION STARVATION | 7 | 6.17e-01 | -1.09e-01 | 9.36e-01 |
| GOBP GERM CELL PROLIFERATION | 9 | 5.71e-01 | -1.09e-01 | 9.31e-01 |
| GOBP REGULATION OF TELOMERASE ACTIVITY | 44 | 2.11e-01 | 1.09e-01 | 7.44e-01 |
| GOBP CARBOHYDRATE BIOSYNTHETIC PROCESS | 144 | 2.42e-02 | -1.09e-01 | 3.20e-01 |
| GOBP MAGNESIUM ION HOMEOSTASIS | 6 | 6.44e-01 | 1.09e-01 | 9.42e-01 |
| GOBP POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE | 12 | 5.13e-01 | -1.09e-01 | 9.18e-01 |
| GOMF PRERIBOSOME BINDING | 8 | 5.94e-01 | 1.09e-01 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF WOUND HEALING | 35 | 2.65e-01 | -1.09e-01 | 7.90e-01 |
| GOBP TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY | 11 | 5.32e-01 | 1.09e-01 | 9.23e-01 |
| GOBP INTERLEUKIN 12 MEDIATED SIGNALING PATHWAY | 6 | 6.44e-01 | 1.09e-01 | 9.42e-01 |
| GOBP REGULATION OF RIBOSOME BIOGENESIS | 9 | 5.72e-01 | 1.09e-01 | 9.31e-01 |
| GOCC CIS GOLGI NETWORK MEMBRANE | 8 | 5.94e-01 | 1.09e-01 | 9.36e-01 |
| GOBP WALKING BEHAVIOR | 20 | 4.00e-01 | 1.09e-01 | 8.71e-01 |
| GOMF FOLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 6.74e-01 | -1.09e-01 | 9.50e-01 |
| GOMF PROTEIN DISULFIDE ISOMERASE ACTIVITY | 18 | 4.25e-01 | -1.09e-01 | 8.81e-01 |
| GOBP PROTEIN LOCALIZATION TO NON MOTILE CILIUM | 9 | 5.72e-01 | -1.09e-01 | 9.31e-01 |
| GOBP REGULATION OF CELL CELL ADHESION | 319 | 8.78e-04 | 1.09e-01 | 3.95e-02 |
| GOBP MAINTENANCE OF LOCATION IN CELL | 163 | 1.68e-02 | 1.09e-01 | 2.72e-01 |
| GOBP MICROTUBULE BASED PROTEIN TRANSPORT | 9 | 5.73e-01 | -1.09e-01 | 9.32e-01 |
| GOBP XYLULOSE 5 PHOSPHATE METABOLIC PROCESS | 6 | 6.45e-01 | -1.09e-01 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE IMPORT | 24 | 3.57e-01 | -1.09e-01 | 8.46e-01 |
| GOBP REGULATION OF CENTROSOME CYCLE | 49 | 1.89e-01 | 1.09e-01 | 7.18e-01 |
| GOBP COMPLEMENT DEPENDENT CYTOTOXICITY | 8 | 5.95e-01 | 1.08e-01 | 9.36e-01 |
| GOBP EMBRYONIC PLACENTA DEVELOPMENT | 57 | 1.57e-01 | 1.08e-01 | 6.80e-01 |
| GOBP POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS | 736 | 6.68e-07 | 1.08e-01 | 1.21e-04 |
| GOBP BLASTOCYST FORMATION | 34 | 2.74e-01 | -1.08e-01 | 7.96e-01 |
| GOBP MACROPHAGE ACTIVATION | 77 | 1.01e-01 | 1.08e-01 | 5.84e-01 |
| GOBP TRNA PSEUDOURIDINE SYNTHESIS | 6 | 6.46e-01 | 1.08e-01 | 9.43e-01 |
| GOBP RUFFLE ASSEMBLY | 35 | 2.68e-01 | -1.08e-01 | 7.91e-01 |
| GOBP ARTERY MORPHOGENESIS | 38 | 2.48e-01 | 1.08e-01 | 7.76e-01 |
| GOCC CHROMATIN SILENCING COMPLEX | 13 | 5.00e-01 | -1.08e-01 | 9.14e-01 |
| GOBP N ACETYLNEURAMINATE CATABOLIC PROCESS | 6 | 6.47e-01 | -1.08e-01 | 9.43e-01 |
| GOBP DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION | 15 | 4.69e-01 | -1.08e-01 | 9.00e-01 |
| GOBP REGULATION OF CYTOCHROME C OXIDASE ACTIVITY | 5 | 6.76e-01 | -1.08e-01 | 9.51e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN BINDING | 47 | 2.00e-01 | 1.08e-01 | 7.32e-01 |
| GOCC TERTIARY GRANULE LUMEN | 41 | 2.32e-01 | -1.08e-01 | 7.59e-01 |
| GOCC ORGANELLE ENVELOPE LUMEN | 80 | 9.57e-02 | -1.08e-01 | 5.74e-01 |
| GOMF ABC TYPE GLUTATHIONE S CONJUGATE TRANSPORTER ACTIVITY | 6 | 6.47e-01 | -1.08e-01 | 9.43e-01 |
| GOBP REGULATION OF METALLOPEPTIDASE ACTIVITY | 11 | 5.36e-01 | -1.08e-01 | 9.23e-01 |
| GOBP SULFATION | 10 | 5.55e-01 | -1.08e-01 | 9.26e-01 |
| GOMF WNT RECEPTOR ACTIVITY | 10 | 5.55e-01 | -1.08e-01 | 9.26e-01 |
| GOBP POSITIVE REGULATION OF HYPERSENSITIVITY | 5 | 6.77e-01 | 1.08e-01 | 9.51e-01 |
| GOBP POSITIVE REGULATION OF AMINO ACID TRANSPORT | 13 | 5.01e-01 | -1.08e-01 | 9.15e-01 |
| GOBP MIRNA CATABOLIC PROCESS | 16 | 4.56e-01 | 1.08e-01 | 8.94e-01 |
| GOBP REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 13 | 5.01e-01 | -1.08e-01 | 9.15e-01 |
| GOBP T CELL PROLIFERATION | 152 | 2.21e-02 | 1.08e-01 | 3.07e-01 |
| GOCC UNCONVENTIONAL MYOSIN COMPLEX | 9 | 5.76e-01 | -1.08e-01 | 9.33e-01 |
| GOBP REGULATION OF MRNA CATABOLIC PROCESS | 159 | 1.94e-02 | 1.08e-01 | 2.91e-01 |
| GOCC NUCLEAR OUTER MEMBRANE | 23 | 3.72e-01 | -1.08e-01 | 8.57e-01 |
| GOBP REGULATION OF LEUKOCYTE DEGRANULATION | 35 | 2.71e-01 | 1.08e-01 | 7.94e-01 |
| GOMF NUCLEOBASE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 45 | 2.12e-01 | -1.08e-01 | 7.45e-01 |
| GOBP MULTIVESICULAR BODY SORTING PATHWAY | 44 | 2.18e-01 | 1.07e-01 | 7.49e-01 |
| GOBP SKELETAL SYSTEM MORPHOGENESIS | 114 | 4.78e-02 | -1.07e-01 | 4.43e-01 |
| GOBP ACTIN FILAMENT BASED TRANSPORT | 17 | 4.43e-01 | 1.07e-01 | 8.87e-01 |
| GOBP MODULATION BY HOST OF VIRAL PROCESS | 44 | 2.18e-01 | 1.07e-01 | 7.49e-01 |
| GOBP MACROPINOCYTOSIS | 10 | 5.57e-01 | -1.07e-01 | 9.27e-01 |
| GOCC SET1C COMPASS COMPLEX | 13 | 5.03e-01 | -1.07e-01 | 9.15e-01 |
| GOMF BHLH TRANSCRIPTION FACTOR BINDING | 22 | 3.84e-01 | 1.07e-01 | 8.64e-01 |
| GOCC KINESIN COMPLEX | 35 | 2.73e-01 | 1.07e-01 | 7.94e-01 |
| GOBP NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS | 17 | 4.44e-01 | -1.07e-01 | 8.87e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS | 32 | 2.94e-01 | 1.07e-01 | 8.09e-01 |
| GOMF ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 94 | 7.30e-02 | -1.07e-01 | 5.22e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERASE ACTIVITY | 10 | 5.58e-01 | -1.07e-01 | 9.27e-01 |
| GOBP INTRACELLULAR MRNA LOCALIZATION | 11 | 5.39e-01 | 1.07e-01 | 9.23e-01 |
| GOBP INTERLEUKIN 6 PRODUCTION | 109 | 5.37e-02 | 1.07e-01 | 4.61e-01 |
| GOBP SKELETAL SYSTEM DEVELOPMENT | 281 | 2.08e-03 | -1.07e-01 | 7.62e-02 |
| GOCC RIBONUCLEASE MRP COMPLEX | 10 | 5.58e-01 | -1.07e-01 | 9.27e-01 |
| GOBP REGULATION OF GLIAL CELL DIFFERENTIATION | 41 | 2.36e-01 | 1.07e-01 | 7.64e-01 |
| GOBP LEUKOTRIENE METABOLIC PROCESS | 15 | 4.73e-01 | 1.07e-01 | 9.02e-01 |
| GOMF OXO ACID LYASE ACTIVITY | 5 | 6.79e-01 | 1.07e-01 | 9.52e-01 |
| GOCC INTRACILIARY TRANSPORT PARTICLE B | 17 | 4.45e-01 | -1.07e-01 | 8.87e-01 |
| GOBP DNA STRAND RESECTION INVOLVED IN REPLICATION FORK PROCESSING | 7 | 6.24e-01 | 1.07e-01 | 9.40e-01 |
| GOBP REGULATION OF VESICLE SIZE | 18 | 4.32e-01 | -1.07e-01 | 8.82e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON OTHER NITROGENOUS COMPOUNDS AS DONORS | 7 | 6.24e-01 | 1.07e-01 | 9.40e-01 |
| GOBP U4 SNRNA 3 END PROCESSING | 8 | 6.01e-01 | 1.07e-01 | 9.36e-01 |
| GOMF U3 SNORNA BINDING | 10 | 5.58e-01 | -1.07e-01 | 9.27e-01 |
| GOBP NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 47 | 2.05e-01 | -1.07e-01 | 7.33e-01 |
| GOBP REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 45 | 2.15e-01 | 1.07e-01 | 7.46e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE BINDING | 22 | 3.86e-01 | 1.07e-01 | 8.65e-01 |
| GOMF CARBOHYDRATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 22 | 3.86e-01 | 1.07e-01 | 8.65e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION | 6 | 6.51e-01 | 1.07e-01 | 9.45e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION INDEPENDENT DECAY | 7 | 6.25e-01 | 1.07e-01 | 9.40e-01 |
| GOBP OXIDATIVE DEMETHYLATION | 7 | 6.25e-01 | 1.07e-01 | 9.40e-01 |
| GOBP MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS | 145 | 2.70e-02 | 1.07e-01 | 3.35e-01 |
| GOBP CARDIAC CONDUCTION SYSTEM DEVELOPMENT | 14 | 4.90e-01 | -1.07e-01 | 9.12e-01 |
| GOMF RETROMER COMPLEX BINDING | 9 | 5.80e-01 | 1.06e-01 | 9.35e-01 |
| GOBP REGULATION OF KIDNEY DEVELOPMENT | 15 | 4.76e-01 | 1.06e-01 | 9.04e-01 |
| GOCC PLATELET ALPHA GRANULE | 61 | 1.51e-01 | -1.06e-01 | 6.73e-01 |
| GOMF PROTEIN KINASE C BINDING | 37 | 2.63e-01 | -1.06e-01 | 7.88e-01 |
| GOBP CARDIAC MUSCLE CONTRACTION | 78 | 1.05e-01 | 1.06e-01 | 5.94e-01 |
| GOBP POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY | 33 | 2.91e-01 | 1.06e-01 | 8.06e-01 |
| GOBP INDOLALKYLAMINE METABOLIC PROCESS | 9 | 5.81e-01 | -1.06e-01 | 9.35e-01 |
| GOBP TRNA METHYLATION | 43 | 2.28e-01 | 1.06e-01 | 7.58e-01 |
| GOCC NUCLEOLAR RIBONUCLEASE P COMPLEX | 7 | 6.26e-01 | 1.06e-01 | 9.40e-01 |
| GOBP HORMONE CATABOLIC PROCESS | 8 | 6.03e-01 | 1.06e-01 | 9.36e-01 |
| GOBP REGULATION OF HEAT GENERATION | 7 | 6.27e-01 | 1.06e-01 | 9.40e-01 |
| GOMF PROTEIN TYROSINE KINASE INHIBITOR ACTIVITY | 5 | 6.81e-01 | -1.06e-01 | 9.52e-01 |
| GOBP REGULATION OF MOTOR NEURON APOPTOTIC PROCESS | 11 | 5.42e-01 | 1.06e-01 | 9.23e-01 |
| GOMF AMINOPEPTIDASE ACTIVITY | 32 | 2.99e-01 | 1.06e-01 | 8.13e-01 |
| GOBP REGULATION OF HAIR CYCLE | 15 | 4.77e-01 | 1.06e-01 | 9.05e-01 |
| GOBP BRANCHING MORPHOGENESIS OF A NERVE | 7 | 6.27e-01 | -1.06e-01 | 9.40e-01 |
| GOBP REGULATION OF CHROMOSOME CONDENSATION | 11 | 5.43e-01 | 1.06e-01 | 9.23e-01 |
| GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 28 | 3.32e-01 | -1.06e-01 | 8.31e-01 |
| GOBP PROTEIN STABILIZATION | 177 | 1.51e-02 | -1.06e-01 | 2.59e-01 |
| GOBP ICOSANOID TRANSPORT | 25 | 3.59e-01 | 1.06e-01 | 8.46e-01 |
| GOBP REGULATION OF GLYCOLYTIC PROCESS | 42 | 2.35e-01 | 1.06e-01 | 7.63e-01 |
| GOBP CELLULAR RESPONSE TO ACID CHEMICAL | 66 | 1.37e-01 | -1.06e-01 | 6.54e-01 |
| GOMF CLASS I DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY | 8 | 6.04e-01 | 1.06e-01 | 9.36e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE ACTIVITY | 350 | 6.98e-04 | 1.06e-01 | 3.33e-02 |
| GOCC ATPASE COMPLEX | 133 | 3.53e-02 | -1.06e-01 | 3.82e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY | 25 | 3.60e-01 | 1.06e-01 | 8.46e-01 |
| GOBP CYTOSKELETON DEPENDENT CYTOKINESIS | 103 | 6.37e-02 | 1.06e-01 | 4.91e-01 |
| GOCC RNA POLYMERASE II TRANSCRIPTION REGULATOR COMPLEX | 205 | 9.18e-03 | 1.06e-01 | 1.89e-01 |
| GOMF DNA N GLYCOSYLASE ACTIVITY | 14 | 4.93e-01 | -1.06e-01 | 9.13e-01 |
| GOBP NEGATIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 10 | 5.63e-01 | 1.06e-01 | 9.29e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS | 97 | 7.25e-02 | 1.06e-01 | 5.21e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 8 | 6.05e-01 | -1.06e-01 | 9.36e-01 |
| GOBP IMPORT ACROSS PLASMA MEMBRANE | 106 | 6.07e-02 | -1.06e-01 | 4.83e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS | 73 | 1.19e-01 | 1.06e-01 | 6.20e-01 |
| GOBP BONE RESORPTION | 46 | 2.16e-01 | -1.05e-01 | 7.47e-01 |
| GOBP NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION | 39 | 2.55e-01 | 1.05e-01 | 7.81e-01 |
| GOCC BRCA1 A COMPLEX | 8 | 6.05e-01 | 1.05e-01 | 9.36e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT TO PLASMA MEMBRANE | 12 | 5.27e-01 | 1.05e-01 | 9.22e-01 |
| GOCC BLOC 1 COMPLEX | 9 | 5.84e-01 | 1.05e-01 | 9.36e-01 |
| GOBP INNER EAR MORPHOGENESIS | 39 | 2.55e-01 | 1.05e-01 | 7.81e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATION | 121 | 4.55e-02 | -1.05e-01 | 4.33e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 9 | 5.84e-01 | 1.05e-01 | 9.36e-01 |
| GOBP PURINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT | 29 | 3.27e-01 | -1.05e-01 | 8.29e-01 |
| GOBP NEURAL CREST CELL DIFFERENTIATION | 52 | 1.89e-01 | -1.05e-01 | 7.18e-01 |
| GOBP RESPONSE TO ETHER | 10 | 5.64e-01 | 1.05e-01 | 9.29e-01 |
| GOMF ACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY | 26 | 3.53e-01 | -1.05e-01 | 8.46e-01 |
| GOCC CLATHRIN COATED ENDOCYTIC VESICLE | 52 | 1.90e-01 | 1.05e-01 | 7.19e-01 |
| GOMF PROTEIN LYSINE DEACETYLASE ACTIVITY | 23 | 3.83e-01 | 1.05e-01 | 8.64e-01 |
| GOCC U1 SNRNP | 19 | 4.28e-01 | 1.05e-01 | 8.82e-01 |
| GOBP MATURATION OF 5 8S RRNA | 36 | 2.75e-01 | -1.05e-01 | 7.96e-01 |
| GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 30 | 3.19e-01 | -1.05e-01 | 8.26e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING | 27 | 3.45e-01 | -1.05e-01 | 8.42e-01 |
| GOBP POSITIVE REGULATION OF MICROGLIAL CELL ACTIVATION | 7 | 6.30e-01 | -1.05e-01 | 9.40e-01 |
| GOBP REGULATION OF EXTENT OF CELL GROWTH | 71 | 1.27e-01 | -1.05e-01 | 6.32e-01 |
| GOBP ACTIN FILAMENT DEPOLYMERIZATION | 44 | 2.29e-01 | -1.05e-01 | 7.58e-01 |
| GOBP TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 43 | 2.34e-01 | 1.05e-01 | 7.63e-01 |
| GOCC MITOCHONDRIAL LARGE RIBOSOMAL SUBUNIT | 56 | 1.75e-01 | -1.05e-01 | 7.05e-01 |
| GOBP FOCAL ADHESION ASSEMBLY | 63 | 1.50e-01 | 1.05e-01 | 6.73e-01 |
| GOBP PLACENTA DEVELOPMENT | 102 | 6.76e-02 | 1.05e-01 | 5.08e-01 |
| GOCC NUCLEAR INCLUSION BODY | 12 | 5.30e-01 | 1.05e-01 | 9.23e-01 |
| GOBP REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 19 | 4.29e-01 | -1.05e-01 | 8.82e-01 |
| GOCC CUL4A RING E3 UBIQUITIN LIGASE COMPLEX | 13 | 5.13e-01 | -1.05e-01 | 9.18e-01 |
| GOBP HETEROTYPIC CELL CELL ADHESION | 43 | 2.35e-01 | -1.05e-01 | 7.63e-01 |
| GOBP REGULATION OF B CELL MEDIATED IMMUNITY | 47 | 2.14e-01 | 1.05e-01 | 7.46e-01 |
| GOBP ENDOTHELIAL CELL DEVELOPMENT | 46 | 2.20e-01 | 1.05e-01 | 7.49e-01 |
| GOBP REGULATION OF MICROVILLUS ASSEMBLY | 6 | 6.57e-01 | -1.05e-01 | 9.48e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 KINASE REGULATORY SUBUNIT BINDING | 7 | 6.32e-01 | -1.05e-01 | 9.41e-01 |
| GOCC DENDRITIC GROWTH CONE | 8 | 6.08e-01 | 1.05e-01 | 9.36e-01 |
| GOCC DYNEIN COMPLEX | 34 | 2.92e-01 | 1.05e-01 | 8.08e-01 |
| GOBP VASCULOGENESIS | 43 | 2.36e-01 | -1.04e-01 | 7.65e-01 |
| GOBP NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY | 9 | 5.87e-01 | -1.04e-01 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 8 | 6.09e-01 | -1.04e-01 | 9.36e-01 |
| GOBP MICROVILLUS ASSEMBLY | 20 | 4.19e-01 | 1.04e-01 | 8.79e-01 |
| GOCC BRUSH BORDER | 63 | 1.52e-01 | -1.04e-01 | 6.74e-01 |
| GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK MEMBRANE | 5 | 6.86e-01 | -1.04e-01 | 9.54e-01 |
| GOMF INSULIN BINDING | 5 | 6.86e-01 | 1.04e-01 | 9.54e-01 |
| GOCC RECYCLING ENDOSOME MEMBRANE | 85 | 9.67e-02 | 1.04e-01 | 5.77e-01 |
| GOMF LYSOPHOSPHOLIPASE ACTIVITY | 19 | 4.32e-01 | -1.04e-01 | 8.82e-01 |
| GOMF CELL ADHESION MEDIATOR ACTIVITY | 33 | 3.00e-01 | -1.04e-01 | 8.14e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS | 30 | 3.23e-01 | -1.04e-01 | 8.29e-01 |
| GOBP TRNA SURVEILLANCE | 8 | 6.10e-01 | 1.04e-01 | 9.36e-01 |
| GOBP EOSINOPHIL MEDIATED IMMUNITY | 6 | 6.59e-01 | 1.04e-01 | 9.49e-01 |
| GOBP MAINTENANCE OF CELL NUMBER | 139 | 3.43e-02 | 1.04e-01 | 3.78e-01 |
| GOBP SMOOTH MUSCLE CELL DIFFERENTIATION | 34 | 2.94e-01 | -1.04e-01 | 8.09e-01 |
| GOBP NEGATIVE REGULATION OF CELL CELL ADHESION | 127 | 4.32e-02 | 1.04e-01 | 4.24e-01 |
| GOMF TRANSLATION INITIATION FACTOR BINDING | 30 | 3.24e-01 | -1.04e-01 | 8.29e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 40 | 2.55e-01 | -1.04e-01 | 7.82e-01 |
| GOBP EPITHELIAL TUBE MORPHOGENESIS | 191 | 1.34e-02 | -1.04e-01 | 2.42e-01 |
| GOBP PROTEIN POLYUFMYLATION | 5 | 6.88e-01 | -1.04e-01 | 9.54e-01 |
| GOBP STRIATED MUSCLE ADAPTATION | 22 | 3.99e-01 | 1.04e-01 | 8.71e-01 |
| GOBP POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION | 16 | 4.72e-01 | 1.04e-01 | 9.02e-01 |
| GOBP STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 183 | 1.57e-02 | 1.04e-01 | 2.65e-01 |
| GOBP PHOSPHATE ION TRANSPORT | 18 | 4.46e-01 | -1.04e-01 | 8.88e-01 |
| GOBP RESPONSE TO PROSTAGLANDIN | 17 | 4.59e-01 | -1.04e-01 | 8.96e-01 |
| GOBP PROTEIN LOCALIZATION TO SITE OF DOUBLE STRAND BREAK | 6 | 6.60e-01 | 1.04e-01 | 9.49e-01 |
| GOMF PROFILIN BINDING | 10 | 5.71e-01 | -1.04e-01 | 9.31e-01 |
| GOMF METALLOAMINOPEPTIDASE ACTIVITY | 21 | 4.11e-01 | 1.04e-01 | 8.77e-01 |
| GOBP REGULATION OF TRANSMISSION OF NERVE IMPULSE | 5 | 6.88e-01 | 1.04e-01 | 9.54e-01 |
| GOBP INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION | 26 | 3.61e-01 | 1.04e-01 | 8.47e-01 |
| GOBP SULFUR AMINO ACID CATABOLIC PROCESS | 5 | 6.89e-01 | -1.04e-01 | 9.54e-01 |
| GOBP AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS | 10 | 5.71e-01 | 1.04e-01 | 9.31e-01 |
| GOBP CHROMOSOME MOVEMENT TOWARDS SPINDLE POLE | 6 | 6.61e-01 | -1.03e-01 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION | 63 | 1.56e-01 | -1.03e-01 | 6.79e-01 |
| GOCC CLATHRIN SCULPTED VESICLE | 6 | 6.61e-01 | -1.03e-01 | 9.49e-01 |
| GOBP REGULATION OF PROTEIN FOLDING | 8 | 6.13e-01 | -1.03e-01 | 9.36e-01 |
| GOBP CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER | 8 | 6.13e-01 | -1.03e-01 | 9.36e-01 |
| GOBP SCARNA LOCALIZATION TO CAJAL BODY | 5 | 6.89e-01 | -1.03e-01 | 9.54e-01 |
| GOBP MORPHOGENESIS OF EMBRYONIC EPITHELIUM | 92 | 8.74e-02 | -1.03e-01 | 5.57e-01 |
| GOCC HRD1P UBIQUITIN LIGASE ERAD L COMPLEX | 6 | 6.62e-01 | -1.03e-01 | 9.49e-01 |
| GOBP CAMERA TYPE EYE MORPHOGENESIS | 69 | 1.39e-01 | 1.03e-01 | 6.59e-01 |
| GOBP REGULATION OF HOMOTYPIC CELL CELL ADHESION | 22 | 4.02e-01 | 1.03e-01 | 8.72e-01 |
| GOBP PEPTIDYL SERINE DEPHOSPHORYLATION | 13 | 5.20e-01 | -1.03e-01 | 9.19e-01 |
| GOBP REGULATION OF LYMPHOCYTE ACTIVATION | 358 | 8.39e-04 | 1.03e-01 | 3.85e-02 |
| GOBP POSITIVE REGULATION OF BINDING | 96 | 8.11e-02 | 1.03e-01 | 5.41e-01 |
| GOBP VENTRICULAR SEPTUM MORPHOGENESIS | 25 | 3.72e-01 | 1.03e-01 | 8.58e-01 |
| GOBP NUCLEUS ORGANIZATION | 127 | 4.52e-02 | 1.03e-01 | 4.31e-01 |
| GOCC ACETYLTRANSFERASE COMPLEX | 91 | 8.97e-02 | -1.03e-01 | 5.59e-01 |
| GOMF DEATH RECEPTOR ACTIVITY | 9 | 5.93e-01 | -1.03e-01 | 9.36e-01 |
| GOBP PRIMARY ALCOHOL BIOSYNTHETIC PROCESS | 6 | 6.62e-01 | 1.03e-01 | 9.49e-01 |
| GOMF RIBONUCLEASE P ACTIVITY | 11 | 5.54e-01 | 1.03e-01 | 9.26e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERSPECIES INTERACTION BETWEEN ORGANISMS | 1115 | 9.86e-09 | 1.03e-01 | 2.95e-06 |
| GOBP PEPTIDYL THREONINE MODIFICATION | 90 | 9.17e-02 | 1.03e-01 | 5.63e-01 |
| GOBP MAMMALIAN OOGENESIS STAGE | 6 | 6.62e-01 | -1.03e-01 | 9.49e-01 |
| GOBP SYNAPTIC MEMBRANE ADHESION | 8 | 6.15e-01 | -1.03e-01 | 9.36e-01 |
| GOCC MYOSIN II COMPLEX | 12 | 5.38e-01 | 1.03e-01 | 9.23e-01 |
| GOBP GUANINE NUCLEOTIDE TRANSPORT | 8 | 6.15e-01 | -1.03e-01 | 9.36e-01 |
| GOBP SNRNA MODIFICATION | 7 | 6.38e-01 | 1.03e-01 | 9.41e-01 |
| GOCC SYNAPTONEMAL STRUCTURE | 23 | 3.94e-01 | 1.03e-01 | 8.69e-01 |
| GOCC TRANSCRIPTION ELONGATION FACTOR COMPLEX | 43 | 2.44e-01 | -1.03e-01 | 7.73e-01 |
| GOMF LYSOPHOSPHATIDIC ACID BINDING | 6 | 6.63e-01 | -1.03e-01 | 9.49e-01 |
| GOMF C ACETYLTRANSFERASE ACTIVITY | 7 | 6.38e-01 | -1.03e-01 | 9.41e-01 |
| GOMF L ASCORBIC ACID BINDING | 16 | 4.77e-01 | -1.03e-01 | 9.05e-01 |
| GOBP POSITIVE REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 5 | 6.91e-01 | -1.03e-01 | 9.54e-01 |
| GOMF TELOMERIC DNA BINDING | 37 | 2.80e-01 | -1.03e-01 | 7.99e-01 |
| GOBP REGULATION OF TYPE B PANCREATIC CELL DEVELOPMENT | 7 | 6.39e-01 | -1.03e-01 | 9.41e-01 |
| GOCC PROTEASOME ACCESSORY COMPLEX | 23 | 3.95e-01 | 1.02e-01 | 8.70e-01 |
| GOBP TRNA 5 END PROCESSING | 16 | 4.78e-01 | 1.02e-01 | 9.05e-01 |
| GOMF 5 DEOXYRIBOSE 5 PHOSPHATE LYASE ACTIVITY | 5 | 6.92e-01 | 1.02e-01 | 9.54e-01 |
| GOCC COP9 SIGNALOSOME | 15 | 4.92e-01 | -1.02e-01 | 9.13e-01 |
| GOMF SIGNALING RECEPTOR COMPLEX ADAPTOR ACTIVITY | 42 | 2.51e-01 | 1.02e-01 | 7.78e-01 |
| GOBP MEIOTIC CYTOKINESIS | 6 | 6.64e-01 | 1.02e-01 | 9.49e-01 |
| GOBP CRANIAL SKELETAL SYSTEM DEVELOPMENT | 37 | 2.82e-01 | 1.02e-01 | 8.00e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 9 | 5.95e-01 | 1.02e-01 | 9.36e-01 |
| GOBP GENOMIC IMPRINTING | 13 | 5.23e-01 | 1.02e-01 | 9.20e-01 |
| GOBP RIBOSE PHOSPHATE METABOLIC PROCESS | 321 | 1.70e-03 | -1.02e-01 | 6.52e-02 |
| GOBP RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 50 | 2.12e-01 | -1.02e-01 | 7.44e-01 |
| GOBP COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY | 8 | 6.17e-01 | 1.02e-01 | 9.36e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 11 | 5.58e-01 | 1.02e-01 | 9.27e-01 |
| GOBP REGULATION OF PROTEIN K63 LINKED UBIQUITINATION | 12 | 5.41e-01 | 1.02e-01 | 9.23e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION | 110 | 6.49e-02 | 1.02e-01 | 4.97e-01 |
| GOBP REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 27 | 3.59e-01 | 1.02e-01 | 8.46e-01 |
| GOMF NUCLEOCYTOPLASMIC CARRIER ACTIVITY | 31 | 3.26e-01 | -1.02e-01 | 8.29e-01 |
| GOBP ESTABLISHMENT OF EPITHELIAL CELL POLARITY | 27 | 3.59e-01 | 1.02e-01 | 8.46e-01 |
| GOMF R SMAD BINDING | 21 | 4.19e-01 | 1.02e-01 | 8.79e-01 |
| GOBP MESENCHYMAL TO EPITHELIAL TRANSITION | 9 | 5.97e-01 | 1.02e-01 | 9.36e-01 |
| GOCC VESICLE LUMEN | 253 | 5.40e-03 | -1.02e-01 | 1.37e-01 |
| GOCC CHROMOSOME CENTROMERIC REGION | 224 | 8.80e-03 | 1.02e-01 | 1.85e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE FIBER DEVELOPMENT | 5 | 6.93e-01 | 1.02e-01 | 9.54e-01 |
| GOBP KETONE BIOSYNTHETIC PROCESS | 34 | 3.04e-01 | -1.02e-01 | 8.15e-01 |
| GOMF CALCIUM SODIUM ANTIPORTER ACTIVITY | 5 | 6.93e-01 | -1.02e-01 | 9.54e-01 |
| GOBP REGULATION OF CIRCADIAN RHYTHM | 80 | 1.16e-01 | 1.02e-01 | 6.14e-01 |
| GOBP CELLULAR RESPONSE TO LEUCINE | 11 | 5.59e-01 | -1.02e-01 | 9.27e-01 |
| GOBP CALCINEURIN MEDIATED SIGNALING | 34 | 3.05e-01 | -1.02e-01 | 8.15e-01 |
| GOBP DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 39 | 2.72e-01 | 1.02e-01 | 7.94e-01 |
| GOBP POSITIVE REGULATION OF COAGULATION | 20 | 4.31e-01 | -1.02e-01 | 8.82e-01 |
| GOMF L GLUTAMATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 5.78e-01 | -1.02e-01 | 9.34e-01 |
| GOBP RESPONSE TO BACTERIUM | 385 | 6.49e-04 | 1.02e-01 | 3.19e-02 |
| GOBP MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 33 | 3.13e-01 | -1.01e-01 | 8.22e-01 |
| GOBP COPII COATED VESICLE BUDDING | 41 | 2.61e-01 | 1.01e-01 | 7.87e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 17 | 4.69e-01 | -1.01e-01 | 9.00e-01 |
| GOBP REGULATION OF ANIMAL ORGAN FORMATION | 10 | 5.79e-01 | -1.01e-01 | 9.34e-01 |
| GOCC GABA ERGIC SYNAPSE | 28 | 3.54e-01 | -1.01e-01 | 8.46e-01 |
| GOBP APOPTOTIC CELL CLEARANCE | 34 | 3.07e-01 | -1.01e-01 | 8.18e-01 |
| GOBP ANATOMICAL STRUCTURE REGRESSION | 5 | 6.95e-01 | -1.01e-01 | 9.54e-01 |
| GOBP MITOTIC SPINDLE ASSEMBLY | 67 | 1.52e-01 | 1.01e-01 | 6.74e-01 |
| GOBP INTRACELLULAR RECEPTOR SIGNALING PATHWAY | 268 | 4.42e-03 | 1.01e-01 | 1.24e-01 |
| GOBP SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING | 7 | 6.43e-01 | -1.01e-01 | 9.42e-01 |
| GOBP REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 726 | 4.00e-06 | 1.01e-01 | 5.89e-04 |
| GOBP POSITIVE REGULATION OF MEMBRANE PERMEABILITY | 41 | 2.62e-01 | -1.01e-01 | 7.87e-01 |
| GOBP REGULATION OF CELL MATRIX ADHESION | 85 | 1.07e-01 | 1.01e-01 | 5.97e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE BINDING | 57 | 1.87e-01 | 1.01e-01 | 7.17e-01 |
| GOMF HISTONE H4 ACETYLTRANSFERASE ACTIVITY | 22 | 4.12e-01 | -1.01e-01 | 8.77e-01 |
| GOBP PURINE CONTAINING COMPOUND SALVAGE | 13 | 5.28e-01 | -1.01e-01 | 9.22e-01 |
| GOBP REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 54 | 1.99e-01 | 1.01e-01 | 7.31e-01 |
| GOCC IMMUNOGLOBULIN COMPLEX | 6 | 6.68e-01 | -1.01e-01 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 6 | 6.68e-01 | -1.01e-01 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDE SECRETION | 23 | 4.02e-01 | 1.01e-01 | 8.72e-01 |
| GOBP NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 9 | 6.00e-01 | 1.01e-01 | 9.36e-01 |
| GOBP REGULATION OF CORTICOSTEROID HORMONE SECRETION | 8 | 6.21e-01 | -1.01e-01 | 9.38e-01 |
| GOBP LYMPHOCYTE COSTIMULATION | 31 | 3.31e-01 | 1.01e-01 | 8.31e-01 |
| GOMF LYSINE N METHYLTRANSFERASE ACTIVITY | 55 | 1.96e-01 | 1.01e-01 | 7.27e-01 |
| GOBP LABYRINTHINE LAYER MORPHOGENESIS | 13 | 5.29e-01 | -1.01e-01 | 9.23e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION IN CELL | 56 | 1.92e-01 | 1.01e-01 | 7.22e-01 |
| GOBP FIBROBLAST PROLIFERATION | 76 | 1.29e-01 | -1.01e-01 | 6.40e-01 |
| GOMF SIGNALING ADAPTOR ACTIVITY | 81 | 1.17e-01 | 1.01e-01 | 6.17e-01 |
| GOBP NUCLEOTIDE SALVAGE | 17 | 4.72e-01 | 1.01e-01 | 9.02e-01 |
| GOBP VENTRICULAR SYSTEM DEVELOPMENT | 26 | 3.74e-01 | -1.01e-01 | 8.60e-01 |
| GOBP ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS | 1383 | 6.17e-10 | -1.01e-01 | 2.23e-07 |
| GOBP MITOCHONDRIAL RIBOSOME ASSEMBLY | 10 | 5.81e-01 | -1.01e-01 | 9.35e-01 |
| GOBP RESPONSE TO NITROSATIVE STRESS | 9 | 6.01e-01 | 1.01e-01 | 9.36e-01 |
| GOBP NEURON MIGRATION | 104 | 7.64e-02 | -1.01e-01 | 5.30e-01 |
| GOBP HOMOCYSTEINE METABOLIC PROCESS | 8 | 6.22e-01 | -1.01e-01 | 9.39e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 78 | 1.25e-01 | -1.01e-01 | 6.29e-01 |
| GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 160 | 2.85e-02 | 1.01e-01 | 3.46e-01 |
| GOBP REGULATION OF HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS | 5 | 6.97e-01 | 1.00e-01 | 9.55e-01 |
| GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS | 10 | 5.82e-01 | 1.00e-01 | 9.36e-01 |
| GOCC APICOLATERAL PLASMA MEMBRANE | 9 | 6.02e-01 | -1.00e-01 | 9.36e-01 |
| GOBP SPINDLE ORGANIZATION | 181 | 2.02e-02 | 1.00e-01 | 2.96e-01 |
| GOMF DYNEIN HEAVY CHAIN BINDING | 8 | 6.24e-01 | -1.00e-01 | 9.40e-01 |
| GOMF NUCLEAR RECEPTOR BINDING | 116 | 6.25e-02 | 1.00e-01 | 4.87e-01 |
| GOBP TRIGLYCERIDE BIOSYNTHETIC PROCESS | 32 | 3.27e-01 | 1.00e-01 | 8.29e-01 |
| GOBP SPHINGOMYELIN BIOSYNTHETIC PROCESS | 10 | 5.84e-01 | 1.00e-01 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 52 | 2.12e-01 | -1.00e-01 | 7.45e-01 |
| GOBP CORPUS CALLOSUM DEVELOPMENT | 20 | 4.39e-01 | 1.00e-01 | 8.85e-01 |
| GOBP ESTROGEN BIOSYNTHETIC PROCESS | 7 | 6.47e-01 | -9.99e-02 | 9.43e-01 |
| GOBP RESPONSE TO ARSENIC CONTAINING SUBSTANCE | 28 | 3.60e-01 | -9.99e-02 | 8.46e-01 |
| GOBP REGULATION OF MRNA 3 END PROCESSING | 12 | 5.49e-01 | -9.99e-02 | 9.25e-01 |
| GOBP HIPPOCAMPUS DEVELOPMENT | 59 | 1.85e-01 | -9.99e-02 | 7.16e-01 |
| GOBP T CELL DIFFERENTIATION IN THYMUS | 58 | 1.89e-01 | 9.98e-02 | 7.18e-01 |
| GOBP REGULATION OF RNA EXPORT FROM NUCLEUS | 13 | 5.33e-01 | -9.98e-02 | 9.23e-01 |
| GOMF PROTEIN PRENYLTRANSFERASE ACTIVITY | 7 | 6.48e-01 | 9.98e-02 | 9.44e-01 |
| GOCC BLOOD MICROPARTICLE | 52 | 2.14e-01 | -9.97e-02 | 7.46e-01 |
| GOBP CELL RECOGNITION | 75 | 1.36e-01 | -9.97e-02 | 6.52e-01 |
| GOBP POSITIVE REGULATION OF MIRNA TRANSCRIPTION | 36 | 3.01e-01 | 9.96e-02 | 8.14e-01 |
| GOBP SECRETORY GRANULE ORGANIZATION | 43 | 2.59e-01 | 9.96e-02 | 7.85e-01 |
| GOBP FATTY ACID ELONGATION | 10 | 5.86e-01 | 9.96e-02 | 9.36e-01 |
| GOBP DETECTION OF MOLECULE OF BACTERIAL ORIGIN | 7 | 6.49e-01 | 9.95e-02 | 9.44e-01 |
| GOBP DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 24 | 3.99e-01 | -9.94e-02 | 8.71e-01 |
| GOBP NUCLEOTIDE TRANSPORT | 37 | 2.96e-01 | -9.94e-02 | 8.10e-01 |
| GOBP PROTEIN LOCALIZATION TO MITOCHONDRION | 123 | 5.73e-02 | -9.94e-02 | 4.70e-01 |
| GOBP MYELOID LEUKOCYTE ACTIVATION | 168 | 2.66e-02 | 9.93e-02 | 3.32e-01 |
| GOBP HISTONE UBIQUITINATION | 9 | 6.06e-01 | 9.93e-02 | 9.36e-01 |
| GOCC ASTER | 9 | 6.06e-01 | -9.93e-02 | 9.36e-01 |
| GOMF TRANSITION METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 34 | 3.17e-01 | -9.93e-02 | 8.23e-01 |
| GOMF ORGANIC HYDROXY COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 24 | 4.00e-01 | -9.93e-02 | 8.71e-01 |
| GOBP SPROUTING ANGIOGENESIS | 70 | 1.51e-01 | -9.92e-02 | 6.74e-01 |
| GOBP POSITIVE REGULATION OF MRNA METABOLIC PROCESS | 121 | 6.00e-02 | 9.91e-02 | 4.79e-01 |
| GOBP REGULATION OF PROTEIN SUMOYLATION | 20 | 4.43e-01 | 9.91e-02 | 8.87e-01 |
| GOBP GAMMA DELTA T CELL ACTIVATION | 13 | 5.36e-01 | 9.91e-02 | 9.23e-01 |
| GOBP MYELOID DENDRITIC CELL CYTOKINE PRODUCTION | 6 | 6.74e-01 | -9.91e-02 | 9.50e-01 |
| GOBP REGULATION OF DIGESTIVE SYSTEM PROCESS | 14 | 5.21e-01 | 9.90e-02 | 9.20e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 17 | 4.80e-01 | -9.90e-02 | 9.07e-01 |
| GOBP REGULATION OF LYSOSOMAL PROTEIN CATABOLIC PROCESS | 8 | 6.28e-01 | 9.90e-02 | 9.40e-01 |
| GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY PHOSPHOTRANSFERASES | 10 | 5.88e-01 | -9.90e-02 | 9.36e-01 |
| GOBP ECTOPIC GERM CELL PROGRAMMED CELL DEATH | 12 | 5.53e-01 | -9.89e-02 | 9.26e-01 |
| GOBP EXECUTION PHASE OF APOPTOSIS | 53 | 2.13e-01 | 9.89e-02 | 7.46e-01 |
| GOBP SULFUR COMPOUND CATABOLIC PROCESS | 29 | 3.57e-01 | -9.89e-02 | 8.46e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 9 | 6.08e-01 | -9.89e-02 | 9.36e-01 |
| GOBP REGULATION OF HEMOPOIESIS | 294 | 3.66e-03 | 9.88e-02 | 1.12e-01 |
| GOBP BIOGENIC AMINE METABOLIC PROCESS | 58 | 1.93e-01 | -9.88e-02 | 7.23e-01 |
| GOBP R LOOP PROCESSING | 6 | 6.75e-01 | 9.88e-02 | 9.51e-01 |
| GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION | 18 | 4.68e-01 | 9.87e-02 | 9.00e-01 |
| GOBP TRNA WOBBLE BASE MODIFICATION | 20 | 4.45e-01 | 9.87e-02 | 8.87e-01 |
| GOBP NEGATIVE REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 8 | 6.29e-01 | -9.87e-02 | 9.40e-01 |
| GOMF K48 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 10 | 5.89e-01 | -9.87e-02 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE | 39 | 2.87e-01 | 9.87e-02 | 8.05e-01 |
| GOBP DEOXYRIBONUCLEOSIDE CATABOLIC PROCESS | 5 | 7.03e-01 | 9.86e-02 | 9.56e-01 |
| GOBP DOPAMINE SECRETION | 15 | 5.08e-01 | 9.86e-02 | 9.18e-01 |
| GOBP STRIATED MUSCLE CONTRACTION | 103 | 8.41e-02 | 9.86e-02 | 5.46e-01 |
| GOMF CYTIDYLYLTRANSFERASE ACTIVITY | 9 | 6.09e-01 | -9.86e-02 | 9.36e-01 |
| GOCC ATPASE DEPENDENT TRANSMEMBRANE TRANSPORT COMPLEX | 10 | 5.89e-01 | -9.86e-02 | 9.36e-01 |
| GOBP RESCUE OF STALLED RIBOSOME | 25 | 3.94e-01 | 9.85e-02 | 8.69e-01 |
| GOMF GUANINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 7.04e-01 | 9.83e-02 | 9.56e-01 |
| GOBP OLIGOSACCHARIDE CATABOLIC PROCESS | 11 | 5.73e-01 | 9.83e-02 | 9.32e-01 |
| GOBP PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 12 | 5.56e-01 | 9.82e-02 | 9.26e-01 |
| GOBP LEUKOCYTE TETHERING OR ROLLING | 16 | 4.97e-01 | -9.82e-02 | 9.13e-01 |
| GOBP ENDODERMAL CELL FATE COMMITMENT | 7 | 6.53e-01 | -9.82e-02 | 9.46e-01 |
| GOBP ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE | 8 | 6.31e-01 | -9.82e-02 | 9.40e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYPOXIA | 9 | 6.10e-01 | -9.81e-02 | 9.36e-01 |
| GOBP PROTEOGLYCAN BIOSYNTHETIC PROCESS | 43 | 2.66e-01 | -9.81e-02 | 7.91e-01 |
| GOCC PLATELET ALPHA GRANULE LUMEN | 44 | 2.61e-01 | -9.81e-02 | 7.87e-01 |
| GOBP POSITIVE REGULATION OF MACROAUTOPHAGY | 64 | 1.75e-01 | 9.81e-02 | 7.05e-01 |
| GOMF RIBOSOME BINDING | 103 | 8.58e-02 | -9.81e-02 | 5.52e-01 |
| GOBP RESPONSE TO VITAMIN E | 6 | 6.78e-01 | -9.80e-02 | 9.51e-01 |
| GOMF IMMUNE RECEPTOR ACTIVITY | 78 | 1.35e-01 | 9.80e-02 | 6.52e-01 |
| GOBP LACTATION | 26 | 3.87e-01 | 9.80e-02 | 8.65e-01 |
| GOBP NEGATIVE REGULATION BY HOST OF VIRAL PROCESS | 13 | 5.41e-01 | 9.80e-02 | 9.23e-01 |
| GOBP PURINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 18 | 4.72e-01 | 9.79e-02 | 9.02e-01 |
| GOBP REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 41 | 2.78e-01 | 9.79e-02 | 7.99e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 419 | 6.18e-04 | 9.79e-02 | 3.05e-02 |
| GOMF AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 52 | 2.22e-01 | -9.79e-02 | 7.51e-01 |
| GOMF N METHYLTRANSFERASE ACTIVITY | 85 | 1.19e-01 | 9.79e-02 | 6.20e-01 |
| GOBP PHOSPHATE ION HOMEOSTASIS | 6 | 6.78e-01 | -9.79e-02 | 9.52e-01 |
| GOCC POLE PLASM | 13 | 5.41e-01 | 9.79e-02 | 9.23e-01 |
| GOMF U2 SNRNA BINDING | 6 | 6.78e-01 | -9.78e-02 | 9.52e-01 |
| GOBP CELLULAR RESPONSE TO STEROL DEPLETION | 13 | 5.42e-01 | 9.78e-02 | 9.23e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS | 68 | 1.63e-01 | 9.78e-02 | 6.89e-01 |
| GOBP ALPHA LINOLENIC ACID METABOLIC PROCESS | 8 | 6.32e-01 | 9.78e-02 | 9.41e-01 |
| GOBP LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE | 8 | 6.32e-01 | -9.78e-02 | 9.41e-01 |
| GOBP INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS | 6 | 6.78e-01 | 9.77e-02 | 9.52e-01 |
| GOBP INTRACELLULAR IRON ION HOMEOSTASIS | 54 | 2.14e-01 | -9.77e-02 | 7.46e-01 |
| GOBP PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 22 | 4.28e-01 | -9.77e-02 | 8.82e-01 |
| GOBP REGULATION OF AMYLOID FIBRIL FORMATION | 13 | 5.42e-01 | -9.77e-02 | 9.23e-01 |
| GOBP PROTEIN AUTOPHOSPHORYLATION | 148 | 4.06e-02 | 9.77e-02 | 4.12e-01 |
| GOMF MODIFIED AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 27 | 3.80e-01 | -9.76e-02 | 8.62e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON CARBON BONDS | 7 | 6.55e-01 | 9.76e-02 | 9.46e-01 |
| GOCC PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN | 11 | 5.75e-01 | -9.76e-02 | 9.33e-01 |
| GOMF POLYPEPTIDE N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 13 | 5.43e-01 | -9.75e-02 | 9.23e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 17 | 4.86e-01 | 9.75e-02 | 9.11e-01 |
| GOMF INORGANIC DIPHOSPHATE PHOSPHATASE ACTIVITY | 5 | 7.06e-01 | 9.75e-02 | 9.57e-01 |
| GOMF VINCULIN BINDING | 9 | 6.12e-01 | 9.75e-02 | 9.36e-01 |
| GOCC CONDENSED CHROMOSOME CENTROMERIC REGION | 170 | 2.86e-02 | 9.75e-02 | 3.46e-01 |
| GOBP ACID SECRETION | 20 | 4.51e-01 | -9.75e-02 | 8.89e-01 |
| GOBP CELLULAR RESPONSE TO VITAMIN D | 13 | 5.43e-01 | 9.74e-02 | 9.23e-01 |
| GOBP REGULATION OF PROTEIN ADP RIBOSYLATION | 8 | 6.34e-01 | -9.73e-02 | 9.41e-01 |
| GOMF CYTOCHROME B5 REDUCTASE ACTIVITY ACTING ON NAD P H | 5 | 7.06e-01 | -9.73e-02 | 9.57e-01 |
| GOCC AXON CYTOPLASM | 50 | 2.34e-01 | 9.73e-02 | 7.63e-01 |
| GOBP REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 24 | 4.10e-01 | -9.71e-02 | 8.77e-01 |
| GOCC MICROTUBULE ASSOCIATED COMPLEX | 116 | 7.11e-02 | 9.71e-02 | 5.17e-01 |
| GOBP CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION | 29 | 3.66e-01 | 9.71e-02 | 8.52e-01 |
| GOBP REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE | 16 | 5.01e-01 | 9.71e-02 | 9.15e-01 |
| GOMF PYRUVATE DEHYDROGENASE ACTIVITY | 5 | 7.07e-01 | -9.71e-02 | 9.57e-01 |
| GOBP PLASMA MEMBRANE RAFT ASSEMBLY | 5 | 7.07e-01 | 9.71e-02 | 9.57e-01 |
| GOBP MOLTING CYCLE PROCESS | 49 | 2.40e-01 | 9.70e-02 | 7.68e-01 |
| GOBP CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 21 | 4.42e-01 | -9.70e-02 | 8.86e-01 |
| GOMF STRUCTURAL CONSTITUENT OF SYNAPSE | 14 | 5.30e-01 | -9.70e-02 | 9.23e-01 |
| GOBP DNA STRAND ELONGATION | 36 | 3.14e-01 | -9.70e-02 | 8.22e-01 |
| GOBP REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 40 | 2.89e-01 | 9.69e-02 | 8.06e-01 |
| GOBP RRNA PSEUDOURIDINE SYNTHESIS | 8 | 6.35e-01 | 9.69e-02 | 9.41e-01 |
| GOBP MRNA ALTERNATIVE POLYADENYLATION | 5 | 7.08e-01 | -9.68e-02 | 9.58e-01 |
| GOBP CELLULAR RESPONSE TO ALCOHOL | 61 | 1.91e-01 | 9.68e-02 | 7.21e-01 |
| GOBP NEGATIVE REGULATION OF MRNA METABOLIC PROCESS | 74 | 1.50e-01 | 9.67e-02 | 6.73e-01 |
| GOBP CIRCADIAN RHYTHM | 139 | 4.93e-02 | 9.67e-02 | 4.46e-01 |
| GOBP CEREBELLAR GRANULAR LAYER DEVELOPMENT | 6 | 6.82e-01 | -9.67e-02 | 9.52e-01 |
| GOBP POSITIVE REGULATION OF CATION CHANNEL ACTIVITY | 31 | 3.51e-01 | 9.67e-02 | 8.46e-01 |
| GOBP RESPONSE TO ALKALOID | 61 | 1.92e-01 | 9.66e-02 | 7.22e-01 |
| GOBP EYE MORPHOGENESIS | 83 | 1.28e-01 | 9.66e-02 | 6.37e-01 |
| GOBP MEMBRANE FUSION | 133 | 5.47e-02 | 9.66e-02 | 4.63e-01 |
| GOBP ENDOCYTIC RECYCLING | 77 | 1.43e-01 | 9.66e-02 | 6.65e-01 |
| GOBP REGULATION OF RESPONSE TO FOOD | 8 | 6.36e-01 | -9.66e-02 | 9.41e-01 |
| GOBP DEHYDROASCORBIC ACID TRANSPORT | 5 | 7.08e-01 | -9.66e-02 | 9.58e-01 |
| GOMF DEHYDROASCORBIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 7.08e-01 | -9.66e-02 | 9.58e-01 |
| GOMF D GLUCOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 7.08e-01 | -9.66e-02 | 9.58e-01 |
| GOBP RECEPTOR SIGNALING PATHWAY VIA STAT | 105 | 8.78e-02 | 9.65e-02 | 5.58e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO HYPOXIA | 9 | 6.16e-01 | -9.65e-02 | 9.36e-01 |
| GOBP REGULATION OF MYELINATION | 31 | 3.53e-01 | 9.65e-02 | 8.46e-01 |
| GOBP MUSCLE ADAPTATION | 64 | 1.83e-01 | 9.64e-02 | 7.13e-01 |
| GOBP CITRATE METABOLIC PROCESS | 5 | 7.09e-01 | -9.63e-02 | 9.58e-01 |
| GOBP MITOCHONDRION MORPHOGENESIS | 19 | 4.68e-01 | 9.62e-02 | 9.00e-01 |
| GOBP REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 8 | 6.38e-01 | -9.62e-02 | 9.41e-01 |
| GOBP POSITIVE REGULATION OF LIPASE ACTIVITY | 32 | 3.47e-01 | -9.61e-02 | 8.43e-01 |
| GOMF DYNEIN COMPLEX BINDING | 18 | 4.80e-01 | 9.61e-02 | 9.08e-01 |
| GOBP APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 23 | 4.25e-01 | 9.61e-02 | 8.81e-01 |
| GOBP ESTABLISHMENT OF SKIN BARRIER | 14 | 5.34e-01 | -9.60e-02 | 9.23e-01 |
| GOBP MITOCHONDRION DISTRIBUTION | 13 | 5.49e-01 | 9.60e-02 | 9.25e-01 |
| GOCC PRESYNAPTIC CYTOSKELETON | 5 | 7.10e-01 | -9.60e-02 | 9.59e-01 |
| GOBP ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS | 12 | 5.65e-01 | -9.60e-02 | 9.29e-01 |
| GOBP MACROPHAGE INFLAMMATORY PROTEIN 1 ALPHA PRODUCTION | 5 | 7.10e-01 | -9.59e-02 | 9.59e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS | 341 | 2.42e-03 | 9.59e-02 | 8.33e-02 |
| GOCC SAGA TYPE COMPLEX | 36 | 3.20e-01 | -9.59e-02 | 8.26e-01 |
| GOBP CHOLESTEROL EFFLUX | 37 | 3.13e-01 | -9.58e-02 | 8.22e-01 |
| GOBP PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER | 35 | 3.27e-01 | 9.58e-02 | 8.29e-01 |
| GOCC NUCLEAR STRESS GRANULE | 6 | 6.85e-01 | -9.58e-02 | 9.53e-01 |
| GOBP VESICLE TARGETING | 62 | 1.93e-01 | 9.58e-02 | 7.22e-01 |
| GOBP HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE | 24 | 4.18e-01 | -9.56e-02 | 8.79e-01 |
| GOBP RETICULOPHAGY | 17 | 4.95e-01 | -9.56e-02 | 9.13e-01 |
| GOMF FATTY ACID DERIVATIVE BINDING | 14 | 5.36e-01 | 9.56e-02 | 9.23e-01 |
| GOMF NADPLUS BINDING | 17 | 4.96e-01 | 9.55e-02 | 9.13e-01 |
| GOCC TRANS GOLGI NETWORK MEMBRANE | 87 | 1.24e-01 | 9.54e-02 | 6.28e-01 |
| GOBP UBIQUITIN DEPENDENT GLYCOPROTEIN ERAD PATHWAY | 7 | 6.62e-01 | 9.54e-02 | 9.49e-01 |
| GOMF MANNOSYL OLIGOSACCHARIDE 1 2 ALPHA MANNOSIDASE ACTIVITY | 7 | 6.62e-01 | 9.54e-02 | 9.49e-01 |
| GOBP REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 18 | 4.84e-01 | -9.54e-02 | 9.09e-01 |
| GOBP CARDIAC SEPTUM MORPHOGENESIS | 42 | 2.85e-01 | 9.54e-02 | 8.04e-01 |
| GOBP GLUTAMATE SECRETION | 13 | 5.52e-01 | -9.54e-02 | 9.26e-01 |
| GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 43 | 2.80e-01 | 9.54e-02 | 7.99e-01 |
| GOCC FILAMENTOUS ACTIN | 20 | 4.60e-01 | -9.54e-02 | 8.97e-01 |
| GOBP MITOTIC G2 DNA DAMAGE CHECKPOINT SIGNALING | 35 | 3.29e-01 | 9.53e-02 | 8.30e-01 |
| GOMF PHOSPHOLIPASE BINDING | 15 | 5.23e-01 | 9.53e-02 | 9.20e-01 |
| GOBP POSTREPLICATION REPAIR | 33 | 3.44e-01 | -9.53e-02 | 8.41e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS DISULFIDE AS ACCEPTOR | 7 | 6.62e-01 | -9.53e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 5 | 7.12e-01 | 9.53e-02 | 9.59e-01 |
| GOBP NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 18 | 4.84e-01 | 9.52e-02 | 9.10e-01 |
| GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 32 | 3.51e-01 | 9.52e-02 | 8.46e-01 |
| GOBP REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 16 | 5.10e-01 | 9.52e-02 | 9.18e-01 |
| GOMF STRUCTURAL CONSTITUENT OF POSTSYNAPSE | 11 | 5.85e-01 | -9.52e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION | 113 | 8.09e-02 | 9.52e-02 | 5.41e-01 |
| GOBP OLIGOSACCHARIDE METABOLIC PROCESS | 35 | 3.30e-01 | 9.52e-02 | 8.30e-01 |
| GOMF CYSTEINE TYPE EXOPEPTIDASE ACTIVITY | 6 | 6.87e-01 | 9.51e-02 | 9.54e-01 |
| GOBP ACTIN FILAMENT BASED MOVEMENT | 82 | 1.37e-01 | 9.51e-02 | 6.54e-01 |
| GOBP COCHLEA DEVELOPMENT | 17 | 4.97e-01 | -9.51e-02 | 9.13e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 50 | 2.45e-01 | -9.51e-02 | 7.73e-01 |
| GOBP DNA DEALKYLATION INVOLVED IN DNA REPAIR | 9 | 6.21e-01 | 9.51e-02 | 9.38e-01 |
| GOBP MYELOID LEUKOCYTE MEDIATED IMMUNITY | 79 | 1.45e-01 | 9.50e-02 | 6.66e-01 |
| GOMF SECONDARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 174 | 3.09e-02 | -9.50e-02 | 3.54e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION | 16 | 5.11e-01 | -9.50e-02 | 9.18e-01 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 40 | 2.99e-01 | 9.50e-02 | 8.13e-01 |
| GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE PHOSPHATASE ACTIVITY | 12 | 5.69e-01 | -9.49e-02 | 9.31e-01 |
| GOCC GAMMA SECRETASE COMPLEX | 7 | 6.64e-01 | 9.49e-02 | 9.49e-01 |
| GOBP DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS | 25 | 4.11e-01 | 9.49e-02 | 8.77e-01 |
| GOBP DNA TEMPLATED DNA REPLICATION | 152 | 4.38e-02 | -9.49e-02 | 4.26e-01 |
| GOCC PML BODY | 98 | 1.05e-01 | 9.49e-02 | 5.94e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE CHECKPOINT | 5 | 7.13e-01 | 9.49e-02 | 9.59e-01 |
| GOBP MESENCHYMAL STEM CELL PROLIFERATION | 5 | 7.14e-01 | -9.48e-02 | 9.59e-01 |
| GOBP POSITIVE REGULATION OF MESENCHYMAL STEM CELL PROLIFERATION | 5 | 7.14e-01 | -9.48e-02 | 9.59e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MONOUBIQUITINATION | 5 | 7.14e-01 | 9.48e-02 | 9.59e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED FLAVIN OR FLAVOPROTEIN AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 10 | 6.04e-01 | -9.47e-02 | 9.36e-01 |
| GOBP RESPONSE TO PURINE CONTAINING COMPOUND | 87 | 1.27e-01 | 9.47e-02 | 6.34e-01 |
| GOBP DEFENSE RESPONSE | 1120 | 1.25e-07 | 9.47e-02 | 2.59e-05 |
| GOBP DENDRITIC SPINE DEVELOPMENT | 70 | 1.71e-01 | 9.47e-02 | 6.99e-01 |
| GOBP PROTEIN SUMOYLATION | 60 | 2.05e-01 | 9.47e-02 | 7.33e-01 |
| GOMF ADENYLATE CYCLASE REGULATOR ACTIVITY | 6 | 6.88e-01 | -9.47e-02 | 9.54e-01 |
| GOBP POSITIVE REGULATION OF CENTRIOLE ELONGATION | 5 | 7.14e-01 | -9.46e-02 | 9.59e-01 |
| GOBP REGULATION OF FATTY ACID BETA OXIDATION | 14 | 5.40e-01 | 9.45e-02 | 9.23e-01 |
| GOBP VITAMIN D METABOLIC PROCESS | 8 | 6.43e-01 | -9.45e-02 | 9.42e-01 |
| GOMF UBIQUITIN LIKE PROTEIN LIGASE ACTIVITY | 280 | 6.69e-03 | 9.44e-02 | 1.57e-01 |
| GOCC PROTEASOME REGULATORY PARTICLE BASE SUBCOMPLEX | 9 | 6.24e-01 | 9.43e-02 | 9.40e-01 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT | 61 | 2.03e-01 | -9.43e-02 | 7.32e-01 |
| GOMF CHONDROITIN SULFATE BINDING | 6 | 6.89e-01 | -9.43e-02 | 9.54e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING ALKYL OR ARYL OTHER THAN METHYL GROUPS | 50 | 2.49e-01 | -9.42e-02 | 7.76e-01 |
| GOBP REGULATION OF CELL CYCLE CHECKPOINT | 44 | 2.80e-01 | 9.42e-02 | 7.99e-01 |
| GOCC CLUSTER OF ACTIN BASED CELL PROJECTIONS | 97 | 1.09e-01 | -9.42e-02 | 6.00e-01 |
| GOCC CHLORIDE CHANNEL COMPLEX | 18 | 4.89e-01 | -9.41e-02 | 9.12e-01 |
| GOBP RESPONSE TO THYROID HORMONE | 21 | 4.55e-01 | -9.41e-02 | 8.94e-01 |
| GOBP MEIOTIC SISTER CHROMATID COHESION | 13 | 5.57e-01 | 9.41e-02 | 9.27e-01 |
| GOBP ACTIN MEDIATED CELL CONTRACTION | 59 | 2.12e-01 | 9.41e-02 | 7.44e-01 |
| GOCC U7 SNRNP | 7 | 6.67e-01 | -9.41e-02 | 9.49e-01 |
| GOBP RESPONSE TO AMYLOID BETA | 32 | 3.57e-01 | -9.41e-02 | 8.46e-01 |
| GOBP TRNA THIO MODIFICATION | 5 | 7.16e-01 | 9.40e-02 | 9.59e-01 |
| GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 23 | 4.35e-01 | 9.40e-02 | 8.83e-01 |
| GOBP DICARBOXYLIC ACID METABOLIC PROCESS | 68 | 1.80e-01 | -9.40e-02 | 7.11e-01 |
| GOBP REGULATION OF CHROMOSOME ORGANIZATION | 226 | 1.51e-02 | 9.40e-02 | 2.59e-01 |
| GOBP SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT | 18 | 4.90e-01 | 9.39e-02 | 9.12e-01 |
| GOBP POSITIVE REGULATION OF MAP KINASE ACTIVITY | 57 | 2.20e-01 | 9.39e-02 | 7.49e-01 |
| GOBP LYMPHOCYTE MIGRATION | 76 | 1.57e-01 | -9.39e-02 | 6.80e-01 |
| GOBP GLYCOLIPID TRANSPORT | 8 | 6.46e-01 | -9.38e-02 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID BETA OXIDATION | 7 | 6.67e-01 | -9.38e-02 | 9.49e-01 |
| GOMF SIGNAL RECOGNITION PARTICLE BINDING | 7 | 6.67e-01 | -9.38e-02 | 9.49e-01 |
| GOBP INTRACELLULAR LIPID TRANSPORT | 41 | 3.00e-01 | 9.37e-02 | 8.14e-01 |
| GOBP MYOBLAST PROLIFERATION | 14 | 5.44e-01 | 9.36e-02 | 9.23e-01 |
| GOBP POSITIVE REGULATION OF HEART GROWTH | 14 | 5.44e-01 | 9.36e-02 | 9.23e-01 |
| GOBP CARDIAC MUSCLE TISSUE MORPHOGENESIS | 25 | 4.18e-01 | 9.36e-02 | 8.79e-01 |
| GOBP MRNA TRANSCRIPTION | 47 | 2.67e-01 | 9.36e-02 | 7.91e-01 |
| GOCC CHROMAFFIN GRANULE MEMBRANE | 6 | 6.92e-01 | 9.36e-02 | 9.54e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL POPULATION MAINTENANCE | 21 | 4.58e-01 | 9.35e-02 | 8.96e-01 |
| GOMF TYPE II TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 9 | 6.27e-01 | 9.35e-02 | 9.40e-01 |
| GOMF SIGNALING RECEPTOR REGULATOR ACTIVITY | 186 | 2.83e-02 | -9.34e-02 | 3.45e-01 |
| GOBP MOLTING CYCLE | 57 | 2.23e-01 | 9.34e-02 | 7.51e-01 |
| GOBP REGULATION OF BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS | 9 | 6.28e-01 | -9.33e-02 | 9.40e-01 |
| GOBP LIVER REGENERATION | 20 | 4.70e-01 | -9.33e-02 | 9.01e-01 |
| GOBP CELLULAR RESPONSE TO CADMIUM ION | 28 | 3.93e-01 | -9.33e-02 | 8.68e-01 |
| GOBP TRANSLESION SYNTHESIS | 24 | 4.29e-01 | -9.33e-02 | 8.82e-01 |
| GOBP CELLULAR RESPONSE TO OSMOTIC STRESS | 42 | 2.96e-01 | -9.33e-02 | 8.10e-01 |
| GOMF SULFUR COMPOUND BINDING | 137 | 5.99e-02 | -9.32e-02 | 4.79e-01 |
| GOMF ARP2 3 COMPLEX BINDING | 12 | 5.76e-01 | 9.32e-02 | 9.33e-01 |
| GOBP REGULATION OF HEART GROWTH | 31 | 3.69e-01 | 9.32e-02 | 8.55e-01 |
| GOBP REGULATION OF IMMUNE SYSTEM PROCESS | 1032 | 5.53e-07 | 9.32e-02 | 1.07e-04 |
| GOBP PROTEIN DNA COMPLEX DISASSEMBLY | 17 | 5.06e-01 | 9.32e-02 | 9.16e-01 |
| GOBP REGULATION OF TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE | 19 | 4.82e-01 | -9.32e-02 | 9.08e-01 |
| GOBP B CELL MEDIATED IMMUNITY | 95 | 1.17e-01 | 9.31e-02 | 6.17e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL PROLIFERATION | 11 | 5.93e-01 | -9.31e-02 | 9.36e-01 |
| GOBP AMMONIUM TRANSMEMBRANE TRANSPORT | 8 | 6.49e-01 | 9.31e-02 | 9.44e-01 |
| GOMF AMMONIUM TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 6.49e-01 | 9.31e-02 | 9.44e-01 |
| GOBP CMP METABOLIC PROCESS | 7 | 6.70e-01 | 9.31e-02 | 9.49e-01 |
| GOBP GLOMERULAR EPITHELIAL CELL DIFFERENTIATION | 11 | 5.93e-01 | 9.30e-02 | 9.36e-01 |
| GOBP REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 81 | 1.48e-01 | 9.29e-02 | 6.72e-01 |
| GOMF CHITIN BINDING | 6 | 6.94e-01 | -9.29e-02 | 9.54e-01 |
| GOBP REGULATION OF CALCIUM MEDIATED SIGNALING | 58 | 2.21e-01 | -9.29e-02 | 7.49e-01 |
| GOBP SOMATIC STEM CELL DIVISION | 5 | 7.19e-01 | 9.29e-02 | 9.60e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGY | 124 | 7.45e-02 | 9.29e-02 | 5.26e-01 |
| GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION | 6 | 6.94e-01 | 9.28e-02 | 9.54e-01 |
| GOBP RESPONSE TO PLATELET DERIVED GROWTH FACTOR | 18 | 4.96e-01 | 9.28e-02 | 9.13e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION | 10 | 6.11e-01 | 9.28e-02 | 9.36e-01 |
| GOBP REGULATION OF INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 6 | 6.94e-01 | -9.27e-02 | 9.54e-01 |
| GOBP NEUROMUSCULAR PROCESS CONTROLLING BALANCE | 27 | 4.04e-01 | 9.27e-02 | 8.72e-01 |
| GOBP REGULATION OF CELL SHAPE | 111 | 9.18e-02 | -9.27e-02 | 5.63e-01 |
| GOBP PROTEIN HOMOTETRAMERIZATION | 44 | 2.88e-01 | 9.27e-02 | 8.05e-01 |
| GOBP POSITIVE REGULATION OF AXONOGENESIS | 51 | 2.52e-01 | -9.27e-02 | 7.78e-01 |
| GOBP POSITIVE REGULATION OF AMIDE METABOLIC PROCESS | 139 | 5.97e-02 | -9.26e-02 | 4.79e-01 |
| GOBP SUPEROXIDE METABOLIC PROCESS | 40 | 3.11e-01 | 9.26e-02 | 8.21e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION | 33 | 3.57e-01 | 9.26e-02 | 8.46e-01 |
| GOBP ENDOCRINE HORMONE SECRETION | 25 | 4.23e-01 | -9.26e-02 | 8.81e-01 |
| GOBP REGULATION OF EMBRYONIC DEVELOPMENT | 68 | 1.87e-01 | 9.25e-02 | 7.17e-01 |
| GOMF INTERLEUKIN 1 BINDING | 6 | 6.95e-01 | -9.25e-02 | 9.54e-01 |
| GOBP POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 14 | 5.49e-01 | 9.25e-02 | 9.25e-01 |
| GOBP NEUTROPHIL MIGRATION | 84 | 1.43e-01 | -9.25e-02 | 6.65e-01 |
| GOMF HEPARAN SULFATE PROTEOGLYCAN BINDING | 6 | 6.95e-01 | 9.25e-02 | 9.54e-01 |
| GOBP PROTEIN O LINKED GLYCOSYLATION | 70 | 1.81e-01 | 9.25e-02 | 7.12e-01 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION | 6 | 6.95e-01 | -9.24e-02 | 9.54e-01 |
| GOMF METAL CLUSTER BINDING | 64 | 2.01e-01 | -9.24e-02 | 7.32e-01 |
| GOBP NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 108 | 9.73e-02 | 9.24e-02 | 5.77e-01 |
| GOBP WYBUTOSINE METABOLIC PROCESS | 6 | 6.95e-01 | -9.24e-02 | 9.54e-01 |
| GOBP CELLULAR RESPONSE TO FLUID SHEAR STRESS | 16 | 5.22e-01 | -9.24e-02 | 9.20e-01 |
| GOBP POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY | 84 | 1.44e-01 | -9.24e-02 | 6.65e-01 |
| GOBP RESPONSE TO FOOD | 19 | 4.86e-01 | 9.24e-02 | 9.11e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE PHOSPHATASE ACTIVITY | 27 | 4.06e-01 | 9.24e-02 | 8.74e-01 |
| GOBP POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 88 | 1.35e-01 | 9.23e-02 | 6.52e-01 |
| GOBP MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 13 | 5.65e-01 | 9.22e-02 | 9.29e-01 |
| GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 5 | 7.21e-01 | 9.22e-02 | 9.62e-01 |
| GOBP REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 28 | 3.99e-01 | -9.21e-02 | 8.71e-01 |
| GOMF HISTONE BINDING | 217 | 1.96e-02 | 9.21e-02 | 2.91e-01 |
| GOMF TASTE RECEPTOR ACTIVITY | 5 | 7.21e-01 | -9.21e-02 | 9.62e-01 |
| GOBP POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION | 31 | 3.75e-01 | 9.21e-02 | 8.60e-01 |
| GOBP MACROPHAGE CYTOKINE PRODUCTION | 30 | 3.83e-01 | 9.21e-02 | 8.64e-01 |
| GOBP RESPONSE TO MURAMYL DIPEPTIDE | 18 | 4.99e-01 | 9.20e-02 | 9.14e-01 |
| GOMF PROTEIN SEQUESTERING ACTIVITY | 21 | 4.66e-01 | -9.19e-02 | 9.00e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME MATURATION | 5 | 7.22e-01 | -9.19e-02 | 9.62e-01 |
| GOBP REGULATION OF MUSCLE TISSUE DEVELOPMENT | 20 | 4.77e-01 | 9.19e-02 | 9.05e-01 |
| GOMF S100 PROTEIN BINDING | 12 | 5.82e-01 | -9.19e-02 | 9.35e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR BINDING | 133 | 6.80e-02 | -9.18e-02 | 5.09e-01 |
| GOBP REGULATION OF LEUKOCYTE PROLIFERATION | 182 | 3.31e-02 | 9.17e-02 | 3.72e-01 |
| GOMF G PROTEIN ACTIVITY | 36 | 3.41e-01 | -9.17e-02 | 8.39e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 27 | 4.10e-01 | -9.17e-02 | 8.77e-01 |
| GOBP REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 49 | 2.67e-01 | 9.16e-02 | 7.91e-01 |
| GOCC RNA CAP BINDING COMPLEX | 19 | 4.89e-01 | -9.16e-02 | 9.12e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 8 | 6.54e-01 | -9.16e-02 | 9.46e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS | 39 | 3.22e-01 | -9.16e-02 | 8.29e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO HEAT | 15 | 5.39e-01 | 9.16e-02 | 9.23e-01 |
| GOBP ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 134 | 6.77e-02 | 9.15e-02 | 5.08e-01 |
| GOBP POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE | 117 | 8.76e-02 | -9.15e-02 | 5.58e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT ENDOSOME TO POSTSYNAPTIC MEMBRANE | 9 | 6.35e-01 | 9.15e-02 | 9.41e-01 |
| GOBP AGGREPHAGY | 8 | 6.54e-01 | -9.14e-02 | 9.46e-01 |
| GOBP ENTRY INTO HOST | 120 | 8.40e-02 | 9.14e-02 | 5.46e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 8 | 6.54e-01 | 9.14e-02 | 9.46e-01 |
| GOMF MYRISTOYLTRANSFERASE ACTIVITY | 10 | 6.17e-01 | 9.14e-02 | 9.36e-01 |
| GOBP BONE REMODELING | 56 | 2.37e-01 | -9.14e-02 | 7.67e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 60 | 2.21e-01 | 9.14e-02 | 7.49e-01 |
| GOBP RESPONSE TO INCREASED OXYGEN LEVELS | 22 | 4.58e-01 | -9.13e-02 | 8.96e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CONTRACTION | 7 | 6.76e-01 | 9.13e-02 | 9.51e-01 |
| GOBP RESPONSE TO ESTROGEN | 43 | 3.00e-01 | -9.13e-02 | 8.14e-01 |
| GOBP REGULATORY NCRNA PROCESSING | 63 | 2.11e-01 | 9.12e-02 | 7.44e-01 |
| GOMF PHOSPHOTRANSFERASE ACTIVITY PHOSPHATE GROUP AS ACCEPTOR | 32 | 3.72e-01 | -9.12e-02 | 8.57e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL | 107 | 1.04e-01 | 9.11e-02 | 5.94e-01 |
| GOBP MITOCHONDRIAL RNA 3 END PROCESSING | 6 | 6.99e-01 | 9.11e-02 | 9.55e-01 |
| GOMF RNA METHYLTRANSFERASE ACTIVITY | 62 | 2.15e-01 | 9.11e-02 | 7.46e-01 |
| GOMF RNA 2 O METHYLTRANSFERASE ACTIVITY | 9 | 6.36e-01 | 9.11e-02 | 9.41e-01 |
| GOBP SULFUR COMPOUND METABOLIC PROCESS | 225 | 1.89e-02 | -9.10e-02 | 2.88e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 7.00e-01 | -9.10e-02 | 9.55e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE | 247 | 1.41e-02 | 9.10e-02 | 2.50e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT | 46 | 2.86e-01 | -9.09e-02 | 8.05e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 PHOSPHATE BINDING | 40 | 3.20e-01 | 9.09e-02 | 8.26e-01 |
| GOBP 3 UTR MEDIATED MRNA DESTABILIZATION | 15 | 5.42e-01 | 9.09e-02 | 9.23e-01 |
| GOMF ALDO KETO REDUCTASE NADP ACTIVITY | 18 | 5.05e-01 | -9.09e-02 | 9.15e-01 |
| GOBP RESPONSE TO GONADOTROPIN | 12 | 5.86e-01 | 9.08e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF DNA BINDING | 29 | 3.98e-01 | 9.08e-02 | 8.71e-01 |
| GOBP FOREBRAIN NEURON DEVELOPMENT | 15 | 5.43e-01 | -9.08e-02 | 9.23e-01 |
| GOBP POST ANAL TAIL MORPHOGENESIS | 10 | 6.19e-01 | -9.08e-02 | 9.37e-01 |
| GOBP RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE | 7 | 6.78e-01 | -9.07e-02 | 9.51e-01 |
| GOBP SMOOTH MUSCLE CELL MIGRATION | 48 | 2.78e-01 | -9.06e-02 | 7.99e-01 |
| GOBP MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 25 | 4.33e-01 | -9.05e-02 | 8.82e-01 |
| GOBP CARDIAC CHAMBER DEVELOPMENT | 96 | 1.26e-01 | 9.05e-02 | 6.31e-01 |
| GOBP MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 114 | 9.55e-02 | 9.05e-02 | 5.73e-01 |
| GOBP REGULATION OF DNA STRAND ELONGATION | 17 | 5.18e-01 | -9.05e-02 | 9.19e-01 |
| GOCC T TUBULE | 32 | 3.76e-01 | -9.05e-02 | 8.60e-01 |
| GOBP TUBULIN DEACETYLATION | 19 | 4.95e-01 | -9.05e-02 | 9.13e-01 |
| GOMF MOLECULAR CONDENSATE SCAFFOLD ACTIVITY | 26 | 4.25e-01 | -9.05e-02 | 8.81e-01 |
| GOBP REGULATION OF COLLAGEN FIBRIL ORGANIZATION | 5 | 7.26e-01 | -9.05e-02 | 9.63e-01 |
| GOBP POSITIVE REGULATION OF CELL ADHESION | 333 | 4.69e-03 | 9.05e-02 | 1.28e-01 |
| GOBP INTERMEDIATE FILAMENT ORGANIZATION | 11 | 6.04e-01 | -9.04e-02 | 9.36e-01 |
| GOBP ADHERENS JUNCTION ASSEMBLY | 11 | 6.04e-01 | 9.04e-02 | 9.36e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 42 | 3.11e-01 | -9.03e-02 | 8.21e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION | 20 | 4.85e-01 | 9.03e-02 | 9.10e-01 |
| GOBP NEGATIVE REGULATION OF AMINE TRANSPORT | 12 | 5.88e-01 | -9.03e-02 | 9.36e-01 |
| GOBP TAIL ANCHORED MEMBRANE PROTEIN INSERTION INTO ER MEMBRANE | 16 | 5.32e-01 | 9.03e-02 | 9.23e-01 |
| GOBP GLYCOSYL COMPOUND METABOLIC PROCESS | 59 | 2.31e-01 | 9.03e-02 | 7.58e-01 |
| GOBP SENSORY ORGAN MORPHOGENESIS | 127 | 7.95e-02 | 9.02e-02 | 5.39e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE REGULATOR ACTIVITY | 14 | 5.59e-01 | -9.02e-02 | 9.27e-01 |
| GOBP KILLING BY HOST OF SYMBIONT CELLS | 7 | 6.79e-01 | 9.02e-02 | 9.52e-01 |
| GOBP T CELL ACTIVATION | 387 | 2.42e-03 | 9.02e-02 | 8.33e-02 |
| GOMF RNA NUCLEASE ACTIVITY | 108 | 1.06e-01 | 9.02e-02 | 5.96e-01 |
| GOBP PHOSPHATIDYLINOSITOL MEDIATED SIGNALING | 19 | 4.96e-01 | 9.01e-02 | 9.13e-01 |
| GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 15 | 5.46e-01 | 9.01e-02 | 9.24e-01 |
| GOBP NEURONAL ION CHANNEL CLUSTERING | 9 | 6.40e-01 | 9.01e-02 | 9.42e-01 |
| GOBP SNRNA TRANSPORT | 6 | 7.02e-01 | -9.01e-02 | 9.56e-01 |
| GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE | 27 | 4.18e-01 | 9.00e-02 | 8.79e-01 |
| GOBP REGULATION OF MIRNA TRANSCRIPTION | 48 | 2.81e-01 | 9.00e-02 | 7.99e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION | 60 | 2.28e-01 | 9.00e-02 | 7.58e-01 |
| GOCC AZUROPHIL GRANULE LUMEN | 72 | 1.87e-01 | -9.00e-02 | 7.17e-01 |
| GOBP RESPONSE TO STEROL DEPLETION | 15 | 5.46e-01 | 9.00e-02 | 9.25e-01 |
| GOBP POSITIVE REGULATION OF LIPID TRANSPORT | 52 | 2.62e-01 | -9.00e-02 | 7.87e-01 |
| GOMF ISOPRENOID BINDING | 14 | 5.60e-01 | -9.00e-02 | 9.28e-01 |
| GOBP LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 48 | 2.81e-01 | 8.99e-02 | 7.99e-01 |
| GOBP SENSORY PERCEPTION OF MECHANICAL STIMULUS | 102 | 1.17e-01 | 8.99e-02 | 6.17e-01 |
| GOBP REGULATION OF AMINO ACID TRANSPORT | 22 | 4.66e-01 | -8.99e-02 | 9.00e-01 |
| GOBP RESPONSE TO AUDITORY STIMULUS | 19 | 4.98e-01 | -8.98e-02 | 9.13e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 21 | 4.76e-01 | 8.98e-02 | 9.04e-01 |
| GOCC MITOCHONDRIAL CRISTA | 6 | 7.03e-01 | 8.98e-02 | 9.56e-01 |
| GOBP ZYMOGEN ACTIVATION | 37 | 3.45e-01 | -8.97e-02 | 8.42e-01 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 12 | 5.91e-01 | -8.97e-02 | 9.36e-01 |
| GOBP V D J RECOMBINATION | 16 | 5.35e-01 | 8.96e-02 | 9.23e-01 |
| GOBP BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS | 18 | 5.10e-01 | -8.96e-02 | 9.18e-01 |
| GOBP DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 10 | 6.24e-01 | -8.95e-02 | 9.40e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 12 | 5.92e-01 | 8.95e-02 | 9.36e-01 |
| GOMF DEATH DOMAIN BINDING | 10 | 6.24e-01 | 8.95e-02 | 9.40e-01 |
| GOBP CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS | 13 | 5.77e-01 | -8.95e-02 | 9.33e-01 |
| GOBP REGULATION OF TRANSLATIONAL FIDELITY | 13 | 5.77e-01 | -8.95e-02 | 9.33e-01 |
| GOBP THIOESTER METABOLIC PROCESS | 75 | 1.81e-01 | -8.94e-02 | 7.12e-01 |
| GOBP REGULATION OF ERYTHROCYTE DIFFERENTIATION | 39 | 3.34e-01 | 8.94e-02 | 8.35e-01 |
| GOCC CLATHRIN COAT OF COATED PIT | 14 | 5.63e-01 | -8.93e-02 | 9.29e-01 |
| GOBP REGULATION OF ISOTYPE SWITCHING | 34 | 3.68e-01 | 8.93e-02 | 8.54e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS | 14 | 5.63e-01 | 8.92e-02 | 9.29e-01 |
| GOBP PUTRESCINE METABOLIC PROCESS | 7 | 6.83e-01 | -8.92e-02 | 9.53e-01 |
| GOBP CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT | 5 | 7.30e-01 | 8.92e-02 | 9.64e-01 |
| GOBP MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY | 38 | 3.42e-01 | 8.91e-02 | 8.40e-01 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 19 | 5.01e-01 | 8.91e-02 | 9.15e-01 |
| GOBP RESPONSE TO ACID CHEMICAL | 94 | 1.36e-01 | -8.91e-02 | 6.52e-01 |
| GOBP RESPONSE TO ORGANOPHOSPHORUS | 77 | 1.77e-01 | 8.91e-02 | 7.07e-01 |
| GOMF NUCLEOSIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 7.06e-01 | 8.91e-02 | 9.57e-01 |
| GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT | 197 | 3.15e-02 | 8.90e-02 | 3.58e-01 |
| GOBP CELLULAR RESPONSE TO INTERLEUKIN 1 | 72 | 1.92e-01 | -8.90e-02 | 7.22e-01 |
| GOBP CELLULAR RESPONSE TO CALCIUM ION | 51 | 2.72e-01 | -8.90e-02 | 7.94e-01 |
| GOMF ZINC ION BINDING | 583 | 2.64e-04 | 8.90e-02 | 1.61e-02 |
| GOBP POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY | 9 | 6.44e-01 | -8.89e-02 | 9.42e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SUMOYLATION | 8 | 6.63e-01 | -8.89e-02 | 9.49e-01 |
| GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 15 | 5.51e-01 | -8.89e-02 | 9.26e-01 |
| GOBP POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY | 23 | 4.61e-01 | 8.89e-02 | 8.97e-01 |
| GOBP AXONAL TRANSPORT | 53 | 2.64e-01 | 8.87e-02 | 7.88e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON SINGLE DONORS WITH INCORPORATION OF MOLECULAR OXYGEN | 13 | 5.80e-01 | -8.87e-02 | 9.35e-01 |
| GOMF WIDE PORE CHANNEL ACTIVITY | 14 | 5.66e-01 | -8.87e-02 | 9.29e-01 |
| GOBP POSITIVE REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 5 | 7.31e-01 | 8.86e-02 | 9.64e-01 |
| GOCC CATION CHANNEL COMPLEX | 83 | 1.63e-01 | 8.86e-02 | 6.88e-01 |
| GOBP REGULATION OF NEURON PROJECTION REGENERATION | 19 | 5.04e-01 | -8.85e-02 | 9.15e-01 |
| GOBP RETINAL ROD CELL DEVELOPMENT | 5 | 7.32e-01 | 8.85e-02 | 9.64e-01 |
| GOBP DEFENSE RESPONSE TO BACTERIUM | 135 | 7.65e-02 | 8.84e-02 | 5.30e-01 |
| GOMF INORGANIC MOLECULAR ENTITY TRANSMEMBRANE TRANSPORTER ACTIVITY | 370 | 3.65e-03 | -8.83e-02 | 1.12e-01 |
| GOMF ENOYL COA HYDRATASE ACTIVITY | 11 | 6.12e-01 | 8.83e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 279 | 1.14e-02 | 8.83e-02 | 2.15e-01 |
| GOBP BENZENE CONTAINING COMPOUND METABOLIC PROCESS | 15 | 5.54e-01 | -8.83e-02 | 9.26e-01 |
| GOCC ENDOPLASMIC RETICULUM PROTEIN CONTAINING COMPLEX | 116 | 1.01e-01 | -8.83e-02 | 5.86e-01 |
| GOBP REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS | 15 | 5.54e-01 | -8.83e-02 | 9.26e-01 |
| GOBP CELLULAR ALDEHYDE METABOLIC PROCESS | 45 | 3.06e-01 | -8.82e-02 | 8.17e-01 |
| GOBP MATURATION OF SSU RRNA | 50 | 2.81e-01 | -8.82e-02 | 7.99e-01 |
| GOBP REGULATION OF PROTEIN KINASE C SIGNALING | 11 | 6.13e-01 | 8.82e-02 | 9.36e-01 |
| GOBP ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT | 28 | 4.19e-01 | -8.82e-02 | 8.80e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 63 | 2.26e-01 | -8.82e-02 | 7.56e-01 |
| GOBP MICROTUBULE ORGANIZING CENTER ORGANIZATION | 135 | 7.74e-02 | 8.82e-02 | 5.33e-01 |
| GOBP REGULATION OF FEAR RESPONSE | 7 | 6.86e-01 | 8.81e-02 | 9.54e-01 |
| GOCC ACTIN FILAMENT BUNDLE | 59 | 2.42e-01 | -8.81e-02 | 7.71e-01 |
| GOMF WATER TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 7.09e-01 | -8.81e-02 | 9.58e-01 |
| GOCC HETEROCHROMATIN | 67 | 2.13e-01 | -8.81e-02 | 7.46e-01 |
| GOBP RESPONSE TO CAFFEINE | 11 | 6.13e-01 | 8.80e-02 | 9.36e-01 |
| GOBP MICROGLIAL CELL MIGRATION | 5 | 7.33e-01 | -8.80e-02 | 9.64e-01 |
| GOMF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 193 | 3.55e-02 | 8.80e-02 | 3.82e-01 |
| GOBP REGULATION OF AXON EXTENSION | 63 | 2.28e-01 | -8.80e-02 | 7.58e-01 |
| GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 70 | 2.04e-01 | 8.79e-02 | 7.32e-01 |
| GOMF METALLODIPEPTIDASE ACTIVITY | 6 | 7.09e-01 | 8.79e-02 | 9.58e-01 |
| GOBP REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 35 | 3.68e-01 | -8.79e-02 | 8.55e-01 |
| GOBP GRANULOCYTE MIGRATION | 99 | 1.31e-01 | -8.79e-02 | 6.41e-01 |
| GOBP INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 27 | 4.29e-01 | 8.79e-02 | 8.82e-01 |
| GOBP NEGATIVE REGULATION OF NEURON DIFFERENTIATION | 31 | 3.97e-01 | 8.79e-02 | 8.71e-01 |
| GOMF HISTONE H3K4 METHYLTRANSFERASE ACTIVITY | 16 | 5.43e-01 | 8.78e-02 | 9.23e-01 |
| GOBP RESPONSE TO MOLECULE OF BACTERIAL ORIGIN | 234 | 2.09e-02 | 8.78e-02 | 3.03e-01 |
| GOBP NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION | 15 | 5.56e-01 | -8.78e-02 | 9.26e-01 |
| GOMF MAP KINASE PHOSPHATASE ACTIVITY | 12 | 5.99e-01 | 8.78e-02 | 9.36e-01 |
| GOBP REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 51 | 2.78e-01 | -8.78e-02 | 7.99e-01 |
| GOMF PHOSPHATIDYLINOSITOL 3 KINASE BINDING | 18 | 5.19e-01 | 8.78e-02 | 9.19e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL CHEMICAL HOMEOSTASIS | 40 | 3.37e-01 | -8.77e-02 | 8.36e-01 |
| GOBP CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 25 | 4.48e-01 | -8.77e-02 | 8.88e-01 |
| GOBP PROTEIN TRIMERIZATION | 11 | 6.15e-01 | 8.77e-02 | 9.36e-01 |
| GOBP CILIUM MOVEMENT | 91 | 1.49e-01 | -8.77e-02 | 6.72e-01 |
| GOMF ATPASE REGULATOR ACTIVITY | 45 | 3.09e-01 | -8.77e-02 | 8.20e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE PRODUCTION | 16 | 5.44e-01 | -8.76e-02 | 9.23e-01 |
| GOBP OLFACTORY LOBE DEVELOPMENT | 20 | 4.98e-01 | -8.76e-02 | 9.13e-01 |
| GOCC TRANSPORTER COMPLEX | 224 | 2.42e-02 | -8.76e-02 | 3.20e-01 |
| GOBP ANTIFUNGAL INNATE IMMUNE RESPONSE | 10 | 6.32e-01 | -8.76e-02 | 9.41e-01 |
| GOMF MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 327 | 6.70e-03 | -8.75e-02 | 1.57e-01 |
| GOBP HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 39 | 3.45e-01 | -8.75e-02 | 8.42e-01 |
| GOCC GOLGI MEDIAL CISTERNA | 11 | 6.15e-01 | 8.75e-02 | 9.36e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 14 | 5.71e-01 | 8.75e-02 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE TETHERING OR ROLLING | 6 | 7.11e-01 | -8.75e-02 | 9.59e-01 |
| GOBP NEUTROPHIL MEDIATED IMMUNITY | 24 | 4.59e-01 | 8.74e-02 | 8.96e-01 |
| GOBP POSITIVE REGULATION OF STEROL TRANSPORT | 26 | 4.41e-01 | -8.74e-02 | 8.85e-01 |
| GOBP NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 12 | 6.01e-01 | 8.73e-02 | 9.36e-01 |
| GOBP CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS | 11 | 6.16e-01 | -8.73e-02 | 9.36e-01 |
| GOBP FLOOR PLATE DEVELOPMENT | 6 | 7.11e-01 | -8.73e-02 | 9.59e-01 |
| GOBP CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 11 | 6.16e-01 | -8.73e-02 | 9.36e-01 |
| GOBP REGULATION OF STEM CELL POPULATION MAINTENANCE | 59 | 2.47e-01 | 8.73e-02 | 7.76e-01 |
| GOBP AUTOPHAGY OF MITOCHONDRION | 91 | 1.51e-01 | -8.73e-02 | 6.73e-01 |
| GOCC TRANSLOCON COMPLEX | 6 | 7.11e-01 | -8.72e-02 | 9.59e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 6 | 7.11e-01 | 8.72e-02 | 9.59e-01 |
| GOMF ADENYLATE KINASE ACTIVITY | 8 | 6.69e-01 | -8.72e-02 | 9.49e-01 |
| GOCC ADHERENS JUNCTION | 128 | 8.93e-02 | 8.71e-02 | 5.59e-01 |
| GOBP MITOCHONDRIAL FRAGMENTATION INVOLVED IN APOPTOTIC PROCESS | 8 | 6.70e-01 | -8.71e-02 | 9.49e-01 |
| GOMF ORGANIC ACID BINDING | 117 | 1.04e-01 | -8.71e-02 | 5.94e-01 |
| GOBP LUNG CELL DIFFERENTIATION | 14 | 5.73e-01 | -8.70e-02 | 9.32e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS | 13 | 5.87e-01 | -8.70e-02 | 9.36e-01 |
| GOBP CAMP METABOLIC PROCESS | 14 | 5.73e-01 | 8.70e-02 | 9.32e-01 |
| GOCC M BAND | 16 | 5.47e-01 | 8.70e-02 | 9.25e-01 |
| GOBP RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE | 13 | 5.88e-01 | -8.69e-02 | 9.36e-01 |
| GOMF NUCLEAR RECEPTOR COACTIVATOR ACTIVITY | 52 | 2.79e-01 | 8.69e-02 | 7.99e-01 |
| GOMF HISTONE CHAPERONE ACTIVITY | 11 | 6.18e-01 | 8.69e-02 | 9.37e-01 |
| GOBP POSITIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 6 | 7.13e-01 | 8.68e-02 | 9.59e-01 |
| GOMF CYTOSKELETAL ANCHOR ACTIVITY | 19 | 5.13e-01 | 8.68e-02 | 9.18e-01 |
| GOBP GMP METABOLIC PROCESS | 25 | 4.53e-01 | 8.68e-02 | 8.91e-01 |
| GOBP RNA EXPORT FROM NUCLEUS | 83 | 1.72e-01 | 8.68e-02 | 7.02e-01 |
| GOBP INNER CELL MASS CELL PROLIFERATION | 13 | 5.88e-01 | 8.68e-02 | 9.36e-01 |
| GOBP RIBONUCLEOPROTEIN COMPLEX BIOGENESIS | 448 | 1.74e-03 | -8.67e-02 | 6.58e-02 |
| GOBP MORPHOGENESIS OF AN EPITHELIUM | 291 | 1.12e-02 | -8.67e-02 | 2.13e-01 |
| GOBP NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING | 12 | 6.03e-01 | -8.67e-02 | 9.36e-01 |
| GOMF DNA TRANSLOCASE ACTIVITY | 5 | 7.37e-01 | 8.67e-02 | 9.65e-01 |
| GOBP TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 85 | 1.68e-01 | 8.67e-02 | 6.96e-01 |
| GOBP MITOCHONDRIAL PROTEIN PROCESSING | 13 | 5.89e-01 | 8.67e-02 | 9.36e-01 |
| GOBP AMINO ACID TRANSMEMBRANE TRANSPORT | 60 | 2.46e-01 | -8.66e-02 | 7.75e-01 |
| GOCC PLASMA MEMBRANE PROTEIN COMPLEX | 309 | 9.06e-03 | 8.66e-02 | 1.88e-01 |
| GOMF ANTIOXIDANT ACTIVITY | 52 | 2.80e-01 | -8.66e-02 | 7.99e-01 |
| GOBP APOPTOTIC MITOCHONDRIAL CHANGES | 93 | 1.49e-01 | -8.66e-02 | 6.72e-01 |
| GOMF POTASSIUM PROTON ANTIPORTER ACTIVITY | 9 | 6.53e-01 | 8.65e-02 | 9.46e-01 |
| GOBP AMINO ACID ACTIVATION | 26 | 4.45e-01 | -8.65e-02 | 8.87e-01 |
| GOMF D LOOP DNA BINDING | 5 | 7.38e-01 | 8.65e-02 | 9.65e-01 |
| GOMF HYDRO LYASE ACTIVITY | 40 | 3.44e-01 | 8.64e-02 | 8.41e-01 |
| GOMF NUCLEOTIDYLTRANSFERASE ACTIVITY | 127 | 9.29e-02 | 8.64e-02 | 5.67e-01 |
| GOCC SM LIKE PROTEIN FAMILY COMPLEX | 85 | 1.69e-01 | -8.64e-02 | 6.96e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE P38 BINDING | 7 | 6.92e-01 | -8.64e-02 | 9.54e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS | 11 | 6.20e-01 | -8.64e-02 | 9.37e-01 |
| GOBP MACROPHAGE CHEMOTAXIS | 29 | 4.21e-01 | -8.63e-02 | 8.81e-01 |
| GOBP NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY | 12 | 6.05e-01 | -8.63e-02 | 9.36e-01 |
| GOBP REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS | 14 | 5.76e-01 | -8.63e-02 | 9.33e-01 |
| GOBP RESPONSE TO INACTIVITY | 6 | 7.14e-01 | 8.63e-02 | 9.59e-01 |
| GOBP MITOCHONDRION ORGANIZATION | 497 | 1.06e-03 | -8.62e-02 | 4.58e-02 |
| GOBP LIPOPROTEIN METABOLIC PROCESS | 109 | 1.20e-01 | 8.62e-02 | 6.22e-01 |
| GOBP RESPONSE TO OSMOTIC STRESS | 66 | 2.26e-01 | -8.62e-02 | 7.56e-01 |
| GOBP POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT | 12 | 6.05e-01 | -8.61e-02 | 9.36e-01 |
| GOBP INNERVATION | 13 | 5.91e-01 | -8.61e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION | 39 | 3.52e-01 | 8.61e-02 | 8.46e-01 |
| GOBP TRNA MODIFICATION | 92 | 1.54e-01 | 8.61e-02 | 6.75e-01 |
| GOCC SCF UBIQUITIN LIGASE COMPLEX | 55 | 2.70e-01 | 8.61e-02 | 7.93e-01 |
| GOBP L AMINO ACID TRANSPORT | 57 | 2.61e-01 | -8.61e-02 | 7.87e-01 |
| GOBP REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 67 | 2.23e-01 | 8.61e-02 | 7.52e-01 |
| GOBP INTESTINAL EPITHELIAL CELL DIFFERENTIATION | 15 | 5.64e-01 | 8.60e-02 | 9.29e-01 |
| GOBP NEGATIVE REGULATION OF RNA SPLICING | 24 | 4.66e-01 | -8.60e-02 | 9.00e-01 |
| GOBP RESPONSE TO COCAINE | 26 | 4.48e-01 | 8.60e-02 | 8.88e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 12 | 6.06e-01 | -8.60e-02 | 9.36e-01 |
| GOBP REGULATION OF METALLOENDOPEPTIDASE ACTIVITY | 6 | 7.15e-01 | 8.60e-02 | 9.59e-01 |
| GOBP SERINE FAMILY AMINO ACID METABOLIC PROCESS | 28 | 4.31e-01 | -8.60e-02 | 8.82e-01 |
| GOBP MRNA CATABOLIC PROCESS | 213 | 3.11e-02 | 8.59e-02 | 3.55e-01 |
| GOCC MIDBODY | 187 | 4.32e-02 | 8.59e-02 | 4.24e-01 |
| GOBP MRNA MODIFICATION | 30 | 4.16e-01 | 8.58e-02 | 8.79e-01 |
| GOBP OUTFLOW TRACT MORPHOGENESIS | 43 | 3.31e-01 | 8.58e-02 | 8.30e-01 |
| GOBP PEPTIDYL GLUTAMIC ACID MODIFICATION | 16 | 5.53e-01 | -8.58e-02 | 9.26e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE PRIMING | 6 | 7.16e-01 | 8.58e-02 | 9.59e-01 |
| GOBP ORGANELLE LOCALIZATION | 501 | 1.08e-03 | 8.57e-02 | 4.60e-02 |
| GOMF SUPEROXIDE GENERATING NADPH OXIDASE ACTIVATOR ACTIVITY | 7 | 6.95e-01 | -8.57e-02 | 9.54e-01 |
| GOMF ER RETENTION SEQUENCE BINDING | 5 | 7.40e-01 | -8.57e-02 | 9.65e-01 |
| GOMF PH DOMAIN BINDING | 7 | 6.95e-01 | 8.57e-02 | 9.54e-01 |
| GOBP GLYCOLYTIC PROCESS THROUGH GLUCOSE 6 PHOSPHATE | 17 | 5.41e-01 | -8.57e-02 | 9.23e-01 |
| GOCC PRONUCLEUS | 12 | 6.07e-01 | 8.57e-02 | 9.36e-01 |
| GOBP CELLULAR RESPONSE TO MECHANICAL STIMULUS | 57 | 2.63e-01 | 8.57e-02 | 7.88e-01 |
| GOBP MRNA METHYLATION | 18 | 5.29e-01 | 8.57e-02 | 9.23e-01 |
| GOBP DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM | 26 | 4.50e-01 | 8.57e-02 | 8.89e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CONTRACTION | 22 | 4.87e-01 | -8.56e-02 | 9.11e-01 |
| GOBP NEURAL TUBE DEVELOPMENT | 117 | 1.10e-01 | -8.56e-02 | 6.02e-01 |
| GOBP MITOTIC SPINDLE ORGANIZATION | 120 | 1.06e-01 | 8.55e-02 | 5.96e-01 |
| GOBP ANTERIOR POSTERIOR PATTERN SPECIFICATION | 94 | 1.52e-01 | -8.55e-02 | 6.74e-01 |
| GOMF EPIDERMAL GROWTH FACTOR RECEPTOR BINDING | 24 | 4.69e-01 | 8.55e-02 | 9.00e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PEROXIDE AS ACCEPTOR | 33 | 3.96e-01 | -8.54e-02 | 8.71e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 26 | 4.51e-01 | -8.54e-02 | 8.90e-01 |
| GOBP POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 7 | 6.96e-01 | 8.54e-02 | 9.55e-01 |
| GOBP NEGATIVE REGULATION OF JNK CASCADE | 29 | 4.26e-01 | 8.54e-02 | 8.82e-01 |
| GOBP POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 29 | 4.27e-01 | 8.53e-02 | 8.82e-01 |
| GOBP NEGATIVE REGULATION OF DNA REPLICATION | 21 | 4.99e-01 | -8.53e-02 | 9.14e-01 |
| GOBP REGULATION OF MITOCHONDRIAL FUSION | 11 | 6.24e-01 | 8.53e-02 | 9.40e-01 |
| GOBP LIPOXYGENASE PATHWAY | 5 | 7.41e-01 | -8.53e-02 | 9.65e-01 |
| GOCC U4 SNRNP | 10 | 6.41e-01 | 8.52e-02 | 9.42e-01 |
| GOBP MITOTIC NUCLEAR DIVISION | 244 | 2.22e-02 | 8.52e-02 | 3.08e-01 |
| GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 5 | 7.42e-01 | -8.51e-02 | 9.65e-01 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION | 32 | 4.05e-01 | 8.51e-02 | 8.73e-01 |
| GOBP CELLULAR RESPONSE TO ACIDIC PH | 8 | 6.77e-01 | -8.51e-02 | 9.51e-01 |
| GOBP ISOPRENOID METABOLIC PROCESS | 81 | 1.86e-01 | -8.51e-02 | 7.17e-01 |
| GOBP ESTABLISHMENT OF SERTOLI CELL BARRIER | 5 | 7.42e-01 | -8.50e-02 | 9.65e-01 |
| GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 8 | 6.77e-01 | 8.50e-02 | 9.51e-01 |
| GOBP PROTEIN LOCALIZATION TO LYSOSOME | 50 | 2.99e-01 | -8.50e-02 | 8.13e-01 |
| GOBP SEROTONIN UPTAKE | 6 | 7.19e-01 | -8.50e-02 | 9.60e-01 |
| GOMF CYTOKINE BINDING | 78 | 1.95e-01 | -8.50e-02 | 7.25e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY | 524 | 9.35e-04 | -8.49e-02 | 4.14e-02 |
| GOMF HSP70 PROTEIN BINDING | 40 | 3.53e-01 | -8.49e-02 | 8.46e-01 |
| GOBP PROTEIN UFMYLATION | 6 | 7.19e-01 | -8.49e-02 | 9.60e-01 |
| GOBP REGULATION OF MICROTUBULE DEPOLYMERIZATION | 25 | 4.63e-01 | -8.48e-02 | 8.99e-01 |
| GOBP L ARGININE TRANSMEMBRANE TRANSPORT | 10 | 6.42e-01 | -8.48e-02 | 9.42e-01 |
| GOBP NEGATIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY | 8 | 6.78e-01 | 8.48e-02 | 9.52e-01 |
| GOMF PHOSPHATIDYLINOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY | 7 | 6.98e-01 | -8.48e-02 | 9.55e-01 |
| GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 5 KINASE ACTIVITY | 7 | 6.98e-01 | 8.47e-02 | 9.55e-01 |
| GOBP NEGATIVE REGULATION OF RIBOSOME BIOGENESIS | 7 | 6.98e-01 | 8.47e-02 | 9.55e-01 |
| GOBP GALACTOSE METABOLIC PROCESS | 8 | 6.78e-01 | -8.47e-02 | 9.52e-01 |
| GOMF BASAL TRANSCRIPTION MACHINERY BINDING | 58 | 2.65e-01 | 8.46e-02 | 7.91e-01 |
| GOBP PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE | 68 | 2.28e-01 | 8.46e-02 | 7.58e-01 |
| GOBP MAINTENANCE OF LOCATION | 245 | 2.30e-02 | 8.46e-02 | 3.12e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 16 | 5.58e-01 | 8.45e-02 | 9.27e-01 |
| GOBP METANEPHRIC GLOMERULUS DEVELOPMENT | 6 | 7.20e-01 | 8.45e-02 | 9.61e-01 |
| GOBP POSITIVE REGULATION OF HISTONE DEACETYLATION | 5 | 7.44e-01 | 8.45e-02 | 9.65e-01 |
| GOBP REGULATION OF HISTONE DEACETYLATION | 5 | 7.44e-01 | 8.45e-02 | 9.65e-01 |
| GOBP NEGATIVE REGULATION OF AXONOGENESIS | 40 | 3.55e-01 | -8.45e-02 | 8.46e-01 |
| GOBP RETINAL METABOLIC PROCESS | 10 | 6.44e-01 | -8.45e-02 | 9.42e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIARY TRANSITION ZONE | 7 | 6.99e-01 | -8.44e-02 | 9.55e-01 |
| GOBP CHROMOSOME SEGREGATION | 370 | 5.46e-03 | 8.44e-02 | 1.37e-01 |
| GOBP RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE | 5 | 7.44e-01 | -8.44e-02 | 9.65e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 15 | 5.72e-01 | 8.44e-02 | 9.31e-01 |
| GOBP REGULATION OF FC GAMMA RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS | 5 | 7.44e-01 | -8.43e-02 | 9.66e-01 |
| GOMF STEROL TRANSFER ACTIVITY | 14 | 5.85e-01 | -8.42e-02 | 9.36e-01 |
| GOMF NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 6.29e-01 | -8.42e-02 | 9.40e-01 |
| GOBP PORE COMPLEX ASSEMBLY | 20 | 5.15e-01 | 8.42e-02 | 9.19e-01 |
| GOMF KINASE ACTIVATOR ACTIVITY | 101 | 1.44e-01 | 8.42e-02 | 6.65e-01 |
| GOBP SELECTIVE AUTOPHAGY | 90 | 1.68e-01 | -8.42e-02 | 6.96e-01 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 28 | 4.41e-01 | -8.42e-02 | 8.85e-01 |
| GOMF MYOSIN II BINDING | 8 | 6.80e-01 | -8.41e-02 | 9.52e-01 |
| GOBP TYPE I PNEUMOCYTE DIFFERENTIATION | 6 | 7.22e-01 | -8.40e-02 | 9.62e-01 |
| GOBP REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 24 | 4.76e-01 | 8.40e-02 | 9.04e-01 |
| GOBP AMINE METABOLIC PROCESS | 68 | 2.31e-01 | -8.40e-02 | 7.59e-01 |
| GOBP NUCLEAR MEMBRANE ORGANIZATION | 43 | 3.41e-01 | 8.40e-02 | 8.39e-01 |
| GOMF INOSITOL POLYPHOSPHATE 5 PHOSPHATASE ACTIVITY | 6 | 7.22e-01 | -8.40e-02 | 9.62e-01 |
| GOBP MESONEPHROS DEVELOPMENT | 44 | 3.35e-01 | 8.40e-02 | 8.36e-01 |
| GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 22 | 4.96e-01 | 8.40e-02 | 9.13e-01 |
| GOBP PROTEIN HETEROOLIGOMERIZATION | 20 | 5.16e-01 | 8.39e-02 | 9.19e-01 |
| GOBP MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 20 | 5.16e-01 | -8.39e-02 | 9.19e-01 |
| GOMF THIOREDOXIN DISULFIDE REDUCTASE NADP ACTIVITY | 6 | 7.22e-01 | -8.39e-02 | 9.62e-01 |
| GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 10 | 6.46e-01 | -8.38e-02 | 9.43e-01 |
| GOBP MONONUCLEAR CELL DIFFERENTIATION | 337 | 8.42e-03 | 8.38e-02 | 1.81e-01 |
| GOBP CARBOHYDRATE DERIVATIVE TRANSPORT | 69 | 2.29e-01 | -8.38e-02 | 7.58e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 13 | 6.01e-01 | -8.38e-02 | 9.36e-01 |
| GOBP VESICLE TETHERING | 32 | 4.12e-01 | 8.37e-02 | 8.77e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 57 | 2.75e-01 | 8.37e-02 | 7.96e-01 |
| GOMF EFFLUX TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 6.47e-01 | 8.37e-02 | 9.43e-01 |
| GOBP REGULATION OF GLUCOCORTICOID METABOLIC PROCESS | 7 | 7.02e-01 | -8.36e-02 | 9.56e-01 |
| GOBP L GLUTAMATE TRANSMEMBRANE TRANSPORT | 20 | 5.18e-01 | -8.36e-02 | 9.19e-01 |
| GOBP NEGATIVE REGULATION OF CIRCADIAN RHYTHM | 7 | 7.02e-01 | 8.35e-02 | 9.56e-01 |
| GOBP T CELL CHEMOTAXIS | 16 | 5.63e-01 | -8.35e-02 | 9.29e-01 |
| GOBP TYPE B PANCREATIC CELL DIFFERENTIATION | 14 | 5.89e-01 | -8.35e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF SYNAPSE ASSEMBLY | 22 | 4.98e-01 | 8.35e-02 | 9.13e-01 |
| GOBP CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 241 | 2.62e-02 | 8.34e-02 | 3.31e-01 |
| GOBP CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 12 | 6.17e-01 | 8.33e-02 | 9.37e-01 |
| GOBP SECRETION BY TISSUE | 20 | 5.19e-01 | 8.33e-02 | 9.19e-01 |
| GOBP CARDIOBLAST PROLIFERATION | 5 | 7.47e-01 | 8.32e-02 | 9.66e-01 |
| GOBP PHOSPHOLIPID HOMEOSTASIS | 11 | 6.33e-01 | -8.31e-02 | 9.41e-01 |
| GOBP RESPONSE TO IMMOBILIZATION STRESS | 15 | 5.77e-01 | -8.31e-02 | 9.34e-01 |
| GOBP MONOSACCHARIDE BIOSYNTHETIC PROCESS | 76 | 2.11e-01 | -8.30e-02 | 7.44e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 16 | 5.65e-01 | -8.30e-02 | 9.29e-01 |
| GOBP ESTABLISHMENT OF ORGANELLE LOCALIZATION | 391 | 5.02e-03 | 8.30e-02 | 1.32e-01 |
| GOBP DIACYLGLYCEROL METABOLIC PROCESS | 23 | 4.91e-01 | -8.29e-02 | 9.13e-01 |
| GOMF PHOSPHOLIPID TRANSFER ACTIVITY | 22 | 5.01e-01 | -8.28e-02 | 9.15e-01 |
| GOMF GLUTAMATE RECEPTOR BINDING | 29 | 4.40e-01 | -8.28e-02 | 8.85e-01 |
| GOBP AXONAL FASCICULATION | 11 | 6.34e-01 | -8.28e-02 | 9.41e-01 |
| GOMF MONOCARBOXYLIC ACID BINDING | 44 | 3.42e-01 | -8.28e-02 | 8.41e-01 |
| GOBP POSITIVE CHEMOTAXIS | 28 | 4.49e-01 | -8.27e-02 | 8.89e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 10 | 6.51e-01 | -8.27e-02 | 9.44e-01 |
| GOBP ETHER METABOLIC PROCESS | 19 | 5.33e-01 | -8.27e-02 | 9.23e-01 |
| GOBP DEVELOPMENTAL PIGMENTATION | 30 | 4.34e-01 | -8.26e-02 | 8.83e-01 |
| GOCC MLL1 2 COMPLEX | 32 | 4.19e-01 | 8.26e-02 | 8.79e-01 |
| GOCC PERICENTRIC HETEROCHROMATIN | 28 | 4.50e-01 | -8.26e-02 | 8.89e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 28 | 4.50e-01 | -8.26e-02 | 8.89e-01 |
| GOBP NEGATIVE REGULATION OF ORGANELLE ASSEMBLY | 44 | 3.44e-01 | 8.25e-02 | 8.41e-01 |
| GOBP NEGATIVE REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION | 5 | 7.49e-01 | -8.25e-02 | 9.67e-01 |
| GOBP REGULATION OF MEIOTIC CELL CYCLE PHASE TRANSITION | 7 | 7.06e-01 | 8.25e-02 | 9.57e-01 |
| GOBP NEGATIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT | 9 | 6.68e-01 | -8.24e-02 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION | 9 | 6.68e-01 | 8.24e-02 | 9.49e-01 |
| GOBP EPIDERMIS DEVELOPMENT | 174 | 6.13e-02 | 8.24e-02 | 4.85e-01 |
| GOCC ENDOPLASMIC RETICULUM QUALITY CONTROL COMPARTMENT | 13 | 6.07e-01 | 8.24e-02 | 9.36e-01 |
| GOBP PROTEIN K48 LINKED UBIQUITINATION | 62 | 2.62e-01 | 8.23e-02 | 7.87e-01 |
| GOBP LYMPHOCYTE APOPTOTIC PROCESS | 62 | 2.63e-01 | 8.23e-02 | 7.87e-01 |
| GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY | 33 | 4.13e-01 | 8.23e-02 | 8.77e-01 |
| GOCC NEUROMUSCULAR JUNCTION | 45 | 3.40e-01 | 8.23e-02 | 8.39e-01 |
| GOMF MYOSIN BINDING | 45 | 3.40e-01 | -8.22e-02 | 8.39e-01 |
| GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN | 6 | 7.27e-01 | -8.22e-02 | 9.63e-01 |
| GOBP EPIDERMAL CELL DIFFERENTIATION | 107 | 1.42e-01 | 8.22e-02 | 6.65e-01 |
| GOCC NUCLEOCYTOPLASMIC TRANSPORT COMPLEX | 11 | 6.37e-01 | 8.21e-02 | 9.41e-01 |
| GOBP RESPONSE TO STARVATION | 170 | 6.52e-02 | 8.21e-02 | 4.98e-01 |
| GOBP TUBE FORMATION | 98 | 1.61e-01 | -8.21e-02 | 6.87e-01 |
| GOBP POSITIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT | 9 | 6.70e-01 | 8.21e-02 | 9.49e-01 |
| GOBP UROGENITAL SYSTEM DEVELOPMENT | 34 | 4.08e-01 | 8.21e-02 | 8.76e-01 |
| GOBP NON MOTILE CILIUM ASSEMBLY | 58 | 2.80e-01 | -8.20e-02 | 7.99e-01 |
| GOCC PCG PROTEIN COMPLEX | 35 | 4.01e-01 | -8.20e-02 | 8.72e-01 |
| GOBP NEURON PROJECTION ARBORIZATION | 19 | 5.36e-01 | -8.20e-02 | 9.23e-01 |
| GOBP LEYDIG CELL DIFFERENTIATION | 6 | 7.28e-01 | -8.20e-02 | 9.64e-01 |
| GOBP KINETOCHORE ORGANIZATION | 21 | 5.16e-01 | 8.20e-02 | 9.19e-01 |
| GOBP NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 68 | 2.43e-01 | -8.19e-02 | 7.73e-01 |
| GOBP REGULATION OF CELLULAR COMPONENT SIZE | 267 | 2.16e-02 | -8.19e-02 | 3.06e-01 |
| GOMF AP 2 ADAPTOR COMPLEX BINDING | 10 | 6.54e-01 | -8.18e-02 | 9.46e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS | 32 | 4.23e-01 | -8.18e-02 | 8.81e-01 |
| GOBP POTASSIUM ION HOMEOSTASIS | 17 | 5.59e-01 | -8.18e-02 | 9.28e-01 |
| GOCC WASH COMPLEX | 10 | 6.54e-01 | 8.18e-02 | 9.46e-01 |
| GOBP REGULATION OF PROTEIN POLYUBIQUITINATION | 22 | 5.07e-01 | 8.17e-02 | 9.17e-01 |
| GOMF MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 386 | 6.05e-03 | -8.17e-02 | 1.47e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 22 | 5.07e-01 | 8.17e-02 | 9.17e-01 |
| GOBP GASTRULATION | 115 | 1.31e-01 | -8.17e-02 | 6.41e-01 |
| GOBP RESPONSE TO CAMP | 53 | 3.04e-01 | 8.16e-02 | 8.15e-01 |
| GOBP CELLULAR OXIDANT DETOXIFICATION | 62 | 2.67e-01 | -8.16e-02 | 7.91e-01 |
| GOMF AMINOACYLTRANSFERASE ACTIVITY | 380 | 6.50e-03 | 8.16e-02 | 1.54e-01 |
| GOCC GOLGI TRANS CISTERNA | 9 | 6.72e-01 | -8.16e-02 | 9.49e-01 |
| GOBP REGULATION OF FILOPODIUM ASSEMBLY | 37 | 3.91e-01 | 8.16e-02 | 8.67e-01 |
| GOMF FLOPPASE ACTIVITY | 14 | 5.97e-01 | 8.16e-02 | 9.36e-01 |
| GOBP CHROMATIN LOOPING | 11 | 6.40e-01 | 8.15e-02 | 9.42e-01 |
| GOMF ENDOPEPTIDASE REGULATOR ACTIVITY | 82 | 2.02e-01 | 8.15e-02 | 7.32e-01 |
| GOBP PROTEIN K48 LINKED DEUBIQUITINATION | 25 | 4.81e-01 | -8.15e-02 | 9.08e-01 |
| GOBP MYELIN ASSEMBLY | 15 | 5.85e-01 | 8.14e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF HAIR FOLLICLE DEVELOPMENT | 6 | 7.30e-01 | -8.14e-02 | 9.64e-01 |
| GOBP HYPEROSMOTIC RESPONSE | 21 | 5.19e-01 | -8.14e-02 | 9.19e-01 |
| GOBP SEQUESTERING OF CALCIUM ION | 84 | 1.98e-01 | 8.14e-02 | 7.30e-01 |
| GOMF PROTEIN TYROSINE KINASE ACTIVITY | 91 | 1.80e-01 | 8.13e-02 | 7.11e-01 |
| GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH | 19 | 5.39e-01 | -8.13e-02 | 9.23e-01 |
| GOBP ORGANIC ANION TRANSPORT | 252 | 2.66e-02 | -8.13e-02 | 3.32e-01 |
| GOBP CELL MATURATION | 100 | 1.61e-01 | 8.13e-02 | 6.87e-01 |
| GOBP REGULATION OF REGULATORY NCRNA PROCESSING | 12 | 6.26e-01 | 8.13e-02 | 9.40e-01 |
| GOBP SUGAR MEDIATED SIGNALING PATHWAY | 7 | 7.10e-01 | 8.12e-02 | 9.59e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE PROCESS | 189 | 5.49e-02 | 8.11e-02 | 4.63e-01 |
| GOBP DEDIFFERENTIATION | 6 | 7.31e-01 | 8.11e-02 | 9.64e-01 |
| GOBP MAINTENANCE OF PROTEIN LOCATION | 77 | 2.19e-01 | 8.11e-02 | 7.49e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 28 | 4.58e-01 | -8.10e-02 | 8.96e-01 |
| GOMF LIPID KINASE ACTIVITY | 35 | 4.07e-01 | 8.10e-02 | 8.75e-01 |
| GOBP PROTEIN MONOUBIQUITINATION | 41 | 3.70e-01 | 8.09e-02 | 8.55e-01 |
| GOBP GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION | 9 | 6.74e-01 | 8.09e-02 | 9.50e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION | 25 | 4.84e-01 | 8.09e-02 | 9.09e-01 |
| GOBP REGULATION OF NEUTROPHIL CHEMOTAXIS | 23 | 5.02e-01 | 8.09e-02 | 9.15e-01 |
| GOCC DENDRITE CYTOPLASM | 22 | 5.12e-01 | -8.09e-02 | 9.18e-01 |
| GOBP NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION | 11 | 6.43e-01 | 8.08e-02 | 9.42e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 7 | 7.11e-01 | -8.08e-02 | 9.59e-01 |
| GOMF DISORDERED DOMAIN SPECIFIC BINDING | 24 | 4.93e-01 | -8.08e-02 | 9.13e-01 |
| GOBP CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING | 30 | 4.44e-01 | 8.08e-02 | 8.87e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION | 8 | 6.92e-01 | 8.08e-02 | 9.54e-01 |
| GOMF GAP JUNCTION CHANNEL ACTIVITY | 5 | 7.55e-01 | 8.07e-02 | 9.68e-01 |
| GOBP NEURON RECOGNITION | 23 | 5.03e-01 | -8.07e-02 | 9.15e-01 |
| GOBP MAINTENANCE OF POSTSYNAPTIC SPECIALIZATION STRUCTURE | 7 | 7.12e-01 | -8.07e-02 | 9.59e-01 |
| GOCC NMDA SELECTIVE GLUTAMATE RECEPTOR COMPLEX | 7 | 7.12e-01 | -8.07e-02 | 9.59e-01 |
| GOMF INSULIN RECEPTOR BINDING | 16 | 5.77e-01 | 8.06e-02 | 9.33e-01 |
| GOBP REGULATION OF PROTEIN KINASE A SIGNALING | 12 | 6.29e-01 | -8.06e-02 | 9.40e-01 |
| GOBP ESTABLISHMENT OF MITOCHONDRION LOCALIZATION | 22 | 5.13e-01 | 8.06e-02 | 9.18e-01 |
| GOBP CELL CYCLE CHECKPOINT SIGNALING | 175 | 6.64e-02 | 8.06e-02 | 5.03e-01 |
| GOBP REGULATION OF ERAD PATHWAY | 20 | 5.33e-01 | 8.06e-02 | 9.23e-01 |
| GOBP CELL CELL JUNCTION MAINTENANCE | 11 | 6.44e-01 | -8.06e-02 | 9.42e-01 |
| GOBP INTERSTRAND CROSS LINK REPAIR | 39 | 3.84e-01 | -8.06e-02 | 8.64e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH HOST | 159 | 8.03e-02 | 8.05e-02 | 5.40e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 6 | 7.33e-01 | -8.04e-02 | 9.64e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 47 | 3.40e-01 | -8.04e-02 | 8.39e-01 |
| GOBP LIMBIC SYSTEM DEVELOPMENT | 69 | 2.48e-01 | -8.04e-02 | 7.76e-01 |
| GOBP IMP METABOLIC PROCESS | 13 | 6.16e-01 | 8.04e-02 | 9.36e-01 |
| GOBP REGULATION OF DNA REPLICATION | 108 | 1.49e-01 | -8.04e-02 | 6.72e-01 |
| GOBP MRNA TRANSPORT | 113 | 1.40e-01 | 8.04e-02 | 6.62e-01 |
| GOBP NUCLEOLAR CHROMATIN ORGANIZATION | 10 | 6.60e-01 | 8.03e-02 | 9.49e-01 |
| GOBP SPERM AXONEME ASSEMBLY | 18 | 5.56e-01 | -8.02e-02 | 9.26e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY | 40 | 3.80e-01 | -8.02e-02 | 8.63e-01 |
| GOMF 3 5 EXONUCLEASE ACTIVITY | 51 | 3.22e-01 | 8.02e-02 | 8.29e-01 |
| GOBP REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 7 | 7.13e-01 | 8.02e-02 | 9.59e-01 |
| GOBP PROGESTERONE RECEPTOR SIGNALING PATHWAY | 8 | 6.95e-01 | -8.02e-02 | 9.54e-01 |
| GOBP POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY | 26 | 4.79e-01 | 8.02e-02 | 9.07e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 29 | 4.55e-01 | 8.01e-02 | 8.93e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL MIGRATION | 7 | 7.14e-01 | -8.01e-02 | 9.59e-01 |
| GOBP PLATELET AGGREGATION | 48 | 3.37e-01 | -8.01e-02 | 8.36e-01 |
| GOCC CLATHRIN COATED ENDOCYTIC VESICLE MEMBRANE | 42 | 3.69e-01 | 8.01e-02 | 8.55e-01 |
| GOCC MICROTUBULE | 349 | 1.05e-02 | 8.00e-02 | 2.05e-01 |
| GOCC MRNA CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR COMPLEX | 14 | 6.04e-01 | -8.00e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR SENESCENCE | 10 | 6.61e-01 | 8.00e-02 | 9.49e-01 |
| GOMF LNCRNA BINDING | 11 | 6.46e-01 | 8.00e-02 | 9.43e-01 |
| GOMF MONOSACCHARIDE BINDING | 53 | 3.14e-01 | -8.00e-02 | 8.22e-01 |
| GOBP POSITIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 6 | 7.35e-01 | -7.99e-02 | 9.65e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY | 8 | 6.96e-01 | 7.99e-02 | 9.55e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY GLUCOSE | 6 | 7.35e-01 | -7.98e-02 | 9.65e-01 |
| GOBP REGULATION OF AXONOGENESIS | 98 | 1.73e-01 | -7.98e-02 | 7.02e-01 |
| GOBP ARACHIDONIC ACID SECRETION | 9 | 6.78e-01 | 7.98e-02 | 9.52e-01 |
| GOBP VIRAL PROTEIN PROCESSING | 29 | 4.57e-01 | -7.98e-02 | 8.95e-01 |
| GOBP CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC | 54 | 3.12e-01 | 7.96e-02 | 8.21e-01 |
| GOBP CELLULAR RESPONSE TO EXTERNAL STIMULUS | 272 | 2.42e-02 | 7.96e-02 | 3.20e-01 |
| GOBP VIRAL PROCESS | 359 | 9.84e-03 | 7.96e-02 | 1.96e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 35 | 4.16e-01 | 7.95e-02 | 8.79e-01 |
| GOBP VITAMIN METABOLIC PROCESS | 73 | 2.40e-01 | -7.95e-02 | 7.68e-01 |
| GOMF MHC CLASS I PROTEIN BINDING | 14 | 6.07e-01 | 7.95e-02 | 9.36e-01 |
| GOMF CALCIUM DEPENDENT PHOSPHOLIPID BINDING | 28 | 4.67e-01 | 7.95e-02 | 9.00e-01 |
| GOMF PROTEIN KINASE ACTIVITY | 440 | 4.43e-03 | 7.95e-02 | 1.24e-01 |
| GOBP MUSCLE CELL DEVELOPMENT | 109 | 1.52e-01 | 7.95e-02 | 6.74e-01 |
| GOBP NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS | 70 | 2.51e-01 | 7.94e-02 | 7.78e-01 |
| GOCC INTERSTITIAL MATRIX | 5 | 7.59e-01 | -7.94e-02 | 9.69e-01 |
| GOMF STEROL ESTERASE ACTIVITY | 6 | 7.36e-01 | -7.94e-02 | 9.65e-01 |
| GOBP MYELOID LEUKOCYTE CYTOKINE PRODUCTION | 41 | 3.80e-01 | 7.93e-02 | 8.62e-01 |
| GOBP REGULATION OF T CELL CHEMOTAXIS | 9 | 6.80e-01 | -7.93e-02 | 9.52e-01 |
| GOBP REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS | 13 | 6.21e-01 | -7.93e-02 | 9.37e-01 |
| GOMF NEUROTROPHIN RECEPTOR BINDING | 6 | 7.37e-01 | 7.93e-02 | 9.65e-01 |
| GOBP LEUKOCYTE CHEMOTAXIS | 154 | 9.01e-02 | -7.93e-02 | 5.60e-01 |
| GOBP ARACHIDONIC ACID METABOLIC PROCESS | 24 | 5.02e-01 | 7.92e-02 | 9.15e-01 |
| GOBP MANNOSE METABOLIC PROCESS | 9 | 6.81e-01 | 7.92e-02 | 9.52e-01 |
| GOBP BODY MORPHOGENESIS | 32 | 4.38e-01 | 7.92e-02 | 8.85e-01 |
| GOBP NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING | 8 | 6.98e-01 | -7.92e-02 | 9.55e-01 |
| GOBP GLYCOSAMINOGLYCAN CATABOLIC PROCESS | 18 | 5.61e-01 | -7.91e-02 | 9.29e-01 |
| GOBP HYALURONAN METABOLIC PROCESS | 19 | 5.51e-01 | 7.91e-02 | 9.26e-01 |
| GOBP CELLULAR RESPONSE TO STARVATION | 144 | 1.02e-01 | 7.91e-02 | 5.88e-01 |
| GOBP REGULATION OF LYASE ACTIVITY | 25 | 4.94e-01 | -7.91e-02 | 9.13e-01 |
| GOBP PINOCYTOSIS | 19 | 5.51e-01 | -7.91e-02 | 9.26e-01 |
| GOBP CALCIUM ION IMPORT | 25 | 4.94e-01 | 7.90e-02 | 9.13e-01 |
| GOMF CUPROUS ION BINDING | 6 | 7.37e-01 | 7.90e-02 | 9.65e-01 |
| GOBP RESPONSE TO LIGHT INTENSITY | 13 | 6.22e-01 | -7.90e-02 | 9.38e-01 |
| GOCC MITOCHONDRION | 1414 | 9.68e-07 | -7.90e-02 | 1.72e-04 |
| GOBP REGULATION OF ATP DEPENDENT ACTIVITY | 46 | 3.55e-01 | -7.89e-02 | 8.46e-01 |
| GOCC NUCLEAR PERIPHERY | 132 | 1.18e-01 | 7.89e-02 | 6.18e-01 |
| GOBP REGULATION OF RESPONSE TO STRESS | 1073 | 1.60e-05 | 7.89e-02 | 1.72e-03 |
| GOCC LEADING EDGE MEMBRANE | 126 | 1.27e-01 | -7.88e-02 | 6.34e-01 |
| GOBP OBSERVATIONAL LEARNING | 5 | 7.60e-01 | 7.88e-02 | 9.70e-01 |
| GOBP SNO S RNA METABOLIC PROCESS | 15 | 5.97e-01 | -7.88e-02 | 9.36e-01 |
| GOBP LYSOSOMAL LUMEN ACIDIFICATION | 22 | 5.23e-01 | -7.87e-02 | 9.20e-01 |
| GOBP SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 48 | 3.46e-01 | -7.87e-02 | 8.42e-01 |
| GOBP REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 14 | 6.10e-01 | -7.87e-02 | 9.36e-01 |
| GOBP LIPID DROPLET FORMATION | 11 | 6.51e-01 | -7.87e-02 | 9.45e-01 |
| GOBP POLYAMINE TRANSPORT | 12 | 6.37e-01 | 7.87e-02 | 9.41e-01 |
| GOBP POSITIVE REGULATION OF INSULIN SECRETION | 50 | 3.36e-01 | 7.87e-02 | 8.36e-01 |
| GOMF ATP DEPENDENT PROTEIN BINDING | 5 | 7.61e-01 | -7.86e-02 | 9.70e-01 |
| GOMF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 22 | 5.24e-01 | -7.86e-02 | 9.20e-01 |
| GOBP MYOBLAST FUSION | 28 | 4.72e-01 | 7.86e-02 | 9.02e-01 |
| GOCC PROTEIN LIPID COMPLEX | 24 | 5.05e-01 | -7.86e-02 | 9.16e-01 |
| GOBP NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION | 13 | 6.24e-01 | -7.85e-02 | 9.40e-01 |
| GOBP HYDROGEN PEROXIDE METABOLIC PROCESS | 28 | 4.72e-01 | -7.85e-02 | 9.02e-01 |
| GOBP MEMORY | 63 | 2.82e-01 | 7.85e-02 | 8.00e-01 |
| GOBP POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 12 | 6.38e-01 | 7.85e-02 | 9.41e-01 |
| GOBP CYTOKINETIC PROCESS | 41 | 3.85e-01 | 7.85e-02 | 8.64e-01 |
| GOMF CARBON SULFUR LYASE ACTIVITY | 12 | 6.38e-01 | 7.85e-02 | 9.41e-01 |
| GOBP REGULATION OF VIRAL TRANSCRIPTION | 18 | 5.65e-01 | 7.84e-02 | 9.29e-01 |
| GOBP FUCOSE METABOLIC PROCESS | 10 | 6.68e-01 | 7.84e-02 | 9.49e-01 |
| GOBP GAS TRANSPORT | 5 | 7.62e-01 | -7.83e-02 | 9.70e-01 |
| GOBP NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT | 11 | 6.53e-01 | -7.83e-02 | 9.46e-01 |
| GOBP DETECTION OF LIGHT STIMULUS | 31 | 4.51e-01 | -7.83e-02 | 8.89e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON SULFUR BONDS | 31 | 4.51e-01 | 7.82e-02 | 8.90e-01 |
| GOBP EPITHELIAL TUBE FORMATION | 89 | 2.03e-01 | -7.82e-02 | 7.32e-01 |
| GOBP LONG CHAIN FATTY ACID METABOLIC PROCESS | 60 | 2.95e-01 | 7.81e-02 | 8.10e-01 |
| GOBP PURINE RIBONUCLEOTIDE SALVAGE | 7 | 7.20e-01 | 7.81e-02 | 9.61e-01 |
| GOBP REGULATION OF CELL ACTIVATION | 450 | 4.69e-03 | 7.81e-02 | 1.28e-01 |
| GOBP REGULATION OF LAMELLIPODIUM MORPHOGENESIS | 11 | 6.54e-01 | -7.81e-02 | 9.46e-01 |
| GOCC SEMAPHORIN RECEPTOR COMPLEX | 8 | 7.02e-01 | -7.80e-02 | 9.56e-01 |
| GOMF SEMAPHORIN RECEPTOR ACTIVITY | 8 | 7.02e-01 | -7.80e-02 | 9.56e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE | 23 | 5.17e-01 | 7.80e-02 | 9.19e-01 |
| GOMF HISTONE H4K20 MONOMETHYLTRANSFERASE ACTIVITY | 5 | 7.63e-01 | -7.80e-02 | 9.70e-01 |
| GOBP GRANULOCYTE ACTIVATION | 35 | 4.25e-01 | 7.80e-02 | 8.81e-01 |
| GOBP MITOCHONDRIAL TRNA PROCESSING | 14 | 6.14e-01 | 7.79e-02 | 9.36e-01 |
| GOBP EXTERNAL ENCAPSULATING STRUCTURE ORGANIZATION | 156 | 9.36e-02 | -7.79e-02 | 5.67e-01 |
| GOBP POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 5 | 7.63e-01 | -7.79e-02 | 9.70e-01 |
| GOMF PHOSPHOTRANSFERASE ACTIVITY FOR OTHER SUBSTITUTED PHOSPHATE GROUPS | 22 | 5.27e-01 | -7.79e-02 | 9.22e-01 |
| GOBP LEUKOCYTE DIFFERENTIATION | 438 | 5.41e-03 | 7.79e-02 | 1.37e-01 |
| GOCC CDC73 PAF1 COMPLEX | 6 | 7.41e-01 | 7.78e-02 | 9.65e-01 |
| GOBP PHOTOPERIODISM | 24 | 5.10e-01 | 7.77e-02 | 9.18e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE BINDING | 9 | 6.86e-01 | 7.77e-02 | 9.54e-01 |
| GOBP NEURON REMODELING | 8 | 7.04e-01 | -7.77e-02 | 9.56e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 6 | 7.42e-01 | 7.77e-02 | 9.65e-01 |
| GOBP SHORT CHAIN FATTY ACID METABOLIC PROCESS | 13 | 6.28e-01 | 7.77e-02 | 9.40e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER UPTAKE | 8 | 7.04e-01 | -7.76e-02 | 9.56e-01 |
| GOBP PLASMA LIPOPROTEIN PARTICLE CLEARANCE | 28 | 4.78e-01 | -7.76e-02 | 9.05e-01 |
| GOMF PROTEIN HORMONE RECEPTOR ACTIVITY | 9 | 6.87e-01 | 7.75e-02 | 9.54e-01 |
| GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS | 34 | 4.34e-01 | -7.75e-02 | 8.83e-01 |
| GOBP DETOXIFICATION | 92 | 1.99e-01 | -7.75e-02 | 7.31e-01 |
| GOBP REGULATION OF CENTRIOLE REPLICATION | 21 | 5.39e-01 | 7.74e-02 | 9.23e-01 |
| GOBP OLIGODENDROCYTE DEVELOPMENT | 25 | 5.03e-01 | -7.74e-02 | 9.15e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINESIS | 6 | 7.43e-01 | -7.74e-02 | 9.65e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS | 120 | 1.44e-01 | 7.74e-02 | 6.65e-01 |
| GOBP GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS | 21 | 5.40e-01 | 7.74e-02 | 9.23e-01 |
| GOBP CELLULAR RESPONSE TO MINERALOCORTICOID STIMULUS | 6 | 7.43e-01 | -7.74e-02 | 9.65e-01 |
| GOBP CRANIAL NERVE DEVELOPMENT | 27 | 4.87e-01 | -7.74e-02 | 9.11e-01 |
| GOBP POSITIVE REGULATION OF MIRNA METABOLIC PROCESS | 45 | 3.70e-01 | 7.73e-02 | 8.55e-01 |
| GOBP PROTEIN DEUBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 6 | 7.43e-01 | 7.73e-02 | 9.65e-01 |
| GOCC ACTIN FILAMENT | 85 | 2.19e-01 | -7.72e-02 | 7.49e-01 |
| GOMF HORMONE BINDING | 34 | 4.36e-01 | 7.72e-02 | 8.84e-01 |
| GOMF GLUTAMATE RECEPTOR ACTIVITY | 10 | 6.73e-01 | 7.71e-02 | 9.49e-01 |
| GOMF IONOTROPIC GLUTAMATE RECEPTOR ACTIVITY | 10 | 6.73e-01 | 7.71e-02 | 9.49e-01 |
| GOBP PEPTIDYL LYSINE DIMETHYLATION | 10 | 6.73e-01 | 7.71e-02 | 9.49e-01 |
| GOBP LIPOPROTEIN BIOSYNTHETIC PROCESS | 82 | 2.28e-01 | 7.71e-02 | 7.58e-01 |
| GOBP REGULATION OF RENAL SYSTEM PROCESS | 7 | 7.24e-01 | -7.71e-02 | 9.62e-01 |
| GOBP CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS | 69 | 2.69e-01 | 7.71e-02 | 7.93e-01 |
| GOBP GLUCOSE METABOLIC PROCESS | 146 | 1.09e-01 | -7.71e-02 | 5.99e-01 |
| GOCC COMPACT MYELIN | 9 | 6.89e-01 | -7.70e-02 | 9.54e-01 |
| GOBP N TERMINAL PROTEIN AMINO ACID MODIFICATION | 24 | 5.14e-01 | -7.70e-02 | 9.18e-01 |
| GOBP ANDROGEN RECEPTOR SIGNALING PATHWAY | 38 | 4.11e-01 | 7.70e-02 | 8.77e-01 |
| GOBP MONOAMINE TRANSPORT | 34 | 4.37e-01 | 7.70e-02 | 8.85e-01 |
| GOBP POSITIVE REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION | 5 | 7.66e-01 | 7.70e-02 | 9.70e-01 |
| GOMF PEPTIDE HORMONE BINDING | 14 | 6.18e-01 | -7.69e-02 | 9.37e-01 |
| GOBP POSITIVE REGULATION OF TRANSPORTER ACTIVITY | 60 | 3.04e-01 | 7.69e-02 | 8.14e-01 |
| GOBP ANATOMICAL STRUCTURE MATURATION | 138 | 1.20e-01 | 7.68e-02 | 6.20e-01 |
| GOBP ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 37 | 4.19e-01 | -7.68e-02 | 8.79e-01 |
| GOBP SURFACTANT HOMEOSTASIS | 9 | 6.90e-01 | -7.68e-02 | 9.54e-01 |
| GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 36 | 4.25e-01 | 7.68e-02 | 8.81e-01 |
| GOBP REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 78 | 2.41e-01 | 7.68e-02 | 7.70e-01 |
| GOCC MITOTIC SPINDLE | 157 | 9.74e-02 | 7.68e-02 | 5.77e-01 |
| GOBP RHYTHMIC PROCESS | 196 | 6.46e-02 | 7.67e-02 | 4.96e-01 |
| GOBP PURINE NUCLEOBASE METABOLIC PROCESS | 16 | 5.96e-01 | 7.66e-02 | 9.36e-01 |
| GOBP PEPTIDE CATABOLIC PROCESS | 17 | 5.85e-01 | 7.64e-02 | 9.36e-01 |
| GOBP CONNECTIVE TISSUE DEVELOPMENT | 157 | 9.92e-02 | -7.64e-02 | 5.82e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION | 11 | 6.61e-01 | 7.64e-02 | 9.49e-01 |
| GOBP CELLULAR RESPONSE TO NUTRIENT | 35 | 4.35e-01 | 7.63e-02 | 8.83e-01 |
| GOBP POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 20 | 5.55e-01 | -7.63e-02 | 9.26e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER TRANSPORT | 55 | 3.28e-01 | -7.62e-02 | 8.30e-01 |
| GOMF EXONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS | 56 | 3.24e-01 | 7.62e-02 | 8.29e-01 |
| GOMF HISTONE MODIFYING ACTIVITY | 187 | 7.30e-02 | 7.62e-02 | 5.22e-01 |
| GOBP NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 27 | 4.94e-01 | 7.61e-02 | 9.13e-01 |
| GOBP HISTONE MRNA CATABOLIC PROCESS | 15 | 6.10e-01 | 7.61e-02 | 9.36e-01 |
| GOCC MICROFIBRIL | 5 | 7.68e-01 | -7.61e-02 | 9.70e-01 |
| GOBP AXO DENDRITIC TRANSPORT | 64 | 2.93e-01 | 7.60e-02 | 8.08e-01 |
| GOBP POSITIVE REGULATION OF ORGANIC ACID TRANSPORT | 23 | 5.28e-01 | 7.60e-02 | 9.22e-01 |
| GOBP REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 9 | 6.93e-01 | 7.60e-02 | 9.54e-01 |
| GOBP NEGATIVE REGULATION OF LIPID LOCALIZATION | 31 | 4.64e-01 | -7.60e-02 | 9.00e-01 |
| GOBP ERROR FREE TRANSLESION SYNTHESIS | 5 | 7.69e-01 | -7.59e-02 | 9.70e-01 |
| GOBP INTESTINAL CHOLESTEROL ABSORPTION | 6 | 7.48e-01 | -7.59e-02 | 9.66e-01 |
| GOBP LIPID DIGESTION | 6 | 7.48e-01 | -7.59e-02 | 9.66e-01 |
| GOBP MEMBRANE PROTEIN PROTEOLYSIS | 48 | 3.64e-01 | 7.58e-02 | 8.50e-01 |
| GOMF PHOSPHATIDYLCHOLINE TRANSPORTER ACTIVITY | 16 | 6.00e-01 | 7.58e-02 | 9.36e-01 |
| GOBP CELLULAR RESPONSE TO DSRNA | 18 | 5.78e-01 | 7.57e-02 | 9.34e-01 |
| GOBP CELLULAR RESPONSE TO UV B | 10 | 6.79e-01 | 7.57e-02 | 9.52e-01 |
| GOBP REGULATION OF HELICASE ACTIVITY | 11 | 6.64e-01 | 7.56e-02 | 9.49e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 24 | 5.22e-01 | 7.55e-02 | 9.20e-01 |
| GOBP AMMONIUM ION METABOLIC PROCESS | 11 | 6.65e-01 | 7.55e-02 | 9.49e-01 |
| GOBP RESPONSE TO PHORBOL 13 ACETATE 12 MYRISTATE | 5 | 7.70e-01 | -7.55e-02 | 9.70e-01 |
| GOCC H4 HISTONE ACETYLTRANSFERASE COMPLEX | 36 | 4.33e-01 | -7.55e-02 | 8.82e-01 |
| GOBP COMPLEMENT ACTIVATION | 29 | 4.82e-01 | -7.55e-02 | 9.08e-01 |
| GOBP RNA CATABOLIC PROCESS | 261 | 3.63e-02 | 7.55e-02 | 3.88e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION | 33 | 4.53e-01 | -7.54e-02 | 8.92e-01 |
| GOBP CGMP METABOLIC PROCESS | 11 | 6.65e-01 | -7.54e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 6.65e-01 | -7.54e-02 | 9.49e-01 |
| GOMF NUCLEOSIDE MONOPHOSPHATE KINASE ACTIVITY | 20 | 5.60e-01 | 7.54e-02 | 9.28e-01 |
| GOBP PROTEIN REPAIR | 6 | 7.50e-01 | 7.53e-02 | 9.67e-01 |
| GOBP CELLULAR RESPONSE TO IONIZING RADIATION | 59 | 3.18e-01 | -7.53e-02 | 8.23e-01 |
| GOCC VACUOLAR LUMEN | 132 | 1.36e-01 | -7.52e-02 | 6.52e-01 |
| GOBP QUINONE METABOLIC PROCESS | 30 | 4.76e-01 | -7.52e-02 | 9.04e-01 |
| GOBP REGULATION OF CELL SUBSTRATE ADHESION | 148 | 1.15e-01 | 7.52e-02 | 6.12e-01 |
| GOMF OMEGA PEPTIDASE ACTIVITY | 11 | 6.66e-01 | 7.51e-02 | 9.49e-01 |
| GOBP LEFT RIGHT AXIS SPECIFICATION | 10 | 6.81e-01 | -7.51e-02 | 9.52e-01 |
| GOMF DNA INSERTION OR DELETION BINDING | 6 | 7.50e-01 | -7.50e-02 | 9.67e-01 |
| GOBP RNA CAPPING | 36 | 4.36e-01 | 7.50e-02 | 8.84e-01 |
| GOCC ENDOPLASMIC RETICULUM LUMEN | 181 | 8.22e-02 | -7.50e-02 | 5.43e-01 |
| GOBP RECEPTOR METABOLIC PROCESS | 62 | 3.07e-01 | -7.50e-02 | 8.19e-01 |
| GOBP PROTEIN HEXAMERIZATION | 9 | 6.97e-01 | 7.50e-02 | 9.55e-01 |
| GOBP NEURON CELL CELL ADHESION | 7 | 7.31e-01 | 7.49e-02 | 9.64e-01 |
| GOBP REGULATION OF ACTIN FILAMENT ORGANIZATION | 194 | 7.26e-02 | -7.49e-02 | 5.21e-01 |
| GOBP NEGATIVE REGULATION OF DNA RECOMBINATION | 36 | 4.37e-01 | 7.49e-02 | 8.85e-01 |
| GOMF SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 16 | 6.04e-01 | -7.49e-02 | 9.36e-01 |
| GOBP GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE | 19 | 5.72e-01 | -7.49e-02 | 9.31e-01 |
| GOBP SINGLE STRAND BREAK REPAIR | 10 | 6.82e-01 | -7.48e-02 | 9.52e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 9 | 6.98e-01 | -7.48e-02 | 9.55e-01 |
| GOBP PROTEIN DEPOLYMERIZATION | 89 | 2.23e-01 | -7.48e-02 | 7.52e-01 |
| GOBP UBIQUITIN DEPENDENT ERAD PATHWAY | 73 | 2.70e-01 | -7.48e-02 | 7.93e-01 |
| GOBP NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING | 6 | 7.51e-01 | -7.47e-02 | 9.68e-01 |
| GOBP PRIMARY ALCOHOL METABOLIC PROCESS | 53 | 3.47e-01 | 7.46e-02 | 8.43e-01 |
| GOMF CIS TRANS ISOMERASE ACTIVITY | 36 | 4.39e-01 | 7.46e-02 | 8.85e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 30 | 4.80e-01 | 7.46e-02 | 9.07e-01 |
| GOBP RESPONSE TO IRON II ION | 5 | 7.73e-01 | 7.46e-02 | 9.72e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM CALCIUM ION CONCENTRATION | 8 | 7.15e-01 | -7.46e-02 | 9.59e-01 |
| GOBP STEROL METABOLIC PROCESS | 101 | 1.96e-01 | -7.45e-02 | 7.28e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO WOUNDING | 49 | 3.68e-01 | -7.45e-02 | 8.54e-01 |
| GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 23 | 5.37e-01 | -7.44e-02 | 9.23e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 16 | 6.06e-01 | 7.44e-02 | 9.36e-01 |
| GOBP MITOCHONDRIAL DNA METABOLIC PROCESS | 21 | 5.55e-01 | -7.43e-02 | 9.26e-01 |
| GOBP RESPONSE TO REDOX STATE | 10 | 6.84e-01 | -7.43e-02 | 9.53e-01 |
| GOBP ACTIN POLYMERIZATION OR DEPOLYMERIZATION | 147 | 1.21e-01 | -7.43e-02 | 6.22e-01 |
| GOBP GLUCOCORTICOID SECRETION | 9 | 7.00e-01 | -7.43e-02 | 9.55e-01 |
| GOBP RNA DECAPPING | 19 | 5.75e-01 | 7.43e-02 | 9.33e-01 |
| GOBP LUNG EPITHELIUM DEVELOPMENT | 22 | 5.47e-01 | -7.42e-02 | 9.25e-01 |
| GOCC 9PLUS2 MOTILE CILIUM | 95 | 2.12e-01 | -7.42e-02 | 7.44e-01 |
| GOBP REGULATION OF STORE OPERATED CALCIUM ENTRY | 11 | 6.70e-01 | -7.42e-02 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 46 | 3.84e-01 | 7.42e-02 | 8.64e-01 |
| GOBP NEGATIVE REGULATION OF TISSUE REMODELING | 12 | 6.57e-01 | -7.41e-02 | 9.47e-01 |
| GOMF RNA CAP BINDING | 19 | 5.76e-01 | 7.41e-02 | 9.33e-01 |
| GOCC SARCOPLASMIC RETICULUM MEMBRANE | 26 | 5.13e-01 | 7.41e-02 | 9.18e-01 |
| GOBP GERM CELL DEVELOPMENT | 185 | 8.28e-02 | 7.41e-02 | 5.44e-01 |
| GOBP VESICLE TETHERING TO GOLGI | 5 | 7.74e-01 | -7.41e-02 | 9.72e-01 |
| GOMF TRIGLYCERIDE LIPASE ACTIVITY | 13 | 6.44e-01 | -7.40e-02 | 9.42e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN SECRETION | 93 | 2.18e-01 | 7.40e-02 | 7.49e-01 |
| GOBP GLYCOLIPID CATABOLIC PROCESS | 11 | 6.71e-01 | -7.40e-02 | 9.49e-01 |
| GOMF SULFATIDE BINDING | 6 | 7.54e-01 | -7.40e-02 | 9.68e-01 |
| GOBP SPERMATID DIFFERENTIATION | 105 | 1.91e-01 | 7.40e-02 | 7.21e-01 |
| GOBP REGULATION OF B CELL PROLIFERATION | 47 | 3.80e-01 | 7.40e-02 | 8.63e-01 |
| GOCC LAMELLIPODIUM | 170 | 9.69e-02 | -7.39e-02 | 5.77e-01 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 6 | 7.54e-01 | 7.39e-02 | 9.68e-01 |
| GOBP NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 9 | 7.01e-01 | -7.39e-02 | 9.56e-01 |
| GOBP NEUTRAL AMINO ACID TRANSPORT | 36 | 4.43e-01 | -7.39e-02 | 8.87e-01 |
| GOBP ERYTHROCYTE MATURATION | 12 | 6.58e-01 | -7.38e-02 | 9.48e-01 |
| GOBP ADAPTIVE THERMOGENESIS | 117 | 1.68e-01 | -7.38e-02 | 6.96e-01 |
| GOBP CHOLESTEROL IMPORT | 7 | 7.35e-01 | -7.38e-02 | 9.65e-01 |
| GOCC MATRIX SIDE OF MITOCHONDRIAL INNER MEMBRANE | 6 | 7.54e-01 | 7.38e-02 | 9.68e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME | 23 | 5.40e-01 | -7.38e-02 | 9.23e-01 |
| GOBP STEROL HOMEOSTASIS | 54 | 3.48e-01 | -7.38e-02 | 8.43e-01 |
| GOBP RESPONSE TO LEAD ION | 16 | 6.09e-01 | -7.38e-02 | 9.36e-01 |
| GOCC TRANSCRIPTION PREINITIATION COMPLEX | 13 | 6.45e-01 | 7.38e-02 | 9.43e-01 |
| GOBP POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS | 11 | 6.72e-01 | -7.38e-02 | 9.49e-01 |
| GOBP REGULATION OF B CELL ACTIVATION | 100 | 2.03e-01 | 7.37e-02 | 7.32e-01 |
| GOBP EPITHELIAL CELL MORPHOGENESIS | 17 | 5.99e-01 | -7.37e-02 | 9.36e-01 |
| GOBP PURINE CONTAINING COMPOUND METABOLIC PROCESS | 383 | 1.37e-02 | -7.37e-02 | 2.44e-01 |
| GOBP CORTICAL CYTOSKELETON ORGANIZATION | 47 | 3.82e-01 | -7.37e-02 | 8.64e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 17 | 5.99e-01 | 7.37e-02 | 9.36e-01 |
| GOBP SOMATIC STEM CELL POPULATION MAINTENANCE | 45 | 3.93e-01 | 7.36e-02 | 8.68e-01 |
| GOBP COENZYME A BIOSYNTHETIC PROCESS | 11 | 6.73e-01 | 7.36e-02 | 9.49e-01 |
| GOMF PHOSPHOFRUCTOKINASE ACTIVITY | 6 | 7.55e-01 | -7.36e-02 | 9.68e-01 |
| GOBP CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS | 12 | 6.59e-01 | -7.35e-02 | 9.49e-01 |
| GOBP INTERMEMBRANE LIPID TRANSFER | 38 | 4.33e-01 | -7.35e-02 | 8.82e-01 |
| GOMF LIPID TRANSFER ACTIVITY | 38 | 4.33e-01 | -7.35e-02 | 8.82e-01 |
| GOCC CORTICAL CYTOSKELETON | 75 | 2.71e-01 | -7.35e-02 | 7.94e-01 |
| GOCC ENDONUCLEASE COMPLEX | 37 | 4.39e-01 | -7.35e-02 | 8.85e-01 |
| GOBP VITAMIN K METABOLIC PROCESS | 7 | 7.36e-01 | 7.35e-02 | 9.65e-01 |
| GOBP CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS | 222 | 5.97e-02 | 7.35e-02 | 4.79e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS | 6 | 7.55e-01 | -7.35e-02 | 9.69e-01 |
| GOBP NEGATIVE REGULATION OF BMP SIGNALING PATHWAY | 33 | 4.65e-01 | -7.34e-02 | 9.00e-01 |
| GOBP PHAGOSOME LYSOSOME FUSION | 12 | 6.60e-01 | 7.34e-02 | 9.49e-01 |
| GOMF ICOSANOID RECEPTOR ACTIVITY | 7 | 7.37e-01 | 7.34e-02 | 9.65e-01 |
| GOBP CYCLIC NUCLEOTIDE METABOLIC PROCESS | 27 | 5.10e-01 | 7.33e-02 | 9.18e-01 |
| GOBP PROTEIN K6 LINKED UBIQUITINATION | 11 | 6.74e-01 | -7.33e-02 | 9.50e-01 |
| GOCC PROTEIN PHOSPHATASE TYPE 1 COMPLEX | 17 | 6.01e-01 | -7.33e-02 | 9.36e-01 |
| GOBP REGULATION OF POSITIVE CHEMOTAXIS | 11 | 6.74e-01 | -7.33e-02 | 9.50e-01 |
| GOBP NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 24 | 5.34e-01 | 7.33e-02 | 9.23e-01 |
| GOBP ETHER BIOSYNTHETIC PROCESS | 11 | 6.74e-01 | 7.33e-02 | 9.50e-01 |
| GOMF ATP HYDROLYSIS ACTIVITY | 338 | 2.12e-02 | 7.32e-02 | 3.04e-01 |
| GOBP DETECTION OF ABIOTIC STIMULUS | 70 | 2.90e-01 | 7.32e-02 | 8.06e-01 |
| GOCC CCR4 NOT CORE COMPLEX | 6 | 7.57e-01 | 7.31e-02 | 9.69e-01 |
| GOBP 2 OXOGLUTARATE METABOLIC PROCESS | 13 | 6.48e-01 | -7.31e-02 | 9.44e-01 |
| GOBP MONOCYTE DIFFERENTIATION | 29 | 4.96e-01 | -7.31e-02 | 9.13e-01 |
| GOBP CELL FATE SPECIFICATION | 33 | 4.68e-01 | -7.31e-02 | 9.00e-01 |
| GOBP HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 9 | 7.05e-01 | -7.30e-02 | 9.56e-01 |
| GOBP IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE | 48 | 3.82e-01 | 7.30e-02 | 8.64e-01 |
| GOBP GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS | 19 | 5.82e-01 | 7.29e-02 | 9.36e-01 |
| GOBP REGULATION OF TOLERANCE INDUCTION | 12 | 6.62e-01 | 7.29e-02 | 9.49e-01 |
| GOBP PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT | 14 | 6.37e-01 | -7.29e-02 | 9.41e-01 |
| GOBP REGULATION OF EXECUTION PHASE OF APOPTOSIS | 12 | 6.62e-01 | -7.29e-02 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF T CELL PROLIFERATION | 47 | 3.88e-01 | 7.29e-02 | 8.65e-01 |
| GOCC CHROMOSOME TELOMERIC REGION | 138 | 1.40e-01 | -7.29e-02 | 6.62e-01 |
| GOCC MITOCHONDRIAL MATRIX | 440 | 9.12e-03 | -7.28e-02 | 1.88e-01 |
| GOBP FUCOSYLATION | 10 | 6.90e-01 | 7.28e-02 | 9.54e-01 |
| GOBP PLATELET DEGRANULATION | 6 | 7.57e-01 | 7.28e-02 | 9.69e-01 |
| GOBP POSITIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS | 10 | 6.90e-01 | 7.27e-02 | 9.54e-01 |
| GOBP HYPOXIA INDUCIBLE FACTOR 1ALPHA SIGNALING PATHWAY | 6 | 7.58e-01 | -7.27e-02 | 9.69e-01 |
| GOBP NEGATIVE REGULATION OF TRANSPORTER ACTIVITY | 38 | 4.38e-01 | -7.27e-02 | 8.85e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN UBIQUITINATION | 68 | 3.00e-01 | 7.27e-02 | 8.14e-01 |
| GOBP RESPONSE TO ETHANOL | 70 | 2.94e-01 | -7.27e-02 | 8.08e-01 |
| GOMF MICROTUBULE BINDING | 218 | 6.52e-02 | 7.26e-02 | 4.98e-01 |
| GOBP PROTEIN KINASE A SIGNALING | 22 | 5.56e-01 | -7.26e-02 | 9.26e-01 |
| GOBP POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 38 | 4.40e-01 | 7.25e-02 | 8.85e-01 |
| GOCC PRC1 COMPLEX | 16 | 6.16e-01 | -7.25e-02 | 9.36e-01 |
| GOBP SODIUM ION TRANSPORT | 111 | 1.88e-01 | 7.25e-02 | 7.17e-01 |
| GOCC TERTIARY GRANULE MEMBRANE | 59 | 3.36e-01 | 7.24e-02 | 8.36e-01 |
| GOBP SPHINGOMYELIN METABOLIC PROCESS | 16 | 6.17e-01 | -7.23e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 44 | 4.07e-01 | 7.23e-02 | 8.75e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 37 | 4.47e-01 | -7.22e-02 | 8.88e-01 |
| GOMF LIGASE ACTIVITY FORMING CARBON OXYGEN BONDS | 22 | 5.58e-01 | -7.22e-02 | 9.27e-01 |
| GOBP HETEROCYCLE CATABOLIC PROCESS | 391 | 1.47e-02 | 7.22e-02 | 2.56e-01 |
| GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 83 | 2.56e-01 | 7.22e-02 | 7.84e-01 |
| GOBP PROSTAGLANDIN TRANSPORT | 14 | 6.40e-01 | 7.22e-02 | 9.42e-01 |
| GOBP CELL CHEMOTAXIS | 187 | 8.96e-02 | -7.21e-02 | 5.59e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 8 | 7.24e-01 | 7.21e-02 | 9.62e-01 |
| GOBP REGULATION OF MONOATOMIC CATION TRANSMEMBRANE TRANSPORT | 173 | 1.03e-01 | 7.21e-02 | 5.90e-01 |
| GOBP HEAD MORPHOGENESIS | 24 | 5.41e-01 | 7.20e-02 | 9.23e-01 |
| GOBP POSITIVE REGULATION OF FAT CELL DIFFERENTIATION | 47 | 3.93e-01 | 7.20e-02 | 8.68e-01 |
| GOBP CD40 SIGNALING PATHWAY | 13 | 6.53e-01 | 7.20e-02 | 9.46e-01 |
| GOBP HEMOGLOBIN BIOSYNTHETIC PROCESS | 10 | 6.93e-01 | -7.20e-02 | 9.54e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE | 241 | 5.48e-02 | 7.20e-02 | 4.63e-01 |
| GOBP POSITIVE REGULATION OF MRNA PROCESSING | 25 | 5.33e-01 | -7.20e-02 | 9.23e-01 |
| GOBP POSITIVE REGULATION OF PHAGOCYTOSIS | 46 | 3.99e-01 | 7.20e-02 | 8.71e-01 |
| GOBP REGULATION OF NEURONAL SYNAPTIC PLASTICITY | 35 | 4.61e-01 | -7.20e-02 | 8.98e-01 |
| GOBP ICOSANOID METABOLIC PROCESS | 59 | 3.40e-01 | 7.19e-02 | 8.39e-01 |
| GOBP CARBON CATABOLITE REGULATION OF TRANSCRIPTION | 7 | 7.42e-01 | 7.19e-02 | 9.65e-01 |
| GOBP HOMEOSTASIS OF NUMBER OF CELLS | 233 | 5.95e-02 | 7.18e-02 | 4.77e-01 |
| GOBP REGULATION OF RUFFLE ASSEMBLY | 25 | 5.34e-01 | -7.18e-02 | 9.23e-01 |
| GOMF UNFOLDED PROTEIN BINDING | 94 | 2.30e-01 | -7.17e-02 | 7.58e-01 |
| GOBP SCHWANN CELL DIFFERENTIATION | 28 | 5.11e-01 | -7.17e-02 | 9.18e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 22 | 5.61e-01 | -7.17e-02 | 9.28e-01 |
| GOBP AUTONOMIC NERVOUS SYSTEM DEVELOPMENT | 19 | 5.89e-01 | -7.17e-02 | 9.36e-01 |
| GOCC CELL CORTEX REGION | 22 | 5.61e-01 | 7.17e-02 | 9.28e-01 |
| GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 6 | 7.61e-01 | 7.17e-02 | 9.70e-01 |
| GOBP MEMBRANE LIPID CATABOLIC PROCESS | 25 | 5.35e-01 | -7.17e-02 | 9.23e-01 |
| GOBP POSITIVE REGULATION OF STRESS FIBER ASSEMBLY | 41 | 4.28e-01 | -7.16e-02 | 8.82e-01 |
| GOBP REGULATION OF FAT CELL DIFFERENTIATION | 86 | 2.51e-01 | 7.16e-02 | 7.78e-01 |
| GOBP STEM CELL DIFFERENTIATION | 152 | 1.28e-01 | -7.16e-02 | 6.37e-01 |
| GOCC H4 H2A HISTONE ACETYLTRANSFERASE COMPLEX | 22 | 5.62e-01 | -7.15e-02 | 9.29e-01 |
| GOBP PROTEIN LOCALIZATION TO SYNAPSE | 48 | 3.92e-01 | -7.15e-02 | 8.68e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 21 | 5.71e-01 | 7.15e-02 | 9.31e-01 |
| GOBP PROTEOGLYCAN CATABOLIC PROCESS | 9 | 7.10e-01 | 7.15e-02 | 9.59e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 10 | 6.96e-01 | 7.15e-02 | 9.55e-01 |
| GOCC MULTIVESICULAR BODY MEMBRANE | 24 | 5.45e-01 | -7.15e-02 | 9.23e-01 |
| GOBP CELLULAR RESPONSE TO RETINOIC ACID | 28 | 5.13e-01 | -7.14e-02 | 9.18e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER SECRETION | 49 | 3.87e-01 | -7.14e-02 | 8.65e-01 |
| GOBP REGULATION OF ANATOMICAL STRUCTURE SIZE | 329 | 2.66e-02 | -7.14e-02 | 3.32e-01 |
| GOBP CARDIAC CHAMBER MORPHOGENESIS | 66 | 3.17e-01 | 7.13e-02 | 8.23e-01 |
| GOBP PROSTANOID BIOSYNTHETIC PROCESS | 20 | 5.81e-01 | 7.13e-02 | 9.35e-01 |
| GOBP REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE | 10 | 6.96e-01 | 7.13e-02 | 9.55e-01 |
| GOBP BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION | 8 | 7.27e-01 | 7.13e-02 | 9.63e-01 |
| GOBP POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY | 15 | 6.33e-01 | -7.13e-02 | 9.41e-01 |
| GOBP INDUCTION OF POSITIVE CHEMOTAXIS | 8 | 7.27e-01 | -7.12e-02 | 9.63e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL DEVELOPMENT | 15 | 6.33e-01 | 7.12e-02 | 9.41e-01 |
| GOBP REGULATION OF NCRNA TRANSCRIPTION | 65 | 3.21e-01 | 7.12e-02 | 8.28e-01 |
| GOBP L SERINE TRANSPORT | 6 | 7.63e-01 | -7.12e-02 | 9.70e-01 |
| GOMF L SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 7.63e-01 | -7.12e-02 | 9.70e-01 |
| GOMF SMALL RIBOSOMAL SUBUNIT RRNA BINDING | 8 | 7.28e-01 | -7.11e-02 | 9.64e-01 |
| GOMF ATP DEPENDENT CHROMATIN REMODELER ACTIVITY | 34 | 4.74e-01 | 7.10e-02 | 9.02e-01 |
| GOCC U2 SNRNP | 25 | 5.39e-01 | -7.10e-02 | 9.23e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY | 6 | 7.63e-01 | 7.10e-02 | 9.70e-01 |
| GOCC ENVELOPE | 1082 | 9.80e-05 | -7.09e-02 | 7.46e-03 |
| GOBP BODY FLUID SECRETION | 48 | 3.95e-01 | 7.09e-02 | 8.70e-01 |
| GOBP RESPONSE TO MISFOLDED PROTEIN | 25 | 5.39e-01 | 7.09e-02 | 9.23e-01 |
| GOBP RESPONSE TO BMP | 87 | 2.54e-01 | -7.09e-02 | 7.79e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL POPULATION MAINTENANCE | 43 | 4.22e-01 | 7.09e-02 | 8.81e-01 |
| GOCC CYTOPLASMIC SIDE OF ENDOSOME MEMBRANE | 6 | 7.64e-01 | -7.08e-02 | 9.70e-01 |
| GOMF ATPASE COUPLED INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 7.64e-01 | -7.08e-02 | 9.70e-01 |
| GOMF SERINE HYDROLASE ACTIVITY | 85 | 2.60e-01 | -7.08e-02 | 7.85e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 67 | 3.17e-01 | 7.08e-02 | 8.23e-01 |
| GOBP RETINOIC ACID METABOLIC PROCESS | 12 | 6.71e-01 | -7.08e-02 | 9.49e-01 |
| GOBP KERATINOCYTE DIFFERENTIATION | 69 | 3.10e-01 | 7.08e-02 | 8.20e-01 |
| GOCC SMN SM PROTEIN COMPLEX | 17 | 6.13e-01 | 7.08e-02 | 9.36e-01 |
| GOMF CYCLOSPORIN A BINDING | 17 | 6.13e-01 | -7.08e-02 | 9.36e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS | 96 | 2.32e-01 | -7.07e-02 | 7.59e-01 |
| GOBP ANOIKIS | 27 | 5.25e-01 | 7.07e-02 | 9.20e-01 |
| GOBP REGULATION OF STRIATED MUSCLE CONTRACTION | 57 | 3.57e-01 | 7.06e-02 | 8.46e-01 |
| GOBP CO TRANSCRIPTIONAL MRNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY | 5 | 7.85e-01 | -7.06e-02 | 9.76e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 30 | 5.04e-01 | 7.05e-02 | 9.15e-01 |
| GOBP ORGANELLE FISSION | 383 | 1.83e-02 | 7.05e-02 | 2.84e-01 |
| GOBP 10 FORMYLTETRAHYDROFOLATE METABOLIC PROCESS | 5 | 7.85e-01 | 7.05e-02 | 9.76e-01 |
| GOCC SPECIFIC GRANULE | 125 | 1.74e-01 | 7.05e-02 | 7.05e-01 |
| GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED EIF2 ALPHA PHOSPHORYLATION | 5 | 7.85e-01 | -7.05e-02 | 9.76e-01 |
| GOBP NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE | 47 | 4.04e-01 | 7.04e-02 | 8.72e-01 |
| GOBP REGULATION OF FERTILIZATION | 5 | 7.85e-01 | -7.04e-02 | 9.76e-01 |
| GOMF BH DOMAIN BINDING | 8 | 7.30e-01 | -7.04e-02 | 9.64e-01 |
| GOBP ESTABLISHMENT OF GOLGI LOCALIZATION | 7 | 7.47e-01 | -7.04e-02 | 9.66e-01 |
| GOBP SPHINGOLIPID TRANSLOCATION | 5 | 7.85e-01 | -7.04e-02 | 9.76e-01 |
| GOBP REGULATION OF NUCLEOTIDE EXCISION REPAIR | 26 | 5.35e-01 | 7.03e-02 | 9.23e-01 |
| GOBP POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE | 9 | 7.15e-01 | 7.03e-02 | 9.59e-01 |
| GOBP REGULATION OF SENSORY PERCEPTION | 6 | 7.66e-01 | 7.03e-02 | 9.70e-01 |
| GOBP CENTRIOLE CENTRIOLE COHESION | 14 | 6.49e-01 | 7.03e-02 | 9.44e-01 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 28 | 5.20e-01 | -7.02e-02 | 9.19e-01 |
| GOBP ENDOSOME TO LYSOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY | 17 | 6.16e-01 | 7.02e-02 | 9.36e-01 |
| GOBP SPHINGOLIPID BIOSYNTHETIC PROCESS | 73 | 3.00e-01 | 7.02e-02 | 8.14e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING | 8 | 7.31e-01 | 7.02e-02 | 9.64e-01 |
| GOBP MITOTIC INTRA S DNA DAMAGE CHECKPOINT SIGNALING | 15 | 6.38e-01 | -7.01e-02 | 9.41e-01 |
| GOBP REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 289 | 4.08e-02 | 7.01e-02 | 4.12e-01 |
| GOCC PARASPECKLES | 8 | 7.31e-01 | -7.01e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF B CELL ACTIVATION | 67 | 3.22e-01 | 7.01e-02 | 8.28e-01 |
| GOMF O METHYLTRANSFERASE ACTIVITY | 22 | 5.69e-01 | 7.01e-02 | 9.31e-01 |
| GOMF HORMONE ACTIVITY | 27 | 5.29e-01 | -7.00e-02 | 9.23e-01 |
| GOBP BLASTOCYST DEVELOPMENT | 89 | 2.54e-01 | -7.00e-02 | 7.80e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III | 18 | 6.07e-01 | -7.00e-02 | 9.36e-01 |
| GOBP CYTOKINESIS | 158 | 1.29e-01 | 7.00e-02 | 6.40e-01 |
| GOBP RESPONSE TO CALCIUM ION | 90 | 2.52e-01 | -7.00e-02 | 7.78e-01 |
| GOBP NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH | 68 | 3.19e-01 | -6.99e-02 | 8.25e-01 |
| GOBP REGULATION OF MIRNA METABOLIC PROCESS | 61 | 3.45e-01 | 6.99e-02 | 8.42e-01 |
| GOBP POSITIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 8 | 7.32e-01 | 6.99e-02 | 9.64e-01 |
| GOBP RESPONSE TO FUNGUS | 29 | 5.15e-01 | 6.99e-02 | 9.19e-01 |
| GOBP POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 36 | 4.68e-01 | -6.99e-02 | 9.00e-01 |
| GOBP REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 34 | 4.81e-01 | -6.99e-02 | 9.08e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 12 | 6.75e-01 | 6.98e-02 | 9.51e-01 |
| GOMF TRANSCRIPTION COACTIVATOR BINDING | 34 | 4.81e-01 | 6.98e-02 | 9.08e-01 |
| GOBP NEGATIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 55 | 3.71e-01 | -6.97e-02 | 8.57e-01 |
| GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 175 | 1.12e-01 | 6.97e-02 | 6.07e-01 |
| GOBP REGULATORY NCRNA MEDIATED GENE SILENCING | 121 | 1.86e-01 | 6.97e-02 | 7.17e-01 |
| GOBP SODIUM ION TRANSMEMBRANE TRANSPORT | 79 | 2.85e-01 | 6.96e-02 | 8.04e-01 |
| GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM | 5 | 7.87e-01 | 6.96e-02 | 9.76e-01 |
| GOBP FEAR RESPONSE | 25 | 5.47e-01 | -6.96e-02 | 9.25e-01 |
| GOBP ACTIVATION OF GTPASE ACTIVITY | 74 | 3.01e-01 | 6.96e-02 | 8.14e-01 |
| GOMF PATTERN RECOGNITION RECEPTOR ACTIVITY | 21 | 5.81e-01 | 6.96e-02 | 9.35e-01 |
| GOBP NEPHRON MORPHOGENESIS | 32 | 4.96e-01 | 6.95e-02 | 9.13e-01 |
| GOBP SYNAPTIC VESICLE MEMBRANE ORGANIZATION | 16 | 6.30e-01 | -6.95e-02 | 9.40e-01 |
| GOBP MIDDLE EAR MORPHOGENESIS | 7 | 7.50e-01 | 6.95e-02 | 9.67e-01 |
| GOBP REGULATION OF SPINDLE ASSEMBLY | 31 | 5.04e-01 | 6.94e-02 | 9.15e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 30 | 5.12e-01 | -6.93e-02 | 9.18e-01 |
| GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 6 | 7.69e-01 | 6.92e-02 | 9.70e-01 |
| GOBP PHASIC SMOOTH MUSCLE CONTRACTION | 5 | 7.89e-01 | 6.92e-02 | 9.76e-01 |
| GOBP ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 67 | 3.28e-01 | -6.91e-02 | 8.29e-01 |
| GOBP RRNA 3 END PROCESSING | 10 | 7.05e-01 | -6.91e-02 | 9.57e-01 |
| GOBP CELL MIGRATION IN HINDBRAIN | 9 | 7.20e-01 | -6.91e-02 | 9.61e-01 |
| GOBP REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 7 | 7.52e-01 | 6.91e-02 | 9.68e-01 |
| GOCC AXONAL GROWTH CONE | 19 | 6.02e-01 | 6.91e-02 | 9.36e-01 |
| GOMF ATP DEPENDENT ACTIVITY | 459 | 1.17e-02 | 6.90e-02 | 2.19e-01 |
| GOBP PROTEIN IMPORT | 6 | 7.70e-01 | -6.90e-02 | 9.70e-01 |
| GOBP DOPAMINE TRANSPORT | 20 | 5.94e-01 | 6.90e-02 | 9.36e-01 |
| GOBP EXOCYTOSIS | 234 | 7.00e-02 | 6.89e-02 | 5.15e-01 |
| GOBP POSITIVE REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 5 | 7.90e-01 | 6.89e-02 | 9.76e-01 |
| GOBP CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS | 504 | 8.48e-03 | -6.88e-02 | 1.82e-01 |
| GOBP AMELOGENESIS | 14 | 6.56e-01 | 6.88e-02 | 9.47e-01 |
| GOMF MICROTUBULE SEVERING ATPASE ACTIVITY | 5 | 7.90e-01 | 6.87e-02 | 9.76e-01 |
| GOBP INDOLE CONTAINING COMPOUND METABOLIC PROCESS | 14 | 6.56e-01 | -6.87e-02 | 9.47e-01 |
| GOBP REGULATION OF MIRNA CATABOLIC PROCESS | 8 | 7.37e-01 | -6.87e-02 | 9.65e-01 |
| GOMF PHOSPHATIDYLINOSITOL BINDING | 224 | 7.76e-02 | 6.86e-02 | 5.33e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 66 | 3.36e-01 | 6.86e-02 | 8.36e-01 |
| GOBP MESENCHYMAL CELL MIGRATION | 29 | 5.23e-01 | -6.85e-02 | 9.20e-01 |
| GOBP RESPONSE TO MUSCLE STRETCH | 18 | 6.15e-01 | 6.85e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF BLOOD CIRCULATION | 15 | 6.46e-01 | 6.85e-02 | 9.43e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 54 | 3.84e-01 | -6.85e-02 | 8.64e-01 |
| GOBP REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL | 13 | 6.69e-01 | -6.85e-02 | 9.49e-01 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 17 | 6.25e-01 | -6.84e-02 | 9.40e-01 |
| GOBP ORGANIC ACID TRANSPORT | 196 | 9.93e-02 | -6.84e-02 | 5.82e-01 |
| GOMF PHOSPHATIDYLCHOLINE FLOPPASE ACTIVITY | 7 | 7.54e-01 | 6.84e-02 | 9.68e-01 |
| GOCC CENTRIOLAR SATELLITE | 92 | 2.58e-01 | 6.84e-02 | 7.85e-01 |
| GOBP MANCHETTE ASSEMBLY | 5 | 7.91e-01 | -6.83e-02 | 9.76e-01 |
| GOBP BRAIN MORPHOGENESIS | 22 | 5.79e-01 | 6.83e-02 | 9.34e-01 |
| GOBP KIDNEY MORPHOGENESIS | 43 | 4.39e-01 | 6.83e-02 | 8.85e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A TRNA | 108 | 2.21e-01 | 6.83e-02 | 7.49e-01 |
| GOBP REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE | 8 | 7.38e-01 | 6.83e-02 | 9.65e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION | 24 | 5.63e-01 | 6.82e-02 | 9.29e-01 |
| GOBP TRYPTOPHAN METABOLIC PROCESS | 8 | 7.38e-01 | -6.82e-02 | 9.65e-01 |
| GOCC ENDOSOME MEMBRANE | 457 | 1.29e-02 | 6.82e-02 | 2.36e-01 |
| GOBP NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS | 17 | 6.26e-01 | 6.82e-02 | 9.40e-01 |
| GOBP TANGENTIAL MIGRATION FROM THE SUBVENTRICULAR ZONE TO THE OLFACTORY BULB | 5 | 7.92e-01 | 6.81e-02 | 9.76e-01 |
| GOMF AMINO ACID MONOATOMIC CATION SYMPORTER ACTIVITY | 14 | 6.59e-01 | -6.81e-02 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS | 102 | 2.35e-01 | -6.81e-02 | 7.63e-01 |
| GOBP PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT | 8 | 7.39e-01 | -6.81e-02 | 9.65e-01 |
| GOBP POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 172 | 1.25e-01 | 6.79e-02 | 6.29e-01 |
| GOBP ANIMAL ORGAN REGENERATION | 41 | 4.52e-01 | 6.79e-02 | 8.90e-01 |
| GOBP AMINO ACID TRANSPORT | 88 | 2.71e-01 | -6.79e-02 | 7.94e-01 |
| GOBP SPERM MOTILITY | 57 | 3.76e-01 | -6.78e-02 | 8.60e-01 |
| GOBP HEART VALVE FORMATION | 7 | 7.56e-01 | -6.78e-02 | 9.69e-01 |
| GOBP REGULATION OF MITOCHONDRION ORGANIZATION | 131 | 1.81e-01 | -6.78e-02 | 7.12e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN ACETYLATION | 8 | 7.40e-01 | 6.78e-02 | 9.65e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL | 9 | 7.25e-01 | -6.77e-02 | 9.63e-01 |
| GOCC CELL LEADING EDGE | 331 | 3.48e-02 | -6.77e-02 | 3.81e-01 |
| GOBP TRANSPORT ALONG MICROTUBULE | 144 | 1.61e-01 | 6.77e-02 | 6.87e-01 |
| GOMF DNA DEMETHYLASE ACTIVITY | 5 | 7.93e-01 | -6.77e-02 | 9.77e-01 |
| GOBP CENTROSOME DUPLICATION | 69 | 3.32e-01 | 6.77e-02 | 8.31e-01 |
| GOBP VAGINA DEVELOPMENT | 7 | 7.57e-01 | 6.77e-02 | 9.69e-01 |
| GOBP REGULATION OF FIBROBLAST MIGRATION | 30 | 5.22e-01 | 6.76e-02 | 9.20e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS | 35 | 4.89e-01 | 6.76e-02 | 9.12e-01 |
| GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 13 | 6.73e-01 | 6.76e-02 | 9.49e-01 |
| GOBP REGULATION OF SPINDLE ORGANIZATION | 41 | 4.54e-01 | 6.76e-02 | 8.93e-01 |
| GOBP AMP METABOLIC PROCESS | 17 | 6.30e-01 | 6.76e-02 | 9.40e-01 |
| GOBP SERINE TRANSPORT | 8 | 7.41e-01 | 6.75e-02 | 9.65e-01 |
| GOMF SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 7.41e-01 | 6.75e-02 | 9.65e-01 |
| GOBP PROTEIN LOCALIZATION TO BASOLATERAL PLASMA MEMBRANE | 6 | 7.75e-01 | 6.75e-02 | 9.73e-01 |
| GOCC ANCHORING JUNCTION | 633 | 4.00e-03 | -6.75e-02 | 1.17e-01 |
| GOBP ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS | 416 | 1.88e-02 | 6.75e-02 | 2.87e-01 |
| GOBP EPITHELIAL STRUCTURE MAINTENANCE | 14 | 6.62e-01 | -6.74e-02 | 9.49e-01 |
| GOBP REGULATION OF ACTION POTENTIAL | 35 | 4.90e-01 | -6.74e-02 | 9.12e-01 |
| GOBP CELLULAR PIGMENTATION | 58 | 3.75e-01 | -6.74e-02 | 8.60e-01 |
| GOBP NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY | 30 | 5.23e-01 | 6.74e-02 | 9.20e-01 |
| GOBP CENTRIOLE ELONGATION | 8 | 7.41e-01 | -6.74e-02 | 9.65e-01 |
| GOBP PURINE NUCLEOSIDE METABOLIC PROCESS | 18 | 6.21e-01 | -6.74e-02 | 9.38e-01 |
| GOMF TRANSFORMING GROWTH FACTOR BETA BINDING | 16 | 6.41e-01 | -6.74e-02 | 9.42e-01 |
| GOBP REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY | 8 | 7.42e-01 | 6.73e-02 | 9.65e-01 |
| GOBP NEGATIVE REGULATION OF G0 TO G1 TRANSITION | 5 | 7.94e-01 | 6.73e-02 | 9.77e-01 |
| GOBP UTERUS DEVELOPMENT | 12 | 6.87e-01 | 6.73e-02 | 9.54e-01 |
| GOBP REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY | 9 | 7.27e-01 | 6.73e-02 | 9.63e-01 |
| GOCC PEPTIDASE INHIBITOR COMPLEX | 7 | 7.58e-01 | 6.73e-02 | 9.69e-01 |
| GOMF CARBON CARBON LYASE ACTIVITY | 35 | 4.91e-01 | 6.72e-02 | 9.13e-01 |
| GOCC CYTOPLASMIC MICROTUBULE | 69 | 3.35e-01 | 6.72e-02 | 8.35e-01 |
| GOBP TYPE B PANCREATIC CELL PROLIFERATION | 15 | 6.52e-01 | 6.72e-02 | 9.46e-01 |
| GOCC NUCLEAR PORE OUTER RING | 9 | 7.27e-01 | 6.72e-02 | 9.63e-01 |
| GOBP ENDOCRINE PANCREAS DEVELOPMENT | 21 | 5.94e-01 | 6.72e-02 | 9.36e-01 |
| GOBP PURINE CONTAINING COMPOUND CATABOLIC PROCESS | 49 | 4.16e-01 | 6.72e-02 | 8.79e-01 |
| GOCC RUFFLE | 157 | 1.47e-01 | -6.71e-02 | 6.70e-01 |
| GOCC GOLGI APPARATUS SUBCOMPARTMENT | 301 | 4.58e-02 | 6.71e-02 | 4.34e-01 |
| GOMF KINASE ACTIVITY | 581 | 6.02e-03 | 6.71e-02 | 1.47e-01 |
| GOBP PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 14 | 6.64e-01 | 6.71e-02 | 9.49e-01 |
| GOBP MEMBRANE DOCKING | 77 | 3.09e-01 | 6.71e-02 | 8.20e-01 |
| GOBP INTERLEUKIN 18 MEDIATED SIGNALING PATHWAY | 6 | 7.76e-01 | 6.71e-02 | 9.73e-01 |
| GOMF ACTIN FILAMENT BINDING | 151 | 1.56e-01 | -6.70e-02 | 6.78e-01 |
| GOBP REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY | 7 | 7.59e-01 | -6.70e-02 | 9.69e-01 |
| GOBP REGULATION OF AMIDE METABOLIC PROCESS | 405 | 2.13e-02 | -6.70e-02 | 3.04e-01 |
| GOBP POST CHAPERONIN TUBULIN FOLDING PATHWAY | 7 | 7.59e-01 | 6.69e-02 | 9.69e-01 |
| GOBP HEMOGLOBIN METABOLIC PROCESS | 11 | 7.01e-01 | -6.69e-02 | 9.56e-01 |
| GOBP REGULATION OF AMINO ACID TRANSMEMBRANE TRANSPORT | 11 | 7.01e-01 | -6.69e-02 | 9.56e-01 |
| GOCC SPINDLE POLE | 156 | 1.50e-01 | 6.68e-02 | 6.73e-01 |
| GOMF CARBON OXYGEN LYASE ACTIVITY | 55 | 3.91e-01 | 6.68e-02 | 8.68e-01 |
| GOBP PHAGOSOME MATURATION | 27 | 5.48e-01 | 6.68e-02 | 9.25e-01 |
| GOBP RNA MODIFICATION | 164 | 1.41e-01 | 6.68e-02 | 6.62e-01 |
| GOBP NEGATIVE REGULATION OF NEUTROPHIL ACTIVATION | 5 | 7.96e-01 | 6.68e-02 | 9.77e-01 |
| GOBP AMINO ACID METABOLIC PROCESS | 190 | 1.13e-01 | -6.67e-02 | 6.10e-01 |
| GOMF PHOSPHATIDYLINOSITOL 4 PHOSPHATE BINDING | 26 | 5.56e-01 | 6.67e-02 | 9.26e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION | 232 | 8.11e-02 | 6.66e-02 | 5.41e-01 |
| GOBP TISSUE MORPHOGENESIS | 346 | 3.39e-02 | -6.66e-02 | 3.77e-01 |
| GOBP RESPONSE TO PROGESTERONE | 26 | 5.57e-01 | 6.66e-02 | 9.27e-01 |
| GOBP NEGATIVE REGULATION OF CELL ADHESION | 189 | 1.15e-01 | 6.66e-02 | 6.12e-01 |
| GOBP LIPID EXPORT FROM CELL | 26 | 5.57e-01 | -6.66e-02 | 9.27e-01 |
| GOBP POSITIVE REGULATION OF CENTRIOLE REPLICATION | 9 | 7.30e-01 | 6.65e-02 | 9.64e-01 |
| GOBP AMINO ACID BIOSYNTHETIC PROCESS | 53 | 4.03e-01 | -6.65e-02 | 8.72e-01 |
| GOBP POSITIVE REGULATION OF FEEDING BEHAVIOR | 5 | 7.97e-01 | -6.65e-02 | 9.77e-01 |
| GOBP CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT | 174 | 1.31e-01 | 6.64e-02 | 6.41e-01 |
| GOCC MALE PRONUCLEUS | 7 | 7.61e-01 | 6.64e-02 | 9.70e-01 |
| GOBP GASTRULATION WITH MOUTH FORMING SECOND | 16 | 6.46e-01 | -6.64e-02 | 9.43e-01 |
| GOMF RNA POLYMERASE ACTIVITY | 31 | 5.23e-01 | -6.64e-02 | 9.20e-01 |
| GOMF METHYLATION DEPENDENT PROTEIN BINDING | 74 | 3.24e-01 | -6.64e-02 | 8.29e-01 |
| GOBP DNA REPLICATION | 254 | 6.97e-02 | -6.63e-02 | 5.14e-01 |
| GOBP POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION | 7 | 7.62e-01 | -6.62e-02 | 9.70e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II | 47 | 4.33e-01 | 6.61e-02 | 8.82e-01 |
| GOBP NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 81 | 3.04e-01 | 6.61e-02 | 8.15e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H OXYGEN AS ACCEPTOR | 11 | 7.04e-01 | 6.61e-02 | 9.56e-01 |
| GOMF TRANSCRIPTION COREPRESSOR BINDING | 43 | 4.54e-01 | -6.61e-02 | 8.93e-01 |
| GOBP VACUOLAR LOCALIZATION | 72 | 3.33e-01 | 6.60e-02 | 8.34e-01 |
| GOBP REGULATION OF LIPID CATABOLIC PROCESS | 38 | 4.82e-01 | -6.60e-02 | 9.08e-01 |
| GOBP RESPONSE TO AXON INJURY | 53 | 4.06e-01 | 6.60e-02 | 8.74e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 60 | 3.78e-01 | -6.59e-02 | 8.61e-01 |
| GOBP MATURE B CELL DIFFERENTIATION | 27 | 5.54e-01 | 6.59e-02 | 9.26e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT | 6 | 7.80e-01 | -6.58e-02 | 9.75e-01 |
| GOBP POSITIVE REGULATION OF INTEGRIN ACTIVATION | 8 | 7.47e-01 | 6.58e-02 | 9.66e-01 |
| GOCC AGGRESOME | 28 | 5.47e-01 | 6.58e-02 | 9.25e-01 |
| GOBP MUCOPOLYSACCHARIDE METABOLIC PROCESS | 61 | 3.75e-01 | -6.58e-02 | 8.60e-01 |
| GOBP ECTODERMAL PLACODE DEVELOPMENT | 6 | 7.80e-01 | -6.57e-02 | 9.75e-01 |
| GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 7 | 7.63e-01 | -6.57e-02 | 9.70e-01 |
| GOBP VESICLE DOCKING | 50 | 4.22e-01 | 6.57e-02 | 8.81e-01 |
| GOMF PEPTIDE N ACETYLTRANSFERASE ACTIVITY | 48 | 4.31e-01 | -6.57e-02 | 8.82e-01 |
| GOBP PHAGOCYTOSIS ENGULFMENT | 38 | 4.84e-01 | -6.57e-02 | 9.09e-01 |
| GOMF PROTEIN TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY | 35 | 5.01e-01 | 6.57e-02 | 9.15e-01 |
| GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 9 | 7.33e-01 | -6.57e-02 | 9.64e-01 |
| GOCC NLS DEPENDENT PROTEIN NUCLEAR IMPORT COMPLEX | 9 | 7.33e-01 | 6.57e-02 | 9.64e-01 |
| GOMF NUCLEOSIDE KINASE ACTIVITY | 9 | 7.33e-01 | 6.56e-02 | 9.64e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION | 8 | 7.48e-01 | 6.56e-02 | 9.66e-01 |
| GOBP POSITIVE REGULATION OF AMINE METABOLIC PROCESS | 5 | 8.00e-01 | -6.56e-02 | 9.77e-01 |
| GOBP SYNAPTIC VESICLE RECYCLING | 58 | 3.88e-01 | 6.56e-02 | 8.65e-01 |
| GOCC PROTEIN COMPLEX INVOLVED IN CELL ADHESION | 35 | 5.02e-01 | -6.56e-02 | 9.15e-01 |
| GOBP SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY | 11 | 7.07e-01 | 6.56e-02 | 9.57e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE | 94 | 2.72e-01 | 6.56e-02 | 7.94e-01 |
| GOBP CALCIUM ION REGULATED EXOCYTOSIS | 31 | 5.28e-01 | 6.55e-02 | 9.22e-01 |
| GOCC NEUROTRANSMITTER RECEPTOR COMPLEX | 17 | 6.40e-01 | -6.55e-02 | 9.42e-01 |
| GOBP TRANSLOCATION OF MOLECULES INTO HOST | 8 | 7.48e-01 | -6.55e-02 | 9.66e-01 |
| GOCC ORGANELLE MEMBRANE CONTACT SITE | 45 | 4.47e-01 | 6.55e-02 | 8.88e-01 |
| GOCC TRANSCRIPTION REGULATOR COMPLEX | 369 | 3.14e-02 | 6.55e-02 | 3.57e-01 |
| GOBP PROTEIN TARGETING TO LYSOSOME | 30 | 5.35e-01 | -6.55e-02 | 9.23e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 68 | 3.51e-01 | 6.55e-02 | 8.46e-01 |
| GOBP REGULATION OF STEROL TRANSPORT | 41 | 4.69e-01 | -6.54e-02 | 9.00e-01 |
| GOMF PROTEIN KINASE A BINDING | 40 | 4.74e-01 | -6.54e-02 | 9.03e-01 |
| GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 85 | 2.98e-01 | 6.54e-02 | 8.13e-01 |
| GOBP HEME TRANSPORT | 8 | 7.49e-01 | -6.54e-02 | 9.66e-01 |
| GOMF HEME TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 7.49e-01 | -6.54e-02 | 9.66e-01 |
| GOBP CHEMOKINE PRODUCTION | 65 | 3.62e-01 | 6.54e-02 | 8.49e-01 |
| GOBP POSITIVE REGULATION OF TELOMERASE ACTIVITY | 29 | 5.43e-01 | 6.54e-02 | 9.23e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 6 | 7.82e-01 | -6.53e-02 | 9.75e-01 |
| GOBP NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 39 | 4.80e-01 | 6.53e-02 | 9.08e-01 |
| GOBP REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 30 | 5.36e-01 | -6.53e-02 | 9.23e-01 |
| GOBP RESPONSE TO ANGIOTENSIN | 24 | 5.80e-01 | 6.53e-02 | 9.35e-01 |
| GOBP RNA 5 END PROCESSING | 22 | 5.97e-01 | 6.51e-02 | 9.36e-01 |
| GOMF ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY | 34 | 5.12e-01 | 6.51e-02 | 9.18e-01 |
| GOBP PROTEIN OXIDATION | 7 | 7.66e-01 | 6.50e-02 | 9.70e-01 |
| GOMF ACYL COA BINDING | 17 | 6.43e-01 | 6.50e-02 | 9.42e-01 |
| GOCC SMOOTH ENDOPLASMIC RETICULUM | 20 | 6.15e-01 | -6.50e-02 | 9.36e-01 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS | 33 | 5.18e-01 | -6.50e-02 | 9.19e-01 |
| GOBP EXOCRINE SYSTEM DEVELOPMENT | 23 | 5.90e-01 | -6.50e-02 | 9.36e-01 |
| GOBP CELL ADHESION MOLECULE PRODUCTION | 7 | 7.66e-01 | 6.50e-02 | 9.70e-01 |
| GOBP HORMONE METABOLIC PROCESS | 122 | 2.16e-01 | -6.49e-02 | 7.47e-01 |
| GOCC ENDOSOME | 806 | 1.90e-03 | 6.49e-02 | 7.12e-02 |
| GOBP CIRCULATORY SYSTEM PROCESS | 313 | 4.93e-02 | 6.48e-02 | 4.46e-01 |
| GOMF QUATERNARY AMMONIUM GROUP TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 7.23e-01 | -6.48e-02 | 9.62e-01 |
| GOBP EMBRYO IMPLANTATION | 33 | 5.20e-01 | -6.48e-02 | 9.19e-01 |
| GOMF GANGLIOSIDE BINDING | 5 | 8.02e-01 | 6.47e-02 | 9.78e-01 |
| GOBP ACTIN NUCLEATION | 47 | 4.43e-01 | -6.47e-02 | 8.87e-01 |
| GOBP POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 78 | 3.24e-01 | 6.47e-02 | 8.29e-01 |
| GOBP IMMUNE SYSTEM DEVELOPMENT | 149 | 1.74e-01 | 6.47e-02 | 7.05e-01 |
| GOBP PIECEMEAL MICROAUTOPHAGY OF THE NUCLEUS | 10 | 7.23e-01 | -6.46e-02 | 9.62e-01 |
| GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY | 13 | 6.87e-01 | 6.46e-02 | 9.54e-01 |
| GOBP MITOTIC NUCLEAR MEMBRANE ORGANIZATION | 10 | 7.24e-01 | -6.46e-02 | 9.62e-01 |
| GOBP POSITIVE REGULATION OF BLOOD PRESSURE | 12 | 6.99e-01 | -6.46e-02 | 9.55e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER FORMATION | 10 | 7.24e-01 | -6.46e-02 | 9.62e-01 |
| GOBP MESONEPHRIC TUBULE MORPHOGENESIS | 25 | 5.77e-01 | 6.45e-02 | 9.33e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 728 | 3.26e-03 | 6.45e-02 | 1.04e-01 |
| GOCC SPINDLE | 371 | 3.35e-02 | 6.45e-02 | 3.74e-01 |
| GOBP NERVE DEVELOPMENT | 44 | 4.59e-01 | -6.45e-02 | 8.96e-01 |
| GOBP GANGLIOSIDE METABOLIC PROCESS | 19 | 6.26e-01 | 6.45e-02 | 9.40e-01 |
| GOCC EMC COMPLEX | 10 | 7.24e-01 | 6.45e-02 | 9.62e-01 |
| GOBP POSITIVE REGULATION OF LIPID KINASE ACTIVITY | 8 | 7.52e-01 | -6.45e-02 | 9.68e-01 |
| GOMF TRANSLATION REPRESSOR ACTIVITY | 28 | 5.55e-01 | -6.45e-02 | 9.26e-01 |
| GOBP KERATAN SULFATE METABOLIC PROCESS | 13 | 6.87e-01 | -6.45e-02 | 9.54e-01 |
| GOCC MICROTUBULE PLUS END | 21 | 6.09e-01 | 6.44e-02 | 9.36e-01 |
| GOBP MONOSACCHARIDE METABOLIC PROCESS | 201 | 1.16e-01 | -6.44e-02 | 6.15e-01 |
| GOBP REGULATION OF CALCIDIOL 1 MONOOXYGENASE ACTIVITY | 6 | 7.85e-01 | -6.44e-02 | 9.76e-01 |
| GOCC CONDENSED CHROMOSOME | 246 | 8.29e-02 | 6.44e-02 | 5.44e-01 |
| GOMF IRON ION BINDING | 78 | 3.26e-01 | -6.44e-02 | 8.29e-01 |
| GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 148 | 1.77e-01 | -6.44e-02 | 7.08e-01 |
| GOCC PRECATALYTIC SPLICEOSOME | 52 | 4.22e-01 | -6.43e-02 | 8.81e-01 |
| GOBP LUNG ALVEOLUS DEVELOPMENT | 28 | 5.56e-01 | 6.43e-02 | 9.26e-01 |
| GOBP REGULATION OF IRON ION TRANSPORT | 5 | 8.03e-01 | 6.43e-02 | 9.79e-01 |
| GOMF PHOSPHATASE ACTIVITY | 204 | 1.14e-01 | 6.43e-02 | 6.11e-01 |
| GOBP REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 11 | 7.12e-01 | 6.43e-02 | 9.59e-01 |
| GOBP MITOCHONDRIAL FISSION | 35 | 5.11e-01 | 6.42e-02 | 9.18e-01 |
| GOBP REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 8 | 7.53e-01 | 6.41e-02 | 9.68e-01 |
| GOBP GOLGI VESICLE TRANSPORT | 273 | 6.90e-02 | 6.41e-02 | 5.12e-01 |
| GOMF MISFOLDED PROTEIN BINDING | 19 | 6.29e-01 | -6.41e-02 | 9.40e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 22 | 6.03e-01 | 6.41e-02 | 9.36e-01 |
| GOBP SNARE COMPLEX ASSEMBLY | 19 | 6.29e-01 | -6.41e-02 | 9.40e-01 |
| GOBP RESPONSE TO RETINOIC ACID | 53 | 4.20e-01 | 6.41e-02 | 8.81e-01 |
| GOBP LAMELLIPODIUM MORPHOGENESIS | 18 | 6.38e-01 | -6.41e-02 | 9.41e-01 |
| GOBP REGULATION OF DENDRITIC SPINE DEVELOPMENT | 43 | 4.68e-01 | 6.41e-02 | 9.00e-01 |
| GOMF POTASSIUM CHANNEL ACTIVITY | 43 | 4.68e-01 | 6.40e-02 | 9.00e-01 |
| GOCC CENTRIOLE | 134 | 2.01e-01 | 6.40e-02 | 7.32e-01 |
| GOBP POSITIVE REGULATION OF HEART RATE | 8 | 7.54e-01 | 6.40e-02 | 9.68e-01 |
| GOBP HISTONE H3 ACETYLATION | 6 | 7.86e-01 | 6.40e-02 | 9.76e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING | 6 | 7.86e-01 | 6.40e-02 | 9.76e-01 |
| GOCC TRANS GOLGI NETWORK | 216 | 1.06e-01 | 6.40e-02 | 5.96e-01 |
| GOMF NUCLEOSOMAL DNA BINDING | 23 | 5.95e-01 | -6.40e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF B CELL DIFFERENTIATION | 14 | 6.79e-01 | 6.39e-02 | 9.52e-01 |
| GOBP ASYMMETRIC CELL DIVISION | 13 | 6.90e-01 | -6.39e-02 | 9.54e-01 |
| GOBP REGULATION OF GLYCOGEN METABOLIC PROCESS | 26 | 5.73e-01 | -6.38e-02 | 9.32e-01 |
| GOBP NEGATIVE REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY | 5 | 8.05e-01 | -6.38e-02 | 9.79e-01 |
| GOMF PROTEIN CARRIER CHAPERONE | 33 | 5.26e-01 | -6.38e-02 | 9.21e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE ACTIVATION | 17 | 6.49e-01 | -6.37e-02 | 9.44e-01 |
| GOBP TRANSMISSION OF NERVE IMPULSE | 31 | 5.39e-01 | -6.37e-02 | 9.23e-01 |
| GOBP RESPONSE TO METAL ION | 230 | 9.70e-02 | -6.37e-02 | 5.77e-01 |
| GOBP NEGATIVE REGULATION OF JUN KINASE ACTIVITY | 11 | 7.15e-01 | -6.36e-02 | 9.59e-01 |
| GOBP MIRNA MEDIATED GENE SILENCING BY MRNA DESTABILIZATION | 5 | 8.05e-01 | 6.36e-02 | 9.79e-01 |
| GOBP ADIPOSE TISSUE DEVELOPMENT | 47 | 4.51e-01 | 6.36e-02 | 8.90e-01 |
| GOBP INTESTINAL ABSORPTION | 22 | 6.06e-01 | -6.36e-02 | 9.36e-01 |
| GOBP SECOND MESSENGER MEDIATED SIGNALING | 167 | 1.57e-01 | -6.35e-02 | 6.80e-01 |
| GOCC MANNOSYLTRANSFERASE COMPLEX | 5 | 8.06e-01 | -6.35e-02 | 9.79e-01 |
| GOMF PHOSPHATIDYLSERINE BINDING | 37 | 5.04e-01 | 6.34e-02 | 9.15e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS | 11 | 7.16e-01 | 6.34e-02 | 9.59e-01 |
| GOBP URINARY BLADDER SMOOTH MUSCLE CONTRACTION | 5 | 8.06e-01 | 6.34e-02 | 9.79e-01 |
| GOBP URINARY TRACT SMOOTH MUSCLE CONTRACTION | 5 | 8.06e-01 | 6.34e-02 | 9.79e-01 |
| GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT | 115 | 2.41e-01 | 6.34e-02 | 7.69e-01 |
| GOMF PHOSPHATIDYLINOSITOL BISPHOSPHATE BINDING | 77 | 3.37e-01 | 6.34e-02 | 8.36e-01 |
| GOBP HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 97 | 2.82e-01 | 6.33e-02 | 8.00e-01 |
| GOBP REGULATION OF KERATINOCYTE PROLIFERATION | 22 | 6.08e-01 | -6.32e-02 | 9.36e-01 |
| GOCC EXON EXON JUNCTION COMPLEX | 11 | 7.17e-01 | 6.32e-02 | 9.59e-01 |
| GOBP NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION | 13 | 6.93e-01 | 6.32e-02 | 9.54e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 18 | 6.43e-01 | 6.32e-02 | 9.42e-01 |
| GOBP REGULATION OF INSULIN SECRETION | 92 | 2.96e-01 | 6.32e-02 | 8.10e-01 |
| GOBP RESPONSE TO ACETYLCHOLINE | 21 | 6.16e-01 | 6.32e-02 | 9.36e-01 |
| GOBP EMBRYONIC EYE MORPHOGENESIS | 16 | 6.62e-01 | -6.31e-02 | 9.49e-01 |
| GOBP KERATINOCYTE APOPTOTIC PROCESS | 6 | 7.89e-01 | -6.31e-02 | 9.76e-01 |
| GOBP CELL CELL RECOGNITION | 36 | 5.13e-01 | -6.31e-02 | 9.18e-01 |
| GOBP CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS | 210 | 1.16e-01 | 6.31e-02 | 6.15e-01 |
| GOBP REGULATION OF COMPLEMENT ACTIVATION | 13 | 6.94e-01 | -6.30e-02 | 9.54e-01 |
| GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 22 | 6.09e-01 | 6.30e-02 | 9.36e-01 |
| GOBP PEPTIDYL AMINO ACID MODIFICATION | 689 | 5.18e-03 | 6.29e-02 | 1.35e-01 |
| GOMF MIRNA BINDING | 33 | 5.32e-01 | -6.29e-02 | 9.23e-01 |
| GOBP MALE GENITALIA DEVELOPMENT | 8 | 7.58e-01 | -6.28e-02 | 9.69e-01 |
| GOMF FK506 BINDING | 9 | 7.45e-01 | 6.27e-02 | 9.66e-01 |
| GOMF MACROLIDE BINDING | 9 | 7.45e-01 | 6.27e-02 | 9.66e-01 |
| GOBP CARDIAC NEURAL CREST CELL MIGRATION INVOLVED IN OUTFLOW TRACT MORPHOGENESIS | 5 | 8.08e-01 | -6.27e-02 | 9.80e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION | 15 | 6.74e-01 | -6.27e-02 | 9.50e-01 |
| GOBP PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION | 9 | 7.45e-01 | -6.27e-02 | 9.66e-01 |
| GOBP LENS FIBER CELL DEVELOPMENT | 7 | 7.74e-01 | 6.26e-02 | 9.72e-01 |
| GOMF MAP KINASE SCAFFOLD ACTIVITY | 10 | 7.32e-01 | -6.26e-02 | 9.64e-01 |
| GOBP CELLULAR RESPONSE TO PROGESTERONE STIMULUS | 5 | 8.09e-01 | 6.25e-02 | 9.80e-01 |
| GOBP ANGIOGENESIS INVOLVED IN WOUND HEALING | 16 | 6.65e-01 | 6.25e-02 | 9.49e-01 |
| GOMF MOLECULAR CARRIER ACTIVITY | 80 | 3.34e-01 | -6.25e-02 | 8.35e-01 |
| GOBP POSITIVE REGULATION OF ATP DEPENDENT ACTIVITY | 30 | 5.54e-01 | -6.25e-02 | 9.26e-01 |
| GOBP SYNAPTIC TRANSMISSION GLUTAMATERGIC | 56 | 4.19e-01 | 6.24e-02 | 8.80e-01 |
| GOBP EMBRYONIC HINDLIMB MORPHOGENESIS | 9 | 7.46e-01 | 6.24e-02 | 9.66e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 36 | 5.17e-01 | 6.24e-02 | 9.19e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 18 | 6.47e-01 | 6.24e-02 | 9.43e-01 |
| GOBP MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION | 33 | 5.36e-01 | -6.23e-02 | 9.23e-01 |
| GOMF LIPOPROTEIN LIPASE ACTIVITY | 6 | 7.92e-01 | -6.22e-02 | 9.76e-01 |
| GOBP RESPONSE TO FIBROBLAST GROWTH FACTOR | 51 | 4.43e-01 | -6.22e-02 | 8.87e-01 |
| GOCC PLASMA MEMBRANE SIGNALING RECEPTOR COMPLEX | 96 | 2.93e-01 | 6.22e-02 | 8.08e-01 |
| GOMF O ACETYLTRANSFERASE ACTIVITY | 6 | 7.92e-01 | -6.22e-02 | 9.76e-01 |
| GOBP REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 233 | 1.03e-01 | 6.21e-02 | 5.93e-01 |
| GOBP POLARIZED EPITHELIAL CELL DIFFERENTIATION | 19 | 6.40e-01 | -6.20e-02 | 9.42e-01 |
| GOBP NETRIN ACTIVATED SIGNALING PATHWAY | 6 | 7.93e-01 | 6.20e-02 | 9.77e-01 |
| GOMF PHOSPHORIC ESTER HYDROLASE ACTIVITY | 264 | 8.37e-02 | 6.20e-02 | 5.45e-01 |
| GOBP REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 101 | 2.83e-01 | -6.19e-02 | 8.01e-01 |
| GOMF RETINAL BINDING | 7 | 7.77e-01 | 6.19e-02 | 9.74e-01 |
| GOBP INSULIN PROCESSING | 6 | 7.93e-01 | -6.19e-02 | 9.77e-01 |
| GOBP POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 95 | 2.98e-01 | 6.19e-02 | 8.13e-01 |
| GOBP ACUTE INFLAMMATORY RESPONSE | 59 | 4.11e-01 | 6.19e-02 | 8.77e-01 |
| GOBP NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION | 9 | 7.48e-01 | 6.18e-02 | 9.66e-01 |
| GOMF RECEPTOR TYROSINE KINASE BINDING | 59 | 4.12e-01 | -6.18e-02 | 8.77e-01 |
| GOBP POSITIVE REGULATION OF CYCLASE ACTIVITY | 18 | 6.50e-01 | 6.18e-02 | 9.44e-01 |
| GOBP REGULATION OF MONONUCLEAR CELL MIGRATION | 85 | 3.25e-01 | 6.18e-02 | 8.29e-01 |
| GOBP REGULATION OF ADENYLATE CYCLASE ACTIVITY | 19 | 6.42e-01 | -6.17e-02 | 9.42e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN MATURATION | 20 | 6.33e-01 | -6.17e-02 | 9.41e-01 |
| GOBP NEGATIVE REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 5 | 8.11e-01 | 6.16e-02 | 9.80e-01 |
| GOMF TRANSITION METAL ION BINDING | 735 | 4.76e-03 | 6.16e-02 | 1.29e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL IRON ION HOMEOSTASIS | 19 | 6.42e-01 | 6.16e-02 | 9.42e-01 |
| GOMF HISTONE DEACETYLASE REGULATOR ACTIVITY | 6 | 7.94e-01 | -6.16e-02 | 9.77e-01 |
| GOBP LEUKOCYTE AGGREGATION | 10 | 7.36e-01 | -6.15e-02 | 9.65e-01 |
| GOBP BRANCHED CHAIN AMINO ACID CATABOLIC PROCESS | 20 | 6.34e-01 | -6.15e-02 | 9.41e-01 |
| GOMF N ACETYLTRANSFERASE ACTIVITY | 59 | 4.14e-01 | -6.15e-02 | 8.77e-01 |
| GOBP REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 31 | 5.54e-01 | -6.15e-02 | 9.26e-01 |
| GOBP EXTRAEMBRYONIC MEMBRANE DEVELOPMENT | 10 | 7.37e-01 | -6.14e-02 | 9.65e-01 |
| GOBP SENSORY SYSTEM DEVELOPMENT | 211 | 1.25e-01 | 6.14e-02 | 6.29e-01 |
| GOBP ENDOPLASMIC RETICULUM MEMBRANE ORGANIZATION | 11 | 7.24e-01 | 6.14e-02 | 9.62e-01 |
| GOBP REGULATION OF CELL SIZE | 137 | 2.15e-01 | -6.14e-02 | 7.46e-01 |
| GOBP GLIAL CELL DEVELOPMENT | 75 | 3.59e-01 | -6.14e-02 | 8.46e-01 |
| GOBP REGULATION OF CELL ADHESION | 521 | 1.72e-02 | 6.13e-02 | 2.74e-01 |
| GOBP PURINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 6 | 7.95e-01 | -6.13e-02 | 9.77e-01 |
| GOMF TYPE I TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 10 | 7.37e-01 | 6.13e-02 | 9.65e-01 |
| GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 39 | 5.08e-01 | 6.13e-02 | 9.18e-01 |
| GOBP MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL | 15 | 6.81e-01 | 6.13e-02 | 9.52e-01 |
| GOBP NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT | 5 | 8.13e-01 | 6.12e-02 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF LIPID METABOLIC PROCESS | 86 | 3.28e-01 | 6.11e-02 | 8.29e-01 |
| GOBP POSITIVE REGULATION OF PINOCYTOSIS | 7 | 7.79e-01 | -6.11e-02 | 9.75e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION | 49 | 4.59e-01 | 6.11e-02 | 8.96e-01 |
| GOBP SULFUR COMPOUND BIOSYNTHETIC PROCESS | 112 | 2.65e-01 | -6.11e-02 | 7.89e-01 |
| GOBP LONG CHAIN FATTY ACID TRANSPORT | 37 | 5.23e-01 | -6.08e-02 | 9.20e-01 |
| GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 28 | 5.78e-01 | -6.08e-02 | 9.34e-01 |
| GOBP HEMOPOIESIS | 671 | 7.71e-03 | 6.07e-02 | 1.72e-01 |
| GOBP REGULATION OF MEMBRANE DEPOLARIZATION | 29 | 5.71e-01 | 6.07e-02 | 9.31e-01 |
| GOBP LEUKOCYTE PROLIFERATION | 233 | 1.11e-01 | 6.07e-02 | 6.04e-01 |
| GOBP NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 28 | 5.78e-01 | -6.07e-02 | 9.34e-01 |
| GOBP REGULATION OF ENDODEOXYRIBONUCLEASE ACTIVITY | 7 | 7.81e-01 | -6.07e-02 | 9.75e-01 |
| GOMF ATP DEPENDENT ACTIVITY ACTING ON RNA | 68 | 3.87e-01 | 6.07e-02 | 8.65e-01 |
| GOBP CYTOKINE MEDIATED SIGNALING PATHWAY | 323 | 6.16e-02 | 6.07e-02 | 4.85e-01 |
| GOMF NMDA GLUTAMATE RECEPTOR ACTIVITY | 6 | 7.97e-01 | 6.07e-02 | 9.77e-01 |
| GOBP REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION | 8 | 7.66e-01 | -6.07e-02 | 9.70e-01 |
| GOBP STRIATED MUSCLE CELL APOPTOTIC PROCESS | 31 | 5.59e-01 | 6.07e-02 | 9.27e-01 |
| GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 60 | 4.17e-01 | 6.06e-02 | 8.79e-01 |
| GOMF GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 47 | 4.72e-01 | 6.06e-02 | 9.02e-01 |
| GOMF PROTEIN FOLDING CHAPERONE BINDING | 108 | 2.77e-01 | -6.06e-02 | 7.98e-01 |
| GOBP RETINA LAYER FORMATION | 12 | 7.17e-01 | 6.05e-02 | 9.59e-01 |
| GOBP REGULATION OF NEURON MIGRATION | 26 | 5.94e-01 | 6.05e-02 | 9.36e-01 |
| GOBP BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE | 72 | 3.75e-01 | -6.05e-02 | 8.60e-01 |
| GOMF MONOOXYGENASE ACTIVITY | 35 | 5.36e-01 | -6.04e-02 | 9.23e-01 |
| GOBP PROTEIN TETRAMERIZATION | 69 | 3.86e-01 | 6.04e-02 | 8.65e-01 |
| GOBP PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS | 29 | 5.74e-01 | 6.04e-02 | 9.32e-01 |
| GOBP NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 7 | 7.82e-01 | 6.03e-02 | 9.75e-01 |
| GOBP REGULATION OF DENDRITE MORPHOGENESIS | 42 | 4.99e-01 | 6.03e-02 | 9.14e-01 |
| GOBP POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 17 | 6.67e-01 | 6.03e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS | 10 | 7.42e-01 | -6.02e-02 | 9.65e-01 |
| GOCC GOLGI CIS CISTERNA | 11 | 7.30e-01 | 6.02e-02 | 9.64e-01 |
| GOMF OXYSTEROL BINDING | 7 | 7.83e-01 | 6.02e-02 | 9.75e-01 |
| GOMF PEPTIDE HORMONE RECEPTOR BINDING | 6 | 7.99e-01 | 6.01e-02 | 9.77e-01 |
| GOBP CELLULAR RESPONSE TO CHOLESTEROL | 11 | 7.30e-01 | -6.01e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF T CELL TOLERANCE INDUCTION | 6 | 7.99e-01 | 6.01e-02 | 9.77e-01 |
| GOMF GABA RECEPTOR BINDING | 11 | 7.30e-01 | 6.01e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 14 | 6.97e-01 | 6.01e-02 | 9.55e-01 |
| GOBP INTRACELLULAR PH REDUCTION | 49 | 4.67e-01 | 6.01e-02 | 9.00e-01 |
| GOBP LYMPHOCYTE ACTIVATION | 558 | 1.58e-02 | 6.01e-02 | 2.66e-01 |
| GOCC GOLGI MEMBRANE | 527 | 1.89e-02 | 6.01e-02 | 2.88e-01 |
| GOBP ALPHA AMINO ACID METABOLIC PROCESS | 136 | 2.27e-01 | -6.01e-02 | 7.58e-01 |
| GOCC INTRACILIARY TRANSPORT PARTICLE | 24 | 6.11e-01 | 6.00e-02 | 9.36e-01 |
| GOBP N TERMINAL PEPTIDYL METHIONINE ACETYLATION | 6 | 7.99e-01 | -6.00e-02 | 9.77e-01 |
| GOMF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 62 | 4.14e-01 | 6.00e-02 | 8.77e-01 |
| GOMF VOLTAGE GATED MONOATOMIC CATION CHANNEL ACTIVITY | 51 | 4.59e-01 | -6.00e-02 | 8.96e-01 |
| GOMF ASPARTIC TYPE PEPTIDASE ACTIVITY | 15 | 6.88e-01 | 6.00e-02 | 9.54e-01 |
| GOBP LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY | 25 | 6.04e-01 | 5.99e-02 | 9.36e-01 |
| GOBP TELOMERE CAPPING | 36 | 5.34e-01 | -5.99e-02 | 9.23e-01 |
| GOBP MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS | 144 | 2.15e-01 | -5.99e-02 | 7.46e-01 |
| GOMF HYALURONONGLUCOSAMINIDASE ACTIVITY | 6 | 7.99e-01 | 5.99e-02 | 9.77e-01 |
| GOBP POSITIVE REGULATION OF CELL MORPHOGENESIS | 27 | 5.90e-01 | 5.99e-02 | 9.36e-01 |
| GOCC ER UBIQUITIN LIGASE COMPLEX | 8 | 7.69e-01 | -5.99e-02 | 9.70e-01 |
| GOMF ENZYME SUBSTRATE ADAPTOR ACTIVITY | 58 | 4.31e-01 | 5.99e-02 | 8.82e-01 |
| GOBP ACTIN FILAMENT ORGANIZATION | 334 | 6.12e-02 | -5.98e-02 | 4.84e-01 |
| GOCC GOLGI CISTERNA | 80 | 3.56e-01 | 5.98e-02 | 8.46e-01 |
| GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 10 | 7.44e-01 | 5.98e-02 | 9.65e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 25 | 6.05e-01 | -5.98e-02 | 9.36e-01 |
| GOBP RESPONSE TO INORGANIC SUBSTANCE | 350 | 5.57e-02 | -5.97e-02 | 4.67e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON RNA | 345 | 5.75e-02 | 5.97e-02 | 4.70e-01 |
| GOMF AMINO ACID BINDING | 25 | 6.05e-01 | -5.97e-02 | 9.36e-01 |
| GOBP REGULATION OF PROTEIN TARGETING | 69 | 3.92e-01 | -5.97e-02 | 8.68e-01 |
| GOBP POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT | 9 | 7.57e-01 | -5.96e-02 | 9.69e-01 |
| GOBP GLIAL CELL PROLIFERATION | 36 | 5.36e-01 | -5.96e-02 | 9.23e-01 |
| GOMF K63 LINKED DEUBIQUITINASE ACTIVITY | 15 | 6.90e-01 | 5.96e-02 | 9.54e-01 |
| GOBP NEGATIVE REGULATION OF MEMBRANE PERMEABILITY | 18 | 6.62e-01 | 5.96e-02 | 9.49e-01 |
| GOBP DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE | 8 | 7.70e-01 | -5.96e-02 | 9.71e-01 |
| GOBP GENITALIA DEVELOPMENT | 22 | 6.29e-01 | 5.95e-02 | 9.40e-01 |
| GOBP REGULATION OF ELECTRON TRANSFER ACTIVITY | 6 | 8.01e-01 | 5.95e-02 | 9.78e-01 |
| GOBP THYMOCYTE APOPTOTIC PROCESS | 14 | 7.00e-01 | -5.95e-02 | 9.55e-01 |
| GOBP BONE MATURATION | 16 | 6.81e-01 | 5.94e-02 | 9.52e-01 |
| GOBP VIRAL TRANSLATION | 20 | 6.46e-01 | 5.94e-02 | 9.43e-01 |
| GOCC ENDOCYTIC VESICLE MEMBRANE | 142 | 2.22e-01 | 5.94e-02 | 7.51e-01 |
| GOBP VESICLE ORGANIZATION | 298 | 7.87e-02 | 5.94e-02 | 5.37e-01 |
| GOMF CYSTEINE TYPE PEPTIDASE ACTIVITY | 142 | 2.23e-01 | 5.94e-02 | 7.51e-01 |
| GOBP PHOTOTRANSDUCTION | 19 | 6.55e-01 | 5.93e-02 | 9.46e-01 |
| GOBP OVARIAN FOLLICLE DEVELOPMENT | 34 | 5.51e-01 | -5.92e-02 | 9.26e-01 |
| GOBP POSITIVE REGULATION OF MRNA 3 END PROCESSING | 6 | 8.02e-01 | 5.91e-02 | 9.78e-01 |
| GOBP INTEGRIN MEDIATED SIGNALING PATHWAY | 85 | 3.47e-01 | -5.91e-02 | 8.43e-01 |
| GOCC TRANSCRIPTION FACTOR TFIID COMPLEX | 32 | 5.63e-01 | 5.90e-02 | 9.29e-01 |
| GOBP REGULATION OF EXOCYTOSIS | 123 | 2.59e-01 | 5.90e-02 | 7.85e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 33 | 5.58e-01 | 5.90e-02 | 9.27e-01 |
| GOMF TRANSCRIPTION COREGULATOR ACTIVITY | 430 | 3.69e-02 | 5.90e-02 | 3.91e-01 |
| GOBP REGULATION OF CHAPERONE MEDIATED AUTOPHAGY | 6 | 8.03e-01 | 5.89e-02 | 9.79e-01 |
| GOBP LYMPHANGIOGENESIS | 8 | 7.73e-01 | 5.88e-02 | 9.72e-01 |
| GOBP POSITIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 51 | 4.68e-01 | 5.88e-02 | 9.00e-01 |
| GOBP MITOCHONDRIAL DEPOLARIZATION | 18 | 6.66e-01 | -5.88e-02 | 9.49e-01 |
| GOBP WATER SOLUBLE VITAMIN METABOLIC PROCESS | 50 | 4.72e-01 | -5.88e-02 | 9.02e-01 |
| GOBP NEURAL NUCLEUS DEVELOPMENT | 44 | 5.00e-01 | -5.88e-02 | 9.14e-01 |
| GOMF S METHYLTRANSFERASE ACTIVITY | 6 | 8.03e-01 | -5.88e-02 | 9.79e-01 |
| GOCC AUTOLYSOSOME | 12 | 7.24e-01 | -5.88e-02 | 9.62e-01 |
| GOBP REGULATION OF CELL DEVELOPMENT | 542 | 2.00e-02 | 5.87e-02 | 2.95e-01 |
| GOBP FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS | 24 | 6.19e-01 | 5.87e-02 | 9.37e-01 |
| GOBP PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 45 | 4.96e-01 | -5.87e-02 | 9.13e-01 |
| GOBP CELLULAR RESPONSE TO PH | 15 | 6.94e-01 | -5.87e-02 | 9.54e-01 |
| GOCC SITE OF POLARIZED GROWTH | 132 | 2.45e-01 | 5.87e-02 | 7.73e-01 |
| GOMF SALT TRANSMEMBRANE TRANSPORTER ACTIVITY | 284 | 8.96e-02 | -5.87e-02 | 5.59e-01 |
| GOBP MUSCLE ATROPHY | 6 | 8.03e-01 | 5.87e-02 | 9.79e-01 |
| GOBP TISSUE REGENERATION | 41 | 5.16e-01 | 5.87e-02 | 9.19e-01 |
| GOMF O ACYLTRANSFERASE ACTIVITY | 42 | 5.11e-01 | -5.87e-02 | 9.18e-01 |
| GOBP CORTICOSTEROID HORMONE SECRETION | 10 | 7.48e-01 | -5.87e-02 | 9.66e-01 |
| GOBP REGULATION OF B CELL DIFFERENTIATION | 25 | 6.12e-01 | 5.86e-02 | 9.36e-01 |
| GOBP MUSCLE CELL MIGRATION | 58 | 4.40e-01 | -5.86e-02 | 8.85e-01 |
| GOMF SUMO TRANSFERASE ACTIVITY | 24 | 6.19e-01 | 5.86e-02 | 9.37e-01 |
| GOMF PROTEIN TYROSINE PHOSPHATASE ACTIVITY | 70 | 3.97e-01 | 5.86e-02 | 8.71e-01 |
| GOBP NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT | 61 | 4.29e-01 | -5.86e-02 | 8.82e-01 |
| GOBP POSITIVE REGULATION OF HIPPO SIGNALING | 7 | 7.89e-01 | -5.85e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF LIPID LOCALIZATION | 69 | 4.01e-01 | -5.85e-02 | 8.72e-01 |
| GOBP AMINO ACID BETAINE TRANSPORT | 10 | 7.49e-01 | -5.85e-02 | 9.66e-01 |
| GOBP REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT | 19 | 6.59e-01 | 5.85e-02 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE | 199 | 1.56e-01 | 5.85e-02 | 6.79e-01 |
| GOCC ORIGIN RECOGNITION COMPLEX | 9 | 7.62e-01 | -5.84e-02 | 9.70e-01 |
| GOMF TRANSPORTER ACTIVITY | 734 | 7.56e-03 | -5.83e-02 | 1.70e-01 |
| GOBP REGULATION OF CATION CHANNEL ACTIVITY | 62 | 4.27e-01 | 5.83e-02 | 8.82e-01 |
| GOMF LIGASE ACTIVITY | 124 | 2.63e-01 | -5.83e-02 | 7.87e-01 |
| GOBP HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 9 | 7.62e-01 | -5.83e-02 | 9.70e-01 |
| GOMF HISTONE H4K5 ACETYLTRANSFERASE ACTIVITY | 11 | 7.38e-01 | -5.83e-02 | 9.65e-01 |
| GOBP NEURON PROJECTION REGENERATION | 38 | 5.34e-01 | -5.83e-02 | 9.23e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 21 | 6.44e-01 | 5.83e-02 | 9.42e-01 |
| GOCC ISWI TYPE COMPLEX | 13 | 7.16e-01 | 5.82e-02 | 9.59e-01 |
| GOBP REGULATION OF TISSUE REMODELING | 48 | 4.87e-01 | -5.81e-02 | 9.11e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 25 | 6.16e-01 | 5.80e-02 | 9.36e-01 |
| GOBP ENERGY HOMEOSTASIS | 47 | 4.92e-01 | -5.80e-02 | 9.13e-01 |
| GOBP SULFUR AMINO ACID TRANSPORT | 9 | 7.63e-01 | -5.80e-02 | 9.70e-01 |
| GOBP NEGATIVE REGULATION OF AMYLOID BETA CLEARANCE | 6 | 8.06e-01 | -5.79e-02 | 9.79e-01 |
| GOBP PROTEIN LOCALIZATION TO VACUOLE | 75 | 3.86e-01 | -5.79e-02 | 8.65e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 86 | 3.55e-01 | -5.78e-02 | 8.46e-01 |
| GOBP NEGATIVE REGULATION OF MIRNA PROCESSING | 6 | 8.07e-01 | -5.77e-02 | 9.79e-01 |
| GOCC PHAGOCYTIC VESICLE | 125 | 2.66e-01 | 5.77e-02 | 7.91e-01 |
| GOBP GDP MANNOSE METABOLIC PROCESS | 6 | 8.07e-01 | 5.77e-02 | 9.79e-01 |
| GOBP DENDRITE MORPHOGENESIS | 91 | 3.42e-01 | 5.77e-02 | 8.40e-01 |
| GOBP SPERM FLAGELLUM ASSEMBLY | 22 | 6.40e-01 | -5.77e-02 | 9.42e-01 |
| GOBP TETRAHYDROFOLATE INTERCONVERSION | 9 | 7.65e-01 | 5.76e-02 | 9.70e-01 |
| GOBP REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 16 | 6.91e-01 | 5.75e-02 | 9.54e-01 |
| GOBP ANTEROGRADE AXONAL TRANSPORT | 40 | 5.30e-01 | 5.75e-02 | 9.23e-01 |
| GOBP SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 9 | 7.65e-01 | -5.74e-02 | 9.70e-01 |
| GOBP TRNA CATABOLIC PROCESS | 15 | 7.00e-01 | 5.74e-02 | 9.55e-01 |
| GOBP G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY | 6 | 8.08e-01 | 5.74e-02 | 9.80e-01 |
| GOMF G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR ACTIVITY | 6 | 8.08e-01 | 5.74e-02 | 9.80e-01 |
| GOBP MICROVILLUS ORGANIZATION | 26 | 6.13e-01 | -5.74e-02 | 9.36e-01 |
| GOMF PROTEASOME BINDING | 16 | 6.91e-01 | 5.73e-02 | 9.54e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 17 | 6.83e-01 | 5.73e-02 | 9.53e-01 |
| GOMF ACETYLTRANSFERASE ACTIVITY | 83 | 3.67e-01 | -5.73e-02 | 8.54e-01 |
| GOMF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY | 8 | 7.79e-01 | 5.73e-02 | 9.75e-01 |
| GOCC B WICH COMPLEX | 7 | 7.93e-01 | -5.72e-02 | 9.77e-01 |
| GOBP DENDRITE DEVELOPMENT | 159 | 2.14e-01 | 5.72e-02 | 7.46e-01 |
| GOBP REGULATION OF OSSIFICATION | 72 | 4.02e-01 | 5.71e-02 | 8.72e-01 |
| GOCC CORTICAL ENDOPLASMIC RETICULUM | 6 | 8.09e-01 | 5.71e-02 | 9.80e-01 |
| GOCC SECRETORY GRANULE | 611 | 1.67e-02 | -5.71e-02 | 2.72e-01 |
| GOMF TUBULIN BINDING | 300 | 9.02e-02 | 5.71e-02 | 5.60e-01 |
| GOBP POSITIVE REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION | 5 | 8.25e-01 | 5.71e-02 | 9.80e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 14 | 7.12e-01 | -5.70e-02 | 9.59e-01 |
| GOCC LYSOSOMAL LUMEN | 73 | 4.00e-01 | -5.70e-02 | 8.71e-01 |
| GOBP BASOLATERAL PROTEIN SECRETION | 5 | 8.26e-01 | -5.68e-02 | 9.80e-01 |
| GOBP NEUROBLAST PROLIFERATION | 38 | 5.45e-01 | -5.68e-02 | 9.23e-01 |
| GOBP CELLULAR RESPONSE TO IRON ION | 5 | 8.26e-01 | -5.68e-02 | 9.80e-01 |
| GOBP MELANOSOME ASSEMBLY | 19 | 6.69e-01 | 5.67e-02 | 9.49e-01 |
| GOMF MYOSIN HEAVY CHAIN BINDING | 7 | 7.95e-01 | 5.67e-02 | 9.77e-01 |
| GOBP ESTABLISHMENT OF CENTROSOME LOCALIZATION | 8 | 7.81e-01 | -5.67e-02 | 9.75e-01 |
| GOMF NF KAPPAB INDUCING KINASE ACTIVITY | 6 | 8.10e-01 | -5.67e-02 | 9.80e-01 |
| GOBP REGULATED EXOCYTOSIS | 142 | 2.45e-01 | 5.66e-02 | 7.73e-01 |
| GOBP FATTY ACID BIOSYNTHETIC PROCESS | 106 | 3.14e-01 | -5.66e-02 | 8.22e-01 |
| GOBP ECTODERM DEVELOPMENT | 14 | 7.14e-01 | 5.66e-02 | 9.59e-01 |
| GOBP REGULATION OF CALCINEURIN MEDIATED SIGNALING | 31 | 5.86e-01 | -5.66e-02 | 9.36e-01 |
| GOBP NEUROTRANSMITTER CATABOLIC PROCESS | 6 | 8.10e-01 | -5.66e-02 | 9.80e-01 |
| GOBP RADIAL GLIA GUIDED PYRAMIDAL NEURON MIGRATION | 5 | 8.27e-01 | -5.65e-02 | 9.80e-01 |
| GOCC DENDRITIC SPINE HEAD | 5 | 8.27e-01 | 5.65e-02 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 104 | 3.20e-01 | 5.65e-02 | 8.26e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 36 | 5.57e-01 | -5.65e-02 | 9.27e-01 |
| GOBP PROTEIN DESTABILIZATION | 45 | 5.12e-01 | 5.65e-02 | 9.18e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 96 | 3.39e-01 | 5.65e-02 | 8.38e-01 |
| GOCC GOLGI STACK | 107 | 3.13e-01 | 5.65e-02 | 8.22e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 10 | 7.57e-01 | 5.64e-02 | 9.69e-01 |
| GOCC NADPH OXIDASE COMPLEX | 10 | 7.57e-01 | -5.64e-02 | 9.69e-01 |
| GOBP NEGATIVE REGULATION OF PHAGOCYTOSIS | 19 | 6.71e-01 | 5.64e-02 | 9.49e-01 |
| GOBP CHONDROCYTE DIFFERENTIATION | 60 | 4.51e-01 | -5.63e-02 | 8.89e-01 |
| GOBP REGULATION OF HETEROCHROMATIN ORGANIZATION | 21 | 6.55e-01 | 5.63e-02 | 9.47e-01 |
| GOBP ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS | 25 | 6.26e-01 | -5.63e-02 | 9.40e-01 |
| GOBP MUSCLE ORGAN DEVELOPMENT | 195 | 1.76e-01 | 5.63e-02 | 7.07e-01 |
| GOCC INTEGRATOR COMPLEX | 16 | 6.97e-01 | -5.63e-02 | 9.55e-01 |
| GOBP POSITIVE REGULATION OF CELL DEVELOPMENT | 302 | 9.36e-02 | 5.63e-02 | 5.67e-01 |
| GOBP REGULATION OF DNA BIOSYNTHETIC PROCESS | 103 | 3.25e-01 | -5.62e-02 | 8.29e-01 |
| GOBP CALCIUM MEDIATED SIGNALING | 121 | 2.86e-01 | -5.62e-02 | 8.05e-01 |
| GOBP DIOL METABOLIC PROCESS | 22 | 6.48e-01 | 5.62e-02 | 9.44e-01 |
| GOBP POLYAMINE METABOLIC PROCESS | 17 | 6.88e-01 | -5.62e-02 | 9.54e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL FISSION | 18 | 6.80e-01 | 5.62e-02 | 9.52e-01 |
| GOMF CARBONYL REDUCTASE NADPH ACTIVITY | 7 | 7.97e-01 | 5.62e-02 | 9.77e-01 |
| GOBP HISTONE H4 ACETYLATION | 12 | 7.36e-01 | -5.62e-02 | 9.65e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM DEVELOPMENT | 39 | 5.44e-01 | -5.62e-02 | 9.23e-01 |
| GOBP NEGATIVE REGULATION OF TRANSPORT | 274 | 1.11e-01 | -5.62e-02 | 6.03e-01 |
| GOBP EXPLORATION BEHAVIOR | 13 | 7.26e-01 | -5.61e-02 | 9.63e-01 |
| GOCC PRESYNAPTIC ACTIVE ZONE CYTOPLASMIC COMPONENT | 11 | 7.47e-01 | -5.61e-02 | 9.66e-01 |
| GOBP INTRACELLULAR DISTRIBUTION OF MITOCHONDRIA | 5 | 8.28e-01 | 5.61e-02 | 9.80e-01 |
| GOBP REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY | 8 | 7.83e-01 | 5.61e-02 | 9.75e-01 |
| GOCC HISTONE DEACETYLASE COMPLEX | 76 | 3.98e-01 | 5.61e-02 | 8.71e-01 |
| GOBP INTERLEUKIN 8 PRODUCTION | 56 | 4.68e-01 | 5.61e-02 | 9.00e-01 |
| GOBP PYRIMIDINE DIMER REPAIR | 9 | 7.71e-01 | 5.61e-02 | 9.71e-01 |
| GOBP PROTEIN POLYUBIQUITINATION | 196 | 1.77e-01 | 5.61e-02 | 7.08e-01 |
| GOMF PROTEIN PHOSPHATASE BINDING | 116 | 2.98e-01 | 5.60e-02 | 8.13e-01 |
| GOBP APOPTOTIC DNA FRAGMENTATION | 15 | 7.08e-01 | -5.59e-02 | 9.58e-01 |
| GOBP PSEUDOURIDINE SYNTHESIS | 18 | 6.81e-01 | 5.59e-02 | 9.52e-01 |
| GOMF MISMATCHED DNA BINDING | 13 | 7.27e-01 | 5.59e-02 | 9.63e-01 |
| GOBP REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS | 20 | 6.66e-01 | -5.58e-02 | 9.49e-01 |
| GOBP L KYNURENINE METABOLIC PROCESS | 6 | 8.13e-01 | -5.58e-02 | 9.80e-01 |
| GOBP FORELIMB MORPHOGENESIS | 17 | 6.90e-01 | -5.58e-02 | 9.54e-01 |
| GOBP GLYCEROLIPID BIOSYNTHETIC PROCESS | 206 | 1.68e-01 | 5.58e-02 | 6.96e-01 |
| GOBP CELLULAR RESPONSE TO HEAT | 53 | 4.83e-01 | 5.58e-02 | 9.08e-01 |
| GOCC TRANSCRIPTION EXPORT COMPLEX | 10 | 7.60e-01 | 5.58e-02 | 9.70e-01 |
| GOBP NEGATIVE REGULATION OF DNA METABOLIC PROCESS | 111 | 3.11e-01 | -5.58e-02 | 8.21e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN K63 LINKED UBIQUITINATION | 7 | 7.98e-01 | 5.57e-02 | 9.77e-01 |
| GOBP NEGATIVE REGULATION OF PROTEOLYSIS | 148 | 2.43e-01 | -5.57e-02 | 7.72e-01 |
| GOBP NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS | 16 | 7.00e-01 | -5.57e-02 | 9.55e-01 |
| GOBP PROTEIN DNA COMPLEX ASSEMBLY | 144 | 2.50e-01 | 5.57e-02 | 7.77e-01 |
| GOBP TELOMERASE HOLOENZYME COMPLEX ASSEMBLY | 6 | 8.14e-01 | 5.56e-02 | 9.80e-01 |
| GOMF MAGNESIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 7.39e-01 | -5.56e-02 | 9.65e-01 |
| GOBP PROTEIN EXPORT FROM NUCLEUS | 57 | 4.68e-01 | 5.56e-02 | 9.00e-01 |
| GOBP CELL SUBSTRATE ADHESION | 228 | 1.49e-01 | 5.55e-02 | 6.72e-01 |
| GOBP LIPID MODIFICATION | 143 | 2.52e-01 | 5.55e-02 | 7.78e-01 |
| GOBP C21 STEROID HORMONE METABOLIC PROCESS | 14 | 7.19e-01 | 5.55e-02 | 9.60e-01 |
| GOBP MUSCLE SYSTEM PROCESS | 246 | 1.35e-01 | 5.55e-02 | 6.52e-01 |
| GOBP PEPTIDYL LYSINE TRIMETHYLATION | 10 | 7.61e-01 | 5.55e-02 | 9.70e-01 |
| GOBP NEGATIVE REGULATION OF HIPPO SIGNALING | 11 | 7.50e-01 | 5.55e-02 | 9.67e-01 |
| GOBP CELLULAR RESPONSE TO GLUCOCORTICOID STIMULUS | 32 | 5.87e-01 | 5.55e-02 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 21 | 6.60e-01 | -5.55e-02 | 9.49e-01 |
| GOBP THREONINE METABOLIC PROCESS | 5 | 8.30e-01 | -5.54e-02 | 9.80e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 51 | 4.94e-01 | 5.54e-02 | 9.13e-01 |
| GOBP REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS | 49 | 5.03e-01 | -5.54e-02 | 9.15e-01 |
| GOBP REGULATION OF MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE | 5 | 8.30e-01 | -5.53e-02 | 9.80e-01 |
| GOMF INHIBITORY MHC CLASS I RECEPTOR ACTIVITY | 7 | 8.00e-01 | 5.53e-02 | 9.77e-01 |
| GOBP SERTOLI CELL DEVELOPMENT | 10 | 7.62e-01 | 5.53e-02 | 9.70e-01 |
| GOBP REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 16 | 7.02e-01 | 5.53e-02 | 9.56e-01 |
| GOMF PROTEIN FOLDING CHAPERONE | 49 | 5.04e-01 | -5.53e-02 | 9.15e-01 |
| GOBP POSITIVE REGULATION OF HELICASE ACTIVITY | 7 | 8.00e-01 | -5.52e-02 | 9.77e-01 |
| GOMF NEUTRAL L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 30 | 6.01e-01 | -5.52e-02 | 9.36e-01 |
| GOMF ADENYL NUCLEOTIDE BINDING | 1280 | 1.07e-03 | 5.52e-02 | 4.59e-02 |
| GOBP CDC42 PROTEIN SIGNAL TRANSDUCTION | 12 | 7.41e-01 | -5.51e-02 | 9.65e-01 |
| GOMF PROSTANOID RECEPTOR ACTIVITY | 5 | 8.31e-01 | -5.51e-02 | 9.80e-01 |
| GOCC NURF COMPLEX | 6 | 8.15e-01 | 5.51e-02 | 9.80e-01 |
| GOBP MORPHOGENESIS OF A BRANCHING STRUCTURE | 100 | 3.42e-01 | -5.50e-02 | 8.41e-01 |
| GOBP TYPE II HYPERSENSITIVITY | 5 | 8.31e-01 | 5.50e-02 | 9.80e-01 |
| GOMF CARBOHYDRATE BINDING | 157 | 2.35e-01 | -5.50e-02 | 7.63e-01 |
| GOBP HYALURONAN CATABOLIC PROCESS | 11 | 7.52e-01 | 5.50e-02 | 9.68e-01 |
| GOBP SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS | 59 | 4.66e-01 | 5.50e-02 | 9.00e-01 |
| GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 21 | 6.63e-01 | -5.49e-02 | 9.49e-01 |
| GOBP ENDOTHELIAL CELL APOPTOTIC PROCESS | 32 | 5.91e-01 | 5.49e-02 | 9.36e-01 |
| GOBP RRNA METABOLIC PROCESS | 245 | 1.40e-01 | -5.49e-02 | 6.61e-01 |
| GOCC LATE ENDOSOME | 250 | 1.36e-01 | 5.49e-02 | 6.52e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR PERMEABILITY | 11 | 7.53e-01 | 5.48e-02 | 9.68e-01 |
| GOBP BEHAVIORAL RESPONSE TO PAIN | 11 | 7.53e-01 | -5.48e-02 | 9.68e-01 |
| GOMF DNA BINDING BENDING | 9 | 7.76e-01 | 5.48e-02 | 9.73e-01 |
| GOBP RETINAL GANGLION CELL AXON GUIDANCE | 11 | 7.53e-01 | 5.47e-02 | 9.68e-01 |
| GOBP TRANSCRIPTION BY RNA POLYMERASE III | 60 | 4.64e-01 | -5.47e-02 | 8.99e-01 |
| GOMF ENZYME INHIBITOR ACTIVITY | 233 | 1.51e-01 | -5.47e-02 | 6.73e-01 |
| GOMF CHOLESTEROL BINDING | 36 | 5.70e-01 | -5.47e-02 | 9.31e-01 |
| GOBP PEPTIDYL ARGININE MODIFICATION | 8 | 7.89e-01 | -5.47e-02 | 9.76e-01 |
| GOBP OUTER EAR MORPHOGENESIS | 5 | 8.32e-01 | 5.47e-02 | 9.80e-01 |
| GOBP BERGMANN GLIAL CELL DIFFERENTIATION | 8 | 7.89e-01 | -5.47e-02 | 9.76e-01 |
| GOBP REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE | 15 | 7.14e-01 | -5.47e-02 | 9.59e-01 |
| GOBP DENDRITIC CELL MIGRATION | 23 | 6.50e-01 | -5.47e-02 | 9.44e-01 |
| GOMF OXIDIZED DNA BINDING | 11 | 7.54e-01 | -5.46e-02 | 9.68e-01 |
| GOBP REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 37 | 5.65e-01 | -5.46e-02 | 9.29e-01 |
| GOBP REGULATION OF PROTEIN STABILITY | 271 | 1.23e-01 | -5.46e-02 | 6.25e-01 |
| GOBP REGULATION OF SYNAPSE MATURATION | 12 | 7.43e-01 | 5.46e-02 | 9.65e-01 |
| GOMF ENZYME ACTIVATOR ACTIVITY | 463 | 4.54e-02 | 5.45e-02 | 4.32e-01 |
| GOCC POSTSYNAPTIC SPECIALIZATION | 214 | 1.70e-01 | -5.45e-02 | 6.98e-01 |
| GOBP POSITIVE REGULATION OF AMINE TRANSPORT | 15 | 7.15e-01 | -5.45e-02 | 9.59e-01 |
| GOBP GLIAL CELL MIGRATION | 42 | 5.41e-01 | 5.45e-02 | 9.23e-01 |
| GOBP NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION | 6 | 8.17e-01 | 5.45e-02 | 9.80e-01 |
| GOBP MAMMARY GLAND EPITHELIUM DEVELOPMENT | 38 | 5.62e-01 | 5.44e-02 | 9.29e-01 |
| GOCC MYOFILAMENT | 15 | 7.15e-01 | 5.44e-02 | 9.59e-01 |
| GOCC COATED VESICLE | 241 | 1.48e-01 | 5.43e-02 | 6.70e-01 |
| GOBP RETINA MORPHOGENESIS IN CAMERA TYPE EYE | 31 | 6.01e-01 | 5.42e-02 | 9.36e-01 |
| GOBP AUTOPHAGIC CELL DEATH | 9 | 7.78e-01 | -5.42e-02 | 9.75e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 43 | 5.39e-01 | 5.42e-02 | 9.23e-01 |
| GOCC VESICLE MEMBRANE | 908 | 6.14e-03 | 5.41e-02 | 1.48e-01 |
| GOBP POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS | 18 | 6.91e-01 | 5.41e-02 | 9.54e-01 |
| GOBP GOLGI LUMEN ACIDIFICATION | 13 | 7.36e-01 | 5.41e-02 | 9.65e-01 |
| GOBP RESPIRATORY SYSTEM DEVELOPMENT | 121 | 3.05e-01 | -5.40e-02 | 8.15e-01 |
| GOMF ACYLGLYCEROL LIPASE ACTIVITY | 10 | 7.67e-01 | 5.40e-02 | 9.70e-01 |
| GOBP CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS | 38 | 5.65e-01 | 5.40e-02 | 9.29e-01 |
| GOCC THO COMPLEX | 6 | 8.19e-01 | -5.40e-02 | 9.80e-01 |
| GOBP REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION | 10 | 7.68e-01 | 5.40e-02 | 9.70e-01 |
| GOCC OUTER MEMBRANE | 212 | 1.77e-01 | -5.40e-02 | 7.07e-01 |
| GOBP B CELL CHEMOTAXIS | 6 | 8.19e-01 | 5.40e-02 | 9.80e-01 |
| GOMF GLYCOSYLTRANSFERASE ACTIVITY | 184 | 2.08e-01 | 5.40e-02 | 7.38e-01 |
| GOMF STEROL BINDING | 45 | 5.31e-01 | -5.39e-02 | 9.23e-01 |
| GOBP RESPONSE TO MECHANICAL STIMULUS | 146 | 2.62e-01 | 5.39e-02 | 7.87e-01 |
| GOBP MULTICELLULAR ORGANISMAL MOVEMENT | 33 | 5.92e-01 | -5.39e-02 | 9.36e-01 |
| GOBP CELLULAR HYPOTONIC RESPONSE | 9 | 7.80e-01 | 5.39e-02 | 9.75e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 107 | 3.36e-01 | 5.39e-02 | 8.36e-01 |
| GOBP CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM | 244 | 1.49e-01 | 5.38e-02 | 6.72e-01 |
| GOCC NUCLEAR UBIQUITIN LIGASE COMPLEX | 42 | 5.48e-01 | -5.37e-02 | 9.25e-01 |
| GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 39 | 5.63e-01 | -5.36e-02 | 9.29e-01 |
| GOBP THIOESTER BIOSYNTHETIC PROCESS | 39 | 5.63e-01 | -5.36e-02 | 9.29e-01 |
| GOBP RESPONSE TO PEPTIDE HORMONE | 287 | 1.20e-01 | 5.36e-02 | 6.20e-01 |
| GOBP AUDITORY RECEPTOR CELL DEVELOPMENT | 18 | 6.94e-01 | 5.36e-02 | 9.54e-01 |
| GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT PHOSPHATASE ACTIVITY | 7 | 8.06e-01 | -5.35e-02 | 9.79e-01 |
| GOBP LEARNING | 86 | 3.91e-01 | -5.35e-02 | 8.68e-01 |
| GOBP CELLULAR RESPONSE TO TYPE II INTERFERON | 84 | 3.97e-01 | -5.35e-02 | 8.71e-01 |
| GOBP CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION | 24 | 6.50e-01 | 5.35e-02 | 9.44e-01 |
| GOBP PROXIMAL DISTAL PATTERN FORMATION | 7 | 8.06e-01 | 5.35e-02 | 9.79e-01 |
| GOBP FIBROBLAST GROWTH FACTOR PRODUCTION | 5 | 8.36e-01 | -5.35e-02 | 9.81e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM | 63 | 4.63e-01 | -5.34e-02 | 8.99e-01 |
| GOMF AMP BINDING | 13 | 7.39e-01 | -5.34e-02 | 9.65e-01 |
| GOCC SYNAPSE | 883 | 7.74e-03 | -5.33e-02 | 1.72e-01 |
| GOBP OLIGODENDROCYTE DIFFERENTIATION | 57 | 4.87e-01 | 5.33e-02 | 9.11e-01 |
| GOBP POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION | 35 | 5.86e-01 | -5.33e-02 | 9.36e-01 |
| GOMF SMAD BINDING | 62 | 4.69e-01 | 5.33e-02 | 9.00e-01 |
| GOBP NEGATIVE REGULATION OF CELL ACTIVATION | 144 | 2.71e-01 | 5.33e-02 | 7.94e-01 |
| GOBP COBALT ION TRANSPORT | 6 | 8.22e-01 | 5.32e-02 | 9.80e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 118 | 3.19e-01 | 5.32e-02 | 8.25e-01 |
| GOCC SARCOLEMMA | 87 | 3.92e-01 | -5.32e-02 | 8.68e-01 |
| GOCC SARCOPLASM | 56 | 4.92e-01 | -5.32e-02 | 9.13e-01 |
| GOCC SEPTIN CYTOSKELETON | 13 | 7.40e-01 | -5.31e-02 | 9.65e-01 |
| GOBP NEGATIVE REGULATION OF GLIOGENESIS | 23 | 6.59e-01 | 5.31e-02 | 9.49e-01 |
| GOBP CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION | 9 | 7.83e-01 | 5.31e-02 | 9.75e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL SHEET | 39 | 5.66e-01 | 5.31e-02 | 9.29e-01 |
| GOBP INFLAMMATORY RESPONSE TO WOUNDING | 20 | 6.81e-01 | 5.31e-02 | 9.52e-01 |
| GOBP REGULATION OF LIPID TRANSPORT | 83 | 4.04e-01 | -5.31e-02 | 8.72e-01 |
| GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 111 | 3.35e-01 | 5.31e-02 | 8.35e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE | 33 | 5.98e-01 | -5.30e-02 | 9.36e-01 |
| GOBP MYELOID CELL DEVELOPMENT | 60 | 4.78e-01 | -5.30e-02 | 9.05e-01 |
| GOMF HELICASE ACTIVITY | 142 | 2.76e-01 | 5.30e-02 | 7.98e-01 |
| GOBP MEIOTIC CELL CYCLE PROCESS | 134 | 2.91e-01 | 5.29e-02 | 8.06e-01 |
| GOMF MONOCARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 30 | 6.16e-01 | -5.29e-02 | 9.36e-01 |
| GOBP EMBRYONIC AXIS SPECIFICATION | 19 | 6.90e-01 | 5.29e-02 | 9.54e-01 |
| GOBP REGULATION OF TRANSCRIPTION BY GLUCOSE | 9 | 7.84e-01 | -5.29e-02 | 9.75e-01 |
| GOBP REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 48 | 5.26e-01 | -5.29e-02 | 9.22e-01 |
| GOBP REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 33 | 5.99e-01 | -5.29e-02 | 9.36e-01 |
| GOBP RETINOL METABOLIC PROCESS | 24 | 6.54e-01 | -5.28e-02 | 9.46e-01 |
| GOMF SCAFFOLD PROTEIN BINDING | 46 | 5.36e-01 | 5.28e-02 | 9.23e-01 |
| GOMF TRANSCRIPTION REGULATOR INHIBITOR ACTIVITY | 16 | 7.15e-01 | 5.28e-02 | 9.59e-01 |
| GOCC NEURON PROJECTION CYTOPLASM | 70 | 4.45e-01 | 5.28e-02 | 8.87e-01 |
| GOBP ASTROCYTE DIFFERENTIATION | 51 | 5.15e-01 | 5.28e-02 | 9.19e-01 |
| GOBP PHOSPHOLIPID TRANSPORT | 75 | 4.30e-01 | 5.28e-02 | 8.82e-01 |
| GOMF NAD BINDING | 52 | 5.11e-01 | -5.27e-02 | 9.18e-01 |
| GOBP EXTRACELLULAR VESICLE BIOGENESIS | 22 | 6.69e-01 | -5.26e-02 | 9.49e-01 |
| GOBP SISTER CHROMATID COHESION | 49 | 5.24e-01 | 5.26e-02 | 9.20e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDE SECRETION | 58 | 4.89e-01 | 5.26e-02 | 9.12e-01 |
| GOBP GERMINAL CENTER B CELL DIFFERENTIATION | 5 | 8.39e-01 | -5.26e-02 | 9.82e-01 |
| GOBP REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION | 75 | 4.32e-01 | -5.25e-02 | 8.82e-01 |
| GOBP SMALL MOLECULE BIOSYNTHETIC PROCESS | 412 | 6.85e-02 | -5.25e-02 | 5.10e-01 |
| GOBP ODONTOGENESIS | 58 | 4.89e-01 | 5.25e-02 | 9.12e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID FIBRIL FORMATION | 5 | 8.39e-01 | -5.25e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION | 803 | 1.22e-02 | 5.25e-02 | 2.25e-01 |
| GOBP REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 20 | 6.85e-01 | -5.25e-02 | 9.53e-01 |
| GOCC UBIQUITIN CONJUGATING ENZYME COMPLEX | 8 | 7.97e-01 | -5.25e-02 | 9.77e-01 |
| GOBP NEGATIVE REGULATION OF MYELINATION | 7 | 8.10e-01 | 5.24e-02 | 9.80e-01 |
| GOBP DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 8 | 7.97e-01 | -5.24e-02 | 9.77e-01 |
| GOBP THYROID HORMONE GENERATION | 10 | 7.74e-01 | -5.24e-02 | 9.72e-01 |
| GOBP CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 33 | 6.03e-01 | -5.24e-02 | 9.36e-01 |
| GOBP REGULATION OF BMP SIGNALING PATHWAY | 56 | 4.98e-01 | -5.23e-02 | 9.13e-01 |
| GOCC TRANSCRIPTION EXPORT COMPLEX 2 | 5 | 8.40e-01 | 5.23e-02 | 9.82e-01 |
| GOCC MMXD COMPLEX | 5 | 8.40e-01 | -5.22e-02 | 9.82e-01 |
| GOMF KINASE BINDING | 593 | 3.10e-02 | 5.22e-02 | 3.54e-01 |
| GOCC FILOPODIUM | 79 | 4.23e-01 | 5.21e-02 | 8.81e-01 |
| GOBP NUCLEOTIDE EXCISION REPAIR | 81 | 4.18e-01 | 5.21e-02 | 8.79e-01 |
| GOBP CELL SUBSTRATE JUNCTION DISASSEMBLY | 7 | 8.11e-01 | 5.21e-02 | 9.80e-01 |
| GOCC CORTICAL ACTIN CYTOSKELETON | 55 | 5.04e-01 | -5.21e-02 | 9.15e-01 |
| GOMF LRR DOMAIN BINDING | 14 | 7.36e-01 | 5.21e-02 | 9.65e-01 |
| GOMF PHOSPHOLIPID BINDING | 351 | 9.51e-02 | 5.20e-02 | 5.72e-01 |
| GOMF UDP GLUCOSYLTRANSFERASE ACTIVITY | 8 | 7.99e-01 | -5.20e-02 | 9.77e-01 |
| GOMF DNA TOPOISOMERASE ACTIVITY | 6 | 8.25e-01 | 5.20e-02 | 9.80e-01 |
| GOBP SCHWANN CELL DEVELOPMENT | 22 | 6.73e-01 | -5.20e-02 | 9.49e-01 |
| GOBP REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY | 16 | 7.19e-01 | 5.20e-02 | 9.60e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE | 55 | 5.05e-01 | -5.20e-02 | 9.16e-01 |
| GOBP NEUTROPHIL DIFFERENTIATION | 9 | 7.87e-01 | 5.20e-02 | 9.76e-01 |
| GOMF DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY | 12 | 7.55e-01 | -5.20e-02 | 9.69e-01 |
| GOBP REGULATION OF CARBOHYDRATE CATABOLIC PROCESS | 51 | 5.22e-01 | 5.19e-02 | 9.20e-01 |
| GOMF DNA HELICASE ACTIVITY | 57 | 4.98e-01 | -5.19e-02 | 9.13e-01 |
| GOCC SUPRAMOLECULAR COMPLEX | 922 | 8.17e-03 | 5.19e-02 | 1.78e-01 |
| GOMF AMYLOID BETA BINDING | 60 | 4.87e-01 | -5.19e-02 | 9.11e-01 |
| GOBP INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 32 | 6.12e-01 | 5.19e-02 | 9.36e-01 |
| GOBP RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION | 6 | 8.26e-01 | -5.18e-02 | 9.80e-01 |
| GOBP ORGANIC ACID BIOSYNTHETIC PROCESS | 216 | 1.91e-01 | -5.18e-02 | 7.21e-01 |
| GOBP RESPONSE TO LITHIUM ION | 9 | 7.88e-01 | 5.17e-02 | 9.76e-01 |
| GOBP MRNA 3 SPLICE SITE RECOGNITION | 6 | 8.26e-01 | 5.17e-02 | 9.80e-01 |
| GOBP PIGMENTATION | 83 | 4.16e-01 | -5.17e-02 | 8.79e-01 |
| GOCC DENDRITIC SHAFT | 25 | 6.55e-01 | -5.16e-02 | 9.47e-01 |
| GOBP CELL PROLIFERATION IN HINDBRAIN | 5 | 8.42e-01 | -5.16e-02 | 9.82e-01 |
| GOBP OSTEOBLAST PROLIFERATION | 18 | 7.05e-01 | -5.16e-02 | 9.56e-01 |
| GOBP REGULATION OF LIPID LOCALIZATION | 104 | 3.64e-01 | -5.16e-02 | 8.50e-01 |
| GOBP RESPONSE TO CATECHOLAMINE | 44 | 5.54e-01 | 5.16e-02 | 9.26e-01 |
| GOBP SUCCINATE METABOLIC PROCESS | 5 | 8.42e-01 | -5.16e-02 | 9.82e-01 |
| GOBP TRACHEA MORPHOGENESIS | 7 | 8.13e-01 | -5.16e-02 | 9.80e-01 |
| GOMF ACYLTRANSFERASE ACTIVITY | 561 | 3.79e-02 | 5.16e-02 | 3.97e-01 |
| GOBP ANIMAL ORGAN FORMATION | 30 | 6.25e-01 | -5.15e-02 | 9.40e-01 |
| GOBP REGULATION OF POLYSACCHARIDE METABOLIC PROCESS | 31 | 6.20e-01 | -5.15e-02 | 9.37e-01 |
| GOBP CELL ACTIVATION | 756 | 1.70e-02 | 5.14e-02 | 2.74e-01 |
| GOBP POST EMBRYONIC CAMERA TYPE EYE DEVELOPMENT | 6 | 8.28e-01 | -5.14e-02 | 9.80e-01 |
| GOBP U2 TYPE PRESPLICEOSOME ASSEMBLY | 24 | 6.63e-01 | -5.13e-02 | 9.49e-01 |
| GOBP NUCLEOSIDE SALVAGE | 9 | 7.90e-01 | 5.13e-02 | 9.76e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE TRANSPORT | 5 | 8.43e-01 | 5.13e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 33 | 6.10e-01 | -5.13e-02 | 9.36e-01 |
| GOBP PROTEIN HYDROXYLATION | 19 | 6.99e-01 | -5.13e-02 | 9.55e-01 |
| GOBP PROTEIN K63 LINKED DEUBIQUITINATION | 30 | 6.27e-01 | 5.13e-02 | 9.40e-01 |
| GOBP CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT | 10 | 7.79e-01 | 5.12e-02 | 9.75e-01 |
| GOBP XENOBIOTIC METABOLIC PROCESS | 53 | 5.19e-01 | -5.12e-02 | 9.19e-01 |
| GOBP PEPTIDE TRANSPORT | 145 | 2.88e-01 | 5.12e-02 | 8.05e-01 |
| GOBP NEGATIVE REGULATION OF ENDOCYTOSIS | 54 | 5.15e-01 | -5.12e-02 | 9.19e-01 |
| GOBP MICROTUBULE CYTOSKELETON ORGANIZATION | 494 | 5.27e-02 | 5.12e-02 | 4.59e-01 |
| GOBP NEGATIVE REGULATION OF COMPLEMENT ACTIVATION | 8 | 8.02e-01 | 5.11e-02 | 9.78e-01 |
| GOBP NUCLEAR EXPORT | 155 | 2.73e-01 | 5.11e-02 | 7.94e-01 |
| GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 7 | 8.15e-01 | -5.11e-02 | 9.80e-01 |
| GOMF PHOSPHOLIPASE C ACTIVITY | 17 | 7.15e-01 | 5.11e-02 | 9.59e-01 |
| GOBP ORGANELLE DISASSEMBLY | 134 | 3.08e-01 | -5.10e-02 | 8.19e-01 |
| GOMF S ADENOSYLMETHIONINE DEPENDENT METHYLTRANSFERASE ACTIVITY | 164 | 2.60e-01 | 5.10e-02 | 7.87e-01 |
| GOBP ADULT LOCOMOTORY BEHAVIOR | 44 | 5.58e-01 | 5.10e-02 | 9.27e-01 |
| GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 46 | 5.50e-01 | -5.10e-02 | 9.26e-01 |
| GOCC NUCLEAR PORE | 86 | 4.14e-01 | 5.10e-02 | 8.77e-01 |
| GOMF CHANNEL INHIBITOR ACTIVITY | 24 | 6.66e-01 | -5.10e-02 | 9.49e-01 |
| GOMF METHYL CPG BINDING | 21 | 6.86e-01 | -5.10e-02 | 9.54e-01 |
| GOBP EMBRYONIC CRANIAL SKELETON MORPHOGENESIS | 23 | 6.72e-01 | 5.10e-02 | 9.49e-01 |
| GOBP STEM CELL PROLIFERATION | 59 | 4.99e-01 | -5.09e-02 | 9.14e-01 |
| GOBP NEGATIVE REGULATION OF DEPHOSPHORYLATION | 30 | 6.30e-01 | -5.09e-02 | 9.40e-01 |
| GOBP KIDNEY EPITHELIUM DEVELOPMENT | 68 | 4.69e-01 | 5.09e-02 | 9.00e-01 |
| GOCC MULTIMERIC RIBONUCLEASE P COMPLEX | 10 | 7.81e-01 | 5.09e-02 | 9.75e-01 |
| GOMF RIBONUCLEASE P RNA BINDING | 10 | 7.81e-01 | 5.09e-02 | 9.75e-01 |
| GOBP REGULATION OF AEROBIC RESPIRATION | 29 | 6.36e-01 | -5.08e-02 | 9.41e-01 |
| GOBP REGULATION OF PROTEIN GLYCOSYLATION | 10 | 7.81e-01 | 5.08e-02 | 9.75e-01 |
| GOBP REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL | 61 | 4.93e-01 | 5.08e-02 | 9.13e-01 |
| GOBP NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE | 7 | 8.16e-01 | 5.08e-02 | 9.80e-01 |
| GOBP NEGATIVE REGULATION OF ORGAN GROWTH | 21 | 6.87e-01 | 5.08e-02 | 9.54e-01 |
| GOBP DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS | 149 | 2.85e-01 | -5.08e-02 | 8.04e-01 |
| GOBP CELLULAR RESPONSE TO PEPTIDE | 252 | 1.66e-01 | 5.08e-02 | 6.93e-01 |
| GOMF PROTEIN TRANSPORTER ACTIVITY | 35 | 6.03e-01 | -5.08e-02 | 9.36e-01 |
| GOMF VITAMIN BINDING | 95 | 3.93e-01 | 5.07e-02 | 8.68e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX | 14 | 7.43e-01 | -5.07e-02 | 9.65e-01 |
| GOBP REGULATION OF INTEGRIN ACTIVATION | 12 | 7.61e-01 | 5.07e-02 | 9.70e-01 |
| GOCC MYELIN SHEATH | 31 | 6.26e-01 | -5.07e-02 | 9.40e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 7 | 8.17e-01 | 5.06e-02 | 9.80e-01 |
| GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 52 | 5.28e-01 | -5.06e-02 | 9.22e-01 |
| GOBP NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS | 17 | 7.18e-01 | 5.06e-02 | 9.60e-01 |
| GOBP GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS | 179 | 2.44e-01 | 5.06e-02 | 7.73e-01 |
| GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM EXIT SITE | 7 | 8.17e-01 | 5.05e-02 | 9.80e-01 |
| GOBP RESPONSE TO PEPTIDOGLYCAN | 9 | 7.93e-01 | 5.05e-02 | 9.77e-01 |
| GOBP REGULATION OF NEURON APOPTOTIC PROCESS | 152 | 2.83e-01 | -5.05e-02 | 8.02e-01 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR | 124 | 3.32e-01 | 5.05e-02 | 8.32e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE | 393 | 8.73e-02 | -5.05e-02 | 5.57e-01 |
| GOMF ORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 19 | 7.03e-01 | -5.05e-02 | 9.56e-01 |
| GOBP POSITIVE REGULATION OF P38MAPK CASCADE | 21 | 6.89e-01 | 5.04e-02 | 9.54e-01 |
| GOBP MALE SEX DIFFERENTIATION | 96 | 3.94e-01 | 5.04e-02 | 8.68e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I | 9 | 7.93e-01 | 5.04e-02 | 9.77e-01 |
| GOBP DUMP METABOLIC PROCESS | 6 | 8.31e-01 | 5.04e-02 | 9.80e-01 |
| GOBP POST EMBRYONIC DEVELOPMENT | 72 | 4.60e-01 | -5.04e-02 | 8.96e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPIRATION | 10 | 7.83e-01 | -5.04e-02 | 9.75e-01 |
| GOCC SUPRAMOLECULAR POLYMER | 612 | 3.44e-02 | 5.04e-02 | 3.79e-01 |
| GOCC CILIARY TIP | 36 | 6.01e-01 | 5.03e-02 | 9.36e-01 |
| GOBP FACULTATIVE HETEROCHROMATIN FORMATION | 37 | 5.97e-01 | -5.03e-02 | 9.36e-01 |
| GOBP ENDOSOMAL TRANSPORT | 225 | 1.95e-01 | 5.03e-02 | 7.25e-01 |
| GOCC GLYCOGEN GRANULE | 7 | 8.18e-01 | -5.02e-02 | 9.80e-01 |
| GOBP CELLULAR RESPONSE TO STEROID HORMONE STIMULUS | 149 | 2.91e-01 | 5.02e-02 | 8.06e-01 |
| GOBP SMOOTH MUSCLE CONTRACTION | 54 | 5.24e-01 | -5.02e-02 | 9.20e-01 |
| GOBP REGULATION OF CILIUM ASSEMBLY | 82 | 4.32e-01 | -5.02e-02 | 8.82e-01 |
| GOBP CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 90 | 4.11e-01 | -5.02e-02 | 8.77e-01 |
| GOBP CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 367 | 1.00e-01 | 5.02e-02 | 5.84e-01 |
| GOBP NEGATIVE REGULATION OF TORC1 SIGNALING | 41 | 5.78e-01 | -5.02e-02 | 9.34e-01 |
| GOMF DEACETYLASE ACTIVITY | 34 | 6.13e-01 | 5.02e-02 | 9.36e-01 |
| GOMF UNMETHYLATED CPG BINDING | 9 | 7.94e-01 | -5.02e-02 | 9.77e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD CIRCULATION | 16 | 7.28e-01 | 5.01e-02 | 9.64e-01 |
| GOMF NADPH BINDING | 15 | 7.37e-01 | 5.01e-02 | 9.65e-01 |
| GOBP CELLULAR RESPONSE TO SODIUM ARSENITE | 5 | 8.46e-01 | -5.01e-02 | 9.82e-01 |
| GOBP RESPONSE TO SODIUM ARSENITE | 5 | 8.46e-01 | -5.01e-02 | 9.82e-01 |
| GOBP KERATINIZATION | 9 | 7.95e-01 | 5.01e-02 | 9.77e-01 |
| GOBP REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 10 | 7.84e-01 | 5.00e-02 | 9.76e-01 |
| GOBP REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 29 | 6.41e-01 | -5.00e-02 | 9.42e-01 |
| GOBP MEMBRANE LIPID BIOSYNTHETIC PROCESS | 106 | 3.74e-01 | 5.00e-02 | 8.60e-01 |
| GOBP REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 278 | 1.53e-01 | 5.00e-02 | 6.74e-01 |
| GOMF TRNA GUANINE METHYLTRANSFERASE ACTIVITY | 12 | 7.65e-01 | 4.99e-02 | 9.70e-01 |
| GOBP MITOTIC CELL CYCLE PHASE TRANSITION | 391 | 9.15e-02 | 4.99e-02 | 5.63e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BASED PROCESS | 265 | 1.63e-01 | -4.99e-02 | 6.88e-01 |
| GOMF FOUR WAY JUNCTION DNA BINDING | 18 | 7.14e-01 | 4.99e-02 | 9.59e-01 |
| GOBP INSULIN SECRETION | 113 | 3.61e-01 | 4.98e-02 | 8.47e-01 |
| GOBP REVERSE CHOLESTEROL TRANSPORT | 13 | 7.56e-01 | 4.98e-02 | 9.69e-01 |
| GOBP GLUTAMATE CATABOLIC PROCESS | 5 | 8.47e-01 | -4.98e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 25 | 6.67e-01 | 4.98e-02 | 9.49e-01 |
| GOBP SPHINGOID METABOLIC PROCESS | 16 | 7.30e-01 | 4.98e-02 | 9.64e-01 |
| GOCC DEUTEROSOME | 5 | 8.47e-01 | 4.98e-02 | 9.82e-01 |
| GOBP REGULATION OF ORGAN GROWTH | 50 | 5.43e-01 | 4.97e-02 | 9.23e-01 |
| GOCC ENDOLYSOSOME | 24 | 6.74e-01 | -4.97e-02 | 9.50e-01 |
| GOBP RESPONSE TO EXTRACELLULAR STIMULUS | 364 | 1.05e-01 | 4.97e-02 | 5.94e-01 |
| GOBP RAB PROTEIN SIGNAL TRANSDUCTION | 18 | 7.15e-01 | 4.97e-02 | 9.59e-01 |
| GOBP RESPONSE TO REACTIVE OXYGEN SPECIES | 156 | 2.86e-01 | -4.96e-02 | 8.04e-01 |
| GOCC TORC1 COMPLEX | 6 | 8.33e-01 | -4.96e-02 | 9.81e-01 |
| GOBP POLYOL BIOSYNTHETIC PROCESS | 43 | 5.74e-01 | 4.96e-02 | 9.32e-01 |
| GOBP DETERMINATION OF DORSAL VENTRAL ASYMMETRY | 6 | 8.34e-01 | 4.96e-02 | 9.81e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS | 22 | 6.88e-01 | 4.95e-02 | 9.54e-01 |
| GOMF KINESIN BINDING | 35 | 6.12e-01 | -4.95e-02 | 9.36e-01 |
| GOMF NUCLEAR LOCALIZATION SEQUENCE BINDING | 20 | 7.02e-01 | 4.95e-02 | 9.56e-01 |
| GOBP ADHESION OF SYMBIONT TO HOST CELL | 6 | 8.34e-01 | -4.95e-02 | 9.81e-01 |
| GOMF BIOACTIVE LIPID RECEPTOR ACTIVITY | 7 | 8.21e-01 | -4.94e-02 | 9.80e-01 |
| GOBP AXON EXTENSION | 85 | 4.31e-01 | -4.94e-02 | 8.82e-01 |
| GOCC CLATHRIN ADAPTOR COMPLEX | 23 | 6.82e-01 | -4.94e-02 | 9.52e-01 |
| GOBP DEVELOPMENTAL INDUCTION | 12 | 7.67e-01 | -4.94e-02 | 9.70e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A RRNA | 22 | 6.89e-01 | 4.94e-02 | 9.54e-01 |
| GOBP MUSCLE CELL APOPTOTIC PROCESS | 50 | 5.46e-01 | 4.93e-02 | 9.25e-01 |
| GOCC PROTEASOME COMPLEX | 58 | 5.16e-01 | 4.93e-02 | 9.19e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 70 | 4.76e-01 | 4.93e-02 | 9.04e-01 |
| GOBP LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT | 14 | 7.50e-01 | -4.93e-02 | 9.67e-01 |
| GOCC AP 3 ADAPTOR COMPLEX | 9 | 7.98e-01 | 4.93e-02 | 9.77e-01 |
| GOBP CELLULAR RESPONSE TO NITROGEN STARVATION | 9 | 7.98e-01 | -4.92e-02 | 9.77e-01 |
| GOBP NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION | 8 | 8.10e-01 | 4.91e-02 | 9.80e-01 |
| GOBP GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS | 18 | 7.18e-01 | 4.91e-02 | 9.60e-01 |
| GOMF NADP RETINOL DEHYDROGENASE ACTIVITY | 10 | 7.88e-01 | 4.91e-02 | 9.76e-01 |
| GOCC PALMITOYLTRANSFERASE COMPLEX | 10 | 7.88e-01 | 4.91e-02 | 9.76e-01 |
| GOBP RRNA BASE METHYLATION | 8 | 8.10e-01 | 4.90e-02 | 9.80e-01 |
| GOBP INTRACILIARY TRANSPORT | 40 | 5.92e-01 | -4.90e-02 | 9.36e-01 |
| GOBP BILE ACID AND BILE SALT TRANSPORT | 11 | 7.78e-01 | -4.90e-02 | 9.75e-01 |
| GOCC MITOTIC SPINDLE ASTRAL MICROTUBULE | 7 | 8.22e-01 | 4.90e-02 | 9.80e-01 |
| GOBP LONG TERM SYNAPTIC POTENTIATION | 42 | 5.83e-01 | 4.90e-02 | 9.36e-01 |
| GOBP AMINE BIOSYNTHETIC PROCESS | 23 | 6.85e-01 | 4.89e-02 | 9.53e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE CHECKPOINT | 5 | 8.50e-01 | 4.89e-02 | 9.82e-01 |
| GOCC CALYX OF HELD | 10 | 7.89e-01 | -4.88e-02 | 9.76e-01 |
| GOMF UBIQUITIN PROTEIN TRANSFERASE ACTIVATOR ACTIVITY | 10 | 7.89e-01 | 4.88e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF SUPEROXIDE ANION GENERATION | 11 | 7.79e-01 | 4.88e-02 | 9.75e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 25 | 6.73e-01 | 4.88e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 23 | 6.86e-01 | -4.87e-02 | 9.54e-01 |
| GOCC LOW DENSITY LIPOPROTEIN PARTICLE | 10 | 7.90e-01 | -4.87e-02 | 9.76e-01 |
| GOBP CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS | 138 | 3.24e-01 | 4.87e-02 | 8.29e-01 |
| GOBP POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS | 62 | 5.08e-01 | 4.87e-02 | 9.18e-01 |
| GOBP GLUCOSE 6 PHOSPHATE METABOLIC PROCESS | 23 | 6.86e-01 | -4.86e-02 | 9.54e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 291 | 1.55e-01 | 4.86e-02 | 6.77e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE RECYCLING | 23 | 6.87e-01 | 4.86e-02 | 9.54e-01 |
| GOBP REGULATION OF TRANSLATION IN RESPONSE TO STRESS | 20 | 7.07e-01 | 4.86e-02 | 9.57e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 108 | 3.84e-01 | -4.85e-02 | 8.64e-01 |
| GOCC CELL TRAILING EDGE | 14 | 7.53e-01 | 4.85e-02 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF TOR SIGNALING | 62 | 5.10e-01 | 4.85e-02 | 9.18e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT | 18 | 7.22e-01 | 4.84e-02 | 9.62e-01 |
| GOBP REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 16 | 7.38e-01 | 4.84e-02 | 9.65e-01 |
| GOCC COPI VESICLE COAT | 13 | 7.63e-01 | -4.84e-02 | 9.70e-01 |
| GOBP CORTICAL ACTIN CYTOSKELETON ORGANIZATION | 40 | 5.97e-01 | -4.84e-02 | 9.36e-01 |
| GOBP RRNA TRANSPORT | 5 | 8.51e-01 | -4.84e-02 | 9.82e-01 |
| GOMF CALCIUM CHANNEL REGULATOR ACTIVITY | 23 | 6.88e-01 | -4.84e-02 | 9.54e-01 |
| GOBP REGULATION OF LEUKOCYTE TETHERING OR ROLLING | 7 | 8.25e-01 | 4.83e-02 | 9.80e-01 |
| GOMF UBIQUITINATION LIKE MODIFICATION DEPENDENT PROTEIN BINDING | 19 | 7.15e-01 | 4.83e-02 | 9.59e-01 |
| GOBP EMBRYONIC MORPHOGENESIS | 335 | 1.30e-01 | -4.83e-02 | 6.40e-01 |
| GOCC RUFFLE MEMBRANE | 84 | 4.45e-01 | -4.83e-02 | 8.87e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN | 10 | 7.92e-01 | -4.82e-02 | 9.76e-01 |
| GOBP FACE MORPHOGENESIS | 20 | 7.09e-01 | 4.82e-02 | 9.58e-01 |
| GOBP POSITIVE REGULATION OF RNA METABOLIC PROCESS | 1314 | 3.83e-03 | 4.82e-02 | 1.15e-01 |
| GOBP MISMATCH REPAIR | 26 | 6.71e-01 | -4.82e-02 | 9.49e-01 |
| GOBP COLLECTING DUCT DEVELOPMENT | 5 | 8.52e-01 | 4.82e-02 | 9.82e-01 |
| GOBP RECEPTOR MEDIATED ENDOCYTOSIS OF VIRUS BY HOST CELL | 8 | 8.14e-01 | 4.82e-02 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF GLUTAMATE SECRETION | 6 | 8.38e-01 | -4.81e-02 | 9.82e-01 |
| GOBP LIPID GLYCOSYLATION | 6 | 8.38e-01 | 4.81e-02 | 9.82e-01 |
| GOMF UBIQUITIN BINDING | 99 | 4.09e-01 | 4.81e-02 | 8.76e-01 |
| GOBP PIGMENT CELL DIFFERENTIATION | 23 | 6.90e-01 | -4.81e-02 | 9.54e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS | 20 | 7.10e-01 | 4.81e-02 | 9.59e-01 |
| GOBP POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION | 5 | 8.52e-01 | 4.80e-02 | 9.82e-01 |
| GOMF ADP BINDING | 32 | 6.38e-01 | -4.80e-02 | 9.41e-01 |
| GOBP REGULATION OF MRNA METABOLIC PROCESS | 246 | 1.96e-01 | 4.80e-02 | 7.27e-01 |
| GOBP CERAMIDE TRANSPORT | 13 | 7.64e-01 | -4.80e-02 | 9.70e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 26 | 6.72e-01 | 4.80e-02 | 9.49e-01 |
| GOBP LYMPH NODE DEVELOPMENT | 14 | 7.56e-01 | 4.80e-02 | 9.69e-01 |
| GOBP REGULATION OF MITOTIC CELL CYCLE | 410 | 9.72e-02 | 4.79e-02 | 5.77e-01 |
| GOBP POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM | 18 | 7.25e-01 | 4.79e-02 | 9.63e-01 |
| GOMF DIPEPTIDASE ACTIVITY | 11 | 7.83e-01 | 4.79e-02 | 9.75e-01 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 73 | 4.80e-01 | 4.79e-02 | 9.08e-01 |
| GOBP POSITIVE REGULATION OF GENE EXPRESSION | 780 | 2.41e-02 | 4.79e-02 | 3.20e-01 |
| GOBP REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 24 | 6.85e-01 | 4.78e-02 | 9.53e-01 |
| GOBP PROTEIN TARGETING | 292 | 1.61e-01 | -4.78e-02 | 6.87e-01 |
| GOMF DNA REPLICATION ORIGIN BINDING | 16 | 7.41e-01 | 4.78e-02 | 9.65e-01 |
| GOBP RESPONSE TO KETONE | 123 | 3.61e-01 | 4.78e-02 | 8.47e-01 |
| GOMF CCR5 CHEMOKINE RECEPTOR BINDING | 7 | 8.27e-01 | -4.77e-02 | 9.80e-01 |
| GOBP MESODERM MORPHOGENESIS | 36 | 6.20e-01 | -4.77e-02 | 9.37e-01 |
| GOCC VOLTAGE GATED CALCIUM CHANNEL COMPLEX | 21 | 7.05e-01 | 4.77e-02 | 9.57e-01 |
| GOBP POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 6 | 8.40e-01 | -4.77e-02 | 9.82e-01 |
| GOBP VESICLE TRANSPORT ALONG MICROTUBULE | 39 | 6.07e-01 | 4.77e-02 | 9.36e-01 |
| GOMF G PROTEIN COUPLED RECEPTOR ACTIVITY | 120 | 3.68e-01 | -4.77e-02 | 8.54e-01 |
| GOBP PEPTIDYL LYSINE METHYLATION | 47 | 5.72e-01 | 4.76e-02 | 9.31e-01 |
| GOCC APICAL JUNCTION COMPLEX | 92 | 4.31e-01 | 4.76e-02 | 8.82e-01 |
| GOBP PROTEIN MATURATION | 409 | 1.00e-01 | -4.76e-02 | 5.84e-01 |
| GOBP AMINOGLYCAN METABOLIC PROCESS | 78 | 4.68e-01 | -4.76e-02 | 9.00e-01 |
| GOBP PHOSPHOLIPID BIOSYNTHETIC PROCESS | 215 | 2.31e-01 | 4.75e-02 | 7.58e-01 |
| GOBP REGULATION OF RESPONSE TO WOUNDING | 100 | 4.12e-01 | -4.75e-02 | 8.77e-01 |
| GOMF NAADP SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 5 | 8.54e-01 | 4.75e-02 | 9.82e-01 |
| GOBP PURINE NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS | 5 | 8.54e-01 | 4.74e-02 | 9.82e-01 |
| GOBP PEPTIDYL LYSINE MODIFICATION | 187 | 2.64e-01 | 4.74e-02 | 7.89e-01 |
| GOBP SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 148 | 3.20e-01 | -4.74e-02 | 8.27e-01 |
| GOCC REPLISOME | 14 | 7.59e-01 | -4.74e-02 | 9.69e-01 |
| GOBP TISSUE MIGRATION | 200 | 2.49e-01 | 4.74e-02 | 7.76e-01 |
| GOBP DENDRITIC SPINE MORPHOGENESIS | 38 | 6.14e-01 | 4.73e-02 | 9.36e-01 |
| GOCC NUCLEAR SPECK | 365 | 1.22e-01 | 4.73e-02 | 6.25e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE PROCESS | 259 | 1.91e-01 | 4.73e-02 | 7.21e-01 |
| GOBP PROTEIN DNA COMPLEX ORGANIZATION | 694 | 3.51e-02 | 4.73e-02 | 3.81e-01 |
| GOCC MOTILE CILIUM | 146 | 3.26e-01 | -4.72e-02 | 8.29e-01 |
| GOBP DNA REPLICATION INITIATION | 34 | 6.34e-01 | -4.72e-02 | 9.41e-01 |
| GOBP LYMPH VESSEL MORPHOGENESIS | 11 | 7.87e-01 | 4.71e-02 | 9.76e-01 |
| GOCC SEC61 TRANSLOCON COMPLEX | 5 | 8.55e-01 | -4.71e-02 | 9.82e-01 |
| GOBP DNA DEALKYLATION | 29 | 6.61e-01 | 4.71e-02 | 9.49e-01 |
| GOBP NEURAL CREST FORMATION | 8 | 8.18e-01 | -4.71e-02 | 9.80e-01 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 41 | 6.02e-01 | -4.71e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 39 | 6.11e-01 | 4.70e-02 | 9.36e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL SURFACE | 47 | 5.77e-01 | 4.70e-02 | 9.33e-01 |
| GOBP XENOBIOTIC TRANSMEMBRANE TRANSPORT | 13 | 7.70e-01 | 4.69e-02 | 9.70e-01 |
| GOMF PURINE NUCLEOTIDE BINDING | 1548 | 2.46e-03 | 4.69e-02 | 8.39e-02 |
| GOBP NEPHRON EPITHELIUM DEVELOPMENT | 50 | 5.67e-01 | 4.69e-02 | 9.29e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 9 | 8.08e-01 | 4.69e-02 | 9.80e-01 |
| GOBP SEX DIFFERENTIATION | 153 | 3.18e-01 | 4.69e-02 | 8.23e-01 |
| GOBP TESTOSTERONE BIOSYNTHETIC PROCESS | 6 | 8.43e-01 | -4.68e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 6 | 8.43e-01 | 4.68e-02 | 9.82e-01 |
| GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING | 18 | 7.31e-01 | 4.68e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF CATABOLIC PROCESS | 448 | 9.13e-02 | 4.68e-02 | 5.63e-01 |
| GOBP RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM | 49 | 5.71e-01 | 4.67e-02 | 9.31e-01 |
| GOCC VARICOSITY | 5 | 8.56e-01 | -4.67e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF VASCULOGENESIS | 6 | 8.43e-01 | -4.67e-02 | 9.82e-01 |
| GOBP CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 18 | 7.32e-01 | 4.67e-02 | 9.64e-01 |
| GOBP RESPIRATORY BURST | 30 | 6.58e-01 | -4.67e-02 | 9.48e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY | 12 | 7.80e-01 | 4.67e-02 | 9.75e-01 |
| GOBP REGULATION OF MAP KINASE ACTIVITY | 98 | 4.26e-01 | 4.66e-02 | 8.81e-01 |
| GOBP PROTEIN GERANYLGERANYLATION | 6 | 8.43e-01 | -4.66e-02 | 9.82e-01 |
| GOBP REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 29 | 6.64e-01 | 4.66e-02 | 9.49e-01 |
| GOBP TERPENOID BIOSYNTHETIC PROCESS | 11 | 7.89e-01 | -4.66e-02 | 9.76e-01 |
| GOBP PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS | 9 | 8.09e-01 | 4.65e-02 | 9.80e-01 |
| GOCC TIM22 MITOCHONDRIAL IMPORT INNER MEMBRANE INSERTION COMPLEX | 7 | 8.31e-01 | 4.65e-02 | 9.80e-01 |
| GOBP NEGATIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION | 8 | 8.20e-01 | 4.65e-02 | 9.80e-01 |
| GOBP NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION | 17 | 7.40e-01 | -4.65e-02 | 9.65e-01 |
| GOMF SH3 DOMAIN BINDING | 93 | 4.39e-01 | 4.65e-02 | 8.85e-01 |
| GOBP PROTEIN AUTOUBIQUITINATION | 60 | 5.34e-01 | 4.64e-02 | 9.23e-01 |
| GOBP VASCULAR WOUND HEALING | 10 | 7.99e-01 | 4.64e-02 | 9.77e-01 |
| GOBP RESPONSE TO PEPTIDE | 345 | 1.40e-01 | 4.64e-02 | 6.61e-01 |
| GOBP POSITIVE REGULATION OF SECRETION | 183 | 2.80e-01 | 4.64e-02 | 7.99e-01 |
| GOMF POTASSIUM CHLORIDE SYMPORTER ACTIVITY | 7 | 8.32e-01 | 4.64e-02 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO STRESS | 7 | 8.32e-01 | 4.63e-02 | 9.80e-01 |
| GOBP EPITHELIAL CELL DEVELOPMENT | 133 | 3.57e-01 | 4.63e-02 | 8.46e-01 |
| GOMF PROTEOGLYCAN BINDING | 17 | 7.41e-01 | 4.63e-02 | 9.65e-01 |
| GOBP KERATINOCYTE PROLIFERATION | 26 | 6.83e-01 | -4.63e-02 | 9.53e-01 |
| GOBP EMBRYONIC CAMERA TYPE EYE DEVELOPMENT | 19 | 7.27e-01 | -4.62e-02 | 9.63e-01 |
| GOBP HYPERSENSITIVITY | 10 | 8.00e-01 | -4.62e-02 | 9.77e-01 |
| GOBP NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 86 | 4.59e-01 | -4.62e-02 | 8.96e-01 |
| GOBP ACUTE PHASE RESPONSE | 20 | 7.21e-01 | 4.62e-02 | 9.61e-01 |
| GOBP ENDOCARDIUM DEVELOPMENT | 8 | 8.21e-01 | 4.62e-02 | 9.80e-01 |
| GOBP DNA METHYLATION | 40 | 6.14e-01 | -4.62e-02 | 9.36e-01 |
| GOBP POINTED END ACTIN FILAMENT CAPPING | 5 | 8.58e-01 | -4.62e-02 | 9.82e-01 |
| GOBP GLYCERALDEHYDE 3 PHOSPHATE METABOLIC PROCESS | 5 | 8.58e-01 | 4.61e-02 | 9.82e-01 |
| GOMF SINGLE STRANDED DNA BINDING | 110 | 4.04e-01 | -4.61e-02 | 8.72e-01 |
| GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS | 8 | 8.21e-01 | -4.61e-02 | 9.80e-01 |
| GOBP TRYPTOPHAN CATABOLIC PROCESS | 6 | 8.45e-01 | -4.61e-02 | 9.82e-01 |
| GOBP GLYCEROL ETHER METABOLIC PROCESS | 17 | 7.42e-01 | -4.61e-02 | 9.65e-01 |
| GOBP REGULATION OF MACROPHAGE DIFFERENTIATION | 17 | 7.42e-01 | -4.61e-02 | 9.65e-01 |
| GOCC SIGNAL RECOGNITION PARTICLE | 7 | 8.33e-01 | -4.61e-02 | 9.80e-01 |
| GOBP ACTIN MYOSIN FILAMENT SLIDING | 5 | 8.58e-01 | -4.61e-02 | 9.82e-01 |
| GOCC ESCRT COMPLEX | 26 | 6.85e-01 | 4.60e-02 | 9.53e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 9 | 8.11e-01 | -4.60e-02 | 9.80e-01 |
| GOBP NEGATIVE REGULATION OF LOCOMOTION | 216 | 2.45e-01 | 4.60e-02 | 7.73e-01 |
| GOBP MUSCLE STRUCTURE DEVELOPMENT | 410 | 1.12e-01 | 4.60e-02 | 6.05e-01 |
| GOBP PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS | 9 | 8.11e-01 | 4.60e-02 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF ENDOCYTIC RECYCLING | 5 | 8.59e-01 | -4.59e-02 | 9.82e-01 |
| GOMF PHOSPHATIDYLETHANOLAMINE FLIPPASE ACTIVITY | 5 | 8.59e-01 | 4.59e-02 | 9.82e-01 |
| GOBP REGULATION OF CELL JUNCTION ASSEMBLY | 123 | 3.80e-01 | 4.59e-02 | 8.62e-01 |
| GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE II PROMOTER | 91 | 4.50e-01 | 4.59e-02 | 8.89e-01 |
| GOCC CASPASE COMPLEX | 9 | 8.12e-01 | -4.58e-02 | 9.80e-01 |
| GOBP CYTOPLASMIC SEQUESTERING OF PROTEIN | 19 | 7.30e-01 | 4.58e-02 | 9.64e-01 |
| GOBP ORGAN GROWTH | 94 | 4.44e-01 | -4.58e-02 | 8.87e-01 |
| GOMF G PROTEIN BETA GAMMA SUBUNIT COMPLEX BINDING | 13 | 7.75e-01 | 4.58e-02 | 9.73e-01 |
| GOBP ORGANOPHOSPHATE CATABOLIC PROCESS | 112 | 4.03e-01 | 4.58e-02 | 8.72e-01 |
| GOBP ENTEROENDOCRINE CELL DIFFERENTIATION | 16 | 7.51e-01 | 4.57e-02 | 9.68e-01 |
| GOBP NEGATIVE REGULATION OF HEMOPOIESIS | 73 | 5.00e-01 | 4.57e-02 | 9.14e-01 |
| GOBP GLYCOPROTEIN CATABOLIC PROCESS | 26 | 6.87e-01 | 4.57e-02 | 9.54e-01 |
| GOBP PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 37 | 6.31e-01 | -4.57e-02 | 9.40e-01 |
| GOMF FERRIC IRON BINDING | 5 | 8.60e-01 | -4.57e-02 | 9.82e-01 |
| GOBP REGULATION OF MEIOTIC CELL CYCLE | 43 | 6.05e-01 | 4.57e-02 | 9.36e-01 |
| GOBP CALCIUM ION TRANSPORT | 254 | 2.11e-01 | 4.57e-02 | 7.44e-01 |
| GOBP CYTOSOLIC TRANSPORT | 168 | 3.08e-01 | -4.56e-02 | 8.19e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 29 | 6.71e-01 | 4.56e-02 | 9.49e-01 |
| GOCC PHOTORECEPTOR CONNECTING CILIUM | 30 | 6.66e-01 | -4.56e-02 | 9.49e-01 |
| GOBP SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 40 | 6.18e-01 | 4.56e-02 | 9.37e-01 |
| GOBP RESPONSE TO TYPE II INTERFERON | 101 | 4.29e-01 | 4.56e-02 | 8.82e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 17 | 7.45e-01 | 4.56e-02 | 9.66e-01 |
| GOCC DISTAL AXON | 173 | 3.02e-01 | 4.55e-02 | 8.14e-01 |
| GOCC SECRETORY VESICLE | 710 | 4.02e-02 | -4.55e-02 | 4.10e-01 |
| GOBP PEPTIDYL TYROSINE AUTOPHOSPHORYLATION | 10 | 8.03e-01 | 4.55e-02 | 9.79e-01 |
| GOBP SKIN EPIDERMIS DEVELOPMENT | 61 | 5.39e-01 | 4.55e-02 | 9.23e-01 |
| GOBP CATECHOLAMINE SECRETION | 21 | 7.18e-01 | 4.55e-02 | 9.60e-01 |
| GOMF HEAT SHOCK PROTEIN BINDING | 107 | 4.17e-01 | 4.54e-02 | 8.79e-01 |
| GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 42 | 6.11e-01 | 4.54e-02 | 9.36e-01 |
| GOBP NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS | 50 | 5.79e-01 | -4.54e-02 | 9.34e-01 |
| GOBP SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 75 | 4.97e-01 | -4.54e-02 | 9.13e-01 |
| GOMF PROTEIN GERANYLGERANYLTRANSFERASE ACTIVITY | 5 | 8.61e-01 | 4.53e-02 | 9.83e-01 |
| GOMF SINGLE STRANDED DNA ENDODEOXYRIBONUCLEASE ACTIVITY | 10 | 8.04e-01 | -4.53e-02 | 9.79e-01 |
| GOMF PHOSPHATASE BINDING | 156 | 3.30e-01 | 4.53e-02 | 8.30e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 52 | 5.72e-01 | -4.53e-02 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF RRNA PROCESSING | 10 | 8.04e-01 | 4.53e-02 | 9.79e-01 |
| GOBP POSITIVE REGULATION OF CELL DIFFERENTIATION | 548 | 7.16e-02 | 4.53e-02 | 5.17e-01 |
| GOBP EPITHELIAL CELL PROLIFERATION | 249 | 2.20e-01 | 4.53e-02 | 7.49e-01 |
| GOCC CILIARY PLASM | 89 | 4.61e-01 | -4.52e-02 | 8.97e-01 |
| GOBP REGULATION OF PEPTIDE TRANSPORT | 106 | 4.22e-01 | 4.52e-02 | 8.81e-01 |
| GOBP MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL | 12 | 7.87e-01 | 4.51e-02 | 9.76e-01 |
| GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION | 193 | 2.81e-01 | 4.51e-02 | 7.99e-01 |
| GOBP POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION | 9 | 8.15e-01 | 4.51e-02 | 9.80e-01 |
| GOMF CARBOHYDRATE DERIVATIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 46 | 5.97e-01 | -4.51e-02 | 9.36e-01 |
| GOBP REGULATION OF STEM CELL DIVISION | 7 | 8.37e-01 | -4.50e-02 | 9.81e-01 |
| GOBP AUTOPHAGOSOME LYSOSOME FUSION | 9 | 8.15e-01 | -4.50e-02 | 9.80e-01 |
| GOBP MATERNAL PLACENTA DEVELOPMENT | 25 | 6.97e-01 | 4.50e-02 | 9.55e-01 |
| GOBP TRANSMEMBRANE TRANSPORT | 901 | 2.34e-02 | -4.49e-02 | 3.16e-01 |
| GOBP POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION | 13 | 7.79e-01 | 4.49e-02 | 9.75e-01 |
| GOCC GLYCOSYLPHOSPHATIDYLINOSITOL N ACETYLGLUCOSAMINYLTRANSFERASE GPI GNT COMPLEX | 6 | 8.49e-01 | -4.49e-02 | 9.82e-01 |
| GOMF INOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY | 11 | 7.97e-01 | 4.49e-02 | 9.77e-01 |
| GOBP SEQUESTERING OF ACTIN MONOMERS | 8 | 8.26e-01 | -4.49e-02 | 9.80e-01 |
| GOMF C2H2 ZINC FINGER DOMAIN BINDING | 8 | 8.26e-01 | -4.49e-02 | 9.80e-01 |
| GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 14 | 7.72e-01 | -4.48e-02 | 9.71e-01 |
| GOMF PROTEIN MEMBRANE ADAPTOR ACTIVITY | 28 | 6.82e-01 | -4.48e-02 | 9.52e-01 |
| GOBP REGULATION OF ORGANIC ACID TRANSPORT | 41 | 6.20e-01 | 4.48e-02 | 9.37e-01 |
| GOMF SNRNA BINDING | 45 | 6.04e-01 | 4.48e-02 | 9.36e-01 |
| GOBP REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 22 | 7.16e-01 | -4.47e-02 | 9.59e-01 |
| GOBP NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS | 31 | 6.67e-01 | -4.47e-02 | 9.49e-01 |
| GOBP CELL CELL JUNCTION ASSEMBLY | 85 | 4.77e-01 | 4.47e-02 | 9.05e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON ESTER BONDS | 554 | 7.40e-02 | 4.47e-02 | 5.24e-01 |
| GOBP FIBROBLAST MIGRATION | 43 | 6.13e-01 | 4.47e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II | 838 | 2.96e-02 | 4.46e-02 | 3.49e-01 |
| GOCC CLATHRIN COAT | 40 | 6.25e-01 | -4.46e-02 | 9.40e-01 |
| GOBP REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION | 134 | 3.73e-01 | 4.46e-02 | 8.59e-01 |
| GOBP TUBE MORPHOGENESIS | 510 | 8.66e-02 | -4.46e-02 | 5.55e-01 |
| GOBP ACTIVATION OF ADENYLATE CYCLASE ACTIVITY | 9 | 8.17e-01 | -4.46e-02 | 9.80e-01 |
| GOBP SPINAL CORD PATTERNING | 7 | 8.38e-01 | -4.45e-02 | 9.82e-01 |
| GOBP KYNURENINE METABOLIC PROCESS | 8 | 8.27e-01 | -4.45e-02 | 9.80e-01 |
| GOBP MALE MEIOTIC NUCLEAR DIVISION | 28 | 6.84e-01 | -4.45e-02 | 9.53e-01 |
| GOBP SPLICEOSOMAL COMPLEX ASSEMBLY | 70 | 5.20e-01 | 4.45e-02 | 9.19e-01 |
| GOCC OMEGASOME | 5 | 8.63e-01 | 4.44e-02 | 9.83e-01 |
| GOBP BLASTODERM SEGMENTATION | 11 | 7.99e-01 | 4.44e-02 | 9.77e-01 |
| GOMF NAD P H OXIDASE H2O2 FORMING ACTIVITY | 7 | 8.39e-01 | -4.44e-02 | 9.82e-01 |
| GOCC T CELL RECEPTOR COMPLEX | 6 | 8.51e-01 | -4.44e-02 | 9.82e-01 |
| GOBP PROTEIN LOCALIZATION TO CYTOSKELETON | 57 | 5.63e-01 | 4.43e-02 | 9.29e-01 |
| GOBP GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS | 15 | 7.66e-01 | -4.43e-02 | 9.70e-01 |
| GOBP NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 9 | 8.18e-01 | 4.43e-02 | 9.80e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 166 | 3.26e-01 | 4.43e-02 | 8.29e-01 |
| GOBP EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS | 37 | 6.41e-01 | -4.43e-02 | 9.42e-01 |
| GOBP I KAPPAB PHOSPHORYLATION | 13 | 7.82e-01 | 4.42e-02 | 9.75e-01 |
| GOBP CHROMATIN REMODELING | 496 | 9.35e-02 | 4.42e-02 | 5.67e-01 |
| GOCC U12 TYPE SPLICEOSOMAL COMPLEX | 26 | 6.97e-01 | 4.42e-02 | 9.55e-01 |
| GOBP REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY | 13 | 7.83e-01 | 4.42e-02 | 9.75e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 115 | 4.14e-01 | -4.42e-02 | 8.77e-01 |
| GOBP LIPID STORAGE | 69 | 5.26e-01 | 4.41e-02 | 9.22e-01 |
| GOCC AP 2 ADAPTOR COMPLEX | 7 | 8.40e-01 | 4.41e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEACETYLATION | 10 | 8.09e-01 | 4.41e-02 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR | 82 | 4.90e-01 | 4.41e-02 | 9.12e-01 |
| GOBP REGULATION OF POSTSYNAPSE ORGANIZATION | 68 | 5.30e-01 | 4.41e-02 | 9.23e-01 |
| GOBP POSITIVE REGULATION OF TORC2 SIGNALING | 5 | 8.65e-01 | 4.41e-02 | 9.83e-01 |
| GOBP UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 33 | 6.62e-01 | -4.40e-02 | 9.49e-01 |
| GOBP INNER CELL MASS CELL DIFFERENTIATION | 5 | 8.65e-01 | 4.40e-02 | 9.83e-01 |
| GOBP APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS | 15 | 7.68e-01 | 4.40e-02 | 9.70e-01 |
| GOBP REGULATION OF SYSTEM PROCESS | 275 | 2.11e-01 | 4.40e-02 | 7.44e-01 |
| GOMF DNA DIRECTED DNA POLYMERASE ACTIVITY | 23 | 7.15e-01 | 4.40e-02 | 9.59e-01 |
| GOBP REGULATION OF CELLULAR KETONE METABOLIC PROCESS | 89 | 4.74e-01 | 4.40e-02 | 9.02e-01 |
| GOBP MOTOR BEHAVIOR | 17 | 7.54e-01 | 4.40e-02 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR BINDING | 5 | 8.65e-01 | 4.39e-02 | 9.83e-01 |
| GOMF DNA BINDING TRANSCRIPTION ACTIVATOR ACTIVITY | 267 | 2.18e-01 | 4.39e-02 | 7.49e-01 |
| GOBP LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE | 9 | 8.20e-01 | -4.39e-02 | 9.80e-01 |
| GOBP CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE | 41 | 6.27e-01 | 4.39e-02 | 9.40e-01 |
| GOMF NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY | 402 | 1.33e-01 | 4.39e-02 | 6.46e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE CONTRACTION | 8 | 8.30e-01 | -4.38e-02 | 9.80e-01 |
| GOBP ENAMEL MINERALIZATION | 10 | 8.11e-01 | -4.38e-02 | 9.80e-01 |
| GOCC NUCLEAR CHROMOSOME | 192 | 2.97e-01 | -4.38e-02 | 8.11e-01 |
| GOBP POST EMBRYONIC ANIMAL MORPHOGENESIS | 12 | 7.93e-01 | 4.38e-02 | 9.77e-01 |
| GOBP TRANSITION METAL ION TRANSPORT | 69 | 5.30e-01 | -4.37e-02 | 9.23e-01 |
| GOCC GOLGI CISTERNA MEMBRANE | 60 | 5.58e-01 | 4.37e-02 | 9.27e-01 |
| GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY | 5 | 8.66e-01 | 4.37e-02 | 9.84e-01 |
| GOBP SENSORY PERCEPTION | 251 | 2.34e-01 | 4.37e-02 | 7.63e-01 |
| GOBP NEUROMUSCULAR SYNAPTIC TRANSMISSION | 15 | 7.69e-01 | -4.37e-02 | 9.70e-01 |
| GOCC NUCLEAR BODY | 729 | 4.61e-02 | 4.37e-02 | 4.35e-01 |
| GOBP T CELL HOMEOSTASIS | 36 | 6.50e-01 | 4.37e-02 | 9.44e-01 |
| GOBP CEREBRAL CORTEX DEVELOPMENT | 84 | 4.89e-01 | 4.37e-02 | 9.12e-01 |
| GOBP VESICLE COATING | 38 | 6.42e-01 | 4.37e-02 | 9.42e-01 |
| GOBP INORGANIC ANION TRANSMEMBRANE TRANSPORT | 62 | 5.53e-01 | -4.36e-02 | 9.26e-01 |
| GOCC MICROBODY LUMEN | 41 | 6.29e-01 | 4.36e-02 | 9.40e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SECRETION | 39 | 6.38e-01 | 4.36e-02 | 9.41e-01 |
| GOBP HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 29 | 6.85e-01 | 4.35e-02 | 9.53e-01 |
| GOMF K48 LINKED DEUBIQUITINASE ACTIVITY | 16 | 7.63e-01 | -4.35e-02 | 9.70e-01 |
| GOBP MUSCLE CELL DIFFERENTIATION | 238 | 2.49e-01 | 4.35e-02 | 7.76e-01 |
| GOCC MEMBRANE MICRODOMAIN | 195 | 2.97e-01 | 4.34e-02 | 8.11e-01 |
| GOMF PEPTIDE LYSINE N ACETYLTRANSFERASE ACTIVITY | 44 | 6.19e-01 | -4.34e-02 | 9.37e-01 |
| GOBP CARDIAC CELL DEVELOPMENT | 51 | 5.92e-01 | 4.34e-02 | 9.36e-01 |
| GOBP ENDOPLASMIC RETICULUM ORGANIZATION | 88 | 4.82e-01 | 4.34e-02 | 9.08e-01 |
| GOBP CARDIAC MUSCLE CELL PROLIFERATION | 24 | 7.13e-01 | 4.34e-02 | 9.59e-01 |
| GOBP SUPEROXIDE ANION GENERATION | 23 | 7.19e-01 | 4.33e-02 | 9.60e-01 |
| GOMF POLYAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 8.43e-01 | 4.33e-02 | 9.82e-01 |
| GOCC DIHYDROLIPOYL DEHYDROGENASE COMPLEX | 8 | 8.32e-01 | -4.33e-02 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF JUN KINASE ACTIVITY | 25 | 7.08e-01 | 4.33e-02 | 9.58e-01 |
| GOBP MICROTUBULE DEPOLYMERIZATION | 36 | 6.53e-01 | -4.33e-02 | 9.46e-01 |
| GOBP POSITIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 13 | 7.87e-01 | -4.32e-02 | 9.76e-01 |
| GOCC I BAND | 87 | 4.86e-01 | 4.32e-02 | 9.11e-01 |
| GOBP MITOTIC CYTOKINETIC PROCESS | 25 | 7.08e-01 | 4.32e-02 | 9.58e-01 |
| GOBP CHROMOSOME ORGANIZATION | 521 | 9.34e-02 | 4.32e-02 | 5.67e-01 |
| GOBP REGULATION OF LEUKOCYTE MIGRATION | 149 | 3.65e-01 | 4.31e-02 | 8.50e-01 |
| GOBP POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 11 | 8.05e-01 | -4.31e-02 | 9.79e-01 |
| GOBP B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 69 | 5.36e-01 | 4.31e-02 | 9.23e-01 |
| GOBP REGULATION OF CHONDROCYTE DIFFERENTIATION | 22 | 7.27e-01 | 4.30e-02 | 9.63e-01 |
| GOBP MITOCHONDRIAL RNA PROCESSING | 21 | 7.33e-01 | 4.30e-02 | 9.64e-01 |
| GOBP G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY | 15 | 7.73e-01 | 4.30e-02 | 9.72e-01 |
| GOBP MEMBRANE DEPOLARIZATION | 44 | 6.22e-01 | 4.30e-02 | 9.39e-01 |
| GOBP GPI ANCHOR METABOLIC PROCESS | 29 | 6.89e-01 | -4.29e-02 | 9.54e-01 |
| GOBP CELLULAR RESPONSE TO BIOTIC STIMULUS | 184 | 3.16e-01 | 4.29e-02 | 8.23e-01 |
| GOBP POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 54 | 5.86e-01 | -4.29e-02 | 9.36e-01 |
| GOBP EPITHELIAL TO MESENCHYMAL TRANSITION | 102 | 4.55e-01 | 4.28e-02 | 8.93e-01 |
| GOBP REGULATION OF T CELL MIGRATION | 34 | 6.66e-01 | 4.28e-02 | 9.49e-01 |
| GOBP PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS | 29 | 6.90e-01 | -4.28e-02 | 9.54e-01 |
| GOBP REGULATION OF PROTEIN ACETYLATION | 33 | 6.70e-01 | 4.28e-02 | 9.49e-01 |
| GOBP INTRACELLULAR OXYGEN HOMEOSTASIS | 6 | 8.56e-01 | 4.28e-02 | 9.82e-01 |
| GOBP REGULATION OF OVARIAN FOLLICLE DEVELOPMENT | 5 | 8.68e-01 | -4.28e-02 | 9.85e-01 |
| GOMF GDP BINDING | 60 | 5.67e-01 | -4.28e-02 | 9.30e-01 |
| GOBP CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES | 116 | 4.27e-01 | -4.27e-02 | 8.82e-01 |
| GOBP GLANDULAR EPITHELIAL CELL DEVELOPMENT | 19 | 7.47e-01 | -4.27e-02 | 9.66e-01 |
| GOBP REGULATION OF VOLTAGE GATED SODIUM CHANNEL ACTIVITY | 6 | 8.56e-01 | 4.27e-02 | 9.82e-01 |
| GOBP REGULATION OF PROTEIN SECRETION | 159 | 3.54e-01 | 4.27e-02 | 8.46e-01 |
| GOBP DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS | 59 | 5.71e-01 | -4.27e-02 | 9.31e-01 |
| GOBP RESPONSE TO HYPEROXIA | 15 | 7.75e-01 | -4.27e-02 | 9.73e-01 |
| GOBP EPITHELIAL CELL CELL ADHESION | 12 | 7.98e-01 | -4.27e-02 | 9.77e-01 |
| GOBP REGULATION OF CHROMATIN ORGANIZATION | 45 | 6.21e-01 | 4.26e-02 | 9.38e-01 |
| GOCC NEURON TO NEURON SYNAPSE | 227 | 2.70e-01 | -4.26e-02 | 7.93e-01 |
| GOBP MONOATOMIC CATION TRANSMEMBRANE TRANSPORT | 483 | 1.11e-01 | -4.26e-02 | 6.03e-01 |
| GOBP CELL DIVISION | 527 | 9.63e-02 | 4.26e-02 | 5.76e-01 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY | 10 | 8.16e-01 | 4.26e-02 | 9.80e-01 |
| GOMF PALMITOYL COA HYDROLASE ACTIVITY | 13 | 7.91e-01 | 4.26e-02 | 9.76e-01 |
| GOBP REGULATION OF PLATELET ACTIVATION | 30 | 6.87e-01 | 4.25e-02 | 9.54e-01 |
| GOBP EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 435 | 1.30e-01 | -4.25e-02 | 6.40e-01 |
| GOCC CUL3 RING UBIQUITIN LIGASE COMPLEX | 34 | 6.68e-01 | -4.25e-02 | 9.49e-01 |
| GOBP HISTONE DEACETYLATION | 22 | 7.30e-01 | 4.25e-02 | 9.64e-01 |
| GOBP POSITIVE REGULATION OF AMYLOID BETA FORMATION | 14 | 7.83e-01 | -4.25e-02 | 9.75e-01 |
| GOBP CHAPERONE MEDIATED PROTEIN FOLDING | 67 | 5.48e-01 | -4.25e-02 | 9.25e-01 |
| GOCC MITOCHONDRIA ASSOCIATED ENDOPLASMIC RETICULUM MEMBRANE | 19 | 7.49e-01 | 4.25e-02 | 9.66e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON DNA | 223 | 2.76e-01 | -4.25e-02 | 7.97e-01 |
| GOBP REGULATION OF OSTEOCLAST DEVELOPMENT | 7 | 8.46e-01 | -4.24e-02 | 9.82e-01 |
| GOBP MRNA METABOLIC PROCESS | 641 | 6.92e-02 | 4.23e-02 | 5.13e-01 |
| GOMF PEPTIDE RECEPTOR ACTIVITY | 28 | 6.98e-01 | 4.23e-02 | 9.55e-01 |
| GOCC CYTOPLASMIC UBIQUITIN LIGASE COMPLEX | 12 | 8.00e-01 | -4.23e-02 | 9.77e-01 |
| GOBP VIRAL TRANSCRIPTION | 46 | 6.20e-01 | -4.23e-02 | 9.37e-01 |
| GOMF TAT PROTEIN BINDING | 9 | 8.26e-01 | -4.23e-02 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 63 | 5.62e-01 | 4.23e-02 | 9.29e-01 |
| GOBP REPLICATION BORN DOUBLE STRAND BREAK REPAIR VIA SISTER CHROMATID EXCHANGE | 6 | 8.58e-01 | 4.23e-02 | 9.82e-01 |
| GOCC LATERAL PLASMA MEMBRANE | 44 | 6.28e-01 | 4.22e-02 | 9.40e-01 |
| GOMF XENOBIOTIC TRANSMEMBRANE TRANSPORTER ACTIVITY | 23 | 7.26e-01 | -4.22e-02 | 9.63e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN NUCLEATION | 6 | 8.58e-01 | 4.22e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 7 | 8.47e-01 | 4.22e-02 | 9.82e-01 |
| GOBP RESPONSE TO CYTOKINE | 637 | 7.13e-02 | 4.22e-02 | 5.17e-01 |
| GOBP REGULATION OF TERMINATION OF DNA TEMPLATED TRANSCRIPTION | 5 | 8.70e-01 | 4.21e-02 | 9.85e-01 |
| GOBP REGULATION OF POLYSACCHARIDE BIOSYNTHETIC PROCESS | 25 | 7.15e-01 | -4.21e-02 | 9.59e-01 |
| GOBP RESPONSE TO HEAT | 78 | 5.20e-01 | 4.21e-02 | 9.19e-01 |
| GOCC IKAPPAB KINASE COMPLEX | 6 | 8.58e-01 | 4.21e-02 | 9.82e-01 |
| GOBP REPLICATIVE SENESCENCE | 13 | 7.93e-01 | 4.21e-02 | 9.77e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 16 | 7.71e-01 | 4.21e-02 | 9.71e-01 |
| GOBP NEGATIVE REGULATION OF HORMONE METABOLIC PROCESS | 8 | 8.37e-01 | -4.21e-02 | 9.81e-01 |
| GOBP VISUAL BEHAVIOR | 33 | 6.76e-01 | -4.20e-02 | 9.51e-01 |
| GOBP TAXIS | 270 | 2.36e-01 | -4.20e-02 | 7.65e-01 |
| GOMF PHOSPHORIC DIESTER HYDROLASE ACTIVITY | 58 | 5.80e-01 | 4.20e-02 | 9.35e-01 |
| GOMF METALLOENDOPEPTIDASE ACTIVITY | 53 | 5.97e-01 | -4.20e-02 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CONTRACTION | 6 | 8.59e-01 | -4.20e-02 | 9.82e-01 |
| GOBP CELLULAR RESPONSE TO HORMONE STIMULUS | 403 | 1.50e-01 | 4.20e-02 | 6.73e-01 |
| GOBP MUSCLE ORGAN MORPHOGENESIS | 33 | 6.77e-01 | -4.20e-02 | 9.51e-01 |
| GOBP ANTRAL OVARIAN FOLLICLE GROWTH | 6 | 8.59e-01 | 4.20e-02 | 9.82e-01 |
| GOBP REGULATION OF WOUND HEALING | 73 | 5.36e-01 | -4.19e-02 | 9.23e-01 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 836 | 4.13e-02 | 4.19e-02 | 4.14e-01 |
| GOBP REGULATION OF EPITHELIAL CELL PROLIFERATION | 207 | 3.00e-01 | 4.19e-02 | 8.14e-01 |
| GOBP BLOOD VESSEL MATURATION | 6 | 8.59e-01 | -4.19e-02 | 9.82e-01 |
| GOBP CARNITINE METABOLIC PROCESS | 9 | 8.28e-01 | -4.19e-02 | 9.80e-01 |
| GOMF CADHERIN BINDING | 272 | 2.36e-01 | -4.18e-02 | 7.65e-01 |
| GOCC ATAC COMPLEX | 13 | 7.94e-01 | -4.18e-02 | 9.77e-01 |
| GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION | 19 | 7.52e-01 | -4.18e-02 | 9.68e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION ELONGATION | 127 | 4.17e-01 | 4.18e-02 | 8.79e-01 |
| GOBP POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING | 15 | 7.79e-01 | -4.18e-02 | 9.75e-01 |
| GOBP RECOMBINATIONAL REPAIR | 165 | 3.55e-01 | -4.18e-02 | 8.46e-01 |
| GOCC SYNAPTIC VESICLE MEMBRANE | 68 | 5.52e-01 | -4.18e-02 | 9.26e-01 |
| GOCC SECONDARY LYSOSOME | 16 | 7.73e-01 | -4.17e-02 | 9.72e-01 |
| GOMF METALLOENDOPEPTIDASE INHIBITOR ACTIVITY | 7 | 8.49e-01 | 4.17e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 19 | 7.54e-01 | 4.16e-02 | 9.68e-01 |
| GOBP MESENCHYMAL CELL PROLIFERATION | 19 | 7.54e-01 | -4.16e-02 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS | 40 | 6.49e-01 | 4.16e-02 | 9.44e-01 |
| GOBP NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION | 120 | 4.33e-01 | -4.15e-02 | 8.82e-01 |
| GOMF MOLECULAR FUNCTION INHIBITOR ACTIVITY | 300 | 2.17e-01 | -4.15e-02 | 7.49e-01 |
| GOCC FEMALE PRONUCLEUS | 9 | 8.29e-01 | -4.15e-02 | 9.80e-01 |
| GOBP MONOATOMIC ANION TRANSPORT | 83 | 5.14e-01 | -4.15e-02 | 9.18e-01 |
| GOBP POSITIVE REGULATION OF CYTOKINESIS | 34 | 6.75e-01 | 4.15e-02 | 9.51e-01 |
| GOBP CALCIUM ION HOMEOSTASIS | 192 | 3.22e-01 | 4.15e-02 | 8.29e-01 |
| GOBP COMPLEMENT ACTIVATION CLASSICAL PATHWAY | 20 | 7.48e-01 | 4.15e-02 | 9.66e-01 |
| GOBP REGULATION OF MULTICELLULAR ORGANISM GROWTH | 43 | 6.38e-01 | -4.15e-02 | 9.41e-01 |
| GOBP SENSORY ORGAN DEVELOPMENT | 286 | 2.29e-01 | 4.15e-02 | 7.58e-01 |
| GOMF SUMO LIGASE ACTIVITY | 13 | 7.96e-01 | 4.15e-02 | 9.77e-01 |
| GOMF GTPASE INHIBITOR ACTIVITY | 10 | 8.20e-01 | -4.15e-02 | 9.80e-01 |
| GOCC 90S PRERIBOSOME | 25 | 7.20e-01 | -4.15e-02 | 9.61e-01 |
| GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING | 17 | 7.67e-01 | 4.15e-02 | 9.70e-01 |
| GOCC POTASSIUM CHANNEL COMPLEX | 41 | 6.46e-01 | 4.15e-02 | 9.43e-01 |
| GOBP CELLULAR RESPONSE TO INSULIN LIKE GROWTH FACTOR STIMULUS | 7 | 8.49e-01 | 4.14e-02 | 9.82e-01 |
| GOMF TRANSMEMBRANE RECEPTOR PROTEIN PHOSPHATASE ACTIVITY | 7 | 8.50e-01 | 4.14e-02 | 9.82e-01 |
| GOCC SAGA COMPLEX | 23 | 7.31e-01 | -4.14e-02 | 9.64e-01 |
| GOBP REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT | 12 | 8.04e-01 | 4.14e-02 | 9.79e-01 |
| GOCC RIBONUCLEASE P COMPLEX | 13 | 7.96e-01 | 4.14e-02 | 9.77e-01 |
| GOBP TISSUE HOMEOSTASIS | 163 | 3.63e-01 | -4.14e-02 | 8.50e-01 |
| GOBP DEVELOPMENTAL GROWTH | 406 | 1.55e-01 | -4.13e-02 | 6.77e-01 |
| GOBP REGULATION OF BLOOD BRAIN BARRIER PERMEABILITY | 5 | 8.73e-01 | 4.13e-02 | 9.85e-01 |
| GOBP PROTEIN COMPLEX OLIGOMERIZATION | 183 | 3.36e-01 | 4.13e-02 | 8.36e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS WITH A FLAVIN AS ACCEPTOR | 11 | 8.13e-01 | -4.13e-02 | 9.80e-01 |
| GOCC ARYL HYDROCARBON RECEPTOR COMPLEX | 5 | 8.73e-01 | -4.13e-02 | 9.85e-01 |
| GOBP DE NOVO PROTEIN FOLDING | 39 | 6.56e-01 | 4.13e-02 | 9.47e-01 |
| GOBP REGULATION OF MACROPHAGE MIGRATION | 30 | 6.96e-01 | 4.12e-02 | 9.55e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION | 10 | 8.21e-01 | 4.12e-02 | 9.80e-01 |
| GOBP LEUCINE METABOLIC PROCESS | 7 | 8.50e-01 | 4.12e-02 | 9.82e-01 |
| GOMF TRANSLATION ACTIVATOR ACTIVITY | 7 | 8.50e-01 | -4.12e-02 | 9.82e-01 |
| GOCC CIA COMPLEX | 5 | 8.73e-01 | 4.12e-02 | 9.85e-01 |
| GOMF MONOATOMIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 65 | 5.66e-01 | -4.12e-02 | 9.29e-01 |
| GOBP EPITHELIAL CELL APOPTOTIC PROCESS | 82 | 5.21e-01 | 4.11e-02 | 9.20e-01 |
| GOMF UBIQUITIN LIKE PROTEIN PEPTIDASE ACTIVITY | 104 | 4.70e-01 | 4.10e-02 | 9.01e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 5 | 8.74e-01 | 4.10e-02 | 9.85e-01 |
| GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS | 5 | 8.74e-01 | 4.10e-02 | 9.85e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS | 62 | 5.77e-01 | -4.10e-02 | 9.33e-01 |
| GOBP CELLULAR RESPONSE TO CAMP | 32 | 6.88e-01 | -4.10e-02 | 9.54e-01 |
| GOBP NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION | 22 | 7.39e-01 | 4.10e-02 | 9.65e-01 |
| GOBP NEGATIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING | 8 | 8.41e-01 | 4.10e-02 | 9.82e-01 |
| GOBP RESPONSE TO FLUID SHEAR STRESS | 26 | 7.18e-01 | 4.10e-02 | 9.60e-01 |
| GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY | 9 | 8.32e-01 | -4.09e-02 | 9.80e-01 |
| GOBP REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 19 | 7.58e-01 | -4.08e-02 | 9.69e-01 |
| GOBP INTESTINAL EPITHELIAL CELL MATURATION | 5 | 8.74e-01 | 4.08e-02 | 9.85e-01 |
| GOMF NEUROTRANSMITTER RECEPTOR REGULATOR ACTIVITY | 5 | 8.74e-01 | -4.08e-02 | 9.85e-01 |
| GOBP PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE | 16 | 7.77e-01 | -4.08e-02 | 9.74e-01 |
| GOBP REGULATION OF PEPTIDYL LYSINE ACETYLATION | 24 | 7.29e-01 | 4.08e-02 | 9.64e-01 |
| GOBP MULTICELLULAR ORGANISMAL RESPONSE TO STRESS | 49 | 6.21e-01 | 4.08e-02 | 9.38e-01 |
| GOBP ACTION POTENTIAL | 77 | 5.37e-01 | 4.08e-02 | 9.23e-01 |
| GOCC GPI ANCHOR TRANSAMIDASE COMPLEX | 5 | 8.75e-01 | -4.08e-02 | 9.86e-01 |
| GOBP LEPTIN MEDIATED SIGNALING PATHWAY | 8 | 8.42e-01 | -4.07e-02 | 9.82e-01 |
| GOBP MONOATOMIC CATION TRANSPORT | 594 | 9.22e-02 | -4.07e-02 | 5.65e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHORYLATION | 437 | 1.47e-01 | 4.07e-02 | 6.69e-01 |
| GOBP RNA TEMPLATED DNA BIOSYNTHETIC PROCESS | 65 | 5.71e-01 | 4.07e-02 | 9.31e-01 |
| GOBP NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 10 | 8.24e-01 | -4.06e-02 | 9.80e-01 |
| GOCC SWI SNF COMPLEX | 27 | 7.15e-01 | 4.06e-02 | 9.59e-01 |
| GOBP SYNAPTIC VESICLE EXOCYTOSIS | 55 | 6.03e-01 | 4.06e-02 | 9.36e-01 |
| GOBP KETONE CATABOLIC PROCESS | 10 | 8.24e-01 | 4.06e-02 | 9.80e-01 |
| GOBP REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION | 6 | 8.63e-01 | -4.06e-02 | 9.83e-01 |
| GOBP ACIDIC AMINO ACID TRANSPORT | 37 | 6.69e-01 | -4.06e-02 | 9.49e-01 |
| GOMF MOLECULAR SEQUESTERING ACTIVITY | 31 | 6.96e-01 | -4.06e-02 | 9.55e-01 |
| GOBP MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT | 15 | 7.86e-01 | -4.06e-02 | 9.76e-01 |
| GOMF VITAMIN B6 BINDING | 36 | 6.74e-01 | 4.06e-02 | 9.50e-01 |
| GOBP REGULATION OF NEURON DIFFERENTIATION | 91 | 5.04e-01 | -4.05e-02 | 9.15e-01 |
| GOMF EPHRIN RECEPTOR BINDING | 19 | 7.60e-01 | 4.05e-02 | 9.69e-01 |
| GOBP REGULATION OF APOPTOTIC SIGNALING PATHWAY | 298 | 2.30e-01 | -4.05e-02 | 7.58e-01 |
| GOBP REGULATION OF CYTOKINESIS | 73 | 5.50e-01 | 4.05e-02 | 9.26e-01 |
| GOBP POSITIVE REGULATION OF ERBB SIGNALING PATHWAY | 21 | 7.48e-01 | -4.05e-02 | 9.66e-01 |
| GOBP PHOTORECEPTOR CELL DIFFERENTIATION | 30 | 7.01e-01 | 4.05e-02 | 9.56e-01 |
| GOMF DNA POLYMERASE BINDING | 21 | 7.48e-01 | 4.04e-02 | 9.66e-01 |
| GOBP LONG TERM MEMORY | 21 | 7.49e-01 | 4.04e-02 | 9.66e-01 |
| GOBP MYELOID DENDRITIC CELL DIFFERENTIATION | 13 | 8.01e-01 | 4.04e-02 | 9.78e-01 |
| GOMF HSP90 PROTEIN BINDING | 34 | 6.84e-01 | 4.03e-02 | 9.53e-01 |
| GOBP NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 37 | 6.72e-01 | 4.03e-02 | 9.49e-01 |
| GOBP MITOTIC DNA REPLICATION | 16 | 7.81e-01 | -4.02e-02 | 9.75e-01 |
| GOBP SMOOTH MUSCLE CELL PROLIFERATION | 87 | 5.17e-01 | -4.02e-02 | 9.19e-01 |
| GOMF PHOSPHOLIPID TRANSPORTER ACTIVITY | 50 | 6.24e-01 | 4.01e-02 | 9.40e-01 |
| GOBP ENSHEATHMENT OF NEURONS | 98 | 4.93e-01 | 4.01e-02 | 9.13e-01 |
| GOBP PROTEIN PHOSPHORYLATION | 937 | 3.95e-02 | 4.01e-02 | 4.07e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER | 15 | 7.88e-01 | 4.01e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 81 | 5.33e-01 | -4.01e-02 | 9.23e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR | 277 | 2.53e-01 | 4.01e-02 | 7.78e-01 |
| GOMF PEPTIDASE REGULATOR ACTIVITY | 115 | 4.59e-01 | 4.00e-02 | 8.96e-01 |
| GOBP NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 9 | 8.36e-01 | 4.00e-02 | 9.81e-01 |
| GOMF ACETYL COA C ACYLTRANSFERASE ACTIVITY | 7 | 8.55e-01 | -4.00e-02 | 9.82e-01 |
| GOBP COBALAMIN METABOLIC PROCESS | 8 | 8.45e-01 | 4.00e-02 | 9.82e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON GLYCOSYL BONDS | 92 | 5.08e-01 | 4.00e-02 | 9.18e-01 |
| GOBP 7 METHYLGUANOSINE CAP HYPERMETHYLATION | 8 | 8.45e-01 | 3.99e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE | 97 | 4.97e-01 | 3.99e-02 | 9.13e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 10 | 8.27e-01 | 3.99e-02 | 9.80e-01 |
| GOBP LAMELLIPODIUM ORGANIZATION | 70 | 5.64e-01 | -3.99e-02 | 9.29e-01 |
| GOBP CELLULAR RESPONSE TO NITROGEN COMPOUND | 453 | 1.48e-01 | 3.99e-02 | 6.70e-01 |
| GOBP CARBOHYDRATE METABOLIC PROCESS | 414 | 1.67e-01 | -3.98e-02 | 6.95e-01 |
| GOBP CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR | 13 | 8.04e-01 | 3.98e-02 | 9.79e-01 |
| GOBP MONOATOMIC ION TRANSPORT | 694 | 7.65e-02 | -3.97e-02 | 5.30e-01 |
| GOBP TUBE DEVELOPMENT | 642 | 8.79e-02 | -3.97e-02 | 5.58e-01 |
| GOBP PROTEIN REFOLDING | 22 | 7.47e-01 | -3.97e-02 | 9.66e-01 |
| GOBP REGULATION OF MICROGLIAL CELL ACTIVATION | 15 | 7.90e-01 | 3.97e-02 | 9.76e-01 |
| GOBP REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 865 | 4.97e-02 | 3.97e-02 | 4.48e-01 |
| GOBP SKELETAL MUSCLE CELL DIFFERENTIATION | 40 | 6.64e-01 | -3.97e-02 | 9.49e-01 |
| GOCC MLL3 4 COMPLEX | 12 | 8.12e-01 | 3.97e-02 | 9.80e-01 |
| GOMF STRUCTURAL CONSTITUENT OF MUSCLE | 24 | 7.37e-01 | -3.97e-02 | 9.65e-01 |
| GOMF PROTEIN KINASE A REGULATORY SUBUNIT BINDING | 21 | 7.53e-01 | 3.96e-02 | 9.68e-01 |
| GOCC NUCLEAR EXOSOME RNASE COMPLEX | 12 | 8.12e-01 | 3.96e-02 | 9.80e-01 |
| GOBP METENCEPHALON DEVELOPMENT | 69 | 5.70e-01 | -3.96e-02 | 9.31e-01 |
| GOCC SPINDLE MIDZONE | 34 | 6.90e-01 | -3.96e-02 | 9.54e-01 |
| GOBP MAST CELL PROLIFERATION | 5 | 8.78e-01 | -3.96e-02 | 9.86e-01 |
| GOMF RIBONUCLEOPROTEIN COMPLEX BINDING | 161 | 3.87e-01 | -3.96e-02 | 8.65e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDES | 53 | 6.19e-01 | 3.95e-02 | 9.37e-01 |
| GOBP ODONTOGENESIS OF DENTIN CONTAINING TOOTH | 40 | 6.66e-01 | 3.95e-02 | 9.49e-01 |
| GOBP REGULATION OF METAL ION TRANSPORT | 219 | 3.15e-01 | 3.95e-02 | 8.22e-01 |
| GOBP CELLULAR RESPONSE TO MURAMYL DIPEPTIDE | 7 | 8.56e-01 | -3.95e-02 | 9.82e-01 |
| GOBP HORMONE TRANSPORT | 169 | 3.77e-01 | 3.95e-02 | 8.61e-01 |
| GOBP CELLULAR RESPONSE TO MANGANESE ION | 8 | 8.47e-01 | 3.95e-02 | 9.82e-01 |
| GOBP OLEFINIC COMPOUND BIOSYNTHETIC PROCESS | 14 | 7.98e-01 | -3.95e-02 | 9.77e-01 |
| GOCC MYOSIN COMPLEX | 30 | 7.08e-01 | 3.95e-02 | 9.58e-01 |
| GOBP DNA CONFORMATION CHANGE | 88 | 5.23e-01 | -3.94e-02 | 9.20e-01 |
| GOCC EARLY ENDOSOME LUMEN | 5 | 8.79e-01 | -3.94e-02 | 9.86e-01 |
| GOCC RSC TYPE COMPLEX | 14 | 7.99e-01 | -3.94e-02 | 9.77e-01 |
| GOBP VESICLE CYTOSKELETAL TRAFFICKING | 57 | 6.08e-01 | 3.93e-02 | 9.36e-01 |
| GOBP PROTEIN POLYMERIZATION | 223 | 3.13e-01 | 3.93e-02 | 8.22e-01 |
| GOBP POSITIVE REGULATION OF RNA SPLICING | 33 | 6.96e-01 | -3.93e-02 | 9.55e-01 |
| GOBP AUTOPHAGOSOME ORGANIZATION | 110 | 4.77e-01 | -3.93e-02 | 9.05e-01 |
| GOBP REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 225 | 3.11e-01 | 3.93e-02 | 8.21e-01 |
| GOMF DIOXYGENASE ACTIVITY | 74 | 5.60e-01 | 3.92e-02 | 9.28e-01 |
| GOBP NEGATIVE REGULATION OF TYPE II INTERFERON PRODUCTION | 23 | 7.45e-01 | 3.92e-02 | 9.66e-01 |
| GOBP POSITIVE REGULATION OF CELL MATRIX ADHESION | 36 | 6.84e-01 | 3.92e-02 | 9.53e-01 |
| GOMF AMINOACYL TRNA HYDROLASE ACTIVITY | 5 | 8.79e-01 | 3.92e-02 | 9.86e-01 |
| GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 23 | 7.45e-01 | 3.92e-02 | 9.66e-01 |
| GOBP POSITIVE REGULATION OF BONE RESORPTION | 14 | 8.00e-01 | -3.92e-02 | 9.77e-01 |
| GOCC IMMUNOLOGICAL SYNAPSE | 35 | 6.89e-01 | 3.91e-02 | 9.54e-01 |
| GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 43 | 6.58e-01 | 3.91e-02 | 9.48e-01 |
| GOMF REGULATORY RNA BINDING | 40 | 6.69e-01 | -3.90e-02 | 9.49e-01 |
| GOBP GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT | 6 | 8.68e-01 | 3.90e-02 | 9.85e-01 |
| GOBP MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 564 | 1.15e-01 | -3.90e-02 | 6.12e-01 |
| GOBP NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT | 76 | 5.57e-01 | -3.90e-02 | 9.27e-01 |
| GOBP TORC2 SIGNALING | 15 | 7.94e-01 | -3.90e-02 | 9.77e-01 |
| GOBP REGULATION OF CELL CYCLE PHASE TRANSITION | 366 | 2.02e-01 | 3.90e-02 | 7.32e-01 |
| GOBP POSITIVE REGULATION OF PROGRAMMED CELL DEATH | 401 | 1.83e-01 | 3.89e-02 | 7.13e-01 |
| GOMF NUCLEOBASE CONTAINING COMPOUND KINASE ACTIVITY | 40 | 6.70e-01 | -3.89e-02 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 62 | 5.97e-01 | 3.89e-02 | 9.36e-01 |
| GOMF SINGLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY | 8 | 8.49e-01 | 3.89e-02 | 9.82e-01 |
| GOBP MUSCLE CONTRACTION | 188 | 3.59e-01 | 3.89e-02 | 8.46e-01 |
| GOCC MEMBRANE PROTEIN COMPLEX | 817 | 6.12e-02 | -3.89e-02 | 4.84e-01 |
| GOBP PROTEIN LIPID COMPLEX ORGANIZATION | 32 | 7.04e-01 | 3.89e-02 | 9.56e-01 |
| GOMF HISTONE H4 METHYLTRANSFERASE ACTIVITY | 15 | 7.94e-01 | -3.89e-02 | 9.77e-01 |
| GOBP REGULATION OF T CELL APOPTOTIC PROCESS | 29 | 7.18e-01 | -3.88e-02 | 9.60e-01 |
| GOBP REGULATION OF CELL CYCLE PROCESS | 578 | 1.13e-01 | 3.88e-02 | 6.09e-01 |
| GOBP RHO PROTEIN SIGNAL TRANSDUCTION | 97 | 5.10e-01 | -3.88e-02 | 9.18e-01 |
| GOBP NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING | 8 | 8.49e-01 | -3.88e-02 | 9.82e-01 |
| GOCC MICROBODY MEMBRANE | 58 | 6.10e-01 | 3.88e-02 | 9.36e-01 |
| GOMF INTEGRIN BINDING | 89 | 5.29e-01 | -3.87e-02 | 9.23e-01 |
| GOCC X CHROMOSOME | 8 | 8.50e-01 | -3.87e-02 | 9.82e-01 |
| GOBP AMYLOID FIBRIL FORMATION | 33 | 7.01e-01 | -3.86e-02 | 9.56e-01 |
| GOCC NUCLEOLUS | 898 | 5.19e-02 | -3.86e-02 | 4.58e-01 |
| GOBP PHOSPHORYLATION | 1149 | 2.93e-02 | 3.86e-02 | 3.49e-01 |
| GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSPORT | 115 | 4.75e-01 | 3.86e-02 | 9.04e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 37 | 6.85e-01 | 3.86e-02 | 9.53e-01 |
| GOBP CELLULAR RESPONSE TO INORGANIC SUBSTANCE | 148 | 4.19e-01 | -3.85e-02 | 8.79e-01 |
| GOMF TRANSCRIPTION COACTIVATOR ACTIVITY | 239 | 3.06e-01 | 3.85e-02 | 8.17e-01 |
| GOBP GLIOGENESIS | 200 | 3.48e-01 | 3.85e-02 | 8.43e-01 |
| GOBP REGULATION OF MYOBLAST DIFFERENTIATION | 50 | 6.38e-01 | 3.85e-02 | 9.41e-01 |
| GOMF DEUBIQUITINASE ACTIVITY | 92 | 5.24e-01 | 3.85e-02 | 9.20e-01 |
| GOBP INTERNAL PROTEIN AMINO ACID ACETYLATION | 50 | 6.38e-01 | -3.85e-02 | 9.41e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 86 | 5.38e-01 | -3.85e-02 | 9.23e-01 |
| GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION | 6 | 8.70e-01 | -3.85e-02 | 9.85e-01 |
| GOCC GUANYL NUCLEOTIDE EXCHANGE FACTOR COMPLEX | 16 | 7.90e-01 | -3.85e-02 | 9.76e-01 |
| GOBP PROTEIN TARGETING TO VACUOLE | 43 | 6.63e-01 | -3.85e-02 | 9.49e-01 |
| GOCC POLYMERIC CYTOSKELETAL FIBER | 468 | 1.56e-01 | 3.84e-02 | 6.79e-01 |
| GOMF 7SK SNRNA BINDING | 8 | 8.51e-01 | -3.84e-02 | 9.82e-01 |
| GOBP REGULATION OF NEUROBLAST PROLIFERATION | 22 | 7.55e-01 | 3.84e-02 | 9.68e-01 |
| GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 25 | 7.40e-01 | -3.84e-02 | 9.65e-01 |
| GOCC ANAPHASE PROMOTING COMPLEX | 19 | 7.72e-01 | -3.84e-02 | 9.72e-01 |
| GOBP COPI COATED VESICLE BUDDING | 6 | 8.71e-01 | -3.84e-02 | 9.85e-01 |
| GOBP CELLULAR RESPONSE TO UNFOLDED PROTEIN | 79 | 5.56e-01 | -3.84e-02 | 9.26e-01 |
| GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT | 8 | 8.51e-01 | 3.84e-02 | 9.82e-01 |
| GOBP PROXIMAL TUBULE DEVELOPMENT | 6 | 8.71e-01 | -3.83e-02 | 9.85e-01 |
| GOMF HISTONE H3K4 DEMETHYLASE ACTIVITY | 8 | 8.51e-01 | 3.82e-02 | 9.82e-01 |
| GOBP SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY | 9 | 8.43e-01 | -3.82e-02 | 9.82e-01 |
| GOCC CHROMOSOMAL REGION | 349 | 2.21e-01 | 3.82e-02 | 7.49e-01 |
| GOBP INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 46 | 6.54e-01 | -3.82e-02 | 9.46e-01 |
| GOBP POSITIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 5 | 8.82e-01 | 3.82e-02 | 9.86e-01 |
| GOBP SODIUM DEPENDENT PHOSPHATE TRANSPORT | 5 | 8.83e-01 | 3.81e-02 | 9.86e-01 |
| GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 44 | 6.62e-01 | -3.81e-02 | 9.49e-01 |
| GOBP DNA TEMPLATED DNA REPLICATION MAINTENANCE OF FIDELITY | 53 | 6.32e-01 | -3.81e-02 | 9.41e-01 |
| GOBP ENDOSOME TO LYSOSOME TRANSPORT | 63 | 6.01e-01 | 3.81e-02 | 9.36e-01 |
| GOBP REGULATION OF REGULATED SECRETORY PATHWAY | 79 | 5.59e-01 | 3.81e-02 | 9.27e-01 |
| GOBP UNSATURATED FATTY ACID METABOLIC PROCESS | 58 | 6.17e-01 | -3.80e-02 | 9.36e-01 |
| GOBP REGULATION OF FATTY ACID METABOLIC PROCESS | 61 | 6.08e-01 | 3.80e-02 | 9.36e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 173 | 3.89e-01 | 3.80e-02 | 8.65e-01 |
| GOMF HYDROLASE ACTIVITY HYDROLYZING O GLYCOSYL COMPOUNDS | 60 | 6.11e-01 | 3.80e-02 | 9.36e-01 |
| GOBP MITOCHONDRIAL DNA REPLICATION | 14 | 8.06e-01 | 3.80e-02 | 9.79e-01 |
| GOMF PEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 8.44e-01 | 3.80e-02 | 9.82e-01 |
| GOBP REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION | 8 | 8.53e-01 | -3.80e-02 | 9.82e-01 |
| GOBP HEPARIN METABOLIC PROCESS | 12 | 8.20e-01 | -3.79e-02 | 9.80e-01 |
| GOBP ENDOMEMBRANE SYSTEM ORGANIZATION | 472 | 1.60e-01 | 3.79e-02 | 6.87e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS | 50 | 6.44e-01 | 3.78e-02 | 9.42e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CONTRACTION | 17 | 7.87e-01 | 3.78e-02 | 9.76e-01 |
| GOBP FATTY ACYL COA METABOLIC PROCESS | 31 | 7.16e-01 | 3.78e-02 | 9.59e-01 |
| GOCC METHYLTRANSFERASE COMPLEX | 92 | 5.32e-01 | -3.77e-02 | 9.23e-01 |
| GOBP REGULATION OF CYTOPLASMIC TRANSLATION | 28 | 7.30e-01 | -3.77e-02 | 9.64e-01 |
| GOBP REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 17 | 7.88e-01 | -3.77e-02 | 9.76e-01 |
| GOBP REGULATION OF PROTEIN TARGETING TO MEMBRANE | 26 | 7.39e-01 | 3.77e-02 | 9.65e-01 |
| GOMF STEROL TRANSPORTER ACTIVITY | 26 | 7.40e-01 | -3.77e-02 | 9.65e-01 |
| GOBP REGULATION OF ENDOCYTIC RECYCLING | 14 | 8.07e-01 | 3.77e-02 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 175 | 3.91e-01 | -3.76e-02 | 8.68e-01 |
| GOBP REGULATION OF VESICLE FUSION | 12 | 8.21e-01 | -3.76e-02 | 9.80e-01 |
| GOBP MICROTUBULE BASED PROCESS | 688 | 9.50e-02 | 3.76e-02 | 5.72e-01 |
| GOBP REACTIVE NITROGEN SPECIES METABOLIC PROCESS | 54 | 6.33e-01 | 3.76e-02 | 9.41e-01 |
| GOBP TRNA PROCESSING | 129 | 4.62e-01 | 3.75e-02 | 8.98e-01 |
| GOBP MACROPHAGE DIFFERENTIATION | 45 | 6.63e-01 | 3.75e-02 | 9.49e-01 |
| GOBP NEGATIVE REGULATION OF LIPID METABOLIC PROCESS | 64 | 6.04e-01 | -3.75e-02 | 9.36e-01 |
| GOBP INTESTINAL LIPID ABSORPTION | 8 | 8.54e-01 | -3.75e-02 | 9.82e-01 |
| GOBP MYELOID CELL HOMEOSTASIS | 137 | 4.50e-01 | 3.75e-02 | 8.89e-01 |
| GOBP ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME | 56 | 6.28e-01 | -3.75e-02 | 9.40e-01 |
| GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 100 | 5.18e-01 | 3.74e-02 | 9.19e-01 |
| GOBP MITOTIC G2 M TRANSITION CHECKPOINT | 49 | 6.50e-01 | 3.74e-02 | 9.44e-01 |
| GOMF ICOSANOID BINDING | 7 | 8.64e-01 | -3.74e-02 | 9.83e-01 |
| GOBP MEMBRANE INVAGINATION | 54 | 6.35e-01 | -3.74e-02 | 9.41e-01 |
| GOBP PARKIN MEDIATED STIMULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 6 | 8.74e-01 | 3.74e-02 | 9.85e-01 |
| GOMF KINASE INHIBITOR ACTIVITY | 63 | 6.08e-01 | -3.74e-02 | 9.36e-01 |
| GOBP ADHERENS JUNCTION ORGANIZATION | 31 | 7.19e-01 | -3.73e-02 | 9.60e-01 |
| GOBP NEUROTRANSMITTER SECRETION | 82 | 5.59e-01 | 3.73e-02 | 9.28e-01 |
| GOBP DEPHOSPHORYLATION | 235 | 3.26e-01 | 3.73e-02 | 8.29e-01 |
| GOMF HISTONE DEACETYLASE BINDING | 92 | 5.37e-01 | -3.73e-02 | 9.23e-01 |
| GOBP POSITIVE REGULATION OF INTERLEUKIN 18 PRODUCTION | 6 | 8.74e-01 | -3.73e-02 | 9.85e-01 |
| GOBP CHONDROCYTE DEVELOPMENT | 16 | 7.96e-01 | 3.73e-02 | 9.77e-01 |
| GOBP IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION | 11 | 8.31e-01 | -3.72e-02 | 9.80e-01 |
| GOBP RESPONSE TO MITOCHONDRIAL DEPOLARISATION | 20 | 7.73e-01 | -3.72e-02 | 9.72e-01 |
| GOMF INTRACILIARY TRANSPORT PARTICLE B BINDING | 5 | 8.86e-01 | -3.72e-02 | 9.86e-01 |
| GOCC MCRD MEDIATED MRNA STABILITY COMPLEX | 5 | 8.86e-01 | -3.71e-02 | 9.86e-01 |
| GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 1045 | 4.48e-02 | 3.71e-02 | 4.31e-01 |
| GOBP MEMBRANE BIOGENESIS | 51 | 6.47e-01 | 3.71e-02 | 9.43e-01 |
| GOMF N ACYLTRANSFERASE ACTIVITY | 73 | 5.84e-01 | -3.71e-02 | 9.36e-01 |
| GOMF 5 3 EXONUCLEASE ACTIVITY | 19 | 7.80e-01 | 3.71e-02 | 9.75e-01 |
| GOBP STEM CELL DEVELOPMENT | 50 | 6.50e-01 | -3.71e-02 | 9.44e-01 |
| GOBP NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 32 | 7.17e-01 | -3.71e-02 | 9.59e-01 |
| GOBP ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 15 | 8.04e-01 | -3.71e-02 | 9.79e-01 |
| GOBP POLYAMINE BIOSYNTHETIC PROCESS | 13 | 8.17e-01 | -3.70e-02 | 9.80e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM MYELIN MAINTENANCE | 6 | 8.75e-01 | 3.70e-02 | 9.86e-01 |
| GOBP REGULATION OF PROTEIN BINDING | 110 | 5.03e-01 | 3.70e-02 | 9.15e-01 |
| GOMF GAMMA TUBULIN BINDING | 31 | 7.22e-01 | -3.70e-02 | 9.62e-01 |
| GOMF FATTY ACID LIGASE ACTIVITY | 13 | 8.18e-01 | 3.70e-02 | 9.80e-01 |
| GOBP REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 102 | 5.20e-01 | -3.69e-02 | 9.19e-01 |
| GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE III | 8 | 8.57e-01 | -3.69e-02 | 9.82e-01 |
| GOBP STRIATED MUSCLE CELL DIFFERENTIATION | 172 | 4.04e-01 | 3.69e-02 | 8.72e-01 |
| GOMF ALPHA TUBULIN BINDING | 36 | 7.02e-01 | 3.69e-02 | 9.56e-01 |
| GOBP ONCOGENE INDUCED CELL SENESCENCE | 5 | 8.86e-01 | -3.69e-02 | 9.86e-01 |
| GOBP REGULATION OF PHOSPHATASE ACTIVITY | 46 | 6.65e-01 | -3.69e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF LIPID CATABOLIC PROCESS | 14 | 8.11e-01 | -3.69e-02 | 9.80e-01 |
| GOMF CYSTEINE TYPE ENDOPEPTIDASE REGULATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 34 | 7.10e-01 | -3.69e-02 | 9.59e-01 |
| GOMF BH3 DOMAIN BINDING | 5 | 8.87e-01 | -3.68e-02 | 9.86e-01 |
| GOMF RAGE RECEPTOR BINDING | 8 | 8.57e-01 | -3.68e-02 | 9.82e-01 |
| GOCC STEREOCILIA COUPLING LINK | 5 | 8.87e-01 | -3.67e-02 | 9.86e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 49 | 6.57e-01 | -3.67e-02 | 9.47e-01 |
| GOMF TRANSCRIPTION REGULATOR ACTIVITY | 1331 | 2.67e-02 | 3.67e-02 | 3.32e-01 |
| GOMF NUCLEAR RETINOIC ACID RECEPTOR BINDING | 22 | 7.66e-01 | 3.67e-02 | 9.70e-01 |
| GOBP RESPONSE TO LIPID | 567 | 1.38e-01 | 3.67e-02 | 6.58e-01 |
| GOBP FIBRINOLYSIS | 12 | 8.26e-01 | -3.67e-02 | 9.80e-01 |
| GOBP REGULATION OF GRANULOCYTE CHEMOTAXIS | 33 | 7.16e-01 | 3.67e-02 | 9.59e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL | 57 | 6.32e-01 | -3.67e-02 | 9.41e-01 |
| GOMF RNA POLYMERASE II CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 14 | 8.13e-01 | -3.66e-02 | 9.80e-01 |
| GOMF CYCLASE ACTIVATOR ACTIVITY | 6 | 8.77e-01 | -3.66e-02 | 9.86e-01 |
| GOBP CELLULAR RESPONSE TO HYDROGEN PEROXIDE | 56 | 6.36e-01 | 3.65e-02 | 9.41e-01 |
| GOMF HISTONE METHYLTRANSFERASE ACTIVITY | 60 | 6.25e-01 | 3.65e-02 | 9.40e-01 |
| GOBP PLATELET DENSE GRANULE ORGANIZATION | 22 | 7.67e-01 | 3.65e-02 | 9.70e-01 |
| GOMF CELL ADHESION MOLECULE BINDING | 389 | 2.19e-01 | -3.65e-02 | 7.49e-01 |
| GOBP REGULATION OF LYSOSOMAL LUMEN PH | 27 | 7.43e-01 | -3.65e-02 | 9.65e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 107 | 5.16e-01 | -3.63e-02 | 9.19e-01 |
| GOBP HINDBRAIN DEVELOPMENT | 89 | 5.54e-01 | -3.63e-02 | 9.26e-01 |
| GOBP CELLULAR RESPONSE TO XENOBIOTIC STIMULUS | 99 | 5.33e-01 | -3.63e-02 | 9.23e-01 |
| GOBP NEGATIVE REGULATION OF CELL DEVELOPMENT | 165 | 4.22e-01 | 3.63e-02 | 8.81e-01 |
| GOBP REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 61 | 6.25e-01 | 3.63e-02 | 9.40e-01 |
| GOBP AMINE TRANSPORT | 42 | 6.84e-01 | -3.63e-02 | 9.53e-01 |
| GOMF SYMPORTER ACTIVITY | 83 | 5.69e-01 | -3.62e-02 | 9.31e-01 |
| GOBP POSITIVE REGULATION OF DNA RECOMBINATION | 64 | 6.17e-01 | 3.62e-02 | 9.36e-01 |
| GOBP REGULATION OF HORMONE METABOLIC PROCESS | 25 | 7.54e-01 | 3.62e-02 | 9.68e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 475 | 1.80e-01 | 3.61e-02 | 7.10e-01 |
| GOBP PHOSPHATIDYLINOSITOL METABOLIC PROCESS | 131 | 4.76e-01 | 3.61e-02 | 9.04e-01 |
| GOBP SPHINGOLIPID METABOLIC PROCESS | 108 | 5.18e-01 | 3.60e-02 | 9.19e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 11 | 8.36e-01 | -3.60e-02 | 9.81e-01 |
| GOBP CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY | 73 | 5.95e-01 | -3.60e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION | 11 | 8.37e-01 | 3.59e-02 | 9.81e-01 |
| GOBP REGULATION OF MRNA EXPORT FROM NUCLEUS | 7 | 8.70e-01 | -3.58e-02 | 9.85e-01 |
| GOBP LUTEOLYSIS | 5 | 8.90e-01 | 3.58e-02 | 9.86e-01 |
| GOMF PROTEIN METHYLTRANSFERASE ACTIVITY | 83 | 5.74e-01 | 3.58e-02 | 9.32e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H HEME PROTEIN AS ACCEPTOR | 9 | 8.53e-01 | -3.57e-02 | 9.82e-01 |
| GOBP PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 20 | 7.83e-01 | -3.57e-02 | 9.75e-01 |
| GOBP SIGNAL RELEASE | 262 | 3.22e-01 | 3.56e-02 | 8.29e-01 |
| GOBP RETROGRADE TRANSPORT ENDOSOME TO GOLGI | 92 | 5.55e-01 | -3.56e-02 | 9.26e-01 |
| GOBP POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 62 | 6.28e-01 | 3.56e-02 | 9.40e-01 |
| GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 4 PHOSPHATASE ACTIVITY | 9 | 8.54e-01 | 3.55e-02 | 9.82e-01 |
| GOBP RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 228 | 3.58e-01 | -3.54e-02 | 8.46e-01 |
| GOMF LIPASE ACTIVATOR ACTIVITY | 15 | 8.12e-01 | 3.54e-02 | 9.80e-01 |
| GOBP CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE | 12 | 8.32e-01 | -3.54e-02 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY | 28 | 7.46e-01 | -3.54e-02 | 9.66e-01 |
| GOBP REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 143 | 4.66e-01 | 3.54e-02 | 9.00e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 21 | 7.79e-01 | 3.54e-02 | 9.75e-01 |
| GOBP AUDITORY RECEPTOR CELL MORPHOGENESIS | 14 | 8.19e-01 | -3.54e-02 | 9.80e-01 |
| GOMF EXONUCLEASE ACTIVITY | 77 | 5.93e-01 | 3.53e-02 | 9.36e-01 |
| GOBP MRNA CIS SPLICING VIA SPLICEOSOME | 23 | 7.70e-01 | 3.53e-02 | 9.70e-01 |
| GOBP RECEPTOR MEDIATED ENDOCYTOSIS | 181 | 4.14e-01 | -3.53e-02 | 8.77e-01 |
| GOBP CELLULAR DEFENSE RESPONSE | 28 | 7.47e-01 | 3.52e-02 | 9.66e-01 |
| GOBP NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS | 482 | 1.87e-01 | -3.52e-02 | 7.17e-01 |
| GOBP REGULATION OF BINDING | 197 | 3.95e-01 | 3.52e-02 | 8.70e-01 |
| GOBP LIPID DROPLET ORGANIZATION | 26 | 7.56e-01 | -3.52e-02 | 9.69e-01 |
| GOBP STEROID HORMONE MEDIATED SIGNALING PATHWAY | 105 | 5.34e-01 | 3.51e-02 | 9.23e-01 |
| GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT | 17 | 8.02e-01 | 3.51e-02 | 9.78e-01 |
| GOBP REGULATION OF CELL CYCLE | 867 | 8.21e-02 | 3.51e-02 | 5.43e-01 |
| GOBP AMINO ACID IMPORT ACROSS PLASMA MEMBRANE | 26 | 7.57e-01 | -3.51e-02 | 9.69e-01 |
| GOMF TETRAPYRROLE BINDING | 71 | 6.10e-01 | 3.51e-02 | 9.36e-01 |
| GOBP REGULATION OF GLUCOSE METABOLIC PROCESS | 75 | 6.00e-01 | -3.51e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY | 11 | 8.40e-01 | 3.51e-02 | 9.82e-01 |
| GOBP ORGANIC HYDROXY COMPOUND TRANSPORT | 162 | 4.42e-01 | -3.51e-02 | 8.86e-01 |
| GOCC MAIN AXON | 38 | 7.09e-01 | -3.50e-02 | 9.58e-01 |
| GOBP REGULATION OF ISOTYPE SWITCHING TO IGE ISOTYPES | 5 | 8.92e-01 | 3.50e-02 | 9.86e-01 |
| GOBP VESICLE BUDDING FROM MEMBRANE | 78 | 5.94e-01 | 3.50e-02 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 40 | 7.02e-01 | -3.49e-02 | 9.56e-01 |
| GOBP REGULATION OF SIGNALING RECEPTOR ACTIVITY | 64 | 6.29e-01 | -3.49e-02 | 9.40e-01 |
| GOCC NUCLEAR ENVELOPE | 408 | 2.28e-01 | 3.49e-02 | 7.58e-01 |
| GOBP NADPH REGENERATION | 20 | 7.87e-01 | -3.49e-02 | 9.76e-01 |
| GOBP RESPONSE TO LEPTIN | 12 | 8.34e-01 | 3.49e-02 | 9.81e-01 |
| GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME BINDING | 31 | 7.37e-01 | 3.49e-02 | 9.65e-01 |
| GOBP RESPONSE TO INTERLEUKIN 1 | 91 | 5.65e-01 | -3.49e-02 | 9.29e-01 |
| GOBP PROTEIN DELIPIDATION | 5 | 8.93e-01 | 3.49e-02 | 9.86e-01 |
| GOBP NEGATIVE REGULATION OF MITOCHONDRIAL FUSION | 8 | 8.64e-01 | -3.49e-02 | 9.83e-01 |
| GOBP REGULATION OF GLIAL CELL MIGRATION | 13 | 8.28e-01 | -3.49e-02 | 9.80e-01 |
| GOBP PROTEIN TARGETING TO PEROXISOME | 19 | 7.93e-01 | 3.48e-02 | 9.77e-01 |
| GOMF ATPASE COUPLED MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 35 | 7.22e-01 | -3.48e-02 | 9.62e-01 |
| GOBP REGULATION OF MRNA PROCESSING | 105 | 5.38e-01 | -3.48e-02 | 9.23e-01 |
| GOBP RESPONSE TO LEUCINE | 13 | 8.28e-01 | -3.48e-02 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF HORMONE METABOLIC PROCESS | 9 | 8.57e-01 | -3.48e-02 | 9.82e-01 |
| GOBP GROWTH | 599 | 1.49e-01 | -3.48e-02 | 6.72e-01 |
| GOBP NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS | 5 | 8.93e-01 | -3.47e-02 | 9.86e-01 |
| GOMF PEPTIDASE ACTIVATOR ACTIVITY | 43 | 6.94e-01 | 3.47e-02 | 9.54e-01 |
| GOBP REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 21 | 7.83e-01 | -3.47e-02 | 9.75e-01 |
| GOBP POSITIVE REGULATION OF LYASE ACTIVITY | 18 | 7.99e-01 | -3.47e-02 | 9.77e-01 |
| GOBP INTERLEUKIN 23 PRODUCTION | 6 | 8.83e-01 | 3.46e-02 | 9.86e-01 |
| GOBP ENDOTHELIUM DEVELOPMENT | 84 | 5.84e-01 | -3.46e-02 | 9.36e-01 |
| GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION | 38 | 7.12e-01 | -3.46e-02 | 9.59e-01 |
| GOBP CELLULAR COMPONENT DISASSEMBLY | 412 | 2.31e-01 | -3.46e-02 | 7.58e-01 |
| GOBP MULTICELLULAR ORGANISM REPRODUCTION | 525 | 1.78e-01 | 3.46e-02 | 7.09e-01 |
| GOMF MODIFIED AMINO ACID BINDING | 50 | 6.73e-01 | 3.45e-02 | 9.49e-01 |
| GOBP MUSCLE TISSUE DEVELOPMENT | 223 | 3.76e-01 | 3.45e-02 | 8.60e-01 |
| GOMF 2 OXOGLUTARATE DEPENDENT DIOXYGENASE ACTIVITY | 54 | 6.61e-01 | 3.45e-02 | 9.49e-01 |
| GOCC CIS GOLGI NETWORK | 52 | 6.67e-01 | 3.45e-02 | 9.49e-01 |
| GOMF INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 72 | 6.14e-01 | -3.44e-02 | 9.36e-01 |
| GOBP REGULATION OF TUBE SIZE | 69 | 6.21e-01 | -3.44e-02 | 9.38e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 12 | 8.36e-01 | 3.44e-02 | 9.81e-01 |
| GOCC BRCA1 C COMPLEX | 6 | 8.84e-01 | -3.44e-02 | 9.86e-01 |
| GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 12 | 8.37e-01 | -3.44e-02 | 9.81e-01 |
| GOCC GOLGI ASSOCIATED VESICLE | 76 | 6.05e-01 | -3.43e-02 | 9.36e-01 |
| GOMF NUCLEOSOME BINDING | 52 | 6.69e-01 | 3.43e-02 | 9.49e-01 |
| GOBP RESPONSE TO TEMPERATURE STIMULUS | 123 | 5.12e-01 | 3.43e-02 | 9.18e-01 |
| GOBP SODIUM INDEPENDENT ORGANIC ANION TRANSPORT | 5 | 8.94e-01 | 3.43e-02 | 9.86e-01 |
| GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 86 | 5.83e-01 | -3.43e-02 | 9.36e-01 |
| GOBP MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 26 | 7.62e-01 | 3.43e-02 | 9.70e-01 |
| GOMF CARBOXYPEPTIDASE ACTIVITY | 24 | 7.72e-01 | -3.42e-02 | 9.71e-01 |
| GOCC ESCRT I COMPLEX | 10 | 8.51e-01 | 3.42e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 23 | 7.77e-01 | 3.41e-02 | 9.74e-01 |
| GOBP MANGANESE ION TRANSPORT | 9 | 8.60e-01 | 3.41e-02 | 9.82e-01 |
| GOMF DOPAMINE RECEPTOR BINDING | 9 | 8.60e-01 | -3.41e-02 | 9.82e-01 |
| GOBP ORGANOPHOSPHATE BIOSYNTHETIC PROCESS | 492 | 1.98e-01 | -3.41e-02 | 7.31e-01 |
| GOBP POSITIVE REGULATION OF CELL SUBSTRATE ADHESION | 82 | 5.94e-01 | 3.40e-02 | 9.36e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID TRANSPORT | 9 | 8.60e-01 | 3.40e-02 | 9.82e-01 |
| GOBP CLATHRIN DEPENDENT ENDOCYTOSIS | 39 | 7.14e-01 | -3.40e-02 | 9.59e-01 |
| GOCC SEX CHROMATIN | 5 | 8.95e-01 | -3.39e-02 | 9.86e-01 |
| GOBP VESICLE FUSION TO PLASMA MEMBRANE | 11 | 8.45e-01 | -3.39e-02 | 9.82e-01 |
| GOBP KERATINOCYTE MIGRATION | 12 | 8.39e-01 | 3.39e-02 | 9.82e-01 |
| GOBP CELL FATE COMMITMENT | 109 | 5.42e-01 | -3.39e-02 | 9.23e-01 |
| GOBP REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 22 | 7.83e-01 | 3.39e-02 | 9.75e-01 |
| GOMF DAMAGED DNA BINDING | 70 | 6.25e-01 | -3.38e-02 | 9.40e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN CATABOLIC PROCESS | 8 | 8.69e-01 | -3.37e-02 | 9.85e-01 |
| GOBP DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION | 542 | 1.82e-01 | 3.37e-02 | 7.13e-01 |
| GOBP ERBB SIGNALING PATHWAY | 86 | 5.89e-01 | 3.37e-02 | 9.36e-01 |
| GOCC PRESYNAPSE | 331 | 2.94e-01 | 3.37e-02 | 8.09e-01 |
| GOBP CATECHOL CONTAINING COMPOUND METABOLIC PROCESS | 27 | 7.63e-01 | -3.36e-02 | 9.70e-01 |
| GOBP EMBRYONIC DIGIT MORPHOGENESIS | 29 | 7.54e-01 | -3.36e-02 | 9.68e-01 |
| GOBP CUT CATABOLIC PROCESS | 5 | 8.96e-01 | 3.36e-02 | 9.86e-01 |
| GOBP POSITIVE REGULATION OF STEM CELL PROLIFERATION | 18 | 8.05e-01 | -3.36e-02 | 9.79e-01 |
| GOBP PEROXISOME ORGANIZATION | 34 | 7.35e-01 | 3.35e-02 | 9.65e-01 |
| GOBP EMBRYONIC SKELETAL SYSTEM DEVELOPMENT | 50 | 6.82e-01 | -3.35e-02 | 9.52e-01 |
| GOCC GOLGI APPARATUS | 1198 | 5.40e-02 | 3.35e-02 | 4.61e-01 |
| GOBP REGULATION OF RNA SPLICING | 150 | 4.80e-01 | -3.35e-02 | 9.07e-01 |
| GOBP REGULATION OF MACROPHAGE CHEMOTAXIS | 21 | 7.91e-01 | 3.35e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 580 | 1.71e-01 | 3.35e-02 | 6.99e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 98 | 5.68e-01 | 3.34e-02 | 9.30e-01 |
| GOCC CATALYTIC COMPLEX | 1502 | 3.31e-02 | -3.34e-02 | 3.72e-01 |
| GOBP REGULATION OF CELL DIFFERENTIATION | 971 | 8.09e-02 | 3.34e-02 | 5.41e-01 |
| GOBP TETRAPYRROLE CATABOLIC PROCESS | 7 | 8.78e-01 | -3.34e-02 | 9.86e-01 |
| GOMF TRANSCRIPTION ELONGATION FACTOR ACTIVITY | 6 | 8.87e-01 | -3.34e-02 | 9.86e-01 |
| GOMF GDP DISSOCIATION INHIBITOR ACTIVITY | 14 | 8.29e-01 | 3.34e-02 | 9.80e-01 |
| GOBP SENSORY PERCEPTION OF PAIN | 37 | 7.26e-01 | 3.33e-02 | 9.63e-01 |
| GOBP RESPONSE TO NITROGEN COMPOUND | 760 | 1.21e-01 | 3.33e-02 | 6.23e-01 |
| GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSPORT | 65 | 6.43e-01 | -3.33e-02 | 9.42e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 15 | 8.23e-01 | -3.33e-02 | 9.80e-01 |
| GOCC SPERM CONNECTING PIECE | 5 | 8.98e-01 | 3.32e-02 | 9.87e-01 |
| GOMF AMIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 35 | 7.34e-01 | -3.32e-02 | 9.65e-01 |
| GOCC INTERCALATED DISC | 36 | 7.30e-01 | 3.32e-02 | 9.64e-01 |
| GOBP INTERMEDIATE FILAMENT BASED PROCESS | 29 | 7.57e-01 | 3.32e-02 | 9.69e-01 |
| GOBP STRESS GRANULE ASSEMBLY | 28 | 7.61e-01 | 3.32e-02 | 9.70e-01 |
| GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 73 | 6.24e-01 | 3.32e-02 | 9.40e-01 |
| GOBP REGULATION OF HEXOKINASE ACTIVITY | 5 | 8.98e-01 | 3.32e-02 | 9.87e-01 |
| GOBP STEROID BIOSYNTHETIC PROCESS | 114 | 5.42e-01 | -3.31e-02 | 9.23e-01 |
| GOBP EPIBOLY | 27 | 7.66e-01 | -3.31e-02 | 9.70e-01 |
| GOBP CARDIOCYTE DIFFERENTIATION | 88 | 5.92e-01 | -3.31e-02 | 9.36e-01 |
| GOBP CARBOHYDRATE MEDIATED SIGNALING | 9 | 8.64e-01 | -3.31e-02 | 9.83e-01 |
| GOCC CELL BODY MEMBRANE | 14 | 8.31e-01 | 3.30e-02 | 9.80e-01 |
| GOCC VACUOLAR MEMBRANE | 414 | 2.52e-01 | 3.30e-02 | 7.78e-01 |
| GOMF UDP GLYCOSYLTRANSFERASE ACTIVITY | 88 | 5.93e-01 | 3.30e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY | 18 | 8.09e-01 | -3.30e-02 | 9.80e-01 |
| GOBP REGULATION OF MUSCLE SYSTEM PROCESS | 133 | 5.13e-01 | 3.29e-02 | 9.18e-01 |
| GOBP REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 45 | 7.02e-01 | 3.29e-02 | 9.56e-01 |
| GOBP REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 554 | 1.89e-01 | -3.28e-02 | 7.18e-01 |
| GOBP CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS | 83 | 6.06e-01 | 3.28e-02 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 62 | 6.55e-01 | 3.28e-02 | 9.47e-01 |
| GOBP SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 16 | 8.20e-01 | 3.28e-02 | 9.80e-01 |
| GOBP AMP BIOSYNTHETIC PROCESS | 11 | 8.51e-01 | 3.28e-02 | 9.82e-01 |
| GOBP REGULATION OF EPITHELIAL CELL MIGRATION | 152 | 4.86e-01 | 3.28e-02 | 9.11e-01 |
| GOBP POST TRANSLATIONAL PROTEIN MODIFICATION | 912 | 9.65e-02 | 3.28e-02 | 5.76e-01 |
| GOBP GLAND DEVELOPMENT | 252 | 3.72e-01 | 3.28e-02 | 8.57e-01 |
| GOBP NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 96 | 5.80e-01 | 3.27e-02 | 9.35e-01 |
| GOBP PHAGOCYTOSIS | 173 | 4.59e-01 | 3.27e-02 | 8.96e-01 |
| GOCC NUCLEOSOME | 33 | 7.45e-01 | -3.27e-02 | 9.66e-01 |
| GOBP REGULATION OF JUN KINASE ACTIVITY | 35 | 7.38e-01 | 3.27e-02 | 9.65e-01 |
| GOBP POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY | 23 | 7.86e-01 | -3.27e-02 | 9.76e-01 |
| GOBP NEURAL TUBE PATTERNING | 24 | 7.82e-01 | -3.27e-02 | 9.75e-01 |
| GOBP CELLULAR RESPONSE TO TOXIC SUBSTANCE | 84 | 6.05e-01 | -3.27e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 12 | 8.45e-01 | -3.27e-02 | 9.82e-01 |
| GOBP POST TRANSCRIPTIONAL REGULATION OF GENE EXPRESSION | 455 | 2.35e-01 | -3.26e-02 | 7.63e-01 |
| GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME ACTIVITY | 36 | 7.35e-01 | 3.26e-02 | 9.65e-01 |
| GOBP NEGATIVE REGULATION OF AXON EXTENSION | 28 | 7.65e-01 | -3.26e-02 | 9.70e-01 |
| GOBP FATTY ACID CATABOLIC PROCESS | 84 | 6.06e-01 | 3.26e-02 | 9.36e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 71 | 6.35e-01 | -3.26e-02 | 9.41e-01 |
| GOBP MULTI PASS TRANSMEMBRANE PROTEIN INSERTION INTO ER MEMBRANE | 9 | 8.66e-01 | -3.25e-02 | 9.84e-01 |
| GOCC MULTI PASS TRANSLOCON COMPLEX | 9 | 8.66e-01 | -3.25e-02 | 9.84e-01 |
| GOMF TRANSFERASE ACTIVITY TRANSFERRING ONE CARBON GROUPS | 194 | 4.36e-01 | 3.25e-02 | 8.84e-01 |
| GOBP ASTRAL MICROTUBULE ORGANIZATION | 9 | 8.66e-01 | 3.25e-02 | 9.84e-01 |
| GOMF BETA CATENIN BINDING | 58 | 6.69e-01 | 3.24e-02 | 9.49e-01 |
| GOCC PICLN SM PROTEIN COMPLEX | 6 | 8.91e-01 | 3.24e-02 | 9.86e-01 |
| GOBP PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION | 16 | 8.22e-01 | -3.24e-02 | 9.80e-01 |
| GOBP QUATERNARY AMMONIUM GROUP TRANSPORT | 15 | 8.28e-01 | -3.24e-02 | 9.80e-01 |
| GOBP GAMETE GENERATION | 444 | 2.44e-01 | 3.24e-02 | 7.73e-01 |
| GOBP PHOSPHATIDYLSERINE METABOLIC PROCESS | 18 | 8.12e-01 | 3.24e-02 | 9.80e-01 |
| GOBP CELLULAR RESPONSE TO LIPID | 394 | 2.73e-01 | 3.23e-02 | 7.94e-01 |
| GOMF ATPASE ACTIVATOR ACTIVITY | 24 | 7.84e-01 | 3.23e-02 | 9.76e-01 |
| GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE | 8 | 8.74e-01 | 3.23e-02 | 9.85e-01 |
| GOBP REGENERATION | 115 | 5.50e-01 | 3.23e-02 | 9.26e-01 |
| GOBP REGULATION OF HISTONE METHYLATION | 17 | 8.18e-01 | 3.23e-02 | 9.80e-01 |
| GOBP ACTOMYOSIN CONTRACTILE RING ORGANIZATION | 10 | 8.60e-01 | 3.23e-02 | 9.82e-01 |
| GOBP COLLAGEN FIBRIL ORGANIZATION | 28 | 7.68e-01 | -3.22e-02 | 9.70e-01 |
| GOBP CELLULAR RESPONSE TO STEROL | 14 | 8.35e-01 | -3.22e-02 | 9.81e-01 |
| GOBP RENAL SYSTEM DEVELOPMENT | 174 | 4.65e-01 | 3.21e-02 | 9.00e-01 |
| GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 7 | 8.83e-01 | 3.21e-02 | 9.86e-01 |
| GOBP HEMOSTASIS | 143 | 5.09e-01 | -3.21e-02 | 9.18e-01 |
| GOBP CHORION DEVELOPMENT | 8 | 8.75e-01 | 3.20e-02 | 9.86e-01 |
| GOCC CILIARY TRANSITION ZONE | 58 | 6.73e-01 | -3.20e-02 | 9.50e-01 |
| GOMF AMIDE BINDING | 261 | 3.74e-01 | 3.20e-02 | 8.60e-01 |
| GOBP ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS | 157 | 4.90e-01 | -3.20e-02 | 9.12e-01 |
| GOBP CHEMICAL HOMEOSTASIS | 629 | 1.74e-01 | -3.20e-02 | 7.05e-01 |
| GOBP NUCLEAR MEMBRANE REASSEMBLY | 25 | 7.82e-01 | 3.20e-02 | 9.75e-01 |
| GOCC RIBONUCLEOPROTEIN GRANULE | 221 | 4.14e-01 | 3.19e-02 | 8.77e-01 |
| GOMF STRUCTURAL CONSTITUENT OF CYTOSKELETON | 61 | 6.67e-01 | -3.19e-02 | 9.49e-01 |
| GOMF GTPASE ACTIVATING PROTEIN BINDING | 11 | 8.55e-01 | -3.19e-02 | 9.82e-01 |
| GOBP MYELOID LEUKOCYTE DIFFERENTIATION | 172 | 4.71e-01 | 3.19e-02 | 9.02e-01 |
| GOBP RESPONSE TO EPIDERMAL GROWTH FACTOR | 37 | 7.37e-01 | 3.19e-02 | 9.65e-01 |
| GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT | 29 | 7.66e-01 | -3.19e-02 | 9.70e-01 |
| GOBP PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL | 109 | 5.66e-01 | 3.19e-02 | 9.29e-01 |
| GOBP IMMUNE RESPONSE INHIBITING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 6 | 8.93e-01 | -3.18e-02 | 9.86e-01 |
| GOBP VENOUS BLOOD VESSEL DEVELOPMENT | 9 | 8.69e-01 | -3.18e-02 | 9.85e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION | 155 | 4.95e-01 | -3.18e-02 | 9.13e-01 |
| GOCC SPLICEOSOMAL SNRNP COMPLEX | 65 | 6.58e-01 | -3.18e-02 | 9.48e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOTAXIS | 39 | 7.31e-01 | 3.18e-02 | 9.64e-01 |
| GOMF BETA GALACTOSIDE CMP ALPHA 2 3 SIALYLTRANSFERASE ACTIVITY | 6 | 8.93e-01 | -3.18e-02 | 9.86e-01 |
| GOBP REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY | 7 | 8.84e-01 | -3.18e-02 | 9.86e-01 |
| GOMF GTPASE ACTIVATOR ACTIVITY | 223 | 4.15e-01 | 3.18e-02 | 8.77e-01 |
| GOBP CARBOHYDRATE DERIVATIVE METABOLIC PROCESS | 778 | 1.35e-01 | -3.18e-02 | 6.52e-01 |
| GOBP REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 29 | 7.67e-01 | 3.18e-02 | 9.70e-01 |
| GOBP CELL MATRIX ADHESION | 149 | 5.04e-01 | 3.17e-02 | 9.15e-01 |
| GOBP POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION | 136 | 5.24e-01 | -3.17e-02 | 9.20e-01 |
| GOBP PROTEIN FOLDING | 182 | 4.62e-01 | -3.17e-02 | 8.98e-01 |
| GOBP POSITIVE REGULATION OF MOLECULAR FUNCTION | 903 | 1.10e-01 | 3.17e-02 | 6.01e-01 |
| GOMF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 136 | 5.24e-01 | 3.17e-02 | 9.20e-01 |
| GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION | 7 | 8.85e-01 | -3.17e-02 | 9.86e-01 |
| GOCC PLASMA MEMBRANE RAFT | 70 | 6.47e-01 | 3.16e-02 | 9.43e-01 |
| GOMF LYASE ACTIVITY | 142 | 5.16e-01 | 3.16e-02 | 9.19e-01 |
| GOBP REGULATION OF MACROPHAGE ACTIVATION | 40 | 7.29e-01 | -3.16e-02 | 9.64e-01 |
| GOBP PROTEIN AUTOPROCESSING | 18 | 8.17e-01 | 3.15e-02 | 9.80e-01 |
| GOBP SPHINGOSINE BIOSYNTHETIC PROCESS | 10 | 8.63e-01 | -3.15e-02 | 9.83e-01 |
| GOBP REGULATION OF SECRETION | 359 | 3.08e-01 | 3.15e-02 | 8.19e-01 |
| GOBP MARGINAL ZONE B CELL DIFFERENTIATION | 7 | 8.85e-01 | 3.15e-02 | 9.86e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION | 1361 | 5.53e-02 | 3.14e-02 | 4.64e-01 |
| GOMF NUCLEASE ACTIVITY | 181 | 4.67e-01 | 3.14e-02 | 9.00e-01 |
| GOBP ANIMAL ORGAN MATURATION | 18 | 8.18e-01 | 3.14e-02 | 9.80e-01 |
| GOBP NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION | 27 | 7.78e-01 | -3.14e-02 | 9.74e-01 |
| GOBP NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION | 5 | 9.03e-01 | 3.14e-02 | 9.87e-01 |
| GOCC NON MOTILE CILIUM | 100 | 5.88e-01 | 3.14e-02 | 9.36e-01 |
| GOBP SECRETION | 573 | 2.02e-01 | 3.14e-02 | 7.32e-01 |
| GOBP PROTEIN ACYLATION | 123 | 5.48e-01 | 3.14e-02 | 9.25e-01 |
| GOCC ANNULATE LAMELLAE | 5 | 9.03e-01 | -3.14e-02 | 9.87e-01 |
| GOBP REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 28 | 7.74e-01 | 3.14e-02 | 9.72e-01 |
| GOBP REGULATION OF MEMBRANE REPOLARIZATION | 20 | 8.09e-01 | 3.13e-02 | 9.80e-01 |
| GOBP REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 16 | 8.29e-01 | -3.13e-02 | 9.80e-01 |
| GOCC ACTOMYOSIN | 58 | 6.81e-01 | -3.13e-02 | 9.52e-01 |
| GOBP BEHAVIORAL RESPONSE TO COCAINE | 8 | 8.78e-01 | 3.13e-02 | 9.86e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 90 | 6.09e-01 | -3.12e-02 | 9.36e-01 |
| GOBP AMINO ACID BETAINE METABOLIC PROCESS | 11 | 8.58e-01 | 3.12e-02 | 9.82e-01 |
| GOBP POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE | 17 | 8.24e-01 | -3.12e-02 | 9.80e-01 |
| GOMF G PROTEIN ALPHA SUBUNIT BINDING | 20 | 8.09e-01 | 3.12e-02 | 9.80e-01 |
| GOBP CELLULAR RESPONSE TO INSULIN STIMULUS | 155 | 5.03e-01 | 3.12e-02 | 9.15e-01 |
| GOBP ESTROGEN METABOLIC PROCESS | 17 | 8.24e-01 | -3.12e-02 | 9.80e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES | 636 | 1.83e-01 | 3.12e-02 | 7.13e-01 |
| GOMF LIPOPOLYSACCHARIDE IMMUNE RECEPTOR ACTIVITY | 6 | 8.95e-01 | -3.12e-02 | 9.86e-01 |
| GOCC SMN COMPLEX | 10 | 8.65e-01 | 3.12e-02 | 9.83e-01 |
| GOBP NEGATIVE REGULATION OF DNA BINDING | 25 | 7.88e-01 | -3.11e-02 | 9.76e-01 |
| GOBP REPRODUCTIVE SYSTEM DEVELOPMENT | 170 | 4.85e-01 | 3.11e-02 | 9.10e-01 |
| GOMF TAU PROTEIN KINASE ACTIVITY | 19 | 8.14e-01 | -3.11e-02 | 9.80e-01 |
| GOBP NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I | 18 | 8.19e-01 | 3.11e-02 | 9.80e-01 |
| GOBP REGULATION OF BLOOD PRESSURE | 87 | 6.16e-01 | 3.11e-02 | 9.36e-01 |
| GOBP DIOL BIOSYNTHETIC PROCESS | 17 | 8.24e-01 | 3.11e-02 | 9.80e-01 |
| GOMF ENDONUCLEASE ACTIVITY | 104 | 5.84e-01 | -3.11e-02 | 9.36e-01 |
| GOCC ENDOCYTIC VESICLE | 255 | 3.95e-01 | 3.10e-02 | 8.70e-01 |
| GOCC SODIUM CHANNEL COMPLEX | 7 | 8.87e-01 | 3.10e-02 | 9.86e-01 |
| GOBP GLIAL CELL DIFFERENTIATION | 142 | 5.25e-01 | 3.09e-02 | 9.21e-01 |
| GOBP MULTIVESICULAR BODY ORGANIZATION | 31 | 7.66e-01 | 3.09e-02 | 9.70e-01 |
| GOBP FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS | 9 | 8.73e-01 | 3.09e-02 | 9.85e-01 |
| GOCC TIGHT JUNCTION | 75 | 6.44e-01 | 3.09e-02 | 9.42e-01 |
| GOBP RESPONSE TO TOXIC SUBSTANCE | 157 | 5.05e-01 | -3.09e-02 | 9.16e-01 |
| GOBP REGULATION OF LOCOMOTION | 656 | 1.81e-01 | 3.08e-02 | 7.12e-01 |
| GOBP PEPTIDYL TYROSINE MODIFICATION | 170 | 4.89e-01 | 3.08e-02 | 9.12e-01 |
| GOBP FOREBRAIN GENERATION OF NEURONS | 25 | 7.90e-01 | 3.08e-02 | 9.76e-01 |
| GOMF AMP ACTIVATED PROTEIN KINASE ACTIVITY | 6 | 8.96e-01 | 3.08e-02 | 9.86e-01 |
| GOBP REGULATION OF ERBB SIGNALING PATHWAY | 50 | 7.07e-01 | -3.08e-02 | 9.57e-01 |
| GOBP REGULATION OF RESPIRATORY BURST | 13 | 8.48e-01 | 3.07e-02 | 9.82e-01 |
| GOCC COATED VESICLE MEMBRANE | 156 | 5.08e-01 | 3.07e-02 | 9.18e-01 |
| GOBP CENTRIOLE ASSEMBLY | 44 | 7.24e-01 | -3.07e-02 | 9.62e-01 |
| GOBP RESPONSE TO COBALT ION | 10 | 8.67e-01 | -3.07e-02 | 9.84e-01 |
| GOBP MICROTUBULE BUNDLE FORMATION | 61 | 6.79e-01 | -3.07e-02 | 9.52e-01 |
| GOMF CORECEPTOR ACTIVITY | 27 | 7.83e-01 | -3.07e-02 | 9.75e-01 |
| GOBP NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 42 | 7.31e-01 | 3.07e-02 | 9.64e-01 |
| GOBP REGULATION OF GASTRULATION | 8 | 8.81e-01 | 3.07e-02 | 9.86e-01 |
| GOBP VACUOLAR ACIDIFICATION | 32 | 7.64e-01 | -3.06e-02 | 9.70e-01 |
| GOMF EXOGENOUS PROTEIN BINDING | 61 | 6.79e-01 | -3.06e-02 | 9.52e-01 |
| GOBP DEOXYRIBONUCLEOSIDE METABOLIC PROCESS | 10 | 8.67e-01 | 3.06e-02 | 9.84e-01 |
| GOBP SKELETAL MUSCLE ORGAN DEVELOPMENT | 102 | 5.94e-01 | 3.06e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 34 | 7.58e-01 | 3.06e-02 | 9.69e-01 |
| GOBP REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I | 12 | 8.54e-01 | 3.06e-02 | 9.82e-01 |
| GOCC CUL4 RING E3 UBIQUITIN LIGASE COMPLEX | 32 | 7.65e-01 | -3.06e-02 | 9.70e-01 |
| GOBP SENSORY PERCEPTION OF CHEMICAL STIMULUS | 30 | 7.72e-01 | -3.06e-02 | 9.72e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 18 | 8.23e-01 | -3.05e-02 | 9.80e-01 |
| GOBP MYELOID LEUKOCYTE MIGRATION | 156 | 5.12e-01 | -3.05e-02 | 9.18e-01 |
| GOMF PDZ DOMAIN BINDING | 55 | 6.96e-01 | 3.05e-02 | 9.55e-01 |
| GOMF DEOXYNUCLEOSIDE KINASE ACTIVITY | 5 | 9.06e-01 | 3.04e-02 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION | 26 | 7.89e-01 | 3.04e-02 | 9.76e-01 |
| GOBP CERAMIDE CATABOLIC PROCESS | 12 | 8.56e-01 | 3.03e-02 | 9.82e-01 |
| GOBP VIRAL GENE EXPRESSION | 93 | 6.14e-01 | -3.03e-02 | 9.36e-01 |
| GOBP APICAL JUNCTION ASSEMBLY | 46 | 7.22e-01 | 3.03e-02 | 9.62e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 5 | 9.07e-01 | -3.03e-02 | 9.88e-01 |
| GOMF DNA BINDING TRANSCRIPTION REPRESSOR ACTIVITY | 230 | 4.30e-01 | 3.03e-02 | 8.82e-01 |
| GOBP REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 166 | 5.03e-01 | 3.02e-02 | 9.15e-01 |
| GOBP NEGATIVE REGULATION OF SECRETION | 94 | 6.13e-01 | -3.02e-02 | 9.36e-01 |
| GOBP TRANSLATIONAL TERMINATION | 16 | 8.34e-01 | -3.02e-02 | 9.81e-01 |
| GOCC ACROSOMAL VESICLE | 68 | 6.68e-01 | -3.01e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS | 12 | 8.57e-01 | 3.01e-02 | 9.82e-01 |
| GOCC AP TYPE MEMBRANE COAT ADAPTOR COMPLEX | 35 | 7.58e-01 | -3.01e-02 | 9.69e-01 |
| GOBP INFLAMMATORY RESPONSE | 535 | 2.37e-01 | 3.01e-02 | 7.66e-01 |
| GOBP SENSORY PERCEPTION OF SMELL | 13 | 8.51e-01 | 3.01e-02 | 9.82e-01 |
| GOBP CELLULAR LIPID BIOSYNTHETIC PROCESS | 11 | 8.63e-01 | 3.00e-02 | 9.83e-01 |
| GOBP NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE | 21 | 8.12e-01 | -3.00e-02 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF NON MOTILE CILIUM ASSEMBLY | 6 | 8.99e-01 | -3.00e-02 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 9 | 8.76e-01 | 3.00e-02 | 9.86e-01 |
| GOCC INTERCELLULAR BRIDGE | 63 | 6.81e-01 | -3.00e-02 | 9.52e-01 |
| GOBP POST TRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE | 14 | 8.46e-01 | 2.99e-02 | 9.82e-01 |
| GOBP CELLULAR RESPONSE TO AMYLOID BETA | 29 | 7.80e-01 | -2.99e-02 | 9.75e-01 |
| GOBP NEGATIVE REGULATION OF REPRODUCTIVE PROCESS | 38 | 7.50e-01 | -2.99e-02 | 9.67e-01 |
| GOMF LAMININ BINDING | 13 | 8.52e-01 | -2.99e-02 | 9.82e-01 |
| GOBP DEVELOPMENTAL CELL GROWTH | 151 | 5.27e-01 | -2.99e-02 | 9.22e-01 |
| GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE | 104 | 5.99e-01 | 2.99e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 53 | 7.07e-01 | 2.99e-02 | 9.57e-01 |
| GOBP T CELL MIGRATION | 47 | 7.24e-01 | 2.98e-02 | 9.62e-01 |
| GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 19 | 8.22e-01 | 2.98e-02 | 9.80e-01 |
| GOMF CYTOKINE RECEPTOR BINDING | 143 | 5.39e-01 | -2.98e-02 | 9.23e-01 |
| GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE REGULATOR ACTIVITY | 42 | 7.39e-01 | 2.98e-02 | 9.65e-01 |
| GOBP PROTEIN LOCALIZATION TO EXTRACELLULAR REGION | 230 | 4.38e-01 | 2.97e-02 | 8.85e-01 |
| GOBP REGULATION OF MITOTIC CENTROSOME SEPARATION | 6 | 9.00e-01 | -2.97e-02 | 9.87e-01 |
| GOBP SEQUESTERING OF METAL ION | 8 | 8.84e-01 | -2.97e-02 | 9.86e-01 |
| GOCC MITOCHONDRIAL ALPHA KETOGLUTARATE DEHYDROGENASE COMPLEX | 6 | 9.00e-01 | 2.96e-02 | 9.87e-01 |
| GOCC AXON | 400 | 3.12e-01 | 2.96e-02 | 8.21e-01 |
| GOCC CAVEOLA | 54 | 7.07e-01 | 2.96e-02 | 9.57e-01 |
| GOBP REGULATION OF TRANS SYNAPTIC SIGNALING | 249 | 4.24e-01 | -2.95e-02 | 8.81e-01 |
| GOBP CELL CYCLE PHASE TRANSITION | 471 | 2.75e-01 | 2.95e-02 | 7.96e-01 |
| GOBP SYNCYTIUM FORMATION | 42 | 7.41e-01 | -2.95e-02 | 9.65e-01 |
| GOMF LYSINE ACETYLATED HISTONE BINDING | 22 | 8.11e-01 | -2.95e-02 | 9.80e-01 |
| GOMF ISOMERASE ACTIVITY | 138 | 5.50e-01 | -2.95e-02 | 9.26e-01 |
| GOBP REGULATION OF NEURON PROJECTION ARBORIZATION | 10 | 8.72e-01 | 2.95e-02 | 9.85e-01 |
| GOBP SYNAPTIC VESICLE LOCALIZATION | 40 | 7.47e-01 | -2.95e-02 | 9.66e-01 |
| GOBP POSITIVE REGULATION OF STEROID METABOLIC PROCESS | 16 | 8.39e-01 | 2.94e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSPORT | 35 | 7.64e-01 | 2.94e-02 | 9.70e-01 |
| GOBP TRANSCYTOSIS | 17 | 8.34e-01 | -2.93e-02 | 9.81e-01 |
| GOCC CELL BODY | 329 | 3.63e-01 | 2.93e-02 | 8.49e-01 |
| GOBP POSITIVE REGULATION OF ENDOCYTOSIS | 106 | 6.03e-01 | 2.93e-02 | 9.36e-01 |
| GOBP MAMMARY GLAND BRANCHING INVOLVED IN PREGNANCY | 5 | 9.10e-01 | 2.93e-02 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF CELL SIZE | 9 | 8.79e-01 | 2.93e-02 | 9.86e-01 |
| GOCC COPI COATED VESICLE | 23 | 8.08e-01 | -2.92e-02 | 9.80e-01 |
| GOBP NEGATIVE REGULATION OF MAPK CASCADE | 121 | 5.79e-01 | 2.92e-02 | 9.34e-01 |
| GOBP REGULATION OF ACTIN FILAMENT BASED MOVEMENT | 27 | 7.93e-01 | 2.92e-02 | 9.77e-01 |
| GOBP POSITIVE REGULATION OF CELL GROWTH | 103 | 6.09e-01 | 2.92e-02 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN POLYMERIZATION | 59 | 6.99e-01 | -2.92e-02 | 9.55e-01 |
| GOBP EMBRYO DEVELOPMENT | 703 | 1.91e-01 | -2.91e-02 | 7.21e-01 |
| GOCC GID COMPLEX | 5 | 9.10e-01 | 2.91e-02 | 9.88e-01 |
| GOCC U2 TYPE CATALYTIC STEP 2 SPLICEOSOME | 30 | 7.83e-01 | -2.91e-02 | 9.75e-01 |
| GOBP TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 156 | 5.33e-01 | 2.90e-02 | 9.23e-01 |
| GOCC TRANSFERASE COMPLEX | 756 | 1.79e-01 | -2.90e-02 | 7.10e-01 |
| GOBP POSITIVE REGULATION OF TROPHOBLAST CELL MIGRATION | 5 | 9.11e-01 | 2.89e-02 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY | 203 | 4.78e-01 | 2.89e-02 | 9.05e-01 |
| GOBP REGULATION OF RECEPTOR BINDING | 9 | 8.81e-01 | -2.89e-02 | 9.86e-01 |
| GOBP DETERMINATION OF ADULT LIFESPAN | 25 | 8.03e-01 | -2.89e-02 | 9.78e-01 |
| GOBP NEGATIVE REGULATION OF CILIUM ASSEMBLY | 18 | 8.32e-01 | 2.89e-02 | 9.80e-01 |
| GOBP RNA METHYLATION | 87 | 6.42e-01 | 2.89e-02 | 9.42e-01 |
| GOBP INSULIN RECEPTOR SIGNALING PATHWAY | 93 | 6.31e-01 | -2.89e-02 | 9.40e-01 |
| GOCC CCAAT BINDING FACTOR COMPLEX | 5 | 9.11e-01 | 2.88e-02 | 9.88e-01 |
| GOBP RESPONSE TO ANTIBIOTIC | 34 | 7.71e-01 | -2.88e-02 | 9.71e-01 |
| GOBP ALDEHYDE BIOSYNTHETIC PROCESS | 8 | 8.88e-01 | -2.88e-02 | 9.86e-01 |
| GOMF PHOSPHATIDYLINOSITOL TRANSFER ACTIVITY | 10 | 8.75e-01 | -2.88e-02 | 9.86e-01 |
| GOBP SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY | 13 | 8.57e-01 | -2.88e-02 | 9.82e-01 |
| GOMF CARBOHYDRATE KINASE ACTIVITY | 18 | 8.33e-01 | 2.88e-02 | 9.80e-01 |
| GOMF PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY | 18 | 8.33e-01 | 2.88e-02 | 9.80e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT | 19 | 8.28e-01 | 2.88e-02 | 9.80e-01 |
| GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDES | 11 | 8.69e-01 | -2.87e-02 | 9.85e-01 |
| GOBP REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 47 | 7.33e-01 | 2.87e-02 | 9.65e-01 |
| GOBP REGULATION OF CELLULAR CATABOLIC PROCESS | 553 | 2.51e-01 | 2.87e-02 | 7.78e-01 |
| GOBP NEUROFILAMENT CYTOSKELETON ORGANIZATION | 8 | 8.88e-01 | 2.87e-02 | 9.86e-01 |
| GOMF DNA SECONDARY STRUCTURE BINDING | 33 | 7.76e-01 | -2.87e-02 | 9.73e-01 |
| GOCC RNA POLYMERASE II HOLOENZYME | 69 | 6.81e-01 | -2.87e-02 | 9.52e-01 |
| GOBP AMINOGLYCOSIDE ANTIBIOTIC METABOLIC PROCESS | 5 | 9.12e-01 | -2.87e-02 | 9.88e-01 |
| GOBP POLYKETIDE METABOLIC PROCESS | 5 | 9.12e-01 | -2.87e-02 | 9.88e-01 |
| GOBP TUBULIN COMPLEX ASSEMBLY | 8 | 8.88e-01 | -2.87e-02 | 9.86e-01 |
| GOBP RENAL SYSTEM VASCULATURE DEVELOPMENT | 17 | 8.38e-01 | -2.86e-02 | 9.82e-01 |
| GOBP REGULATION OF HORMONE SECRETION | 133 | 5.69e-01 | 2.86e-02 | 9.31e-01 |
| GOBP REGULATION OF LIPASE ACTIVITY | 42 | 7.49e-01 | -2.86e-02 | 9.66e-01 |
| GOCC SCHAFFER COLLATERAL CA1 SYNAPSE | 51 | 7.24e-01 | -2.86e-02 | 9.62e-01 |
| GOBP TRANSCRIPTION BY RNA POLYMERASE I | 62 | 6.98e-01 | 2.85e-02 | 9.55e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION | 5 | 9.12e-01 | 2.85e-02 | 9.88e-01 |
| GOBP TRNA TRANSPORT | 5 | 9.12e-01 | 2.85e-02 | 9.88e-01 |
| GOBP EPITHELIUM DEVELOPMENT | 665 | 2.13e-01 | -2.85e-02 | 7.46e-01 |
| GOMF DNA POLYMERASE ACTIVITY | 28 | 7.94e-01 | -2.85e-02 | 9.77e-01 |
| GOCC TRNA SPLICING LIGASE COMPLEX | 8 | 8.89e-01 | -2.85e-02 | 9.86e-01 |
| GOCC TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 256 | 4.33e-01 | -2.85e-02 | 8.82e-01 |
| GOMF TRANSCRIPTION COREPRESSOR ACTIVITY | 163 | 5.31e-01 | 2.85e-02 | 9.23e-01 |
| GOBP REGULATION OF CHEMOTAXIS | 134 | 5.70e-01 | 2.85e-02 | 9.31e-01 |
| GOBP SPHINGOLIPID MEDIATED SIGNALING PATHWAY | 10 | 8.76e-01 | 2.84e-02 | 9.86e-01 |
| GOBP REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION | 20 | 8.26e-01 | -2.84e-02 | 9.80e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 80 | 6.61e-01 | 2.84e-02 | 9.49e-01 |
| GOBP FRUCTOSE 1 6 BISPHOSPHATE METABOLIC PROCESS | 5 | 9.12e-01 | 2.84e-02 | 9.88e-01 |
| GOMF 4 IRON 4 SULFUR CLUSTER BINDING | 42 | 7.50e-01 | -2.84e-02 | 9.67e-01 |
| GOBP NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION | 30 | 7.88e-01 | 2.84e-02 | 9.76e-01 |
| GOCC PROTEASOME REGULATORY PARTICLE | 19 | 8.31e-01 | 2.84e-02 | 9.80e-01 |
| GOBP COPULATION | 7 | 8.97e-01 | -2.84e-02 | 9.86e-01 |
| GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 15 | 8.49e-01 | 2.83e-02 | 9.82e-01 |
| GOBP RESPONSE TO CORTICOSTEROID | 86 | 6.50e-01 | -2.83e-02 | 9.44e-01 |
| GOBP PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 162 | 5.35e-01 | -2.83e-02 | 9.23e-01 |
| GOBP REGULATION OF PIGMENTATION | 10 | 8.77e-01 | -2.83e-02 | 9.86e-01 |
| GOBP DNA SYNTHESIS INVOLVED IN DNA REPAIR | 34 | 7.75e-01 | 2.83e-02 | 9.73e-01 |
| GOMF DELTA CATENIN BINDING | 6 | 9.04e-01 | 2.83e-02 | 9.88e-01 |
| GOMF VITAMIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 21 | 8.22e-01 | -2.83e-02 | 9.80e-01 |
| GOBP ESTABLISHMENT OF RNA LOCALIZATION | 143 | 5.61e-01 | 2.82e-02 | 9.28e-01 |
| GOBP LAMELLIPODIUM ASSEMBLY | 51 | 7.28e-01 | -2.82e-02 | 9.64e-01 |
| GOBP OVULATION CYCLE | 38 | 7.64e-01 | -2.82e-02 | 9.70e-01 |
| GOBP VITAMIN D RECEPTOR SIGNALING PATHWAY | 9 | 8.84e-01 | 2.81e-02 | 9.86e-01 |
| GOBP RESPONSE TO TUMOR NECROSIS FACTOR | 180 | 5.16e-01 | -2.81e-02 | 9.19e-01 |
| GOBP TYPE B PANCREATIC CELL DEVELOPMENT | 13 | 8.61e-01 | -2.81e-02 | 9.83e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 42 | 7.53e-01 | -2.81e-02 | 9.68e-01 |
| GOBP TELOMERASE RNA LOCALIZATION | 19 | 8.32e-01 | -2.81e-02 | 9.80e-01 |
| GOBP SPLICEOSOMAL SNRNP ASSEMBLY | 38 | 7.64e-01 | 2.81e-02 | 9.70e-01 |
| GOBP SERTOLI CELL DIFFERENTIATION | 13 | 8.61e-01 | -2.81e-02 | 9.83e-01 |
| GOBP NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 45 | 7.44e-01 | 2.81e-02 | 9.66e-01 |
| GOMF PHOSPHOPROTEIN BINDING | 78 | 6.68e-01 | 2.81e-02 | 9.49e-01 |
| GOCC RECEPTOR COMPLEX | 192 | 5.03e-01 | 2.81e-02 | 9.15e-01 |
| GOBP NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 175 | 5.23e-01 | -2.80e-02 | 9.20e-01 |
| GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL ACTIVATION | 6 | 9.05e-01 | -2.80e-02 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 248 | 4.49e-01 | -2.80e-02 | 8.89e-01 |
| GOBP TIGHT JUNCTION ORGANIZATION | 47 | 7.40e-01 | 2.80e-02 | 9.65e-01 |
| GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 20 | 8.29e-01 | 2.80e-02 | 9.80e-01 |
| GOMF HYDROXYMETHYL FORMYL AND RELATED TRANSFERASE ACTIVITY | 7 | 8.98e-01 | 2.79e-02 | 9.87e-01 |
| GOBP DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 14 | 8.57e-01 | 2.79e-02 | 9.82e-01 |
| GOMF PRENYLTRANSFERASE ACTIVITY | 17 | 8.42e-01 | 2.79e-02 | 9.82e-01 |
| GOBP MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 38 | 7.67e-01 | -2.78e-02 | 9.70e-01 |
| GOMF ACTIN BINDING | 310 | 4.01e-01 | -2.78e-02 | 8.72e-01 |
| GOBP OSTEOBLAST DEVELOPMENT | 9 | 8.85e-01 | 2.78e-02 | 9.86e-01 |
| GOMF BASIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 8.79e-01 | 2.78e-02 | 9.86e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 121 | 5.98e-01 | -2.78e-02 | 9.36e-01 |
| GOBP HEXOSE PHOSPHATE TRANSPORT | 5 | 9.14e-01 | 2.78e-02 | 9.88e-01 |
| GOBP GLYCEROLIPID CATABOLIC PROCESS | 42 | 7.56e-01 | -2.78e-02 | 9.69e-01 |
| GOBP SNO S RNA PROCESSING | 12 | 8.68e-01 | -2.77e-02 | 9.84e-01 |
| GOBP NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 13 | 8.63e-01 | -2.77e-02 | 9.83e-01 |
| GOBP POSITIVE REGULATION OF HISTONE ACETYLATION | 9 | 8.86e-01 | -2.76e-02 | 9.86e-01 |
| GOBP CELLULAR RESPONSE TO LEUCINE STARVATION | 12 | 8.69e-01 | 2.76e-02 | 9.85e-01 |
| GOBP CELL SUBSTRATE JUNCTION ORGANIZATION | 79 | 6.72e-01 | 2.76e-02 | 9.49e-01 |
| GOBP HORMONE MEDIATED SIGNALING PATHWAY | 131 | 5.86e-01 | 2.76e-02 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE | 14 | 8.58e-01 | -2.76e-02 | 9.82e-01 |
| GOBP PROTEIN CONTAINING COMPLEX LOCALIZATION | 145 | 5.68e-01 | -2.75e-02 | 9.30e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OH GROUP OF DONORS | 93 | 6.47e-01 | -2.75e-02 | 9.43e-01 |
| GOCC MRNA EDITING COMPLEX | 13 | 8.64e-01 | -2.75e-02 | 9.83e-01 |
| GOBP RESPONSE TO AMPHETAMINE | 14 | 8.59e-01 | 2.75e-02 | 9.82e-01 |
| GOCC RNA POLYMERASE III TRANSCRIPTION REGULATOR COMPLEX | 9 | 8.86e-01 | 2.75e-02 | 9.86e-01 |
| GOBP VESICLE DOCKING INVOLVED IN EXOCYTOSIS | 33 | 7.85e-01 | 2.74e-02 | 9.76e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHATASE ACTIVITY | 21 | 8.28e-01 | -2.74e-02 | 9.80e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO HYPOXIA | 13 | 8.64e-01 | -2.74e-02 | 9.83e-01 |
| GOBP NEUROTRANSMITTER UPTAKE | 20 | 8.32e-01 | -2.74e-02 | 9.80e-01 |
| GOBP CELLULAR SENESCENCE | 78 | 6.76e-01 | 2.74e-02 | 9.51e-01 |
| GOCC MKS COMPLEX | 13 | 8.64e-01 | 2.74e-02 | 9.83e-01 |
| GOBP PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS | 23 | 8.21e-01 | -2.73e-02 | 9.80e-01 |
| GOBP TEMPERATURE HOMEOSTASIS | 123 | 6.01e-01 | -2.73e-02 | 9.36e-01 |
| GOBP REGULATION OF GLUCONEOGENESIS | 39 | 7.68e-01 | -2.73e-02 | 9.70e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE CYCLE | 10 | 8.81e-01 | 2.73e-02 | 9.86e-01 |
| GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 671 | 2.32e-01 | 2.73e-02 | 7.59e-01 |
| GOMF SIALYLTRANSFERASE ACTIVITY | 11 | 8.76e-01 | 2.73e-02 | 9.86e-01 |
| GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR BINDING | 23 | 8.21e-01 | -2.73e-02 | 9.80e-01 |
| GOBP NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION | 8 | 8.94e-01 | -2.72e-02 | 9.86e-01 |
| GOCC EXTRINSIC COMPONENT OF MEMBRANE | 135 | 5.86e-01 | -2.72e-02 | 9.36e-01 |
| GOBP REGULATION OF PHOSPHOLIPASE C ACTIVITY | 24 | 8.18e-01 | 2.72e-02 | 9.80e-01 |
| GOBP MRNA PROCESSING | 428 | 3.37e-01 | 2.72e-02 | 8.36e-01 |
| GOBP PEROXISOMAL TRANSPORT | 23 | 8.22e-01 | 2.72e-02 | 9.80e-01 |
| GOBP FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 32 | 7.90e-01 | 2.72e-02 | 9.76e-01 |
| GOMF NUCLEAR ESTROGEN RECEPTOR BINDING | 33 | 7.87e-01 | -2.71e-02 | 9.76e-01 |
| GOMF MRNA BINDING | 266 | 4.47e-01 | -2.71e-02 | 8.88e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 22 | 8.26e-01 | -2.71e-02 | 9.80e-01 |
| GOBP RESPONSE TO CARBOHYDRATE | 149 | 5.69e-01 | 2.71e-02 | 9.31e-01 |
| GOBP DEVELOPMENT OF SECONDARY SEXUAL CHARACTERISTICS | 6 | 9.09e-01 | 2.71e-02 | 9.88e-01 |
| GOBP REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 49 | 7.43e-01 | -2.71e-02 | 9.65e-01 |
| GOCC ENDOSOME LUMEN | 22 | 8.26e-01 | 2.70e-02 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 6 | 9.09e-01 | -2.70e-02 | 9.88e-01 |
| GOBP ADRENAL GLAND DEVELOPMENT | 16 | 8.52e-01 | 2.70e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 113 | 6.21e-01 | 2.70e-02 | 9.37e-01 |
| GOBP REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 155 | 5.63e-01 | -2.70e-02 | 9.29e-01 |
| GOBP EMBRYONIC ORGAN MORPHOGENESIS | 132 | 5.93e-01 | -2.70e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF HEAT GENERATION | 6 | 9.09e-01 | -2.69e-02 | 9.88e-01 |
| GOBP EXPORT ACROSS PLASMA MEMBRANE | 38 | 7.74e-01 | -2.69e-02 | 9.72e-01 |
| GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 10 | 8.83e-01 | 2.69e-02 | 9.86e-01 |
| GOMF POLY ADP D RIBOSE BINDING | 6 | 9.09e-01 | 2.69e-02 | 9.88e-01 |
| GOBP MITOTIC CELL CYCLE PROCESS | 657 | 2.44e-01 | 2.69e-02 | 7.73e-01 |
| GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION | 49 | 7.45e-01 | 2.68e-02 | 9.66e-01 |
| GOBP APPENDAGE DEVELOPMENT | 99 | 6.45e-01 | 2.68e-02 | 9.43e-01 |
| GOBP EAR DEVELOPMENT | 99 | 6.45e-01 | 2.68e-02 | 9.43e-01 |
| GOBP REGULATION OF GLIOGENESIS | 59 | 7.22e-01 | 2.68e-02 | 9.62e-01 |
| GOBP REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 66 | 7.07e-01 | -2.68e-02 | 9.57e-01 |
| GOBP NEGATIVE REGULATION OF BEHAVIOR | 5 | 9.17e-01 | 2.68e-02 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF CELL POPULATION PROLIFERATION | 760 | 2.13e-01 | -2.68e-02 | 7.46e-01 |
| GOBP LIPID OXIDATION | 88 | 6.65e-01 | 2.67e-02 | 9.49e-01 |
| GOBP NEUROBLAST DIVISION | 9 | 8.90e-01 | -2.67e-02 | 9.86e-01 |
| GOMF UBIQUITIN LIGASE COMPLEX SCAFFOLD ACTIVITY | 6 | 9.10e-01 | -2.67e-02 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF REPRODUCTIVE PROCESS | 41 | 7.68e-01 | 2.67e-02 | 9.70e-01 |
| GOBP MAINTENANCE OF CELL POLARITY | 13 | 8.68e-01 | 2.67e-02 | 9.84e-01 |
| GOBP RESPONSE TO ISOQUINOLINE ALKALOID | 8 | 8.96e-01 | 2.67e-02 | 9.86e-01 |
| GOBP REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 17 | 8.49e-01 | -2.66e-02 | 9.82e-01 |
| GOBP CELLULAR RESPONSE TO RADIATION | 144 | 5.82e-01 | -2.66e-02 | 9.35e-01 |
| GOBP REGULATION OF CALCIUM ION IMPORT | 16 | 8.54e-01 | 2.66e-02 | 9.82e-01 |
| GOBP STEROL TRANSPORT | 87 | 6.68e-01 | -2.66e-02 | 9.49e-01 |
| GOBP PROTEIN K11 LINKED UBIQUITINATION | 29 | 8.04e-01 | 2.66e-02 | 9.79e-01 |
| GOBP SINGLE FERTILIZATION | 65 | 7.11e-01 | -2.66e-02 | 9.59e-01 |
| GOBP REGULATION OF PROTEIN UBIQUITINATION | 176 | 5.44e-01 | 2.66e-02 | 9.23e-01 |
| GOMF PROTEIN SELF ASSOCIATION | 52 | 7.40e-01 | 2.66e-02 | 9.65e-01 |
| GOBP POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 98 | 6.50e-01 | -2.66e-02 | 9.44e-01 |
| GOBP ANIMAL ORGAN MORPHOGENESIS | 531 | 2.98e-01 | -2.66e-02 | 8.13e-01 |
| GOBP EARLY ENDOSOME TO GOLGI TRANSPORT | 12 | 8.73e-01 | 2.65e-02 | 9.85e-01 |
| GOBP PROTEIN ACETYLATION | 89 | 6.66e-01 | -2.65e-02 | 9.49e-01 |
| GOCC CELL CELL CONTACT ZONE | 51 | 7.43e-01 | 2.65e-02 | 9.65e-01 |
| GOBP POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS | 15 | 8.59e-01 | 2.65e-02 | 9.82e-01 |
| GOBP VESICLE MEDIATED TRANSPORT | 1163 | 1.33e-01 | 2.65e-02 | 6.47e-01 |
| GOBP NEGATIVE REGULATION OF CELL CYCLE | 316 | 4.20e-01 | 2.64e-02 | 8.81e-01 |
| GOBP REGULATION OF MRNA SPLICING VIA SPLICEOSOME | 84 | 6.76e-01 | -2.64e-02 | 9.51e-01 |
| GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 100 | 6.48e-01 | -2.64e-02 | 9.44e-01 |
| GOBP DELAMINATION | 5 | 9.19e-01 | -2.64e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF STEROL TRANSPORT | 5 | 9.19e-01 | -2.64e-02 | 9.88e-01 |
| GOBP REGULATION OF PROTEIN CATABOLIC PROCESS | 298 | 4.35e-01 | -2.64e-02 | 8.83e-01 |
| GOBP CORPUS CALLOSUM MORPHOGENESIS | 5 | 9.19e-01 | -2.64e-02 | 9.88e-01 |
| GOBP REGULATION OF DNA METABOLIC PROCESS | 442 | 3.44e-01 | -2.64e-02 | 8.41e-01 |
| GOBP MODULATION BY HOST OF SYMBIONT PROCESS | 70 | 7.04e-01 | 2.63e-02 | 9.56e-01 |
| GOBP MAMMARY GLAND MORPHOGENESIS | 21 | 8.35e-01 | -2.63e-02 | 9.81e-01 |
| GOBP NEPHRON DEVELOPMENT | 73 | 6.98e-01 | 2.63e-02 | 9.55e-01 |
| GOBP MRNA 3 END PROCESSING | 48 | 7.53e-01 | -2.63e-02 | 9.68e-01 |
| GOBP GLUCOSE IMPORT | 49 | 7.50e-01 | -2.63e-02 | 9.67e-01 |
| GOBP REGULATION OF PROTEIN MODIFICATION PROCESS | 962 | 1.72e-01 | 2.63e-02 | 7.02e-01 |
| GOCC ACTIN CYTOSKELETON | 355 | 3.97e-01 | -2.62e-02 | 8.71e-01 |
| GOBP REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION | 7 | 9.04e-01 | -2.62e-02 | 9.88e-01 |
| GOBP CARDIAC MYOFIBRIL ASSEMBLY | 9 | 8.92e-01 | 2.62e-02 | 9.86e-01 |
| GOBP OSTEOCLAST FUSION | 6 | 9.11e-01 | -2.62e-02 | 9.88e-01 |
| GOBP CELL CELL ADHESION MEDIATED BY CADHERIN | 17 | 8.52e-01 | -2.62e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 75 | 6.95e-01 | -2.62e-02 | 9.54e-01 |
| GOBP SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 391 | 3.76e-01 | 2.62e-02 | 8.60e-01 |
| GOMF TRANSMITTER GATED CHANNEL ACTIVITY | 13 | 8.70e-01 | 2.62e-02 | 9.85e-01 |
| GOBP ONE CARBON METABOLIC PROCESS | 23 | 8.28e-01 | -2.62e-02 | 9.80e-01 |
| GOBP NEGATIVE REGULATION OF TOR SIGNALING | 59 | 7.28e-01 | -2.62e-02 | 9.64e-01 |
| GOBP CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS | 10 | 8.86e-01 | 2.62e-02 | 9.86e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 36 | 7.86e-01 | -2.61e-02 | 9.76e-01 |
| GOMF OPSONIN RECEPTOR ACTIVITY | 5 | 9.20e-01 | -2.61e-02 | 9.88e-01 |
| GOBP REGULATION OF HISTONE MODIFICATION | 35 | 7.90e-01 | 2.60e-02 | 9.76e-01 |
| GOMF PEPTIDASE ACTIVITY | 355 | 4.01e-01 | 2.60e-02 | 8.72e-01 |
| GOMF NEUREXIN FAMILY PROTEIN BINDING | 9 | 8.92e-01 | 2.60e-02 | 9.86e-01 |
| GOBP DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM | 44 | 7.66e-01 | 2.60e-02 | 9.70e-01 |
| GOBP MACROMOLECULE DEPALMITOYLATION | 11 | 8.81e-01 | -2.60e-02 | 9.86e-01 |
| GOMF PALMITOYL HYDROLASE ACTIVITY | 11 | 8.81e-01 | -2.60e-02 | 9.86e-01 |
| GOBP CELLULAR RESPONSE TO UV | 78 | 6.92e-01 | -2.60e-02 | 9.54e-01 |
| GOBP CRD MEDIATED MRNA STABILIZATION | 10 | 8.87e-01 | -2.60e-02 | 9.86e-01 |
| GOBP POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT | 124 | 6.18e-01 | 2.60e-02 | 9.37e-01 |
| GOBP DEVELOPMENTAL MATURATION | 186 | 5.43e-01 | 2.59e-02 | 9.23e-01 |
| GOBP NERVOUS SYSTEM PROCESS | 533 | 3.08e-01 | 2.59e-02 | 8.19e-01 |
| GOBP MALE GAMETE GENERATION | 335 | 4.17e-01 | 2.59e-02 | 8.79e-01 |
| GOMF U1 SNRNP BINDING | 6 | 9.13e-01 | 2.59e-02 | 9.88e-01 |
| GOBP OSTEOBLAST DIFFERENTIATION | 138 | 6.01e-01 | -2.58e-02 | 9.36e-01 |
| GOCC TOR COMPLEX | 11 | 8.82e-01 | 2.58e-02 | 9.86e-01 |
| GOBP SYNAPTIC VESICLE ENDOSOMAL PROCESSING | 9 | 8.93e-01 | 2.58e-02 | 9.86e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 86 | 6.80e-01 | -2.58e-02 | 9.52e-01 |
| GOBP POSITIVE REGULATION OF EXOSOMAL SECRETION | 13 | 8.72e-01 | -2.58e-02 | 9.85e-01 |
| GOMF PROMOTER SPECIFIC CHROMATIN BINDING | 54 | 7.43e-01 | -2.58e-02 | 9.65e-01 |
| GOBP REGULATION OF CELL DIVISION | 126 | 6.18e-01 | 2.57e-02 | 9.37e-01 |
| GOBP REGULATION OF DNA RECOMBINATION | 113 | 6.37e-01 | 2.57e-02 | 9.41e-01 |
| GOBP SMALL MOLECULE METABOLIC PROCESS | 1329 | 1.21e-01 | -2.57e-02 | 6.23e-01 |
| GOBP RNA GUANINE N7 METHYLATION | 6 | 9.13e-01 | -2.57e-02 | 9.88e-01 |
| GOBP DNA RECOMBINATION | 278 | 4.62e-01 | -2.57e-02 | 8.99e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 145 | 5.94e-01 | 2.57e-02 | 9.36e-01 |
| GOBP PHOTORECEPTOR CELL DEVELOPMENT | 25 | 8.24e-01 | 2.57e-02 | 9.80e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING | 15 | 8.63e-01 | 2.57e-02 | 9.83e-01 |
| GOBP POSITIVE REGULATION OF RESPIRATORY BURST | 5 | 9.21e-01 | -2.56e-02 | 9.88e-01 |
| GOBP REGULATION OF GONAD DEVELOPMENT | 5 | 9.21e-01 | -2.56e-02 | 9.88e-01 |
| GOMF CALMODULIN BINDING | 132 | 6.11e-01 | 2.56e-02 | 9.36e-01 |
| GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 38 | 7.85e-01 | -2.56e-02 | 9.76e-01 |
| GOBP REGULATION OF NEUROINFLAMMATORY RESPONSE | 25 | 8.25e-01 | 2.56e-02 | 9.80e-01 |
| GOCC MRNA CLEAVAGE FACTOR COMPLEX | 19 | 8.47e-01 | 2.56e-02 | 9.82e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 30 | 8.08e-01 | -2.56e-02 | 9.80e-01 |
| GOBP REGULATION OF MEMBRANE POTENTIAL | 223 | 5.11e-01 | -2.56e-02 | 9.18e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A NUCLEIC ACID | 543 | 3.11e-01 | 2.56e-02 | 8.21e-01 |
| GOBP REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 33 | 7.99e-01 | 2.56e-02 | 9.77e-01 |
| GOBP NEGATIVE REGULATION OF DNA REPAIR | 35 | 7.94e-01 | -2.55e-02 | 9.77e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSPORT | 19 | 8.47e-01 | -2.55e-02 | 9.82e-01 |
| GOBP NUCLEAR BODY ORGANIZATION | 13 | 8.73e-01 | -2.55e-02 | 9.85e-01 |
| GOBP REGULATION OF CARDIOCYTE DIFFERENTIATION | 12 | 8.78e-01 | -2.55e-02 | 9.86e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMATIN | 36 | 7.91e-01 | -2.55e-02 | 9.76e-01 |
| GOBP TRNA AMINOACYLATION FOR MITOCHONDRIAL PROTEIN TRANSLATION | 7 | 9.07e-01 | 2.55e-02 | 9.88e-01 |
| GOBP MULTI MULTICELLULAR ORGANISM PROCESS | 112 | 6.42e-01 | 2.55e-02 | 9.42e-01 |
| GOCC RECYCLING ENDOSOME | 158 | 5.82e-01 | 2.54e-02 | 9.35e-01 |
| GOBP REGULATION OF HETEROTYPIC CELL CELL ADHESION | 18 | 8.52e-01 | 2.54e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY | 11 | 8.84e-01 | 2.54e-02 | 9.86e-01 |
| GOBP IRON COORDINATION ENTITY TRANSPORT | 9 | 8.95e-01 | -2.54e-02 | 9.86e-01 |
| GOBP POSITIVE REGULATION OF HISTONE METHYLATION | 14 | 8.69e-01 | 2.54e-02 | 9.85e-01 |
| GOMF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY | 16 | 8.60e-01 | -2.54e-02 | 9.83e-01 |
| GOBP RESPONSE TO TESTOSTERONE | 30 | 8.10e-01 | -2.54e-02 | 9.80e-01 |
| GOMF PHOSPHOLIPASE D ACTIVITY | 5 | 9.22e-01 | 2.54e-02 | 9.88e-01 |
| GOBP REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 75 | 7.05e-01 | 2.53e-02 | 9.56e-01 |
| GOBP POSITIVE REGULATION OF TORC1 SIGNALING | 50 | 7.57e-01 | 2.53e-02 | 9.69e-01 |
| GOMF CAMP RESPONSE ELEMENT BINDING PROTEIN BINDING | 8 | 9.01e-01 | -2.53e-02 | 9.87e-01 |
| GOMF PEPTIDE BINDING | 194 | 5.45e-01 | 2.53e-02 | 9.23e-01 |
| GOBP LYSOSOMAL PROTEIN CATABOLIC PROCESS | 17 | 8.57e-01 | 2.52e-02 | 9.82e-01 |
| GOBP GOLGI LOCALIZATION | 13 | 8.75e-01 | -2.52e-02 | 9.86e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION | 43 | 7.75e-01 | -2.52e-02 | 9.73e-01 |
| GOBP MONOCARBOXYLIC ACID CATABOLIC PROCESS | 100 | 6.64e-01 | 2.52e-02 | 9.49e-01 |
| GOBP PROTEIN INSERTION INTO ER MEMBRANE | 29 | 8.15e-01 | -2.52e-02 | 9.80e-01 |
| GOBP DIGESTION | 47 | 7.65e-01 | -2.52e-02 | 9.70e-01 |
| GOBP VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS | 10 | 8.91e-01 | 2.51e-02 | 9.86e-01 |
| GOCC LATE ENDOSOME MEMBRANE | 148 | 5.98e-01 | 2.51e-02 | 9.36e-01 |
| GOBP SPERM CAPACITATION | 9 | 8.96e-01 | -2.51e-02 | 9.86e-01 |
| GOBP HISTONE MRNA METABOLIC PROCESS | 24 | 8.32e-01 | 2.51e-02 | 9.80e-01 |
| GOBP MITOTIC CELL CYCLE | 768 | 2.41e-01 | 2.51e-02 | 7.69e-01 |
| GOBP ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 696 | 2.63e-01 | -2.51e-02 | 7.88e-01 |
| GOBP REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION | 288 | 4.66e-01 | -2.51e-02 | 9.00e-01 |
| GOBP ASTROCYTE DEVELOPMENT | 27 | 8.22e-01 | -2.50e-02 | 9.80e-01 |
| GOBP FATTY ACID DERIVATIVE METABOLIC PROCESS | 47 | 7.67e-01 | 2.50e-02 | 9.70e-01 |
| GOBP NEUTROPHIL MEDIATED CYTOTOXICITY | 5 | 9.23e-01 | 2.50e-02 | 9.88e-01 |
| GOBP ENGULFMENT OF APOPTOTIC CELL | 8 | 9.03e-01 | -2.50e-02 | 9.87e-01 |
| GOBP RESPONSE TO SALT | 228 | 5.18e-01 | -2.49e-02 | 9.19e-01 |
| GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 34 | 8.02e-01 | 2.49e-02 | 9.78e-01 |
| GOBP SYNAPSE ORGANIZATION | 259 | 4.92e-01 | -2.49e-02 | 9.13e-01 |
| GOBP REGULATION OF CDC42 PROTEIN SIGNAL TRANSDUCTION | 6 | 9.16e-01 | 2.49e-02 | 9.88e-01 |
| GOBP GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY | 10 | 8.92e-01 | 2.49e-02 | 9.86e-01 |
| GOCC CLEAVAGE FURROW | 47 | 7.69e-01 | -2.48e-02 | 9.70e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA SYNTHESIS DEPENDENT STRAND ANNEALING | 7 | 9.10e-01 | -2.48e-02 | 9.88e-01 |
| GOBP PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS | 113 | 6.49e-01 | 2.48e-02 | 9.44e-01 |
| GOBP DOUBLE STRAND BREAK REPAIR VIA CLASSICAL NONHOMOLOGOUS END JOINING | 6 | 9.16e-01 | 2.48e-02 | 9.88e-01 |
| GOBP DNA MODIFICATION | 84 | 6.95e-01 | 2.48e-02 | 9.54e-01 |
| GOBP REGULATION OF STEM CELL DIFFERENTIATION | 61 | 7.38e-01 | -2.48e-02 | 9.65e-01 |
| GOCC TRAPPII PROTEIN COMPLEX | 11 | 8.87e-01 | 2.47e-02 | 9.86e-01 |
| GOBP RESPONSE TO UV B | 16 | 8.64e-01 | -2.47e-02 | 9.83e-01 |
| GOMF ALCOHOL DEHYDROGENASE NADPPLUS ACTIVITY | 14 | 8.73e-01 | 2.47e-02 | 9.85e-01 |
| GOBP NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 11 | 8.87e-01 | 2.47e-02 | 9.86e-01 |
| GOBP NEGATIVE REGULATION OF KINASE ACTIVITY | 145 | 6.09e-01 | 2.47e-02 | 9.36e-01 |
| GOBP OSSIFICATION | 247 | 5.06e-01 | -2.46e-02 | 9.17e-01 |
| GOMF ADENYLATE CYCLASE ACTIVITY | 11 | 8.88e-01 | 2.45e-02 | 9.86e-01 |
| GOCC AZUROPHIL GRANULE | 130 | 6.29e-01 | -2.45e-02 | 9.40e-01 |
| GOBP TOR SIGNALING | 140 | 6.17e-01 | 2.45e-02 | 9.36e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION | 10 | 8.93e-01 | 2.45e-02 | 9.86e-01 |
| GOBP ORGANIC ACID METABOLIC PROCESS | 657 | 2.87e-01 | -2.45e-02 | 8.05e-01 |
| GOBP NEGATIVE REGULATION OF ATP DEPENDENT ACTIVITY | 11 | 8.88e-01 | 2.45e-02 | 9.86e-01 |
| GOCC APICAL PART OF CELL | 245 | 5.10e-01 | -2.45e-02 | 9.18e-01 |
| GOBP NUCLEAR TRANSPORT | 290 | 4.75e-01 | 2.45e-02 | 9.03e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN ACETYLATION | 20 | 8.50e-01 | 2.45e-02 | 9.82e-01 |
| GOBP REGULATION OF MYOTUBE DIFFERENTIATION | 26 | 8.29e-01 | 2.44e-02 | 9.80e-01 |
| GOBP EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS | 11 | 8.88e-01 | -2.44e-02 | 9.86e-01 |
| GOBP SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT | 9 | 8.99e-01 | 2.44e-02 | 9.87e-01 |
| GOMF C C CHEMOKINE BINDING | 8 | 9.05e-01 | -2.44e-02 | 9.88e-01 |
| GOBP REGULATION OF ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME | 40 | 7.90e-01 | -2.44e-02 | 9.76e-01 |
| GOBP SODIUM ION IMPORT ACROSS PLASMA MEMBRANE | 11 | 8.89e-01 | 2.44e-02 | 9.86e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS | 13 | 8.79e-01 | -2.44e-02 | 9.86e-01 |
| GOMF NUCLEAR ANDROGEN RECEPTOR BINDING | 23 | 8.40e-01 | 2.43e-02 | 9.82e-01 |
| GOBP REGULATION OF PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS | 5 | 9.25e-01 | 2.43e-02 | 9.88e-01 |
| GOBP TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING | 6 | 9.18e-01 | -2.43e-02 | 9.88e-01 |
| GOBP HINDBRAIN MORPHOGENESIS | 28 | 8.24e-01 | -2.43e-02 | 9.80e-01 |
| GOBP CELLULAR RESPONSE TO ESTRADIOL STIMULUS | 23 | 8.40e-01 | -2.43e-02 | 9.82e-01 |
| GOMF CYCLIN BINDING | 32 | 8.13e-01 | 2.42e-02 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF VACUOLE ORGANIZATION | 22 | 8.44e-01 | -2.42e-02 | 9.82e-01 |
| GOBP RESPONSE TO HYDROXYUREA | 10 | 8.95e-01 | -2.42e-02 | 9.86e-01 |
| GOBP REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 36 | 8.02e-01 | -2.42e-02 | 9.78e-01 |
| GOCC PROTEASOME REGULATORY PARTICLE LID SUBCOMPLEX | 7 | 9.12e-01 | 2.42e-02 | 9.88e-01 |
| GOBP HISTONE MODIFICATION | 110 | 6.62e-01 | 2.42e-02 | 9.49e-01 |
| GOBP 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS | 9 | 9.00e-01 | 2.41e-02 | 9.87e-01 |
| GOBP RESPONSE TO MANGANESE ION | 15 | 8.71e-01 | 2.41e-02 | 9.85e-01 |
| GOCC CLATHRIN COATED VESICLE | 153 | 6.07e-01 | 2.41e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC CELL CYTOKINE PRODUCTION | 9 | 9.00e-01 | 2.41e-02 | 9.87e-01 |
| GOBP REGULATION OF SUPEROXIDE ANION GENERATION | 13 | 8.80e-01 | 2.41e-02 | 9.86e-01 |
| GOBP MITOCHONDRION ENDOPLASMIC RETICULUM MEMBRANE TETHERING | 7 | 9.12e-01 | 2.41e-02 | 9.88e-01 |
| GOBP SPHINGOLIPID CATABOLIC PROCESS | 21 | 8.49e-01 | -2.41e-02 | 9.82e-01 |
| GOCC PEPTIDASE COMPLEX | 106 | 6.69e-01 | -2.41e-02 | 9.49e-01 |
| GOBP REGULATION OF SULFUR METABOLIC PROCESS | 12 | 8.86e-01 | -2.40e-02 | 9.86e-01 |
| GOBP REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 32 | 8.15e-01 | 2.39e-02 | 9.80e-01 |
| GOBP VESICLE TARGETING TO FROM OR WITHIN GOLGI | 32 | 8.15e-01 | 2.39e-02 | 9.80e-01 |
| GOMF MONOATOMIC ANION CHANNEL ACTIVITY | 40 | 7.94e-01 | -2.39e-02 | 9.77e-01 |
| GOBP AROMATIC AMINO ACID TRANSPORT | 8 | 9.07e-01 | -2.39e-02 | 9.88e-01 |
| GOBP GLYCOSPHINGOLIPID METABOLIC PROCESS | 39 | 7.96e-01 | 2.39e-02 | 9.77e-01 |
| GOCC SIN3 TYPE COMPLEX | 22 | 8.46e-01 | -2.39e-02 | 9.82e-01 |
| GOBP REGULATION OF TRANSPORTER ACTIVITY | 133 | 6.35e-01 | 2.38e-02 | 9.41e-01 |
| GOMF NEUROTROPHIN TRK RECEPTOR BINDING | 5 | 9.27e-01 | 2.38e-02 | 9.88e-01 |
| GOBP DTTP METABOLIC PROCESS | 5 | 9.27e-01 | -2.38e-02 | 9.88e-01 |
| GOBP KETONE BODY METABOLIC PROCESS | 5 | 9.27e-01 | 2.38e-02 | 9.88e-01 |
| GOCC TRANSPORT VESICLE MEMBRANE | 152 | 6.13e-01 | 2.38e-02 | 9.36e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIUM | 57 | 7.57e-01 | 2.37e-02 | 9.69e-01 |
| GOBP REGULATION OF SISTER CHROMATID COHESION | 14 | 8.78e-01 | 2.37e-02 | 9.86e-01 |
| GOMF POLYSACCHARIDE BINDING | 13 | 8.82e-01 | 2.37e-02 | 9.86e-01 |
| GOBP REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS | 71 | 7.30e-01 | -2.37e-02 | 9.64e-01 |
| GOCC AUTOPHAGOSOME | 104 | 6.77e-01 | -2.37e-02 | 9.51e-01 |
| GOMF CHROMATIN PROTEIN ADAPTOR ACTIVITY | 14 | 8.78e-01 | -2.36e-02 | 9.86e-01 |
| GOBP RESPONSE TO WATER | 7 | 9.14e-01 | 2.36e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 83 | 7.11e-01 | 2.35e-02 | 9.59e-01 |
| GOMF ACYLTRANSFERASE ACTIVITY TRANSFERRING GROUPS OTHER THAN AMINO ACYL GROUPS | 175 | 5.92e-01 | -2.35e-02 | 9.36e-01 |
| GOBP REGULATION OF CD40 SIGNALING PATHWAY | 5 | 9.27e-01 | -2.35e-02 | 9.88e-01 |
| GOBP PROTEIN PROCESSING | 162 | 6.07e-01 | -2.35e-02 | 9.36e-01 |
| GOBP DNA TEMPLATED TRANSCRIPTION INITIATION | 125 | 6.51e-01 | 2.35e-02 | 9.44e-01 |
| GOBP PROTEASOMAL PROTEIN CATABOLIC PROCESS | 472 | 3.85e-01 | 2.35e-02 | 8.64e-01 |
| GOBP REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 98 | 6.89e-01 | 2.35e-02 | 9.54e-01 |
| GOBP REGULATION OF ACTIN NUCLEATION | 31 | 8.22e-01 | -2.34e-02 | 9.80e-01 |
| GOBP METHYLATION | 240 | 5.33e-01 | 2.34e-02 | 9.23e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 18 | 8.63e-01 | -2.34e-02 | 9.83e-01 |
| GOBP CELLULAR COMPONENT MORPHOGENESIS | 471 | 3.87e-01 | 2.34e-02 | 8.65e-01 |
| GOMF HISTONE H4K16 ACETYLTRANSFERASE ACTIVITY | 9 | 9.03e-01 | 2.34e-02 | 9.87e-01 |
| GOBP ERK1 AND ERK2 CASCADE | 194 | 5.76e-01 | -2.34e-02 | 9.33e-01 |
| GOBP REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 160 | 6.11e-01 | 2.33e-02 | 9.36e-01 |
| GOBP REGULATION OF PHOSPHORYLATION | 724 | 2.89e-01 | 2.33e-02 | 8.06e-01 |
| GOBP REGULATION OF MICROTUBULE BASED PROCESS | 198 | 5.73e-01 | 2.33e-02 | 9.32e-01 |
| GOBP RESPONSE TO ORGANIC CYCLIC COMPOUND | 574 | 3.43e-01 | 2.33e-02 | 8.41e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDASE ACTIVITY | 73 | 7.31e-01 | 2.33e-02 | 9.64e-01 |
| GOMF MOLECULAR ADAPTOR ACTIVITY | 481 | 3.84e-01 | 2.33e-02 | 8.64e-01 |
| GOBP HEART TRABECULA MORPHOGENESIS | 20 | 8.57e-01 | -2.32e-02 | 9.82e-01 |
| GOBP REGULATION OF LIPID BIOSYNTHETIC PROCESS | 124 | 6.55e-01 | -2.32e-02 | 9.47e-01 |
| GOBP ALPHA AMINO ACID CATABOLIC PROCESS | 60 | 7.56e-01 | 2.32e-02 | 9.69e-01 |
| GOBP CORONARY VASCULATURE DEVELOPMENT | 31 | 8.23e-01 | -2.32e-02 | 9.80e-01 |
| GOBP GOLGI TO LYSOSOME TRANSPORT | 11 | 8.94e-01 | -2.32e-02 | 9.86e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 15 | 8.76e-01 | 2.32e-02 | 9.86e-01 |
| GOBP POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 292 | 4.97e-01 | 2.32e-02 | 9.13e-01 |
| GOBP EPITHELIAL CELL DIFFERENTIATION | 370 | 4.46e-01 | 2.32e-02 | 8.88e-01 |
| GOBP REGULATION OF OSTEOBLAST DIFFERENTIATION | 72 | 7.34e-01 | -2.31e-02 | 9.65e-01 |
| GOCC ACTIN BASED CELL PROJECTION | 149 | 6.26e-01 | -2.31e-02 | 9.40e-01 |
| GOBP NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY | 19 | 8.61e-01 | 2.31e-02 | 9.83e-01 |
| GOBP HETEROCHROMATIN ORGANIZATION | 80 | 7.21e-01 | 2.31e-02 | 9.62e-01 |
| GOMF UBIQUITIN LIKE PROTEIN LIGASE BINDING | 287 | 5.02e-01 | 2.31e-02 | 9.15e-01 |
| GOBP ALDEHYDE CATABOLIC PROCESS | 10 | 8.99e-01 | -2.31e-02 | 9.87e-01 |
| GOBP STEROID HORMONE BIOSYNTHETIC PROCESS | 22 | 8.51e-01 | -2.31e-02 | 9.82e-01 |
| GOMF INTERMEDIATE FILAMENT BINDING | 5 | 9.29e-01 | -2.31e-02 | 9.88e-01 |
| GOBP REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION | 21 | 8.55e-01 | 2.31e-02 | 9.82e-01 |
| GOBP PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 36 | 8.11e-01 | 2.30e-02 | 9.80e-01 |
| GOCC ORGANELLE SUBCOMPARTMENT | 1138 | 1.96e-01 | 2.30e-02 | 7.28e-01 |
| GOBP NEURON DEVELOPMENT | 696 | 3.05e-01 | 2.30e-02 | 8.15e-01 |
| GOBP ISOTYPE SWITCHING TO IGG ISOTYPES | 11 | 8.95e-01 | 2.30e-02 | 9.86e-01 |
| GOBP POSTSYNAPTIC CYTOSKELETON ORGANIZATION | 10 | 9.00e-01 | -2.30e-02 | 9.87e-01 |
| GOBP REGULATION OF ENDOSOME ORGANIZATION | 5 | 9.29e-01 | -2.30e-02 | 9.88e-01 |
| GOBP MONONUCLEAR CELL MIGRATION | 131 | 6.50e-01 | -2.30e-02 | 9.44e-01 |
| GOBP PHOSPHOLIPID CATABOLIC PROCESS | 40 | 8.02e-01 | -2.30e-02 | 9.78e-01 |
| GOBP PEPTIDYL LYSINE ACETYLATION | 59 | 7.61e-01 | 2.29e-02 | 9.70e-01 |
| GOBP PROTEIN TARGETING TO MEMBRANE | 101 | 6.91e-01 | 2.29e-02 | 9.54e-01 |
| GOMF CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 35 | 8.15e-01 | -2.29e-02 | 9.80e-01 |
| GOBP ANDROGEN METABOLIC PROCESS | 17 | 8.70e-01 | 2.29e-02 | 9.85e-01 |
| GOBP LIPID LOCALIZATION | 304 | 4.94e-01 | 2.29e-02 | 9.13e-01 |
| GOMF PROTEIN BINDING INVOLVED IN HETEROTYPIC CELL CELL ADHESION | 8 | 9.11e-01 | -2.29e-02 | 9.88e-01 |
| GOCC MICROBODY | 121 | 6.64e-01 | 2.29e-02 | 9.49e-01 |
| GOBP MESODERM DEVELOPMENT | 66 | 7.48e-01 | -2.29e-02 | 9.66e-01 |
| GOMF PROTEIN MACROMOLECULE ADAPTOR ACTIVITY | 349 | 4.65e-01 | 2.28e-02 | 9.00e-01 |
| GOBP NEGATIVE REGULATION OF THYMOCYTE APOPTOTIC PROCESS | 6 | 9.23e-01 | 2.28e-02 | 9.88e-01 |
| GOBP REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 33 | 8.21e-01 | 2.28e-02 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 28 | 8.35e-01 | -2.28e-02 | 9.81e-01 |
| GOMF NEUROTRANSMITTER RECEPTOR ACTIVITY | 23 | 8.50e-01 | 2.28e-02 | 9.82e-01 |
| GOBP EXPORT FROM CELL | 546 | 3.65e-01 | 2.28e-02 | 8.52e-01 |
| GOBP HEPATICOBILIARY SYSTEM DEVELOPMENT | 94 | 7.03e-01 | -2.28e-02 | 9.56e-01 |
| GOMF NUCLEOBASE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 9.11e-01 | 2.28e-02 | 9.88e-01 |
| GOBP B CELL RECEPTOR SIGNALING PATHWAY | 46 | 7.90e-01 | 2.27e-02 | 9.76e-01 |
| GOBP POSITIVE REGULATION OF LOCOMOTION | 373 | 4.53e-01 | 2.27e-02 | 8.91e-01 |
| GOBP POSITIVE REGULATION OF LEUKOCYTE MIGRATION | 98 | 6.98e-01 | -2.27e-02 | 9.55e-01 |
| GOMF ACID THIOL LIGASE ACTIVITY | 21 | 8.57e-01 | 2.27e-02 | 9.82e-01 |
| GOMF LEUCINE ZIPPER DOMAIN BINDING | 9 | 9.06e-01 | 2.27e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 8 | 9.12e-01 | 2.27e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF AUTOPHAGY | 81 | 7.24e-01 | 2.27e-02 | 9.62e-01 |
| GOCC TRANSPORT VESICLE | 291 | 5.07e-01 | 2.27e-02 | 9.17e-01 |
| GOBP GLYCEROPHOSPHOLIPID CATABOLIC PROCESS | 24 | 8.48e-01 | 2.27e-02 | 9.82e-01 |
| GOBP MIDBRAIN DEVELOPMENT | 53 | 7.76e-01 | -2.26e-02 | 9.73e-01 |
| GOBP NEUROTRANSMITTER TRANSPORT | 109 | 6.84e-01 | 2.26e-02 | 9.53e-01 |
| GOBP REGULATION OF VASCULATURE DEVELOPMENT | 179 | 6.03e-01 | -2.26e-02 | 9.36e-01 |
| GOMF PYRIMIDINE NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 9.07e-01 | 2.26e-02 | 9.88e-01 |
| GOBP POLYPRENOL METABOLIC PROCESS | 23 | 8.52e-01 | -2.26e-02 | 9.82e-01 |
| GOBP DEADENYLATION DEPENDENT DECAPPING OF NUCLEAR TRANSCRIBED MRNA | 11 | 8.97e-01 | -2.25e-02 | 9.86e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION | 77 | 7.33e-01 | 2.25e-02 | 9.64e-01 |
| GOBP HOMOLOGOUS RECOMBINATION | 48 | 7.87e-01 | -2.25e-02 | 9.76e-01 |
| GOBP SYNAPTIC VESICLE BUDDING | 8 | 9.12e-01 | -2.25e-02 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION | 17 | 8.73e-01 | -2.25e-02 | 9.85e-01 |
| GOBP TISSUE REMODELING | 104 | 6.92e-01 | -2.25e-02 | 9.54e-01 |
| GOBP POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 13 | 8.88e-01 | -2.25e-02 | 9.86e-01 |
| GOBP CELLULAR RESPONSE TO GAMMA RADIATION | 22 | 8.55e-01 | 2.24e-02 | 9.82e-01 |
| GOMF PROTEIN TYROSINE KINASE BINDING | 82 | 7.26e-01 | -2.24e-02 | 9.63e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS | 1116 | 2.12e-01 | 2.24e-02 | 7.45e-01 |
| GOBP REGULATION OF CELL PROJECTION ASSEMBLY | 181 | 6.04e-01 | -2.24e-02 | 9.36e-01 |
| GOBP GLYCEROLIPID METABOLIC PROCESS | 290 | 5.13e-01 | 2.24e-02 | 9.18e-01 |
| GOBP TRNA METABOLIC PROCESS | 174 | 6.11e-01 | 2.24e-02 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF AMIDE METABOLIC PROCESS | 187 | 5.98e-01 | 2.24e-02 | 9.36e-01 |
| GOBP BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS | 13 | 8.89e-01 | 2.24e-02 | 9.86e-01 |
| GOBP NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 14 | 8.85e-01 | 2.23e-02 | 9.86e-01 |
| GOBP CELLULAR RESPONSE TO GONADOTROPIN STIMULUS | 8 | 9.13e-01 | -2.23e-02 | 9.88e-01 |
| GOMF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 86 | 7.21e-01 | 2.23e-02 | 9.62e-01 |
| GOBP HISTONE H3 K4 METHYLATION | 19 | 8.66e-01 | 2.23e-02 | 9.84e-01 |
| GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 22 | 8.56e-01 | 2.23e-02 | 9.82e-01 |
| GOBP REGULATION OF VASOCONSTRICTION | 29 | 8.36e-01 | 2.23e-02 | 9.81e-01 |
| GOCC MEMBRANE COAT | 85 | 7.23e-01 | 2.23e-02 | 9.62e-01 |
| GOMF CHROMATIN DNA BINDING | 82 | 7.28e-01 | -2.22e-02 | 9.64e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 37 | 8.15e-01 | -2.22e-02 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION | 9 | 9.08e-01 | -2.22e-02 | 9.88e-01 |
| GOMF RNA POLYMERASE III GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 12 | 8.94e-01 | 2.22e-02 | 9.86e-01 |
| GOBP REGULATION OF BODY FLUID LEVELS | 213 | 5.78e-01 | -2.22e-02 | 9.34e-01 |
| GOCC R2TP COMPLEX | 5 | 9.32e-01 | -2.21e-02 | 9.89e-01 |
| GOMF POTASSIUM ION BINDING | 7 | 9.19e-01 | -2.21e-02 | 9.88e-01 |
| GOBP MEMBRANE REPOLARIZATION | 26 | 8.46e-01 | 2.21e-02 | 9.82e-01 |
| GOBP MITOTIC SISTER CHROMATID COHESION | 28 | 8.40e-01 | 2.21e-02 | 9.82e-01 |
| GOBP PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 5 | 9.32e-01 | 2.20e-02 | 9.89e-01 |
| GOBP POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 12 | 8.95e-01 | 2.20e-02 | 9.86e-01 |
| GOMF RNA ENDONUCLEASE ACTIVITY | 60 | 7.68e-01 | -2.20e-02 | 9.70e-01 |
| GOBP AMINOGLYCAN BIOSYNTHETIC PROCESS | 53 | 7.82e-01 | -2.20e-02 | 9.75e-01 |
| GOBP NEURON PROJECTION EXTENSION | 118 | 6.80e-01 | -2.20e-02 | 9.52e-01 |
| GOBP REGULATION OF DNA BINDING | 62 | 7.65e-01 | 2.20e-02 | 9.70e-01 |
| GOCC PHAGOPHORE ASSEMBLY SITE | 36 | 8.20e-01 | -2.19e-02 | 9.80e-01 |
| GOMF U6 SNRNA BINDING | 14 | 8.87e-01 | 2.18e-02 | 9.86e-01 |
| GOBP NEURAL PLATE DEVELOPMENT | 5 | 9.33e-01 | 2.18e-02 | 9.89e-01 |
| GOBP POST TRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION | 7 | 9.20e-01 | -2.18e-02 | 9.88e-01 |
| GOCC FASCIA ADHERENS | 5 | 9.33e-01 | 2.18e-02 | 9.89e-01 |
| GOBP CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS | 25 | 8.50e-01 | -2.18e-02 | 9.82e-01 |
| GOBP CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 23 | 8.56e-01 | -2.18e-02 | 9.82e-01 |
| GOMF LIPOPOLYSACCHARIDE BINDING | 20 | 8.66e-01 | -2.18e-02 | 9.84e-01 |
| GOBP PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS | 31 | 8.34e-01 | 2.18e-02 | 9.81e-01 |
| GOBP RESPONSE TO DSRNA | 33 | 8.29e-01 | 2.18e-02 | 9.80e-01 |
| GOCC CYTOPLASMIC STRESS GRANULE | 77 | 7.41e-01 | 2.18e-02 | 9.65e-01 |
| GOBP ENTRY OF BACTERIUM INTO HOST CELL | 7 | 9.21e-01 | -2.17e-02 | 9.88e-01 |
| GOCC BRISC COMPLEX | 6 | 9.27e-01 | -2.17e-02 | 9.88e-01 |
| GOCC PHOSPHATASE COMPLEX | 47 | 7.97e-01 | -2.17e-02 | 9.77e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION | 24 | 8.54e-01 | -2.17e-02 | 9.82e-01 |
| GOCC SITE OF DNA DAMAGE | 107 | 6.99e-01 | -2.17e-02 | 9.55e-01 |
| GOCC SWI SNF SUPERFAMILY TYPE COMPLEX | 86 | 7.29e-01 | -2.17e-02 | 9.64e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM | 38 | 8.18e-01 | -2.16e-02 | 9.80e-01 |
| GOBP CELLULAR RESPONSE TO DECREASED OXYGEN LEVELS | 108 | 6.98e-01 | 2.16e-02 | 9.55e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS | 28 | 8.43e-01 | -2.16e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT | 15 | 8.85e-01 | -2.16e-02 | 9.86e-01 |
| GOMF POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 54 | 7.84e-01 | 2.16e-02 | 9.76e-01 |
| GOBP CELL PROJECTION ASSEMBLY | 460 | 4.31e-01 | 2.15e-02 | 8.82e-01 |
| GOCC NUCLEOLAR EXOSOME RNASE COMPLEX | 10 | 9.06e-01 | 2.15e-02 | 9.88e-01 |
| GOBP HEPATOCYTE DIFFERENTIATION | 6 | 9.27e-01 | 2.15e-02 | 9.88e-01 |
| GOBP RNA SPLICING VIA TRANSESTERIFICATION REACTIONS | 272 | 5.43e-01 | 2.15e-02 | 9.23e-01 |
| GOBP MESENCHYME DEVELOPMENT | 169 | 6.31e-01 | -2.15e-02 | 9.40e-01 |
| GOBP HOMOTYPIC CELL CELL ADHESION | 64 | 7.67e-01 | -2.15e-02 | 9.70e-01 |
| GOBP REGULATION OF PEPTIDASE ACTIVITY | 205 | 5.97e-01 | 2.15e-02 | 9.36e-01 |
| GOBP PROTEIN INSERTION INTO MITOCHONDRIAL INNER MEMBRANE | 13 | 8.94e-01 | 2.14e-02 | 9.86e-01 |
| GOBP ENUCLEATE ERYTHROCYTE DIFFERENTIATION | 7 | 9.22e-01 | 2.14e-02 | 9.88e-01 |
| GOBP REGULATION OF GLIAL CELL PROLIFERATION | 26 | 8.51e-01 | 2.13e-02 | 9.82e-01 |
| GOBP REGULATION OF RECEPTOR INTERNALIZATION | 41 | 8.13e-01 | 2.13e-02 | 9.80e-01 |
| GOBP RESPONSE TO UV | 129 | 6.76e-01 | 2.13e-02 | 9.51e-01 |
| GOBP ACTIVATION OF PHOSPHOLIPASE C ACTIVITY | 15 | 8.87e-01 | -2.13e-02 | 9.86e-01 |
| GOBP REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 169 | 6.34e-01 | 2.13e-02 | 9.41e-01 |
| GOBP RESPONSE TO DOPAMINE | 34 | 8.30e-01 | -2.13e-02 | 9.80e-01 |
| GOBP PROTEIN METHYLATION | 70 | 7.59e-01 | 2.12e-02 | 9.69e-01 |
| GOBP RESPONSE TO COLD | 34 | 8.30e-01 | -2.12e-02 | 9.80e-01 |
| GOBP VACUOLAR TRANSPORT | 148 | 6.56e-01 | 2.12e-02 | 9.47e-01 |
| GOBP FOREBRAIN CELL MIGRATION | 39 | 8.19e-01 | -2.12e-02 | 9.80e-01 |
| GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 126 | 6.81e-01 | 2.12e-02 | 9.52e-01 |
| GOMF FMN BINDING | 9 | 9.12e-01 | -2.12e-02 | 9.88e-01 |
| GOBP REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II | 83 | 7.39e-01 | 2.12e-02 | 9.65e-01 |
| GOBP REGULATION OF ADIPOSE TISSUE DEVELOPMENT | 12 | 8.99e-01 | 2.12e-02 | 9.87e-01 |
| GOCC PRERIBOSOME SMALL SUBUNIT PRECURSOR | 14 | 8.91e-01 | -2.11e-02 | 9.86e-01 |
| GOBP PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION | 693 | 3.47e-01 | 2.11e-02 | 8.43e-01 |
| GOCC APICAL DENDRITE | 11 | 9.04e-01 | 2.11e-02 | 9.87e-01 |
| GOBP CENTROSOME SEPARATION | 12 | 8.99e-01 | -2.11e-02 | 9.87e-01 |
| GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 35 | 8.29e-01 | 2.11e-02 | 9.80e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 5 | 9.35e-01 | 2.10e-02 | 9.90e-01 |
| GOBP RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 31 | 8.40e-01 | 2.10e-02 | 9.82e-01 |
| GOBP PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY | 15 | 8.88e-01 | -2.10e-02 | 9.86e-01 |
| GOMF RACEMASE AND EPIMERASE ACTIVITY ACTING ON CARBOHYDRATES AND DERIVATIVES | 8 | 9.18e-01 | -2.09e-02 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF KINASE ACTIVITY | 230 | 5.86e-01 | 2.09e-02 | 9.36e-01 |
| GOBP T TUBULE ORGANIZATION | 5 | 9.36e-01 | -2.09e-02 | 9.90e-01 |
| GOBP REGULATION OF CALCIUM ION TRANSPORT | 142 | 6.68e-01 | 2.09e-02 | 9.49e-01 |
| GOBP PURINE NUCLEOSIDE CATABOLIC PROCESS | 7 | 9.24e-01 | 2.09e-02 | 9.88e-01 |
| GOCC MYELIN SHEATH ADAXONAL REGION | 5 | 9.36e-01 | 2.09e-02 | 9.90e-01 |
| GOBP ENDOSOME ORGANIZATION | 89 | 7.34e-01 | -2.08e-02 | 9.65e-01 |
| GOCC CENTROSOME | 551 | 4.06e-01 | 2.08e-02 | 8.74e-01 |
| GOBP POSITIVE REGULATION OF T CELL MIGRATION | 26 | 8.54e-01 | -2.08e-02 | 9.82e-01 |
| GOBP IN UTERO EMBRYONIC DEVELOPMENT | 287 | 5.46e-01 | -2.08e-02 | 9.25e-01 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSPORT | 23 | 8.63e-01 | 2.07e-02 | 9.83e-01 |
| GOMF PSEUDOURIDINE SYNTHASE ACTIVITY | 13 | 8.97e-01 | 2.07e-02 | 9.86e-01 |
| GOBP RNA LOCALIZATION | 179 | 6.33e-01 | 2.07e-02 | 9.41e-01 |
| GOBP RECEPTOR RECYCLING | 39 | 8.23e-01 | 2.07e-02 | 9.80e-01 |
| GOBP RESPONSE TO NUTRIENT | 97 | 7.25e-01 | 2.07e-02 | 9.63e-01 |
| GOBP CELLULAR RESPONSE TO ABIOTIC STIMULUS | 254 | 5.72e-01 | -2.06e-02 | 9.31e-01 |
| GOBP GLYCOLIPID BIOSYNTHETIC PROCESS | 51 | 7.99e-01 | 2.06e-02 | 9.77e-01 |
| GOBP POSITIVE REGULATION OF TRANSPORT | 590 | 3.95e-01 | 2.06e-02 | 8.70e-01 |
| GOBP REGULATION OF CELL MORPHOGENESIS | 186 | 6.29e-01 | -2.06e-02 | 9.40e-01 |
| GOMF PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY | 34 | 8.35e-01 | -2.06e-02 | 9.81e-01 |
| GOMF G QUADRUPLEX DNA BINDING | 11 | 9.06e-01 | 2.06e-02 | 9.88e-01 |
| GOBP AXON DEVELOPMENT | 289 | 5.49e-01 | -2.06e-02 | 9.25e-01 |
| GOMF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 902 | 3.02e-01 | 2.05e-02 | 8.14e-01 |
| GOBP POSITIVE REGULATION OF GLIAL CELL PROLIFERATION | 14 | 8.95e-01 | -2.05e-02 | 9.86e-01 |
| GOCC NUCLEOTIDE ACTIVATED PROTEIN KINASE COMPLEX | 10 | 9.11e-01 | 2.05e-02 | 9.88e-01 |
| GOBP MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE | 22 | 8.68e-01 | -2.04e-02 | 9.85e-01 |
| GOCC POSTSYNAPSE | 388 | 4.92e-01 | -2.04e-02 | 9.13e-01 |
| GOBP REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 105 | 7.20e-01 | -2.03e-02 | 9.61e-01 |
| GOBP RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE | 12 | 9.03e-01 | 2.03e-02 | 9.87e-01 |
| GOBP PHOSPHOLIPID METABOLIC PROCESS | 292 | 5.52e-01 | 2.03e-02 | 9.26e-01 |
| GOBP REGULATION OF GERM CELL PROLIFERATION | 7 | 9.26e-01 | -2.03e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS | 935 | 2.98e-01 | 2.03e-02 | 8.13e-01 |
| GOBP ACTOMYOSIN STRUCTURE ORGANIZATION | 143 | 6.76e-01 | -2.03e-02 | 9.51e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL JUNCTION | 71 | 7.68e-01 | -2.03e-02 | 9.70e-01 |
| GOBP POSITIVE REGULATION OF CELL MIGRATION BY VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 6 | 9.32e-01 | -2.02e-02 | 9.89e-01 |
| GOBP CENTROMERE COMPLEX ASSEMBLY | 27 | 8.56e-01 | 2.02e-02 | 9.82e-01 |
| GOBP REGULATION OF KINASE ACTIVITY | 421 | 4.80e-01 | 2.02e-02 | 9.07e-01 |
| GOBP NEGATIVE REGULATION OF EXOCYTOSIS | 27 | 8.56e-01 | -2.02e-02 | 9.82e-01 |
| GOBP REGULATION OF GOLGI ORGANIZATION | 17 | 8.86e-01 | 2.01e-02 | 9.86e-01 |
| GOCC CELL CELL JUNCTION | 311 | 5.44e-01 | 2.01e-02 | 9.23e-01 |
| GOBP PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 17 | 8.86e-01 | -2.01e-02 | 9.86e-01 |
| GOCC BLEB | 9 | 9.17e-01 | -2.01e-02 | 9.88e-01 |
| GOMF MANGANESE ION BINDING | 54 | 7.99e-01 | -2.00e-02 | 9.77e-01 |
| GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 31 | 8.47e-01 | 2.00e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 80 | 7.57e-01 | 2.00e-02 | 9.69e-01 |
| GOBP MEIOTIC CELL CYCLE | 189 | 6.36e-01 | 2.00e-02 | 9.41e-01 |
| GOBP HEMATOPOIETIC STEM CELL PROLIFERATION | 25 | 8.63e-01 | -2.00e-02 | 9.83e-01 |
| GOCC SEX CHROMOSOME | 28 | 8.55e-01 | -1.99e-02 | 9.82e-01 |
| GOBP FOREBRAIN DEVELOPMENT | 233 | 6.01e-01 | 1.99e-02 | 9.36e-01 |
| GOBP EMBRYONIC ORGAN DEVELOPMENT | 234 | 6.01e-01 | -1.99e-02 | 9.36e-01 |
| GOBP MICROTUBULE BASED MOVEMENT | 270 | 5.75e-01 | 1.99e-02 | 9.33e-01 |
| GOBP REGULATION OF STEM CELL PROLIFERATION | 39 | 8.30e-01 | 1.98e-02 | 9.80e-01 |
| GOBP CDP DIACYLGLYCEROL BIOSYNTHETIC PROCESS | 13 | 9.02e-01 | 1.98e-02 | 9.87e-01 |
| GOBP LYSOSOMAL TRANSPORT | 115 | 7.15e-01 | 1.97e-02 | 9.59e-01 |
| GOBP NUCLEOBASE TRANSPORT | 9 | 9.18e-01 | -1.97e-02 | 9.88e-01 |
| GOBP CELL CELL ADHESION | 526 | 4.42e-01 | 1.97e-02 | 8.86e-01 |
| GOBP CELLULAR KETONE METABOLIC PROCESS | 144 | 6.84e-01 | 1.96e-02 | 9.53e-01 |
| GOBP RELAXATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE | 5 | 9.39e-01 | -1.96e-02 | 9.92e-01 |
| GOCC PODOSOME | 30 | 8.52e-01 | -1.96e-02 | 9.82e-01 |
| GOBP CYCLIC NUCLEOTIDE TRANSPORT | 8 | 9.24e-01 | 1.96e-02 | 9.88e-01 |
| GOBP PLASMA MEMBRANE REPAIR | 27 | 8.60e-01 | 1.96e-02 | 9.83e-01 |
| GOBP POSITIVE REGULATION OF NECROPTOTIC PROCESS | 5 | 9.40e-01 | -1.96e-02 | 9.92e-01 |
| GOBP POSITIVE REGULATION OF DENDRITE DEVELOPMENT | 10 | 9.15e-01 | 1.96e-02 | 9.88e-01 |
| GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY | 27 | 8.60e-01 | -1.96e-02 | 9.83e-01 |
| GOBP GMP BIOSYNTHETIC PROCESS | 13 | 9.03e-01 | 1.96e-02 | 9.87e-01 |
| GOCC AXONEMAL DYNEIN COMPLEX | 10 | 9.15e-01 | 1.95e-02 | 9.88e-01 |
| GOBP SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE | 167 | 6.65e-01 | 1.95e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY | 15 | 8.96e-01 | 1.94e-02 | 9.86e-01 |
| GOMF LIPID BINDING | 569 | 4.32e-01 | 1.94e-02 | 8.82e-01 |
| GOBP DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS | 131 | 7.02e-01 | 1.94e-02 | 9.56e-01 |
| GOMF MRNA 3 UTR BINDING | 85 | 7.58e-01 | 1.94e-02 | 9.69e-01 |
| GOBP SPERMIDINE METABOLIC PROCESS | 8 | 9.24e-01 | 1.94e-02 | 9.88e-01 |
| GOBP ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 87 | 7.55e-01 | 1.94e-02 | 9.68e-01 |
| GOBP REGULATION OF CARTILAGE DEVELOPMENT | 30 | 8.54e-01 | -1.94e-02 | 9.82e-01 |
| GOBP NCRNA PROCESSING | 398 | 5.09e-01 | -1.94e-02 | 9.18e-01 |
| GOBP L SERINE METABOLIC PROCESS | 10 | 9.16e-01 | 1.93e-02 | 9.88e-01 |
| GOBP NUCLEOBASE BIOSYNTHETIC PROCESS | 17 | 8.90e-01 | -1.93e-02 | 9.86e-01 |
| GOBP CELLULAR CATABOLIC PROCESS | 1228 | 2.61e-01 | 1.93e-02 | 7.87e-01 |
| GOBP REGULATION OF CELL PROJECTION ORGANIZATION | 469 | 4.75e-01 | -1.93e-02 | 9.04e-01 |
| GOBP TORC1 SIGNALING | 91 | 7.50e-01 | 1.93e-02 | 9.67e-01 |
| GOBP GLYCOPROTEIN BIOSYNTHETIC PROCESS | 206 | 6.34e-01 | -1.93e-02 | 9.41e-01 |
| GOBP RESPONSE TO STEROL | 22 | 8.76e-01 | 1.92e-02 | 9.86e-01 |
| GOBP REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY | 22 | 8.76e-01 | -1.92e-02 | 9.86e-01 |
| GOBP G0 TO G1 TRANSITION | 34 | 8.47e-01 | 1.92e-02 | 9.82e-01 |
| GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX | 26 | 8.66e-01 | 1.91e-02 | 9.84e-01 |
| GOMF ATPASE COUPLED TRANSMEMBRANE TRANSPORTER ACTIVITY | 66 | 7.88e-01 | -1.91e-02 | 9.76e-01 |
| GOMF CIS REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 768 | 3.72e-01 | 1.91e-02 | 8.57e-01 |
| GOMF SIRNA BINDING | 9 | 9.21e-01 | 1.91e-02 | 9.88e-01 |
| GOCC SOMATODENDRITIC COMPARTMENT | 500 | 4.68e-01 | 1.90e-02 | 9.00e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 54 | 8.09e-01 | 1.90e-02 | 9.80e-01 |
| GOBP MONOCARBOXYLIC ACID TRANSPORT | 89 | 7.57e-01 | -1.90e-02 | 9.69e-01 |
| GOBP POSITIVE REGULATION OF FILOPODIUM ASSEMBLY | 21 | 8.80e-01 | 1.90e-02 | 9.86e-01 |
| GOBP DETECTION OF CELL DENSITY | 6 | 9.36e-01 | 1.90e-02 | 9.90e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO LYSOSOME | 5 | 9.42e-01 | 1.89e-02 | 9.92e-01 |
| GOBP MEIOTIC CHROMOSOME CONDENSATION | 6 | 9.36e-01 | 1.89e-02 | 9.90e-01 |
| GOBP POSITIVE REGULATION OF NEUROGENESIS | 147 | 6.93e-01 | -1.89e-02 | 9.54e-01 |
| GOCC NUCLEAR PROTEIN CONTAINING COMPLEX | 1090 | 2.98e-01 | 1.89e-02 | 8.13e-01 |
| GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE | 20 | 8.84e-01 | -1.89e-02 | 9.86e-01 |
| GOBP REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS | 14 | 9.03e-01 | 1.89e-02 | 9.87e-01 |
| GOBP POSITIVE REGULATION OF FATTY ACID OXIDATION | 10 | 9.18e-01 | 1.88e-02 | 9.88e-01 |
| GOBP NEUTRAL LIPID METABOLIC PROCESS | 88 | 7.60e-01 | 1.88e-02 | 9.70e-01 |
| GOMF ABC TYPE TRANSPORTER ACTIVITY | 33 | 8.52e-01 | 1.88e-02 | 9.82e-01 |
| GOBP PEPTIDYL LYSINE MONOMETHYLATION | 9 | 9.22e-01 | -1.88e-02 | 9.88e-01 |
| GOMF HISTONE H4K20 METHYLTRANSFERASE ACTIVITY | 9 | 9.22e-01 | 1.88e-02 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF ERAD PATHWAY | 14 | 9.03e-01 | 1.88e-02 | 9.87e-01 |
| GOBP HYPOTHALAMUS DEVELOPMENT | 12 | 9.10e-01 | 1.88e-02 | 9.88e-01 |
| GOBP INSULIN METABOLIC PROCESS | 10 | 9.18e-01 | 1.88e-02 | 9.88e-01 |
| GOBP REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING | 8 | 9.27e-01 | -1.87e-02 | 9.88e-01 |
| GOBP REGULATION OF MACROPHAGE APOPTOTIC PROCESS | 7 | 9.32e-01 | 1.87e-02 | 9.89e-01 |
| GOBP REGULATION OF EXOSOMAL SECRETION | 17 | 8.94e-01 | 1.87e-02 | 9.86e-01 |
| GOBP EMBRYONIC PATTERN SPECIFICATION | 31 | 8.57e-01 | -1.87e-02 | 9.82e-01 |
| GOMF METALLOPEPTIDASE ACTIVITY | 104 | 7.42e-01 | -1.87e-02 | 9.65e-01 |
| GOCC SITE OF DOUBLE STRAND BREAK | 80 | 7.73e-01 | 1.87e-02 | 9.72e-01 |
| GOMF SOLUTE POTASSIUM ANTIPORTER ACTIVITY | 11 | 9.15e-01 | 1.87e-02 | 9.88e-01 |
| GOCC CONTRACTILE FIBER | 150 | 6.94e-01 | 1.87e-02 | 9.54e-01 |
| GOCC SYNAPTIC MEMBRANE | 186 | 6.62e-01 | 1.86e-02 | 9.49e-01 |
| GOBP INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 43 | 8.33e-01 | -1.86e-02 | 9.80e-01 |
| GOMF MOLECULAR FUNCTION ACTIVATOR ACTIVITY | 664 | 4.16e-01 | 1.86e-02 | 8.79e-01 |
| GOMF SEQUENCE SPECIFIC DNA BINDING | 1109 | 3.02e-01 | 1.86e-02 | 8.14e-01 |
| GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 20 | 8.86e-01 | 1.86e-02 | 9.86e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHATASE ACTIVITY | 20 | 8.86e-01 | -1.85e-02 | 9.86e-01 |
| GOBP RNA PROCESSING | 860 | 3.60e-01 | -1.85e-02 | 8.46e-01 |
| GOBP RESPONSE TO TUMOR CELL | 31 | 8.58e-01 | -1.85e-02 | 9.82e-01 |
| GOBP PROTEIN DEPHOSPHORYLATION | 162 | 6.85e-01 | 1.85e-02 | 9.53e-01 |
| GOBP TELOMERE MAINTENANCE | 146 | 7.00e-01 | -1.85e-02 | 9.56e-01 |
| GOBP REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS | 16 | 8.98e-01 | 1.85e-02 | 9.87e-01 |
| GOCC BASAL PART OF CELL | 181 | 6.69e-01 | 1.85e-02 | 9.49e-01 |
| GOBP GLYCOSPHINGOLIPID CATABOLIC PROCESS | 9 | 9.24e-01 | 1.85e-02 | 9.88e-01 |
| GOCC DENDRITIC TREE | 379 | 5.39e-01 | 1.84e-02 | 9.23e-01 |
| GOBP CELL CELL SIGNALING BY WNT | 295 | 5.87e-01 | -1.84e-02 | 9.36e-01 |
| GOBP RESPONSE TO MUSCLE ACTIVITY | 15 | 9.02e-01 | -1.84e-02 | 9.87e-01 |
| GOBP MITOCHONDRIAL RNA METABOLIC PROCESS | 51 | 8.20e-01 | -1.84e-02 | 9.80e-01 |
| GOMF NUCLEAR EXPORT SIGNAL RECEPTOR ACTIVITY | 12 | 9.12e-01 | 1.84e-02 | 9.88e-01 |
| GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 389 | 5.36e-01 | 1.84e-02 | 9.23e-01 |
| GOBP SKELETAL MUSCLE CONTRACTION | 23 | 8.79e-01 | -1.83e-02 | 9.86e-01 |
| GOBP PROTEIN INSERTION INTO ER MEMBRANE BY STOP TRANSFER MEMBRANE ANCHOR SEQUENCE | 11 | 9.16e-01 | 1.83e-02 | 9.88e-01 |
| GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 23 | 8.79e-01 | -1.83e-02 | 9.86e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE BINDING | 28 | 8.67e-01 | 1.83e-02 | 9.84e-01 |
| GOBP NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY | 67 | 7.96e-01 | -1.83e-02 | 9.77e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 680 | 4.21e-01 | 1.82e-02 | 8.81e-01 |
| GOBP PURINE RIBONUCLEOSIDE CATABOLIC PROCESS | 5 | 9.44e-01 | 1.82e-02 | 9.92e-01 |
| GOBP REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 148 | 7.03e-01 | 1.82e-02 | 9.56e-01 |
| GOBP NEGATIVE REGULATION OF CELL DIVISION | 11 | 9.17e-01 | -1.82e-02 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF FOCAL ADHESION ASSEMBLY | 18 | 8.94e-01 | 1.81e-02 | 9.86e-01 |
| GOBP RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN | 141 | 7.11e-01 | -1.81e-02 | 9.59e-01 |
| GOBP PROTEIN LOCALIZATION TO POSTSYNAPSE | 31 | 8.62e-01 | -1.81e-02 | 9.83e-01 |
| GOBP NEGATIVE REGULATION OF CELL DIFFERENTIATION | 380 | 5.48e-01 | -1.80e-02 | 9.25e-01 |
| GOBP MITOCHONDRIAL GENOME MAINTENANCE | 29 | 8.67e-01 | 1.80e-02 | 9.84e-01 |
| GOBP POSITIVE REGULATION OF CATALYTIC ACTIVITY | 665 | 4.32e-01 | 1.80e-02 | 8.82e-01 |
| GOMF PHOSPHATASE REGULATOR ACTIVITY | 80 | 7.81e-01 | 1.80e-02 | 9.75e-01 |
| GOBP REGULATION OF MACROAUTOPHAGY | 144 | 7.10e-01 | 1.80e-02 | 9.59e-01 |
| GOBP REGULATION OF CYCLASE ACTIVITY | 23 | 8.81e-01 | -1.80e-02 | 9.86e-01 |
| GOBP REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 59 | 8.11e-01 | 1.80e-02 | 9.80e-01 |
| GOCC NEURON PROJECTION TERMINUS | 62 | 8.07e-01 | 1.80e-02 | 9.79e-01 |
| GOBP REGULATION OF WNT SIGNALING PATHWAY | 210 | 6.55e-01 | 1.80e-02 | 9.46e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 831 | 3.85e-01 | 1.79e-02 | 8.64e-01 |
| GOBP VIRAL RELEASE FROM HOST CELL | 27 | 8.72e-01 | 1.79e-02 | 9.85e-01 |
| GOCC NSL COMPLEX | 11 | 9.18e-01 | 1.78e-02 | 9.88e-01 |
| GOCC EXOCYTIC VESICLE | 144 | 7.12e-01 | 1.78e-02 | 9.59e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT | 48 | 8.31e-01 | 1.78e-02 | 9.80e-01 |
| GOBP CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS | 10 | 9.23e-01 | -1.78e-02 | 9.88e-01 |
| GOBP PENTOSE METABOLIC PROCESS | 10 | 9.23e-01 | 1.78e-02 | 9.88e-01 |
| GOMF SNRNP BINDING | 9 | 9.27e-01 | -1.77e-02 | 9.88e-01 |
| GOMF MYOSIN PHOSPHATASE ACTIVITY | 64 | 8.06e-01 | 1.77e-02 | 9.79e-01 |
| GOMF CYTOKINE RECEPTOR ACTIVITY | 48 | 8.33e-01 | 1.77e-02 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 24 | 8.81e-01 | -1.76e-02 | 9.86e-01 |
| GOCC POSTSYNAPTIC DENSITY INTRACELLULAR COMPONENT | 12 | 9.16e-01 | 1.76e-02 | 9.88e-01 |
| GOBP LIPID BIOSYNTHETIC PROCESS | 519 | 4.94e-01 | 1.76e-02 | 9.13e-01 |
| GOBP CARBOHYDRATE TRANSMEMBRANE TRANSPORT | 84 | 7.81e-01 | -1.76e-02 | 9.75e-01 |
| GOBP REGULATION OF CELLULAR LOCALIZATION | 726 | 4.23e-01 | 1.76e-02 | 8.81e-01 |
| GOBP CYTOSKELETON ORGANIZATION | 1063 | 3.38e-01 | 1.76e-02 | 8.37e-01 |
| GOBP EPIGENETIC REGULATION OF GENE EXPRESSION | 184 | 6.82e-01 | 1.76e-02 | 9.52e-01 |
| GOBP DORSAL VENTRAL PATTERN FORMATION | 39 | 8.50e-01 | -1.75e-02 | 9.82e-01 |
| GOBP REGULATION OF FIBRINOLYSIS | 9 | 9.27e-01 | -1.75e-02 | 9.88e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR INTERNALIZATION | 6 | 9.41e-01 | -1.75e-02 | 9.92e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE | 16 | 9.04e-01 | -1.75e-02 | 9.87e-01 |
| GOCC SARCOPLASMIC RETICULUM | 43 | 8.43e-01 | 1.74e-02 | 9.82e-01 |
| GOBP REGULATION OF DOSAGE COMPENSATION BY INACTIVATION OF X CHROMOSOME | 13 | 9.14e-01 | 1.74e-02 | 9.88e-01 |
| GOBP CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION | 12 | 9.17e-01 | 1.74e-02 | 9.88e-01 |
| GOCC INTRACELLULAR PROTEIN CONTAINING COMPLEX | 804 | 4.08e-01 | -1.73e-02 | 8.75e-01 |
| GOBP FATTY ACID TRANSPORT | 60 | 8.17e-01 | -1.73e-02 | 9.80e-01 |
| GOCC CAJAL BODY | 57 | 8.21e-01 | 1.73e-02 | 9.80e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO STRESS | 544 | 4.93e-01 | 1.73e-02 | 9.13e-01 |
| GOBP MICROTUBULE BASED TRANSPORT | 168 | 7.00e-01 | 1.73e-02 | 9.55e-01 |
| GOBP PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS | 9 | 9.29e-01 | 1.72e-02 | 9.88e-01 |
| GOMF GTPASE ACTIVITY | 251 | 6.39e-01 | -1.72e-02 | 9.42e-01 |
| GOMF PROTEIN HETERODIMERIZATION ACTIVITY | 177 | 6.93e-01 | 1.72e-02 | 9.54e-01 |
| GOMF 3 5 DNA HELICASE ACTIVITY | 15 | 9.08e-01 | 1.72e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF HYPOXIA INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 6 | 9.42e-01 | 1.72e-02 | 9.92e-01 |
| GOBP CHORIONIC TROPHOBLAST CELL DIFFERENTIATION | 5 | 9.47e-01 | 1.72e-02 | 9.93e-01 |
| GOMF ENDOPEPTIDASE ACTIVITY | 207 | 6.72e-01 | 1.71e-02 | 9.49e-01 |
| GOBP RESPONSE TO INSULIN | 201 | 6.76e-01 | 1.71e-02 | 9.51e-01 |
| GOBP MITOTIC DNA INTEGRITY CHECKPOINT SIGNALING | 77 | 7.95e-01 | 1.71e-02 | 9.77e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR SENESCENCE | 15 | 9.09e-01 | 1.71e-02 | 9.88e-01 |
| GOBP REGULATION OF PROTEIN DEPHOSPHORYLATION | 62 | 8.16e-01 | -1.71e-02 | 9.80e-01 |
| GOCC NUCLEAR MEMBRANE | 262 | 6.35e-01 | 1.71e-02 | 9.41e-01 |
| GOBP NADP METABOLIC PROCESS | 37 | 8.57e-01 | 1.71e-02 | 9.82e-01 |
| GOMF PHOSPHOTYROSINE RESIDUE BINDING | 38 | 8.56e-01 | -1.71e-02 | 9.82e-01 |
| GOBP BEHAVIOR | 349 | 5.85e-01 | -1.71e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF ORGANELLE ASSEMBLY | 76 | 7.97e-01 | -1.70e-02 | 9.77e-01 |
| GOCC CLATHRIN COATED VESICLE MEMBRANE | 94 | 7.76e-01 | -1.70e-02 | 9.73e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 14 | 9.12e-01 | 1.70e-02 | 9.88e-01 |
| GOMF ADP D RIBOSE MODIFICATION DEPENDENT PROTEIN BINDING | 5 | 9.48e-01 | 1.70e-02 | 9.93e-01 |
| GOBP REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 262 | 6.37e-01 | 1.70e-02 | 9.41e-01 |
| GOBP B CELL PROLIFERATION | 60 | 8.21e-01 | 1.69e-02 | 9.80e-01 |
| GOBP REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT | 12 | 9.19e-01 | 1.69e-02 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF SIGNALING | 1165 | 3.38e-01 | 1.69e-02 | 8.37e-01 |
| GOCC U5 SNRNP | 19 | 8.99e-01 | -1.68e-02 | 9.87e-01 |
| GOBP RECEPTOR LOCALIZATION TO SYNAPSE | 40 | 8.54e-01 | 1.68e-02 | 9.82e-01 |
| GOBP REGULATION OF AUTOPHAGY | 309 | 6.12e-01 | 1.68e-02 | 9.36e-01 |
| GOBP POSITIVE REGULATION OF VESICLE TRANSPORT ALONG MICROTUBULE | 5 | 9.48e-01 | 1.68e-02 | 9.93e-01 |
| GOCC MICROTUBULE ORGANIZING CENTER | 708 | 4.50e-01 | 1.68e-02 | 8.89e-01 |
| GOBP ARF PROTEIN SIGNAL TRANSDUCTION | 20 | 8.97e-01 | -1.68e-02 | 9.86e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR | 40 | 8.54e-01 | -1.68e-02 | 9.82e-01 |
| GOBP CELL FATE DETERMINATION | 12 | 9.20e-01 | -1.68e-02 | 9.88e-01 |
| GOBP CEREBELLAR CORTEX MORPHOGENESIS | 21 | 8.94e-01 | -1.67e-02 | 9.86e-01 |
| GOBP NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC | 100 | 7.74e-01 | 1.67e-02 | 9.72e-01 |
| GOBP REGULATION OF PHOSPHOLIPASE ACTIVITY | 35 | 8.65e-01 | 1.66e-02 | 9.83e-01 |
| GOCC PERIKARYON | 75 | 8.04e-01 | -1.66e-02 | 9.79e-01 |
| GOBP CONSTITUTIVE HETEROCHROMATIN FORMATION | 11 | 9.24e-01 | -1.66e-02 | 9.88e-01 |
| GOBP MACROPHAGE APOPTOTIC PROCESS | 10 | 9.28e-01 | 1.66e-02 | 9.88e-01 |
| GOBP SUPRAMOLECULAR FIBER ORGANIZATION | 562 | 5.07e-01 | -1.65e-02 | 9.17e-01 |
| GOBP RENAL TUBULE DEVELOPMENT | 43 | 8.52e-01 | 1.64e-02 | 9.82e-01 |
| GOBP GLYCEROPHOSPHOLIPID METABOLIC PROCESS | 238 | 6.64e-01 | 1.64e-02 | 9.49e-01 |
| GOBP CELL CYCLE PROCESS | 1039 | 3.78e-01 | 1.64e-02 | 8.61e-01 |
| GOBP NEURON PROJECTION ORGANIZATION | 67 | 8.18e-01 | -1.63e-02 | 9.80e-01 |
| GOBP AMINO ACID CATABOLIC PROCESS | 77 | 8.05e-01 | -1.63e-02 | 9.79e-01 |
| GOMF NITRIC OXIDE SYNTHASE REGULATOR ACTIVITY | 5 | 9.50e-01 | 1.63e-02 | 9.93e-01 |
| GOBP TRANSCRIPTION INITIATION COUPLED CHROMATIN REMODELING | 35 | 8.68e-01 | 1.63e-02 | 9.84e-01 |
| GOBP RENAL SYSTEM PROCESS | 57 | 8.32e-01 | 1.63e-02 | 9.80e-01 |
| GOBP INTRACELLULAR TRANSPORT | 1365 | 3.22e-01 | 1.62e-02 | 8.29e-01 |
| GOMF PROTEASE BINDING | 100 | 7.80e-01 | -1.62e-02 | 9.75e-01 |
| GOBP OLEFINIC COMPOUND METABOLIC PROCESS | 75 | 8.09e-01 | -1.62e-02 | 9.80e-01 |
| GOMF ATP DEPENDENT ACTIVITY ACTING ON DNA | 110 | 7.70e-01 | 1.62e-02 | 9.70e-01 |
| GOCC RETROMER COMPLEX | 12 | 9.23e-01 | 1.62e-02 | 9.88e-01 |
| GOBP ERAD PATHWAY | 98 | 7.83e-01 | -1.61e-02 | 9.75e-01 |
| GOBP REGULATION OF FAT CELL PROLIFERATION | 7 | 9.41e-01 | -1.61e-02 | 9.92e-01 |
| GOBP REGULATION OF VASCULOGENESIS | 7 | 9.41e-01 | -1.61e-02 | 9.92e-01 |
| GOBP RESPONSE TO IRON ION | 21 | 8.99e-01 | 1.61e-02 | 9.87e-01 |
| GOBP ENDOCYTOSIS | 505 | 5.39e-01 | 1.60e-02 | 9.23e-01 |
| GOMF P53 BINDING | 55 | 8.37e-01 | -1.60e-02 | 9.82e-01 |
| GOBP REGULATION OF DNA METHYLATION | 13 | 9.20e-01 | -1.60e-02 | 9.88e-01 |
| GOCC TORC2 COMPLEX | 9 | 9.34e-01 | 1.60e-02 | 9.90e-01 |
| GOMF MICROTUBULE PLUS END BINDING | 21 | 8.99e-01 | 1.60e-02 | 9.87e-01 |
| GOMF JUN KINASE BINDING | 10 | 9.30e-01 | 1.59e-02 | 9.89e-01 |
| GOBP POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT | 31 | 8.78e-01 | 1.59e-02 | 9.86e-01 |
| GOBP PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 219 | 6.86e-01 | 1.59e-02 | 9.54e-01 |
| GOBP TRIGLYCERIDE METABOLIC PROCESS | 66 | 8.23e-01 | -1.59e-02 | 9.80e-01 |
| GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 25 | 8.91e-01 | -1.59e-02 | 9.86e-01 |
| GOBP POSTSYNAPTIC SIGNAL TRANSDUCTION | 24 | 8.93e-01 | -1.58e-02 | 9.86e-01 |
| GOCC CILIUM | 462 | 5.63e-01 | 1.58e-02 | 9.29e-01 |
| GOMF ALCOHOL BINDING | 53 | 8.42e-01 | -1.58e-02 | 9.82e-01 |
| GOCC BRUSH BORDER MEMBRANE | 30 | 8.81e-01 | -1.58e-02 | 9.86e-01 |
| GOBP REGULATION OF PROTEIN MATURATION | 48 | 8.50e-01 | -1.58e-02 | 9.82e-01 |
| GOBP CYTOPLASMIC MICROTUBULE ORGANIZATION | 51 | 8.46e-01 | -1.58e-02 | 9.82e-01 |
| GOBP REGULATION OF LIPID METABOLIC PROCESS | 214 | 6.92e-01 | -1.57e-02 | 9.54e-01 |
| GOBP REGULATION OF CYTOSKELETON ORGANIZATION | 389 | 5.96e-01 | -1.57e-02 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF BINDING | 88 | 7.99e-01 | 1.57e-02 | 9.77e-01 |
| GOBP PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS | 67 | 8.24e-01 | -1.57e-02 | 9.80e-01 |
| GOCC TERMINAL BOUTON | 20 | 9.03e-01 | -1.57e-02 | 9.87e-01 |
| GOBP MACROAUTOPHAGY | 308 | 6.37e-01 | -1.57e-02 | 9.41e-01 |
| GOBP PURINE RIBONUCLEOSIDE METABOLIC PROCESS | 13 | 9.22e-01 | -1.57e-02 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 29 | 8.84e-01 | -1.57e-02 | 9.86e-01 |
| GOBP RESPONSE TO WOUNDING | 350 | 6.16e-01 | 1.57e-02 | 9.36e-01 |
| GOMF PHOSPHOLIPASE ACTIVITY | 63 | 8.30e-01 | 1.56e-02 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF DNA METABOLIC PROCESS | 256 | 6.69e-01 | -1.56e-02 | 9.49e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 27 | 8.89e-01 | 1.56e-02 | 9.86e-01 |
| GOCC EXTERNAL SIDE OF PLASMA MEMBRANE | 193 | 7.10e-01 | -1.55e-02 | 9.59e-01 |
| GOBP MAPK CASCADE | 497 | 5.56e-01 | 1.55e-02 | 9.26e-01 |
| GOBP NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 14 | 9.20e-01 | -1.55e-02 | 9.88e-01 |
| GOBP REGULATION OF CHOLESTEROL METABOLIC PROCESS | 26 | 8.91e-01 | 1.55e-02 | 9.86e-01 |
| GOMF TRANSLATION TERMINATION FACTOR ACTIVITY | 6 | 9.48e-01 | -1.55e-02 | 9.93e-01 |
| GOMF SPHINGOLIPID BINDING | 21 | 9.02e-01 | 1.55e-02 | 9.87e-01 |
| GOBP REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION | 146 | 7.48e-01 | 1.54e-02 | 9.66e-01 |
| GOMF AMINO ACID SODIUM SYMPORTER ACTIVITY | 10 | 9.33e-01 | -1.54e-02 | 9.89e-01 |
| GOBP PROTEIN LOCALIZATION TO CELL PERIPHERY | 262 | 6.68e-01 | 1.54e-02 | 9.49e-01 |
| GOBP DETECTION OF VISIBLE LIGHT | 24 | 8.96e-01 | 1.54e-02 | 9.86e-01 |
| GOCC PSEUDOPODIUM | 13 | 9.24e-01 | -1.54e-02 | 9.88e-01 |
| GOBP BOX C D SNORNP ASSEMBLY | 9 | 9.36e-01 | -1.54e-02 | 9.90e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MEMBRANE | 6 | 9.48e-01 | 1.53e-02 | 9.93e-01 |
| GOBP ERBB4 SIGNALING PATHWAY | 5 | 9.53e-01 | 1.53e-02 | 9.93e-01 |
| GOBP REGULATION OF ADIPONECTIN SECRETION | 6 | 9.48e-01 | -1.52e-02 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 17 | 9.13e-01 | -1.52e-02 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION | 12 | 9.27e-01 | 1.52e-02 | 9.88e-01 |
| GOBP PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 16 | 9.16e-01 | 1.52e-02 | 9.88e-01 |
| GOMF KINASE REGULATOR ACTIVITY | 204 | 7.09e-01 | -1.52e-02 | 9.58e-01 |
| GOMF GROWTH FACTOR RECEPTOR BINDING | 73 | 8.23e-01 | 1.52e-02 | 9.80e-01 |
| GOBP REGULATION OF PLASMA MEMBRANE ORGANIZATION | 15 | 9.19e-01 | 1.52e-02 | 9.88e-01 |
| GOMF PHOSPHORUS OXYGEN LYASE ACTIVITY | 16 | 9.16e-01 | -1.52e-02 | 9.88e-01 |
| GOCC ER MEMBRANE INSERTION COMPLEX | 13 | 9.25e-01 | 1.51e-02 | 9.88e-01 |
| GOBP GLANDULAR EPITHELIAL CELL DIFFERENTIATION | 31 | 8.84e-01 | 1.51e-02 | 9.86e-01 |
| GOCC PERINUCLEAR ENDOPLASMIC RETICULUM | 17 | 9.14e-01 | 1.51e-02 | 9.88e-01 |
| GOBP RESPONSE TO XENOBIOTIC STIMULUS | 246 | 6.85e-01 | 1.51e-02 | 9.53e-01 |
| GOBP REGULATION OF TRANSFERASE ACTIVITY | 516 | 5.60e-01 | 1.51e-02 | 9.28e-01 |
| GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC STRUCTURE | 7 | 9.45e-01 | -1.51e-02 | 9.93e-01 |
| GOBP PROTEOGLYCAN METABOLIC PROCESS | 56 | 8.46e-01 | -1.50e-02 | 9.82e-01 |
| GOBP DENDRITIC SPINE MAINTENANCE | 18 | 9.12e-01 | -1.50e-02 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF RECEPTOR CLUSTERING | 5 | 9.54e-01 | 1.50e-02 | 9.93e-01 |
| GOBP REGULATION OF LENS FIBER CELL DIFFERENTIATION | 6 | 9.49e-01 | -1.50e-02 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION | 50 | 8.55e-01 | -1.49e-02 | 9.82e-01 |
| GOCC AZUROPHIL GRANULE MEMBRANE | 53 | 8.51e-01 | 1.49e-02 | 9.82e-01 |
| GOBP POLY A PLUS MRNA EXPORT FROM NUCLEUS | 19 | 9.10e-01 | 1.49e-02 | 9.88e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE | 229 | 6.98e-01 | -1.49e-02 | 9.55e-01 |
| GOBP POTASSIUM ION TRANSPORT | 111 | 7.87e-01 | 1.49e-02 | 9.76e-01 |
| GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 11 | 9.32e-01 | -1.49e-02 | 9.89e-01 |
| GOCC NUCLEAR INNER MEMBRANE | 45 | 8.63e-01 | 1.49e-02 | 9.83e-01 |
| GOBP CELLULAR RESPONSE TO LIGHT STIMULUS | 96 | 8.02e-01 | 1.48e-02 | 9.78e-01 |
| GOBP CELLULAR RESPONSE TO TESTOSTERONE STIMULUS | 12 | 9.29e-01 | -1.48e-02 | 9.88e-01 |
| GOBP MIRNA MEDIATED GENE SILENCING BY INHIBITION OF TRANSLATION | 16 | 9.18e-01 | 1.48e-02 | 9.88e-01 |
| GOBP HEART FORMATION | 16 | 9.18e-01 | -1.48e-02 | 9.88e-01 |
| GOBP REGULATION OF SYNAPSE ASSEMBLY | 54 | 8.51e-01 | -1.48e-02 | 9.82e-01 |
| GOCC PHOTORECEPTOR OUTER SEGMENT | 53 | 8.53e-01 | -1.48e-02 | 9.82e-01 |
| GOBP ENDOCYTOSIS INVOLVED IN VIRAL ENTRY INTO HOST CELL | 10 | 9.36e-01 | 1.47e-02 | 9.90e-01 |
| GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 26 | 8.97e-01 | 1.46e-02 | 9.86e-01 |
| GOMF VIRION BINDING | 9 | 9.39e-01 | 1.46e-02 | 9.92e-01 |
| GOBP RAS PROTEIN SIGNAL TRANSDUCTION | 273 | 6.79e-01 | -1.46e-02 | 9.52e-01 |
| GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 8 | 9.43e-01 | -1.46e-02 | 9.92e-01 |
| GOBP LYTIC VACUOLE ORGANIZATION | 94 | 8.07e-01 | 1.46e-02 | 9.80e-01 |
| GOBP FOREBRAIN NEURON DIFFERENTIATION | 21 | 9.08e-01 | -1.45e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 8 | 9.43e-01 | -1.45e-02 | 9.92e-01 |
| GOMF COA HYDROLASE ACTIVITY | 18 | 9.15e-01 | 1.45e-02 | 9.88e-01 |
| GOCC SWR1 COMPLEX | 13 | 9.28e-01 | 1.45e-02 | 9.88e-01 |
| GOBP RHYTHMIC BEHAVIOR | 27 | 8.97e-01 | -1.45e-02 | 9.86e-01 |
| GOBP IMPORT INTO NUCLEUS | 139 | 7.69e-01 | -1.45e-02 | 9.70e-01 |
| GOBP PONS DEVELOPMENT | 7 | 9.47e-01 | 1.44e-02 | 9.93e-01 |
| GOCC GOLGI LUMEN | 41 | 8.73e-01 | -1.44e-02 | 9.85e-01 |
| GOBP NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 39 | 8.77e-01 | -1.43e-02 | 9.86e-01 |
| GOBP REGULATION OF SUPEROXIDE METABOLIC PROCESS | 19 | 9.14e-01 | 1.43e-02 | 9.88e-01 |
| GOMF MAGNESIUM ION BINDING | 184 | 7.39e-01 | 1.43e-02 | 9.65e-01 |
| GOCC SCHMIDT LANTERMAN INCISURE | 6 | 9.52e-01 | 1.43e-02 | 9.93e-01 |
| GOCC FICOLIN 1 RICH GRANULE MEMBRANE | 49 | 8.63e-01 | 1.42e-02 | 9.83e-01 |
| GOCC CHROMOSOME | 1333 | 3.91e-01 | 1.42e-02 | 8.67e-01 |
| GOBP POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION | 13 | 9.30e-01 | -1.42e-02 | 9.89e-01 |
| GOBP REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 58 | 8.53e-01 | -1.41e-02 | 9.82e-01 |
| GOBP NON MEMBRANE BOUNDED ORGANELLE ASSEMBLY | 342 | 6.55e-01 | -1.41e-02 | 9.47e-01 |
| GOCC CLATHRIN COATED PIT | 59 | 8.52e-01 | 1.41e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS | 12 | 9.33e-01 | 1.40e-02 | 9.89e-01 |
| GOMF GTPASE BINDING | 273 | 6.91e-01 | 1.40e-02 | 9.54e-01 |
| GOCC INCLUSION BODY | 57 | 8.55e-01 | 1.40e-02 | 9.82e-01 |
| GOBP ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 585 | 5.65e-01 | 1.40e-02 | 9.29e-01 |
| GOBP REGULATION OF DENDRITIC SPINE MAINTENANCE | 10 | 9.39e-01 | 1.40e-02 | 9.92e-01 |
| GOCC MONOATOMIC ION CHANNEL COMPLEX | 121 | 7.91e-01 | 1.40e-02 | 9.76e-01 |
| GOBP REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 1267 | 4.11e-01 | 1.39e-02 | 8.77e-01 |
| GOBP STRIATED MUSCLE TISSUE DEVELOPMENT | 127 | 7.87e-01 | 1.39e-02 | 9.76e-01 |
| GOBP CERAMIDE METABOLIC PROCESS | 72 | 8.39e-01 | 1.39e-02 | 9.82e-01 |
| GOBP PROSTHETIC GROUP METABOLIC PROCESS | 5 | 9.57e-01 | -1.39e-02 | 9.93e-01 |
| GOMF ATP DEPENDENT DNA DAMAGE SENSOR ACTIVITY | 14 | 9.29e-01 | -1.39e-02 | 9.88e-01 |
| GOBP REGULATION OF NOTCH SIGNALING PATHWAY | 63 | 8.49e-01 | 1.38e-02 | 9.82e-01 |
| GOBP T CELL ANTIGEN PROCESSING AND PRESENTATION | 5 | 9.57e-01 | 1.38e-02 | 9.93e-01 |
| GOBP CILIUM ORGANIZATION | 313 | 6.75e-01 | 1.38e-02 | 9.51e-01 |
| GOBP KINETOCHORE ASSEMBLY | 17 | 9.21e-01 | -1.38e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF HEART RATE | 6 | 9.53e-01 | -1.38e-02 | 9.93e-01 |
| GOBP REGULATION OF CYTOPLASMIC TRANSPORT | 32 | 8.93e-01 | 1.38e-02 | 9.86e-01 |
| GOBP REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 40 | 8.80e-01 | -1.38e-02 | 9.86e-01 |
| GOCC SPLICEOSOMAL TRI SNRNP COMPLEX | 36 | 8.86e-01 | -1.38e-02 | 9.86e-01 |
| GOBP RESPONSE TO STEROID HORMONE | 216 | 7.28e-01 | 1.38e-02 | 9.64e-01 |
| GOMF MONOATOMIC ANION MONOATOMIC CATION SYMPORTER ACTIVITY | 13 | 9.32e-01 | -1.37e-02 | 9.89e-01 |
| GOBP RRNA MODIFICATION | 31 | 8.95e-01 | 1.37e-02 | 9.86e-01 |
| GOBP BASEMENT MEMBRANE ORGANIZATION | 25 | 9.05e-01 | 1.37e-02 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT | 9 | 9.43e-01 | -1.37e-02 | 9.92e-01 |
| GOBP REGULATION OF TRANSLATION INITIATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 8 | 9.47e-01 | -1.37e-02 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF WOUND HEALING | 38 | 8.84e-01 | 1.37e-02 | 9.86e-01 |
| GOBP REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY | 111 | 8.04e-01 | 1.37e-02 | 9.79e-01 |
| GOBP REGULATION OF CELL GROWTH | 281 | 6.95e-01 | -1.36e-02 | 9.54e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN BINDING | 59 | 8.56e-01 | 1.36e-02 | 9.82e-01 |
| GOBP MEMBRANE LIPID METABOLIC PROCESS | 146 | 7.77e-01 | 1.36e-02 | 9.74e-01 |
| GOMF UBIQUITIN LIGASE SUBSTRATE ADAPTOR ACTIVITY | 49 | 8.69e-01 | -1.36e-02 | 9.85e-01 |
| GOBP TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 361 | 6.60e-01 | 1.35e-02 | 9.49e-01 |
| GOMF PROTEIN KINASE A CATALYTIC SUBUNIT BINDING | 11 | 9.38e-01 | 1.35e-02 | 9.91e-01 |
| GOBP NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 18 | 9.21e-01 | -1.35e-02 | 9.88e-01 |
| GOBP REGULATION OF NERVOUS SYSTEM PROCESS | 58 | 8.59e-01 | 1.35e-02 | 9.82e-01 |
| GOBP VACUOLE ORGANIZATION | 205 | 7.40e-01 | -1.35e-02 | 9.65e-01 |
| GOBP SNRNA METABOLIC PROCESS | 53 | 8.66e-01 | -1.35e-02 | 9.84e-01 |
| GOBP PYRUVATE METABOLIC PROCESS | 97 | 8.19e-01 | -1.35e-02 | 9.80e-01 |
| GOMF ACID PHOSPHATASE ACTIVITY | 6 | 9.55e-01 | -1.34e-02 | 9.93e-01 |
| GOBP REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 37 | 8.88e-01 | 1.34e-02 | 9.86e-01 |
| GOBP REGULATION OF OSTEOCLAST DIFFERENTIATION | 49 | 8.71e-01 | 1.34e-02 | 9.85e-01 |
| GOBP POSITIVE REGULATION OF DEVELOPMENTAL GROWTH | 90 | 8.27e-01 | -1.34e-02 | 9.80e-01 |
| GOCC LIPID DROPLET | 83 | 8.34e-01 | 1.33e-02 | 9.81e-01 |
| GOBP NEGATIVE REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 6 | 9.55e-01 | 1.33e-02 | 9.93e-01 |
| GOBP LYMPHATIC ENDOTHELIAL CELL DIFFERENTIATION | 5 | 9.59e-01 | -1.33e-02 | 9.93e-01 |
| GOBP REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 69 | 8.49e-01 | 1.33e-02 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE | 65 | 8.53e-01 | -1.33e-02 | 9.82e-01 |
| GOBP DOPAMINE METABOLIC PROCESS | 21 | 9.16e-01 | 1.33e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF FILOPODIUM ASSEMBLY | 5 | 9.59e-01 | -1.32e-02 | 9.93e-01 |
| GOMF METALLOEXOPEPTIDASE ACTIVITY | 41 | 8.84e-01 | 1.32e-02 | 9.86e-01 |
| GOBP CELLULAR RESPONSE TO LAMINAR FLUID SHEAR STRESS | 6 | 9.55e-01 | -1.32e-02 | 9.93e-01 |
| GOCC EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE | 46 | 8.77e-01 | -1.32e-02 | 9.86e-01 |
| GOBP CARDIOLIPIN BIOSYNTHETIC PROCESS | 7 | 9.52e-01 | 1.32e-02 | 9.93e-01 |
| GOBP CARDIAC MUSCLE CELL DIFFERENTIATION | 69 | 8.50e-01 | -1.32e-02 | 9.82e-01 |
| GOCC CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 48 | 8.75e-01 | -1.31e-02 | 9.86e-01 |
| GOMF 5 3 DNA EXONUCLEASE ACTIVITY | 9 | 9.46e-01 | -1.31e-02 | 9.93e-01 |
| GOBP LABYRINTHINE LAYER DEVELOPMENT | 29 | 9.03e-01 | -1.31e-02 | 9.87e-01 |
| GOBP RNA 3 END PROCESSING | 89 | 8.32e-01 | -1.30e-02 | 9.80e-01 |
| GOBP AGGRESOME ASSEMBLY | 5 | 9.60e-01 | -1.30e-02 | 9.94e-01 |
| GOBP LIPID PHOSPHORYLATION | 9 | 9.46e-01 | 1.30e-02 | 9.93e-01 |
| GOMF ATP DEPENDENT DIACYLGLYCEROL KINASE ACTIVITY | 9 | 9.46e-01 | 1.30e-02 | 9.93e-01 |
| GOBP HEART GROWTH | 45 | 8.80e-01 | 1.30e-02 | 9.86e-01 |
| GOBP REGULATION OF RESPONSE TO OXIDATIVE STRESS | 26 | 9.09e-01 | 1.30e-02 | 9.88e-01 |
| GOMF CHANNEL REGULATOR ACTIVITY | 79 | 8.42e-01 | 1.30e-02 | 9.82e-01 |
| GOBP REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 51 | 8.73e-01 | 1.30e-02 | 9.85e-01 |
| GOBP MONOCARBOXYLIC ACID METABOLIC PROCESS | 425 | 6.48e-01 | -1.30e-02 | 9.44e-01 |
| GOBP NUCLEAR PORE ORGANIZATION | 15 | 9.31e-01 | 1.29e-02 | 9.89e-01 |
| GOBP CAMP BIOSYNTHETIC PROCESS | 6 | 9.56e-01 | -1.29e-02 | 9.93e-01 |
| GOMF PROTEIN DIMERIZATION ACTIVITY | 697 | 5.65e-01 | 1.29e-02 | 9.29e-01 |
| GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 89 | 8.34e-01 | -1.29e-02 | 9.81e-01 |
| GOBP REGULATION OF CELLULAR SENESCENCE | 33 | 8.98e-01 | 1.29e-02 | 9.87e-01 |
| GOBP CELL JUNCTION ASSEMBLY | 244 | 7.30e-01 | 1.29e-02 | 9.64e-01 |
| GOBP ENDOTHELIAL CELL MIGRATION | 138 | 7.95e-01 | 1.28e-02 | 9.77e-01 |
| GOMF GATED CHANNEL ACTIVITY | 129 | 8.02e-01 | 1.28e-02 | 9.78e-01 |
| GOBP SYNAPSE ASSEMBLY | 90 | 8.34e-01 | -1.28e-02 | 9.81e-01 |
| GOBP CELL CELL JUNCTION ORGANIZATION | 125 | 8.05e-01 | 1.28e-02 | 9.79e-01 |
| GOBP REGULATION OF HYALURONAN BIOSYNTHETIC PROCESS | 5 | 9.61e-01 | 1.27e-02 | 9.94e-01 |
| GOBP GLOMERULUS DEVELOPMENT | 36 | 8.95e-01 | 1.27e-02 | 9.86e-01 |
| GOBP NEGATIVE REGULATION OF TRANSFERASE ACTIVITY | 176 | 7.72e-01 | -1.27e-02 | 9.71e-01 |
| GOBP BASIC AMINO ACID TRANSPORT | 14 | 9.34e-01 | 1.27e-02 | 9.90e-01 |
| GOBP RESPONSE TO OXIDATIVE STRESS | 310 | 7.02e-01 | -1.27e-02 | 9.56e-01 |
| GOBP PROTEIN LOCALIZATION TO MICROTUBULE | 18 | 9.26e-01 | -1.26e-02 | 9.88e-01 |
| GOBP REGULATION OF PHOSPHATIDYLCHOLINE METABOLIC PROCESS | 10 | 9.45e-01 | -1.26e-02 | 9.93e-01 |
| GOBP VIRAL BUDDING | 24 | 9.15e-01 | -1.26e-02 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF GLIOGENESIS | 40 | 8.91e-01 | 1.26e-02 | 9.86e-01 |
| GOBP NEGATIVE REGULATION OF MAP KINASE ACTIVITY | 38 | 8.93e-01 | 1.26e-02 | 9.86e-01 |
| GOMF GLYCOLIPID BINDING | 21 | 9.21e-01 | -1.26e-02 | 9.88e-01 |
| GOMF ACETYLCHOLINE RECEPTOR ACTIVITY | 5 | 9.61e-01 | 1.25e-02 | 9.94e-01 |
| GOBP REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 75 | 8.52e-01 | -1.25e-02 | 9.82e-01 |
| GOBP GLUCOCORTICOID METABOLIC PROCESS | 12 | 9.40e-01 | 1.25e-02 | 9.92e-01 |
| GOBP NUCLEOTIDE SUGAR METABOLIC PROCESS | 33 | 9.01e-01 | 1.25e-02 | 9.87e-01 |
| GOCC MICROTUBULE CYTOSKELETON | 1097 | 4.91e-01 | 1.25e-02 | 9.13e-01 |
| GOBP CELLULAR RESPONSE TO ELECTRICAL STIMULUS | 5 | 9.62e-01 | -1.25e-02 | 9.94e-01 |
| GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE | 15 | 9.33e-01 | 1.25e-02 | 9.89e-01 |
| GOBP REGULATION OF DNA REPAIR | 199 | 7.63e-01 | 1.24e-02 | 9.70e-01 |
| GOBP NEGATIVE REGULATION OF HORMONE SECRETION | 34 | 9.00e-01 | 1.24e-02 | 9.87e-01 |
| GOCC CONDENSED NUCLEAR CHROMOSOME | 57 | 8.72e-01 | 1.24e-02 | 9.85e-01 |
| GOBP MULTICELLULAR ORGANISMAL LEVEL HOMEOSTASIS | 522 | 6.31e-01 | 1.24e-02 | 9.40e-01 |
| GOBP NEGATIVE REGULATION OF CATALYTIC ACTIVITY | 319 | 7.05e-01 | -1.24e-02 | 9.57e-01 |
| GOBP CELLULAR RESPONSE TO ATP | 14 | 9.36e-01 | 1.23e-02 | 9.90e-01 |
| GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 8 | 9.52e-01 | 1.23e-02 | 9.93e-01 |
| GOBP NCRNA TRANSCRIPTION | 103 | 8.29e-01 | 1.23e-02 | 9.80e-01 |
| GOBP ORGANOPHOSPHATE METABOLIC PROCESS | 755 | 5.68e-01 | -1.23e-02 | 9.30e-01 |
| GOBP REGULATION OF CAMP MEDIATED SIGNALING | 12 | 9.41e-01 | 1.23e-02 | 9.92e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 799 | 5.58e-01 | 1.23e-02 | 9.27e-01 |
| GOBP ERYTHROCYTE HOMEOSTASIS | 111 | 8.23e-01 | -1.23e-02 | 9.80e-01 |
| GOBP CELL GROWTH | 336 | 7.00e-01 | -1.23e-02 | 9.55e-01 |
| GOBP PROTEIN ACTIVATION CASCADE | 9 | 9.49e-01 | -1.23e-02 | 9.93e-01 |
| GOBP SEROTONIN METABOLIC PROCESS | 6 | 9.59e-01 | 1.23e-02 | 9.93e-01 |
| GOMF EXOPEPTIDASE ACTIVITY | 67 | 8.63e-01 | 1.22e-02 | 9.83e-01 |
| GOCC PAM COMPLEX TIM23 ASSOCIATED IMPORT MOTOR | 5 | 9.62e-01 | -1.22e-02 | 9.94e-01 |
| GOBP CELL ADHESION | 851 | 5.51e-01 | 1.22e-02 | 9.26e-01 |
| GOBP TRIPARTITE REGIONAL SUBDIVISION | 9 | 9.50e-01 | 1.21e-02 | 9.93e-01 |
| GOBP REGULATION OF HUMORAL IMMUNE RESPONSE | 20 | 9.25e-01 | 1.21e-02 | 9.88e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL PROCESS | 21 | 9.23e-01 | 1.21e-02 | 9.88e-01 |
| GOBP COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY | 9 | 9.50e-01 | 1.21e-02 | 9.93e-01 |
| GOBP REGULATION OF REPRODUCTIVE PROCESS | 113 | 8.24e-01 | -1.21e-02 | 9.80e-01 |
| GOMF SMALL PROTEIN ACTIVATING ENZYME BINDING | 5 | 9.63e-01 | 1.21e-02 | 9.94e-01 |
| GOBP NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION | 14 | 9.38e-01 | -1.21e-02 | 9.91e-01 |
| GOMF DNA BINDING TRANSCRIPTION FACTOR BINDING | 375 | 6.90e-01 | -1.21e-02 | 9.54e-01 |
| GOBP RESPONSE TO GAMMA RADIATION | 44 | 8.90e-01 | -1.21e-02 | 9.86e-01 |
| GOBP ERYTHROCYTE DEVELOPMENT | 28 | 9.12e-01 | 1.21e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF PROGRAMMED CELL DEATH | 598 | 6.18e-01 | -1.20e-02 | 9.37e-01 |
| GOBP GLAND MORPHOGENESIS | 63 | 8.69e-01 | 1.20e-02 | 9.85e-01 |
| GOCC CATALYTIC STEP 2 SPLICEOSOME | 88 | 8.46e-01 | -1.20e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHORYLATION | 238 | 7.52e-01 | 1.19e-02 | 9.68e-01 |
| GOCC CELL SURFACE | 460 | 6.64e-01 | -1.19e-02 | 9.49e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 47 | 8.88e-01 | 1.19e-02 | 9.86e-01 |
| GOBP INNER EAR RECEPTOR CELL DEVELOPMENT | 32 | 9.08e-01 | -1.19e-02 | 9.88e-01 |
| GOBP FORMATION OF TRANSLATION PREINITIATION COMPLEX | 8 | 9.54e-01 | -1.19e-02 | 9.93e-01 |
| GOMF BETA TUBULIN BINDING | 36 | 9.02e-01 | -1.18e-02 | 9.87e-01 |
| GOBP FAT CELL DIFFERENTIATION | 159 | 7.97e-01 | 1.18e-02 | 9.77e-01 |
| GOBP RENAL SYSTEM VASCULATURE MORPHOGENESIS | 5 | 9.64e-01 | -1.18e-02 | 9.95e-01 |
| GOBP RIBONUCLEOPROTEIN COMPLEX LOCALIZATION | 9 | 9.51e-01 | -1.18e-02 | 9.93e-01 |
| GOCC METHYLOSOME | 12 | 9.44e-01 | -1.18e-02 | 9.92e-01 |
| GOBP NCRNA METABOLIC PROCESS | 538 | 6.43e-01 | -1.17e-02 | 9.42e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN LEVELS | 120 | 8.25e-01 | 1.17e-02 | 9.80e-01 |
| GOBP OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS | 21 | 9.26e-01 | 1.17e-02 | 9.88e-01 |
| GOBP PIGMENT GRANULE ORGANIZATION | 37 | 9.02e-01 | 1.17e-02 | 9.87e-01 |
| GOMF L LEUCINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 9.61e-01 | 1.16e-02 | 9.94e-01 |
| GOBP POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 69 | 8.68e-01 | 1.16e-02 | 9.84e-01 |
| GOBP NEGATIVE REGULATION OF MACROAUTOPHAGY | 31 | 9.11e-01 | 1.16e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II | 675 | 6.10e-01 | 1.16e-02 | 9.36e-01 |
| GOBP REGULATION OF VESICLE MEDIATED TRANSPORT | 366 | 7.04e-01 | 1.16e-02 | 9.56e-01 |
| GOBP REGULATION OF INTRACELLULAR TRANSPORT | 281 | 7.40e-01 | 1.16e-02 | 9.65e-01 |
| GOCC CYTOPLASMIC SIDE OF PLASMA MEMBRANE | 122 | 8.26e-01 | 1.15e-02 | 9.80e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS DISULFIDE AS ACCEPTOR | 7 | 9.58e-01 | -1.15e-02 | 9.93e-01 |
| GOBP REGULATION OF BEHAVIOR | 36 | 9.05e-01 | -1.15e-02 | 9.88e-01 |
| GOCC POSTSYNAPTIC CYTOSOL | 11 | 9.47e-01 | 1.15e-02 | 9.93e-01 |
| GOBP ALCOHOL METABOLIC PROCESS | 243 | 7.58e-01 | 1.15e-02 | 9.69e-01 |
| GOMF L PROLINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 9.65e-01 | -1.15e-02 | 9.95e-01 |
| GOCC PROTEIN KINASE COMPLEX | 125 | 8.25e-01 | 1.14e-02 | 9.80e-01 |
| GOBP NEGATIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 6 | 9.61e-01 | 1.14e-02 | 9.94e-01 |
| GOBP REGULATION OF NEUTROPHIL ACTIVATION | 12 | 9.45e-01 | -1.14e-02 | 9.93e-01 |
| GOBP BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 83 | 8.58e-01 | -1.14e-02 | 9.82e-01 |
| GOBP LIPID CATABOLIC PROCESS | 216 | 7.73e-01 | -1.14e-02 | 9.72e-01 |
| GOBP REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 33 | 9.10e-01 | -1.14e-02 | 9.88e-01 |
| GOBP RRNA TRANSCRIPTION | 33 | 9.10e-01 | -1.14e-02 | 9.88e-01 |
| GOBP LOCOMOTORY BEHAVIOR | 110 | 8.37e-01 | 1.13e-02 | 9.82e-01 |
| GOBP CEREBELLAR CORTEX DEVELOPMENT | 32 | 9.12e-01 | -1.13e-02 | 9.88e-01 |
| GOBP TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 73 | 8.67e-01 | 1.13e-02 | 9.84e-01 |
| GOCC SECRETORY GRANULE MEMBRANE | 233 | 7.67e-01 | 1.13e-02 | 9.70e-01 |
| GOBP DNA INTEGRITY CHECKPOINT SIGNALING | 123 | 8.29e-01 | 1.13e-02 | 9.80e-01 |
| GOBP REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 10 | 9.51e-01 | 1.13e-02 | 9.93e-01 |
| GOBP PLACENTA BLOOD VESSEL DEVELOPMENT | 23 | 9.25e-01 | -1.13e-02 | 9.88e-01 |
| GOBP CARBOHYDRATE CATABOLIC PROCESS | 126 | 8.27e-01 | -1.13e-02 | 9.80e-01 |
| GOMF PROTEIN PHOSPHORYLATED AMINO ACID BINDING | 50 | 8.90e-01 | -1.13e-02 | 9.86e-01 |
| GOBP RESPONSE TO LIGHT STIMULUS | 232 | 7.69e-01 | -1.12e-02 | 9.70e-01 |
| GOMF CARBOXYLIC ESTER HYDROLASE ACTIVITY | 89 | 8.55e-01 | 1.12e-02 | 9.82e-01 |
| GOBP PROSTATE GLAND DEVELOPMENT | 27 | 9.20e-01 | 1.12e-02 | 9.88e-01 |
| GOBP REGULATION OF DEVELOPMENTAL GROWTH | 190 | 7.91e-01 | -1.12e-02 | 9.76e-01 |
| GOCC GLIAL CELL PROJECTION | 18 | 9.35e-01 | 1.12e-02 | 9.90e-01 |
| GOMF MRNA REGULATORY ELEMENT BINDING TRANSLATION REPRESSOR ACTIVITY | 13 | 9.44e-01 | -1.12e-02 | 9.93e-01 |
| GOBP REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 35 | 9.09e-01 | 1.12e-02 | 9.88e-01 |
| GOBP SYNAPTIC VESICLE COATING | 5 | 9.66e-01 | 1.12e-02 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 38 | 9.05e-01 | -1.11e-02 | 9.88e-01 |
| GOMF IMPORTIN ALPHA FAMILY PROTEIN BINDING | 9 | 9.54e-01 | 1.11e-02 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION | 11 | 9.49e-01 | -1.11e-02 | 9.93e-01 |
| GOBP REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS | 60 | 8.82e-01 | 1.11e-02 | 9.86e-01 |
| GOBP NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION | 119 | 8.35e-01 | -1.11e-02 | 9.81e-01 |
| GOMF ENZYME REGULATOR ACTIVITY | 954 | 5.66e-01 | 1.11e-02 | 9.29e-01 |
| GOBP LEUKOCYTE MIGRATION | 251 | 7.63e-01 | -1.11e-02 | 9.70e-01 |
| GOMF HISTONE H3K4 TRIMETHYLTRANSFERASE ACTIVITY | 8 | 9.57e-01 | 1.11e-02 | 9.93e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE | 14 | 9.43e-01 | -1.11e-02 | 9.92e-01 |
| GOBP REGULATION OF GTPASE ACTIVITY | 221 | 7.77e-01 | -1.11e-02 | 9.74e-01 |
| GOBP PANCREAS DEVELOPMENT | 36 | 9.09e-01 | 1.10e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF GROWTH | 163 | 8.09e-01 | -1.10e-02 | 9.80e-01 |
| GOBP REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 56 | 8.87e-01 | 1.10e-02 | 9.86e-01 |
| GOBP REGULATION OF MESENCHYMAL CELL PROLIFERATION | 17 | 9.38e-01 | -1.09e-02 | 9.91e-01 |
| GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 249 | 7.68e-01 | 1.09e-02 | 9.70e-01 |
| GOMF MOLECULAR TRANSDUCER ACTIVITY | 476 | 6.86e-01 | 1.09e-02 | 9.54e-01 |
| GOBP DORSAL VENTRAL NEURAL TUBE PATTERNING | 14 | 9.44e-01 | 1.08e-02 | 9.92e-01 |
| GOCC ENDOPEPTIDASE COMPLEX | 75 | 8.71e-01 | 1.08e-02 | 9.85e-01 |
| GOBP CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 37 | 9.10e-01 | 1.08e-02 | 9.88e-01 |
| GOBP REGULATION OF GROWTH | 395 | 7.14e-01 | -1.08e-02 | 9.59e-01 |
| GOMF GROWTH FACTOR BINDING | 75 | 8.72e-01 | -1.08e-02 | 9.85e-01 |
| GOBP GLYCOPROTEIN METABOLIC PROCESS | 253 | 7.69e-01 | 1.07e-02 | 9.70e-01 |
| GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY | 14 | 9.45e-01 | -1.07e-02 | 9.93e-01 |
| GOCC CILIARY BASE | 28 | 9.22e-01 | -1.07e-02 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF DEPHOSPHORYLATION | 40 | 9.07e-01 | 1.07e-02 | 9.88e-01 |
| GOMF MRNA 3 UTR AU RICH REGION BINDING | 25 | 9.26e-01 | -1.07e-02 | 9.88e-01 |
| GOBP REGULATION OF GLUTAMATE SECRETION NEUROTRANSMISSION | 5 | 9.67e-01 | -1.07e-02 | 9.96e-01 |
| GOBP TELENCEPHALON DEVELOPMENT | 166 | 8.13e-01 | -1.07e-02 | 9.80e-01 |
| GOBP RESPONSE TO RADIATION | 324 | 7.43e-01 | -1.07e-02 | 9.65e-01 |
| GOBP REGULATION OF PHOSPHORUS METABOLIC PROCESS | 820 | 6.08e-01 | 1.06e-02 | 9.36e-01 |
| GOBP TERMINATION OF RNA POLYMERASE II TRANSCRIPTION | 10 | 9.54e-01 | 1.06e-02 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF CHEMOTAXIS | 87 | 8.64e-01 | -1.06e-02 | 9.83e-01 |
| GOMF PHOSPHOLIPASE ACTIVATOR ACTIVITY | 14 | 9.45e-01 | -1.06e-02 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF SIGNALING | 930 | 5.88e-01 | 1.06e-02 | 9.36e-01 |
| GOMF PROTEIN CONTAINING COMPLEX BINDING | 1311 | 5.26e-01 | -1.06e-02 | 9.22e-01 |
| GOBP POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 11 | 9.52e-01 | 1.06e-02 | 9.93e-01 |
| GOBP ADULT BEHAVIOR | 78 | 8.72e-01 | -1.05e-02 | 9.85e-01 |
| GOBP L GLUTAMATE IMPORT | 27 | 9.24e-01 | -1.05e-02 | 9.88e-01 |
| GOCC EUCHROMATIN | 43 | 9.05e-01 | 1.05e-02 | 9.88e-01 |
| GOCC EXTRINSIC COMPONENT OF SYNAPTIC MEMBRANE | 10 | 9.54e-01 | -1.05e-02 | 9.93e-01 |
| GOBP CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 344 | 7.39e-01 | -1.05e-02 | 9.65e-01 |
| GOBP REGULATION OF MYELOID CELL DIFFERENTIATION | 146 | 8.27e-01 | 1.05e-02 | 9.80e-01 |
| GOMF SOLUTE SODIUM SYMPORTER ACTIVITY | 30 | 9.21e-01 | 1.05e-02 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 6 | 9.65e-01 | 1.04e-02 | 9.95e-01 |
| GOBP CELL MOTILITY | 1029 | 5.76e-01 | -1.04e-02 | 9.33e-01 |
| GOBP REGULATION OF CATABOLIC PROCESS | 847 | 6.11e-01 | 1.04e-02 | 9.36e-01 |
| GOBP SALIVARY GLAND DEVELOPMENT | 18 | 9.39e-01 | -1.04e-02 | 9.92e-01 |
| GOBP CARNITINE TRANSMEMBRANE TRANSPORT | 5 | 9.68e-01 | -1.04e-02 | 9.96e-01 |
| GOCC PHAGOLYSOSOME | 5 | 9.68e-01 | 1.04e-02 | 9.96e-01 |
| GOBP REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 58 | 8.92e-01 | 1.04e-02 | 9.86e-01 |
| GOBP HEMATOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT | 68 | 8.83e-01 | 1.04e-02 | 9.86e-01 |
| GOBP RESPONSE TO HYDROPEROXIDE | 12 | 9.51e-01 | -1.03e-02 | 9.93e-01 |
| GOBP CRANIAL NERVE MORPHOGENESIS | 14 | 9.47e-01 | 1.03e-02 | 9.93e-01 |
| GOBP WOUND HEALING | 264 | 7.73e-01 | 1.03e-02 | 9.72e-01 |
| GOBP REGULATION OF MONOATOMIC ION TRANSPORT | 288 | 7.64e-01 | 1.03e-02 | 9.70e-01 |
| GOBP REGULATION OF VASCULAR PERMEABILITY | 26 | 9.28e-01 | 1.03e-02 | 9.88e-01 |
| GOBP REGULATION OF CATALYTIC ACTIVITY | 1057 | 5.76e-01 | 1.03e-02 | 9.33e-01 |
| GOCC NEURON SPINE | 106 | 8.55e-01 | 1.03e-02 | 9.82e-01 |
| GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH | 14 | 9.47e-01 | 1.03e-02 | 9.93e-01 |
| GOCC CYTOPLASMIC REGION | 180 | 8.12e-01 | 1.03e-02 | 9.80e-01 |
| GOBP RESPONSE TO HORMONE | 556 | 6.81e-01 | 1.03e-02 | 9.52e-01 |
| GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT | 15 | 9.45e-01 | -1.03e-02 | 9.93e-01 |
| GOBP GOLGI VESICLE BUDDING | 10 | 9.55e-01 | -1.02e-02 | 9.93e-01 |
| GOBP MITOCHONDRIAL RNA MODIFICATION | 10 | 9.55e-01 | -1.02e-02 | 9.93e-01 |
| GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III | 29 | 9.24e-01 | 1.02e-02 | 9.88e-01 |
| GOCC SMC5 SMC6 COMPLEX | 9 | 9.58e-01 | 1.02e-02 | 9.93e-01 |
| GOBP LIPID METABOLIC PROCESS | 917 | 6.04e-01 | 1.02e-02 | 9.36e-01 |
| GOBP REGULATION OF LIPOPHAGY | 5 | 9.69e-01 | -1.02e-02 | 9.96e-01 |
| GOBP LOCOMOTOR RHYTHM | 12 | 9.51e-01 | 1.02e-02 | 9.93e-01 |
| GOBP INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 41 | 9.10e-01 | 1.02e-02 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF DNA REPAIR | 120 | 8.48e-01 | 1.01e-02 | 9.82e-01 |
| GOBP CANONICAL WNT SIGNALING PATHWAY | 190 | 8.10e-01 | 1.01e-02 | 9.80e-01 |
| GOBP INTESTINAL EPITHELIAL CELL DEVELOPMENT | 12 | 9.52e-01 | 1.01e-02 | 9.93e-01 |
| GOBP FACE DEVELOPMENT | 34 | 9.19e-01 | -1.01e-02 | 9.88e-01 |
| GOMF MONOATOMIC CATION CHANNEL ACTIVITY | 151 | 8.31e-01 | -1.01e-02 | 9.80e-01 |
| GOBP NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 542 | 6.90e-01 | -1.01e-02 | 9.54e-01 |
| GOBP CELL PART MORPHOGENESIS | 415 | 7.26e-01 | 1.01e-02 | 9.63e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MRNA STABILITY | 7 | 9.63e-01 | 1.01e-02 | 9.94e-01 |
| GOBP SNRNA PROCESSING | 26 | 9.29e-01 | -1.01e-02 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 15 | 9.46e-01 | -1.01e-02 | 9.93e-01 |
| GOBP RNA SECONDARY STRUCTURE UNWINDING | 9 | 9.59e-01 | 1.00e-02 | 9.93e-01 |
| GOCC U2 TYPE SPLICEOSOMAL COMPLEX | 89 | 8.71e-01 | -1.00e-02 | 9.85e-01 |
| GOBP REGULATION OF PROTEIN DEACETYLATION | 28 | 9.27e-01 | 1.00e-02 | 9.88e-01 |
| GOCC NUCLEAR OUTER MEMBRANE ENDOPLASMIC RETICULUM MEMBRANE NETWORK | 905 | 6.14e-01 | 9.97e-03 | 9.36e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 26 | 9.30e-01 | -9.94e-03 | 9.89e-01 |
| GOCC BCL 2 FAMILY PROTEIN COMPLEX | 9 | 9.59e-01 | 9.93e-03 | 9.93e-01 |
| GOBP MACROMOLECULE METHYLATION | 185 | 8.16e-01 | 9.92e-03 | 9.80e-01 |
| GOMF SIGNALING RECEPTOR BINDING | 774 | 6.42e-01 | -9.90e-03 | 9.42e-01 |
| GOBP GRANULOCYTE DIFFERENTIATION | 30 | 9.25e-01 | 9.89e-03 | 9.88e-01 |
| GOBP RESPONSE TO HYDROGEN PEROXIDE | 83 | 8.77e-01 | 9.85e-03 | 9.86e-01 |
| GOBP NEGATIVE REGULATION OF HYDROLASE ACTIVITY | 128 | 8.48e-01 | 9.84e-03 | 9.82e-01 |
| GOBP ENDOTHELIAL CELL PROLIFERATION | 89 | 8.73e-01 | 9.84e-03 | 9.85e-01 |
| GOBP MECHANORECEPTOR DIFFERENTIATION | 39 | 9.15e-01 | 9.83e-03 | 9.88e-01 |
| GOMF GLUCURONOSYL N ACETYLGALACTOSAMINYL PROTEOGLYCAN 4 BETA N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 6 | 9.67e-01 | 9.80e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 83 | 8.78e-01 | 9.79e-03 | 9.86e-01 |
| GOBP MESENCHYMAL CELL DIFFERENTIATION | 145 | 8.39e-01 | -9.77e-03 | 9.82e-01 |
| GOBP RESPONSE TO IONIZING RADIATION | 120 | 8.54e-01 | -9.76e-03 | 9.82e-01 |
| GOCC BASOLATERAL PLASMA MEMBRANE | 149 | 8.37e-01 | 9.76e-03 | 9.82e-01 |
| GOBP PROTEIN LOCALIZATION TO CILIARY MEMBRANE | 10 | 9.57e-01 | -9.76e-03 | 9.93e-01 |
| GOBP STEROID METABOLIC PROCESS | 187 | 8.18e-01 | -9.76e-03 | 9.80e-01 |
| GOBP CELLULAR LIPID METABOLIC PROCESS | 686 | 6.66e-01 | 9.75e-03 | 9.49e-01 |
| GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT MEMBRANE | 67 | 8.91e-01 | 9.73e-03 | 9.86e-01 |
| GOBP NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 1124 | 5.88e-01 | 9.70e-03 | 9.36e-01 |
| GOMF URIDYLYLTRANSFERASE ACTIVITY | 7 | 9.65e-01 | 9.69e-03 | 9.95e-01 |
| GOBP REGULATION OF STEROID BIOSYNTHETIC PROCESS | 48 | 9.08e-01 | 9.67e-03 | 9.88e-01 |
| GOBP REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS | 18 | 9.43e-01 | -9.67e-03 | 9.92e-01 |
| GOBP LOCALIZATION WITHIN MEMBRANE | 541 | 7.03e-01 | 9.64e-03 | 9.56e-01 |
| GOCC INO80 TYPE COMPLEX | 26 | 9.32e-01 | -9.64e-03 | 9.89e-01 |
| GOBP PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 8 | 9.62e-01 | -9.62e-03 | 9.94e-01 |
| GOBP REGULATION OF HISTONE ACETYLATION | 16 | 9.47e-01 | -9.57e-03 | 9.93e-01 |
| GOBP REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 136 | 8.48e-01 | -9.53e-03 | 9.82e-01 |
| GOCC U2AF COMPLEX | 5 | 9.71e-01 | -9.49e-03 | 9.96e-01 |
| GOBP SENSORY PERCEPTION OF LIGHT STIMULUS | 101 | 8.69e-01 | 9.48e-03 | 9.85e-01 |
| GOBP PHAGOLYSOSOME ASSEMBLY | 16 | 9.48e-01 | 9.47e-03 | 9.93e-01 |
| GOBP MACROMOLECULE CATABOLIC PROCESS | 1147 | 5.93e-01 | 9.47e-03 | 9.36e-01 |
| GOBP PEPTIDYL ARGININE METHYLATION | 5 | 9.71e-01 | -9.46e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION | 33 | 9.25e-01 | 9.45e-03 | 9.88e-01 |
| GOBP RISC COMPLEX ASSEMBLY | 10 | 9.59e-01 | 9.40e-03 | 9.93e-01 |
| GOBP B CELL DIFFERENTIATION | 101 | 8.71e-01 | -9.37e-03 | 9.85e-01 |
| GOBP REGULATION OF MEMBRANE PERMEABILITY | 59 | 9.01e-01 | 9.36e-03 | 9.87e-01 |
| GOBP ORGANIC ACID CATABOLIC PROCESS | 184 | 8.28e-01 | -9.33e-03 | 9.80e-01 |
| GOBP REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY | 17 | 9.47e-01 | -9.31e-03 | 9.93e-01 |
| GOBP AMIDE TRANSPORT | 204 | 8.19e-01 | 9.30e-03 | 9.80e-01 |
| GOBP PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS | 49 | 9.10e-01 | -9.29e-03 | 9.88e-01 |
| GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX SUBSTRATE RELEASE | 5 | 9.71e-01 | -9.28e-03 | 9.96e-01 |
| GOBP ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT | 124 | 8.59e-01 | 9.28e-03 | 9.82e-01 |
| GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY | 51 | 9.09e-01 | -9.27e-03 | 9.88e-01 |
| GOMF PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY | 80 | 8.86e-01 | -9.26e-03 | 9.86e-01 |
| GOBP HOMEOSTATIC PROCESS | 1095 | 6.09e-01 | -9.26e-03 | 9.36e-01 |
| GOCC GEMINI OF COILED BODIES | 12 | 9.56e-01 | -9.26e-03 | 9.93e-01 |
| GOBP CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 43 | 9.17e-01 | -9.22e-03 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 22 | 9.41e-01 | -9.18e-03 | 9.92e-01 |
| GOBP REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY | 23 | 9.39e-01 | -9.17e-03 | 9.92e-01 |
| GOBP REGULATION OF TELOMERE MAINTENANCE | 99 | 8.75e-01 | 9.16e-03 | 9.86e-01 |
| GOBP REGULATION OF SYNAPTIC PLASTICITY | 102 | 8.73e-01 | 9.14e-03 | 9.85e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN UBIQUITINATION | 95 | 8.78e-01 | -9.10e-03 | 9.86e-01 |
| GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 6 | 9.69e-01 | 9.08e-03 | 9.96e-01 |
| GOBP AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM | 13 | 9.55e-01 | -9.07e-03 | 9.93e-01 |
| GOBP REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION | 16 | 9.50e-01 | 9.06e-03 | 9.93e-01 |
| GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH SYMBIONT | 81 | 8.88e-01 | 9.06e-03 | 9.86e-01 |
| GOBP PEPTIDYL METHIONINE MODIFICATION | 10 | 9.61e-01 | -9.02e-03 | 9.94e-01 |
| GOBP REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 9 | 9.63e-01 | -9.01e-03 | 9.94e-01 |
| GOBP CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 85 | 8.86e-01 | 8.97e-03 | 9.86e-01 |
| GOBP PROTEIN LOCALIZATION TO NUCLEUS | 266 | 8.02e-01 | 8.95e-03 | 9.78e-01 |
| GOBP POSITIVE REGULATION OF T HELPER 1 CELL DIFFERENTIATION | 5 | 9.72e-01 | -8.94e-03 | 9.96e-01 |
| GOBP T CELL LINEAGE COMMITMENT | 21 | 9.44e-01 | -8.93e-03 | 9.92e-01 |
| GOBP REGULATION OF PH | 74 | 8.94e-01 | 8.93e-03 | 9.86e-01 |
| GOBP POSITIVE REGULATION OF ORGAN GROWTH | 21 | 9.44e-01 | 8.90e-03 | 9.92e-01 |
| GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK | 26 | 9.37e-01 | 8.90e-03 | 9.91e-01 |
| GOBP PROCESS UTILIZING AUTOPHAGIC MECHANISM | 517 | 7.31e-01 | -8.88e-03 | 9.64e-01 |
| GOBP AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS | 56 | 9.09e-01 | 8.86e-03 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 74 | 8.96e-01 | 8.83e-03 | 9.86e-01 |
| GOBP POSTSYNAPTIC SPECIALIZATION ORGANIZATION | 25 | 9.39e-01 | -8.78e-03 | 9.92e-01 |
| GOMF SODIUM CHANNEL ACTIVITY | 17 | 9.50e-01 | 8.78e-03 | 9.93e-01 |
| GOCC CELL DIVISION SITE | 64 | 9.04e-01 | -8.76e-03 | 9.87e-01 |
| GOMF NADP BINDING | 42 | 9.22e-01 | 8.76e-03 | 9.88e-01 |
| GOBP REGULATION OF POTASSIUM ION TRANSPORT | 52 | 9.13e-01 | 8.74e-03 | 9.88e-01 |
| GOMF CENTROMERIC DNA BINDING | 6 | 9.71e-01 | 8.68e-03 | 9.96e-01 |
| GOBP ACTIN FILAMENT BASED PROCESS | 556 | 7.28e-01 | -8.67e-03 | 9.64e-01 |
| GOBP CHLORIDE TRANSPORT | 53 | 9.13e-01 | 8.63e-03 | 9.88e-01 |
| GOBP PROTEIN POLYGLUTAMYLATION | 7 | 9.69e-01 | -8.61e-03 | 9.96e-01 |
| GOMF CERAMIDE BINDING | 18 | 9.50e-01 | -8.58e-03 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT | 11 | 9.61e-01 | -8.58e-03 | 9.94e-01 |
| GOBP MAST CELL CHEMOTAXIS | 8 | 9.67e-01 | 8.54e-03 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION | 5 | 9.74e-01 | -8.54e-03 | 9.96e-01 |
| GOBP PROTEIN CONTAINING COMPLEX DISASSEMBLY | 214 | 8.30e-01 | 8.53e-03 | 9.80e-01 |
| GOCC 9PLUS0 NON MOTILE CILIUM | 81 | 8.95e-01 | 8.51e-03 | 9.86e-01 |
| GOBP NEGATIVE REGULATION OF TRANSLATIONAL INITIATION | 20 | 9.48e-01 | 8.48e-03 | 9.93e-01 |
| GOBP RESPONSE TO ENDOGENOUS STIMULUS | 1084 | 6.42e-01 | 8.47e-03 | 9.42e-01 |
| GOBP FOAM CELL DIFFERENTIATION | 25 | 9.42e-01 | -8.46e-03 | 9.92e-01 |
| GOBP POSITIVE REGULATION OF EXOCYTOSIS | 49 | 9.19e-01 | 8.44e-03 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 279 | 8.10e-01 | -8.41e-03 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS | 5 | 9.74e-01 | -8.41e-03 | 9.96e-01 |
| GOCC DOPAMINERGIC SYNAPSE | 5 | 9.74e-01 | -8.41e-03 | 9.96e-01 |
| GOBP LIPID IMPORT INTO CELL | 14 | 9.57e-01 | -8.38e-03 | 9.93e-01 |
| GOBP RRNA METHYLATION | 22 | 9.46e-01 | -8.37e-03 | 9.93e-01 |
| GOBP INORGANIC ION HOMEOSTASIS | 319 | 7.98e-01 | -8.36e-03 | 9.77e-01 |
| GOMF CYCLIC NUCLEOTIDE BINDING | 25 | 9.42e-01 | -8.36e-03 | 9.92e-01 |
| GOBP CHAPERONE MEDIATED AUTOPHAGY | 13 | 9.59e-01 | 8.33e-03 | 9.93e-01 |
| GOCC VESICLE COAT | 55 | 9.15e-01 | -8.30e-03 | 9.88e-01 |
| GOMF LIPASE ACTIVITY | 75 | 9.01e-01 | 8.30e-03 | 9.87e-01 |
| GOBP PROTEIN LOCALIZATION TO CHROMOSOME | 93 | 8.90e-01 | 8.29e-03 | 9.86e-01 |
| GOBP ALCOHOL BIOSYNTHETIC PROCESS | 98 | 8.87e-01 | -8.29e-03 | 9.86e-01 |
| GOBP RESPONSE TO ALCOHOL | 153 | 8.60e-01 | -8.28e-03 | 9.82e-01 |
| GOCC UBIQUITIN LIGASE COMPLEX | 284 | 8.12e-01 | -8.23e-03 | 9.80e-01 |
| GOBP BROWN FAT CELL DIFFERENTIATION | 37 | 9.31e-01 | -8.18e-03 | 9.89e-01 |
| GOBP POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE | 34 | 9.35e-01 | 8.15e-03 | 9.90e-01 |
| GOBP AXON GUIDANCE | 110 | 8.83e-01 | 8.14e-03 | 9.86e-01 |
| GOBP INTEGRATED STRESS RESPONSE SIGNALING | 39 | 9.30e-01 | -8.13e-03 | 9.89e-01 |
| GOBP REGULATION OF LIGASE ACTIVITY | 9 | 9.66e-01 | -8.12e-03 | 9.96e-01 |
| GOBP DNA REPAIR | 538 | 7.49e-01 | 8.12e-03 | 9.66e-01 |
| GOMF TRANSCRIPTION COREGULATOR BINDING | 92 | 8.93e-01 | -8.11e-03 | 9.86e-01 |
| GOMF PROTEIN HOMODIMERIZATION ACTIVITY | 519 | 7.54e-01 | 8.07e-03 | 9.68e-01 |
| GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 54 | 9.18e-01 | 8.06e-03 | 9.88e-01 |
| GOBP NEURON APOPTOTIC PROCESS | 189 | 8.49e-01 | 8.05e-03 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 45 | 9.26e-01 | -8.05e-03 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF CARTILAGE DEVELOPMENT | 12 | 9.62e-01 | -8.05e-03 | 9.94e-01 |
| GOMF S ADENOSYL L METHIONINE BINDING | 16 | 9.56e-01 | 8.04e-03 | 9.93e-01 |
| GOBP NEURAL PRECURSOR CELL PROLIFERATION | 88 | 8.96e-01 | -8.04e-03 | 9.86e-01 |
| GOBP REGULATION OF FEEDING BEHAVIOR | 11 | 9.63e-01 | -8.03e-03 | 9.94e-01 |
| GOBP POSITIVE REGULATION OF HORMONE SECRETION | 74 | 9.05e-01 | 8.03e-03 | 9.88e-01 |
| GOBP CELL MORPHOGENESIS | 605 | 7.38e-01 | -8.02e-03 | 9.65e-01 |
| GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 70 | 9.08e-01 | 8.02e-03 | 9.88e-01 |
| GOMF CYCLASE ACTIVITY | 17 | 9.55e-01 | 7.99e-03 | 9.93e-01 |
| GOBP MACROMOLECULE DEACYLATION | 62 | 9.13e-01 | -7.98e-03 | 9.88e-01 |
| GOBP NOTCH SIGNALING PATHWAY | 105 | 8.88e-01 | 7.98e-03 | 9.86e-01 |
| GOBP POSITIVE REGULATION OF ORGANELLE ORGANIZATION | 401 | 7.85e-01 | -7.97e-03 | 9.76e-01 |
| GOBP RESPONSE TO OXYGEN CONTAINING COMPOUND | 1150 | 6.53e-01 | 7.97e-03 | 9.46e-01 |
| GOBP MAMMARY GLAND DUCT MORPHOGENESIS | 16 | 9.56e-01 | 7.96e-03 | 9.93e-01 |
| GOBP PROTEIN CATABOLIC PROCESS | 836 | 7.00e-01 | -7.92e-03 | 9.55e-01 |
| GOBP CIRCULATORY SYSTEM DEVELOPMENT | 680 | 7.27e-01 | -7.91e-03 | 9.63e-01 |
| GOBP POSITIVE REGULATION OF GTPASE ACTIVITY | 170 | 8.59e-01 | -7.91e-03 | 9.82e-01 |
| GOBP EMBRYONIC APPENDAGE MORPHOGENESIS | 61 | 9.15e-01 | -7.90e-03 | 9.88e-01 |
| GOBP REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 124 | 8.80e-01 | -7.86e-03 | 9.86e-01 |
| GOBP POSITIVE REGULATION OF RESPONSE TO WOUNDING | 48 | 9.25e-01 | 7.86e-03 | 9.88e-01 |
| GOBP COGNITION | 177 | 8.57e-01 | 7.86e-03 | 9.82e-01 |
| GOBP CELLULAR HOMEOSTASIS | 531 | 7.58e-01 | -7.85e-03 | 9.69e-01 |
| GOBP REGULATION OF ENDOCYTOSIS | 206 | 8.46e-01 | -7.85e-03 | 9.82e-01 |
| GOBP REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 45 | 9.28e-01 | 7.84e-03 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION | 68 | 9.11e-01 | 7.83e-03 | 9.88e-01 |
| GOBP NEURON MATURATION | 30 | 9.41e-01 | -7.79e-03 | 9.92e-01 |
| GOCC NEURON PROJECTION | 785 | 7.13e-01 | 7.79e-03 | 9.59e-01 |
| GOBP POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 162 | 8.65e-01 | -7.78e-03 | 9.83e-01 |
| GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY | 258 | 8.31e-01 | -7.76e-03 | 9.80e-01 |
| GOBP NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION | 123 | 8.82e-01 | -7.75e-03 | 9.86e-01 |
| GOBP SMALL MOLECULE CATABOLIC PROCESS | 269 | 8.28e-01 | 7.72e-03 | 9.80e-01 |
| GOBP NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 23 | 9.49e-01 | -7.71e-03 | 9.93e-01 |
| GOCC INTERMEDIATE FILAMENT CYTOSKELETON | 70 | 9.11e-01 | 7.71e-03 | 9.88e-01 |
| GOMF LIPID TRANSPORTER ACTIVITY | 111 | 8.89e-01 | 7.67e-03 | 9.86e-01 |
| GOBP REGULATION OF STEROID METABOLIC PROCESS | 61 | 9.18e-01 | -7.64e-03 | 9.88e-01 |
| GOBP MORPHOGENESIS OF AN EPITHELIAL BUD | 6 | 9.74e-01 | -7.62e-03 | 9.96e-01 |
| GOMF CALCIUM ION BINDING | 328 | 8.13e-01 | -7.61e-03 | 9.80e-01 |
| GOBP LYMPHOID PROGENITOR CELL DIFFERENTIATION | 16 | 9.58e-01 | -7.61e-03 | 9.93e-01 |
| GOBP SHORT CHAIN FATTY ACID CATABOLIC PROCESS | 6 | 9.74e-01 | 7.58e-03 | 9.96e-01 |
| GOMF HEXOSYLTRANSFERASE ACTIVITY | 126 | 8.84e-01 | -7.56e-03 | 9.86e-01 |
| GOBP MEMBRANE HYPERPOLARIZATION | 7 | 9.72e-01 | -7.55e-03 | 9.96e-01 |
| GOBP REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 254 | 8.37e-01 | 7.54e-03 | 9.81e-01 |
| GOBP POSITIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION | 10 | 9.67e-01 | -7.54e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 137 | 8.80e-01 | -7.51e-03 | 9.86e-01 |
| GOBP FATTY ACID BETA OXIDATION | 64 | 9.18e-01 | -7.48e-03 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF WNT SIGNALING PATHWAY | 97 | 8.99e-01 | 7.48e-03 | 9.87e-01 |
| GOBP TRACHEA FORMATION | 6 | 9.75e-01 | -7.47e-03 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 21 | 9.53e-01 | -7.47e-03 | 9.93e-01 |
| GOBP CELL CYCLE | 1442 | 6.41e-01 | 7.46e-03 | 9.42e-01 |
| GOBP MONOATOMIC ION HOMEOSTASIS | 378 | 8.04e-01 | -7.45e-03 | 9.79e-01 |
| GOBP POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION | 13 | 9.63e-01 | -7.43e-03 | 9.94e-01 |
| GOBP SYNAPTIC VESICLE DOCKING | 6 | 9.75e-01 | -7.43e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION REGENERATION | 8 | 9.71e-01 | -7.42e-03 | 9.96e-01 |
| GOBP CERAMIDE BIOSYNTHETIC PROCESS | 47 | 9.30e-01 | -7.39e-03 | 9.89e-01 |
| GOBP NEGATIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 6 | 9.75e-01 | 7.36e-03 | 9.96e-01 |
| GOCC PROCENTRIOLE REPLICATION COMPLEX | 6 | 9.75e-01 | 7.36e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 5 | 9.77e-01 | -7.32e-03 | 9.97e-01 |
| GOMF GUANYL NUCLEOTIDE BINDING | 305 | 8.28e-01 | 7.25e-03 | 9.80e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 153 | 8.77e-01 | 7.25e-03 | 9.86e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE BINDING | 12 | 9.65e-01 | 7.24e-03 | 9.95e-01 |
| GOCC BASEMENT MEMBRANE | 37 | 9.39e-01 | 7.23e-03 | 9.92e-01 |
| GOMF THIOLESTER HYDROLASE ACTIVITY | 33 | 9.43e-01 | 7.20e-03 | 9.92e-01 |
| GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING TENSILE STRENGTH | 19 | 9.57e-01 | -7.18e-03 | 9.93e-01 |
| GOBP ERROR PRONE TRANSLESION SYNTHESIS | 11 | 9.67e-01 | -7.15e-03 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 525 | 7.80e-01 | -7.15e-03 | 9.75e-01 |
| GOBP POSITIVE REGULATION OF DNA REPLICATION | 31 | 9.45e-01 | -7.14e-03 | 9.93e-01 |
| GOBP POSTSYNAPSE ORGANIZATION | 125 | 8.91e-01 | 7.14e-03 | 9.86e-01 |
| GOBP DECIDUALIZATION | 18 | 9.58e-01 | -7.12e-03 | 9.93e-01 |
| GOMF HISTONE DECROTONYLASE ACTIVITY | 5 | 9.78e-01 | 7.11e-03 | 9.97e-01 |
| GOBP CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS | 13 | 9.65e-01 | -7.11e-03 | 9.95e-01 |
| GOCC AXON INITIAL SEGMENT | 12 | 9.66e-01 | -7.11e-03 | 9.96e-01 |
| GOBP ENDOSOMAL LUMEN ACIDIFICATION | 13 | 9.65e-01 | -7.05e-03 | 9.95e-01 |
| GOBP CELLULAR RESPONSE TO SALT | 127 | 8.91e-01 | -7.05e-03 | 9.86e-01 |
| GOBP DEPYRIMIDINATION | 8 | 9.73e-01 | 7.02e-03 | 9.96e-01 |
| GOBP REGULATION OF PHAGOCYTOSIS | 70 | 9.19e-01 | 7.02e-03 | 9.88e-01 |
| GOMF G PROTEIN COUPLED AMINE RECEPTOR ACTIVITY | 9 | 9.71e-01 | -7.01e-03 | 9.96e-01 |
| GOBP BASE EXCISION REPAIR | 42 | 9.37e-01 | -7.01e-03 | 9.91e-01 |
| GOBP MEIOTIC CELL CYCLE CHECKPOINT SIGNALING | 7 | 9.74e-01 | -6.99e-03 | 9.96e-01 |
| GOBP REGULATION OF NON MOTILE CILIUM ASSEMBLY | 9 | 9.71e-01 | -6.98e-03 | 9.96e-01 |
| GOCC CILIARY BASAL BODY | 137 | 8.88e-01 | -6.97e-03 | 9.86e-01 |
| GOBP VASCULAR TRANSPORT | 51 | 9.32e-01 | -6.92e-03 | 9.89e-01 |
| GOMF HISTONE H3K14 ACETYLTRANSFERASE ACTIVITY | 9 | 9.71e-01 | 6.89e-03 | 9.96e-01 |
| GOBP CELLULAR METABOLIC COMPOUND SALVAGE | 27 | 9.51e-01 | -6.89e-03 | 9.93e-01 |
| GOCC TERTIARY GRANULE | 130 | 8.92e-01 | -6.88e-03 | 9.86e-01 |
| GOMF PROTEIN DOMAIN SPECIFIC BINDING | 491 | 7.95e-01 | 6.87e-03 | 9.77e-01 |
| GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 39 | 9.41e-01 | 6.85e-03 | 9.92e-01 |
| GOBP DNA CATABOLIC PROCESS | 24 | 9.54e-01 | -6.83e-03 | 9.93e-01 |
| GOBP BRANCHED CHAIN AMINO ACID METABOLIC PROCESS | 26 | 9.52e-01 | -6.82e-03 | 9.93e-01 |
| GOBP REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 24 | 9.54e-01 | -6.79e-03 | 9.93e-01 |
| GOMF RIBOSOMAL PROTEIN S6 KINASE ACTIVITY | 6 | 9.77e-01 | -6.72e-03 | 9.97e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 10 | 9.71e-01 | 6.72e-03 | 9.96e-01 |
| GOBP PROTEIN PEPTIDYL PROLYL ISOMERIZATION | 18 | 9.61e-01 | -6.70e-03 | 9.94e-01 |
| GOBP HEART DEVELOPMENT | 357 | 8.29e-01 | -6.69e-03 | 9.80e-01 |
| GOBP TRNA 3 END PROCESSING | 7 | 9.76e-01 | 6.69e-03 | 9.96e-01 |
| GOBP REGULATION OF PROTEOLYSIS | 457 | 8.08e-01 | -6.67e-03 | 9.80e-01 |
| GOMF SIGNAL SEQUENCE BINDING | 40 | 9.42e-01 | 6.66e-03 | 9.92e-01 |
| GOCC PROTEIN DNA COMPLEX | 867 | 7.42e-01 | -6.66e-03 | 9.65e-01 |
| GOCC CYTOPLASMIC SIDE OF MEMBRANE | 152 | 8.88e-01 | -6.63e-03 | 9.86e-01 |
| GOBP REGULATION OF LIPID KINASE ACTIVITY | 21 | 9.58e-01 | 6.62e-03 | 9.93e-01 |
| GOMF PROTEIN PHOSPHATASE 1 BINDING | 20 | 9.59e-01 | 6.62e-03 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF VASCULATURE DEVELOPMENT | 107 | 9.06e-01 | -6.62e-03 | 9.88e-01 |
| GOBP REGULATION OF CELLULAR COMPONENT BIOGENESIS | 750 | 7.61e-01 | 6.59e-03 | 9.70e-01 |
| GOCC DYNACTIN COMPLEX | 8 | 9.74e-01 | 6.58e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF MEMBRANE POTENTIAL | 11 | 9.70e-01 | 6.58e-03 | 9.96e-01 |
| GOBP MYELOID CELL DIFFERENTIATION | 315 | 8.42e-01 | 6.57e-03 | 9.82e-01 |
| GOBP RENAL FILTRATION | 13 | 9.67e-01 | 6.55e-03 | 9.96e-01 |
| GOBP PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 661 | 7.75e-01 | 6.55e-03 | 9.73e-01 |
| GOBP VALINE METABOLIC PROCESS | 7 | 9.76e-01 | -6.53e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF LIPID STORAGE | 18 | 9.62e-01 | 6.53e-03 | 9.94e-01 |
| GOBP MYOBLAST DIFFERENTIATION | 77 | 9.21e-01 | -6.52e-03 | 9.88e-01 |
| GOMF CHROMATIN BINDING | 460 | 8.12e-01 | 6.51e-03 | 9.80e-01 |
| GOCC EXCITATORY SYNAPSE | 31 | 9.50e-01 | 6.51e-03 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION | 552 | 7.95e-01 | -6.50e-03 | 9.77e-01 |
| GOBP CELL CELL SIGNALING | 900 | 7.44e-01 | -6.47e-03 | 9.66e-01 |
| GOBP CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS | 97 | 9.12e-01 | 6.47e-03 | 9.88e-01 |
| GOMF ESTROGEN RESPONSE ELEMENT BINDING | 8 | 9.75e-01 | -6.45e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION | 368 | 8.33e-01 | 6.41e-03 | 9.81e-01 |
| GOBP RESPONSE TO VITAMIN | 51 | 9.37e-01 | -6.39e-03 | 9.91e-01 |
| GOBP MAMMARY GLAND DEVELOPMENT | 72 | 9.26e-01 | 6.37e-03 | 9.88e-01 |
| GOBP DENDRITIC CELL CHEMOTAXIS | 17 | 9.64e-01 | 6.34e-03 | 9.95e-01 |
| GOBP POSITIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 140 | 8.97e-01 | -6.32e-03 | 9.87e-01 |
| GOBP SNRNA 3 END PROCESSING | 21 | 9.60e-01 | -6.31e-03 | 9.94e-01 |
| GOCC CYTOPLASMIC SIDE OF ENDOPLASMIC RETICULUM MEMBRANE | 14 | 9.67e-01 | -6.30e-03 | 9.96e-01 |
| GOBP REGULATION OF PROGRAMMED CELL DEATH | 1048 | 7.34e-01 | -6.27e-03 | 9.65e-01 |
| GOBP REGULATION OF LIPID STORAGE | 41 | 9.45e-01 | -6.24e-03 | 9.93e-01 |
| GOBP TERTIARY ALCOHOL METABOLIC PROCESS | 9 | 9.74e-01 | 6.23e-03 | 9.96e-01 |
| GOBP MAST CELL MIGRATION | 11 | 9.72e-01 | -6.18e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF NUCLEASE ACTIVITY | 7 | 9.77e-01 | -6.18e-03 | 9.97e-01 |
| GOCC CHYLOMICRON | 6 | 9.79e-01 | 6.17e-03 | 9.97e-01 |
| GOMF PROTEIN CARBOXYL O METHYLTRANSFERASE ACTIVITY | 6 | 9.79e-01 | -6.15e-03 | 9.97e-01 |
| GOBP NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 194 | 8.83e-01 | 6.15e-03 | 9.86e-01 |
| GOBP REGULATION OF AUTOPHAGOSOME ASSEMBLY | 44 | 9.44e-01 | -6.14e-03 | 9.92e-01 |
| GOBP NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 10 | 9.73e-01 | 6.07e-03 | 9.96e-01 |
| GOBP GENERATION OF NEURONS | 872 | 7.63e-01 | -6.07e-03 | 9.70e-01 |
| GOBP GLYCOLYTIC PROCESS | 72 | 9.29e-01 | 6.07e-03 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION | 88 | 9.22e-01 | 6.06e-03 | 9.88e-01 |
| GOBP PROTEIN CONTAINING COMPLEX ASSEMBLY | 1229 | 7.26e-01 | -6.03e-03 | 9.63e-01 |
| GOBP BONE CELL DEVELOPMENT | 14 | 9.69e-01 | -6.01e-03 | 9.96e-01 |
| GOBP TELOMERE ORGANIZATION | 151 | 8.99e-01 | -6.00e-03 | 9.87e-01 |
| GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 13 | 9.70e-01 | -5.98e-03 | 9.96e-01 |
| GOBP VESICLE MEDIATED TRANSPORT IN SYNAPSE | 141 | 9.03e-01 | 5.95e-03 | 9.87e-01 |
| GOBP REGULATION OF HYDROLASE ACTIVITY | 527 | 8.16e-01 | 5.95e-03 | 9.80e-01 |
| GOBP APOPTOTIC PROCESS | 1356 | 7.17e-01 | -5.95e-03 | 9.59e-01 |
| GOBP CELLULAR RESPONSE TO OXIDATIVE STRESS | 199 | 8.85e-01 | 5.93e-03 | 9.86e-01 |
| GOBP POSITIVE REGULATION OF HYDROLASE ACTIVITY | 354 | 8.53e-01 | -5.77e-03 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF NEURON MIGRATION | 16 | 9.68e-01 | 5.75e-03 | 9.96e-01 |
| GOBP B CELL ACTIVATION | 196 | 8.90e-01 | 5.74e-03 | 9.86e-01 |
| GOBP N ACETYLNEURAMINATE METABOLIC PROCESS | 11 | 9.74e-01 | 5.73e-03 | 9.96e-01 |
| GOBP PHENOL CONTAINING COMPOUND METABOLIC PROCESS | 55 | 9.41e-01 | -5.72e-03 | 9.92e-01 |
| GOBP OSTEOCLAST DIFFERENTIATION | 79 | 9.30e-01 | -5.69e-03 | 9.89e-01 |
| GOBP REGULATION OF TRANSMEMBRANE TRANSPORT | 306 | 8.65e-01 | 5.69e-03 | 9.83e-01 |
| GOMF COMPLEMENT BINDING | 10 | 9.75e-01 | 5.69e-03 | 9.96e-01 |
| GOMF FLAP ENDONUCLEASE ACTIVITY | 6 | 9.81e-01 | 5.68e-03 | 9.97e-01 |
| GOBP CEREBRAL CORTEX CELL MIGRATION | 31 | 9.56e-01 | -5.68e-03 | 9.93e-01 |
| GOBP CORONARY ARTERY MORPHOGENESIS | 7 | 9.79e-01 | -5.65e-03 | 9.97e-01 |
| GOBP REGULATION OF ENDOTHELIAL CELL MIGRATION | 107 | 9.20e-01 | 5.63e-03 | 9.88e-01 |
| GOCC NUCLEAR PORE NUCLEAR BASKET | 12 | 9.73e-01 | 5.61e-03 | 9.96e-01 |
| GOBP SKELETAL MUSCLE TISSUE REGENERATION | 26 | 9.61e-01 | 5.57e-03 | 9.94e-01 |
| GOBP CARBOHYDRATE TRANSPORT | 104 | 9.22e-01 | -5.57e-03 | 9.88e-01 |
| GOBP APPENDAGE MORPHOGENESIS | 76 | 9.33e-01 | -5.57e-03 | 9.89e-01 |
| GOCC PERINUCLEAR REGION OF CYTOPLASM | 543 | 8.26e-01 | 5.55e-03 | 9.80e-01 |
| GOBP HYPOTONIC RESPONSE | 10 | 9.76e-01 | 5.54e-03 | 9.96e-01 |
| GOBP REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 134 | 9.12e-01 | -5.53e-03 | 9.88e-01 |
| GOBP SYNAPSE MATURATION | 18 | 9.68e-01 | -5.53e-03 | 9.96e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 332 | 8.63e-01 | -5.53e-03 | 9.83e-01 |
| GOMF RRNA ADENINE METHYLTRANSFERASE ACTIVITY | 7 | 9.80e-01 | 5.48e-03 | 9.97e-01 |
| GOBP FERTILIZATION | 85 | 9.31e-01 | 5.41e-03 | 9.89e-01 |
| GOMF TOLL LIKE RECEPTOR 4 BINDING | 5 | 9.83e-01 | 5.37e-03 | 9.97e-01 |
| GOMF SH2 DOMAIN BINDING | 31 | 9.59e-01 | 5.36e-03 | 9.93e-01 |
| GOBP REGULATION OF MUSCLE CONTRACTION | 91 | 9.30e-01 | -5.36e-03 | 9.89e-01 |
| GOBP CELL AGGREGATION | 6 | 9.82e-01 | 5.35e-03 | 9.97e-01 |
| GOBP PROTEIN HOMOOLIGOMERIZATION | 133 | 9.15e-01 | 5.35e-03 | 9.88e-01 |
| GOBP RESPONSE TO ACIDIC PH | 15 | 9.72e-01 | -5.33e-03 | 9.96e-01 |
| GOBP REGULATION OF HISTONE H3 K4 METHYLATION | 12 | 9.75e-01 | -5.30e-03 | 9.96e-01 |
| GOBP REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 185 | 9.01e-01 | 5.29e-03 | 9.87e-01 |
| GOBP CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN | 99 | 9.28e-01 | -5.28e-03 | 9.88e-01 |
| GOBP CARBOHYDRATE HOMEOSTASIS | 155 | 9.10e-01 | -5.26e-03 | 9.88e-01 |
| GOBP TELOMERE LOCALIZATION | 7 | 9.81e-01 | 5.25e-03 | 9.97e-01 |
| GOBP PLASMA MEMBRANE TO ENDOSOME TRANSPORT | 8 | 9.80e-01 | -5.22e-03 | 9.97e-01 |
| GOBP HISTONE H3 K9 METHYLATION | 5 | 9.84e-01 | -5.21e-03 | 9.97e-01 |
| GOBP POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 5 | 9.84e-01 | 5.18e-03 | 9.97e-01 |
| GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 5 | 9.84e-01 | -5.18e-03 | 9.97e-01 |
| GOCC SIDE OF MEMBRANE | 397 | 8.60e-01 | 5.18e-03 | 9.83e-01 |
| GOBP RESPONSE TO GROWTH FACTOR | 444 | 8.53e-01 | -5.16e-03 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL | 116 | 9.24e-01 | -5.15e-03 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF CATECHOLAMINE SECRETION | 5 | 9.84e-01 | -5.13e-03 | 9.97e-01 |
| GOBP ANTIBACTERIAL HUMORAL RESPONSE | 14 | 9.74e-01 | 5.11e-03 | 9.96e-01 |
| GOMF ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 22 | 9.67e-01 | 5.10e-03 | 9.96e-01 |
| GOBP STRIATED MUSCLE CELL DEVELOPMENT | 39 | 9.56e-01 | 5.08e-03 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY | 45 | 9.53e-01 | 5.06e-03 | 9.93e-01 |
| GOMF IMMUNOGLOBULIN RECEPTOR ACTIVITY | 6 | 9.83e-01 | -5.05e-03 | 9.97e-01 |
| GOBP REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 12 | 9.76e-01 | 5.04e-03 | 9.96e-01 |
| GOMF HISTONE H3 ACETYLTRANSFERASE ACTIVITY | 14 | 9.74e-01 | -5.01e-03 | 9.96e-01 |
| GOBP REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 211 | 9.01e-01 | 4.99e-03 | 9.87e-01 |
| GOBP NEUROMUSCULAR PROCESS | 89 | 9.35e-01 | -4.99e-03 | 9.90e-01 |
| GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 7 | 9.82e-01 | -4.99e-03 | 9.97e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDASE ACTIVITY | 128 | 9.23e-01 | 4.97e-03 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF CHROMOSOME ORGANIZATION | 100 | 9.32e-01 | 4.97e-03 | 9.89e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY | 42 | 9.56e-01 | -4.97e-03 | 9.93e-01 |
| GOBP REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE | 21 | 9.69e-01 | 4.97e-03 | 9.96e-01 |
| GOBP CELL PROJECTION ORGANIZATION | 1064 | 7.87e-01 | 4.97e-03 | 9.76e-01 |
| GOBP REGULATION OF HORMONE LEVELS | 277 | 8.88e-01 | -4.94e-03 | 9.86e-01 |
| GOMF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 64 | 9.46e-01 | 4.91e-03 | 9.93e-01 |
| GOBP REGULATION OF VACUOLE ORGANIZATION | 53 | 9.51e-01 | 4.91e-03 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF MAPK CASCADE | 286 | 8.87e-01 | 4.88e-03 | 9.86e-01 |
| GOCC VACUOLE | 684 | 8.31e-01 | 4.84e-03 | 9.80e-01 |
| GOBP LIPOSACCHARIDE METABOLIC PROCESS | 76 | 9.43e-01 | -4.79e-03 | 9.92e-01 |
| GOCC MULTIVESICULAR BODY | 44 | 9.56e-01 | -4.78e-03 | 9.93e-01 |
| GOBP RESPONSE TO ABIOTIC STIMULUS | 790 | 8.22e-01 | -4.76e-03 | 9.80e-01 |
| GOBP XENOBIOTIC TRANSPORT | 28 | 9.65e-01 | 4.75e-03 | 9.95e-01 |
| GOBP DNA BIOSYNTHETIC PROCESS | 162 | 9.17e-01 | -4.75e-03 | 9.88e-01 |
| GOBP MITOCHONDRIAL CALCIUM ION HOMEOSTASIS | 22 | 9.69e-01 | 4.73e-03 | 9.96e-01 |
| GOMF ATPASE BINDING | 62 | 9.49e-01 | -4.71e-03 | 9.93e-01 |
| GOBP FATTY ACID METABOLIC PROCESS | 264 | 8.97e-01 | -4.65e-03 | 9.86e-01 |
| GOBP SYNAPTIC SIGNALING | 384 | 8.76e-01 | 4.65e-03 | 9.86e-01 |
| GOMF POTASSIUM CHANNEL REGULATOR ACTIVITY | 30 | 9.65e-01 | 4.65e-03 | 9.95e-01 |
| GOBP REGULATION OF LYMPHOCYTE MIGRATION | 49 | 9.55e-01 | -4.65e-03 | 9.93e-01 |
| GOMF SIALIC ACID BINDING | 12 | 9.78e-01 | -4.61e-03 | 9.97e-01 |
| GOBP REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 320 | 8.88e-01 | 4.61e-03 | 9.86e-01 |
| GOBP TONGUE MORPHOGENESIS | 6 | 9.84e-01 | 4.58e-03 | 9.97e-01 |
| GOBP REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 23 | 9.70e-01 | 4.55e-03 | 9.96e-01 |
| GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY | 25 | 9.69e-01 | -4.52e-03 | 9.96e-01 |
| GOBP MEIOSIS I CELL CYCLE PROCESS | 85 | 9.43e-01 | 4.49e-03 | 9.92e-01 |
| GOBP LEUKOTRIENE TRANSPORT | 5 | 9.86e-01 | -4.42e-03 | 9.98e-01 |
| GOBP IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 18 | 9.74e-01 | 4.40e-03 | 9.96e-01 |
| GOBP AXIS SPECIFICATION | 46 | 9.59e-01 | 4.38e-03 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 21 | 9.72e-01 | 4.37e-03 | 9.96e-01 |
| GOBP REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY | 148 | 9.27e-01 | -4.35e-03 | 9.88e-01 |
| GOBP PALLIUM DEVELOPMENT | 120 | 9.35e-01 | -4.31e-03 | 9.90e-01 |
| GOBP ROOF OF MOUTH DEVELOPMENT | 46 | 9.60e-01 | 4.26e-03 | 9.94e-01 |
| GOBP HORMONE BIOSYNTHETIC PROCESS | 35 | 9.65e-01 | 4.26e-03 | 9.95e-01 |
| GOBP NEGATIVE REGULATION OF CATABOLIC PROCESS | 276 | 9.04e-01 | 4.25e-03 | 9.87e-01 |
| GOCC GLUTAMATERGIC SYNAPSE | 262 | 9.06e-01 | -4.24e-03 | 9.88e-01 |
| GOMF CAMP DEPENDENT PROTEIN KINASE INHIBITOR ACTIVITY | 9 | 9.82e-01 | -4.23e-03 | 9.97e-01 |
| GOMF NUCLEOSIDE BINDING | 7 | 9.85e-01 | -4.23e-03 | 9.97e-01 |
| GOCC TRAPP COMPLEX | 15 | 9.78e-01 | -4.20e-03 | 9.97e-01 |
| GOBP POSITIVE REGULATION OF GROWTH | 151 | 9.29e-01 | 4.19e-03 | 9.88e-01 |
| GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 351 | 8.94e-01 | 4.17e-03 | 9.86e-01 |
| GOBP SYNAPTIC VESICLE TRANSPORT | 35 | 9.66e-01 | -4.14e-03 | 9.96e-01 |
| GOCC HISTONE METHYLTRANSFERASE COMPLEX | 61 | 9.56e-01 | -4.11e-03 | 9.93e-01 |
| GOCC CELL PROJECTION MEMBRANE | 229 | 9.15e-01 | -4.10e-03 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT | 11 | 9.81e-01 | 4.10e-03 | 9.97e-01 |
| GOBP VASCULAR PROCESS IN CIRCULATORY SYSTEM | 139 | 9.34e-01 | -4.09e-03 | 9.90e-01 |
| GOBP PROTEIN DEACETYLATION | 51 | 9.60e-01 | -4.08e-03 | 9.94e-01 |
| GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 87 | 9.48e-01 | 4.05e-03 | 9.93e-01 |
| GOBP DIGESTIVE SYSTEM DEVELOPMENT | 63 | 9.56e-01 | 4.02e-03 | 9.93e-01 |
| GOBP T CELL APOPTOTIC PROCESS | 42 | 9.64e-01 | -4.01e-03 | 9.95e-01 |
| GOBP HEMATOPOIETIC STEM CELL DIFFERENTIATION | 30 | 9.70e-01 | 3.95e-03 | 9.96e-01 |
| GOBP LOCOMOTION | 764 | 8.54e-01 | 3.94e-03 | 9.82e-01 |
| GOBP PROSTANOID METABOLIC PROCESS | 31 | 9.70e-01 | 3.92e-03 | 9.96e-01 |
| GOBP DOSAGE COMPENSATION | 30 | 9.70e-01 | -3.92e-03 | 9.96e-01 |
| GOBP REGULATION OF NEURON PROJECTION DEVELOPMENT | 285 | 9.10e-01 | 3.91e-03 | 9.88e-01 |
| GOBP ORGANIC HYDROXY COMPOUND METABOLIC PROCESS | 346 | 9.02e-01 | -3.88e-03 | 9.87e-01 |
| GOBP PROTEOLYSIS | 1184 | 8.25e-01 | -3.86e-03 | 9.80e-01 |
| GOBP REPRODUCTION | 834 | 8.52e-01 | 3.83e-03 | 9.82e-01 |
| GOBP POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 107 | 9.46e-01 | 3.83e-03 | 9.93e-01 |
| GOBP CENTRAL NERVOUS SYSTEM DEVELOPMENT | 603 | 8.74e-01 | 3.80e-03 | 9.85e-01 |
| GOMF TRANSMEMBRANE TRANSPORTER BINDING | 90 | 9.50e-01 | 3.80e-03 | 9.93e-01 |
| GOBP REGULATION OF ORGANELLE ASSEMBLY | 214 | 9.24e-01 | -3.79e-03 | 9.88e-01 |
| GOCC PLASMA MEMBRANE REGION | 747 | 8.62e-01 | -3.77e-03 | 9.83e-01 |
| GOBP IMPORT INTO CELL | 615 | 8.74e-01 | 3.76e-03 | 9.85e-01 |
| GOBP PRIMARY AMINO COMPOUND METABOLIC PROCESS | 8 | 9.85e-01 | 3.74e-03 | 9.98e-01 |
| GOBP RIBONUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 9 | 9.85e-01 | -3.72e-03 | 9.97e-01 |
| GOBP POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION | 14 | 9.81e-01 | 3.69e-03 | 9.97e-01 |
| GOMF 14 3 3 PROTEIN BINDING | 29 | 9.73e-01 | 3.66e-03 | 9.96e-01 |
| GOBP PROLINE TRANSPORT | 7 | 9.87e-01 | -3.63e-03 | 9.98e-01 |
| GOBP INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 17 | 9.79e-01 | -3.60e-03 | 9.97e-01 |
| GOBP ESTABLISHMENT OR MAINTENANCE OF CYTOSKELETON POLARITY | 6 | 9.88e-01 | -3.59e-03 | 9.98e-01 |
| GOBP POSITIVE REGULATION OF PROTEOLYSIS | 278 | 9.18e-01 | 3.58e-03 | 9.88e-01 |
| GOBP NEGATIVE REGULATION OF GTPASE ACTIVITY | 16 | 9.80e-01 | -3.57e-03 | 9.97e-01 |
| GOBP POSITIVE REGULATION OF INTRACELLULAR TRANSPORT | 173 | 9.36e-01 | 3.53e-03 | 9.90e-01 |
| GOBP HEART MORPHOGENESIS | 136 | 9.44e-01 | -3.51e-03 | 9.92e-01 |
| GOBP REGULATION OF MUSCLE CELL DIFFERENTIATION | 91 | 9.54e-01 | -3.48e-03 | 9.93e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN | 100 | 9.52e-01 | 3.47e-03 | 9.93e-01 |
| GOBP LYSOSOMAL MICROAUTOPHAGY | 13 | 9.83e-01 | -3.45e-03 | 9.97e-01 |
| GOBP POSITIVE REGULATION OF B CELL PROLIFERATION | 33 | 9.73e-01 | 3.43e-03 | 9.96e-01 |
| GOCC CULLIN RING UBIQUITIN LIGASE COMPLEX | 158 | 9.42e-01 | -3.39e-03 | 9.92e-01 |
| GOMF RNA POLYMERASE II SPECIFIC DNA BINDING TRANSCRIPTION FACTOR BINDING | 266 | 9.25e-01 | 3.38e-03 | 9.88e-01 |
| GOBP POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 103 | 9.53e-01 | 3.34e-03 | 9.93e-01 |
| GOCC FIBRILLAR CENTER | 127 | 9.48e-01 | 3.33e-03 | 9.93e-01 |
| GOBP RESPONSE TO TRANSFORMING GROWTH FACTOR BETA | 193 | 9.37e-01 | -3.32e-03 | 9.91e-01 |
| GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION | 11 | 9.85e-01 | 3.32e-03 | 9.97e-01 |
| GOBP RIBONUCLEOTIDE CATABOLIC PROCESS | 41 | 9.71e-01 | 3.31e-03 | 9.96e-01 |
| GOBP MRNA POLYADENYLATION | 23 | 9.78e-01 | 3.30e-03 | 9.97e-01 |
| GOBP AMINO SUGAR METABOLIC PROCESS | 33 | 9.74e-01 | 3.30e-03 | 9.96e-01 |
| GOBP AMP SALVAGE | 5 | 9.90e-01 | -3.28e-03 | 9.99e-01 |
| GOBP ORGAN INDUCTION | 8 | 9.87e-01 | -3.27e-03 | 9.98e-01 |
| GOBP PURINE NUCLEOTIDE SALVAGE | 10 | 9.86e-01 | 3.27e-03 | 9.98e-01 |
| GOMF METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 220 | 9.35e-01 | -3.21e-03 | 9.90e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 78 | 9.61e-01 | 3.18e-03 | 9.94e-01 |
| GOBP ACTIVATION OF PROTEIN KINASE B ACTIVITY | 15 | 9.83e-01 | -3.17e-03 | 9.97e-01 |
| GOBP NEGATIVE REGULATION OF CELL GROWTH | 129 | 9.51e-01 | 3.15e-03 | 9.93e-01 |
| GOBP REGULATION OF LEUKOCYTE CHEMOTAXIS | 82 | 9.61e-01 | 3.12e-03 | 9.94e-01 |
| GOMF DIPEPTIDYL PEPTIDASE ACTIVITY | 7 | 9.89e-01 | 3.12e-03 | 9.98e-01 |
| GOCC DESMOSOME | 13 | 9.84e-01 | -3.11e-03 | 9.97e-01 |
| GOBP CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 28 | 9.78e-01 | 3.06e-03 | 9.97e-01 |
| GOBP INORGANIC ANION TRANSPORT | 82 | 9.62e-01 | 3.03e-03 | 9.94e-01 |
| GOCC STRIATED MUSCLE THIN FILAMENT | 11 | 9.86e-01 | -3.01e-03 | 9.98e-01 |
| GOBP AMEBOIDAL TYPE CELL MIGRATION | 273 | 9.32e-01 | 3.00e-03 | 9.89e-01 |
| GOBP REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 201 | 9.42e-01 | -3.00e-03 | 9.92e-01 |
| GOMF ACTIN MONOMER BINDING | 20 | 9.82e-01 | -2.99e-03 | 9.97e-01 |
| GOBP MACROPHAGE MIGRATION | 39 | 9.74e-01 | -2.99e-03 | 9.96e-01 |
| GOBP ORGANOPHOSPHATE ESTER TRANSPORT | 115 | 9.56e-01 | -2.97e-03 | 9.93e-01 |
| GOCC CELL CORTEX | 221 | 9.40e-01 | 2.97e-03 | 9.92e-01 |
| GOMF DYNEIN LIGHT INTERMEDIATE CHAIN BINDING | 23 | 9.81e-01 | -2.94e-03 | 9.97e-01 |
| GOBP NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 34 | 9.76e-01 | 2.93e-03 | 9.96e-01 |
| GOMF CLATHRIN BINDING | 47 | 9.72e-01 | -2.92e-03 | 9.96e-01 |
| GOBP REGULATION OF ORGANELLE ORGANIZATION | 960 | 8.80e-01 | -2.92e-03 | 9.86e-01 |
| GOMF MODIFICATION DEPENDENT PROTEIN BINDING | 168 | 9.48e-01 | 2.91e-03 | 9.93e-01 |
| GOBP REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 8 | 9.89e-01 | 2.91e-03 | 9.98e-01 |
| GOBP PLASMA MEMBRANE ORGANIZATION | 113 | 9.58e-01 | -2.90e-03 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS | 360 | 9.25e-01 | -2.89e-03 | 9.88e-01 |
| GOBP CELLULAR RESPONSE TO STRESS | 1591 | 8.54e-01 | 2.82e-03 | 9.82e-01 |
| GOCC EXTRINSIC COMPONENT OF ENDOSOME MEMBRANE | 5 | 9.91e-01 | 2.80e-03 | 9.99e-01 |
| GOBP CELL CYCLE G1 S PHASE TRANSITION | 212 | 9.45e-01 | 2.78e-03 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF MOLECULAR FUNCTION | 512 | 9.15e-01 | 2.77e-03 | 9.88e-01 |
| GOCC GERM CELL NUCLEUS | 46 | 9.74e-01 | 2.77e-03 | 9.96e-01 |
| GOBP VERY LONG CHAIN FATTY ACID CATABOLIC PROCESS | 6 | 9.91e-01 | -2.75e-03 | 9.99e-01 |
| GOBP RESPONSE TO MONOSACCHARIDE | 129 | 9.57e-01 | -2.75e-03 | 9.93e-01 |
| GOBP GOLGI TO VACUOLE TRANSPORT | 19 | 9.83e-01 | 2.74e-03 | 9.97e-01 |
| GOCC AUTOPHAGOSOME MEMBRANE | 46 | 9.75e-01 | -2.69e-03 | 9.96e-01 |
| GOMF ADRENERGIC RECEPTOR BINDING | 11 | 9.88e-01 | -2.64e-03 | 9.98e-01 |
| GOBP RECEPTOR CLUSTERING | 39 | 9.78e-01 | 2.60e-03 | 9.97e-01 |
| GOBP EPITHELIAL CELL MATURATION | 15 | 9.86e-01 | 2.58e-03 | 9.98e-01 |
| GOBP RAP PROTEIN SIGNAL TRANSDUCTION | 12 | 9.88e-01 | -2.52e-03 | 9.98e-01 |
| GOMF CARBOXY LYASE ACTIVITY | 23 | 9.83e-01 | 2.52e-03 | 9.97e-01 |
| GOBP REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 88 | 9.68e-01 | -2.50e-03 | 9.96e-01 |
| GOBP RNA SPLICING | 402 | 9.32e-01 | -2.50e-03 | 9.89e-01 |
| GOBP RESPONSE TO PH | 22 | 9.84e-01 | 2.50e-03 | 9.97e-01 |
| GOBP LENS DEVELOPMENT IN CAMERA TYPE EYE | 42 | 9.78e-01 | 2.49e-03 | 9.97e-01 |
| GOBP VESICLE LOCALIZATION | 181 | 9.54e-01 | 2.49e-03 | 9.93e-01 |
| GOBP SEQUESTERING OF TRIGLYCERIDE | 14 | 9.87e-01 | 2.48e-03 | 9.98e-01 |
| GOBP REGULATION OF DEPHOSPHORYLATION | 85 | 9.69e-01 | -2.47e-03 | 9.96e-01 |
| GOBP REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 8 | 9.90e-01 | 2.46e-03 | 9.99e-01 |
| GOBP VASOCONSTRICTION | 38 | 9.79e-01 | 2.45e-03 | 9.97e-01 |
| GOMF PRE MRNA BINDING | 31 | 9.81e-01 | -2.43e-03 | 9.97e-01 |
| GOBP GOLGI RIBBON FORMATION | 9 | 9.90e-01 | -2.42e-03 | 9.99e-01 |
| GOBP FAS SIGNALING PATHWAY | 6 | 9.92e-01 | -2.42e-03 | 9.99e-01 |
| GOBP ANATOMICAL STRUCTURE ARRANGEMENT | 9 | 9.90e-01 | -2.39e-03 | 9.99e-01 |
| GOBP REGULATION OF CELLULAR RESPIRATION | 39 | 9.79e-01 | 2.39e-03 | 9.97e-01 |
| GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY | 5 | 9.93e-01 | -2.38e-03 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO OXYGEN RADICAL | 14 | 9.88e-01 | -2.37e-03 | 9.98e-01 |
| GOBP ISOPRENOID BIOSYNTHETIC PROCESS | 23 | 9.84e-01 | 2.37e-03 | 9.97e-01 |
| GOBP NEGATIVE REGULATION OF VITAMIN METABOLIC PROCESS | 5 | 9.93e-01 | 2.33e-03 | 9.99e-01 |
| GOBP TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 241 | 9.51e-01 | 2.30e-03 | 9.93e-01 |
| GOBP REGULATION OF POSTSYNAPTIC DENSITY ASSEMBLY | 5 | 9.93e-01 | -2.30e-03 | 9.99e-01 |
| GOMF TRANSCRIPTION FACTOR BINDING | 477 | 9.32e-01 | -2.29e-03 | 9.89e-01 |
| GOCC SPLICEOSOMAL COMPLEX | 189 | 9.57e-01 | -2.28e-03 | 9.93e-01 |
| GOBP REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 195 | 9.56e-01 | 2.27e-03 | 9.93e-01 |
| GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY | 94 | 9.70e-01 | 2.24e-03 | 9.96e-01 |
| GOBP CELL JUNCTION ORGANIZATION | 432 | 9.38e-01 | -2.21e-03 | 9.91e-01 |
| GOBP ORGANELLE ASSEMBLY | 793 | 9.17e-01 | 2.21e-03 | 9.88e-01 |
| GOBP ER NUCLEUS SIGNALING PATHWAY | 43 | 9.80e-01 | -2.18e-03 | 9.97e-01 |
| GOBP DOLICHYL DIPHOSPHATE METABOLIC PROCESS | 5 | 9.93e-01 | -2.14e-03 | 9.99e-01 |
| GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 23 | 9.86e-01 | 2.13e-03 | 9.98e-01 |
| GOMF SERINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 35 | 9.83e-01 | 2.05e-03 | 9.97e-01 |
| GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE BINDING | 8 | 9.92e-01 | -2.00e-03 | 9.99e-01 |
| GOMF CATALYTIC ACTIVITY ACTING ON A GLYCOPROTEIN | 14 | 9.90e-01 | 1.98e-03 | 9.99e-01 |
| GOBP AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 45 | 9.82e-01 | 1.98e-03 | 9.97e-01 |
| GOBP NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY | 18 | 9.88e-01 | 1.97e-03 | 9.98e-01 |
| GOBP DNA DAMAGE RESPONSE | 782 | 9.26e-01 | 1.97e-03 | 9.88e-01 |
| GOBP PROTEIN CONTAINING COMPLEX REMODELING | 19 | 9.88e-01 | 1.96e-03 | 9.98e-01 |
| GOBP VASCULAR ENDOTHELIAL CELL PROLIFERATION | 18 | 9.89e-01 | -1.94e-03 | 9.98e-01 |
| GOBP MUSCLE CELL PROLIFERATION | 122 | 9.71e-01 | 1.93e-03 | 9.96e-01 |
| GOCC WNT SIGNALOSOME | 9 | 9.92e-01 | 1.87e-03 | 9.99e-01 |
| GOBP RESPONSE TO OXYGEN LEVELS | 232 | 9.63e-01 | 1.79e-03 | 9.94e-01 |
| GOBP CELL CYCLE G2 M PHASE TRANSITION | 140 | 9.71e-01 | 1.78e-03 | 9.96e-01 |
| GOBP REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 150 | 9.71e-01 | 1.72e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 9.92e-01 | -1.72e-03 | 9.99e-01 |
| GOBP REGULATION OF KETONE BIOSYNTHETIC PROCESS | 14 | 9.91e-01 | 1.71e-03 | 9.99e-01 |
| GOBP FEMALE SEX DIFFERENTIATION | 67 | 9.81e-01 | 1.71e-03 | 9.97e-01 |
| GOBP NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 413 | 9.53e-01 | -1.70e-03 | 9.93e-01 |
| GOBP NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS | 675 | 9.43e-01 | -1.63e-03 | 9.92e-01 |
| GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT | 65 | 9.82e-01 | -1.62e-03 | 9.97e-01 |
| GOMF CHROMO SHADOW DOMAIN BINDING | 6 | 9.95e-01 | -1.56e-03 | 9.99e-01 |
| GOBP INTRACELLULAR PROTEIN TRANSPORT | 756 | 9.42e-01 | 1.56e-03 | 9.92e-01 |
| GOBP FRUCTOSE METABOLIC PROCESS | 10 | 9.93e-01 | -1.56e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 25 | 9.89e-01 | 1.55e-03 | 9.99e-01 |
| GOBP REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 33 | 9.88e-01 | -1.55e-03 | 9.98e-01 |
| GOMF VOLTAGE GATED SODIUM CHANNEL ACTIVITY | 8 | 9.94e-01 | 1.54e-03 | 9.99e-01 |
| GOBP REGULATION OF OSTEOBLAST PROLIFERATION | 13 | 9.93e-01 | 1.49e-03 | 9.99e-01 |
| GOMF TRNA BINDING | 66 | 9.84e-01 | 1.43e-03 | 9.97e-01 |
| GOMF TRNA SPECIFIC RIBONUCLEASE ACTIVITY | 15 | 9.92e-01 | -1.40e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 6 | 9.95e-01 | -1.37e-03 | 9.99e-01 |
| GOBP REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 11 | 9.94e-01 | 1.36e-03 | 9.99e-01 |
| GOCC RNA POLYMERASE COMPLEX | 96 | 9.82e-01 | 1.36e-03 | 9.97e-01 |
| GOBP POSITIVE REGULATION OF MYELINATION | 11 | 9.94e-01 | -1.35e-03 | 9.99e-01 |
| GOBP DIGESTIVE SYSTEM PROCESS | 44 | 9.88e-01 | -1.33e-03 | 9.98e-01 |
| GOBP REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS | 7 | 9.95e-01 | -1.32e-03 | 9.99e-01 |
| GOBP NEURAL PLATE PATTERN SPECIFICATION | 5 | 9.96e-01 | 1.32e-03 | 9.99e-01 |
| GOBP ORGANONITROGEN COMPOUND CATABOLIC PROCESS | 1083 | 9.42e-01 | -1.31e-03 | 9.92e-01 |
| GOBP HEMATOPOIETIC STEM CELL HOMEOSTASIS | 15 | 9.93e-01 | 1.31e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF CELL DIVISION | 58 | 9.86e-01 | 1.31e-03 | 9.98e-01 |
| GOCC POSTSYNAPTIC MEMBRANE | 115 | 9.81e-01 | -1.28e-03 | 9.97e-01 |
| GOMF VERY LONG CHAIN FATTY ACID COA LIGASE ACTIVITY | 7 | 9.95e-01 | 1.27e-03 | 9.99e-01 |
| GOBP CELLULAR RESPONSE TO GLUCOSE STARVATION | 42 | 9.89e-01 | 1.26e-03 | 9.98e-01 |
| GOBP MEMBRANE ORGANIZATION | 648 | 9.57e-01 | -1.26e-03 | 9.93e-01 |
| GOBP VIRION ASSEMBLY | 33 | 9.90e-01 | -1.26e-03 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF BMP SIGNALING PATHWAY | 20 | 9.92e-01 | 1.22e-03 | 9.99e-01 |
| GOCC EXTRINSIC COMPONENT OF PLASMA MEMBRANE | 71 | 9.86e-01 | 1.22e-03 | 9.98e-01 |
| GOCC POST MRNA RELEASE SPLICEOSOMAL COMPLEX | 9 | 9.95e-01 | 1.20e-03 | 9.99e-01 |
| GOMF UBIQUITIN LIKE PROTEIN BINDING | 118 | 9.82e-01 | 1.19e-03 | 9.97e-01 |
| GOMF COPPER ION BINDING | 35 | 9.90e-01 | 1.17e-03 | 9.99e-01 |
| GOBP RESPONSE TO ESTRADIOL | 67 | 9.87e-01 | 1.16e-03 | 9.98e-01 |
| GOBP PRO B CELL DIFFERENTIATION | 10 | 9.95e-01 | -1.15e-03 | 9.99e-01 |
| GOBP PROTEIN LOCALIZATION TO ORGANELLE | 814 | 9.56e-01 | 1.14e-03 | 9.93e-01 |
| GOBP TRANSLATIONAL ELONGATION | 61 | 9.88e-01 | -1.14e-03 | 9.98e-01 |
| GOBP MELANOCYTE DIFFERENTIATION | 12 | 9.95e-01 | -1.12e-03 | 9.99e-01 |
| GOMF CARBOHYDRATE PHOSPHATASE ACTIVITY | 6 | 9.96e-01 | -1.12e-03 | 9.99e-01 |
| GOBP SUBTELOMERIC HETEROCHROMATIN FORMATION | 7 | 9.96e-01 | -1.11e-03 | 9.99e-01 |
| GOBP REGULATION OF KERATINOCYTE MIGRATION | 9 | 9.95e-01 | 1.09e-03 | 9.99e-01 |
| GOBP REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 226 | 9.78e-01 | 1.08e-03 | 9.97e-01 |
| GOBP SPLEEN DEVELOPMENT | 26 | 9.92e-01 | 1.08e-03 | 9.99e-01 |
| GOBP MYELOID DENDRITIC CELL ACTIVATION | 19 | 9.94e-01 | -1.07e-03 | 9.99e-01 |
| GOBP APOPTOTIC SIGNALING PATHWAY | 473 | 9.69e-01 | -1.05e-03 | 9.96e-01 |
| GOBP POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION | 9 | 9.96e-01 | -1.03e-03 | 9.99e-01 |
| GOBP VESICLE TARGETING ROUGH ER TO CIS GOLGI | 25 | 9.94e-01 | -9.37e-04 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF BLOOD PRESSURE | 21 | 9.94e-01 | 9.14e-04 | 9.99e-01 |
| GOMF CYCLASE REGULATOR ACTIVITY | 8 | 9.96e-01 | -9.09e-04 | 9.99e-01 |
| GOBP CELLULAR LIPID CATABOLIC PROCESS | 161 | 9.84e-01 | 9.02e-04 | 9.97e-01 |
| GOMF CALCIUM DEPENDENT PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY | 7 | 9.97e-01 | -8.88e-04 | 9.99e-01 |
| GOBP SYNAPTIC VESICLE PRIMING | 11 | 9.96e-01 | -8.78e-04 | 9.99e-01 |
| GOBP RESPONSE TO LEUKEMIA INHIBITORY FACTOR | 74 | 9.90e-01 | 8.78e-04 | 9.99e-01 |
| GOBP AMYLOID BETA METABOLIC PROCESS | 43 | 9.92e-01 | 8.72e-04 | 9.99e-01 |
| GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION | 13 | 9.96e-01 | 8.24e-04 | 9.99e-01 |
| GOBP BLOOD VESSEL MORPHOGENESIS | 365 | 9.79e-01 | -8.06e-04 | 9.97e-01 |
| GOBP REGULATION OF NEUROGENESIS | 228 | 9.84e-01 | 7.95e-04 | 9.97e-01 |
| GOBP HEAD DEVELOPMENT | 465 | 9.77e-01 | 7.90e-04 | 9.97e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION | 14 | 9.96e-01 | 7.84e-04 | 9.99e-01 |
| GOBP REGULATION OF MITOTIC SPINDLE ASSEMBLY | 22 | 9.95e-01 | -7.76e-04 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN POLYMERIZATION | 64 | 9.92e-01 | -7.26e-04 | 9.99e-01 |
| GOBP INTRACELLULAR GLUCOSE HOMEOSTASIS | 96 | 9.90e-01 | 7.18e-04 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF ORGANELLE ORGANIZATION | 297 | 9.84e-01 | 6.70e-04 | 9.97e-01 |
| GOBP STORE OPERATED CALCIUM ENTRY | 16 | 9.96e-01 | 6.61e-04 | 9.99e-01 |
| GOMF CYTOSKELETAL PROTEIN BINDING | 730 | 9.76e-01 | 6.51e-04 | 9.96e-01 |
| GOBP NUCLEOSOME ORGANIZATION | 59 | 9.93e-01 | 6.39e-04 | 9.99e-01 |
| GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS | 52 | 9.94e-01 | -6.35e-04 | 9.99e-01 |
| GOCC HIGH DENSITY LIPOPROTEIN PARTICLE | 14 | 9.97e-01 | 6.24e-04 | 9.99e-01 |
| GOBP POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 968 | 9.74e-01 | -6.22e-04 | 9.96e-01 |
| GOBP PLATELET ACTIVATION | 88 | 9.92e-01 | -6.18e-04 | 9.99e-01 |
| GOBP CDP CHOLINE PATHWAY | 6 | 9.98e-01 | 6.17e-04 | 1.00e+00 |
| GOMF PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 227 | 9.87e-01 | -6.09e-04 | 9.98e-01 |
| GOBP SEXUAL REPRODUCTION | 608 | 9.80e-01 | -5.93e-04 | 9.97e-01 |
| GOMF STEROID BINDING | 63 | 9.94e-01 | 5.88e-04 | 9.99e-01 |
| GOBP DNA METABOLIC PROCESS | 878 | 9.79e-01 | 5.37e-04 | 9.97e-01 |
| GOBP REGULATION OF TRANSPORT | 1099 | 9.77e-01 | 5.22e-04 | 9.97e-01 |
| GOBP REGULATION OF PROTEIN POLYMERIZATION | 152 | 9.92e-01 | -4.64e-04 | 9.99e-01 |
| GOBP VASCULATURE DEVELOPMENT | 450 | 9.88e-01 | 4.17e-04 | 9.98e-01 |
| GOBP NEUROGENESIS | 1031 | 9.82e-01 | 4.14e-04 | 9.97e-01 |
| GOMF G PROTEIN COUPLED GLUTAMATE RECEPTOR BINDING | 6 | 9.99e-01 | -3.97e-04 | 1.00e+00 |
| GOMF VOLTAGE GATED CHANNEL ACTIVITY | 82 | 9.95e-01 | -3.94e-04 | 9.99e-01 |
| GOBP HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING | 11 | 9.98e-01 | -3.85e-04 | 1.00e+00 |
| GOBP POSTSYNAPTIC MEMBRANE ORGANIZATION | 23 | 9.98e-01 | 3.57e-04 | 1.00e+00 |
| GOBP ARGININE CATABOLIC PROCESS | 6 | 9.99e-01 | 3.30e-04 | 1.00e+00 |
| GOCC INO80 COMPLEX | 15 | 9.98e-01 | 2.91e-04 | 1.00e+00 |
| GOBP GLYCOSYLATION | 166 | 9.95e-01 | -2.91e-04 | 9.99e-01 |
| GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION | 10 | 9.99e-01 | 2.51e-04 | 1.00e+00 |
| GOCC MALE GERM CELL NUCLEUS | 37 | 9.98e-01 | -2.40e-04 | 1.00e+00 |
| GOBP SENSORY PERCEPTION OF BITTER TASTE | 6 | 9.99e-01 | 2.20e-04 | 1.00e+00 |
| GOBP REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 12 | 9.99e-01 | -1.98e-04 | 1.00e+00 |
| GOCC PHOTORECEPTOR INNER SEGMENT | 35 | 9.98e-01 | -1.93e-04 | 1.00e+00 |
| GOBP CELLULAR RESPONSE TO INTERFERON ALPHA | 7 | 9.99e-01 | -1.89e-04 | 1.00e+00 |
| GOBP CELLULAR RESPONSE TO CHEMICAL STRESS | 248 | 9.96e-01 | -1.85e-04 | 9.99e-01 |
| GOBP OVULATION CYCLE PROCESS | 24 | 9.99e-01 | -1.32e-04 | 1.00e+00 |
| GOCC SPECIFIC GRANULE LUMEN | 44 | 9.99e-01 | 8.43e-05 | 1.00e+00 |
| GOBP PROTEIN LOCALIZATION TO GOLGI APPARATUS | 27 | 9.99e-01 | 7.35e-05 | 1.00e+00 |
| GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT | 7 | 1.00e+00 | 3.78e-05 | 1.00e+00 |
| GOBP RECEPTOR INTERNALIZATION | 85 | 1.00e+00 | 3.44e-05 | 1.00e+00 |
| GOBP POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 121 | 1.00e+00 | 1.54e-05 | 1.00e+00 |
| GOBP FOLIC ACID METABOLIC PROCESS | 15 | 1.00e+00 | 0.00e+00 | 1.00e+00 |
Detailed Gene set reports
GOMF TAP BINDING
| set | GOMF TAP BINDING |
| setSize | 7 |
| pANOVA | 8.9e-06 |
| s.dist | 0.969 |
| p.adjustANOVA | 0.00109 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HLA-C | 7324 |
| HLA-F | 7300 |
| TAP1 | 7281 |
| HLA-B | 7274 |
| TAP2 | 7146 |
| HLA-A | 7094 |
| TAPBP | 6928 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HLA-C | 7324 |
| HLA-F | 7300 |
| TAP1 | 7281 |
| HLA-B | 7274 |
| TAP2 | 7146 |
| HLA-A | 7094 |
| TAPBP | 6928 |
GOBP POSITIVE REGULATION OF PYROPTOSIS
| set | GOBP POSITIVE REGULATION OF PYROPTOSIS |
| setSize | 5 |
| pANOVA | 0.00157 |
| s.dist | 0.816 |
| p.adjustANOVA | 0.0613 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| GBP1 | 7359 |
| GBP3 | 7319 |
| GBP5 | 7318 |
| GBP2 | 6817 |
| CASP3 | 1357 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| GBP1 | 7359 |
| GBP3 | 7319 |
| GBP5 | 7318 |
| GBP2 | 6817 |
| CASP3 | 1357 |
GOCC MHC CLASS I PROTEIN COMPLEX
| set | GOCC MHC CLASS I PROTEIN COMPLEX |
| setSize | 9 |
| pANOVA | 2.49e-05 |
| s.dist | 0.811 |
| p.adjustANOVA | 0.00249 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HLA-C | 7324 |
| HLA-F | 7300 |
| HLA-B | 7274 |
| B2M | 7263 |
| HLA-E | 7217 |
| HLA-A | 7094 |
| MR1 | 4622 |
| HFE | 3817 |
| HLA-G | 2058 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HLA-C | 7324 |
| HLA-F | 7300 |
| HLA-B | 7274 |
| B2M | 7263 |
| HLA-E | 7217 |
| HLA-A | 7094 |
| MR1 | 4622 |
| HFE | 3817 |
| HLA-G | 2058 |
GOBP CYTOLYSIS
| set | GOBP CYTOLYSIS |
| setSize | 5 |
| pANOVA | 0.00195 |
| s.dist | 0.8 |
| p.adjustANOVA | 0.0724 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| GBP1 | 7359 |
| GBP3 | 7319 |
| GBP5 | 7318 |
| GBP2 | 6817 |
| CAMP | 743 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| GBP1 | 7359 |
| GBP3 | 7319 |
| GBP5 | 7318 |
| GBP2 | 6817 |
| CAMP | 743 |
GOMF STRUCTURAL CONSTITUENT OF EYE LENS
| set | GOMF STRUCTURAL CONSTITUENT OF EYE LENS |
| setSize | 5 |
| pANOVA | 0.00201 |
| s.dist | -0.798 |
| p.adjustANOVA | 0.0744 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CPOX | -7358 |
| VIM | -6952 |
| CRYGS | -6601 |
| CRYBB1 | -5133 |
| CRYBG3 | -4822 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CPOX | -7358 |
| VIM | -6952 |
| CRYGS | -6601 |
| CRYBB1 | -5133 |
| CRYBG3 | -4822 |
GOMF PYRUVATE DEHYDROGENASE ACETYL TRANSFERRING KINASE ACTIVITY
| set | GOMF PYRUVATE DEHYDROGENASE ACETYL TRANSFERRING KINASE ACTIVITY |
| setSize | 5 |
| pANOVA | 0.00218 |
| s.dist | -0.791 |
| p.adjustANOVA | 0.0785 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PDK1 | -6954 |
| PDK3 | -6586 |
| PDK4 | -6158 |
| PDK2 | -5558 |
| BCKDK | -5381 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PDK1 | -6954 |
| PDK3 | -6586 |
| PDK4 | -6158 |
| PDK2 | -5558 |
| BCKDK | -5381 |
GOCC STEREOCILIUM BASE
| set | GOCC STEREOCILIUM BASE |
| setSize | 5 |
| pANOVA | 0.00234 |
| s.dist | -0.786 |
| p.adjustANOVA | 0.082 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PJVK | -7383 |
| TPRN | -7276 |
| GRXCR2 | -6749 |
| MYO7A | -6695 |
| TRIOBP | -2322 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PJVK | -7383 |
| TPRN | -7276 |
| GRXCR2 | -6749 |
| MYO7A | -6695 |
| TRIOBP | -2322 |
GOBP MODULATION OF MICROTUBULE CYTOSKELETON INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION
| set | GOBP MODULATION OF MICROTUBULE CYTOSKELETON INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION |
| setSize | 5 |
| pANOVA | 0.00241 |
| s.dist | 0.784 |
| p.adjustANOVA | 0.0833 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SRGAP2 | 7218 |
| SYNE2 | 7162 |
| SUN2 | 6867 |
| SRGAP2C | 6665 |
| SUN1 | 1031 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SRGAP2 | 7218 |
| SYNE2 | 7162 |
| SUN2 | 6867 |
| SRGAP2C | 6665 |
| SUN1 | 1031 |
GOBP RESPONSE TO MOLECULE OF FUNGAL ORIGIN
| set | GOBP RESPONSE TO MOLECULE OF FUNGAL ORIGIN |
| setSize | 5 |
| pANOVA | 0.00325 |
| s.dist | 0.76 |
| p.adjustANOVA | 0.104 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MYD88 | 7297 |
| SCIMP | 7132 |
| BTK | 6767 |
| SYK | 6197 |
| CLEC7A | 655 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| MYD88 | 7297 |
| SCIMP | 7132 |
| BTK | 6767 |
| SYK | 6197 |
| CLEC7A | 655 |
GOCC EKC KEOPS COMPLEX
| set | GOCC EKC KEOPS COMPLEX |
| setSize | 5 |
| pANOVA | 0.00326 |
| s.dist | -0.76 |
| p.adjustANOVA | 0.104 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TP53RK | -7374 |
| LAGE3 | -6859 |
| OSGEP | -5238 |
| GON7 | -5231 |
| TPRKB | -4739 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| TP53RK | -7374 |
| LAGE3 | -6859 |
| OSGEP | -5238 |
| GON7 | -5231 |
| TPRKB | -4739 |
GOMF CCR1 CHEMOKINE RECEPTOR BINDING
| set | GOMF CCR1 CHEMOKINE RECEPTOR BINDING |
| setSize | 5 |
| pANOVA | 0.00374 |
| s.dist | -0.749 |
| p.adjustANOVA | 0.114 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CCL7 | -7703 |
| CCL4 | -7697 |
| CCL23 | -7603 |
| CCL5 | -3824 |
| CCL3 | -2189 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CCL7 | -7703 |
| CCL4 | -7697 |
| CCL23 | -7603 |
| CCL5 | -3824 |
| CCL3 | -2189 |
GOBP REGULATION OF NATURAL KILLER CELL CHEMOTAXIS
| set | GOBP REGULATION OF NATURAL KILLER CELL CHEMOTAXIS |
| setSize | 5 |
| pANOVA | 0.00386 |
| s.dist | -0.746 |
| p.adjustANOVA | 0.115 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CCL7 | -7703 |
| CCL4 | -7697 |
| CCL2 | -7510 |
| CCL5 | -3824 |
| CCL3 | -2189 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CCL7 | -7703 |
| CCL4 | -7697 |
| CCL2 | -7510 |
| CCL5 | -3824 |
| CCL3 | -2189 |
GOBP REGULATION OF ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE
| set | GOBP REGULATION OF ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE |
| setSize | 8 |
| pANOVA | 0.000351 |
| s.dist | 0.73 |
| p.adjustANOVA | 0.0197 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| BIRC5 | 7298 |
| KAT2B | 6912 |
| AURKB | 6645 |
| INCENP | 6564 |
| KAT5 | 5329 |
| HNRNPU | 5198 |
| CDCA8 | 3079 |
| BECN1 | 2008 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| BIRC5 | 7298 |
| KAT2B | 6912 |
| AURKB | 6645 |
| INCENP | 6564 |
| KAT5 | 5329 |
| HNRNPU | 5198 |
| CDCA8 | 3079 |
| BECN1 | 2008 |
GOMF NEUROPEPTIDE RECEPTOR ACTIVITY
| set | GOMF NEUROPEPTIDE RECEPTOR ACTIVITY |
| setSize | 5 |
| pANOVA | 0.00534 |
| s.dist | -0.719 |
| p.adjustANOVA | 0.137 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SORCS1 | -7594 |
| TACR1 | -6219 |
| GAL | -5831 |
| OPRM1 | -5823 |
| SSTR2 | -2442 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SORCS1 | -7594 |
| TACR1 | -6219 |
| GAL | -5831 |
| OPRM1 | -5823 |
| SSTR2 | -2442 |
GOBP INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY
| set | GOBP INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY |
| setSize | 7 |
| pANOVA | 0.00112 |
| s.dist | 0.711 |
| p.adjustANOVA | 0.0474 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| OAS1 | 7422 |
| OAS2 | 7421 |
| STAT1 | 7404 |
| OASL | 7389 |
| MX1 | 7375 |
| IL6ST | 98 |
| IL27RA | -432 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| OAS1 | 7422 |
| OAS2 | 7421 |
| STAT1 | 7404 |
| OASL | 7389 |
| MX1 | 7375 |
| IL6ST | 98 |
| IL27RA | -432 |
GOBP ISG15 PROTEIN CONJUGATION
| set | GOBP ISG15 PROTEIN CONJUGATION |
| setSize | 6 |
| pANOVA | 0.00268 |
| s.dist | 0.708 |
| p.adjustANOVA | 0.0895 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ISG15 | 7417 |
| HERC5 | 7382 |
| UBE2L6 | 7340 |
| UBA7 | 6698 |
| UBE2E1 | 1732 |
| UBE2E2 | 714 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ISG15 | 7417 |
| HERC5 | 7382 |
| UBE2L6 | 7340 |
| UBA7 | 6698 |
| UBE2E1 | 1732 |
| UBE2E2 | 714 |
GOMF OXALATE TRANSMEMBRANE TRANSPORTER ACTIVITY
| set | GOMF OXALATE TRANSMEMBRANE TRANSPORTER ACTIVITY |
| setSize | 5 |
| pANOVA | 0.00644 |
| s.dist | -0.704 |
| p.adjustANOVA | 0.153 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SLC26A6 | -7384 |
| SLC26A3 | -5950 |
| SLC26A2 | -5904 |
| SLC26A8 | -5791 |
| SLC26A5 | -2282 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SLC26A6 | -7384 |
| SLC26A3 | -5950 |
| SLC26A2 | -5904 |
| SLC26A8 | -5791 |
| SLC26A5 | -2282 |
GOMF CXCR CHEMOKINE RECEPTOR BINDING
| set | GOMF CXCR CHEMOKINE RECEPTOR BINDING |
| setSize | 6 |
| pANOVA | 0.00335 |
| s.dist | -0.692 |
| p.adjustANOVA | 0.106 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PPBP | -7706 |
| CXCL3 | -7579 |
| CXCL2 | -7139 |
| CXCL10 | -6363 |
| CXCL8 | -5805 |
| ITCH | 2363 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PPBP | -7706 |
| CXCL3 | -7579 |
| CXCL2 | -7139 |
| CXCL10 | -6363 |
| CXCL8 | -5805 |
| ITCH | 2363 |
GOBP UREA CYCLE
| set | GOBP UREA CYCLE |
| setSize | 5 |
| pANOVA | 0.008 |
| s.dist | -0.685 |
| p.adjustANOVA | 0.176 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ASL | -7388 |
| SLC25A15 | -6526 |
| ARG2 | -6034 |
| CEBPA | -4257 |
| AGMAT | -2399 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ASL | -7388 |
| SLC25A15 | -6526 |
| ARG2 | -6034 |
| CEBPA | -4257 |
| AGMAT | -2399 |
GOBP UREA METABOLIC PROCESS
| set | GOBP UREA METABOLIC PROCESS |
| setSize | 5 |
| pANOVA | 0.008 |
| s.dist | -0.685 |
| p.adjustANOVA | 0.176 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| ASL | -7388 |
| SLC25A15 | -6526 |
| ARG2 | -6034 |
| CEBPA | -4257 |
| AGMAT | -2399 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| ASL | -7388 |
| SLC25A15 | -6526 |
| ARG2 | -6034 |
| CEBPA | -4257 |
| AGMAT | -2399 |
GOCC RIPOPTOSOME
| set | GOCC RIPOPTOSOME |
| setSize | 6 |
| pANOVA | 0.00378 |
| s.dist | 0.683 |
| p.adjustANOVA | 0.114 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CASP10 | 7190 |
| CASP8 | 7181 |
| TICAM1 | 5817 |
| CFLAR | 5377 |
| FADD | 3241 |
| RIPK1 | 1336 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CASP10 | 7190 |
| CASP8 | 7181 |
| TICAM1 | 5817 |
| CFLAR | 5377 |
| FADD | 3241 |
| RIPK1 | 1336 |
GOMF NADPLUS PROTEIN CYSTEINE ADP RIBOSYLTRANSFERASE ACTIVITY
| set | GOMF NADPLUS PROTEIN CYSTEINE ADP RIBOSYLTRANSFERASE ACTIVITY |
| setSize | 6 |
| pANOVA | 0.00383 |
| s.dist | 0.682 |
| p.adjustANOVA | 0.115 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PARP12 | 6975 |
| TIPARP | 6451 |
| PARP6 | 6101 |
| SIRT4 | 5659 |
| PARP8 | 2634 |
| PARP11 | 2279 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PARP12 | 6975 |
| TIPARP | 6451 |
| PARP6 | 6101 |
| SIRT4 | 5659 |
| PARP8 | 2634 |
| PARP11 | 2279 |
GOBP REGULATION OF CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION
| set | GOBP REGULATION OF CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION |
| setSize | 5 |
| pANOVA | 0.00867 |
| s.dist | 0.678 |
| p.adjustANOVA | 0.184 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| KLHL25 | 7062 |
| HLA-DRB1 | 5825 |
| HLA-DRA | 4855 |
| LGALS9 | 4323 |
| IL2RG | 2875 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| KLHL25 | 7062 |
| HLA-DRB1 | 5825 |
| HLA-DRA | 4855 |
| LGALS9 | 4323 |
| IL2RG | 2875 |
GOBP PROTECTION FROM NATURAL KILLER CELL MEDIATED CYTOTOXICITY
| set | GOBP PROTECTION FROM NATURAL KILLER CELL MEDIATED CYTOTOXICITY |
| setSize | 5 |
| pANOVA | 0.0091 |
| s.dist | 0.674 |
| p.adjustANOVA | 0.188 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HLA-B | 7274 |
| HLA-E | 7217 |
| HLA-A | 7094 |
| HLA-G | 2058 |
| SERPINB9 | 1133 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HLA-B | 7274 |
| HLA-E | 7217 |
| HLA-A | 7094 |
| HLA-G | 2058 |
| SERPINB9 | 1133 |
GOBP POSITIVE REGULATION OF URINE VOLUME
| set | GOBP POSITIVE REGULATION OF URINE VOLUME |
| setSize | 5 |
| pANOVA | 0.00932 |
| s.dist | -0.671 |
| p.adjustANOVA | 0.19 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| GNAI2 | -6993 |
| INPP5K | -6100 |
| NPR1 | -5809 |
| HYAL2 | -3610 |
| OPRL1 | -3585 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| GNAI2 | -6993 |
| INPP5K | -6100 |
| NPR1 | -5809 |
| HYAL2 | -3610 |
| OPRL1 | -3585 |
GOBP REGULATION OF 3 UTR MEDIATED MRNA STABILIZATION
| set | GOBP REGULATION OF 3 UTR MEDIATED MRNA STABILIZATION |
| setSize | 5 |
| pANOVA | 0.00984 |
| s.dist | 0.667 |
| p.adjustANOVA | 0.196 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| METTL16 | 6673 |
| ELAVL4 | 6525 |
| TENT4B | 5521 |
| LARP4B | 3277 |
| TENT4A | 2518 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| METTL16 | 6673 |
| ELAVL4 | 6525 |
| TENT4B | 5521 |
| LARP4B | 3277 |
| TENT4A | 2518 |
GOBP REGULATION OF FLAGELLATED SPERM MOTILITY
| set | GOBP REGULATION OF FLAGELLATED SPERM MOTILITY |
| setSize | 5 |
| pANOVA | 0.0102 |
| s.dist | -0.663 |
| p.adjustANOVA | 0.202 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TAC4 | -7289 |
| KIF9 | -6615 |
| TACR1 | -6219 |
| CFAP206 | -4724 |
| PGAM4 | -937 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| TAC4 | -7289 |
| KIF9 | -6615 |
| TACR1 | -6219 |
| CFAP206 | -4724 |
| PGAM4 | -937 |
GOBP REGULATION OF SKELETAL MUSCLE SATELLITE CELL PROLIFERATION
| set | GOBP REGULATION OF SKELETAL MUSCLE SATELLITE CELL PROLIFERATION |
| setSize | 6 |
| pANOVA | 0.005 |
| s.dist | 0.662 |
| p.adjustANOVA | 0.132 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| EPHB1 | 6999 |
| PAXBP1 | 6362 |
| JAK2 | 6329 |
| CFLAR | 5377 |
| PPARD | 4047 |
| AKIRIN1 | 78 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| EPHB1 | 6999 |
| PAXBP1 | 6362 |
| JAK2 | 6329 |
| CFLAR | 5377 |
| PPARD | 4047 |
| AKIRIN1 | 78 |
GOBP GOLGI DISASSEMBLY
| set | GOBP GOLGI DISASSEMBLY |
| setSize | 6 |
| pANOVA | 0.00521 |
| s.dist | 0.659 |
| p.adjustANOVA | 0.135 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CDK1 | 7253 |
| PLK3 | 7202 |
| GOLGA2 | 6132 |
| STX5 | 4319 |
| VRK1 | 3928 |
| GBF1 | 219 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CDK1 | 7253 |
| PLK3 | 7202 |
| GOLGA2 | 6132 |
| STX5 | 4319 |
| VRK1 | 3928 |
| GBF1 | 219 |
GOCC CYTOSOLIC SMALL RIBOSOMAL SUBUNIT
| set | GOCC CYTOSOLIC SMALL RIBOSOMAL SUBUNIT |
| setSize | 38 |
| pANOVA | 2.44e-12 |
| s.dist | -0.657 |
| p.adjustANOVA | 2.12e-09 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPS6 | -7637 |
| RPS17 | -7599 |
| RACK1 | -7553 |
| RPS5 | -7501 |
| RPS21 | -7471 |
| RPS11 | -7421 |
| RPS27A | -7369 |
| RPS3A | -7177 |
| RPS3 | -7029 |
| RPS18 | -6854 |
| RPS12 | -6844 |
| RPS20 | -6678 |
| RPS14 | -6620 |
| RPS25 | -6604 |
| RPS24 | -6417 |
| RPS23 | -6366 |
| RPS13 | -6346 |
| RPS7 | -6145 |
| RPS2 | -6007 |
| RPS8 | -5864 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| RPS6 | -7637 |
| RPS17 | -7599 |
| RACK1 | -7553 |
| RPS5 | -7501 |
| RPS21 | -7471 |
| RPS11 | -7421 |
| RPS27A | -7369 |
| RPS3A | -7177 |
| RPS3 | -7029 |
| RPS18 | -6854 |
| RPS12 | -6844 |
| RPS20 | -6678 |
| RPS14 | -6620 |
| RPS25 | -6604 |
| RPS24 | -6417 |
| RPS23 | -6366 |
| RPS13 | -6346 |
| RPS7 | -6145 |
| RPS2 | -6007 |
| RPS8 | -5864 |
| RPS15A | -5544 |
| UBA52 | -5489 |
| DHX29 | -5212 |
| RPS28 | -4868 |
| RPSA | -4834 |
| RPS16 | -4163 |
| RPS29 | -4056 |
| RPS27 | -4023 |
| RPS9 | -3048 |
| RPS15 | -2973 |
| RPS4X | -2759 |
| FAU | -2421 |
| RPS19 | -1755 |
| RPS10 | -1689 |
| RPS26 | -1674 |
| RPS27L | -1141 |
| RPS4Y1 | -626 |
| EIF2A | 123 |
GOBP REGULATION OF ACYL COA BIOSYNTHETIC PROCESS
| set | GOBP REGULATION OF ACYL COA BIOSYNTHETIC PROCESS |
| setSize | 5 |
| pANOVA | 0.0111 |
| s.dist | -0.656 |
| p.adjustANOVA | 0.212 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PDK1 | -6954 |
| PDK3 | -6586 |
| PDK4 | -6158 |
| PDK2 | -5558 |
| SNCA | -260 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PDK1 | -6954 |
| PDK3 | -6586 |
| PDK4 | -6158 |
| PDK2 | -5558 |
| SNCA | -260 |
GOBP ZINC ION IMPORT ACROSS PLASMA MEMBRANE
| set | GOBP ZINC ION IMPORT ACROSS PLASMA MEMBRANE |
| setSize | 8 |
| pANOVA | 0.00138 |
| s.dist | -0.653 |
| p.adjustANOVA | 0.0547 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| SLC39A8 | -7665 |
| SLC39A14 | -7604 |
| SLC39A6 | -6746 |
| SLC39A12 | -6354 |
| SLC39A10 | -6165 |
| SLC30A1 | -5874 |
| SLC39A4 | -5813 |
| SLC39A11 | 5581 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| SLC39A8 | -7665 |
| SLC39A14 | -7604 |
| SLC39A6 | -6746 |
| SLC39A12 | -6354 |
| SLC39A10 | -6165 |
| SLC30A1 | -5874 |
| SLC39A4 | -5813 |
| SLC39A11 | 5581 |
GOBP CYTIDINE TO URIDINE EDITING
| set | GOBP CYTIDINE TO URIDINE EDITING |
| setSize | 7 |
| pANOVA | 0.00284 |
| s.dist | 0.651 |
| p.adjustANOVA | 0.0937 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| APOBEC3G | 7291 |
| APOBEC3A | 7113 |
| APOBEC3H | 6185 |
| APOBEC3D | 5998 |
| RBM47 | 5744 |
| APOBEC3C | 2618 |
| APOBEC3F | -1443 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| APOBEC3G | 7291 |
| APOBEC3A | 7113 |
| APOBEC3H | 6185 |
| APOBEC3D | 5998 |
| RBM47 | 5744 |
| APOBEC3C | 2618 |
| APOBEC3F | -1443 |
GOCC CD95 DEATH INDUCING SIGNALING COMPLEX
| set | GOCC CD95 DEATH INDUCING SIGNALING COMPLEX |
| setSize | 6 |
| pANOVA | 0.00607 |
| s.dist | 0.647 |
| p.adjustANOVA | 0.147 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CASP10 | 7190 |
| CASP8 | 7181 |
| CFLAR | 5377 |
| FAS | 3595 |
| FADD | 3241 |
| FAF1 | 1936 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CASP10 | 7190 |
| CASP8 | 7181 |
| CFLAR | 5377 |
| FAS | 3595 |
| FADD | 3241 |
| FAF1 | 1936 |
GOBP 5 PHOSPHORIBOSE 1 DIPHOSPHATE METABOLIC PROCESS
| set | GOBP 5 PHOSPHORIBOSE 1 DIPHOSPHATE METABOLIC PROCESS |
| setSize | 5 |
| pANOVA | 0.0127 |
| s.dist | -0.644 |
| p.adjustANOVA | 0.233 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| PRPSAP2 | -7417 |
| PRPS1 | -6828 |
| PRPS2 | -6593 |
| PRPSAP1 | -4064 |
| PYGL | -144 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| PRPSAP2 | -7417 |
| PRPS1 | -6828 |
| PRPS2 | -6593 |
| PRPSAP1 | -4064 |
| PYGL | -144 |
GOCC CYTOSOLIC LARGE RIBOSOMAL SUBUNIT
| set | GOCC CYTOSOLIC LARGE RIBOSOMAL SUBUNIT |
| setSize | 55 |
| pANOVA | 2.57e-16 |
| s.dist | -0.638 |
| p.adjustANOVA | 3.18e-13 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| RPLP0 | -7676 |
| RPLP1 | -7642 |
| RPL10 | -7453 |
| RPL23 | -7426 |
| RPL7 | -7286 |
| RPL7A | -7173 |
| RPL14 | -7143 |
| RPL5 | -7090 |
| RPL24 | -7019 |
| RPL4 | -6946 |
| RPL27 | -6833 |
| RPLP2 | -6827 |
| RPL22 | -6785 |
| RPL35A | -6579 |
| RPL8 | -6577 |
| RPL10A | -6559 |
| RPL41 | -6485 |
| RPL13 | -6471 |
| RPL34 | -6433 |
| RPL18 | -6359 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| RPLP0 | -7676 |
| RPLP1 | -7642 |
| RPL10 | -7453 |
| RPL23 | -7426 |
| RPL7 | -7286 |
| RPL7A | -7173 |
| RPL14 | -7143 |
| RPL5 | -7090 |
| RPL24 | -7019 |
| RPL4 | -6946 |
| RPL27 | -6833 |
| RPLP2 | -6827 |
| RPL22 | -6785 |
| RPL35A | -6579 |
| RPL8 | -6577 |
| RPL10A | -6559 |
| RPL41 | -6485 |
| RPL13 | -6471 |
| RPL34 | -6433 |
| RPL18 | -6359 |
| RPL6 | -6266 |
| RPL37A | -6163 |
| RPL9 | -6140 |
| RPL3 | -6082 |
| RPL26 | -5796 |
| RPL13A | -5773 |
| RPL27A | -5766 |
| RPL38 | -5728 |
| RPL32 | -5511 |
| UBA52 | -5489 |
| RPL15 | -5319 |
| RPL36AL | -5194 |
| RPL18A | -4931 |
| RPL28 | -4920 |
| RPL21 | -4891 |
| RPL30 | -4823 |
| RPL23A | -4769 |
| RPL11 | -4706 |
| RPL37 | -4629 |
| RPL12 | -4425 |
| RPL19 | -4417 |
| RPL31 | -4214 |
| RPL36 | -3986 |
| RSL1D1 | -3899 |
| RPL7L1 | -3553 |
| RPL17 | -3463 |
| RPL39 | -3382 |
| RPL29 | -3031 |
| RPL35 | -2688 |
| RPL36A | -2434 |
| ZCCHC17 | -1022 |
| SNU13 | -388 |
| NHP2 | -18 |
| RPL26L1 | 3523 |
| RPL39L | 6667 |
GOBP REGULATION OF NATURAL KILLER CELL DIFFERENTIATION
| set | GOBP REGULATION OF NATURAL KILLER CELL DIFFERENTIATION |
| setSize | 9 |
| pANOVA | 0.00104 |
| s.dist | 0.631 |
| p.adjustANOVA | 0.0453 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| IL15 | 7283 |
| PRDM1 | 7007 |
| STAT5B | 6570 |
| IL15RA | 6017 |
| ZBTB1 | 4441 |
| GAS6 | 3249 |
| RASGRP1 | 3127 |
| AXL | 2843 |
| TOX | 1157 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| IL15 | 7283 |
| PRDM1 | 7007 |
| STAT5B | 6570 |
| IL15RA | 6017 |
| ZBTB1 | 4441 |
| GAS6 | 3249 |
| RASGRP1 | 3127 |
| AXL | 2843 |
| TOX | 1157 |
GOBP POSITIVE REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE
| set | GOBP POSITIVE REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE |
| setSize | 11 |
| pANOVA | 0.000294 |
| s.dist | 0.63 |
| p.adjustANOVA | 0.0175 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| BIRC5 | 7298 |
| KAT2B | 6912 |
| AURKB | 6645 |
| INCENP | 6564 |
| CCNB1 | 6383 |
| KAT5 | 5329 |
| HNRNPU | 5198 |
| CDCA8 | 3079 |
| BECN1 | 2008 |
| RCC2 | 1915 |
| SIRT2 | -438 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| BIRC5 | 7298 |
| KAT2B | 6912 |
| AURKB | 6645 |
| INCENP | 6564 |
| CCNB1 | 6383 |
| KAT5 | 5329 |
| HNRNPU | 5198 |
| CDCA8 | 3079 |
| BECN1 | 2008 |
| RCC2 | 1915 |
| SIRT2 | -438 |
GOCC MHC PROTEIN COMPLEX
| set | GOCC MHC PROTEIN COMPLEX |
| setSize | 21 |
| pANOVA | 5.91e-07 |
| s.dist | 0.629 |
| p.adjustANOVA | 0.000112 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HLA-C | 7324 |
| HLA-F | 7300 |
| HLA-B | 7274 |
| B2M | 7263 |
| HLA-E | 7217 |
| HLA-A | 7094 |
| HLA-DRB1 | 5825 |
| HLA-DPB1 | 5664 |
| HLA-DPA1 | 5571 |
| HLA-DMA | 5019 |
| HLA-DRA | 4855 |
| HLA-DQB1 | 4762 |
| MR1 | 4622 |
| CD74 | 4351 |
| HFE | 3817 |
| HLA-DOB | 2557 |
| HLA-DMB | 2498 |
| HLA-DQA1 | 2230 |
| HLA-G | 2058 |
| HLA-DRB5 | 1321 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HLA-C | 7324 |
| HLA-F | 7300 |
| HLA-B | 7274 |
| B2M | 7263 |
| HLA-E | 7217 |
| HLA-A | 7094 |
| HLA-DRB1 | 5825 |
| HLA-DPB1 | 5664 |
| HLA-DPA1 | 5571 |
| HLA-DMA | 5019 |
| HLA-DRA | 4855 |
| HLA-DQB1 | 4762 |
| MR1 | 4622 |
| CD74 | 4351 |
| HFE | 3817 |
| HLA-DOB | 2557 |
| HLA-DMB | 2498 |
| HLA-DQA1 | 2230 |
| HLA-G | 2058 |
| HLA-DRB5 | 1321 |
| HLA-DOA | -1670 |
GOBP DNA CYTOSINE DEAMINATION
| set | GOBP DNA CYTOSINE DEAMINATION |
| setSize | 7 |
| pANOVA | 0.00405 |
| s.dist | 0.627 |
| p.adjustANOVA | 0.118 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| APOBEC3G | 7291 |
| APOBEC3A | 7113 |
| APOBEC3H | 6185 |
| APOBEC3D | 5998 |
| CDADC1 | 4469 |
| APOBEC3C | 2618 |
| APOBEC3F | -1443 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| APOBEC3G | 7291 |
| APOBEC3A | 7113 |
| APOBEC3H | 6185 |
| APOBEC3D | 5998 |
| CDADC1 | 4469 |
| APOBEC3C | 2618 |
| APOBEC3F | -1443 |
GOMF DEOXYCYTIDINE DEAMINASE ACTIVITY
| set | GOMF DEOXYCYTIDINE DEAMINASE ACTIVITY |
| setSize | 7 |
| pANOVA | 0.00429 |
| s.dist | 0.623 |
| p.adjustANOVA | 0.122 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| APOBEC3G | 7291 |
| APOBEC3A | 7113 |
| APOBEC3H | 6185 |
| APOBEC3D | 5998 |
| CDA | 4263 |
| APOBEC3C | 2618 |
| APOBEC3F | -1443 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| APOBEC3G | 7291 |
| APOBEC3A | 7113 |
| APOBEC3H | 6185 |
| APOBEC3D | 5998 |
| CDA | 4263 |
| APOBEC3C | 2618 |
| APOBEC3F | -1443 |
GOBP CYTIDINE METABOLIC PROCESS
| set | GOBP CYTIDINE METABOLIC PROCESS |
| setSize | 8 |
| pANOVA | 0.00233 |
| s.dist | 0.622 |
| p.adjustANOVA | 0.0819 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| APOBEC3G | 7291 |
| APOBEC3A | 7113 |
| APOBEC3H | 6185 |
| APOBEC3D | 5998 |
| CDADC1 | 4469 |
| CDA | 4263 |
| APOBEC3C | 2618 |
| APOBEC3F | -1443 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| APOBEC3G | 7291 |
| APOBEC3A | 7113 |
| APOBEC3H | 6185 |
| APOBEC3D | 5998 |
| CDADC1 | 4469 |
| CDA | 4263 |
| APOBEC3C | 2618 |
| APOBEC3F | -1443 |
GOMF CYTIDINE DEAMINASE ACTIVITY
| set | GOMF CYTIDINE DEAMINASE ACTIVITY |
| setSize | 8 |
| pANOVA | 0.00233 |
| s.dist | 0.622 |
| p.adjustANOVA | 0.0819 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| APOBEC3G | 7291 |
| APOBEC3A | 7113 |
| APOBEC3H | 6185 |
| APOBEC3D | 5998 |
| CDADC1 | 4469 |
| CDA | 4263 |
| APOBEC3C | 2618 |
| APOBEC3F | -1443 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| APOBEC3G | 7291 |
| APOBEC3A | 7113 |
| APOBEC3H | 6185 |
| APOBEC3D | 5998 |
| CDADC1 | 4469 |
| CDA | 4263 |
| APOBEC3C | 2618 |
| APOBEC3F | -1443 |
GOCC KNL1 SPC105 COMPLEX
| set | GOCC KNL1 SPC105 COMPLEX |
| setSize | 5 |
| pANOVA | 0.0163 |
| s.dist | 0.62 |
| p.adjustANOVA | 0.272 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| NUF2 | 6763 |
| SPC25 | 6637 |
| NDC80 | 5754 |
| KNL1 | 5262 |
| ZWINT | -1656 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| NUF2 | 6763 |
| SPC25 | 6637 |
| NDC80 | 5754 |
| KNL1 | 5262 |
| ZWINT | -1656 |
GOMF BETA N ACETYLHEXOSAMINIDASE ACTIVITY
| set | GOMF BETA N ACETYLHEXOSAMINIDASE ACTIVITY |
| setSize | 5 |
| pANOVA | 0.0168 |
| s.dist | 0.617 |
| p.adjustANOVA | 0.272 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| OGA | 5781 |
| HEXA | 5605 |
| HEXD | 4969 |
| GM2A | 3418 |
| HEXB | 2873 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| OGA | 5781 |
| HEXA | 5605 |
| HEXD | 4969 |
| GM2A | 3418 |
| HEXB | 2873 |
GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN
| set | GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN |
| setSize | 19 |
| pANOVA | 3.26e-06 |
| s.dist | 0.617 |
| p.adjustANOVA | 0.000506 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| HLA-C | 7324 |
| HLA-F | 7300 |
| TAP1 | 7281 |
| HLA-B | 7274 |
| B2M | 7263 |
| HLA-E | 7217 |
| TAP2 | 7146 |
| HLA-A | 7094 |
| TAPBP | 6928 |
| HLA-DRB1 | 5825 |
| MICB | 5615 |
| HLA-DRA | 4855 |
| ERAP1 | 4318 |
| IDE | 4229 |
| HFE | 3817 |
| HLA-G | 2058 |
| ERAP2 | -194 |
| ULBP2 | -2582 |
| MICA | -6883 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| HLA-C | 7324 |
| HLA-F | 7300 |
| TAP1 | 7281 |
| HLA-B | 7274 |
| B2M | 7263 |
| HLA-E | 7217 |
| TAP2 | 7146 |
| HLA-A | 7094 |
| TAPBP | 6928 |
| HLA-DRB1 | 5825 |
| MICB | 5615 |
| HLA-DRA | 4855 |
| ERAP1 | 4318 |
| IDE | 4229 |
| HFE | 3817 |
| HLA-G | 2058 |
| ERAP2 | -194 |
| ULBP2 | -2582 |
| MICA | -6883 |
GOBP INNER DYNEIN ARM ASSEMBLY
| set | GOBP INNER DYNEIN ARM ASSEMBLY |
| setSize | 6 |
| pANOVA | 0.00922 |
| s.dist | -0.614 |
| p.adjustANOVA | 0.189 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| CCDC40 | -7078 |
| DNAAF2 | -6403 |
| DNAAF4 | -6274 |
| DNAAF5 | -4673 |
| DNAH1 | -4575 |
| DNAH7 | 304 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| CCDC40 | -7078 |
| DNAAF2 | -6403 |
| DNAAF4 | -6274 |
| DNAAF5 | -4673 |
| DNAH1 | -4575 |
| DNAH7 | 304 |
GOCC MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX III
| set | GOCC MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX III |
| setSize | 13 |
| pANOVA | 0.000148 |
| s.dist | -0.608 |
| p.adjustANOVA | 0.0104 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| MT-CO1 | -7474 |
| UQCRHL | -7444 |
| UQCRH | -7300 |
| UQCRC1 | -6446 |
| MT-CYB | -6025 |
| UQCRQ | -5999 |
| UQCRB | -5868 |
| CYC1 | -5651 |
| UQCR11 | -4388 |
| UQCRC2 | -3932 |
| UQCRFS1 | -1246 |
| UQCR10 | -1042 |
| BCS1L | 1245 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| MT-CO1 | -7474 |
| UQCRHL | -7444 |
| UQCRH | -7300 |
| UQCRC1 | -6446 |
| MT-CYB | -6025 |
| UQCRQ | -5999 |
| UQCRB | -5868 |
| CYC1 | -5651 |
| UQCR11 | -4388 |
| UQCRC2 | -3932 |
| UQCRFS1 | -1246 |
| UQCR10 | -1042 |
| BCS1L | 1245 |
GOMF ARMADILLO REPEAT DOMAIN BINDING
| set | GOMF ARMADILLO REPEAT DOMAIN BINDING |
| setSize | 7 |
| pANOVA | 0.00558 |
| s.dist | 0.605 |
| p.adjustANOVA | 0.139 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| TCF7L2 | 6903 |
| STRN4 | 6847 |
| STRN3 | 6092 |
| AXIN1 | 4481 |
| CTNNBIP1 | 3854 |
| STRN | 1453 |
| CNOT1 | 1416 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| TCF7L2 | 6903 |
| STRN4 | 6847 |
| STRN3 | 6092 |
| AXIN1 | 4481 |
| CTNNBIP1 | 3854 |
| STRN | 1453 |
| CNOT1 | 1416 |
GOBP MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C
| set | GOBP MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C |
| setSize | 13 |
| pANOVA | 0.000178 |
| s.dist | -0.6 |
| p.adjustANOVA | 0.012 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| UQCRHL | -7444 |
| UQCRH | -7300 |
| UQCRC1 | -6446 |
| MT-CYB | -6025 |
| UQCRQ | -5999 |
| UQCRB | -5868 |
| CYC1 | -5651 |
| UQCR11 | -4388 |
| UQCRC2 | -3932 |
| UQCC3 | -3384 |
| CYCS | -2110 |
| UQCRFS1 | -1246 |
| UQCR10 | -1042 |
Click HERE to show all gene set members
| GeneID | Gene Rank |
|---|---|
| UQCRHL | -7444 |
| UQCRH | -7300 |
| UQCRC1 | -6446 |
| MT-CYB | -6025 |
| UQCRQ | -5999 |
| UQCRB | -5868 |
| CYC1 | -5651 |
| UQCR11 | -4388 |
| UQCRC2 | -3932 |
| UQCC3 | -3384 |
| CYCS | -2110 |
| UQCRFS1 | -1246 |
| UQCR10 | -1042 |
Here is the session info with all the versions of packages used.
sessionInfo()## R version 4.4.1 (2024-06-14)
## Platform: x86_64-pc-linux-gnu
## Running under: Ubuntu 22.04.4 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.10.0
## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.10.0
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## time zone: Australia/Melbourne
## tzcode source: system (glibc)
##
## attached base packages:
## [1] parallel stats4 stats graphics grDevices utils datasets
## [8] methods base
##
## other attached packages:
## [1] pkgload_1.4.0 GGally_2.2.1
## [3] reshape2_1.4.4 gplots_3.1.3.1
## [5] gtools_3.9.5 tibble_3.2.1
## [7] dplyr_1.1.4 echarts4r_0.4.5
## [9] limma_3.60.0 SingleR_2.6.0
## [11] celldex_1.14.0 harmony_1.2.0
## [13] Rcpp_1.0.12 mitch_1.16.0
## [15] DESeq2_1.44.0 muscat_1.18.0
## [17] beeswarm_0.4.0 stringi_1.8.4
## [19] SingleCellExperiment_1.26.0 SummarizedExperiment_1.34.0
## [21] Biobase_2.64.0 GenomicRanges_1.56.0
## [23] GenomeInfoDb_1.40.0 IRanges_2.38.0
## [25] S4Vectors_0.42.0 BiocGenerics_0.50.0
## [27] MatrixGenerics_1.16.0 matrixStats_1.3.0
## [29] hdf5r_1.3.11 Seurat_5.1.0
## [31] SeuratObject_5.0.2 sp_2.1-4
## [33] plyr_1.8.9 ggplot2_3.5.1
## [35] kableExtra_1.4.0
##
## loaded via a namespace (and not attached):
## [1] progress_1.2.3 goftest_1.2-3
## [3] Biostrings_2.72.0 HDF5Array_1.32.0
## [5] vctrs_0.6.5 spatstat.random_3.2-3
## [7] digest_0.6.36 png_0.1-8
## [9] corpcor_1.6.10 shape_1.4.6.1
## [11] gypsum_1.0.1 ggrepel_0.9.5
## [13] deldir_2.0-4 parallelly_1.37.1
## [15] MASS_7.3-61 httpuv_1.6.15
## [17] foreach_1.5.2 withr_3.0.0
## [19] xfun_0.45 survival_3.7-0
## [21] memoise_2.0.1.9000 ggbeeswarm_0.7.2
## [23] systemfonts_1.1.0 zoo_1.8-12
## [25] GlobalOptions_0.1.2 pbapply_1.7-2
## [27] prettyunits_1.2.0 KEGGREST_1.44.0
## [29] promises_1.3.0 httr_1.4.7
## [31] globals_0.16.3 fitdistrplus_1.1-11
## [33] rhdf5filters_1.16.0 rhdf5_2.48.0
## [35] rstudioapi_0.16.0 UCSC.utils_1.0.0
## [37] miniUI_0.1.1.1 generics_0.1.3
## [39] curl_5.2.1 zlibbioc_1.50.0
## [41] ScaledMatrix_1.12.0 polyclip_1.10-6
## [43] GenomeInfoDbData_1.2.12 ExperimentHub_2.12.0
## [45] SparseArray_1.4.3 xtable_1.8-4
## [47] stringr_1.5.1 doParallel_1.0.17
## [49] evaluate_0.24.0 S4Arrays_1.4.0
## [51] BiocFileCache_2.12.0 hms_1.1.3
## [53] irlba_2.3.5.1 colorspace_2.1-0
## [55] filelock_1.0.3 ROCR_1.0-11
## [57] reticulate_1.38.0 spatstat.data_3.1-2
## [59] magrittr_2.0.3 lmtest_0.9-40
## [61] later_1.3.2 viridis_0.6.5
## [63] lattice_0.22-6 spatstat.geom_3.2-9
## [65] future.apply_1.11.2 scattermore_1.2
## [67] scuttle_1.14.0 cowplot_1.1.3
## [69] RcppAnnoy_0.0.22 pillar_1.9.0
## [71] nlme_3.1-165 iterators_1.0.14
## [73] caTools_1.18.2 compiler_4.4.1
## [75] beachmat_2.20.0 RSpectra_0.16-1
## [77] tensor_1.5 minqa_1.2.7
## [79] crayon_1.5.3 abind_1.4-5
## [81] scater_1.32.0 blme_1.0-5
## [83] locfit_1.5-9.10 bit_4.0.5
## [85] codetools_0.2-20 BiocSingular_1.20.0
## [87] bslib_0.7.0 alabaster.ranges_1.4.0
## [89] GetoptLong_1.0.5 plotly_4.10.4
## [91] remaCor_0.0.18 mime_0.12
## [93] splines_4.4.1 circlize_0.4.16
## [95] fastDummies_1.7.3 dbplyr_2.5.0
## [97] sparseMatrixStats_1.16.0 knitr_1.48
## [99] blob_1.2.4 utf8_1.2.4
## [101] clue_0.3-65 BiocVersion_3.19.1
## [103] lme4_1.1-35.3 listenv_0.9.1
## [105] DelayedMatrixStats_1.26.0 Rdpack_2.6
## [107] Matrix_1.7-0 statmod_1.5.0
## [109] svglite_2.1.3 fANCOVA_0.6-1
## [111] pkgconfig_2.0.3 tools_4.4.1
## [113] cachem_1.1.0 RhpcBLASctl_0.23-42
## [115] rbibutils_2.2.16 RSQLite_2.3.7
## [117] viridisLite_0.4.2 DBI_1.2.3
## [119] numDeriv_2016.8-1.1 fastmap_1.2.0
## [121] rmarkdown_2.27 scales_1.3.0
## [123] grid_4.4.1 ica_1.0-3
## [125] broom_1.0.6 AnnotationHub_3.12.0
## [127] sass_0.4.9 patchwork_1.2.0
## [129] BiocManager_1.30.23 ggstats_0.6.0
## [131] dotCall64_1.1-1 RANN_2.6.1
## [133] alabaster.schemas_1.4.0 farver_2.1.2
## [135] aod_1.3.3 mgcv_1.9-1
## [137] yaml_2.3.9 cli_3.6.3
## [139] purrr_1.0.2 leiden_0.4.3.1
## [141] lifecycle_1.0.4 uwot_0.2.2
## [143] glmmTMB_1.1.9 mvtnorm_1.2-5
## [145] backports_1.5.0 BiocParallel_1.38.0
## [147] gtable_0.3.5 rjson_0.2.21
## [149] ggridges_0.5.6 progressr_0.14.0
## [151] jsonlite_1.8.8 edgeR_4.2.0
## [153] RcppHNSW_0.6.0 bitops_1.0-7
## [155] bit64_4.0.5 Rtsne_0.17
## [157] alabaster.matrix_1.4.0 spatstat.utils_3.0-5
## [159] BiocNeighbors_1.22.0 highr_0.11
## [161] jquerylib_0.1.4 alabaster.se_1.4.0
## [163] pbkrtest_0.5.3 lazyeval_0.2.2
## [165] alabaster.base_1.4.1 shiny_1.8.1.1
## [167] htmltools_0.5.8.1 sctransform_0.4.1
## [169] rappdirs_0.3.3 glue_1.7.0
## [171] spam_2.10-0 httr2_1.0.1
## [173] XVector_0.44.0 gridExtra_2.3
## [175] EnvStats_2.8.1 boot_1.3-30
## [177] igraph_2.0.3 variancePartition_1.34.0
## [179] TMB_1.9.11 R6_2.5.1
## [181] tidyr_1.3.1 labeling_0.4.3
## [183] cluster_2.1.6 Rhdf5lib_1.26.0
## [185] nloptr_2.1.1 DelayedArray_0.30.1
## [187] tidyselect_1.2.1 vipor_0.4.7
## [189] xml2_1.3.6 AnnotationDbi_1.66.0
## [191] future_1.33.2 rsvd_1.0.5
## [193] munsell_0.5.1 KernSmooth_2.23-24
## [195] data.table_1.15.4 htmlwidgets_1.6.4
## [197] ComplexHeatmap_2.20.0 RColorBrewer_1.1-3
## [199] rlang_1.1.4 spatstat.sparse_3.1-0
## [201] spatstat.explore_3.2-7 lmerTest_3.1-3
## [203] fansi_1.0.6END of report